0.3289425.9328472.html.plaintext.txt	0	new pathogenic mutation app gene i716v increases relative proportion abeta4243 new pathogenic mutation app gene i716v increases relative proportion beta4243 christopher b eckman12 nitin d mehta13 richard crook13 jordi perez tur13 guy prihar13 eric pfeiffer3 neill graff radford1 paul hinder1 debra yager1 brenda zenk1 lawrence m refolo1 cristian mihail prada1 steven g younkin1 mike hutton13 john hardy13
0.3289425.9328472.html.plaintext.txt	1	1mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa 2department neuroscience case western reserve university cleveland oh 44106 usa 3suncoast gerontology center laboratory departments psychiatry pharmacology neurology biochemistry university south florida tampa fl 33613 usa
0.3289425.9328472.html.plaintext.txt	2	received june 13 1997 revised accepted august 13 1997
0.3289425.9328472.html.plaintext.txt	3	report novel mutation amyloid precursor protein gene app i716v probably leads familial early onset alzheimers disease onset age mid 50s cells transfected cdnas bearing mutation produce abeta1 4243 transfected wild type app effect additive previously reported app v717i mutation thus providing novel approach increasing abeta1 4243 model systems introduction
0.3289425.9328472.html.plaintext.txt	4	report novel mutation amyloid precursor protein gene app i716v probably leads familial early onset alzheimers disease onset age mid 50s cells transfected cdnas bearing mutation produce abeta1 4243 transfected wild type app effect additive previously reported app v717i mutation thus providing novel approach increasing abeta1 4243 model systems introduction
0.3289425.9328472.html.plaintext.txt	5	mutations amyloid precursor protein app cause early onset familial alzheimers disease fad previously identified 1 lead solely ad reported two sites codon 717 double mutation codons 6701 km6701nl review see ref 1 mutations presenilin mutations also lead fad common feature increase concentration abeta ending abeta4243 2 8 report identification novel mutation app associated alzheimer phenotype show results increased extracellular concentration abeta4243 results discussion
0.3289425.9328472.html.plaintext.txt	6	mutations amyloid precursor protein app cause early onset familial alzheimers disease fad previously identified 1 lead solely ad reported two sites codon 717 double mutation codons 6701 km6701nl review see ref 1 mutations presenilin mutations also lead fad common feature increase concentration abeta ending abeta4243 2 8 report identification novel mutation app associated alzheimer phenotype show results increased extracellular concentration abeta4243 results discussion
0.3289425.9328472.html.plaintext.txt	7	report identification new mutation app gene i716v demonstrate mutation also increases relative concentration abeta1 4243 transfected cells plasma providing additional support hypothesis alterations abeta concentration critical early feature development ad demonstrate additive increase relative concentration abeta1 4243 cells transfected constructs containing i716v v717i mutations finding provides novel approach increasing abeta1 4243 concentration model systems
0.3289425.9328472.html.plaintext.txt	8	report identification new mutation app gene i716v demonstrate mutation also increases relative concentration abeta1 4243 transfected cells plasma providing additional support hypothesis alterations abeta concentration critical early feature development ad demonstrate additive increase relative concentration abeta1 4243 cells transfected constructs containing i716v v717i mutations finding provides novel approach increasing abeta1 4243 concentration model systems
0.3289425.9328472.html.plaintext.txt	9	families ad caused app mutations disease onset ages 45 60 years typically onset age mid 50s context family report mean documented onset age 53 years candidate app mutation sequencing revealed mutation changing predicted amino acid codon 716 isoleucine valine mutation likely pathogenic due proximity previously identified v717i mutation previously observed hundreds normal samples others previously sequenced living affected family member wish sampled precluded segregation analysis mutation
0.3289425.9328472.html.plaintext.txt	10	families ad caused app mutations disease onset ages 45 60 years typically onset age mid 50s context family report mean documented onset age 53 years candidate app mutation sequencing revealed mutation changing predicted amino acid codon 716 isoleucine valine mutation likely pathogenic due proximity previously identified v717i mutation previously observed hundreds normal samples others previously sequenced living affected family member wish sampled precluded segregation analysis mutation
0.3289425.9328472.html.plaintext.txt	11	common feature early onset fad linked mutations increase concentration abeta ending abeta4243 determine whether i716v mutation also affected extracellular concentration abeta1 4243 performed transient transfection analysis cho human embryonic kidney hek 293 cells results obtained representative experiment shown table 1 relative wild type vector control i716v mutant cdna caused 30 60 increase proportion abeta1 4243 cell lines examined increase similar effects v717i mutation analyzed parallel series experiments reported previously 3 8 importantly increase absolute concentration abeta1 4243 produced i716v transfected cells observed even absolute concentrations abeta1 40 essentially identical order increase n number statistical analysis account variance transfection efficiency experiments focused subsequent analysis ratio abeta1 4243 abeta1 40 previously shown elevated invariably app v717i presenilin mutations 2 8 ratios obtained three additional independent transient transfections hek 293 cho cells combined ratios obtained experiment table 1 produce figure 1 results demonstrate 2 fold increase ratio abeta1 4243 abeta1 40 compared wild type control p 00026 mann whitney
0.3289425.9328472.html.plaintext.txt	12	common feature early onset fad linked mutations increase concentration abeta ending abeta4243 determine whether i716v mutation also affected extracellular concentration abeta1 4243 performed transient transfection analysis cho human embryonic kidney hek 293 cells results obtained representative experiment shown table 1 relative wild type vector control i716v mutant cdna caused 30 60 increase proportion abeta1 4243 cell lines examined increase similar effects v717i mutation analyzed parallel series experiments reported previously 3 8 importantly increase absolute concentration abeta1 4243 produced i716v transfected cells observed even absolute concentrations abeta1 40 essentially identical order increase n number statistical analysis account variance transfection efficiency experiments focused subsequent analysis ratio abeta1 4243 abeta1 40 previously shown elevated invariably app v717i presenilin mutations 2 8 ratios obtained three additional independent transient transfections hek 293 cho cells combined ratios obtained experiment table 1 produce figure 1 results demonstrate 2 fold increase ratio abeta1 4243 abeta1 40 compared wild type control p 00026 mann whitney
0.3289425.9328472.html.plaintext.txt	13	table 1 effects app mutations abeta concentration 293 cells cho cells abeta1 40
0.3289425.9328472.html.plaintext.txt	14	control plasma n 5 1167 plus minus 114
0.3289425.9328472.html.plaintext.txt	15	data point mean two wells analyzed duplicate expressed pm plus minus standard deviation plasma concentration reported pm plus minus se data show i716v v717i mutations increase proportion abeta1 4243 double mutant i716vv717i increases proportion abeta1 4243 mutant individually ratio shows abeta1 4243abeta1 40 percentage
0.3289425.9328472.html.plaintext.txt	16	data point mean two wells analyzed duplicate expressed pm plus minus standard deviation plasma concentration reported pm plus minus se data show i716v v717i mutations increase proportion abeta1 4243 double mutant i716vv717i increases proportion abeta1 4243 mutant individually ratio shows abeta1 4243abeta1 40 percentage
0.3289425.9328472.html.plaintext.txt	17	figure 1 effect i716v ratio abeta1 4243ab1 40 compiled four independent experiments ratio represents abeta1 4243abeta1 40 expressed percentage
0.3289425.9328472.html.plaintext.txt	18	previously reported elevations plasma abeta4243 concentration patients fad linked mutations 3 availability single living identified carrier i716v mutation precluded depth analysis plasma abeta concentration kindred increase absolute concentration abeta4243 however observed plasma patient compared average concentration five non demented control subjects analyzed parallel table 1 fact individual highest concentration abeta4243 series despite second lowest concentration abeta1 40 thus mutation causes clear increase absolute concentration abeta4243 vivo
0.3289425.9328472.html.plaintext.txt	19	previously reported elevations plasma abeta4243 concentration patients fad linked mutations 3 availability single living identified carrier i716v mutation precluded depth analysis plasma abeta concentration kindred increase absolute concentration abeta4243 however observed plasma patient compared average concentration five non demented control subjects analyzed parallel table 1 fact individual highest concentration abeta4243 series despite second lowest concentration abeta1 40 thus mutation causes clear increase absolute concentration abeta4243 vivo
0.3289425.9328472.html.plaintext.txt	20	thus mutations adjacent residues app i716v v717i result similar increases relative concentration abeta1 4243 due proximity mutations nature amino acid changes interested exploring effect combination mutations abeta42 phenotype address question constructed cdna containing i716v v717i mutations pcdna3 vector analysis cells transiently transfected artificial double mutant construct demonstrated increase ratio abeta1 4243 abeta1 40 compared individual mutation either separately p 002 pooled p 00066 table 1 feature may useful designing constructs maximize abeta1 4243 concentration modeling disease process
0.3289425.9328472.html.plaintext.txt	21	thus mutations adjacent residues app i716v v717i result similar increases relative concentration abeta1 4243 due proximity mutations nature amino acid changes interested exploring effect combination mutations abeta42 phenotype address question constructed cdna containing i716v v717i mutations pcdna3 vector analysis cells transiently transfected artificial double mutant construct demonstrated increase ratio abeta1 4243 abeta1 40 compared individual mutation either separately p 002 pooled p 00066 table 1 feature may useful designing constructs maximize abeta1 4243 concentration modeling disease process
0.3289425.9328472.html.plaintext.txt	22	conclusion results reported extend sites pathogenic app mutations observed five importantly pathogenic mutations continue follow established pattern increase extracellular concentration abeta1 4243 thus results provide support hypothesis alterations concentration abeta play early critical role pathogenesis ad materials methods family ascertainment clinical features
0.3289425.9328472.html.plaintext.txt	23	conclusion results reported extend sites pathogenic app mutations observed five importantly pathogenic mutations continue follow established pattern increase extracellular concentration abeta1 4243 thus results provide support hypothesis alterations concentration abeta play early critical role pathogenesis ad materials methods family ascertainment clinical features
0.3289425.9328472.html.plaintext.txt	24	family identified telephone call professional caregiver research laboratory detailing case family history proband 58 year old right handed woman slowly progressive cognitive difficulty 5 year period history significant head injury rarely drank alcohol
0.3289425.9328472.html.plaintext.txt	25	family identified telephone call professional caregiver research laboratory detailing case family history proband 58 year old right handed woman slowly progressive cognitive difficulty 5 year period history significant head injury rarely drank alcohol
0.3289425.9328472.html.plaintext.txt	26	examination proband preserved social graces mini mental test score 10 30 9 impaired knowledge current events anomia scoring 2960 boston naming test 10 neurological examination otherwise normal scored 39144 dementia rating scale 11 difficulty visual spatial tasks 12 language fluent made semantic substitutions circumlocutions scored 1144 multilingual aphasia examination token test 13 comprehension commands impaired repetition phrases intact recognition memory test 14 scored 5th percentile mri scan showed diffuse cortical atrophy prominent left anterior temporal lobe diagnosis probable ad 15
0.3289425.9328472.html.plaintext.txt	27	examination proband preserved social graces mini mental test score 10 30 9 impaired knowledge current events anomia scoring 2960 boston naming test 10 neurological examination otherwise normal scored 39144 dementia rating scale 11 difficulty visual spatial tasks 12 language fluent made semantic substitutions circumlocutions scored 1144 multilingual aphasia examination token test 13 comprehension commands impaired repetition phrases intact recognition memory test 14 scored 5th percentile mri scan showed diffuse cortical atrophy prominent left anterior temporal lobe diagnosis probable ad 15
0.3289425.9328472.html.plaintext.txt	28	father died heart disease age 80 years mother died probable ad early 60s cognitive problems early 50s sister sibling age 55 years progressive memory difficulty 2 year period maternal grandmother also probable ad uncertain age onset death clinical features age onset slow progression disease preservation social graces reminiscent first family f23 i717v discovered 16 indeed similarity pronounced exon 17 app gene sequenced immediately genetic analysis
0.3289425.9328472.html.plaintext.txt	29	father died heart disease age 80 years mother died probable ad early 60s cognitive problems early 50s sister sibling age 55 years progressive memory difficulty 2 year period maternal grandmother also probable ad uncertain age onset death clinical features age onset slow progression disease preservation social graces reminiscent first family f23 i717v discovered 16 indeed similarity pronounced exon 17 app gene sequenced immediately genetic analysis
0.3289425.9328472.html.plaintext.txt	30	exon 17 app gene sequenced previously described except pharmacia alf automated sequencer used dna sequencing revealed heterozygote g transversion codon 716 changing predicted amino acid sequence isoleucine atc valine gtc resequencing opposite orientation revealed corresponding change change destroys sau3ai enzyme cut site pcr amplification exon 17 flanking intronic primers 17inf 5 cctcatccaaatgtccc 3 17inr 5 ggtaagttgcaatgaat 3 followed restriction digestion sau3ai gives two fragments 256 243 bp normal individuals carriers mutation additional fragment 499 bp corresponds uncut pcr product observed screening change proband confirmed alteration failed find change 50 normals addition exon app gene sequenced group order 500 times without finding changes except cases ad segregating autosomal dominant disorder onset age 50s mutagenesis transfection abeta assay
0.3289425.9328472.html.plaintext.txt	31	exon 17 app gene sequenced previously described except pharmacia alf automated sequencer used dna sequencing revealed heterozygote g transversion codon 716 changing predicted amino acid sequence isoleucine atc valine gtc resequencing opposite orientation revealed corresponding change change destroys sau3ai enzyme cut site pcr amplification exon 17 flanking intronic primers 17inf 5 cctcatccaaatgtccc 3 17inr 5 ggtaagttgcaatgaat 3 followed restriction digestion sau3ai gives two fragments 256 243 bp normal individuals carriers mutation additional fragment 499 bp corresponds uncut pcr product observed screening change proband confirmed alteration failed find change 50 normals addition exon app gene sequenced group order 500 times without finding changes except cases ad segregating autosomal dominant disorder onset age 50s mutagenesis transfection abeta assay
0.3289425.9328472.html.plaintext.txt	32	transformer mutagenesis system clontech used convert wild type app695 sequence mutants evaluate effect mutant app cdnas abeta concentrations employed transient transfection paradigm coupled well characterized ban50ba27 ban50bc05 sandwich elisa systems determine extracellular concentration abeta1 40 abeta1 4243 respectively table 1 cells transfected pcdna3 vector alone pcdna3 containing app695 wild type app695 i716v app695 v717i app695 i716vv717i using dotap boehringer mannheim 293 cells lipofectamine gibco brl laboratories chinese hamster ovary cho cells dna concentrations previously determined yield maximal transfection efficiency cell types data shown 6 h post transfection medium changed growth medium fresh medium conditioned 24 48 h facilitate measurement abeta sandwich elisa due variation transfection efficiency focused analysis ratio abeta1 4243to abeta1 40 absolute concentrations abeta1 40 abeta1 4243 representative experiment provided comparison analysis plasma abeta concentration performed essentially described previously 3 except ban50 capture replaced bnt77raised abeta11 28 determination abeta ending abeta4243 7 change obviates need pre clearance non specific igg1kappa
0.3289425.9328472.html.plaintext.txt	33	transformer mutagenesis system clontech used convert wild type app695 sequence mutants evaluate effect mutant app cdnas abeta concentrations employed transient transfection paradigm coupled well characterized ban50ba27 ban50bc05 sandwich elisa systems determine extracellular concentration abeta1 40 abeta1 4243 respectively table 1 cells transfected pcdna3 vector alone pcdna3 containing app695 wild type app695 i716v app695 v717i app695 i716vv717i using dotap boehringer mannheim 293 cells lipofectamine gibco brl laboratories chinese hamster ovary cho cells dna concentrations previously determined yield maximal transfection efficiency cell types data shown 6 h post transfection medium changed growth medium fresh medium conditioned 24 48 h facilitate measurement abeta sandwich elisa due variation transfection efficiency focused analysis ratio abeta1 4243to abeta1 40 absolute concentrations abeta1 40 abeta1 4243 representative experiment provided comparison analysis plasma abeta concentration performed essentially described previously 3 except ban50 capture replaced bnt77raised abeta11 28 determination abeta ending abeta4243 7 change obviates need pre clearance non specific igg1kappa
0.3289425.9328472.html.plaintext.txt	34	family nurse caregiver thanked interest support enthusiasm work work supported mayousf nih program project grant jh sy mh nih ro1 grants jh sy adcc pilot grant ce references 1 hardyj 1997 amyloid presenilins alzheimers disease trends neurosci 20 154 159 medline abstract
0.3289425.9328472.html.plaintext.txt	35	family nurse caregiver thanked interest support enthusiasm work work supported mayousf nih program project grant jh sy mh nih ro1 grants jh sy adcc pilot grant ce references 1 hardyj 1997 amyloid presenilins alzheimers disease trends neurosci 20 154 159 medline abstract
0.3289425.9328472.html.plaintext.txt	36	2 younkins 1997 evidence abeta42 real culprit alzheimers disease ann neurol 37 287 288
0.3289425.9328472.html.plaintext.txt	37	12 weschlerd 1987 weschler memory scale revised psychological corporation new york
0.3289425.9328472.html.plaintext.txt	38	14 warringtone 1984 recognition memory test nfer nelson windsor uk
0.3289425.9328472.html.plaintext.txt	39	correspondence addressed mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa tel 1 904 953 7356 fax 1 904 953 7370 email hardymayoedu page maintained oup admin last updated sat oct 18 133913 bst 1997 part oup journals world wide web service copyright oxford university press 1997
0.3289425.9328472.html.plaintext.txt	40	correspondence addressed mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa tel 1 904 953 7356 fax 1 904 953 7370 email hardymayoedu page maintained oup admin last updated sat oct 18 133913 bst 1997 part oup journals world wide web service copyright oxford university press 1997
0.3291776.12119298.html.plaintext.txt	0	presenilin 1 mutations activate 42 secretase reciprocally inhibit secretase cleavage amyloid precursor protein app s3 cleavage notch fusheng chen yongjun gu hiroshi hasegawa xueying ruan shigeki arawaka paul fraser david westaway howard mount peter st george hyslop
0.3291776.12119298.html.plaintext.txt	1	centre research neurodegenerative diseases departments medicine medical biophysics laboratory medicine pathobiology university toronto toronto ontario m5s 3h2 canada department medicine division neurology university health network toronto ontario m5s 3h2 canada
0.3291776.12119298.html.plaintext.txt	2	received publication may 23 2002 revised form july 9 2002
0.3291776.12119298.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	4	presenilin 1 ps1 presenilin 2 ps2 proteins necessary proteolytic cleavage amyloid precursor protein app within transmembrane domain one cleavage events termed secretase generates c terminal end peptide proteolysis near residue 710 712 app770 another event termed like secretase cleavage cleaves near residue 721 2 5 residues inside cytoplasmic membrane boundary generate series stable c terminal app fragments latter cleavage analogous s3 cleavage notch report specific mutations n terminus loop c terminus ps1 increase production a42 cause inhibition secretase cleavage app s3 cleavage notch data support hypothesis cleavage app s3 cleavage notch similar events also argue although site site cleavage app presenilin dependent likely independent catalytic events introduction top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	5	presenilin 1 ps1 presenilin 2 ps2 proteins necessary proteolytic cleavage amyloid precursor protein app within transmembrane domain one cleavage events termed secretase generates c terminal end peptide proteolysis near residue 710 712 app770 another event termed like secretase cleavage cleaves near residue 721 2 5 residues inside cytoplasmic membrane boundary generate series stable c terminal app fragments latter cleavage analogous s3 cleavage notch report specific mutations n terminus loop c terminus ps1 increase production a42 cause inhibition secretase cleavage app s3 cleavage notch data support hypothesis cleavage app s3 cleavage notch similar events also argue although site site cleavage app presenilin dependent likely independent catalytic events introduction top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	6	amyloid precursor protein app1 undergoes series proteolytic processing events fig 1 one processing event mediated sequentially first secretase secretase generates several proteolytic fragments including 40 42 amino acid fragment termed number c terminal fragments ctfs contain cytoplasmic tail app ctfs variously termed stubs stubs app intracellular domain aicd detailed analysis products revealed cleavage events give rise c terminus occur residues 40 42 secretase stub fig 1 however give rise predominant stable ctfs n terminus residues 49 50 52 located 2 5 residues inside cytoplasmic membrane boundary 1 7 latter cleavage events s3 cleavage notch occur approximately position relative inner surface membrane ie within 2 5 residues surface fig 1 1 7 beyreuther colleagues 1 referred cleavages residues 40 42 secretase cleavage cleavages residues 49 52 cleavage sake clarity retain terminology
0.3291776.12119298.html.plaintext.txt	7	view larger version 21k fig 1 schematic diagram app notch cleavage pathways sites 40 42 secretase cleavage app indicated arrows upper panel stubs peptide depicted horizontal bars numbers near amino acid sequence app top panel notch codon numbers numbers parentheses next app codon numbers correspond amino acid numbering c99 app secretase product transmembrane domains depicted blue boxes tace tumor necrosis factor converting enzyme
0.3291776.12119298.html.plaintext.txt	8	pathogenic presenilin mutations cause familial alzheimer disease fad enhance production highly amyloidogenic a42 variant 8 10 consequently suggested ps1 ps2 mutations gain function effect secretase activity paradoxically several mutations suppress ability human presenilin proteins complement notch signaling phenotype induced loss function c60s mutant caenorhabditis elegans 11 12 conversely c60s loss function mutation sel 12 presenilin homologue inhibits notch processing c elegans causes increased a42 production introduced human ps1 c92s mutation 13 14 however secretase cleavages app near residue 42 15 cleavages app near residue 50 1 5 s3 cleavage notch 7 16 appear presenilin dependent difficult therefore reconcile apparently opposing action pathogenic presenilin mutations production mammalian cells notch cleavage invertebrates report although ps1 mutations augment secretase cleavage residue 42 fact suppress s3 cleavage notch cleavage app near residue 50 data suggest secretase cleavage residue 42 s3 cleavage likely independent activities experimental procedures top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	9	pathogenic presenilin mutations cause familial alzheimer disease fad enhance production highly amyloidogenic a42 variant 8 10 consequently suggested ps1 ps2 mutations gain function effect secretase activity paradoxically several mutations suppress ability human presenilin proteins complement notch signaling phenotype induced loss function c60s mutant caenorhabditis elegans 11 12 conversely c60s loss function mutation sel 12 presenilin homologue inhibits notch processing c elegans causes increased a42 production introduced human ps1 c92s mutation 13 14 however secretase cleavages app near residue 42 15 cleavages app near residue 50 1 5 s3 cleavage notch 7 16 appear presenilin dependent difficult therefore reconcile apparently opposing action pathogenic presenilin mutations production mammalian cells notch cleavage invertebrates report although ps1 mutations augment secretase cleavage residue 42 fact suppress s3 cleavage notch cleavage app near residue 50 data suggest secretase cleavage residue 42 s3 cleavage likely independent activities experimental procedures top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	10	cell culture transfection human embryonic kidney 293 hek293 cell lines stably transfected wild type ps1 various mutant ps1s including l392v g206a exon 9 missplicing mutation exon 9 d385a certain cell lines also stably expressed app695 swedish mutant experiments cells transiently transfected cdna encoding membrane bound notch protein myc tagged notche cloned pcs2 vector 17 18 examine ability app mutants increase decrease production cells co transfected cdnas encoding wild type mutant forms c terminal 99 amino acids app corresponding product secretase cleavage fl app fused artificial signal peptide ensure correct orientation cloned pcep4 vector 19 cell lines maintained 10 fetal bovine serum dulbeccos modified eagles medium 200 microgml zeocin invitrogen orand 10 microgml blasticidin invitrogen orand 200 microgml g418 invitrogen
0.3291776.12119298.html.plaintext.txt	11	cell culture transfection human embryonic kidney 293 hek293 cell lines stably transfected wild type ps1 various mutant ps1s including l392v g206a exon 9 missplicing mutation exon 9 d385a certain cell lines also stably expressed app695 swedish mutant experiments cells transiently transfected cdna encoding membrane bound notch protein myc tagged notche cloned pcs2 vector 17 18 examine ability app mutants increase decrease production cells co transfected cdnas encoding wild type mutant forms c terminal 99 amino acids app corresponding product secretase cleavage fl app fused artificial signal peptide ensure correct orientation cloned pcep4 vector 19 cell lines maintained 10 fetal bovine serum dulbeccos modified eagles medium 200 microgml zeocin invitrogen orand 10 microgml blasticidin invitrogen orand 200 microgml g418 invitrogen
0.3291776.12119298.html.plaintext.txt	12	generation stubs cell free assay systems generation stubs performed cell free assay systems described previously 4 20 hek293 cells resuspended 5 mm hepes ph 74 1 mm edta 025 m sucrose plus protease inhibitors homogenized postnuclear supernatant prepared described 21 microsomal membranes pelleted postnuclear supernatant centrifugation 100000 x g 1 h 4 degrees c detergent solubilized purified high molecular weight ps1 complexes see washed assay buffer resuspended assay buffer ph 64 10 mm koac 15 mm mgcl2 75 mm sodium citrate containing protease inhibitors incubated 37 degrees c indicated times generate stubs control samples kept ice end assay microsomal membrane samples either used western blotting separated pellet supernatant fractions ultracentrifugation 1 h 100000 x g 4 degrees c purified ps1 complexes prepared sds page adding 2 x sample buffer
0.3291776.12119298.html.plaintext.txt	13	generation stubs cell free assay systems generation stubs performed cell free assay systems described previously 4 20 hek293 cells resuspended 5 mm hepes ph 74 1 mm edta 025 m sucrose plus protease inhibitors homogenized postnuclear supernatant prepared described 21 microsomal membranes pelleted postnuclear supernatant centrifugation 100000 x g 1 h 4 degrees c detergent solubilized purified high molecular weight ps1 complexes see washed assay buffer resuspended assay buffer ph 64 10 mm koac 15 mm mgcl2 75 mm sodium citrate containing protease inhibitors incubated 37 degrees c indicated times generate stubs control samples kept ice end assay microsomal membrane samples either used western blotting separated pellet supernatant fractions ultracentrifugation 1 h 100000 x g 4 degrees c purified ps1 complexes prepared sds page adding 2 x sample buffer
0.3291776.12119298.html.plaintext.txt	14	western blot immunoprecipitation purified detergent solubilized high molecular weight ps1 complexes crude microsomal membrane preparations lysed adding 1 nonidet p 40 tris buffered saline protein assay equal amounts total protein sample dissolved sds sample buffer separated sds page transferred nitrocellulose membrane target proteins visualized enhanced chemiluminescence amersham biosciences antibodies c terminus app app c terminal polyclonal antibody sigma ps1 ntf antibody 14 gift dr se gandy 3340 3542 gifts dr f checler 6e10 4g8 signet laboratories inc necessary nitrocellulose membranes stripped reuse immunoprecipitation reaction lysates generated vitro cell free preparations conditioned medium secreted intact cells performed described previously 17 using antibodies 6e10 4g8 3340 3542 detection electrophoretic separation a40 a42 bicinetris sds page system employed described 22
0.3291776.12119298.html.plaintext.txt	15	western blot immunoprecipitation purified detergent solubilized high molecular weight ps1 complexes crude microsomal membrane preparations lysed adding 1 nonidet p 40 tris buffered saline protein assay equal amounts total protein sample dissolved sds sample buffer separated sds page transferred nitrocellulose membrane target proteins visualized enhanced chemiluminescence amersham biosciences antibodies c terminus app app c terminal polyclonal antibody sigma ps1 ntf antibody 14 gift dr se gandy 3340 3542 gifts dr f checler 6e10 4g8 signet laboratories inc necessary nitrocellulose membranes stripped reuse immunoprecipitation reaction lysates generated vitro cell free preparations conditioned medium secreted intact cells performed described previously 17 using antibodies 6e10 4g8 3340 3542 detection electrophoretic separation a40 a42 bicinetris sds page system employed described 22
0.3291776.12119298.html.plaintext.txt	16	metabolic labeling quantification nicd aicd pulse chase experiments cells metabolically labeled 35smethioninecysteine icn pharmaceuticals 20 min chased 1 h maximum nicd formation occurred 1 h 17 21 23 cell lysates subjected immunoprecipitation antibody myc epitope fused c terminus notche
0.3291776.12119298.html.plaintext.txt	17	metabolic labeling quantification nicd aicd pulse chase experiments cells metabolically labeled 35smethioninecysteine icn pharmaceuticals 20 min chased 1 h maximum nicd formation occurred 1 h 17 21 23 cell lysates subjected immunoprecipitation antibody myc epitope fused c terminus notche
0.3291776.12119298.html.plaintext.txt	18	intensities autoradiographic bands ecl signals notch app ctfs including stubaicd fl app measured densitometry andor phosphorimager analysis ratios stub c99 app fl app nicd total notch protein nicd notche calculated cell line permit comparison across different replications normalized ratios cells expressing wild type ps1 set 100 pairwise comparisons made using students test independent groups preplanned comparisons stub nicd generation normalized production cells expressing ps1 wt
0.3291776.12119298.html.plaintext.txt	19	intensities autoradiographic bands ecl signals notch app ctfs including stubaicd fl app measured densitometry andor phosphorimager analysis ratios stub c99 app fl app nicd total notch protein nicd notche calculated cell line permit comparison across different replications normalized ratios cells expressing wild type ps1 set 100 pairwise comparisons made using students test independent groups preplanned comparisons stub nicd generation normalized production cells expressing ps1 wt
0.3291776.12119298.html.plaintext.txt	20	presenilin 1 complex purification microsomal membranes see lysed 1 detergent containing immunoprecipitation buffer 25 mm hepes ph 74 150 mm nacl 2 mm edta plus mixture protease inhibitors sigma lysates centrifuged 45000 rpm tla 1003 rotor 1 h supernatants immunoprecipitated anti ps1 n terminal antibody described 17
0.3291776.12119298.html.plaintext.txt	21	presenilin 1 complex purification microsomal membranes see lysed 1 detergent containing immunoprecipitation buffer 25 mm hepes ph 74 150 mm nacl 2 mm edta plus mixture protease inhibitors sigma lysates centrifuged 45000 rpm tla 1003 rotor 1 h supernatants immunoprecipitated anti ps1 n terminal antibody described 17
0.3291776.12119298.html.plaintext.txt	22	mass spectrometric analysis app c terminal stubs products cleavage immunoprecipitated supernatant fractions either crude microsomal membrane preparations purified ps1 complexes using anti app ctf monoclonal antibody c161 gift paul mathews captured c terminal app stubs eluted beads 5 microl 1 trifluoroacetic acid30 acetonitrile prepare sample matrix solution 1 microl immunoprecipitated stub sample mixed 1 microl saturated cyano 4 hydroxycinnamic acid solution 01 trifluoroacetic acidacetonitrile sample matrix solution applied sample plate dried ambient temperature prior mass spectrometric analysis matrix assisted laser desorptionionization mass spectrometric maldi ms analysis performed voyager de str mass spectrometer
0.3291776.12119298.html.plaintext.txt	23	protein assay protein concentration determined using bca protein assay reagents according manufacturers instructions
0.3291776.12119298.html.plaintext.txt	24	replications experiments performed least triplicate results top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	25	replications experiments performed least triplicate results top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	26	generation app c terminal stubs microsomal membranes purified ps1 complexes incubation microsomal membrane fractions derived either native hek293 cells hek293 cells expressing appswedish generated 6 kda app c terminal fragment migrated major app c terminal fragments ie stub stub arising secretase secretase cleavage fl app fig 2a left panel similar result observed microsomal membrane fractions generated fibroblasts ps1 wild type mice contrast microsomal membrane fractions fibroblasts ps1 mice hek293 cells stably expressing loss function ps1 d385a mutant showed significant inhibition production 6 kda c terminal fragment app fig 2b similarly significant inhibition production 6 kda c terminal fragment app microsomal membranes extracted hek293 cell lines expressing appswedish resulting microsomal membranes incubated compound e well documented secretase inhibitor production 24 fig 2b detergent solubilized immuno purified high molecular weight presenilin complexes contained c99 app ps1 ntf ps1 ctf nicastrin investigated assay conditions 6 kda app c terminal band also produced fig 2a right panel generation 6 kda fragment highly sensitive detergent used thus chapso permitted robust production fragment whereas detergents digitonin dodecylmaltoside supported cleavage event less efficiently data shown triton x 100 nonidet p 40 disassemble ps1 complexes resulted c terminal app stubs generation data shown data taken together imply 6 kda fragment authentic presenilin dependent proteolytic cleavage product
0.3291776.12119298.html.plaintext.txt	27	view larger version 44k fig 2 generation c terminal app fragments c terminal stub generation microsomal membranes left panel purified ps1 complexes right panel microsomal membranes stable hek293 cells expressing appswedish appswe purified ps1 complexes stable hek293 cells expressing c99 app incubated 37 degrees c 30 min 2 h 6 kda stub migrating major app ctfs stub stub generated cleavage stub detected western blot anti app ctf antibody variation stub density reflects differences stub abundance cells used prepare ps1 complexes overexpressed c99 app shown b cleavage dependent presence functional presenilin stubs inhibited microsomal membranes fibroblasts ps1 mice d385a mutant ps1 transfected hek293 cells microsomal membrane preparations treated secretase activity inhibitor compound e
0.3291776.12119298.html.plaintext.txt	28	mass spectrometric identification c terminal app stubs establish identity 6 kda c terminal app band generated microsomal membrane preparations immuno purified ps1 complexes soluble c terminal app fragments immunoprecipitated reaction supernatants using c161 anti app ctf monoclonal antibody immunoprecipitation products subjected maldi ms analysis fig 3 agreement previous data three major c terminal products stub beginning residue 49 stub49 99 calculated mass 60249 measured mass 60277 stub beginning residue 50 stub50 99 calculated mass 59117 measured mass 591243 stub beginning residue 52 stub52 99 calculated mass 56814 measured mass 586160 c terminal app stubs beginning residues 41 43 44 identified fig 3
0.3291776.12119298.html.plaintext.txt	29	mass spectrometric identification c terminal app stubs establish identity 6 kda c terminal app band generated microsomal membrane preparations immuno purified ps1 complexes soluble c terminal app fragments immunoprecipitated reaction supernatants using c161 anti app ctf monoclonal antibody immunoprecipitation products subjected maldi ms analysis fig 3 agreement previous data three major c terminal products stub beginning residue 49 stub49 99 calculated mass 60249 measured mass 60277 stub beginning residue 50 stub50 99 calculated mass 59117 measured mass 591243 stub beginning residue 52 stub52 99 calculated mass 56814 measured mass 586160 c terminal app stubs beginning residues 41 43 44 identified fig 3
0.3291776.12119298.html.plaintext.txt	30	view larger version 15k fig 3 maldi ms spectra c terminal app products supernatants microsomal membrane preparations left right panels immuno purified high molecular weight detergent soluble ps1 complexes center panel peaks corresponding predicted molecular masses stub49 99 stub50 99 stub52 99 detected principal components 6 kda band generated microsomal membranes ps1 complexes fragments beginning position 41 43 representing counterpart detected microsomal membranes expressing mutant ps1 right panel fragments similar mass wild type ps1 membranes purified complexes
0.3291776.12119298.html.plaintext.txt	31	ps1 fad mutations enhance a42 inhibit stubs explore effects ps1 mutations app notch processing compared production app stubs nicd fragments hek293 cells stably expressing either wild type ps1 one three different ps1 missense mutations associated fad ie g206a exon 9 l392v analysis conditioned media cultured cell lines fig 4a upper panel table revealed pathogenic ps1 mutations produced increased amounts a42 compared either mock transfected cells cells expressing wild type ps1 normalized values ps1 wt 10 plus minus 0 ps1 l392v 342 plus minus 081 ps1 g206a 243 plus minus 004 p 005 a42 production also increased supernatants microsomal preparations mutant ps1 cells ps1 wt 104 plus minus 012 ps1 l392v 200 plus minus 048 ps1 g206a 166 plus minus 019 p 005 fig 4a lower panel table agreement prior data a40 levels statistically increased ps1 mutant cells either conditioned medium ps1 wt 10 plus minus 011 ps1 l392v 105 plus minus 026 ps1 g206a 117 plus minus 007 p significant cell free preparations ps1 wt 109 plus minus 003 ps1 l392v 115 plus minus 011 ps1 g206a 122 plus minus 013 p significant intuitive expectation increased secretase activity induced mutations would accompanied increased levels n terminal c terminal stubs cleavage products fact microsomal membrane preparations containing mutant ps1 produced lower amounts 6 kda stubs regardless whether production stubs assessed microsomal membranes fig 4b table supernatant membranes pelleted shown differences cleavage microsomal membrane preparations cell lines expressing mutant ps1 statistically significant compared similar preparations mock transfected ps1 wild type transfected controls ps1 l392v 054 plus minus 007 p 005 ps1 g206a 057 plus minus 012 p 005 ps1 exon9 047 plus minus 007 p 005 furthermore despite increased production a42 maldi ms analysis c terminal app fragments revealed presence stubs beginning positions 49 50 52 fig 3 right panel decrease generation stubs due differences expression full length app maturation processing app steady state levels secretase generated c terminal stubs app direct substrates secretase secretase cleavage
0.3291776.12119298.html.plaintext.txt	32	view larger version 58k fig 4 ps1 mutations inhibit generation stubs enhance production ab42 stably transfected hek293 cells immunoprecipitation western blot secreted a40 a42 hek293 cell lines double expressing appswedish either ps1 l392v ps1 g208a a42 levels conditioned medium top panel ps1 mutant cell lines increased 2 4 fold similar increases 15 2 fold observed microsomal membrane preparations bottom panel a40 levels statistically different b stub formation inhibited ps1 mutations l392v g206a exon 9 decrease stub generation correlate differences fl app ctf app levels n three independent replications
0.3291776.12119298.html.plaintext.txt	33	view table table effects fad associated ps1 mutations production stub nicd production stub nicd vitro analyzed stably expressing ps1 wt ps fad l392v g206a exon 9 mutations described experimental procedures means plus minus se represent results three independent experiments ratios stub ctf app fl app nicd total notch protein nicd notch de values level normalized relative cells expressing wild type ps1 set 100 p values indicated significance two tailed students test relative wild type ps1 nd detectable ns significant
0.3291776.12119298.html.plaintext.txt	34	ps1 fad mutations reduce generation nicd site cleavage within transmembrane domain app similar site s3 cleavage notch however studies using isocoumarin inhibitors 25 analysis effects specific ps1 mutations revealed biological functions ps proteins generation nicd separated 13 26 compare s3 cleavage notch cleavage app next investigated effects fad mutations s3 cleavage notch stable hek293 cell lines expressing either wild type mutant ps1 transiently transfected notche 16 18 notche encodes membrane tethered notch tagged c terminus c myc substrate presenilin dependent cleavage s3 site 16 nicd formation followed pulse chase experiments contrast cells expressing wild type ps1 expressing mutant ps1 showed significant reductions nicd formation half amount wild type cells ps1 l392v 059 plus minus 006 p 005 ps1 g206a 048 plus minus 011 p 005 ps1 exon 9 056 plus minus 009 p 005 fig 5 table
0.3291776.12119298.html.plaintext.txt	35	ps1 fad mutations reduce generation nicd site cleavage within transmembrane domain app similar site s3 cleavage notch however studies using isocoumarin inhibitors 25 analysis effects specific ps1 mutations revealed biological functions ps proteins generation nicd separated 13 26 compare s3 cleavage notch cleavage app next investigated effects fad mutations s3 cleavage notch stable hek293 cell lines expressing either wild type mutant ps1 transiently transfected notche 16 18 notche encodes membrane tethered notch tagged c terminus c myc substrate presenilin dependent cleavage s3 site 16 nicd formation followed pulse chase experiments contrast cells expressing wild type ps1 expressing mutant ps1 showed significant reductions nicd formation half amount wild type cells ps1 l392v 059 plus minus 006 p 005 ps1 g206a 048 plus minus 011 p 005 ps1 exon 9 056 plus minus 009 p 005 fig 5 table
0.3291776.12119298.html.plaintext.txt	36	view larger version 23k fig 5 ps1 mutations inhibit generation nicd hek293 cell lines stably expressing wild type ps1 ps1 mutations proven enhance a42 production transiently transfected notche cdna nicd formation assessed pulse chase experiments incubation 1 h incubation 37 degrees c nicd generation cells expressing ps1 mutations significantly inhibited n three independent replications
0.3291776.12119298.html.plaintext.txt	37	c99 app mutations alter a42 production alter stub generation data demonstrated although fad mutations ps1 increase a42 secretion inhibit stub generation determine whether mutations substrate cleavage ie c99c83 app might also effect hek293 cells transfected wild type c99 app i45f mutant c99 app increases a42 19 v50f mutant c99 app decreases a42 19 equivalent amounts total membrane cell line incubated assay system described agreement similar results published preparation manuscript 1 amounts stubs generated cell lines essentially equivalent suggesting c99 mutations affect generation stubs fig 6 although significantly alter production a42
0.3291776.12119298.html.plaintext.txt	38	c99 app mutations alter a42 production alter stub generation data demonstrated although fad mutations ps1 increase a42 secretion inhibit stub generation determine whether mutations substrate cleavage ie c99c83 app might also effect hek293 cells transfected wild type c99 app i45f mutant c99 app increases a42 19 v50f mutant c99 app decreases a42 19 equivalent amounts total membrane cell line incubated assay system described agreement similar results published preparation manuscript 1 amounts stubs generated cell lines essentially equivalent suggesting c99 mutations affect generation stubs fig 6 although significantly alter production a42
0.3291776.12119298.html.plaintext.txt	39	view larger version 32k fig 6 mutations c terminus app substrate cleavage significantly modulate stub generation following incubation 1 h western blot app ctf antibody sigma reveals equivalent amounts stubs generated microsomal membranes hek293 cells expressing wild type c99 app c99 appi45f increases 19 c99 appv50f decreases 19 identity band beneath stub unknown discussion top abstract introduction experimental procedures results discussion references
0.3291776.12119298.html.plaintext.txt	40	data reveal three pathogenic ps1 mutations tested differentially affect several presenilin dependent activities three mutations different domains ps1 cause increase activity secretase producing a42 whereas simultaneously inhibiting cleavage app s3 cleavage notch differential effect ps1 mutations provides insight complex regulated intramembranous proteolysis type 1 membrane proteins app notch first data support growing body evidence suggests cleavage app s3 cleavage notch likely similar identical proteolytic processing events 1 5 single difference noted date s3 cleavages s3 cleavage notch sequence dependent whereas cleavage app 1 5
0.3291776.12119298.html.plaintext.txt	41	data reveal three pathogenic ps1 mutations tested differentially affect several presenilin dependent activities three mutations different domains ps1 cause increase activity secretase producing a42 whereas simultaneously inhibiting cleavage app s3 cleavage notch differential effect ps1 mutations provides insight complex regulated intramembranous proteolysis type 1 membrane proteins app notch first data support growing body evidence suggests cleavage app s3 cleavage notch likely similar identical proteolytic processing events 1 5 single difference noted date s3 cleavages s3 cleavage notch sequence dependent whereas cleavage app 1 5
0.3291776.12119298.html.plaintext.txt	42	second data show increase 42 cleavage app accompanied decreases s3 cleavage activities conclusion entirely compatible prior data suggest fad pathogenic mutations loss function effect s3 cleavage notch examined vivo c elegans biochemically vitro 7 11 12 reduction s3 cleavage notch modest provides explanation fad associated mutations ps1 clinical evidence embryonic defects humans usually heterozygous ps1 mutations transgenes encoding fad linked ps1 mutants able rescue notch phenotype ps1 mice 27 however aware one case compound heterozygote mutation ps1 m146vs365t affected proband several minor congenital malformations 28 data also accord previously published data indicating c elegans sel 12 c60s loss function mutant expressed mammalian cells human ps1 c92s homologue reduced processing notch increased a42 production 13 14
0.3291776.12119298.html.plaintext.txt	43	second data show increase 42 cleavage app accompanied decreases s3 cleavage activities conclusion entirely compatible prior data suggest fad pathogenic mutations loss function effect s3 cleavage notch examined vivo c elegans biochemically vitro 7 11 12 reduction s3 cleavage notch modest provides explanation fad associated mutations ps1 clinical evidence embryonic defects humans usually heterozygous ps1 mutations transgenes encoding fad linked ps1 mutants able rescue notch phenotype ps1 mice 27 however aware one case compound heterozygote mutation ps1 m146vs365t affected proband several minor congenital malformations 28 data also accord previously published data indicating c elegans sel 12 c60s loss function mutant expressed mammalian cells human ps1 c92s homologue reduced processing notch increased a42 production 13 14
0.3291776.12119298.html.plaintext.txt	44	finally reciprocal relationship 42 secretase secretases3 cleavage suggests molecular events leading production peptide probably complex single proteolytic cleavage seems likely secretase s3 cleavage functions presenilin dependent however remains unclear whether secretase cleavages necessary generation order cleavage events occur fact authentic stub containing residues 43 99 never observed taken support view cleavage may initial necessary cleavage followed carboxyl exopeptidase degradation back residue 42 however data suggest two activities likely separate events indeed parsimonious explanation data two pathways physiological pathway mediating s3 cleavage generate signal transduction molecules aicd nicd default pathway generates a42 functionally distinct pathways however could still subserved catalytic machinery thus absence presenilin complex neither pathway would active however functional modulation presenilin complex instance missense mutations post translational modification presenilins components presenilin complex eg glycosylation nicastrin might alter relative balance cleavage pathways cannot course preclude alternate possibility distinct structural components involved two pathways data agreement previously published data show although many missense mutations substrate secretase cleavage c99 app alter production modulate cleavage 1 29 observations compatible hypotheses 1 molecular mechanisms substratecatalysis interactions generation stubnicd production different 2 ps1 mutations might primarily affect regulatory function rather directly execute catalytic cleavage
0.3291776.12119298.html.plaintext.txt	45	finally reciprocal relationship 42 secretase secretases3 cleavage suggests molecular events leading production peptide probably complex single proteolytic cleavage seems likely secretase s3 cleavage functions presenilin dependent however remains unclear whether secretase cleavages necessary generation order cleavage events occur fact authentic stub containing residues 43 99 never observed taken support view cleavage may initial necessary cleavage followed carboxyl exopeptidase degradation back residue 42 however data suggest two activities likely separate events indeed parsimonious explanation data two pathways physiological pathway mediating s3 cleavage generate signal transduction molecules aicd nicd default pathway generates a42 functionally distinct pathways however could still subserved catalytic machinery thus absence presenilin complex neither pathway would active however functional modulation presenilin complex instance missense mutations post translational modification presenilins components presenilin complex eg glycosylation nicastrin might alter relative balance cleavage pathways cannot course preclude alternate possibility distinct structural components involved two pathways data agreement previously published data show although many missense mutations substrate secretase cleavage c99 app alter production modulate cleavage 1 29 observations compatible hypotheses 1 molecular mechanisms substratecatalysis interactions generation stubnicd production different 2 ps1 mutations might primarily affect regulatory function rather directly execute catalytic cleavage
0.3291776.12119298.html.plaintext.txt	46	cumulatively data provide basis arguing secretase cleavage results generation a42 functionally distinct cleavages necessary production signaling molecules aicd nicd work must undertaken understand molecular mechanisms underlying distinct pathways however taken conjunction results data raise possibility generating compounds selectively inhibit peptide production minimally affecting aicd nicd production acknowledgement
0.3291776.12119298.html.plaintext.txt	47	cumulatively data provide basis arguing secretase cleavage results generation a42 functionally distinct cleavages necessary production signaling molecules aicd nicd work must undertaken understand molecular mechanisms underlying distinct pathways however taken conjunction results data raise possibility generating compounds selectively inhibit peptide production minimally affecting aicd nicd production acknowledgement
0.3291776.12119298.html.plaintext.txt	48	thank dr ying yang mass spectrometry lab university toronto help mass spectrometric analyses
0.3291776.12119298.html.plaintext.txt	49	work supported grants canadian institutes health research canadian genetic disease network alzheimer society ontario howard hughes medical institute scottish rite charitable foundationthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3291776.12119298.html.plaintext.txt	50	work supported grants canadian institutes health research canadian genetic disease network alzheimer society ontario howard hughes medical institute scottish rite charitable foundationthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3291776.12119298.html.plaintext.txt	51	correspondence addressed centre research neurodegenerative diseases university toronto 6 queens park crescent w tanz neuroscience building toronto m5s 3h2 canada tel 416 978 7461 fax 416 978 1878 e mail physloputorontoca
0.3291776.12119298.html.plaintext.txt	52	correspondence addressed centre research neurodegenerative diseases university toronto 6 queens park crescent w tanz neuroscience building toronto m5s 3h2 canada tel 416 978 7461 fax 416 978 1878 e mail physloputorontoca
0.3291776.12119298.html.plaintext.txt	53	published jbc papers press july 15 2002 doi 101074jbcm205093200
0.3291776.12119298.html.plaintext.txt	54	abbreviations used app amyloid precursor protein fl app full length amyloid precursor protein ps presenilin fad familial alzheimer disease aicd app intracellular domain nicd notch intracellular domain ctf c terminal fragment maldi ms matrix assisted laser desorptionionization mass spectrometry chapso 3 3 cholamidopropyldimethylammonio 2 hydroxy 1 propanesulfonic acid bicine nn bis2 hydroxyethylglycine
0.3291776.12119298.html.plaintext.txt	55	references top abstract introduction experimental procedures results discussion references 1 weidemann eggert reinhard f b vogel m paliga k baier g masters c l beyreuther k evin g 2002 biochemistry 41 2825 2835crossrefmedline order article via infotrieve 2 gu y misonou h sato dohmae n takio k ihara y 2001 j biol chem 276 35235 35238abstractfree full text 3 cupers p orlans craessaerts k annaert w de strooper b 2001 j neurochem 78 1168 1178crossrefmedline order article via infotrieve 4 sastre m steiner h fuchs k capell multhaup g condron m m teplow d b haass c 2001 embo rep 2 835 841abstractfree full text 5 yu c kim h ikeuchi xu h gasparini l wang r sisodia 2001 j biol chem 276 43756 43760abstractfree full text 6 cao x sudhof c 2001 science 293 115 120abstractfree full text 7 song w nadeau p yuan m yang x shen j yankner b 1999 proc natl acad sci u 96 6959 6963abstractfree full text 8 scheuner d eckman l jensen m sung x citron m suzuki n bird hardy j hutton m lannfelt l selkoe d younkin 1996 nat med 2 864 870medline order article via infotrieve 9 citron m westaway d xia w carlson g diehl levesque g johnson wood k lee m seubert p davis kholodenko d motter r sherrington r perry b yao h strome r lieberburg rommens j kim schenk d fraser p st george hyslop p selkoe d j 1997 nat med 3 67 72medline order article via infotrieve 10 borchelt d r thinakaran g eckman c b lee m k davenport f ratovitsky prada c m kim g seekins yager d slunt h h wang r seeger m levey gandy e copeland n g jenkins n price d l younkin g sisodia 1996 neuron 17 1005 1013medline order article via infotrieve 11 levitan d doyle brousseau d lee m thinakaran g slunt h sisodia greenwald 1996 proc natl acad sci u 93 14940 14944abstractfree full text 12 baumeister r leimer u zweckbronner jakubek c grunberg j haass c 1997 genes func 1 149 13 zhang d levitan d yu g nishimura m chen f tandon kawarai arawaka supala song y rogaeva y liang y holmes e milman p sato c zhang l st george hyslop p 2000 neuroreport 11 3227 3231medline order article via infotrieve 14 okochi m eimer bottcher baumeister r romig h walter j capell steiner h haass c 2000 j biol chem 275 40925 40932abstractfree full text 15 de strooper b saftig p craessaerts k vanderstichele h guhde g annaert w von figura k van leuven f 1998 nature 391 387 390crossrefmedline order article via infotrieve 16 de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 398 518 522crossrefmedline order article via infotrieve 17 chen f yu g arawaka nishimura m kawarai yu h tandon supala song y rogaeva e milman p sato c yu c janus c lee j song l zhang l fraser p st george hyslop p 2001 nat cell bio 3 751 754crossrefmedline order article via infotrieve 18 schroeter e h kisslinger j kopan r 1998 nature 393 382 386crossrefmedline order article via infotrieve 19 lichtenthaler f wang r grimm h uljon n masters c l beyreuther k 1999 proc natl acad sci u 96 3053 3058abstractfree full text 20 li y m lai m xu m huang q dimuzio mower j sardana m k shi x p yin k c shafer j gardell j 2000 proc natl acad sci u 97 6138 6143abstractfree full text 21 chen f yang d tandon rozmahel r yu g nishimura m kawarai westaway d gandy e fraser p e st george hyslop p 2000 j biol chem 275 36794 36802abstractfree full text 22 wiltfang j smirnov schnierstein b kelemen g matthies u klafki h w staufenbiel m huther g ruther e kornhuber j 1997 electrophoresis 18 527 532medline order article via infotrieve 23 steiner h duff k capell romig h grim m g lincoln hardy j yu x picciano m fechteler k citron m kopan r pesold b keck baader m tomita iwatsubo baumeister r haass c 1999 j biol chem 274 28669 28673abstractfree full text 24 seiffert d bradley j d rominger c m rominger d h yang f meredith j e jr wang q roach h thompson l spitz m higaki j n prakash r combs p copeland r arneric p hartig p r robertson d w cordell b stern m olson r e zaczek r 2000 j biol chem 275 34086 34091abstractfree full text 25 petit bihel f da costa c pourquie o kraus j l checler f 2001 nat cell bio 3 507 511crossrefmedline order article via infotrieve 26 kulic l walter j multhaup g teplow d b baumeister r romig h capell steiner h haass c 2000 proc natl acad sci u 97 5913 5918abstractfree full text 27 davis j naruse chen h eckman c younkin price d borchelt d r sisodia wong p c 1998 neuron 20 603 609medline order article via infotrieve 28 rogaeva e fafel k c song y q medeiros h sato c liang y richard e rogaev e frommelt p sadovnick d meschino w rockwood k boss m mayeux r st george hyslop p 2001 neurology 57 621 625abstractfree full text 29 lichtenthaler f ida n multhaup g masters c l beyreuther k 1997 biochemistry 36 15396 15403crossrefmedline order article via infotrieve
0.3291776.12119298.html.plaintext.txt	56	copyright 2002 american society biochemistry molecular biology inc
0.32985634.11331298.html.plaintext.txt	0	negative regulation sapkjnk signaling pathway presenilin 1 jin woo kima tong shin changa ji eun leea sung ho huha seung woo yeonb wan seok yangc cheol o joec inhee mook jungb rudolph e tanzid tae wan kimd eui ju choia national creative research initiative center cell death graduate school biotechnology korea university seoul 136 701 korea b brain disease research center ajou university school medicine suwon kyongki korea c department biological sciences korea advanced institute science technology taejon 305 701 korea d genetics aging research unit department neurology massachusetts general hospital harvard medical school charlestown massachusetts 02129
0.32985634.11331298.html.plaintext.txt	1	negative regulation sapkjnk signaling pathway presenilin 1 jin woo kima tong shin changa ji eun leea sung ho huha seung woo yeonb wan seok yangc cheol o joec inhee mook jungb rudolph e tanzid tae wan kimd eui ju choia national creative research initiative center cell death graduate school biotechnology korea university seoul 136 701 korea b brain disease research center ajou university school medicine suwon kyongki korea c department biological sciences korea advanced institute science technology taejon 305 701 korea d genetics aging research unit department neurology massachusetts general hospital harvard medical school charlestown massachusetts 02129
0.32985634.11331298.html.plaintext.txt	2	correspondence eui ju choi national creative research initiative center cell death graduate school biotechnology korea university seoul 136 701 korea tel82 2 3290 3446 fax82 2 927 9028 e mailejchoiatmailkoreaackr u d
0.32985634.11331298.html.plaintext.txt	3	correspondence eui ju choi national creative research initiative center cell death graduate school biotechnology korea university seoul 136 701 korea tel82 2 3290 3446 fax82 2 927 9028 e mailejchoiatmailkoreaackr u d
0.32985634.11331298.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	5	presenilin 1 ps1 plays pivotal role notch signaling intracellular metabolism amyloid ss protein understand intracellular signaling events downstream ps1 investigated study action ps1 mitogen activated protein kinase pathways overexpressed ps1 suppressed stress induced stimulation stress activated protein kinase sapkc jun nh2 terminal kinase jnk human embryonic kidney 293 cells interestingly two functionally inactive ps1 mutants ps1d257a ps1d385a failed inhibit uv stimulated sapkjnk furthermore h2o2 uv stimulated sapk activity higher mouse embryonic fibroblast mef cells ps1 null mice mef cells ps mice mefps1 cells sensitive h2o2 induced apoptosis mefps1 cells ectopic expression ps1 mefps1 cells suppressed h2o2 stimulated sapkjnk activity apoptotic cell death together data suggest ps1 inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	6	presenilin 1 ps1 plays pivotal role notch signaling intracellular metabolism amyloid ss protein understand intracellular signaling events downstream ps1 investigated study action ps1 mitogen activated protein kinase pathways overexpressed ps1 suppressed stress induced stimulation stress activated protein kinase sapkc jun nh2 terminal kinase jnk human embryonic kidney 293 cells interestingly two functionally inactive ps1 mutants ps1d257a ps1d385a failed inhibit uv stimulated sapkjnk furthermore h2o2 uv stimulated sapk activity higher mouse embryonic fibroblast mef cells ps1 null mice mef cells ps mice mefps1 cells sensitive h2o2 induced apoptosis mefps1 cells ectopic expression ps1 mefps1 cells suppressed h2o2 stimulated sapkjnk activity apoptotic cell death together data suggest ps1 inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	7	key words apoptosis c jun nh2 terminal kinase presenilin 1 secretase stress activated protein kinase
0.32985634.11331298.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	9	alzheimers disease ad1 progressive fatal neurodegenerative disorder characterized loss neurons brain regions involved learning memory one early events development ad accumulation amyloid ss peptide ass cerebral cortex ass1 42 produced amyloid ss protein precursor app ss secretase secrease mediated processing selkoe 1998 cases early onset familial ad fad caused mutations genes encoding presenilin 1 ps1 sherrington et al 1995 presenilin 2 ps2 levy lahad et al 1995 rogaev et al 1995 presenilins appear required processing app ass secretase activation de strooper et al 1998 wolfe et al 1999 li et al 2000
0.32985634.11331298.html.plaintext.txt	10	alzheimers disease ad1 progressive fatal neurodegenerative disorder characterized loss neurons brain regions involved learning memory one early events development ad accumulation amyloid ss peptide ass cerebral cortex ass1 42 produced amyloid ss protein precursor app ss secretase secrease mediated processing selkoe 1998 cases early onset familial ad fad caused mutations genes encoding presenilin 1 ps1 sherrington et al 1995 presenilin 2 ps2 levy lahad et al 1995 rogaev et al 1995 presenilins appear required processing app ass secretase activation de strooper et al 1998 wolfe et al 1999 li et al 2000
0.32985634.11331298.html.plaintext.txt	11	ps1 membrane protein contains eight putative transmembrane domains primarily localized intracellular membranes including endoplasmic reticulum golgi apparatus cook et al 1996 doan et al 1996 kovacs et al 1996 de strooper et al 1997 presenilins homologous two caenorhabitis elegans gene products sel 12 hop1 facilitate notchlin 12 signaling artavanis tsakonas et al 1999 indeed ps1 plays pivotal role notch signaling regulation notch processing secretase activation levitan greenwald 1995 li greenwald 1997 chan jan 1999 de strooper et al 1999 ray et al 1999 li et al 2000 notch signaling appears associated regulatory mechanisms variety cellular events including cell fate control embryonic development differentiation cell growth apoptosis artavanis tsakonas et al 1999
0.32985634.11331298.html.plaintext.txt	12	mitogen activated protein kinase mapk pathway one major signaling pathways transmit intracellular signals initiated extracellular stimuli nucleus mapk pathway regulates variety cellular functions including cell proliferation differentiation death minden karin 1997 ip davis 1998 schaeffer weber 1999 mapk pathway includes three distinct components mapks mapk kinases mapkks mapkk kinases mapkkks mapkkks phosphorylate activate mapkks turn phosphorylate activate mapks activated mapks phosphorylate various proteins include transcription factors thereby regulating gene expression cellular functions family mammalian mapks includes three subfamilies extracellular signal regulated kinase erk stress activated protein kinase sapkc jun nh2 terminal kinase jnk p38 mapk boulton et al 1991 han et al 1994 cobb goldsmith 1995 kyriakis avruch 1996 su karin 1996 fanger et al 1997 erk pathway consists erk upstream kinases include mapkerk kinase 1 raf 1 schaeffer weber 1999 pathway often stimulated mitogenic stimuli p38 mapk pathway consists p38 mapk upstream kinases include mapkks mkk3 mkk6 mapkkk ask1 tak1 schaeffer weber 1999 sapkjnk pathway consists sapkjnk upstream kinases include mapkks sek1jnkk1mkk4 mkk7 mapkkks mekk1 ask1 tak1 minden karin 1997 ip davis 1998 like p38 pathway sapkjnk pathway activated variety cellular stresses include genotoxic stress free radicals heat shock osmotic shock ischemia proinflammatory cytokines tumor necrosis factor interleukin 1ss minden karin 1997 ip davis 1998 activated sapkjnk phosphorylate activate c jun transcription factors including atf 2 elk 1 gupta et al 1995 minden et al 1995 yang et al 1998 although physiological role sapkjnk fully understood sapkjnk shown involved cellular mechanism apoptotic cell death certain conditions minden karin 1997 ip davis 1998 particular series studies using mice demonstrated pivotal role sapkjnk apoptotic cell death excitotoxic neuronal death yang et al 1997 dong et al 1998 kuan et al 1999 tournier et al 2000
0.32985634.11331298.html.plaintext.txt	13	mitogen activated protein kinase mapk pathway one major signaling pathways transmit intracellular signals initiated extracellular stimuli nucleus mapk pathway regulates variety cellular functions including cell proliferation differentiation death minden karin 1997 ip davis 1998 schaeffer weber 1999 mapk pathway includes three distinct components mapks mapk kinases mapkks mapkk kinases mapkkks mapkkks phosphorylate activate mapkks turn phosphorylate activate mapks activated mapks phosphorylate various proteins include transcription factors thereby regulating gene expression cellular functions family mammalian mapks includes three subfamilies extracellular signal regulated kinase erk stress activated protein kinase sapkc jun nh2 terminal kinase jnk p38 mapk boulton et al 1991 han et al 1994 cobb goldsmith 1995 kyriakis avruch 1996 su karin 1996 fanger et al 1997 erk pathway consists erk upstream kinases include mapkerk kinase 1 raf 1 schaeffer weber 1999 pathway often stimulated mitogenic stimuli p38 mapk pathway consists p38 mapk upstream kinases include mapkks mkk3 mkk6 mapkkk ask1 tak1 schaeffer weber 1999 sapkjnk pathway consists sapkjnk upstream kinases include mapkks sek1jnkk1mkk4 mkk7 mapkkks mekk1 ask1 tak1 minden karin 1997 ip davis 1998 like p38 pathway sapkjnk pathway activated variety cellular stresses include genotoxic stress free radicals heat shock osmotic shock ischemia proinflammatory cytokines tumor necrosis factor interleukin 1ss minden karin 1997 ip davis 1998 activated sapkjnk phosphorylate activate c jun transcription factors including atf 2 elk 1 gupta et al 1995 minden et al 1995 yang et al 1998 although physiological role sapkjnk fully understood sapkjnk shown involved cellular mechanism apoptotic cell death certain conditions minden karin 1997 ip davis 1998 particular series studies using mice demonstrated pivotal role sapkjnk apoptotic cell death excitotoxic neuronal death yang et al 1997 dong et al 1998 kuan et al 1999 tournier et al 2000
0.32985634.11331298.html.plaintext.txt	14	better understand intracellular signaling downstream ps1 investigated whether ps1 could modulate mapk signaling pathways report study ps1 inhibits sapkjnk pathway ps1 induced suppression sapkjnk pathway requires functionally active ps1 findings suggest ps1 inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	15	better understand intracellular signaling downstream ps1 investigated whether ps1 could modulate mapk signaling pathways report study ps1 inhibits sapkjnk pathway ps1 induced suppression sapkjnk pathway requires functionally active ps1 findings suggest ps1 inhibits stress activated signaling suppressing sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	17	plasmids cdna clones encoding wild type ps1 mutants inserted pcdna3 flag vector described kovacs et al 1996 pcdna3 sapkss flag j woodgett ontario cancer institute toronto canada pcdna3 sapkss hemagglutinin ha pcep4 ha erk2 mh cobb university texas southwestern medical center dallas tx pcdna3 p38 flag rj ulevitch scripps research institute la jolla ca pebg sek1 li zou harvard medicaal school boston ma pcdna3 ha mekk1 gl johnson university colorado denver co pcdna3 mekk1 pexv rac1v12 hall university college london london uk described previously shim et al 1996 shim et al 2000
0.32985634.11331298.html.plaintext.txt	18	cell culture dna transfection human embryonic kidney hek 293 cells b103 rat neuroblastoma cells mouse embryonic fibroblasts mefs wild type ps1 null mice shen et al 1997 grown dme gibco brl supplemented 10 fetal bovine serum mefps1 mefps1 cells j shen brigham womens hospital harvard medical school boston ma passage three six used passage experiments cultured cells transfected calcium phosphate method lipofectamine gibco brl establish cells stably expressed ectopic ps1 b103 cells transfected pcdna3 empty vector pcdna3 ps1 48 h transfection cells maintained complete medium containing 500 microgml g418 select neomycin resistant cells expression ectopic ps1 neomycin resistant cells analyzed immunoblot using anti ps1 antibody
0.32985634.11331298.html.plaintext.txt	19	cell culture dna transfection human embryonic kidney hek 293 cells b103 rat neuroblastoma cells mouse embryonic fibroblasts mefs wild type ps1 null mice shen et al 1997 grown dme gibco brl supplemented 10 fetal bovine serum mefps1 mefps1 cells j shen brigham womens hospital harvard medical school boston ma passage three six used passage experiments cultured cells transfected calcium phosphate method lipofectamine gibco brl establish cells stably expressed ectopic ps1 b103 cells transfected pcdna3 empty vector pcdna3 ps1 48 h transfection cells maintained complete medium containing 500 microgml g418 select neomycin resistant cells expression ectopic ps1 neomycin resistant cells analyzed immunoblot using anti ps1 antibody
0.32985634.11331298.html.plaintext.txt	20	apoptosis assay proper treatments cultured cells fixed 70 ethanol ice 1 h stained 10 microgml propidium iodide propidium iodide stained cells analyzed flow cytometry facscalibur becton dickinson alternatively cells transfected indicated vector constructs plus pegfp 24 h transfection cells treated indicated apoptotic stimuli cells fixed 4 formaldehyde 30 min stained 10 microgml dapi 10 min dapi stained nuclei examined apoptotic morphology zeiss axiovert fluorescence microscope green fluorescent protein gfp expressing cells scored apoptotic nuclei 200 cells counted experiment data three independent experiments analyzed
0.32985634.11331298.html.plaintext.txt	21	apoptosis assay proper treatments cultured cells fixed 70 ethanol ice 1 h stained 10 microgml propidium iodide propidium iodide stained cells analyzed flow cytometry facscalibur becton dickinson alternatively cells transfected indicated vector constructs plus pegfp 24 h transfection cells treated indicated apoptotic stimuli cells fixed 4 formaldehyde 30 min stained 10 microgml dapi 10 min dapi stained nuclei examined apoptotic morphology zeiss axiovert fluorescence microscope green fluorescent protein gfp expressing cells scored apoptotic nuclei 200 cells counted experiment data three independent experiments analyzed
0.32985634.11331298.html.plaintext.txt	22	immune complex kinase assay cultured cells lysed lysis buffer cell lysates subjected immunoprecipitation using appropriate antibodies park et al 2000 shim et al 2000 resultant immunopellets assayed activities indicated protein kinases park et al 2000 gst c jun 1 79 used substrate sapkjnk gst atf2 1 109 p38 myelin basic protein erk2 gst sapkssk55r sek1 gst sek1k129r mekk1 phosphorylated proteins resolved sds page 10 polyacrylamide gel analyzed fuji bas 2500 phosphorimager cell lysates also subjected immunoblot analysis using indicated antibodies bands immunoblot visualized using enhanced chemiluminescence system amersham pharmacia biotech
0.32985634.11331298.html.plaintext.txt	23	results top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	24	ps1 suppresses sapkjnk pathway investigate whether ps1 might modulate function sapkjnk pathway transfected hek293 cells sapkssjnk3 ps1 constructs fig 1 exposure transfected cells 80 jm2 uv light resulted stimulation sapk activity interestingly ectopically expressed ps1 suppressed uv stimulated sapk activity similarly ectopic ps1 suppressed sapk activity stimulated sorbitol fig 1 stresses including anisomycin data shown ps1 also inhibited p38 mapk activity stimulated uv light whereas affect pma induced stimulation erk2 activity fig 1 b following experiments looked mechanism ps1 inhibited sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	25	ps1 suppresses sapkjnk pathway investigate whether ps1 might modulate function sapkjnk pathway transfected hek293 cells sapkssjnk3 ps1 constructs fig 1 exposure transfected cells 80 jm2 uv light resulted stimulation sapk activity interestingly ectopically expressed ps1 suppressed uv stimulated sapk activity similarly ectopic ps1 suppressed sapk activity stimulated sorbitol fig 1 stresses including anisomycin data shown ps1 also inhibited p38 mapk activity stimulated uv light whereas affect pma induced stimulation erk2 activity fig 1 b following experiments looked mechanism ps1 inhibited sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	26	view larger version 32k figure 1 ps1 suppresses sapkjnk pathway overexpressed ps1 inhibited stress stimulated sapkjnk activity hek293 cells b effect ps1 p38 erk2 activity b hek293 cells 100 mm dishes transiently transfected ps1 construct 4 microg along ha sapkss 1 microg ha p38 1 microg ha erk2 1 microg constructs indicated 48 h transfection cells exposed uv light 80 jm2 sorbitol 06 m tpa 200 nm incubated 30 min cell lysates examined indicated protein kinase activities immune complex kinase assays protein phoshorylation quantified using phosphorimager ib immunoblot analysis transfected cells indicated antibodies
0.32985634.11331298.html.plaintext.txt	27	view larger version 32k figure 1 ps1 suppresses sapkjnk pathway overexpressed ps1 inhibited stress stimulated sapkjnk activity hek293 cells b effect ps1 p38 erk2 activity b hek293 cells 100 mm dishes transiently transfected ps1 construct 4 microg along ha sapkss 1 microg ha p38 1 microg ha erk2 1 microg constructs indicated 48 h transfection cells exposed uv light 80 jm2 sorbitol 06 m tpa 200 nm incubated 30 min cell lysates examined indicated protein kinase activities immune complex kinase assays protein phoshorylation quantified using phosphorimager ib immunoblot analysis transfected cells indicated antibodies
0.32985634.11331298.html.plaintext.txt	28	sapkjnk pathway composed sapkjnk upstream kinases include sek1 mekk1 minden karin 1997 ip davis 1998 activated mekk1 phosphorylate activate sek1 phosphorylates activates sapkjnk better understand ps1 suppressed sapk activity cells examined possible action ps1 sek1 mekk1 ectopic ps1 inhibited uv stimulated sek1 mekk1 activity transfected hek293 cells fig 2a fig b overexpressed ps1 however failed inhibit sapk activity stimulated coexpression constitutively active form mekk1 mekk1 fig 2 c results suggest ps1 might suppress sapkjnk pathway acting site sites upstream mekk1 rac1 member small gtp binding protein rho family shown act upstream mekk1 stimulate sapkjnk pathway coso et al 1995 minden et al 1995 overexpression rac1v12 constitutively active mutant rac1 induced sapk stimulation transfected hek293 cells fig 2 d ps1 repress rac1v12 induced sapk stimulation suggests ps1 may inhibit sapkjnk pathway acting site upstream rac1 pathway independent rac1 mediated signaling
0.32985634.11331298.html.plaintext.txt	29	sapkjnk pathway composed sapkjnk upstream kinases include sek1 mekk1 minden karin 1997 ip davis 1998 activated mekk1 phosphorylate activate sek1 phosphorylates activates sapkjnk better understand ps1 suppressed sapk activity cells examined possible action ps1 sek1 mekk1 ectopic ps1 inhibited uv stimulated sek1 mekk1 activity transfected hek293 cells fig 2a fig b overexpressed ps1 however failed inhibit sapk activity stimulated coexpression constitutively active form mekk1 mekk1 fig 2 c results suggest ps1 might suppress sapkjnk pathway acting site sites upstream mekk1 rac1 member small gtp binding protein rho family shown act upstream mekk1 stimulate sapkjnk pathway coso et al 1995 minden et al 1995 overexpression rac1v12 constitutively active mutant rac1 induced sapk stimulation transfected hek293 cells fig 2 d ps1 repress rac1v12 induced sapk stimulation suggests ps1 may inhibit sapkjnk pathway acting site upstream rac1 pathway independent rac1 mediated signaling
0.32985634.11331298.html.plaintext.txt	30	view larger version 38k figure 2 ps1 inhibits uv stimulated activity sek1 mekk1 ps1 inhibits sek1 activity b ps1 inhibits mekk1 activity b hek293 cells 100 mm dishes transfected pcdna3 ps1 flag 4 microg pebg sek1 1 microg pcdna3 ha mekk1 1 microg indicated 48 h transfection cells exposed 80 jm2 uv light incubated 30 min lysed measuring gst sek1 activity gst sek1 isolated cell lysates using glutathione agarose beads assayed phosphorylation gst sapkssk55r measuring ha mekk1 activity cell lysates subjected immunoprecipitation using anti ha antibody immunopellets assayed mekk1 activity immune complex kinase assay c ps1 affect mekk1 stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ps1 flag 4 microg pcdna3 sek1k129r 1 microg pcdna3 mekk1 flag 1 microg along pcdna3 ha sapkss 1 microg indicated d ps1 change rac1 stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ps1 flag 4 microg pcdna3 rac1v12 1 microg along pcdna3 ha sapkss 1 microg c d transfected cells lysed 48 h transfection sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody ib immunoblot analysis transfected cells indicated antibodies
0.32985634.11331298.html.plaintext.txt	31	view larger version 38k figure 2 ps1 inhibits uv stimulated activity sek1 mekk1 ps1 inhibits sek1 activity b ps1 inhibits mekk1 activity b hek293 cells 100 mm dishes transfected pcdna3 ps1 flag 4 microg pebg sek1 1 microg pcdna3 ha mekk1 1 microg indicated 48 h transfection cells exposed 80 jm2 uv light incubated 30 min lysed measuring gst sek1 activity gst sek1 isolated cell lysates using glutathione agarose beads assayed phosphorylation gst sapkssk55r measuring ha mekk1 activity cell lysates subjected immunoprecipitation using anti ha antibody immunopellets assayed mekk1 activity immune complex kinase assay c ps1 affect mekk1 stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ps1 flag 4 microg pcdna3 sek1k129r 1 microg pcdna3 mekk1 flag 1 microg along pcdna3 ha sapkss 1 microg indicated d ps1 change rac1 stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ps1 flag 4 microg pcdna3 rac1v12 1 microg along pcdna3 ha sapkss 1 microg c d transfected cells lysed 48 h transfection sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody ib immunoblot analysis transfected cells indicated antibodies
0.32985634.11331298.html.plaintext.txt	32	ps1 induced suppression sapkjnk pathway requires functionally active ps1 following experiments examined effects several fad linked ps1 mutants sapk pathway fad linked ps1 mutants m146v c410y l286v inhibited uv stimulated sapk activity cotransfected hek293 cells wild type ps1 fig 3 contrast biologically inactive transmembrane aspartate mutants ps1 d257a d385a could inhibit uv induced sapk stimulation fig 3 b two aspartic acid residues d257 d385 ps1 essential ps1 endoproteolysis secretase activation wolfe et al 1999 uv induced sapk stimulation also repressed overexpression ps1ex9 fig 3 b ps1ex9 functional ps1 mutant lacking exon 9 amino acids 290 319 contains endoproteolytic site m298 thinakaran et al 1996 podlisny et al 1997 thus ps1ex9 undergo endoproteolysis competent secretase activation li et al 2000 data therefore suggest secretase activation may important ps1 suppress sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	33	ps1 induced suppression sapkjnk pathway requires functionally active ps1 following experiments examined effects several fad linked ps1 mutants sapk pathway fad linked ps1 mutants m146v c410y l286v inhibited uv stimulated sapk activity cotransfected hek293 cells wild type ps1 fig 3 contrast biologically inactive transmembrane aspartate mutants ps1 d257a d385a could inhibit uv induced sapk stimulation fig 3 b two aspartic acid residues d257 d385 ps1 essential ps1 endoproteolysis secretase activation wolfe et al 1999 uv induced sapk stimulation also repressed overexpression ps1ex9 fig 3 b ps1ex9 functional ps1 mutant lacking exon 9 amino acids 290 319 contains endoproteolytic site m298 thinakaran et al 1996 podlisny et al 1997 thus ps1ex9 undergo endoproteolysis competent secretase activation li et al 2000 data therefore suggest secretase activation may important ps1 suppress sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	34	view larger version 56k figure 3 effects ps1 mutants sapkjnk effects fad linked ps1 variants uv stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ha sapkss 1 microg pcdna3 flag vector 4 microg expressing ps1 variant wild type m146v c410y l286v indicated 48 h transfection cells exposed uv light 80 jm2 incubated 30 min cell lysates examined sapk activity immune complex kinase assay using mouse anti ha antibody b effects endoproteolysis mutants ps1 uv stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ha sapkss 1 microg pcdna3 flag vector 4 microg expressing ps1 variant wild type d257a d385a ex9 indicated transfected cells exposed uv light 80 jm2 sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody ib immunoblot analysis transfected cells anti ha anti flag antibody ctf cooh terminal fragment ps1 ps1 endoproteolysis
0.32985634.11331298.html.plaintext.txt	35	view larger version 56k figure 3 effects ps1 mutants sapkjnk effects fad linked ps1 variants uv stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ha sapkss 1 microg pcdna3 flag vector 4 microg expressing ps1 variant wild type m146v c410y l286v indicated 48 h transfection cells exposed uv light 80 jm2 incubated 30 min cell lysates examined sapk activity immune complex kinase assay using mouse anti ha antibody b effects endoproteolysis mutants ps1 uv stimulated sapk activity hek293 cells 100 mm dishes cotransfected pcdna3 ha sapkss 1 microg pcdna3 flag vector 4 microg expressing ps1 variant wild type d257a d385a ex9 indicated transfected cells exposed uv light 80 jm2 sapk activity cell lysates measured immune complex kinase assay using mouse anti ha antibody ib immunoblot analysis transfected cells anti ha anti flag antibody ctf cooh terminal fragment ps1 ps1 endoproteolysis
0.32985634.11331298.html.plaintext.txt	36	ps1 protects neuroblastoma b103 cells apoptosis mediated sapkjnk activation next stably transfected rat neuroblastoma b103 cells ps1 b103 ps1 cells empty vector b103 neo cells investigated inhibitory effect ps1 sapkjnk immunoblot data confirmed expression ps1 b103 ps1 cells b103 neo control cells fig 4 exposure b103 neo control cells uv light h2o2 resulted stimulation endogenous sapkjnk whereas uv h2o2 induced stimulation sapkjnk activity repressed b103 ps1 cells fig 4 b stably expressed ectopic ps1 also inhibited h2o2 induced stimulation endogenous sek1 mekk1 b103 ps1 cells fig 4 c
0.32985634.11331298.html.plaintext.txt	37	ps1 protects neuroblastoma b103 cells apoptosis mediated sapkjnk activation next stably transfected rat neuroblastoma b103 cells ps1 b103 ps1 cells empty vector b103 neo cells investigated inhibitory effect ps1 sapkjnk immunoblot data confirmed expression ps1 b103 ps1 cells b103 neo control cells fig 4 exposure b103 neo control cells uv light h2o2 resulted stimulation endogenous sapkjnk whereas uv h2o2 induced stimulation sapkjnk activity repressed b103 ps1 cells fig 4 b stably expressed ectopic ps1 also inhibited h2o2 induced stimulation endogenous sek1 mekk1 b103 ps1 cells fig 4 c
0.32985634.11331298.html.plaintext.txt	38	view larger version 17k figure 4 overexpressed ps1 inhibits stress induced stimulation sapkjnk pathway b103 rat neuroblastoma cells establishment b103 cells stably expressing ps1 b103 cells transfected pcdna3 ps1 pcdna3 empty vector expression ps1 isolated clones examined immunoblot analysis mouse anti ps1 monoclonal antibody fl full length ntf nh2 terminal fragment ps1 ps1 endoproteolysis b overexpressed ps1 inhibits uv h2o2 stimulated activity endogenous sapkjnk b103 cells either b103 neo b103 ps1 cells exposed uv light 80 jm2 h2o2 200 microm 2 hr cell lysates subjected immunoprecipitation using mouse anti sapkjnk1 antibody resultant immunopellets examined sapkjnk1 activity immune complex kinase assay c overexpressed ps1 inhibits h2o2 induced stimulation endogenous sek1 mekk1 b103 neo b103 ps1 cells exposed 200 microm h2o2 2 h enzymatic activity sek1 mekk1 b103 neo b103 ps1 cells examined immune complex kinase assay using anti sek1 anti mekk1 antibody
0.32985634.11331298.html.plaintext.txt	39	view larger version 17k figure 4 overexpressed ps1 inhibits stress induced stimulation sapkjnk pathway b103 rat neuroblastoma cells establishment b103 cells stably expressing ps1 b103 cells transfected pcdna3 ps1 pcdna3 empty vector expression ps1 isolated clones examined immunoblot analysis mouse anti ps1 monoclonal antibody fl full length ntf nh2 terminal fragment ps1 ps1 endoproteolysis b overexpressed ps1 inhibits uv h2o2 stimulated activity endogenous sapkjnk b103 cells either b103 neo b103 ps1 cells exposed uv light 80 jm2 h2o2 200 microm 2 hr cell lysates subjected immunoprecipitation using mouse anti sapkjnk1 antibody resultant immunopellets examined sapkjnk1 activity immune complex kinase assay c overexpressed ps1 inhibits h2o2 induced stimulation endogenous sek1 mekk1 b103 neo b103 ps1 cells exposed 200 microm h2o2 2 h enzymatic activity sek1 mekk1 b103 neo b103 ps1 cells examined immune complex kinase assay using anti sek1 anti mekk1 antibody
0.32985634.11331298.html.plaintext.txt	40	sapkjnk shown mediate stress induced apoptotic cell death certain conditions xia et al 1995 verheij et al 1996 minden karin 1997 ip davis 1998 examined whether ps1 could modulate sapk involved apoptotic cell death b103 cells fig 5 exposure b103 cells h2o2 resulted increase apoptosis fig 5 h2o2 induced apoptotic cell death markedly reduced cells transfected sek1k129r dominant negative form sek1 apoptosis induced mekk1 overexpression also repressed b103 cells transfected sek1k129r fig 5 b results suggest sapkjnk signaling cascade involved mechanism h2o2 mekk1 induced apoptosis b103 cells overexpressed ps1 prevented apoptotic cell death induced h2o2 fig 5 mekk1 fig 5 b data suggest ps1 might prevent h2o2 induced apoptotic cell death inhibiting sapkjnk pathway inhibition occurs site upstream mekk1 sapkjnk pathway data also show ps1ex9 retains ability secretase activation li et al 2000 suppressed sapkjnk pathway fig 3 also inhibited h2o2 induced apoptotic cell death fig 5 contrast ps1d257a lacks ability secretase activation wolfe et al 1999 could suppress sapk pathway fig 3 failed block h2o2 induced apoptotic cell death
0.32985634.11331298.html.plaintext.txt	41	view larger version 21k figure 5 ps1 suppresses h2o2 induced apoptotic cell death b103 cells b103 cells 35 mm dishes transfected pegfp 05 microg along pcdna3 flag expressing ps1 variant wild type d257a ex9 1 microg pcdna3 ha sek1k129a 05 microg pcmv5 mekk1 05 microg b indicated indicated 48 h transfection cells exposed h2o2 05 mm 6 h cells fixed 4 formaldehyde stained dapi 10 microgml 30 min gfp expressing cells counted apoptotic nuclei 200 cells counted experiment data represent results three independent experiments
0.32985634.11331298.html.plaintext.txt	42	view larger version 21k figure 5 ps1 suppresses h2o2 induced apoptotic cell death b103 cells b103 cells 35 mm dishes transfected pegfp 05 microg along pcdna3 flag expressing ps1 variant wild type d257a ex9 1 microg pcdna3 ha sek1k129a 05 microg pcmv5 mekk1 05 microg b indicated indicated 48 h transfection cells exposed h2o2 05 mm 6 h cells fixed 4 formaldehyde stained dapi 10 microgml 30 min gfp expressing cells counted apoptotic nuclei 200 cells counted experiment data represent results three independent experiments
0.32985634.11331298.html.plaintext.txt	43	elevated sapkjnk activity cells ps1 null mice next examined h2o2 induced jnk1sapk stimulation mef cells ps1 ps1 mice shen et al 1997 interestingly endogenous jnk1sapk activity basal state h2o2 stimulated state higher mefps1 cells mefps1 cells fig 6 ectopic expression ps1 mefps1 cells resulted decrease h2o2 stimulated sapkjnk activity fig 6 b also examined h2o2 induced apoptotic cell death mefps1 mefps1 cells mefps1 cells sensitive h2o2 induced apoptosis mefps1 cells fig 6 c furthermore overexpressed ps1 converted mefps1 cells resistant h2o2 induced apoptosis fig 6 d hand biologically inactive ps1d257a failed suppress sapk pathway fig 3 lower h2o2 induced apoptotic cell death mefps1 cells together data strongly suggest ps1 functions negative regulator sapkjnk pathway ps1 suppresses h2o2 induced apoptosis inhibiting sapkjnk pathway
0.32985634.11331298.html.plaintext.txt	44	view larger version 29k figure 6 sapkjnk activity h2o2 induced apoptotic cell death higher mefps1 cells mefps1 cells sapkjnk activity mef cells ps1 ps1 mice mefps1 mefps1 cells exposed 200 microm h2o2 2 h cell lysates subjected immunoprecipitation using anti sapkjnk1 antibody resultant immunopellets examined sapkjnk1 activity immune complex kinase assay b overexpression ps1 results decrease h2o2 stimulated sapkjnk activity mefps1 cells mef cells ps1 mice transiently transfected pcdna3 ha sapkss 1 microg pcdna3 ps1 flag 4 microg indicated 48 h transfection cells exposed 200 microm h2o2 2 h examined sapkjnk activity immune complex kinase assay using anti ha antibody c h2o2 induced apoptotic cell death mefps1 mefps1 cells mefps1 mefps1 cells exposed 500 microm h2o2 12 h fixed 70 ethanol stained 10 microgml propidium iodide percentage apoptotic cells sub g1 dna content determined measuring fluorescence propidium iodide stained cells using facscan d overexpressed ps1 suppresses h2o2 induced apoptosis mefps1 cells mefps1 cells transfected plasmids expressing indicated proteins along pegfp 40 h transfection cells exposed 500 microm h2o2 12 h stained dapi gfp positive cells scored dapi stained apoptotic nuclei zeiss axiovert fluorescence microscope
0.32985634.11331298.html.plaintext.txt	45	view larger version 29k figure 6 sapkjnk activity h2o2 induced apoptotic cell death higher mefps1 cells mefps1 cells sapkjnk activity mef cells ps1 ps1 mice mefps1 mefps1 cells exposed 200 microm h2o2 2 h cell lysates subjected immunoprecipitation using anti sapkjnk1 antibody resultant immunopellets examined sapkjnk1 activity immune complex kinase assay b overexpression ps1 results decrease h2o2 stimulated sapkjnk activity mefps1 cells mef cells ps1 mice transiently transfected pcdna3 ha sapkss 1 microg pcdna3 ps1 flag 4 microg indicated 48 h transfection cells exposed 200 microm h2o2 2 h examined sapkjnk activity immune complex kinase assay using anti ha antibody c h2o2 induced apoptotic cell death mefps1 mefps1 cells mefps1 mefps1 cells exposed 500 microm h2o2 12 h fixed 70 ethanol stained 10 microgml propidium iodide percentage apoptotic cells sub g1 dna content determined measuring fluorescence propidium iodide stained cells using facscan d overexpressed ps1 suppresses h2o2 induced apoptosis mefps1 cells mefps1 cells transfected plasmids expressing indicated proteins along pegfp 40 h transfection cells exposed 500 microm h2o2 12 h stained dapi gfp positive cells scored dapi stained apoptotic nuclei zeiss axiovert fluorescence microscope
0.32985634.11331298.html.plaintext.txt	46	discussion top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	47	study demonstrate ps1 inhibits sapkjnk pathway ectopically expressed ps1 blocked stress induced stimulation sapkjnk upstream kinases including sek1 mekk1 fad linked ps1 mutants m146v c410y l286v also able inhibit sapk stimulation interestingly biologically inactive ps1 mutants d257a d385a shown lack secretase activation ps1 endoproteolysis wolfe et al 1999 failed inhibit sapk stimulation furthermore ps1ex9 lacks endoproteolysis site competent activation secretase activity li et al 2000 retained inhibitory effect sapkjnk pathway data suggest secretase activation rather ps1 endoproteolysis required ps1 induced inhibition sapkjnk pathway secretase two major substrates app notch de strooper et al 1998 de strooper et al 1999 cleavage app notch secretase produces ass intracellular domain notch notch ic respectively ass1 42 inhibit sapkjnk activity data shown comparison preliminary data showed overexpression notch intracellular domain active form intracellular notch resulted suppression sapkjnk activation data shown findings imply ps1 mediated cleavage notch might involved mechanism ps1 induced suppression sapk pathway regard notch previously proposed play role regulation sapkjnk pathway ordentlich et al 1998 zecchini et al 1999
0.32985634.11331298.html.plaintext.txt	48	study demonstrate ps1 inhibits sapkjnk pathway ectopically expressed ps1 blocked stress induced stimulation sapkjnk upstream kinases including sek1 mekk1 fad linked ps1 mutants m146v c410y l286v also able inhibit sapk stimulation interestingly biologically inactive ps1 mutants d257a d385a shown lack secretase activation ps1 endoproteolysis wolfe et al 1999 failed inhibit sapk stimulation furthermore ps1ex9 lacks endoproteolysis site competent activation secretase activity li et al 2000 retained inhibitory effect sapkjnk pathway data suggest secretase activation rather ps1 endoproteolysis required ps1 induced inhibition sapkjnk pathway secretase two major substrates app notch de strooper et al 1998 de strooper et al 1999 cleavage app notch secretase produces ass intracellular domain notch notch ic respectively ass1 42 inhibit sapkjnk activity data shown comparison preliminary data showed overexpression notch intracellular domain active form intracellular notch resulted suppression sapkjnk activation data shown findings imply ps1 mediated cleavage notch might involved mechanism ps1 induced suppression sapk pathway regard notch previously proposed play role regulation sapkjnk pathway ordentlich et al 1998 zecchini et al 1999
0.32985634.11331298.html.plaintext.txt	49	several lines evidence suggest presenilins involved apoptosis kim tanzi 1997 kim et al 1997 overexpression ps2 shown potentiate apoptosis pc12 cells induced ngf withdrawal neurotoxic ass1 42 wolozin et al 1998 another study showed alg3 truncated form murine ps2 reduced cell receptor fas induced apoptosis mouse cell hybridoma vito et al 1996 studies using ps1 null mice demonstrated ps1 involved neuronal survival shen et al 1997 study show ectopic ps1 suppressed h2o2 induced apoptosis b103 neuroblastoma cells moreover deficiency ps1 caused elevation h2o2 induced apoptosis mef cells ps1 null mice compared mef cells ps1 wild type mice h2o2 induced apoptosis blocked overexpression sek1k129r suggesting sapkjnk pathway involved mechanism h2o2 induced apoptosis thus findings suggest ps1 inhibiting sapk pathway protect cells stress induced apoptotic cell death precise mechanism ps1 inhibits sapkjnk pathway however needs studied
0.32985634.11331298.html.plaintext.txt	50	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.32985634.11331298.html.plaintext.txt	51	work supported creative research initiatives program korean ministry science technology e j choi
0.32985634.11331298.html.plaintext.txt	52	submitted 2 november 2000 revised 14 march 2001 accepted 19 march 2001
0.32985634.11331298.html.plaintext.txt	53	references top abstract introduction materials methods results discussion acknowledgements references
0.3369568.15123598.html.plaintext.txt	0	presenilin proteins components multiple membrane bound complexes different biological activities yongjun gu nobuo sanjo fusheng chen hiroshi hasegawa agnes petit xueying ruan wenping li cortney shier toshitaka kawarai gerold schmitt ulms david westaway peter st george hyslop paul e fraser
0.3369568.15123598.html.plaintext.txt	1	centre research neurodegenerative diseases departments medicine laboratory medicine pathobiology medical biophysics university toronto 6 queens park crescent west toronto ontario m5s 3h2 canada department medicine division neurology toronto western hospital toronto ontario m5s 3h2 canada
0.3369568.15123598.html.plaintext.txt	2	received publication february 11 2004 revised form april 26 2004
0.3369568.15123598.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references several lines evidence indicated presenilin proteins function within macromolecular complexes necessary regulated intramembranous proteolysis certain type 1 transmembrane proteins including amyloid precursor protein notch p75 data multiple complementary experiments suggest may several distinct presenilin complexes show presenilin mutations certain detergents affect abundance componentry presenilin complexes structural effects correlate effects secretase activity data suggest least three complexes including 150 kda nicastrin aph 1 complex likely precursor complex stable abundant intermediate complex 440 kda contains aph 1 pen 2 nicastrin ps1 however low abundance high mass 670 kda heteromeric complexes associated highest secretase specific activity
0.3369568.15123598.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references several lines evidence indicated presenilin proteins function within macromolecular complexes necessary regulated intramembranous proteolysis certain type 1 transmembrane proteins including amyloid precursor protein notch p75 data multiple complementary experiments suggest may several distinct presenilin complexes show presenilin mutations certain detergents affect abundance componentry presenilin complexes structural effects correlate effects secretase activity data suggest least three complexes including 150 kda nicastrin aph 1 complex likely precursor complex stable abundant intermediate complex 440 kda contains aph 1 pen 2 nicastrin ps1 however low abundance high mass 670 kda heteromeric complexes associated highest secretase specific activity
0.3369568.15123598.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references initial cloning site mutations causing familial alzheimer disease 1 3 numerous functional studies shown presenilin proteins necessary unusual form proteolytic cleavage selected type 1 transmembrane proteins cleaved within hydrophobic transmembrane domains form regulated intramembranous proteolysis requires presence complex interacting membrane bound proteins including presenilin proteins aph 1 4 5 pen 2 5 nicastrin 6 others previously suggested although proteins clearly physically interact may fact form single complex 7 11 report results several complementary experiments directly support notion show functional secretase activity mostly arises low abundance high molecular weight complex 670 kda data continue raise possibility either additional proteins may present functional complexes functional complex higher order multimer presenilin aph 1 pen 2 nicastrin proteins data also provide partial structural explanation differential effects detergents certain mutations secretase activity
0.3369568.15123598.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references initial cloning site mutations causing familial alzheimer disease 1 3 numerous functional studies shown presenilin proteins necessary unusual form proteolytic cleavage selected type 1 transmembrane proteins cleaved within hydrophobic transmembrane domains form regulated intramembranous proteolysis requires presence complex interacting membrane bound proteins including presenilin proteins aph 1 4 5 pen 2 5 nicastrin 6 others previously suggested although proteins clearly physically interact may fact form single complex 7 11 report results several complementary experiments directly support notion show functional secretase activity mostly arises low abundance high molecular weight complex 670 kda data continue raise possibility either additional proteins may present functional complexes functional complex higher order multimer presenilin aph 1 pen 2 nicastrin proteins data also provide partial structural explanation differential effects detergents certain mutations secretase activity
0.3369568.15123598.html.plaintext.txt	7	experimental procedures top abstract introduction experimental procedures results discussion references immunocytochemistry kns human glioma cells mouse cerebellar glial cells a3 mouse cerebellar granule neurons cultured fixed described previously 8 12 cells permeabilized 04 triton x 100 pbs1 5 acetic acid ethanol 30 min room temperature cells blocked 5 normal goat serum pbs 1 h incubated overnight primary antibodies primary antibodies used study rabbit polyclonal antibody human aph 11 o2c2 8 guinea pig polyclonal antibody nicastrin chemicon temecula ca mouse monoclonal antibody ps1 nt1 gift paul m mathews secondary antibodies cy5 conjugated goat anti mouse igg cy3 conjugated goat anti guinea pig igg cy2 conjugated goat anti rabbit igg jackson immunoresearch laboratories west grove pa cells examined bio rad laser scanning confocal imaging system microradiance r2000ag 2 equipped lasersharp2000 software bio rad images processed using lasersharp2000 postprocessing software
0.3369568.15123598.html.plaintext.txt	8	experimental procedures top abstract introduction experimental procedures results discussion references immunocytochemistry kns human glioma cells mouse cerebellar glial cells a3 mouse cerebellar granule neurons cultured fixed described previously 8 12 cells permeabilized 04 triton x 100 pbs1 5 acetic acid ethanol 30 min room temperature cells blocked 5 normal goat serum pbs 1 h incubated overnight primary antibodies primary antibodies used study rabbit polyclonal antibody human aph 11 o2c2 8 guinea pig polyclonal antibody nicastrin chemicon temecula ca mouse monoclonal antibody ps1 nt1 gift paul m mathews secondary antibodies cy5 conjugated goat anti mouse igg cy3 conjugated goat anti guinea pig igg cy2 conjugated goat anti rabbit igg jackson immunoresearch laboratories west grove pa cells examined bio rad laser scanning confocal imaging system microradiance r2000ag 2 equipped lasersharp2000 software bio rad images processed using lasersharp2000 postprocessing software
0.3369568.15123598.html.plaintext.txt	9	cell culture sample preparation human embryonic kidney hek 293 cells cultured dulbeccos modified eagles medium plus 10 fetal bovine serum supplemented 200 microgml g418 cells stably expressing app c99 app695 swedish mutant ps1e9 andor 120 microgml zeocin cells stably expressing wild type ps1 mutant d385a presenilin 1 described previously 6 8 13 16
0.3369568.15123598.html.plaintext.txt	10	cells harvested homogenized buffer containing 20 mm hepes ph 74 150 mm nacl 10 glycerol complete protease inhibitor mixture roche applied science postnuclear supernatant collected centrifugation cell homogenates 1000 x g 5 min 15 ml eppendorf tubes membranous fractions pelleted centrifugation 100000 x g 1 h
0.3369568.15123598.html.plaintext.txt	11	cells harvested homogenized buffer containing 20 mm hepes ph 74 150 mm nacl 10 glycerol complete protease inhibitor mixture roche applied science postnuclear supernatant collected centrifugation cell homogenates 1000 x g 5 min 15 ml eppendorf tubes membranous fractions pelleted centrifugation 100000 x g 1 h
0.3369568.15123598.html.plaintext.txt	12	two dimensional gel electrophoresis western blotting first dimensional blue native bn polyacrylamide gel electrophoresis performed essentially described previously 17 brief microsomal membranes prepared described solubilized ice cold bn lysis buffer containing 1 wv detergent either digitonin chapso 500 mm 6 aminocaproic acid 50 mm bis tris ph 70 plus complete protease inhibitor mixture roche applied science lysate 100 microl centrifuged 100000 x g 20 min supernatant adjusted 05 volumes bn sample buffer containing 075 wv coomassie brilliant blue g 250 500 mm 6 aminocaproic acid 50 mm bis tris ph 70 30 glycerol 1 detergent samples separated 6 13 blue native polyacrylamide gel poured 1 day analysis described previously 17 marker proteins used bn page thyroglobulin 669 kda apoferritin 443 kda amylase 200 kda bovine serum albumin 66 kda sigma
0.3369568.15123598.html.plaintext.txt	13	two dimensional gel electrophoresis western blotting first dimensional blue native bn polyacrylamide gel electrophoresis performed essentially described previously 17 brief microsomal membranes prepared described solubilized ice cold bn lysis buffer containing 1 wv detergent either digitonin chapso 500 mm 6 aminocaproic acid 50 mm bis tris ph 70 plus complete protease inhibitor mixture roche applied science lysate 100 microl centrifuged 100000 x g 20 min supernatant adjusted 05 volumes bn sample buffer containing 075 wv coomassie brilliant blue g 250 500 mm 6 aminocaproic acid 50 mm bis tris ph 70 30 glycerol 1 detergent samples separated 6 13 blue native polyacrylamide gel poured 1 day analysis described previously 17 marker proteins used bn page thyroglobulin 669 kda apoferritin 443 kda amylase 200 kda bovine serum albumin 66 kda sigma
0.3369568.15123598.html.plaintext.txt	14	second dimensional sds page blue native gel destained 5 acetic acid25 methanol thorough washing 25 methanol individual lanes excised equilibrated 15 min two dimensional 2d sample buffer 125 mm tris hcl ph 88 6 m urea 2 sds 25 glycerol 1 dithiothreitol bromphenol blue gel strip loaded onto nu page bis tris 4 12 precast 2d gel invitrogen sds page
0.3369568.15123598.html.plaintext.txt	15	second dimensional sds page blue native gel destained 5 acetic acid25 methanol thorough washing 25 methanol individual lanes excised equilibrated 15 min two dimensional 2d sample buffer 125 mm tris hcl ph 88 6 m urea 2 sds 25 glycerol 1 dithiothreitol bromphenol blue gel strip loaded onto nu page bis tris 4 12 precast 2d gel invitrogen sds page
0.3369568.15123598.html.plaintext.txt	16	western blotting resolved proteins transferred nitrocellulose membrane target proteins visualized enhanced chemiluminescence ecl amersham biosciences primary antibodies mouse monoclonal anti nicastrin clone 35 bd transduction laboratories rabbit polyclonal anti nicastrin pai 758 affinity bioreagents rabbit anti aph 11 n terminal antibody o2c2 8 rabbit polyclonal antibody pen 2 gift c haass mouse monoclonal anti ps1 n terminal antibody nt1 gift p mathews rabbit polyclonal antibody ps1 ntf ab14 gift gandy intensity profiles western blotting signals plotted using nih image software rsbinfonihgovnih image
0.3369568.15123598.html.plaintext.txt	17	western blotting resolved proteins transferred nitrocellulose membrane target proteins visualized enhanced chemiluminescence ecl amersham biosciences primary antibodies mouse monoclonal anti nicastrin clone 35 bd transduction laboratories rabbit polyclonal anti nicastrin pai 758 affinity bioreagents rabbit anti aph 11 n terminal antibody o2c2 8 rabbit polyclonal antibody pen 2 gift c haass mouse monoclonal anti ps1 n terminal antibody nt1 gift p mathews rabbit polyclonal antibody ps1 ntf ab14 gift gandy intensity profiles western blotting signals plotted using nih image software rsbinfonihgovnih image
0.3369568.15123598.html.plaintext.txt	18	glycerol velocity gradients hek293 cells stably expressing app c99 washed 4 degrees c cold pbs resuspended 5 mm hepes ph 74 1 mm edta 025 m sucrose plus protease inhibitors homogenized postnuclear supernatant prepared described previously 16 microsomal membranes pelleted postnuclear supernatant centrifugation 100000 x g 1 h 4 degrees c lysised 1 chapso 50 mm tris hcl ph 75 2 mm edta 150 mm nacl plus protease inhibitors lysates re centrifuged 100000 x g 30 min supernatants used glycerol gradient centrifugation fractionation experiments described previously 7 brief 1 ml total protein extracts applied top 110 ml 10 40 wv linear glycerol gradient containing 25 mm hepes ph 72 150 mm nacl 05 chapso gradients centrifuged 15 h 35000 rpm 4 degrees c using beckman sw41 rotor collected 10 ml fractions top centrifugation tube
0.3369568.15123598.html.plaintext.txt	19	cell free secretase assay chapso solubilized membranes resolved glycerol velocity gradient fractionation precleared preimmune serum linked beads incubated overnight 4 degrees c antibody ps1 n terminus antibody 14 cross linked protein sepharose dimethylpimelimidate sigma immunopurified high molecular weight ps1 complexes washed assay buffer resuspended 025 detergent chapso digitonin containing assay buffer ph 64 10 mm koac 15 mm mgcl2 75 mm sodium citrate containing protease inhibitors incubated 37 degrees c 4 h generate stubs control samples kept ice end assay samples resuspended sds sample buffer 4 sds 450 mm tris 12 glycerol 00025 coomassie blue g 00025 phenol red ph 84 used western blotting measure appearance stubs described previously 16
0.3369568.15123598.html.plaintext.txt	20	cell free secretase assay chapso solubilized membranes resolved glycerol velocity gradient fractionation precleared preimmune serum linked beads incubated overnight 4 degrees c antibody ps1 n terminus antibody 14 cross linked protein sepharose dimethylpimelimidate sigma immunopurified high molecular weight ps1 complexes washed assay buffer resuspended 025 detergent chapso digitonin containing assay buffer ph 64 10 mm koac 15 mm mgcl2 75 mm sodium citrate containing protease inhibitors incubated 37 degrees c 4 h generate stubs control samples kept ice end assay samples resuspended sds sample buffer 4 sds 450 mm tris 12 glycerol 00025 coomassie blue g 00025 phenol red ph 84 used western blotting measure appearance stubs described previously 16
0.3369568.15123598.html.plaintext.txt	21	results top abstract introduction experimental procedures results discussion references apparent stoichiometric discrepancy predominant localization presenilin complex components within early secretory pathway eg ps1 aph 1 versus functional observation secretase cleavage notch app occur predominantly near cell surface explore undertook immunocytochemical studies endogenous presenilin components kns glioma cells mouse cerebellar granule neurons shown mouse cerebellar glial cells fig 1 immediately apparent although overlap distributions proteins degree overlap far perfect spatial co registration fig 1 results hint either may one type complex formed various different combinations proteins complex components might added complexes spatially temporally defined order conclusion may single presenilin complex would good agreement previously published biochemical experiments shown aph 1 immature forms nicastrin co fractionate separately ps1 pen 2 glycerol velocity gradient 2d gel electrophoretic fractionations 8 9 nicastrin aph 1 pen 2 presenilins indeed form single type complex immediately begs question whether complexes secretase activity
0.3369568.15123598.html.plaintext.txt	22	view larger version 56k fig 1 mouse cerebellar glial cells a3 investigated confocal microscopy prepared fixed co stained anti aph 11 red anti nicastrin green anti ps1 blue antibodies described experimental procedures top row two components showed partial overlap bottom row three components showed modest overlap b
0.3369568.15123598.html.plaintext.txt	23	begin address issues undertook detailed 2d gel electrophoresis studies using bn gel electrophoresis first dimension followed standard sds page gel electrophoresis second dimension initial cell lysates hek293 cells expressing appswedish prepared using 1 chapso solubilizing detergent least two distinct ps1 immunoreactive spots identified 440 670 kda together smear pattern even higher masses fig 2 left 440 670 kda complexes contained maturely glycosylated nicastrin aph 1 pen 2 ps1 ntf ps1 ctf however 670 kda complex contained app ctfs observations unlikely simply represent idiosyncrasies gel electrophoresis methodology broad distribution complexes ranging 150 670 kda also seen lysates resolved glycerol velocity gradients fig 3a left resolution individual complexes less robust unidimensional glycerol velocity gradients glycerol velocity gradients resolve proteins according relative buoyancy rather charge mass gel electrophoretic separations predicted mass measurements identical 2d gel studies velocity gradients nevertheless general agreement result 2d gels immature nicastrin one two peaks aph 1 enriched lower molecular weight fractions 100 200 kda fig 3a left fractions 3 5 hand ps1 pen 2 maturely glycosylated nicastrin enriched higher molecular weight fractions 200 670 kda secondary peak aph 1 440 kda fig 3a left fraction 8
0.3369568.15123598.html.plaintext.txt	24	begin address issues undertook detailed 2d gel electrophoresis studies using bn gel electrophoresis first dimension followed standard sds page gel electrophoresis second dimension initial cell lysates hek293 cells expressing appswedish prepared using 1 chapso solubilizing detergent least two distinct ps1 immunoreactive spots identified 440 670 kda together smear pattern even higher masses fig 2 left 440 670 kda complexes contained maturely glycosylated nicastrin aph 1 pen 2 ps1 ntf ps1 ctf however 670 kda complex contained app ctfs observations unlikely simply represent idiosyncrasies gel electrophoresis methodology broad distribution complexes ranging 150 670 kda also seen lysates resolved glycerol velocity gradients fig 3a left resolution individual complexes less robust unidimensional glycerol velocity gradients glycerol velocity gradients resolve proteins according relative buoyancy rather charge mass gel electrophoretic separations predicted mass measurements identical 2d gel studies velocity gradients nevertheless general agreement result 2d gels immature nicastrin one two peaks aph 1 enriched lower molecular weight fractions 100 200 kda fig 3a left fractions 3 5 hand ps1 pen 2 maturely glycosylated nicastrin enriched higher molecular weight fractions 200 670 kda secondary peak aph 1 440 kda fig 3a left fraction 8
0.3369568.15123598.html.plaintext.txt	25	view larger version 73k fig 2 two dimensional gel electrophoresis presenilin complexes hek293 cells expressing appswedish solubilized 1 chapso left 1 digitonin right reveal presence several distinct complexes chapso supports secretase activity cell free assays least two heteromeric complexes 670 440 kda containing ps1 nicastrin nct aph 1 pen 2 digitonin support secretase activity cell free assays abundance 670 kda complex dramatically reduced
0.3369568.15123598.html.plaintext.txt	26	view larger version 38k fig 3 glycerol velocity gradient analyses membrane preparations containing presenilin complexes solubilized 1 chapso left 1 digitonin right studies confirm existence low molecular mass 150 kda complex enriched aph 1 immature nicastrin lanes 3 4 one higher molecular weight complexes 200 670 kda containing ps1 varying amounts mature nicastrin nct aph 1 pen 2 lanes 5 11 like 2d gel studies 670 kda complexes lanes 8 11 essentially absent membranes solubilized 1 digitonin b cell free secretase assays performed pooled fractions chapso glycerol velocity gradients left3 digitonin glycerol velocity gradients right compared control fractions incubated 0 degrees c top left stubs actively generated chapso solubilized fractions 5 6 7 8 9 10 11 12 incubated 37 degrees c 4 h middle left highest specific activity relative starting amount ps1 fractions 9 10 11 12 lower left ps1 complexes digitonin solubilized fractions failed co immunoprecipitate app ctfs consequently failed generate stubs right failure generate stubs digitonin solubilized ps1 complexes could reversed adding additional exogenous app ctfs see fig 3d addition digitonin chapso solubilized ps1 complexes docked substrate also resulted loss secretase activity data shown arguing digitonin alters conformation andor componentry ps1 complex rendering non functional c histograms specific secretase activity pooled fractions glycerol velocity gradients secretase activity calculated quantity stubs producedquantity stubs produced plus residual app ctfs relative amount ps1 fraction pooled fractions containing proteins molecular mass less 600 kda fractions 3 6 3 8 less secretase activity fractions proteins molecular mass greater 600 kda fractions 9 12 d addition exogenous substrate app c99 resulted robust generation stubs chapso solubilized ps1 complexes chp incubated 37 degrees c failed induce stub production 4 degrees c negative control digitonin solubilized membranes dig temperature result argues absence stub generation digitonin solubilized ps1 complexes b right caused failure digitonin solubilized ps1 complexes dock secretase substrates
0.3369568.15123598.html.plaintext.txt	27	150 kda aph 1 nicastrin complex unlikely subserve catalytic activity present ps1 cells support secretase activity experiments alone possible conclude higher mass complexes associated functional secretase activity attempts measure activity specific complexes isolated 2d gels successful presumably low abundance properly folded complexes recovered circumvent problem elected use three complementary strategies might taken together indirectly infer complexes necessary functional activity three approaches 1 direct ascertainment functional secretase activity glycerol velocity gradient fractions 2 analysis differential effects detergents secretase activity complex composition complex size 3 analysis differential effects ps1 mutations secretase activity complex composition complex size
0.3369568.15123598.html.plaintext.txt	28	150 kda aph 1 nicastrin complex unlikely subserve catalytic activity present ps1 cells support secretase activity experiments alone possible conclude higher mass complexes associated functional secretase activity attempts measure activity specific complexes isolated 2d gels successful presumably low abundance properly folded complexes recovered circumvent problem elected use three complementary strategies might taken together indirectly infer complexes necessary functional activity three approaches 1 direct ascertainment functional secretase activity glycerol velocity gradient fractions 2 analysis differential effects detergents secretase activity complex composition complex size 3 analysis differential effects ps1 mutations secretase activity complex composition complex size
0.3369568.15123598.html.plaintext.txt	29	estimate secretase activity complexes used cell free assay 16 investigate generation stubs anti ps1 immunopurified membranes solubilized 1 chapso resolved size glycerol velocity gradients highest specific secretase activity relative amount ps1 ntf fraction found higher mass fractions 500 kda glycerol velocity gradient specific activity 346 plus minus 147 443 plus minus 171 fractions 9 10 11 12 respectively compared 121 plus minus 97 235 plus minus 1063 fractions 3 4 5 6 respectively p 005 fig 3 b lower left c
0.3369568.15123598.html.plaintext.txt	30	estimate secretase activity complexes used cell free assay 16 investigate generation stubs anti ps1 immunopurified membranes solubilized 1 chapso resolved size glycerol velocity gradients highest specific secretase activity relative amount ps1 ntf fraction found higher mass fractions 500 kda glycerol velocity gradient specific activity 346 plus minus 147 443 plus minus 171 fractions 9 10 11 12 respectively compared 121 plus minus 97 235 plus minus 1063 fractions 3 4 5 6 respectively p 005 fig 3 b lower left c
0.3369568.15123598.html.plaintext.txt	31	previous vitro studies shown chapso optimum detergent preserving secretase activity cell free membrane preparations secretase activity significantly reduced digitonin completely abolished triton x 100 n octyl glucoside many detergents 18 19 glycerol velocity 2d gel electrophoretic experiments repeated using digitonin significant 100 fold reduction abundance high molecular weight presenilin complexes 2d gel electrophoreses fig 2 right glycerol velocity fractionation experiments fig 3a right furthermore fractions contain little co immunoprecipitating app ctfs failed generate significant quantities stubs cell free secretase assay fig 3b right confirm absence secretase activity digitonin solubilized fractions caused failure docking cleavage app ctfs digitonin solubilized complexes opposed artifacts simple degradation app ctfs assay performed two additional experiments first immunopurified chapso solubilized ps1 complexes split product two aliquots one aliquot submitted directly secretase assay whereas digitonin added aliquot final concentration 025 submitted secretase assay stubs generated aliquot containing digitonin data shown second experiment simply added additional purified app c99 chapso solubilized digitonin solubilized ps1 complexes fig 3d despite abundant presence substrate digitonin solubilized ps1 complexes failed generate stubs fig 3d taken together experiments suggest digitonin solubilized ps1 complexes undergone either conformational shift andor lost substrated adaptor protein presenilin complexes solubilized 1 triton x 100 1 n octyl glucoside neither support secretase activity high molecular weight presenilin complex species essentially abolished monomeric species found data shown
0.3369568.15123598.html.plaintext.txt	32	previous vitro studies shown chapso optimum detergent preserving secretase activity cell free membrane preparations secretase activity significantly reduced digitonin completely abolished triton x 100 n octyl glucoside many detergents 18 19 glycerol velocity 2d gel electrophoretic experiments repeated using digitonin significant 100 fold reduction abundance high molecular weight presenilin complexes 2d gel electrophoreses fig 2 right glycerol velocity fractionation experiments fig 3a right furthermore fractions contain little co immunoprecipitating app ctfs failed generate significant quantities stubs cell free secretase assay fig 3b right confirm absence secretase activity digitonin solubilized fractions caused failure docking cleavage app ctfs digitonin solubilized complexes opposed artifacts simple degradation app ctfs assay performed two additional experiments first immunopurified chapso solubilized ps1 complexes split product two aliquots one aliquot submitted directly secretase assay whereas digitonin added aliquot final concentration 025 submitted secretase assay stubs generated aliquot containing digitonin data shown second experiment simply added additional purified app c99 chapso solubilized digitonin solubilized ps1 complexes fig 3d despite abundant presence substrate digitonin solubilized ps1 complexes failed generate stubs fig 3d taken together experiments suggest digitonin solubilized ps1 complexes undergone either conformational shift andor lost substrated adaptor protein presenilin complexes solubilized 1 triton x 100 1 n octyl glucoside neither support secretase activity high molecular weight presenilin complex species essentially abolished monomeric species found data shown
0.3369568.15123598.html.plaintext.txt	33	functional secretase activity also modulated selected mutations presenilin proteins particular mutation either two aspartyl residues within membrane embedded hydrophobic domains ps1 d257a ps1 d385a associated loss proteolytic activity 20 22 therefore investigated structure relative abundance presenilin complexes isolated cells overexpressing either wild type ps1 ps1 d385a loss function mutant shown previously ps1 d385a mutation causes reduction abundance higher mw species glycerol velocity gradient fractionation 23 also shown reduction caused simple failure endoproteolytic cleavage ps1 23 thus high molecular weight complexes comparable size wild type ps1 ntfctfs observed cells expressing holoprotein ps1 exon 9 deletion mutant causes increased 42 secretase activity impaired ps1 endoproteolysis 23 agreement prior observations current 2d gel analyses ps1 d385a mutation associated altered distribution complexes components fig 4 thus 670 kda complex absent digitonin solubilized lysates ps1 d385a expressing cells displayed 440 kda complex monomeric bands nicastrin 110 kda ps1 d385a holoprotein 65 kda observed fig 4a right similar less profound changes relative abundance 670 440 kda complexes also apparent chapso solubilization fig 4 b f thus cells expressing wild type ps1 fig 4 b left c f greater abundance 670 kda complex relative 440 kda complexes 670 kda470 kda ratio 111 plus minus 015 n 4 replications however ps1 d385a overexpressing cells fig 4 b right c f significant loss 670 kda complex corresponding overabundance 440 kda complex 670 kda440 kda ratio 057 plus minus 003 p 0002
0.3369568.15123598.html.plaintext.txt	34	functional secretase activity also modulated selected mutations presenilin proteins particular mutation either two aspartyl residues within membrane embedded hydrophobic domains ps1 d257a ps1 d385a associated loss proteolytic activity 20 22 therefore investigated structure relative abundance presenilin complexes isolated cells overexpressing either wild type ps1 ps1 d385a loss function mutant shown previously ps1 d385a mutation causes reduction abundance higher mw species glycerol velocity gradient fractionation 23 also shown reduction caused simple failure endoproteolytic cleavage ps1 23 thus high molecular weight complexes comparable size wild type ps1 ntfctfs observed cells expressing holoprotein ps1 exon 9 deletion mutant causes increased 42 secretase activity impaired ps1 endoproteolysis 23 agreement prior observations current 2d gel analyses ps1 d385a mutation associated altered distribution complexes components fig 4 thus 670 kda complex absent digitonin solubilized lysates ps1 d385a expressing cells displayed 440 kda complex monomeric bands nicastrin 110 kda ps1 d385a holoprotein 65 kda observed fig 4a right similar less profound changes relative abundance 670 440 kda complexes also apparent chapso solubilization fig 4 b f thus cells expressing wild type ps1 fig 4 b left c f greater abundance 670 kda complex relative 440 kda complexes 670 kda470 kda ratio 111 plus minus 015 n 4 replications however ps1 d385a overexpressing cells fig 4 b right c f significant loss 670 kda complex corresponding overabundance 440 kda complex 670 kda440 kda ratio 057 plus minus 003 p 0002
0.3369568.15123598.html.plaintext.txt	35	view larger version 82k fig 4 loss function ps1 d385a mutant alters abundance size distribution ps1 complexes 2d gel analyses digitonin solubilized membrane preparations hek293 cells overexpressing wild type ps1 left ps1 d385a mutant right ps1 d385a cells show accumulation 440 kda complex loss 670 kda complex 150 kda nicastrinaph 1 complex b 2d gel analyses chapso solubilized membranes preparations hek293 cells overexpressing wild type ps1 left ps1 d385a mutant right wild type ps1 cells show equal greater abundance 670 kda complex compared 440 kda complexes contrast ps1d385a mutant cells show greater abundance 440 kda complex relative loss 670 kda complex c f confirm results direct visual interpretations intensity profiles western blotting signals plotted using nih image software solid line wild type ps1 dotted line ps1 d385a peak heights computed 440 670 kda complexes data used compare effects detergents ps1 mutations using 670 kda440 kda peak height ratio wild type ps1 expressing cells 670 kda complex predominated whereas ps1 d385a mutant cells 440 kda complex predominated p 0002
0.3369568.15123598.html.plaintext.txt	36	discussion top abstract introduction experimental procedures results discussion references immunocytochemical data data glycerol velocity gradient 2d gel electrophoretic separations functional data arising differential effects detergents ps1 mutations cumulatively argue several authentic independent complexes different molecular masses although techniques differs observed sizes complexes results congruent therefore seems unlikely apparently distinct complexes artifacts probable explanation multiplicity complexes relates maturation presenilin complex functional regulation based upon fact aph 1 relatively stable absence ps1 binds immature nicastrin previously suggested aph 1 initial scaffolding molecule upon functional complex built 8 supported fact ps1 cells 150 kda aph 1 nicastrin complex stable contains immature nicastrin whereas 440 670 kda complexes destabilized propose 440 kda complex contains additional components aph 1 ps1 nicastrin pen 2 dock app ctf substrate efficiently relatively abundant non functional intermediary complex support 440 kda complex stably present conditions associated functional secretase activity ie presence digitonin ps1 d385a missense loss function mutation prevalence albeit low levels abundance high molecular weight 670 kda complex conditions associated functional secretase activity suggests complexes species contain full enzymatic activity directly supported fact highest specific activity secretase activity obtained glycerol velocity fractions containing complexes 500 kda
0.3369568.15123598.html.plaintext.txt	37	discussion top abstract introduction experimental procedures results discussion references immunocytochemical data data glycerol velocity gradient 2d gel electrophoretic separations functional data arising differential effects detergents ps1 mutations cumulatively argue several authentic independent complexes different molecular masses although techniques differs observed sizes complexes results congruent therefore seems unlikely apparently distinct complexes artifacts probable explanation multiplicity complexes relates maturation presenilin complex functional regulation based upon fact aph 1 relatively stable absence ps1 binds immature nicastrin previously suggested aph 1 initial scaffolding molecule upon functional complex built 8 supported fact ps1 cells 150 kda aph 1 nicastrin complex stable contains immature nicastrin whereas 440 670 kda complexes destabilized propose 440 kda complex contains additional components aph 1 ps1 nicastrin pen 2 dock app ctf substrate efficiently relatively abundant non functional intermediary complex support 440 kda complex stably present conditions associated functional secretase activity ie presence digitonin ps1 d385a missense loss function mutation prevalence albeit low levels abundance high molecular weight 670 kda complex conditions associated functional secretase activity suggests complexes species contain full enzymatic activity directly supported fact highest specific activity secretase activity obtained glycerol velocity fractions containing complexes 500 kda
0.3369568.15123598.html.plaintext.txt	38	two potential explanations results first straightforward explanation complexes reflect evolution presenilin complexes assembled lower mass 150 440 kda complexes might represent initial intermediary complexes whereas low abundance high mass complexes 670 kda could represent functional complexes contain either additional components contain four known components higher order stoichiometry eg 2222 direct experiments analyzing composition complexes required resolve possibility however two caveats hypothesis first small measurable amounts 670 kda complexes still present chapso lysates ps1 d385a cells although complexes considerably reduced abundance relative 440 kda complexes completely negate hypothesis 670 kda complexes functional conform substantial proportion ps1 d385a molecules clearly aberrant conformational 440 kda state chapso nearly ps1 d385a molecules 400 kda complex digitonin result probable ps1 d385a molecules 670 kda complexes chapso entirely normal conform second caveat concerning postulated hierarchy complexes arises observation ps1 d385a expressing cells assemble robust nicastrin aph 1 150 kda complex could argued 150 kda nicastrinaph 1 complex precursor complex postulated represents downstream catabolic product 440 670 kda complexes stable presence 150 kda complex ps1 cells makes hypothesis unlikely alternate explanation disappearance 150 kda complex ps1 d385a cells ps1 cells 150 kda complex could dual role complex could involved presenting new nicastrin molecules 440 kda complexes involved recovering re presenting used nicastrin molecules back 440 kda complex conceivable presence ps1 d385a mutant available aph 1 might become locked ps1 d385a mutant 440 kda complex fails mature thereby causing disappearance 150 kda nicastrin aph 1 complex
0.3369568.15123598.html.plaintext.txt	39	two potential explanations results first straightforward explanation complexes reflect evolution presenilin complexes assembled lower mass 150 440 kda complexes might represent initial intermediary complexes whereas low abundance high mass complexes 670 kda could represent functional complexes contain either additional components contain four known components higher order stoichiometry eg 2222 direct experiments analyzing composition complexes required resolve possibility however two caveats hypothesis first small measurable amounts 670 kda complexes still present chapso lysates ps1 d385a cells although complexes considerably reduced abundance relative 440 kda complexes completely negate hypothesis 670 kda complexes functional conform substantial proportion ps1 d385a molecules clearly aberrant conformational 440 kda state chapso nearly ps1 d385a molecules 400 kda complex digitonin result probable ps1 d385a molecules 670 kda complexes chapso entirely normal conform second caveat concerning postulated hierarchy complexes arises observation ps1 d385a expressing cells assemble robust nicastrin aph 1 150 kda complex could argued 150 kda nicastrinaph 1 complex precursor complex postulated represents downstream catabolic product 440 670 kda complexes stable presence 150 kda complex ps1 cells makes hypothesis unlikely alternate explanation disappearance 150 kda complex ps1 d385a cells ps1 cells 150 kda complex could dual role complex could involved presenting new nicastrin molecules 440 kda complexes involved recovering re presenting used nicastrin molecules back 440 kda complex conceivable presence ps1 d385a mutant available aph 1 might become locked ps1 d385a mutant 440 kda complex fails mature thereby causing disappearance 150 kda nicastrin aph 1 complex
0.3369568.15123598.html.plaintext.txt	40	second observation note results fact c terminal fragments app arising secretase cleavage app holoprotein substrates presenilin dependent secretase cleavage uniformly present presenilin complexes see figs 3 4 fact app c terminal stubs abundant complexes associated functional secretase activity increase apparent molecular mass non functional complexes functional complexes cannot accounted simple addition one molecule c terminal app stubs per complex although cannot exclude possibility multiple app stubs docked onto functional complexes however differential presence app ctfs raises intriguing plausible possibility detergents mutants associated loss secretase activity either 1 altered conformation andor complex stoichiometry way precludes efficient docking substrates 2 perturbed binding adapter molecules might required allow substrate docking keeping hypothesis recent cross competition assays different classes secretase inhibitors supported notion substrate binding catalytic sites secretase may physically separate correct conformational shifts required bring bound substrate catalytic site 24
0.3369568.15123598.html.plaintext.txt	41	conclusion experiments suggest maturation functional deployment presenilin proteins complex previously thought data raise possibility additional components may exist high molecular mass functional complexes results also require detailed assessment whether substrates undergo presenilin dependent proteolysis dependent set presenilin complexes whether specialized complexes subserving cleavage specific proteins instance conceivable complexes may differ componentry according subcellular distribution eg lipid rich raft domains plasma membrane endosomal lysosomal pathway autophagic vacuoles 25 29 case site specific composition complex might confer either substrate specificity preferred proteolytic cleavage sites within transmembrane domains might therefore potentially exploited therapeutically
0.3369568.15123598.html.plaintext.txt	42	conclusion experiments suggest maturation functional deployment presenilin proteins complex previously thought data raise possibility additional components may exist high molecular mass functional complexes results also require detailed assessment whether substrates undergo presenilin dependent proteolysis dependent set presenilin complexes whether specialized complexes subserving cleavage specific proteins instance conceivable complexes may differ componentry according subcellular distribution eg lipid rich raft domains plasma membrane endosomal lysosomal pathway autophagic vacuoles 25 29 case site specific composition complex might confer either substrate specificity preferred proteolytic cleavage sites within transmembrane domains might therefore potentially exploited therapeutically
0.3369568.15123598.html.plaintext.txt	43	footnotes work supported grants canadian institutes health research howard hughes medical institute alzheimer society ontario scottish rite charitable foundation canada costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3369568.15123598.html.plaintext.txt	44	footnotes work supported grants canadian institutes health research howard hughes medical institute alzheimer society ontario scottish rite charitable foundation canada costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3369568.15123598.html.plaintext.txt	45	authors contributed equally work
0.3369568.15123598.html.plaintext.txt	46	correspondence addressed p st george hyslop centre research neurodegenerative diseases tanz neuroscience bldg university toronto 6 queens park crescent west toronto ontario m5s 3h2 canada tel 416 978 7461 fax 416 978 1878 e mail physlopatutorontoca u d
0.3369568.15123598.html.plaintext.txt	47	1 abbreviations used pbs phosphate buffered saline bn blue native chapso 3 3 cholamidopropyldimethylammonio 2 hydroxy 1 propanesulfonic acid 2d two dimensional hek human embryonic kidney aph 1 anterior pharynx defective 1 pen 2 presenilin enhancer 2 ps1 presenilin 1 app amyloid precursor protein ntf n terminal fragment ctf c terminal fragment bis tris 2 bis2 hydroxyethylamino 2 hydroxymethylpropane 13 diol
0.3369568.15123598.html.plaintext.txt	48	references top abstract introduction experimental procedures results discussion references sherrington r rogaev e liang y rogaeva e levesque g ikeda m chi h lin c holman k tsuda mar l fraser p rommens j m st george hyslop p 1995 nature 375 754 760crossrefmedline order article via infotrieve rogaev e sherrington r rogaeva e levesque g ikeda m liang y chi h lin c holman k tsuda mar l sorbi nacmias b piacentini amaducci l chumakov cohen d lannfelt l fraser p e rommens j m st george hyslop p 1995 nature 376 775 778crossrefmedline order article via infotrieve levy lahad e wijsman e m nemens e anderson l goddard k weber j l bird d schellenberg g d 1995 science 269 970 973medline order article via infotrieve goutte c tsunozaki m hale v priess j r 2002 proc natl acad sci u 99 775 779abstractfree full text francis r mcgrath g zhang j ruddy d sym m apfeld j nicoll m maxwell m hai b ellis m c parks l xu w li j gurney m myers r l himes c hiebsch r ruble c nye j curtis d 2002 dev cell 3 85 97medline order article via infotrieve yu g nishimura m arawaka levitan d zhang l tandon song y rogaeva e chen f kawarai supala levesque l yu h yang d holmes e milman p liang y zhang d m xu d h x sato c rogaev e smith m janus c zhang y aebersold r farrer l sorbi bruni c fraser p e st george hyslop p h 2000 nature 407 48 54crossrefmedline order article via infotrieve yu g chen f levesque g nishimura m zhang d m levesque l rogaeva e xu d liang y duthie m st george hyslop p fraser p e 1998 j biol chem 273 16470 16475abstractfree full text gu y chen f sanjo n kawarai hasegawa h duthie m li w ruan x luthra mount h tandon fraser p e st george hyslop p 2003 j biol chem 278 7374 7380abstractfree full text lavoie m j fraering p c ostaszewski b l ye w kimberly w wolfe m selkoe d j 2003 j biol chem 278 37213 37222abstractfree full text fraering p c lavoie m j ye w ostaszewski b l kimberly w selkoe d j wolfe m 2004 biochemistry 43 323 333crossrefmedline order article via infotrieve culvenor j g ilaya n ryan m canterford l hoke d e williamson n mclean c masters c l evin g 2004 eur j biochem 271 375 385abstractfree full text yang d tandon chen f yu g yu h arawaka hasegawa h duthie m schmidt d ramabhadran v nixon r mathews p m gandy e mount h st george hyslop p fraser p e 2002 j biol chem 277 28135 28142abstractfree full text chen f yang d tandon rozmahel r yu g nishimura m kawarai westaway d gandy e fraser p e st george hyslop p fraser p e 2000 j biol chem 275 36794 36802abstractfree full text chen f yu g arawaka nishimura m kawarai yu h tandon supala song y rogaeva e milman p sato c yu c janus c lee j song l zhang l fraser p st george hyslop p 2001 nat cell biol 3 751 754crossrefmedline order article via infotrieve nishimura m yu g levesque g zhang d m ruel l chen f milman p holmes e liang y kawarai jo e supala rogaeva e xu d m janus c levesque l bi q duthie m rozmahel r mattila k lannfelt l westaway d mount h woodgett j fraser p st george hyslop p 1999 nat med 5 164 169crossrefmedline order article via infotrieve chen f gu y hasegawa h ruan x arawaka fraser p westaway d mount h st george hyslop p 2002 j biol chem 277 36521 36526abstractfree full text schagger h von jagow g 1991 anal biochem 199 223 231medline order article via infotrieve li y m lai m xu m huang q dimuzio mower j sardana m k shi x p yin k c shafer j gardell j 2000 proc natl acad sci u 97 6138 6143abstractfree full text pinnix musunuru u tun h sridharan golde eckman c ziani cherif c onstead l sambamurti k 2001 j biol chem 276 481 487abstractfree full text wolfe m xia w ostaszewski b l diehl kimberly w selkoe d 1999 nature 398 513 517crossrefmedline order article via infotrieve steiner h kostka m romig h basset g pesold b hardy j capell meyn l grim m l baumeister r fechteler k haass c 2000 nat cell biol 2 848 851crossrefmedline order article via infotrieve steiner h duff k capell romig h grim m g lincoln hardy j yu x picciano m fechteler k citron m kopan r pesold b keck baader m tomita iwatsubo baumeister r haass c 1999 j biol chem 274 28669 28673abstractfree full text yu g chen f nishimura m steiner h tandon kawarai arawaka supala song y q rogaeva e holmes e zhang d m milman p fraser p haass c st george hyslop p 2000 j biol chem 275 27348 27353abstractfree full text tian g ghanekar v aharony d shenvi b jacobs r liu x greenberg b d 2003 j biol chem 278 28968 28975abstractfree full text hayashi h mizuno michikawa m haass c yanagisawa k 2000 biochim biophys acta 1483 81 90medline order article via infotrieve lee j liyanage u bickel p xia w lansbury p kosik k 1998 nat med 4 730 734medline order article via infotrieve haass c koo e h mellon hung y selkoe d j 1992 nature 357 500 503crossrefmedline order article via infotrieve koo e h squazzo l 1994 j biol chem 269 17386 17389abstractfree full text nixon r mathews p m cataldo m 2001 j alzheimers dis 3 97 107medline order article via infotrieve
0.33924845.15583026.html.plaintext.txt	0	rockefeller university press 0021 9525 800 jcb volume 167 number 5 809 812 article abstract pdf full text alert article cited citation map services alert new content jcb download citation manager google scholar articles kaether c articles haass c articles citing article pubmed pubmed citation articles kaether c articles haass c comment
0.33924845.15583026.html.plaintext.txt	1	rockefeller university press 0021 9525 800 jcb volume 167 number 5 809 812 article abstract pdf full text alert article cited citation map services alert new content jcb download citation manager google scholar articles kaether c articles haass c articles citing article pubmed pubmed citation articles kaether c articles haass c comment
0.33924845.15583026.html.plaintext.txt	2	lipid boundary separates app secretases limits amyloid ss peptide generation christoph kaether christian haass
0.33924845.15583026.html.plaintext.txt	3	adolf butenandt institute department biochemistry laboratory alzheimers parkinsons disease research ludwig maximilians university 80336 munchen germany
0.33924845.15583026.html.plaintext.txt	4	correspondence christian haass chaassatmeduni muenchende
0.33924845.15583026.html.plaintext.txt	5	abstract millions patients suffer alzheimers disease intensive efforts find cure devastating disorder center proteases release deadly amyloid ss peptide precursor cutting procedure thought cholesterol dependent strategies lower cholesterol therapeutic treatment intensive investigation recent findings suggest complete proteolytic machinery required amyloid ss peptide generation located within lipid rafts data dotti colleagues abad rodriguez et al 2004 issue suggest rafts isolate cutting machinery away deadly substrate findings describe novel mechanism controlling proteolytic activity building lipid boundary proteases substrates
0.33924845.15583026.html.plaintext.txt	6	abstract millions patients suffer alzheimers disease intensive efforts find cure devastating disorder center proteases release deadly amyloid ss peptide precursor cutting procedure thought cholesterol dependent strategies lower cholesterol therapeutic treatment intensive investigation recent findings suggest complete proteolytic machinery required amyloid ss peptide generation located within lipid rafts data dotti colleagues abad rodriguez et al 2004 issue suggest rafts isolate cutting machinery away deadly substrate findings describe novel mechanism controlling proteolytic activity building lipid boundary proteases substrates
0.33924845.15583026.html.plaintext.txt	7	abbreviations used paper ass amyloid ss peptide ad alzheimers disease app ss amyloid precursor protein
0.33924845.15583026.html.plaintext.txt	8	developed countries humans live longer longer although wish enjoy increased longevity longer life unfortunately associated dramatic increase risk alzheimers disease ad widely recognized years numerous scientists studied cellular mechanisms causing ad goal finally identifying targets treatment indeed likely genes directly involved generation deadly amyloid ss peptide ass forms disease defining amyloid plaques identified haass 2004 currently clear ass generated proteolytic processing ss amyloid precursor protein app two amyloidogenic secretases ss secretase involved fig 1 ss secretase ss site app cleaving enzyme bace typical aspartyl protease secretase however unusual aspartyl protease complex composed four individual proteins presenilin nicastrin aph 1 pen 2 presenilin carrying protease active site haass 2004 secretase uncommon molecular composition also proteolytic activity since able cleave substrate within membrane fig 1 prerequisite intramembrane cut release ectodomain app via cleavage bace secretase removal ectodomain bace results production ass following secretase cleavage whereas ectodomain cleavage secretase nonamyloidogenic since cuts within ass domain fig 1
0.33924845.15583026.html.plaintext.txt	9	developed countries humans live longer longer although wish enjoy increased longevity longer life unfortunately associated dramatic increase risk alzheimers disease ad widely recognized years numerous scientists studied cellular mechanisms causing ad goal finally identifying targets treatment indeed likely genes directly involved generation deadly amyloid ss peptide ass forms disease defining amyloid plaques identified haass 2004 currently clear ass generated proteolytic processing ss amyloid precursor protein app two amyloidogenic secretases ss secretase involved fig 1 ss secretase ss site app cleaving enzyme bace typical aspartyl protease secretase however unusual aspartyl protease complex composed four individual proteins presenilin nicastrin aph 1 pen 2 presenilin carrying protease active site haass 2004 secretase uncommon molecular composition also proteolytic activity since able cleave substrate within membrane fig 1 prerequisite intramembrane cut release ectodomain app via cleavage bace secretase removal ectodomain bace results production ass following secretase cleavage whereas ectodomain cleavage secretase nonamyloidogenic since cuts within ass domain fig 1
0.33924845.15583026.html.plaintext.txt	10	view larger version 23k figure 1 processing app secretases secretase cleavage occurs within ass domain prevents amyloidogenesis however small peptide p3 generated subsequent cleavage c83 fragment secretase besides p3 large ectodomain apps secreted shorter apps species secreted upon cleavage bace apps ss resulting c99 fragment cleaved secretase produce ass secretase cut releases app intracellular domain aicd may involved nuclear signaling
0.33924845.15583026.html.plaintext.txt	11	view larger version 23k figure 1 processing app secretases secretase cleavage occurs within ass domain prevents amyloidogenesis however small peptide p3 generated subsequent cleavage c83 fragment secretase besides p3 large ectodomain apps secreted shorter apps species secreted upon cleavage bace apps ss resulting c99 fragment cleaved secretase produce ass secretase cut releases app intracellular domain aicd may involved nuclear signaling
0.33924845.15583026.html.plaintext.txt	12	amyloidogenesis known dependent cholesterol levels simons et al 2001 moreover seems direct relevance ad since high cholesterol correlated increased risk disease kuo et al 1998 addition apolipoprotein 4 allele known major genetic risk factor ad corder et al 1993 cellular level ass generation found occur special cholesterol rich membrane subdomains called drms detergent resistant membranes lowering cholesterol levels treatment cholesterol synthesis inhibitors statins resulted strong decrease ass production simons et al 1998 fassbender et al 2001 ehehalt et al 2003 likely due part increase nonamyloidogenic cleavage secretase kojro et al 2001 animal models statin treatment also associated significant drop ass load fassbender et al 2001 furthermore clear correlation cholesteryl ester levels ass generation reported cultured cells puglielli et al 2001 recently demonstrated inhibition enzyme regulates conversion free cholesterol cholesteryl esters leads dramatic lowering ad pathology animal models also associated reversion cognitive deficits hutter paier et al 2004 surprisingly efforts way use cholesterol lowering drugs patients decrease ass production indeed preliminary epidemiological studies small clinical trials suggest lowering cholesterol levels may reduce risk ad wolozin et al 2000 simons et al 2002
0.33924845.15583026.html.plaintext.txt	13	amyloidogenesis known dependent cholesterol levels simons et al 2001 moreover seems direct relevance ad since high cholesterol correlated increased risk disease kuo et al 1998 addition apolipoprotein 4 allele known major genetic risk factor ad corder et al 1993 cellular level ass generation found occur special cholesterol rich membrane subdomains called drms detergent resistant membranes lowering cholesterol levels treatment cholesterol synthesis inhibitors statins resulted strong decrease ass production simons et al 1998 fassbender et al 2001 ehehalt et al 2003 likely due part increase nonamyloidogenic cleavage secretase kojro et al 2001 animal models statin treatment also associated significant drop ass load fassbender et al 2001 furthermore clear correlation cholesteryl ester levels ass generation reported cultured cells puglielli et al 2001 recently demonstrated inhibition enzyme regulates conversion free cholesterol cholesteryl esters leads dramatic lowering ad pathology animal models also associated reversion cognitive deficits hutter paier et al 2004 surprisingly efforts way use cholesterol lowering drugs patients decrease ass production indeed preliminary epidemiological studies small clinical trials suggest lowering cholesterol levels may reduce risk ad wolozin et al 2000 simons et al 2002
0.33924845.15583026.html.plaintext.txt	14	strong cholesterol dependency ass generation suggested secretases might located within drms may regulate processing app indeed ehehalt et al 2003 demonstrated antibody cross linking induced bace app copatch within cholesterol rich microdomains resulted increased ass production proposed localization secretases supported recent findings two different laboratories abad rodriguez et al 2004 report able identify endogenous bace within drms primary hippocampal neurons elsewhere vetrivel et al 2004 recently demonstrated completely assembled biologically active secretase complex consisting presenilin fragments aph 1 mature nicastrin pen 2 resides within drms moreover secretase found syntaxin 6 syntaxin 13 vamp4 positive vesicles demonstrating secretase accumulates drms late golgi endosomes vetrivel et al 2004 exactly bace thought biologically active haass et al 1995 vassar et al 1999 walter et al 2001 similarly monomeric oligomeric ass concentrated drms brains mouse model ad lee et al 1998 kawarabayashi et al 2004 thus appears complete ass generating proteolytic machinery coexists within drms vesicles
0.33924845.15583026.html.plaintext.txt	15	issue researchers provide novel unexpected explanation secretases localized cholesterol rich membrane domains present data suggesting drm association bace restricts access app demonstrate accumulates detergent sensitive membrane domains outside drms see fig 2 may indicate aberrant access app drms hence aberrant ass production ad may indicate even physiological conditions app molecules come close contact drms latter seems likely since ass physiologically normal product produced brains ad patients haass 2004 findings also demonstrate completely novel cellular mechanism controlling protease activity cells undergo major efforts prevent proteases contacting proteins destined digested accomplished numerous mechanisms including synthesis inactive proforms activated appropriate sites tagging protease substrates ubiquitin sequestering proteases membrane surrounded environments endosomeslysosomes hiding active sites proteases within narrow tunnels proteasomes abad rodriguez et al 2004 vetrivel et al 2004 add yet another control mechanism show lipids build invisible boundary corralling secretase complex bace away substrate app certainly mechanism evolve protect us ad secretases concentrate within drms probable explanation secretase involved several signaling pathways including notch signaling selkoe kopan 2003 haass 2004 concentrating proteolytic machinery small membrane domains facilitates processes would however imply physiological substrates notch others must gain access drms observation yet made
0.33924845.15583026.html.plaintext.txt	16	issue researchers provide novel unexpected explanation secretases localized cholesterol rich membrane domains present data suggesting drm association bace restricts access app demonstrate accumulates detergent sensitive membrane domains outside drms see fig 2 may indicate aberrant access app drms hence aberrant ass production ad may indicate even physiological conditions app molecules come close contact drms latter seems likely since ass physiologically normal product produced brains ad patients haass 2004 findings also demonstrate completely novel cellular mechanism controlling protease activity cells undergo major efforts prevent proteases contacting proteins destined digested accomplished numerous mechanisms including synthesis inactive proforms activated appropriate sites tagging protease substrates ubiquitin sequestering proteases membrane surrounded environments endosomeslysosomes hiding active sites proteases within narrow tunnels proteasomes abad rodriguez et al 2004 vetrivel et al 2004 add yet another control mechanism show lipids build invisible boundary corralling secretase complex bace away substrate app certainly mechanism evolve protect us ad secretases concentrate within drms probable explanation secretase involved several signaling pathways including notch signaling selkoe kopan 2003 haass 2004 concentrating proteolytic machinery small membrane domains facilitates processes would however imply physiological substrates notch others must gain access drms observation yet made
0.33924845.15583026.html.plaintext.txt	17	view larger version 29k figure 2 model describing effects cholesterol reduction ass generation details see text
0.33924845.15583026.html.plaintext.txt	18	view larger version 29k figure 2 model describing effects cholesterol reduction ass generation details see text
0.33924845.15583026.html.plaintext.txt	19	however one obvious discrepancy results current study earlier ones must addressed abad rodriguez et al 2004 demonstrate upon moderate lowering cholesterol ass generation surprisingly increased whereas large body previously published data see clearly demonstrated reduced ass generation upon cholesterol reduction could case mean previous approaches simply wrong truth may found sides findings dotti colleagues abad rodriguez et al 2004 indeed apparent disagreement studies showing lowering cholesterol inhibits amyloidogenesis cultured cells animal models simons et al 1998 fassbender et al 2001 ehehalt et al 2003 however studies cholesterol always strongly depleted cells used overexpressed app contrast current study investigated neurons cells affected deadly activity ass moderate reduction cholesterol led increased ass levels whereas strong cholesterol reduction resulted significant drop ass generation fig 2 similar observed simons et al 1998 fassbender et al 2001 ehehalt et al 2003 thus effects cholesterol reduction dose dependent two apparently independent cellular mechanisms affected moderate reduction cholesterol causes disorganization drms allowing bace contact app resulting enhanced ass generation fig 2 strong reduction cholesterol inhibits bace secretase activity results dramatic drop ass generation even though bace secretase contact app directly fig 2 clear contrast model ehehalt et al reported bace cleavage app occurs within lipid drms ehehalt et al 2003 discrepancy might due fact overexpressed fraction app may mislocalized drms cleaved bace observation also made abad rodriguez et al 2004 work needed settle controversy since effects lowering brain cholesterol production endogenous ass mouse neurons human brains directly demonstrated although current findings raise interesting questions necessarily challenge cholesterol lowering tactics ad therapyprevention since animal studies date clear favor strategy fassbender et al 2001 hutter paier et al 2004 moreover cholesterol lowering drugs taken numerous patients enormous beneficial effects cardiovascular disorders side effects concerning ass generation dementia reported cholesterol dependent processing app provides striking example disease based research dramatically advance basic knowledge cell biology vice versa would thought 10 years ago drms might contain regulate deadly machinery responsible abundant human neurodegenerative disorder machinery might function via novel totally unexpected mechanism intramembrane proteolysis
0.33924845.15583026.html.plaintext.txt	20	submitted 15 october 2004accepted 12 november 2004
0.33924845.15583026.html.plaintext.txt	21	article abstract pdf full text alert article cited citation map services alert new content jcb download citation manager google scholar articles kaether c articles haass c articles citing article pubmed pubmed citation articles kaether c articles haass c
0.33924845.15583026.html.plaintext.txt	22	home help feedback subscriptions archive search table contents
0.33943188.11502763.html.plaintext.txt	0	rockefeller university press 0021 952520018731 500 journal cell biology volume 154 number 4 august 20 2001 731 740 article
0.33943188.11502763.html.plaintext.txt	1	rockefeller university press 0021 952520018731 500 journal cell biology volume 154 number 4 august 20 2001 731 740 article
0.33943188.11502763.html.plaintext.txt	2	discrepancy presenilin subcellular localization secretase processing amyloid precursor protein philippe cupers1 mustapha bentahir1 katleen craessaerts1 isabelle orlans1 hugo vanderstichele3 paul saftig2 bart de strooper1 wim annaert1
0.33943188.11502763.html.plaintext.txt	3	1 center human genetics neuronal cell biology group flanders interuniversity institute biotechnology catholic university leuven b 3000 leuven belgium 2 department biochemistry 2 university gottingen d 37073 gottingen germany 3 innogenetics nv b 9052 gent belgium
0.33943188.11502763.html.plaintext.txt	4	address correspondence wim annaert bart de strooper center human genetics neuronal cell biology group herestraat 49 b 3000 leuven belgium tel 32 16 346 27 fax 32 16 347 181 e mail adatmedkuleuvenacbe
0.33943188.11502763.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references investigated relationship ps1 secretase processing amyloid precursor protein app primary cultures neurons increasing amount app cell surface towards endosomes significantly affect ps1 dependent secretase cleavage although little ps1 present subcellular compartments contrast almost secretase processing observed holo app app c99 direct substrate secretase specifically retained endoplasmic reticulum er double lysine retention motif nevertheless app c99 dilysine kk colocalized ps1 er contrast app c99 colocalize ps1 efficiently processed ps1 dependent secretase app c99 resides compartment negative er intermediate compartment golgi marker proteins conclude secretase cleavage app c99 occurs specialized subcellular compartment little ps1 detected suggests least one factor ps1 located downstream er required cleavage app c99 agreement found intracellular secretase processing app c99 kk 40 42 site could restored partially brefeldin treatment data confirm spatial paradox raise several questions regarding ps1 secretase hypothesis
0.33943188.11502763.html.plaintext.txt	6	abstract top abstract introduction results discussion materials methods references investigated relationship ps1 secretase processing amyloid precursor protein app primary cultures neurons increasing amount app cell surface towards endosomes significantly affect ps1 dependent secretase cleavage although little ps1 present subcellular compartments contrast almost secretase processing observed holo app app c99 direct substrate secretase specifically retained endoplasmic reticulum er double lysine retention motif nevertheless app c99 dilysine kk colocalized ps1 er contrast app c99 colocalize ps1 efficiently processed ps1 dependent secretase app c99 resides compartment negative er intermediate compartment golgi marker proteins conclude secretase cleavage app c99 occurs specialized subcellular compartment little ps1 detected suggests least one factor ps1 located downstream er required cleavage app c99 agreement found intracellular secretase processing app c99 kk 40 42 site could restored partially brefeldin treatment data confirm spatial paradox raise several questions regarding ps1 secretase hypothesis
0.33943188.11502763.html.plaintext.txt	7	key words presenilin 1 amyloid peptide secretase er retention app processing
0.33943188.11502763.html.plaintext.txt	8	introduction top abstract introduction results discussion materials methods references amyloid precursor protein app presenilins pss key proteins pathogenesis alzheimers disease selkoe 1999 pss multimembrane spanning domain proteins essentially located er intermediate compartment cis golgi region walter et al 1996 culvenor et al 1997 annaert et al 1999 kim et al 2000 evidence presence minute amounts ps cell surface provided ray et al 1999 app type transmembrane protein processed secretases resulting generation various fragments notoriously amyloid peptide ass aggregation peptide considered central event process leading alzheimers disease selkoe 1999 ss secretase bace ss site amyloid cleaving enzyme identified recently aspartyl protease cleaving app nh2 terminus amyloid peptide sequence vassar et al 1999 secretase cleaves ass sequence precluding ass production several members adam family disintegrin metalloprotease ie tace mdc9 adam10 implied secretase processing app buxbaum et al 1998 koike et al 1999 lammich et al 1999 finally presenilin 1 ps1 dependent secretase cleavage app releases cooh terminus amyloid peptide de strooper et al 1998 ps dependent secretase activities also involved processing integral membrane proteins like notch aplp 1 de strooper et al 1999 naruse et al 1998 song et al 1999 struhl greenwald 1999 secretase cleavage novel type proteolytic processing occurring hydrophobic environment cell membrane case notch cleavage results release intracellular domain regulates gene transcription process called regulated intramembrane proteolysis annaert de strooper 1999 brown et al 2000
0.33943188.11502763.html.plaintext.txt	9	introduction top abstract introduction results discussion materials methods references amyloid precursor protein app presenilins pss key proteins pathogenesis alzheimers disease selkoe 1999 pss multimembrane spanning domain proteins essentially located er intermediate compartment cis golgi region walter et al 1996 culvenor et al 1997 annaert et al 1999 kim et al 2000 evidence presence minute amounts ps cell surface provided ray et al 1999 app type transmembrane protein processed secretases resulting generation various fragments notoriously amyloid peptide ass aggregation peptide considered central event process leading alzheimers disease selkoe 1999 ss secretase bace ss site amyloid cleaving enzyme identified recently aspartyl protease cleaving app nh2 terminus amyloid peptide sequence vassar et al 1999 secretase cleaves ass sequence precluding ass production several members adam family disintegrin metalloprotease ie tace mdc9 adam10 implied secretase processing app buxbaum et al 1998 koike et al 1999 lammich et al 1999 finally presenilin 1 ps1 dependent secretase cleavage app releases cooh terminus amyloid peptide de strooper et al 1998 ps dependent secretase activities also involved processing integral membrane proteins like notch aplp 1 de strooper et al 1999 naruse et al 1998 song et al 1999 struhl greenwald 1999 secretase cleavage novel type proteolytic processing occurring hydrophobic environment cell membrane case notch cleavage results release intracellular domain regulates gene transcription process called regulated intramembrane proteolysis annaert de strooper 1999 brown et al 2000
0.33943188.11502763.html.plaintext.txt	10	several lines evidence led hypothesis ps secretase first secretase cleavage app notch inactivated partially ps1 deficient cells completely ps1ps2 double deficient cells de strooper et al 1998 1999 song et al 1999 struhl greenwald 1999 herreman et al 2000 zhang et al 2000 moreover mutagenesis one two aspartyl residues located transmembrane domain 6 7 results dominant negative like effects secretase cleavage suggesting aspartates contribute active site ps wolfe et al 1999 similarities prepilin peptidases taken evidence ps proteases steiner et al 2000 however strongest argument favor idea comes observation several compounds inhibit secretase bind specifically ps esler et al 2000 li et al 2000 seiffert et al 2000 nevertheless direct proof ps hydrolyze peptide bounds still lacking
0.33943188.11502763.html.plaintext.txt	11	several lines evidence led hypothesis ps secretase first secretase cleavage app notch inactivated partially ps1 deficient cells completely ps1ps2 double deficient cells de strooper et al 1998 1999 song et al 1999 struhl greenwald 1999 herreman et al 2000 zhang et al 2000 moreover mutagenesis one two aspartyl residues located transmembrane domain 6 7 results dominant negative like effects secretase cleavage suggesting aspartates contribute active site ps wolfe et al 1999 similarities prepilin peptidases taken evidence ps proteases steiner et al 2000 however strongest argument favor idea comes observation several compounds inhibit secretase bind specifically ps esler et al 2000 li et al 2000 seiffert et al 2000 nevertheless direct proof ps hydrolyze peptide bounds still lacking
0.33943188.11502763.html.plaintext.txt	12	remarkably notch app apparently first need proteolytical trimming extracellular domain tace ss secretase respectively become substrate ps secretase de strooper et al 1998 brou et al 2000 mumm et al 2000 struhl adachi 2000 proteases located downstream biosynthetic pathway therefore notch app first leave er become substrate ps secretase despite significant advances understanding secretase processing remains unclear app cleavage ss secretase becomes exposed ps moreover ass appears produced mainly endosomal compartment koo squazzo 1994 hartmann et al 1997 whereas ps abundantly present er intermediate compartment walter et al 1996 culvenor et al 1997 annaert et al 1999 kim et al 2000 problem summarized spatial paradox annaert de strooper 1999 tackle problem analyzing processing series app trafficking mutants primary cortical neurons derived ps1 ps1 mice analyzed consequences restricting app trafficking certain subcellular compartments generation total ass ass42 constructs tested app deleted cytosolic tail app ct b app double lysine er retention motif cytoplasmic tail app kk c app cytoplasmic tail ldl receptor app ldl d app truncated ss secretase cleavage site app c99 e app c99 double lysine kk motif app ct poorly reinternalized stays longer times cell surface tienari et al 1996 kk motif acts er retrieval signal jackson et al 1993 gaynor et al 1994 therefore app kk colocalizes abundantly endogenous ps1 peraus et al 1997 annaert et al 1999 app ldl recycles endosomal system cell surface annaert et al 1999 app c99 direct substrate secretase addition kk er retention motif app c99 kk anticipated creating excellent substrate ps1 secretase overall data confirm spatial paradox ps secretase hypothesis provide evidence transfer app c99 compartment downstream er needed addition processed ps1 obtain secretase activity primary cultures neurons
0.33943188.11502763.html.plaintext.txt	13	results top abstract introduction results discussion materials methods references different app trafficking mutants fig 1 expressed primary cortical neurons derived ps1 ps1 littermate embryos metabolically labeled full length app secretase cleaved app fragments immunoprecipitated analyzed phosphorimaging described materials methods constructs protein expression levels similar ps1 ps1 cells fig 2 full length wild type app ldl chimera run doublet fig 2 120 kd corresponding mature immature glycosylated app majority app kk app ct recombinant proteins however immature protein expected app kk dilysine motif actively retains protein pre golgi compartments stronger immature app ct band could reflect rapid processing mature form secretase cell surface tienari et al 1997 next analyzed proteolytic fragments derived different app mutants secretion soluble ectodomain ss secretase cleavage generated different trafficking mutants significantly altered ps1 deficiency although app ct instance produced roughly twice many apps fig 2 ss cleaved cooh terminal stubs app ctf derived app wt accumulated strongly ps1 neurons fig 2 b confirming previous data de strooper et al 1998 interestingly relative accumulation observed app ctf derived app ldl chimera also total ass secretion severely decreased ps1 neurons transduced app wt app ldl fig 2 b although secretion ass42 derived app ldl reduced 80 ps1 neurons line previous observations koo squazzo 1994 perez et al 1999 additional relative decrease caused ps1 deficiency remained unaltered compared app wt fig 2 b c together data suggest case app ldl chimera enhanced recycling endosomal limb directly influence ps1 dependent secretase processing
0.33943188.11502763.html.plaintext.txt	14	results top abstract introduction results discussion materials methods references different app trafficking mutants fig 1 expressed primary cortical neurons derived ps1 ps1 littermate embryos metabolically labeled full length app secretase cleaved app fragments immunoprecipitated analyzed phosphorimaging described materials methods constructs protein expression levels similar ps1 ps1 cells fig 2 full length wild type app ldl chimera run doublet fig 2 120 kd corresponding mature immature glycosylated app majority app kk app ct recombinant proteins however immature protein expected app kk dilysine motif actively retains protein pre golgi compartments stronger immature app ct band could reflect rapid processing mature form secretase cell surface tienari et al 1997 next analyzed proteolytic fragments derived different app mutants secretion soluble ectodomain ss secretase cleavage generated different trafficking mutants significantly altered ps1 deficiency although app ct instance produced roughly twice many apps fig 2 ss cleaved cooh terminal stubs app ctf derived app wt accumulated strongly ps1 neurons fig 2 b confirming previous data de strooper et al 1998 interestingly relative accumulation observed app ctf derived app ldl chimera also total ass secretion severely decreased ps1 neurons transduced app wt app ldl fig 2 b although secretion ass42 derived app ldl reduced 80 ps1 neurons line previous observations koo squazzo 1994 perez et al 1999 additional relative decrease caused ps1 deficiency remained unaltered compared app wt fig 2 b c together data suggest case app ldl chimera enhanced recycling endosomal limb directly influence ps1 dependent secretase processing
0.33943188.11502763.html.plaintext.txt	15	view larger version 23k figure 1 app trafficking mutants app schematically represented app wt different relevant proteolytic fragments indicated top ectodomain detected pab207 amyloid peptide region 1 16 detected pab b7 region 1 5 mab 3d6 region 17 24 detected mab4g8 last 20 amino acids cooh terminal cytoplasmic tail detected pab b114 pab 6687 ss secretase cleavage sites indicated app c99 construct supplementary asp ala residue da added obtain cleavage signal peptidase ss secretase site see lichtenthaler et al 1999 details see materials methods
0.33943188.11502763.html.plaintext.txt	16	view larger version 23k figure 2 processing app trafficking mutants ps1 ps1 neurons ps1 ps1 primary neuronal cultures transduced psfv bearing app wt app ct app kk app ldl described metabolically labeled 35smethionine 4 h 37 degrees c cell extracts two top panels culture media two bottom panels immunoprecipitated using appropriate antibodies analyzed 10 4 12 nupage gels position various app fragments indicated note app ct holo forms cooh terminal ss fragments migrate faster cytoplasmic domain deleted whereas app ldl fragments migrates slower due large ldl receptor cytoplasmic domain cooh terminal stub detected antibody b7 react fragment b app fragments three independent experiments quantified using phosphorimaging normalized level expression app holo forms de strooper et al 1995 1998 annaert et al 1999 data obtained ps1 neurons compared data obtained ps1 neurons shows relative effect absence ps1 app fragment separately since app ct processed ss secretase limited extent results displayed fig 3 significant conclusions regarding level secretase processing construct c secretion ass42 analyzed elisa results normalized level secreted ps1 neurons transfected app wt dark bars light bars represent data obtained ps1 ps1 neurons respectively
0.33943188.11502763.html.plaintext.txt	17	view larger version 23k figure 2 processing app trafficking mutants ps1 ps1 neurons ps1 ps1 primary neuronal cultures transduced psfv bearing app wt app ct app kk app ldl described metabolically labeled 35smethionine 4 h 37 degrees c cell extracts two top panels culture media two bottom panels immunoprecipitated using appropriate antibodies analyzed 10 4 12 nupage gels position various app fragments indicated note app ct holo forms cooh terminal ss fragments migrate faster cytoplasmic domain deleted whereas app ldl fragments migrates slower due large ldl receptor cytoplasmic domain cooh terminal stub detected antibody b7 react fragment b app fragments three independent experiments quantified using phosphorimaging normalized level expression app holo forms de strooper et al 1995 1998 annaert et al 1999 data obtained ps1 neurons compared data obtained ps1 neurons shows relative effect absence ps1 app fragment separately since app ct processed ss secretase limited extent results displayed fig 3 significant conclusions regarding level secretase processing construct c secretion ass42 analyzed elisa results normalized level secreted ps1 neurons transfected app wt dark bars light bars represent data obtained ps1 ps1 neurons respectively
0.33943188.11502763.html.plaintext.txt	18	view larger version 73k figure 3 secretion p3 ps1 neurons expressing app ct neurons transduced metabolically labeled cell extracts top culture media bottom immunoprecipitated using pab207 holo app mab4g8 apps assp3 intermediate band running ass p3 cells transduced app wt corresponds truncated ass generated ss secretase cleavage glu11 position creemers et al 2000
0.33943188.11502763.html.plaintext.txt	19	view larger version 73k figure 3 secretion p3 ps1 neurons expressing app ct neurons transduced metabolically labeled cell extracts top culture media bottom immunoprecipitated using pab207 holo app mab4g8 apps assp3 intermediate band running ass p3 cells transduced app wt corresponds truncated ass generated ss secretase cleavage glu11 position creemers et al 2000
0.33943188.11502763.html.plaintext.txt	20	reduction ss cleaved app ctf app ct transduced wild type neurons accompanied 80 decrease secretion total ass ass42 fig 2 c moreover relative accumulation ss cleaved app ctf ps1 neurons observed explained predominant secretase cleavage app ct near plasma membrane reflected increased secretion apps cleaved secretase site concomitant fivefold increase p3 secretion fig 3 interestingly secretion p3 dramatically inhibited absence ps1 fig 3 bottom indicating stubs generated near cell surface still substrates ps1 dependent secretase processing therefore data app ct app ldl clearly demonstrate ps1 needed normal secretase processing late golgi region cell surface endosomal compartments
0.33943188.11502763.html.plaintext.txt	21	contrast mutants levels apps cooh terminal ss stubs generated app kk low confirming low ss secretase activity er fig 2 b accordingly total ass fig 2 b ass42 fig 2 c secretion also strongly reduced 90 however overexpressed ps1 neurons secretion ass peptides inhibited extent observed peptides derived app wt fig 2 b c
0.33943188.11502763.html.plaintext.txt	22	circumvent need preactivation app kk ss secretase generated app c99 kk corresponding app truncated ss secretase site lichtenthaler et al 1999 containing kk er retention motif expressed neurons app c99 kk migrated apparent molecular weight 10 kd ss stub coming app wt app c99 without kk motif fig 4 lichtenthaler et al 1999 app c99 like app wt processed secretase reflected generation appctf fig 4 app c99 kk contrast either processed processed little ss secretase confirming specific retention app c99 kk er cis golgi region line prediction app c99 require ss secretase cleavage become substrate secretase estimated sevenfold increase total ass secretion fig 4 observed effect also observed ass42 detected elisa fig 4 b secretase cleavage app c99 strongly inhibited absence ps1 fig 4 c surprisingly however observation app c99 kk also expected substrate ps1 secretase retained er turned yield little ass peptides fig 4 b unlikely kk motif directly interfered recognition c99 secretase complex since cytoplasmic tail app removed without affecting secretase cleavage fig 3 moreover c99kk becomes substrate secretase conditions specified alternatively low ass secretion neurons expressing app c99 kk might explained intracellular retention newly formed ass peptides could ruled increased amounts ass could immunoprecipitated cell extracts result shown see fig 7
0.33943188.11502763.html.plaintext.txt	23	circumvent need preactivation app kk ss secretase generated app c99 kk corresponding app truncated ss secretase site lichtenthaler et al 1999 containing kk er retention motif expressed neurons app c99 kk migrated apparent molecular weight 10 kd ss stub coming app wt app c99 without kk motif fig 4 lichtenthaler et al 1999 app c99 like app wt processed secretase reflected generation appctf fig 4 app c99 kk contrast either processed processed little ss secretase confirming specific retention app c99 kk er cis golgi region line prediction app c99 require ss secretase cleavage become substrate secretase estimated sevenfold increase total ass secretion fig 4 observed effect also observed ass42 detected elisa fig 4 b secretase cleavage app c99 strongly inhibited absence ps1 fig 4 c surprisingly however observation app c99 kk also expected substrate ps1 secretase retained er turned yield little ass peptides fig 4 b unlikely kk motif directly interfered recognition c99 secretase complex since cytoplasmic tail app removed without affecting secretase cleavage fig 3 moreover c99kk becomes substrate secretase conditions specified alternatively low ass secretion neurons expressing app c99 kk might explained intracellular retention newly formed ass peptides could ruled increased amounts ass could immunoprecipitated cell extracts result shown see fig 7
0.33943188.11502763.html.plaintext.txt	24	view larger version 23k figure 4 secretase processing app c99 trafficking mutants ps1 ps1 neurons cells extracts top culture media bottom neurons expressing app wt app c99 app c99 kk immunoprecipitated using antibodies b114 app cooh terminal domain top b7 amyloid region arrows gels indicate position various app fragments notice striking absence ass generation app c99 kk 65 kd stub seen app c99 app c99 kk ps1 independent probably physiologically relevant since never observed app wt b ass42 levels measured elisa fig 2 b results expressed relatively obtained ps1 neurons transfected app wt ns nonsignificant values detection limit c ass fragments quantified using phosphorimaging normalized level expression app holo forms n 3 mean plus minus sem data obtained ps1 neurons compared data obtained ps1 neurons shows relative effect absence ps1 ass production app wt app c99 ass signals obtained app c99 kk detection limit
0.33943188.11502763.html.plaintext.txt	25	view larger version 23k figure 4 secretase processing app c99 trafficking mutants ps1 ps1 neurons cells extracts top culture media bottom neurons expressing app wt app c99 app c99 kk immunoprecipitated using antibodies b114 app cooh terminal domain top b7 amyloid region arrows gels indicate position various app fragments notice striking absence ass generation app c99 kk 65 kd stub seen app c99 app c99 kk ps1 independent probably physiologically relevant since never observed app wt b ass42 levels measured elisa fig 2 b results expressed relatively obtained ps1 neurons transfected app wt ns nonsignificant values detection limit c ass fragments quantified using phosphorimaging normalized level expression app holo forms n 3 mean plus minus sem data obtained ps1 neurons compared data obtained ps1 neurons shows relative effect absence ps1 ass production app wt app c99 ass signals obtained app c99 kk detection limit
0.33943188.11502763.html.plaintext.txt	26	view larger version 71k figure 7 bfa treatment partially restores secretase processing app c99 kk neurons transduced sfv app c99 app c99 kk treated without 10 microm bfa 4 h culture media cell extracts immunoprecipitated using antibody b7 separated 10 nupage gels detection secreted intracellular ass done western blotting using w0 2 mab raised nh2 terminus ass sequence ida et al 1996 neurons transduced sfv app c99 kk treated bfa cell extracts sequentially immunoprecipitated using antibody fca42 specific ass peptides ending residue 42 fca40 specific ass peptides ending residue 42 barelli et al 1997 separated 10 nupage gels blotting ass peptides revealed using wo 2 mab
0.33943188.11502763.html.plaintext.txt	27	view larger version 71k figure 7 bfa treatment partially restores secretase processing app c99 kk neurons transduced sfv app c99 app c99 kk treated without 10 microm bfa 4 h culture media cell extracts immunoprecipitated using antibody b7 separated 10 nupage gels detection secreted intracellular ass done western blotting using w0 2 mab raised nh2 terminus ass sequence ida et al 1996 neurons transduced sfv app c99 kk treated bfa cell extracts sequentially immunoprecipitated using antibody fca42 specific ass peptides ending residue 42 fca40 specific ass peptides ending residue 42 barelli et al 1997 separated 10 nupage gels blotting ass peptides revealed using wo 2 mab
0.33943188.11502763.html.plaintext.txt	28	using confocal scanning microscopy confirmed app c99 kk effectively retained er demonstrated colocalization er marker protein bip fig 5 c limited extent intermediate compartment marker ergic 53 fig 5 g importantly app c99 kk colocalized abundantly ps1 fig 5 d f indicating simple presence ps1 sufficient secretase processing occur respect important note demonstrated previously ps1 er already processed towards nh2 cooh terminal fragments annaert et al 1999 next investigated subcellular localization app c99 primary cortical neurons app c99 clearly distributed er fig 6 c deduced complete lack colocalization bip similarly little colocalization observed ergic 53 marking intermediate compartment arrowheads fig 6 d f including horizontal section arrow surprisingly however observation app c99 immunoreactivity also essentially distribute golgi apparatus demonstrated gm130 staining fig 6 g finally despite app c99 good secretase substrate fig 4 fragment colocalize ps1 arrowheads vertical section fig 6 j l clear contrast colocalization ps1 inactive secretase substrate app c99 kk see also fig 5
0.33943188.11502763.html.plaintext.txt	29	using confocal scanning microscopy confirmed app c99 kk effectively retained er demonstrated colocalization er marker protein bip fig 5 c limited extent intermediate compartment marker ergic 53 fig 5 g importantly app c99 kk colocalized abundantly ps1 fig 5 d f indicating simple presence ps1 sufficient secretase processing occur respect important note demonstrated previously ps1 er already processed towards nh2 cooh terminal fragments annaert et al 1999 next investigated subcellular localization app c99 primary cortical neurons app c99 clearly distributed er fig 6 c deduced complete lack colocalization bip similarly little colocalization observed ergic 53 marking intermediate compartment arrowheads fig 6 d f including horizontal section arrow surprisingly however observation app c99 immunoreactivity also essentially distribute golgi apparatus demonstrated gm130 staining fig 6 g finally despite app c99 good secretase substrate fig 4 fragment colocalize ps1 arrowheads vertical section fig 6 j l clear contrast colocalization ps1 inactive secretase substrate app c99 kk see also fig 5
0.33943188.11502763.html.plaintext.txt	30	view larger version 35k figure 5 app c99 kk colocalizes ps1 endoplasmic reticulum hippocampal neurons transduced sfv app c99 kk fixed 6 h postinfection stained antibody app pab 6687 d g mab 3d6 bip b ps1 e ergic 53 h c f represent merged pictures app c99 kk abundantly colocalized er marker protein bip ps1 little colocalization observed ergic 53 resident protein intermediate compartment detection primary antibodies done alexa 488 alexa 546 conjugated goat anti mouse goat anti rabbit secondary antibodies 11000 diluted bar 10 microm
0.33943188.11502763.html.plaintext.txt	31	view larger version 35k figure 5 app c99 kk colocalizes ps1 endoplasmic reticulum hippocampal neurons transduced sfv app c99 kk fixed 6 h postinfection stained antibody app pab 6687 d g mab 3d6 bip b ps1 e ergic 53 h c f represent merged pictures app c99 kk abundantly colocalized er marker protein bip ps1 little colocalization observed ergic 53 resident protein intermediate compartment detection primary antibodies done alexa 488 alexa 546 conjugated goat anti mouse goat anti rabbit secondary antibodies 11000 diluted bar 10 microm
0.33943188.11502763.html.plaintext.txt	32	view larger version 29k figure 6 app c99 colocalize ps1 essentially present bip ergic 53 gm130 negative compartment sfv app c99 transduced hippocampal neurons fixed subcellular localization app c99 g pab 6687 d j mab 3d6 compared established marker proteins er bip b intermediate compartment ergic 53 e golgi apparatus gm130 h finally ps1 k c f l show merged pictures d f j l arrows point position corresponding vertical sections immunodetection done fig 6 app c99 immunoreactivity mainly concentrated discrete spots colocalize er c bip arrowheads l ps1 golgi region merged panel occasionally minor colocalization ergic 53 could observed arrowheads d f bar 10 microm
0.33943188.11502763.html.plaintext.txt	33	view larger version 29k figure 6 app c99 colocalize ps1 essentially present bip ergic 53 gm130 negative compartment sfv app c99 transduced hippocampal neurons fixed subcellular localization app c99 g pab 6687 d j mab 3d6 compared established marker proteins er bip b intermediate compartment ergic 53 e golgi apparatus gm130 h finally ps1 k c f l show merged pictures d f j l arrows point position corresponding vertical sections immunodetection done fig 6 app c99 immunoreactivity mainly concentrated discrete spots colocalize er c bip arrowheads l ps1 golgi region merged panel occasionally minor colocalization ergic 53 could observed arrowheads d f bar 10 microm
0.33943188.11502763.html.plaintext.txt	34	test hypothesis component downstream subcellular compartment needed process app c99 kk er treated neurons expressing app c99 app c99 kk brefeldin bfa drug causes rapid redistribution golgi apparatus er lippincott schwartz et al 1989 treatment resulted drastic reduction app c99 derived ass secretion whereas difference observed case app c99 kk fig 7 however addition bfa resulted strong increase intracellular ass generated app c99 kk towards levels indistinguishable obtained bfa treated app c99 transduced cells suggests unknown factors required secretase activity redistributed golgi region er appears sufficient partially restore ass production app c99 kk suggested ass generated endoplasmic reticulum consists mainly ass ending residue 42 chyung et al 1997 cook et al 1997 hartmann et al 1997 wild bode et al 1997 remarkably although detect little intracellular ass experimental conditions fig 7 b treatment bfa induces generation ass peptides ending residue 40 well residue 42 fig 7 b
0.33943188.11502763.html.plaintext.txt	35	discussion top abstract introduction results discussion materials methods references previous studies koo squazzo 1994 hartmann et al 1997 tienari et al 1997 shown ass generated cell surface endosomes neurons little ps1 present annaert et al 1999 first aim current study investigate extent secretase activity subcellular compartments depends indeed ps1 end expressed app ct app ldl two previously characterized trafficking mutants app peraus et al 1997 tienari et al 1997 annaert et al 1999 neurons app ct lacks endocytosis signals cytoplasmic domain app therefore slowly internalized compared app wt app ct processed mainly secretase activity cell surface sisodia 1992 tienari et al 1997 annaert et al 1999 results replacement ass production roughly equal production p3 product consecutive secretase activity figs 2 3 confirming app ct construct indeed behaves predicted therefore p3 production substrate reflects mainly secretase cleavage appctf cell surface expression construct ps1 deficient neurons resulted strong decrease p3 demonstrating secretase cleavage cell surface depends ps1 fig 3 since apps secretion affected absence ps1 fig 3 rule possibility decreased p3 production caused decreased secretase activity ps1 deficient cells
0.33943188.11502763.html.plaintext.txt	36	app ldl expression selectively increased ass40 secretion predicted preferential localization endosomes koo squazzo 1994 peraus et al 1997 perez et al 1999 absence ps1 ass generation app ldl strongly decreased demonstrating secretase processing app endosomes depends ps1 noted able detect endogenous ps1 immunoreactivity cell surface endosomes neuronal cells used current study annaert et al 1999
0.33943188.11502763.html.plaintext.txt	37	next investigated whether could increase secretase processing app er intermediate compartment contain bulk ps1 immunoreactivity neurons although several authors provided evidence er production site peptide particular ass42 chyung et al 1997 cook et al 1997 hartmann et al 1997 wild bode et al 1997 others able confirm observations annaert et al 1999 iwata et al 2001 maltese et al 2001 shown fig 2 severe decrease ass40 ass42 secretion observed app retained er means double lysine retention motif app kk since retention app er implies cleavage ss secretase residing tgn cell surface endosomes becomes strongly compromised since proteolytic trimming app ectodomain prerequisite secretase processing struhl adachi 2000 seems logical app kk mutation results strongly decreased secretase cleavage inhibition ass generation consequence difficult interpret data obtained app kk regard secretase sensitivity therefore generated app c99 construct direct substrate secretase lichtenthaler et al 1999 added double lysine er retention motif shown fig 5 construct indeed retained er codistributes abundantly ps1 although expected increased ass production significant amount ass could precipitated wild type neurons fig 4 iwata et al 2001 maltese et al 2001 result even significant neurons expressing app c99 secreted seven times total ass specifically ass42 expressing app wt possibility ass generated app c99 kk retained cells ruled since significant accumulation cells associated ass could demonstrated fig 7 lane 9 b lanes 2 5the possibility kk motif directly interfered secretase cleavage ruled two observations first clear results app ct cytoplasmic domain app involved processing app secretase second treatment cell cultures bfa could restore processing c99 kk clearly demonstrating inhibitory effect kk mutations trans cis phenomenon fig 7 pointed ps1 er already proteolytically processed presenilinase present ps1 ctf ps1 ntf annaert et al 1999 thus putative active conformation follows data simple colocalization substrate app c99 kk putative protease ps1 sufficient proteolytic cleavage
0.33943188.11502763.html.plaintext.txt	38	next investigated whether could increase secretase processing app er intermediate compartment contain bulk ps1 immunoreactivity neurons although several authors provided evidence er production site peptide particular ass42 chyung et al 1997 cook et al 1997 hartmann et al 1997 wild bode et al 1997 others able confirm observations annaert et al 1999 iwata et al 2001 maltese et al 2001 shown fig 2 severe decrease ass40 ass42 secretion observed app retained er means double lysine retention motif app kk since retention app er implies cleavage ss secretase residing tgn cell surface endosomes becomes strongly compromised since proteolytic trimming app ectodomain prerequisite secretase processing struhl adachi 2000 seems logical app kk mutation results strongly decreased secretase cleavage inhibition ass generation consequence difficult interpret data obtained app kk regard secretase sensitivity therefore generated app c99 construct direct substrate secretase lichtenthaler et al 1999 added double lysine er retention motif shown fig 5 construct indeed retained er codistributes abundantly ps1 although expected increased ass production significant amount ass could precipitated wild type neurons fig 4 iwata et al 2001 maltese et al 2001 result even significant neurons expressing app c99 secreted seven times total ass specifically ass42 expressing app wt possibility ass generated app c99 kk retained cells ruled since significant accumulation cells associated ass could demonstrated fig 7 lane 9 b lanes 2 5the possibility kk motif directly interfered secretase cleavage ruled two observations first clear results app ct cytoplasmic domain app involved processing app secretase second treatment cell cultures bfa could restore processing c99 kk clearly demonstrating inhibitory effect kk mutations trans cis phenomenon fig 7 pointed ps1 er already proteolytically processed presenilinase present ps1 ctf ps1 ntf annaert et al 1999 thus putative active conformation follows data simple colocalization substrate app c99 kk putative protease ps1 sufficient proteolytic cleavage
0.33943188.11502763.html.plaintext.txt	39	conclude ass production including ass42 occur directly er requires least one factor derived post er compartment conclusion corroborated two important pieces evidence current work first app c99 good substrate secretase mainly localized ps1 bip ergic53 negative subcellular compartment fig 6 although characterization compartment requires experimentation result suggests least proteolytic cleavage app c99 substrate occurs non er compartment second important argument comes experiments using bfa bfa drug causes redistribution post er compartments er lippincott schwartz et al 1989 treatment drug sufficient restore partially secretase processing app c99 kk proving least one non er component needed activate secretase er fig 7 bfa treatment results secretase processing app position ass42 something could possibly anticipated based current knowledge chyung et al 1997 cook et al 1997 hartmann et al 1997 wild bode et al 1997 surprisingly however cleavage position ass40 also observed fig 7 b believed occur mainly late compartments secretory endosomal limbs subcellular trafficking pathways koo squazzo 1994 hartmann et al 1997 tienari et al 1997
0.33943188.11502763.html.plaintext.txt	40	conclude ass production including ass42 occur directly er requires least one factor derived post er compartment conclusion corroborated two important pieces evidence current work first app c99 good substrate secretase mainly localized ps1 bip ergic53 negative subcellular compartment fig 6 although characterization compartment requires experimentation result suggests least proteolytic cleavage app c99 substrate occurs non er compartment second important argument comes experiments using bfa bfa drug causes redistribution post er compartments er lippincott schwartz et al 1989 treatment drug sufficient restore partially secretase processing app c99 kk proving least one non er component needed activate secretase er fig 7 bfa treatment results secretase processing app position ass42 something could possibly anticipated based current knowledge chyung et al 1997 cook et al 1997 hartmann et al 1997 wild bode et al 1997 surprisingly however cleavage position ass40 also observed fig 7 b believed occur mainly late compartments secretory endosomal limbs subcellular trafficking pathways koo squazzo 1994 hartmann et al 1997 tienari et al 1997
0.33943188.11502763.html.plaintext.txt	41	summarizing data indicate efficient secretase cleavage app occur compartments contain little ps1 little secretase activity observed compartments abundant maturated ps1 residing surprising result since data currently available imply ps1 closely involved secretase type enzymatic activity de strooper et al 1998 1999 steiner et al 1999 2000 struhl greenwald 1999 wolfe et al 1999 esler et al 2000 herreman et al 2000 li et al 2000 zhang et al 2000 spatial paradox ps1 localization secretase activity explained two hypotheses minute amounts ps1 post cis golgi compartments active enzymes implies addition activation presenilinase additional proteins compartments needed make ps1 enzymatically active b ps1 actually secretase acts probably concert proteins er intermediate compartment dispatch app secretase subcellular compartment cleavage occur hypothesis bfa treatment results relocalization catalytic subunits secretase er
0.33943188.11502763.html.plaintext.txt	42	summarizing data indicate efficient secretase cleavage app occur compartments contain little ps1 little secretase activity observed compartments abundant maturated ps1 residing surprising result since data currently available imply ps1 closely involved secretase type enzymatic activity de strooper et al 1998 1999 steiner et al 1999 2000 struhl greenwald 1999 wolfe et al 1999 esler et al 2000 herreman et al 2000 li et al 2000 zhang et al 2000 spatial paradox ps1 localization secretase activity explained two hypotheses minute amounts ps1 post cis golgi compartments active enzymes implies addition activation presenilinase additional proteins compartments needed make ps1 enzymatically active b ps1 actually secretase acts probably concert proteins er intermediate compartment dispatch app secretase subcellular compartment cleavage occur hypothesis bfa treatment results relocalization catalytic subunits secretase er
0.33943188.11502763.html.plaintext.txt	43	support first hypothesis evidence presence minute amounts ps1 compartments er provided studies specificity antibodies used questioned dewji singer 1997 polarized cell types like mdck cells georgakopoulos et al 1999 specialized cell membranes like growth cones lamellipodia schwarzman et al 1999 ps1 seems located near cell surface ray et al 1999 provided evidence ps1 travel complex notch cell surface albeit conclusion based single type experimental approach ie cell surface biotinylation furthermore hypothesis ps travels together substrates er cell surface becomes activated probably tenable one takes account relative amount ps1 substrates extremely low thinakaran et al 1998 ps1 needs accompany every substrate cleave er cell surface becomes given limited amounts ps available cell type difficult understand strong overexpression app saturate system lead inefficient secretase processing
0.33943188.11502763.html.plaintext.txt	44	support first hypothesis evidence presence minute amounts ps1 compartments er provided studies specificity antibodies used questioned dewji singer 1997 polarized cell types like mdck cells georgakopoulos et al 1999 specialized cell membranes like growth cones lamellipodia schwarzman et al 1999 ps1 seems located near cell surface ray et al 1999 provided evidence ps1 travel complex notch cell surface albeit conclusion based single type experimental approach ie cell surface biotinylation furthermore hypothesis ps travels together substrates er cell surface becomes activated probably tenable one takes account relative amount ps1 substrates extremely low thinakaran et al 1998 ps1 needs accompany every substrate cleave er cell surface becomes given limited amounts ps available cell type difficult understand strong overexpression app saturate system lead inefficient secretase processing
0.33943188.11502763.html.plaintext.txt	45	although remains impossible exclude minute amounts ps1 endosomes cell surface active enzymes clear hypothesis raises several new questions need addressed addition function inactive pool ps1 er also remains explained bfa experiments follows least one component non er compartment needed obtain activated ps1 component elusive protease called presenilinase responsible ps maturation probably nicastrin since protein present er yu et al 2000
0.33943188.11502763.html.plaintext.txt	46	although remains impossible exclude minute amounts ps1 endosomes cell surface active enzymes clear hypothesis raises several new questions need addressed addition function inactive pool ps1 er also remains explained bfa experiments follows least one component non er compartment needed obtain activated ps1 component elusive protease called presenilinase responsible ps maturation probably nicastrin since protein present er yu et al 2000
0.33943188.11502763.html.plaintext.txt	47	second hypothesis ps1 needed correct trafficking secretase substrates finds theoretical support analogy sterol regulatory element binding protein srebp screb cleavage activating protein scap complex regulation proteolytical cleavage srebp brown et al 2000 scap like ps1 er resident multitransmembrane domain containing protein regulates trafficking membrane bound transcription factor srebp post er compartments upon cholesterol depletion srebp travels cis golgi site 1 protease cleaves srebp luminal domain remaining nh2 terminal membrane bound fragment becomes substrate site 2 protease cleaves transmembrane domain srebp rawson et al 1997 nohturfft et al 1999 coupling vesicular protein transport proteolysis provides stringent control activation system could envisaged ps1 like scap provides similar control app notch processing however pointed case srebp processing scap regulates luminal cleavage site 2 intramembraneous cleavage occurs default case ps1 role limited regulation intramembraneous secretase cleavage de strooper et al 1998
0.33943188.11502763.html.plaintext.txt	48	conclusion data indicate complex relationship app trafficking processing secretase moreover directly question exact role ps1 secretase processing demonstrate least one cofactor first hypothesis protease second hypothesis located compartment downstream er future reconstitution secretase processing app mixing extracts purified er fractions post er compartments allow us define molecular level highly intriguing proteolytic system
0.33943188.11502763.html.plaintext.txt	49	conclusion data indicate complex relationship app trafficking processing secretase moreover directly question exact role ps1 secretase processing demonstrate least one cofactor first hypothesis protease second hypothesis located compartment downstream er future reconstitution secretase processing app mixing extracts purified er fractions post er compartments allow us define molecular level highly intriguing proteolytic system
0.33943188.11502763.html.plaintext.txt	50	materials methods top abstract introduction results discussion materials methods references neuronal cell culture primary cultures mixed cortical neurons derived wild type ps1 knock littermates generated described previously de strooper et al 1998 brief total brain 14 d old embryos dissected hbss medium gibco brl trypsinized plated dishes nunc precoated poly l lysine sigma aldrich cultures maintained neurobasal medium gibco brl b27 supplement gibco brl 5 microm cytosine arabinoside prevent glial cell proliferation
0.33943188.11502763.html.plaintext.txt	51	semliki forest virus sfv constructs following modifications made cdna coding human app695 fig 1 deletion last 43 amino acids cytoplasmic tail app ct described tienari et al 1996 b addition di lysine motif qm mutated kk app kk site directed mutagenesis stratagene c exchange cytoplasmic domain ldl receptor app ldl d full deletion app ectodomain asp1 amino acid amyloid peptide region ss secretase site additional aspala da cloned site directed mutagenesis stratagene last amino acid signal sequence ala first ass region lichtenthaler et al 1999 app c99 site directed mutagenesis used add di lysine motif app c99 kk recombinant sfv containing app mutants generated described previously de strooper et al 1995
0.33943188.11502763.html.plaintext.txt	52	semliki forest virus sfv constructs following modifications made cdna coding human app695 fig 1 deletion last 43 amino acids cytoplasmic tail app ct described tienari et al 1996 b addition di lysine motif qm mutated kk app kk site directed mutagenesis stratagene c exchange cytoplasmic domain ldl receptor app ldl d full deletion app ectodomain asp1 amino acid amyloid peptide region ss secretase site additional aspala da cloned site directed mutagenesis stratagene last amino acid signal sequence ala first ass region lichtenthaler et al 1999 app c99 site directed mutagenesis used add di lysine motif app c99 kk recombinant sfv containing app mutants generated described previously de strooper et al 1995
0.33943188.11502763.html.plaintext.txt	53	transduction metabolic labeling neuronal cell cultures recombinant sfv diluted 10 fold neurobasal medium added culture dishes 1 h incubation 37 degrees c fresh neurobasal medium added 2 h cells metabolically labeled methionine free mem gibco brl supplemented b27 100 microciml 35smethionine icn biomedicals 10 microm bfa epicentre added indicated 4 h conditioned medium cells recovered cells lysed ip buffer 20 mm tris hcl ph 74 150 mm nacl 1 triton x 100 1 sodium deoxycholate 01 sds cleared centrifugation labeled protein immunoprecipitated using 25 microl protein g sepharose specific antibodies indicated fig 1 immunoprecipitates finally solubilized 25 microl nu page sample buffer invitrogen electrophoresed 4 12 10 acrylamide nupage bis tris gels reducing conditions mes running buffer invitrogen results analyzed using phosphorimager molecular dynamics imagquant41 data normalized value obtained corresponding app holoform normalize variations culture dishes following antibodies used fig 1 rabbit pab b7 recognizes first 17 amino acids ass b11 last 20 amino acids app cooh terminal domain de strooper et al 1995 goat pab 207 app ectodomain provided dr m savage cephalon inc west chester pa mab 4g8 senetek amino acids 17 24 ass mab w0 2 nh2 terminal region ass provided dr tobias hartmann konrad beyreuther university heidelberg heidelberg germany ida et al 1996 antibodies fca40 fca42 specifically precipitate ass peptides ending residue 40 40 42 42 provided dr f checler institut de pharmacologie moleculaire et cellulaire valbonne france barelli et al 1997
0.33943188.11502763.html.plaintext.txt	54	transduction metabolic labeling neuronal cell cultures recombinant sfv diluted 10 fold neurobasal medium added culture dishes 1 h incubation 37 degrees c fresh neurobasal medium added 2 h cells metabolically labeled methionine free mem gibco brl supplemented b27 100 microciml 35smethionine icn biomedicals 10 microm bfa epicentre added indicated 4 h conditioned medium cells recovered cells lysed ip buffer 20 mm tris hcl ph 74 150 mm nacl 1 triton x 100 1 sodium deoxycholate 01 sds cleared centrifugation labeled protein immunoprecipitated using 25 microl protein g sepharose specific antibodies indicated fig 1 immunoprecipitates finally solubilized 25 microl nu page sample buffer invitrogen electrophoresed 4 12 10 acrylamide nupage bis tris gels reducing conditions mes running buffer invitrogen results analyzed using phosphorimager molecular dynamics imagquant41 data normalized value obtained corresponding app holoform normalize variations culture dishes following antibodies used fig 1 rabbit pab b7 recognizes first 17 amino acids ass b11 last 20 amino acids app cooh terminal domain de strooper et al 1995 goat pab 207 app ectodomain provided dr m savage cephalon inc west chester pa mab 4g8 senetek amino acids 17 24 ass mab w0 2 nh2 terminal region ass provided dr tobias hartmann konrad beyreuther university heidelberg heidelberg germany ida et al 1996 antibodies fca40 fca42 specifically precipitate ass peptides ending residue 40 40 42 42 provided dr f checler institut de pharmacologie moleculaire et cellulaire valbonne france barelli et al 1997
0.33943188.11502763.html.plaintext.txt	55	quantification ass42 peptide elisa levels ass42 conditioned media cell lysates quantified sandwich elisa test de strooper et al 1998 according published protocols vanderstichele et al 2000 brief samples dried speed vacuum savant resuspended 300 microl sample diluent incubated 96 well elisa plates precoated mab 3d6 ass washing samples incubated biotin labeled anti ass42 antibody mab 21f12 recognizes final two amino acids ass42 sequence followed streptavidine hrp adding hrp substrate samples measured spectrophotometrically using victor2 wallac 450 nm filter ass42 concentration samples calculated based ass42 standards sigmoid curve equation using prism 30 graphpad software
0.33943188.11502763.html.plaintext.txt	56	quantification ass42 peptide elisa levels ass42 conditioned media cell lysates quantified sandwich elisa test de strooper et al 1998 according published protocols vanderstichele et al 2000 brief samples dried speed vacuum savant resuspended 300 microl sample diluent incubated 96 well elisa plates precoated mab 3d6 ass washing samples incubated biotin labeled anti ass42 antibody mab 21f12 recognizes final two amino acids ass42 sequence followed streptavidine hrp adding hrp substrate samples measured spectrophotometrically using victor2 wallac 450 nm filter ass42 concentration samples calculated based ass42 standards sigmoid curve equation using prism 30 graphpad software
0.33943188.11502763.html.plaintext.txt	57	confocal microscopy hippocampal neurons grown poly l lysine coated glass coverslips presence glial feeder layer goslin banker 1991 de strooper et al 1995 transduced sfv app c99 c99kk 4 h transduction cycloheximide 100 microgml added block protein synthesis 6 h neurons fixed 120 mm phosphate buffer containing 4 paraformaldehyde ph 73 4 sucrose permeabilized ice cold methanol acetone immunostained annaert et al 1999 recombinant app c99 detected pab 6687 gift dr c haass university munchen germany mab 3d6 gift dr seubert elan pharmaceuticals san francisco ca mabs bip purchased sigma pab b172 used detect endogenous ps1 annaert et al 1999 intermediate compartment golgi region identified using anti ergic 53 provided dr j saraste university bergen norway anti gm130 transduction laboratories respectively alexa 488 alexa 546 conjugated secondary antibodies molecular probes biorad mrc1024 confocal microscope adobe photoshop 52 used final processing annaert et al 1999
0.33943188.11502763.html.plaintext.txt	58	confocal microscopy hippocampal neurons grown poly l lysine coated glass coverslips presence glial feeder layer goslin banker 1991 de strooper et al 1995 transduced sfv app c99 c99kk 4 h transduction cycloheximide 100 microgml added block protein synthesis 6 h neurons fixed 120 mm phosphate buffer containing 4 paraformaldehyde ph 73 4 sucrose permeabilized ice cold methanol acetone immunostained annaert et al 1999 recombinant app c99 detected pab 6687 gift dr c haass university munchen germany mab 3d6 gift dr seubert elan pharmaceuticals san francisco ca mabs bip purchased sigma pab b172 used detect endogenous ps1 annaert et al 1999 intermediate compartment golgi region identified using anti ergic 53 provided dr j saraste university bergen norway anti gm130 transduction laboratories respectively alexa 488 alexa 546 conjugated secondary antibodies molecular probes biorad mrc1024 confocal microscope adobe photoshop 52 used final processing annaert et al 1999
0.33943188.11502763.html.plaintext.txt	59	footnotes abbreviations used paper ass amyloid peptide app amyloid precursor protein bfa brefeldin ctf cooh terminal fragment kk dilysine pab polyclonal antibody ps presenilin scap screb cleavage activating protein sfv semliki forest virus screb sterol regulatory element binding protein
0.33943188.11502763.html.plaintext.txt	60	acknowledgments authors acknowledge dr p seubert elan pharmaceuticals dr k beyreuther dr hartmann university heidelberg germany dr c haass university munchen germany dr f checler dr m savage cephalon west chester pa dr j saraste university bergen bergen norway providing us valuable antibodies also thank dr p tienari embl heidelberg germany providing us app ct construct
0.33943188.11502763.html.plaintext.txt	61	work financially supported fwo vlaanderen ku leuven flanders interuniversity institute biotechnology bayer alzheimer disease research network barn p cupers w annaert holders fonds voor wetenschappelijik onderzoek postdoctoral fellowship
0.33943188.11502763.html.plaintext.txt	62	submitted 11 april 2001revised 27 june 2001accepted 4 july 2001
0.33943188.11502763.html.plaintext.txt	63	references top abstract introduction results discussion materials methods references
0.34432584.9115271.html.plaintext.txt	0	evidence six transmembrane domain structure presenilin 1
0.34432584.9115271.html.plaintext.txt	1	received publication february 21 1997 revised form march 13 1997
0.34432584.9115271.html.plaintext.txt	2	sylvain lehmann roberto chiesa david harris
0.34432584.9115271.html.plaintext.txt	3	department cell biology physiology washington university school medicine st louis missouri 63110 abstract introduction experimental procedures results discussion footnotes acknowledgements references
0.34432584.9115271.html.plaintext.txt	4	department cell biology physiology washington university school medicine st louis missouri 63110 abstract introduction experimental procedures results discussion footnotes acknowledgements references
0.34432584.9115271.html.plaintext.txt	5	mutations genes encoding presenilin 1 presenilin 2 account majority cases early onset familial alzheimers disease presenilins localized endoplasmic reticulum golgi multiple hydrophobic segments polypeptide chain span lipid bilayer unclear address question constructed series chimeric molecules topologically neutral reporter protein c terminal fragment prolactin containing three artificial glycosylation sites fused presenilin 1 following 10 potential transmembrane domains identified hydrophobicity plots expressed chimeras translation reticulocyte lysate containing canine pancreatic microsomes synthesis transfected cos cells based utilization glycosylation sites sensitivity reporter protease digestion provide evidence presenilin 1 six transmembrane segments n c termini cytoplasm model provides important clues potential functions different parts presenilin molecule might relate pathogenesis alzheimers disease
0.34432584.9115271.html.plaintext.txt	6	mutations genes encoding presenilin 1 presenilin 2 account majority cases early onset familial alzheimers disease presenilins localized endoplasmic reticulum golgi multiple hydrophobic segments polypeptide chain span lipid bilayer unclear address question constructed series chimeric molecules topologically neutral reporter protein c terminal fragment prolactin containing three artificial glycosylation sites fused presenilin 1 following 10 potential transmembrane domains identified hydrophobicity plots expressed chimeras translation reticulocyte lysate containing canine pancreatic microsomes synthesis transfected cos cells based utilization glycosylation sites sensitivity reporter protease digestion provide evidence presenilin 1 six transmembrane segments n c termini cytoplasm model provides important clues potential functions different parts presenilin molecule might relate pathogenesis alzheimers disease
0.34432584.9115271.html.plaintext.txt	7	alzheimers disease ad1 debilitating neurodegenerative disorder characterized dementia neuronal loss accumulation brain extracellular amyloid plaques intraneuronal neurofibrillary tangles 1 familial forms ad linked mutations three different genes encoding amyloid precursor protein app presenilin 1 ps1 presenilin 2 ps2 chromosomes 21 14 1 respectively 2 5 50 cases early onset familial ad attributable mutations presenilin genes mutations described include 35 different amino acid substitutions well frame deletion exon 9 reviewed ref 6
0.34432584.9115271.html.plaintext.txt	8	alzheimers disease ad1 debilitating neurodegenerative disorder characterized dementia neuronal loss accumulation brain extracellular amyloid plaques intraneuronal neurofibrillary tangles 1 familial forms ad linked mutations three different genes encoding amyloid precursor protein app presenilin 1 ps1 presenilin 2 ps2 chromosomes 21 14 1 respectively 2 5 50 cases early onset familial ad attributable mutations presenilin genes mutations described include 35 different amino acid substitutions well frame deletion exon 9 reviewed ref 6
0.34432584.9115271.html.plaintext.txt	9	ps1 ps2 polypeptides 467 448 amino acids respectively multiple hydrophobic segments 2 4 5 proteins expressed number tissues addition brain encoded several alternatively spliced mrnas 4 7 8 presenilins exhibit significant homology protein caenorhabditis elegans called sel 12 based genetic evidence modulates signaling lin 12notch pathway 9 show weaker homology spe 4 membrane protein c elegans sperm 10 immunofluorescence localization studies transfected cells indicate protein present steady state primarily er perhaps golgi also probably plasma membrane 11 neuronal cell line ps1 expressed using viral vector localized cell body dendrites 12 recent evidence indicates ps1 proteolytically cleaved amino acids 260 320 transfected cells well brain tissue although significance cleavage unclear 13 reports recombinant forms ps2 positively regulate apoptosis lymphocytes pc12 cells whether endogenous protein normally functions way unclear 14 15 taken together none available evidence clearly identifies physiological role presenilins however analysis patient fibroblasts transfected cells transgenic mice co express ps1 app indicate pathogenic mutations presenilin protein enhance production amyloidgenic a42 fragment 15 2 fold 16 19
0.34432584.9115271.html.plaintext.txt	10	ps1 ps2 polypeptides 467 448 amino acids respectively multiple hydrophobic segments 2 4 5 proteins expressed number tissues addition brain encoded several alternatively spliced mrnas 4 7 8 presenilins exhibit significant homology protein caenorhabditis elegans called sel 12 based genetic evidence modulates signaling lin 12notch pathway 9 show weaker homology spe 4 membrane protein c elegans sperm 10 immunofluorescence localization studies transfected cells indicate protein present steady state primarily er perhaps golgi also probably plasma membrane 11 neuronal cell line ps1 expressed using viral vector localized cell body dendrites 12 recent evidence indicates ps1 proteolytically cleaved amino acids 260 320 transfected cells well brain tissue although significance cleavage unclear 13 reports recombinant forms ps2 positively regulate apoptosis lymphocytes pc12 cells whether endogenous protein normally functions way unclear 14 15 taken together none available evidence clearly identifies physiological role presenilins however analysis patient fibroblasts transfected cells transgenic mice co express ps1 app indicate pathogenic mutations presenilin protein enhance production amyloidgenic a42 fragment 15 2 fold 16 19
0.34432584.9115271.html.plaintext.txt	11	determination membrane topology presenilins words defining parts polypeptide chain traverse lipid bilayer enormous importance understanding function proteins role ad several reasons first knowing domains polypeptide lie cytoplasm lumen er golgi dictate hypotheses function domains second experimental attempts identify cytoplasmic proteins interact presenilins using screening procedures yeast two hybrid system interaction cloning require knowledge segments polypeptide chain lie cytoplasm third membrane topology presenilins correlated positions pathogenic mutations providing clues mutations alter function proteins finally knowledge membrane topology presenilins allow detailed comparison possible homologues possible simply basis hydrophobicity plots
0.34432584.9115271.html.plaintext.txt	12	determination membrane topology presenilins words defining parts polypeptide chain traverse lipid bilayer enormous importance understanding function proteins role ad several reasons first knowing domains polypeptide lie cytoplasm lumen er golgi dictate hypotheses function domains second experimental attempts identify cytoplasmic proteins interact presenilins using screening procedures yeast two hybrid system interaction cloning require knowledge segments polypeptide chain lie cytoplasm third membrane topology presenilins correlated positions pathogenic mutations providing clues mutations alter function proteins finally knowledge membrane topology presenilins allow detailed comparison possible homologues possible simply basis hydrophobicity plots
0.34432584.9115271.html.plaintext.txt	13	report analysis membrane topology ps1 using vitro vivo expression systems results suggest protein spans membrane six times n c termini located cytoplasm model stands marked contrast ones originally proposed basis hydrophobicity plots hypothesized either seven nine transmembrane domains ps1 ps2 2 4 5 20 conclusions consistent significantly extend recent report suggesting ps1 possesses either six eight transmembrane segments 21 differ second study proposing eight transmembrane topology presenilin homologue sel 12 22
0.34432584.9115271.html.plaintext.txt	14	report analysis membrane topology ps1 using vitro vivo expression systems results suggest protein spans membrane six times n c termini located cytoplasm model stands marked contrast ones originally proposed basis hydrophobicity plots hypothesized either seven nine transmembrane domains ps1 ps2 2 4 5 20 conclusions consistent significantly extend recent report suggesting ps1 possesses either six eight transmembrane segments 21 differ second study proposing eight transmembrane topology presenilin homologue sel 12 22
0.34432584.9115271.html.plaintext.txt	15	ps1 segments hr prl chimeras generated pcr using template ps1 cdna derived rna splice variant lacking exon 4 encodes sequence vsrq provided dr alison goate ref 8 5 primer gatcaggaattcatgacagagttacctgcaccg 3 primer consisted sequence gactagggtaaccaa followed complement sequence encoding following amino acids 122 128 hr1 prl 151 157 hr2 prl 181 187 hr3 prl 209 215 hr4 prl 233 239 hr5 prl 271 277 hr6 prl 370 376 hr7 prl 397 403 hr8 prl 423 429 hr9 prl 457 463 hr10 prl reporter segment chimeras generated amplification 148 c terminal amino acids bovine prolactin using template pbp292 american type culture collection 5 primer gatcaggaattcgatcttggttaccatggccctcaacagctgccat 3 primer encoded three consensus sites n glycosylation ha tag sequence ctgctatctagactatgcgtaatctggaacatcgtatgggtacatagttccgttcatggatccgttagtgcagttgttgttgtagatgat ps1 fragments digested ecori bsteii reporter fragment bsteii xbai fragments ligated ecori xbai digested pcdna3 invitrogen constructs sequenced entirety
0.34432584.9115271.html.plaintext.txt	16	vitro transcription translation
0.34432584.9115271.html.plaintext.txt	17	plasmids linearized xbai capped mrnas synthesized t7 rna polymerase using kit ambion rabbit reticulocyte lysate canine pancreatic microsomes obtained promega used translate mrnas presence 35smethionine described manufacturer proteinase k treatment translation reactions performed final concentration 50 microgml 1 h ice presence absence 05 triton x 100 followed inactivation protease 3 mm phenylmethylsulfonyl fluoride
0.34432584.9115271.html.plaintext.txt	18	plasmids linearized xbai capped mrnas synthesized t7 rna polymerase using kit ambion rabbit reticulocyte lysate canine pancreatic microsomes obtained promega used translate mrnas presence 35smethionine described manufacturer proteinase k treatment translation reactions performed final concentration 50 microgml 1 h ice presence absence 05 triton x 100 followed inactivation protease 3 mm phenylmethylsulfonyl fluoride
0.34432584.9115271.html.plaintext.txt	19	6 microl translation reaction added 40 microl lysis buffer 150 mm nacl 50 mm tris ph 75 05 triton x 100 05 sodium deoxycholate 05 sds supplemented protease inhibitors pepstatin leupeptin 1 microgml phenylmethylsulfonyl fluoride 05 mm edta 2 mm 5 min 25 degrees c 160 microl dilution buffer 50 mm nacl 05 triton x 100 containing protease inhibitors added samples precleared protein sepharose beads supernatants incubated one following rabbit antibodies anti ha babco anti bovine prolactin dr f parlow anti ps1 prepared dr jeanne nerbonne synthetic peptide encompassing residues 26 42 immunocomplexes collected protein sepharose beads analyzed sds page autoradiography samples heated 60 degrees c 5 min prior sds page since boiling results aggregation ps1 proteins 23
0.34432584.9115271.html.plaintext.txt	20	cos 7 cells grown dulbeccos modified eagles medium containing 10 fetal calf serum 1 mm pyruvate penicillinstreptomycin atmosphere 5 c02 95 air cells transfected lipofectamine life technologies inc according manufacturers directions 48 h later labeled 3 h 35smethionine labeled cultures extracted lysis buffer ps1 prl proteins immunoprecipitated anti ha antibody described protease digestion experiments labeled cells collected phosphate buffered saline gently homogenized passage eight times 025 mm diameter plastic tubing attached end 27 gauge needle syringe centrifugation 700 x g 3 min postnuclear supernatant treated proteinase k presence absence triton x 100 proteins immunoprecipitated described
0.34432584.9115271.html.plaintext.txt	21	cos 7 cells grown dulbeccos modified eagles medium containing 10 fetal calf serum 1 mm pyruvate penicillinstreptomycin atmosphere 5 c02 95 air cells transfected lipofectamine life technologies inc according manufacturers directions 48 h later labeled 3 h 35smethionine labeled cultures extracted lysis buffer ps1 prl proteins immunoprecipitated anti ha antibody described protease digestion experiments labeled cells collected phosphate buffered saline gently homogenized passage eight times 025 mm diameter plastic tubing attached end 27 gauge needle syringe centrifugation 700 x g 3 min postnuclear supernatant treated proteinase k presence absence triton x 100 proteins immunoprecipitated described
0.34432584.9115271.html.plaintext.txt	22	addition lysis dilution buffers described reticulocyte lysate treated 0025 unitml n glycosidase f boehringer mannheim 6 h 37 degrees c proteins precipitated 4 volumes methanol analyzed sds page autoradiography diluted lysates cos cells treated 001 unitml enzyme 16 h 37 degrees c prior immunoprecipitation
0.34432584.9115271.html.plaintext.txt	23	addition lysis dilution buffers described reticulocyte lysate treated 0025 unitml n glycosidase f boehringer mannheim 6 h 37 degrees c proteins precipitated 4 volumes methanol analyzed sds page autoradiography diluted lysates cos cells treated 001 unitml enzyme 16 h 37 degrees c prior immunoprecipitation
0.34432584.9115271.html.plaintext.txt	24	hydrophobicity plots identify 10 segments least 15 amino acids sequence ps1 could potentially span membrane fig 1a constructed chimeras prolactin reporter fused hydrophobic regions fig 1b reporter c terminal fragment bovine prolactin residues 82 229 onto appended three consensus sites n glycosylation well ha tag proteins recognized anti ha well anti prolactin antibodies number studies utilized portion prolactin reporter since lacks signals might influence membrane orientation adjacent polypeptide 24 26 fusion proteins synthesized membrane attached ribosomes reporter glycosylated protected proteases applied cytoplasmic surface resides lumen er topologically equivalent extracellular space two techniques combined tagging protein artificial glycosylation sites fusing reporter molecule recognized antibody binding enzymatic activity used individually map topology number membrane proteins 27 28 recognize although techniques provide evidence support specific model membrane topology always possible experimental modifications polypeptide chain may perturb interaction lipid bilayer fig 1 hydrophobicity plot ps1 schematic illustration fusion constructs panel hydrophobicity plot human ps1 method kyte doolittle 31 used window size 10 residues amino acid positions bounding 10 hydrophobic regions hrs follows hr1 78 101 hr2 129 150 hr3 158 178 hr4 188 209 hr5 217 234 hr6 240 261 hr7 278 294 hr8 378 393 hr9 404 424 hr10 430 445 numbering based rna splice variant lacks exon 4 encoding sequence vrsq ref 8 panel b ps1 prolactin fusion proteins prolactin prl reporter fused following residues ps1 hr1 128 hr2 157 hr3 187 hr4 215 hr5 239 hr6 277 hr7 376 hr8 403 hr9 429 hr10 463 fusion point construct positioned c terminal possible minimize effects reporter topology adjacent hydrophobic region nctngsngt three artificial glycosylation sites ha hemagglutinin tag engineered c terminus prolactin reporter view larger version image 38k gif file
0.34432584.9115271.html.plaintext.txt	25	first translated synthetic mrnas encoding ps1 prolactin chimeras reticulocyte lysate system absence canine pancreatic microsomes proteins ranging size 33 70 kda recovered immunoprecipitation anti ha antibody corresponding unglycosylated fusion proteins fig 2a lane 1 translation performed presence microsomes hr1 prl hr3 prl hr5 prl constructs yielded additional products slightly higher molecular weight fig 2a lane 2 larger products represent glycosylated forms proteins since eliminated samples treated n glycosidase f fig 2b lanes 3 4 observed others 25 26 glycosylation vitro system inefficient resulting presence unglycosylated protein even translation performed microsomes fig 2a lane 2 fig 2b lane 3 noted ps1 prl fusion proteins often migrated closely spaced doublets sds page see fig 2b lanes 1 2 phenomenon observed full length ps1 synthesized vitro transfected cells likely result uncharacterized posttranslational modification 11 12 29 fig 2 vitro translation ps1 prolactin chimeras panel mrnas encoding hr prl constructs shown fig 1b translated reticulocyte lysate absence lane 1 presence lanes 2 3 4 canine pancreatic microsomes samples left untreated lanes 1 2 digested proteinase k absence lane 3 presence lane 4 triton x 100 samples immunoprecipitated anti ha antibody unglycosylated fusion proteins indicated filled arrowheads glycosylated forms open arrowheads protease protected fragments asterisks protease protected fragments like intact fusion proteins sometimes migrated doublets unknown posttranslational modification described text see lane 3 hr1 molecular mass markers kilodaltons panel b mrnas encoding hr1 prl hr3 prl hr5 prl translated reticulocyte lysate absence lanes 1 2 presence lanes 3 4 canine pancreatic microsomes samples left untreated lanes 1 3 digested n glycosidase f remove n linked sugars lanes 2 4 proteins analyzed without immunoprecipitation avoid distortion gel bands immunoglobulin arrowheads mark positions glycosylated forms fusion proteins similar analysis 7 chimeras showed glycosylated shown view larger version image 54k gif file
0.34432584.9115271.html.plaintext.txt	26	first translated synthetic mrnas encoding ps1 prolactin chimeras reticulocyte lysate system absence canine pancreatic microsomes proteins ranging size 33 70 kda recovered immunoprecipitation anti ha antibody corresponding unglycosylated fusion proteins fig 2a lane 1 translation performed presence microsomes hr1 prl hr3 prl hr5 prl constructs yielded additional products slightly higher molecular weight fig 2a lane 2 larger products represent glycosylated forms proteins since eliminated samples treated n glycosidase f fig 2b lanes 3 4 observed others 25 26 glycosylation vitro system inefficient resulting presence unglycosylated protein even translation performed microsomes fig 2a lane 2 fig 2b lane 3 noted ps1 prl fusion proteins often migrated closely spaced doublets sds page see fig 2b lanes 1 2 phenomenon observed full length ps1 synthesized vitro transfected cells likely result uncharacterized posttranslational modification 11 12 29 fig 2 vitro translation ps1 prolactin chimeras panel mrnas encoding hr prl constructs shown fig 1b translated reticulocyte lysate absence lane 1 presence lanes 2 3 4 canine pancreatic microsomes samples left untreated lanes 1 2 digested proteinase k absence lane 3 presence lane 4 triton x 100 samples immunoprecipitated anti ha antibody unglycosylated fusion proteins indicated filled arrowheads glycosylated forms open arrowheads protease protected fragments asterisks protease protected fragments like intact fusion proteins sometimes migrated doublets unknown posttranslational modification described text see lane 3 hr1 molecular mass markers kilodaltons panel b mrnas encoding hr1 prl hr3 prl hr5 prl translated reticulocyte lysate absence lanes 1 2 presence lanes 3 4 canine pancreatic microsomes samples left untreated lanes 1 3 digested n glycosidase f remove n linked sugars lanes 2 4 proteins analyzed without immunoprecipitation avoid distortion gel bands immunoglobulin arrowheads mark positions glycosylated forms fusion proteins similar analysis 7 chimeras showed glycosylated shown view larger version image 54k gif file
0.34432584.9115271.html.plaintext.txt	27	hr1 prl hr3 prl hr5 prl also three chimeras produced protected fragment reactive anti ha antibody treatment microsome containing translation mixture proteinase k fig 2a lane 3 protected fragment glycosylated shown migrated approximately 7 kda lower corresponding intact glycosylated protein fig 2a lane 2 fragment eliminated microsomes permeabilized triton x 100 prior protease digestion fig 2a lane 4 demonstrating represent intrinsically protease resistant portion molecule protected fragment could immunoprecipitated anti prolactin well anti ha antibodies antibody n terminus ps1 fig 3 lanes 2 4 indicating n terminus protease accessible therefore cytoplasmic based 7 kda reduction molecular size infer proteinase k removes approximately 70 amino acids n terminus hr1 hr3 hr5 prl point near beginning hr1 cytoplasmic loops transmembrane hydrophobic segments resistant cleavage probably short 10 amino acids therefore closely apposed lipid bilayer 25 fig 3 antibody reactivity protease protected fragments generated vitro translation mrnas encoding hr1 prl hr3 prl hr5 prl translated reticulocyte lysate presence canine pancreatic microsomes left untreated lanes 1 3 digested proteinase k lanes 2 4 samples immunoprecipitated either anti prolactin antibody lanes 1 2 antibody raised ps1 residues 26 42 lanes 3 4 view larger version image 61k gif file
0.34432584.9115271.html.plaintext.txt	28	confirm vitro translation results intact cells expressed ps1 prl fusion proteins cos cells observed hr1 hr3 hr5 prl glycosylated indicated reduction molecular weight proteins upon treatment n glycosidase f fig 4a contrast situation reticulocyte lysate glycosylation chimeras cos cells essentially quantitative making unlikely proteins heterogeneous respect localization reporter three fusion proteins also produces protected fragment 7 kda smaller intact protein following proteinase k digestion postnuclear supernatant derived transfected cells fig 4b seven fusion proteins yield protected fragments data shown results similar shown fig 4 also obtained transfected chinese hamster ovary cells shown fig 4 expression ps1 prl fusion proteins cos cells panel fusion proteins immunoprecipitated anti ha antibody metabolically labeled cos cells transiently transfected plasmids encoding hr1 hr10 prl prior immunoprecipitation cell lysates either left untreated lanes digested n glycosidase f lanes panel b postnuclear supernatants prepared metabolically labeled cos cells expressing hr1 hr3 hr5 prl either left untreated lane 1 digested proteinase k absence lane 2 presence triton x 100 lane 3 fusion proteins immunoprecipitated anti ha antibody arrowheads mark positions protease protected fragments view larger version image 49k gif file
0.34432584.9115271.html.plaintext.txt	29	confirm vitro translation results intact cells expressed ps1 prl fusion proteins cos cells observed hr1 hr3 hr5 prl glycosylated indicated reduction molecular weight proteins upon treatment n glycosidase f fig 4a contrast situation reticulocyte lysate glycosylation chimeras cos cells essentially quantitative making unlikely proteins heterogeneous respect localization reporter three fusion proteins also produces protected fragment 7 kda smaller intact protein following proteinase k digestion postnuclear supernatant derived transfected cells fig 4b seven fusion proteins yield protected fragments data shown results similar shown fig 4 also obtained transfected chinese hamster ovary cells shown fig 4 expression ps1 prl fusion proteins cos cells panel fusion proteins immunoprecipitated anti ha antibody metabolically labeled cos cells transiently transfected plasmids encoding hr1 hr10 prl prior immunoprecipitation cell lysates either left untreated lanes digested n glycosidase f lanes panel b postnuclear supernatants prepared metabolically labeled cos cells expressing hr1 hr3 hr5 prl either left untreated lane 1 digested proteinase k absence lane 2 presence triton x 100 lane 3 fusion proteins immunoprecipitated anti ha antibody arrowheads mark positions protease protected fragments view larger version image 49k gif file
0.34432584.9115271.html.plaintext.txt	30	taken together results glycosylation site utilization protease protection vitro cells suggest model ps1 topology shown fig 5 hr1 hr3 hr5 span membrane cytoplasmic lumenal side hr2 hr4 hr6 lumenal cytoplasmic side n c termini cytoplasmic hr7 hr10 constitute transmembrane domains although analysis address issue whether segments associate closely lipid bilayer manner reentrant loops described channel proteins 25 27 30 model places two consensus sites n linked glycosylation asparagine residues 275 401 cytoplasm consistent fact full length ps1 expressed cells vitro translation glycosylated 12 23 29 given high degree homology ps1 ps2 would predict ps2 membrane topology shown fig 5 although data support six transmembrane domain structure ps1 course possible membrane topology native protein different one inferred based properties ps1 prolactin fusions however fusion reporter segment introduction ectopic glycosylation sites found disturb topology number membrane proteins 27 28 fig 5 model membrane topology ps1 although data indicate hr7 hr10 span membrane one hydrophobic segments may associate closely lipid bilayer view larger version image 15k gif file
0.34432584.9115271.html.plaintext.txt	31	results consistent doan et al 21 concluded ps1 either six eight transmembrane domains data distinguish two possibilities n terminus c terminus part loop region residues 320 390 cytoplasm however results differ li greenwald 22 proposed model c elegans ps1 homologue sel 12 eight transmembrane segments including hr1 hr6 hr 8 hr 9 think unlikely theoretical grounds hr8 ps1 spans membrane since short 16 amino acids marginally hydrophobic see fig 1a identification hr8 hr9 transmembrane segments sel 12 inferred indirectly enzymatic activity pair galactosidase fusions hr8 deleted possible deletion modified membrane topology protein altered activity galactosidase reporter also conceivable membrane topologies ps1 sel 12 different
0.34432584.9115271.html.plaintext.txt	32	results consistent doan et al 21 concluded ps1 either six eight transmembrane domains data distinguish two possibilities n terminus c terminus part loop region residues 320 390 cytoplasm however results differ li greenwald 22 proposed model c elegans ps1 homologue sel 12 eight transmembrane segments including hr1 hr6 hr 8 hr 9 think unlikely theoretical grounds hr8 ps1 spans membrane since short 16 amino acids marginally hydrophobic see fig 1a identification hr8 hr9 transmembrane segments sel 12 inferred indirectly enzymatic activity pair galactosidase fusions hr8 deleted possible deletion modified membrane topology protein altered activity galactosidase reporter also conceivable membrane topologies ps1 sel 12 different
0.34432584.9115271.html.plaintext.txt	33	model topology ps1 important implications function protein role ad find polypeptide chain ps1 cytoplasmic including n terminal region long c terminal tail encompassing hr7 hr10 segments may therefore important interactions cytoplasmic proteins much cytoplasmic region hr6 c terminus exclusive segment hr7 hr8 highly conserved presenilins sel 12 suggesting essential functions domain number pathogenic mutations found end hr6 end hr7 reviewed ref 6 one might speculate alter associations ps1 molecules cytoplasm since little polypeptide chain protrudes er lumen direct interaction ps1 lumenal proteins seems unlikely although associations er membrane proteins possible ps1 binds app possibility suggested enhanced production 42 fragment cells expressing mutant ps1 16 19 interaction would likely occur transiently transit app er golgi would probably involve either transmembrane region short cytoplasmic tail app
0.34432584.9115271.html.plaintext.txt	34	model topology ps1 important implications function protein role ad find polypeptide chain ps1 cytoplasmic including n terminal region long c terminal tail encompassing hr7 hr10 segments may therefore important interactions cytoplasmic proteins much cytoplasmic region hr6 c terminus exclusive segment hr7 hr8 highly conserved presenilins sel 12 suggesting essential functions domain number pathogenic mutations found end hr6 end hr7 reviewed ref 6 one might speculate alter associations ps1 molecules cytoplasm since little polypeptide chain protrudes er lumen direct interaction ps1 lumenal proteins seems unlikely although associations er membrane proteins possible ps1 binds app possibility suggested enhanced production 42 fragment cells expressing mutant ps1 16 19 interaction would likely occur transiently transit app er golgi would probably involve either transmembrane region short cytoplasmic tail app
0.34432584.9115271.html.plaintext.txt	35	topology model proposed makes unlikely ps1 functions conventional g protein coupled receptor consistent role ps1 processes vesicle docking budding membrane cytoskeletal interactions ion solute transport recently described endoproteolytic cleavage ps1 13 predicted occur following hr6 would expected generate c terminal fragment lacks transmembrane segments whether fragment soluble would depend tightly hr7 hr10 associated lipid bilayer diffusible could serve transmit signal regions cell knowing membrane topology ps1 facilitate attempts isolate interacting molecules provide starting point investigations biological activity normal mutant forms protein
0.34432584.9115271.html.plaintext.txt	36	topology model proposed makes unlikely ps1 functions conventional g protein coupled receptor consistent role ps1 processes vesicle docking budding membrane cytoskeletal interactions ion solute transport recently described endoproteolytic cleavage ps1 13 predicted occur following hr6 would expected generate c terminal fragment lacks transmembrane segments whether fragment soluble would depend tightly hr7 hr10 associated lipid bilayer diffusible could serve transmit signal regions cell knowing membrane topology ps1 facilitate attempts isolate interacting molecules provide starting point investigations biological activity normal mutant forms protein
0.34432584.9115271.html.plaintext.txt	37	work supported gift funds alzheimers disease research center washington universitythe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact recipient postdoctoral fellowship physicians howard hughes medical institute recipient fellowship telethon italia correspondence addressed dept cell biology physiology washington university school medicine 660 south euclid ave st louis mo 63110 tel 314 362 4690 fax 314 362 7463 e mail dharrisatcellbiowustledu u d 1 abbreviations used ad alzheimers disease app amyloid precursor protein ha hemagglutinin hr hydrophobic region prl prolactin ps1 presenilin 1 ps2 presenilin 2 er endoplasmic reticulum page polyacrylamide gel electrophoresis acknowledgements
0.34432584.9115271.html.plaintext.txt	38	work supported gift funds alzheimers disease research center washington universitythe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact recipient postdoctoral fellowship physicians howard hughes medical institute recipient fellowship telethon italia correspondence addressed dept cell biology physiology washington university school medicine 660 south euclid ave st louis mo 63110 tel 314 362 4690 fax 314 362 7463 e mail dharrisatcellbiowustledu u d 1 abbreviations used ad alzheimers disease app amyloid precursor protein ha hemagglutinin hr hydrophobic region prl prolactin ps1 presenilin 1 ps2 presenilin 2 er endoplasmic reticulum page polyacrylamide gel electrophoresis acknowledgements
0.34432584.9115271.html.plaintext.txt	39	thank alison goate ps1 cdna jeanne nerbonne athena guo f parlow antibodies jane wu advice automated dna sequencing brendan walsh dung le technical assistance also acknowledge maurine linder carl romano members harris laboratory comments manuscript
0.34448025.16033878.html.plaintext.txt	0	large meta analysis establishes ace insertion deletion polymorphism marker alzheimers disease donald j lehmann1 mario cortina borja2 donald r warden1 david smith1 kristel sleegers3 jonathan prince4 cornelia m van duijn3 patrick g kehoe5
0.34448025.16033878.html.plaintext.txt	1	large meta analysis establishes ace insertion deletion polymorphism marker alzheimers disease donald j lehmann1 mario cortina borja2 donald r warden1 david smith1 kristel sleegers3 jonathan prince4 cornelia m van duijn3 patrick g kehoe5
0.34448025.16033878.html.plaintext.txt	2	1 oxford project investigate memory ageing optima department pharmacology university oxford oxford united kingdom 2 centre paediatric epidemiology biostatistics institute child health university college london london united kingdom 3 department epidemiology biostatistics erasmus mc rotterdam netherlands 4 center genomics bioinformatics karolinska institute stockholm sweden 5 care elderly department clinical science north bristol university bristol frenchay hospital bristol united kingdom
0.34448025.16033878.html.plaintext.txt	3	received publication january 5 2005 accepted publication march 22 2005
0.34448025.16033878.html.plaintext.txt	4	received publication january 5 2005 accepted publication march 22 2005
0.34448025.16033878.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references apolipoprotein e 4 apoe4 fully established susceptibility allele alzheimers disease one studied candidates insertion ideletion d polymorphism indel gene angiotensin converting enzyme ace study aimed clarify association alzheimers disease meta analysis included 39 samples comprising 6037 cases alzheimers disease 12099 controls using mainly primary data potential interactions gender age ethnic group carrier status apolipoprotein e 4 allele examined d homozygotes reduced risk alzheimers disease odds ratio 081 95 confidence interval 072 090 corrected p 00004 homozygotes showed association alzheimers disease heterozygotes increased risk although clear differences among three ethnic groups examined north europeans south caucasians east asians groups d homozygotes reduced risk results confirm association angiotensin converting enzyme indel alzheimers disease across diverse populations although probably due linkage disequilibrium true risk factor north europeans association hardy weinberg analysis suggested partial heterosis increased risk heterozygotes due hidden interaction another yet unknown risk factor interaction warrants investigation
0.34448025.16033878.html.plaintext.txt	6	abstract top abstract introduction materials methods results discussion references apolipoprotein e 4 apoe4 fully established susceptibility allele alzheimers disease one studied candidates insertion ideletion d polymorphism indel gene angiotensin converting enzyme ace study aimed clarify association alzheimers disease meta analysis included 39 samples comprising 6037 cases alzheimers disease 12099 controls using mainly primary data potential interactions gender age ethnic group carrier status apolipoprotein e 4 allele examined d homozygotes reduced risk alzheimers disease odds ratio 081 95 confidence interval 072 090 corrected p 00004 homozygotes showed association alzheimers disease heterozygotes increased risk although clear differences among three ethnic groups examined north europeans south caucasians east asians groups d homozygotes reduced risk results confirm association angiotensin converting enzyme indel alzheimers disease across diverse populations although probably due linkage disequilibrium true risk factor north europeans association hardy weinberg analysis suggested partial heterosis increased risk heterozygotes due hidden interaction another yet unknown risk factor interaction warrants investigation
0.34448025.16033878.html.plaintext.txt	7	alzheimer disease heterogeneity meta analysis
0.34448025.16033878.html.plaintext.txt	8	abbreviations ace angiotensin converting enzyme protein ace angiotensin converting enzyme gene apoe4 apolipoprotein e 4 allele
0.34448025.16033878.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references 1999 kehoe et al 1 first proposed association alzheimers disease insertion ideletion d polymorphism indel intron 16 gene angiotensin converting enzyme ace chromosome 17q23 enzyme converts angiotensin angiotensin ii potently hypertensive d allele associated raised plasma levels enzyme 2 3 kehoe et al 1 found positives di ii increased risk alzheimers disease study comprised three samples cardiff london britain belfast northern ireland strikingly similar results
0.34448025.16033878.html.plaintext.txt	10	introduction top abstract introduction materials methods results discussion references 1999 kehoe et al 1 first proposed association alzheimers disease insertion ideletion d polymorphism indel intron 16 gene angiotensin converting enzyme ace chromosome 17q23 enzyme converts angiotensin angiotensin ii potently hypertensive d allele associated raised plasma levels enzyme 2 3 kehoe et al 1 found positives di ii increased risk alzheimers disease study comprised three samples cardiff london britain belfast northern ireland strikingly similar results
0.34448025.16033878.html.plaintext.txt	11	since potential association examined 40 samples 4 5 table 1 around world several studies replicated report increased risk positives contradicted many found association alzheimers disease one study suggested effect age association 6 another proposed influence gender 7 association onset age alzheimers disease also proposed 8
0.34448025.16033878.html.plaintext.txt	12	since potential association examined 40 samples 4 5 table 1 around world several studies replicated report increased risk positives contradicted many found association alzheimers disease one study suggested effect age association 6 another proposed influence gender 7 association onset age alzheimers disease also proposed 8
0.34448025.16033878.html.plaintext.txt	13	view table table 1 cohorts used meta analysis ace insertion deletion polymorphism alzheimers disease
0.34448025.16033878.html.plaintext.txt	14	association recently studied longitudinal observational cohorts oxford project investigate memory ageing optima rotterdam study 9 groups found suggestion gender difference results consistent previous report 7 therefore undertook meta analysis studies association ace indel alzheimers disease stratified gender age ethnic group apolipoprotein e 4 allele apoe4 carrier status using mainly primary data supplied authors
0.34448025.16033878.html.plaintext.txt	15	association recently studied longitudinal observational cohorts oxford project investigate memory ageing optima rotterdam study 9 groups found suggestion gender difference results consistent previous report 7 therefore undertook meta analysis studies association ace indel alzheimers disease stratified gender age ethnic group apolipoprotein e 4 allele apoe4 carrier status using mainly primary data supplied authors
0.34448025.16033878.html.plaintext.txt	16	although three previous meta analyses ace studies reported 10 12 subsequent studies made data available compared even latest meta analysis 12 10 samples eight studies available us 9 13 18 study oxford project investigate memory ageing addition previous meta analyses based published data largely unstratified thus limited interpretations allowed using primary data able explore deeply searching sources heterogeneity two previous stratified meta analyses alzheimers disease genes 19 20 based primary data deepened understanding
0.34448025.16033878.html.plaintext.txt	17	although three previous meta analyses ace studies reported 10 12 subsequent studies made data available compared even latest meta analysis 12 10 samples eight studies available us 9 13 18 study oxford project investigate memory ageing addition previous meta analyses based published data largely unstratified thus limited interpretations allowed using primary data able explore deeply searching sources heterogeneity two previous stratified meta analyses alzheimers disease genes 19 20 based primary data deepened understanding
0.34448025.16033878.html.plaintext.txt	18	egger et al 21 stressed need examine sources heterogeneity meta analyses case control studies therefore divided analysis two phases first broad overall analysis second detailed examination sources heterogeneity aimed discover whether ace indel associated alzheimers disease nature association
0.34448025.16033878.html.plaintext.txt	19	materials methods top abstract introduction materials methods results discussion references phase 1 broad analysis april 2003 following pubmed searches study references abstracts communication experts wrote authors association studies ace indel alzheimers disease known us 33 studies involving 41 samples 4 5 table 1 including seven samples unpublished studies searches updated november 2004 without data arising stratified analyses used raw data stratified summaries received authors 26 samples overall analyses also used published data making 39 samples altogether table 1 early onset cases 50 years young controls 50 years excluded identifiable subjects incomplete data distinct populations treated separately possible large number controls cohort sleegers et al 9 fully assessed 22 samples genotyped ace indel except two prince et al 23 24 used ace rs4343 marker 85 90 percent linkage disequilibrium indel north europeans
0.34448025.16033878.html.plaintext.txt	20	materials methods top abstract introduction materials methods results discussion references phase 1 broad analysis april 2003 following pubmed searches study references abstracts communication experts wrote authors association studies ace indel alzheimers disease known us 33 studies involving 41 samples 4 5 table 1 including seven samples unpublished studies searches updated november 2004 without data arising stratified analyses used raw data stratified summaries received authors 26 samples overall analyses also used published data making 39 samples altogether table 1 early onset cases 50 years young controls 50 years excluded identifiable subjects incomplete data distinct populations treated separately possible large number controls cohort sleegers et al 9 fully assessed 22 samples genotyped ace indel except two prince et al 23 24 used ace rs4343 marker 85 90 percent linkage disequilibrium indel north europeans
0.34448025.16033878.html.plaintext.txt	21	phase 2 examination heterogeneity examined six possible sources heterogeneity performed analyses stratified age gender apoe4 status age stratifications 65 years 65 75 years 75 years divided samples two groups according ages cases defined example onset first group examination death second group also conducted analyses restricted controls diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease cerad 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda 26 26 full samples two part samples separate analyses excluded eight samples hardy weinberg analysis genotyping methods compatible mistyping underreporting heterozygotes may occur unless either 5 percent dimethyl sulfoxide included polymerase chain reaction 27 dd genotype confirmed insertion specific second amplification 28 analyses samples placed possible 34 39 samples one three ethnic groups north european 19 samples south caucasian 11 samples defined mediterranean middle east east asian four samples china japan
0.34448025.16033878.html.plaintext.txt	22	phase 2 examination heterogeneity examined six possible sources heterogeneity performed analyses stratified age gender apoe4 status age stratifications 65 years 65 75 years 75 years divided samples two groups according ages cases defined example onset first group examination death second group also conducted analyses restricted controls diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease cerad 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda 26 26 full samples two part samples separate analyses excluded eight samples hardy weinberg analysis genotyping methods compatible mistyping underreporting heterozygotes may occur unless either 5 percent dimethyl sulfoxide included polymerase chain reaction 27 dd genotype confirmed insertion specific second amplification 28 analyses samples placed possible 34 39 samples one three ethnic groups north european 19 samples south caucasian 11 samples defined mediterranean middle east east asian four samples china japan
0.34448025.16033878.html.plaintext.txt	23	data analysis statistical methods three methods commonly used produce odds ratios genetic association studies method 1 allelic ie d vs case method 2 comparing genotype one turn eg dd vs di method 3 comparing genotype turn two combined three methods subject bias degree bias depending imperfectly model fits reality instance method 1 best suited testing codominant model allelic dose effect eg dd di ii method 3 hand may used test either dominantd recessive d dominanti recessive model chose follow hypothesis generating study 1 using method 3 partly preliminary examination subsequent studies shown evidence codominance also used methods 2 3 examine heterosis heterozygotes greater lesser risk either homozygote main approach method 3 gives estimate risk associated genotype compared rest population
0.34448025.16033878.html.plaintext.txt	24	pooled odds ratios calculated three times fixed effects method mantel haenszel 29 random effects method dersimonian laird 30 bayesian random effects method warn et al 31 however results three methods similar first two shown table 2 methods meta analysis permit accumulation results across independent studies even number subjects ratio cases controls varies considerably cohort sleegers et al 9 example heterogeneity test method armitage 32 logistic regression analysis used compare odds ratios among ethnic groups funnel plots 33 cumulative meta analysis 34 used investigate bias analyses performed using r 35 package rmeta thomas lumley httpwwwcranr projectorgsrccontribdescriptionsrmetahtml tests significance two sided bonferroni correction factor 3 applied p values genotype
0.34448025.16033878.html.plaintext.txt	25	view table table 2 odds ratios alzheimers disease ace genotype versus two meta analysis
0.34448025.16033878.html.plaintext.txt	26	results top abstract introduction materials methods results discussion references phase 1 broad analysis examination bias found evidence publication bias funnel plots comparisons commonly made d homozygotes versus positives ie di ii homozygotes versus d positives shown figure 1 plots gave p 019 p 021 respectively figure 2 shows cumulative meta analysis study july 1998 november 2004 d homozygotes versus positives comparison made hypothesis generating study kehoe et al 1 four 39 cohorts studied odds ratio dersimonian laird 30 became significantly less 1 remained thereafter changed little around 08 2001
0.34448025.16033878.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references phase 1 broad analysis examination bias found evidence publication bias funnel plots comparisons commonly made d homozygotes versus positives ie di ii homozygotes versus d positives shown figure 1 plots gave p 019 p 021 respectively figure 2 shows cumulative meta analysis study july 1998 november 2004 d homozygotes versus positives comparison made hypothesis generating study kehoe et al 1 four 39 cohorts studied odds ratio dersimonian laird 30 became significantly less 1 remained thereafter changed little around 08 2001
0.34448025.16033878.html.plaintext.txt	28	view larger version 18k figure 1 funnel plots angiotensin converting enzyme gene ace studies d homozygotes versus di ii p 021 b homozygotes versus di dd p 019 d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals dashed vertical lines summary log odds ratios
0.34448025.16033878.html.plaintext.txt	29	view larger version 18k figure 1 funnel plots angiotensin converting enzyme gene ace studies d homozygotes versus di ii p 021 b homozygotes versus di dd p 019 d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals dashed vertical lines summary log odds ratios
0.34448025.16033878.html.plaintext.txt	30	view larger version 45k figure 2 cumulative meta analysis odds ratio alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals vertical dotted line summary odds ratio optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	31	view larger version 45k figure 2 cumulative meta analysis odds ratio alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals vertical dotted line summary odds ratio optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	32	risk alzheimers disease genotype odds ratios genotype versus two shown figures 3 4 5 summarized table 2 d homozygotes reduced risk alzheimers disease overall odds ratio 081 95 percent confidence interval 072 090 corrected p 00004 method dersimonian laird 30 heterozygotes increased risk alzheimers disease overall odds ratio 112 95 percent confidence interval 104 122 corrected p 0006 odds ratio alzheimers disease homozygotes versus d positives differ significantly 1 two three results heterogeneous
0.34448025.16033878.html.plaintext.txt	33	risk alzheimers disease genotype odds ratios genotype versus two shown figures 3 4 5 summarized table 2 d homozygotes reduced risk alzheimers disease overall odds ratio 081 95 percent confidence interval 072 090 corrected p 00004 method dersimonian laird 30 heterozygotes increased risk alzheimers disease overall odds ratio 112 95 percent confidence interval 104 122 corrected p 0006 odds ratio alzheimers disease homozygotes versus d positives differ significantly 1 two three results heterogeneous
0.34448025.16033878.html.plaintext.txt	34	view larger version 45k figure 3 odds ratios alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	35	view larger version 45k figure 3 odds ratios alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	36	view larger version 48k figure 4 odds ratios alzheimers disease ace heterozygotes versus homozygotes horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	37	view larger version 48k figure 4 odds ratios alzheimers disease ace heterozygotes versus homozygotes horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	38	view larger version 46k figure 5 odds ratios alzheimers disease acei homozygotes versus d positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	39	view larger version 46k figure 5 odds ratios alzheimers disease acei homozygotes versus d positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.34448025.16033878.html.plaintext.txt	40	onset age alzheimers disease onset age data available 13 samples comprising 2309 cases alzheimers disease stratified analyses linear regression analysis performed data also subset 10 north european samples comprising 1822 cases alzheimers disease effect acei carrier status onset age alzheimers disease surprisingly modest effect apoe4 carrier status onset age seen data shown
0.34448025.16033878.html.plaintext.txt	41	onset age alzheimers disease onset age data available 13 samples comprising 2309 cases alzheimers disease stratified analyses linear regression analysis performed data also subset 10 north european samples comprising 1822 cases alzheimers disease effect acei carrier status onset age alzheimers disease surprisingly modest effect apoe4 carrier status onset age seen data shown
0.34448025.16033878.html.plaintext.txt	42	phase 2 examination heterogeneity examined six potential sources heterogeneity age gender race apoe4 status misdiagnosis mistyping
0.34448025.16033878.html.plaintext.txt	43	stratification gender apoe4 status significant effects seen gender apoe4 status associations alzheimers disease stratification either two factors remove heterogeneity data shown
0.34448025.16033878.html.plaintext.txt	44	stratification gender apoe4 status significant effects seen gender apoe4 status associations alzheimers disease stratification either two factors remove heterogeneity data shown
0.34448025.16033878.html.plaintext.txt	45	stratification age calculated odds ratios alzheimers disease aced homozygotes versus positives stratified age 65 years 65 75 years 75 years rather little effect age seen association d homozygotes alzheimers disease data shown reduction heterogeneity stratification age
0.34448025.16033878.html.plaintext.txt	46	examination diagnosis repeated overall analyses three genotypes restricting data 28 samples could limited rigorous diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association 26 odds ratios similar shown table 2 significant odds ratios method dersimonian laird 30 077 d homozygotes 115 heterozygotes nonsignificant odds ratio 110 homozygotes heterogeneity remained d homozygotes p 0005 longer significant p 016 homozygotes
0.34448025.16033878.html.plaintext.txt	47	examination genotyping 12 instances hardy weinberg disequilibrium individual studies four six groups pooled cases controls analyzed race table 3 therefore excluded eight samples mistyping considered possible underreporting heterozygotes taking account genotyping methods hardy weinberg analysis repeated overall analyses remaining 31 samples odds ratios similar table 2 significant odds ratios 081 d homozygotes 112 heterozygotes nonsignificant odds ratio 109 homozygotes heterogeneity remained homozygotes p 002 longer significant d homozygotes p 019
0.34448025.16033878.html.plaintext.txt	48	view table table 3 odds ratios alzheimers disease ace genotype meta analysis ethnic group
0.34448025.16033878.html.plaintext.txt	49	ethnic stratification samples divided three ethnic groups possible north european 19 samples south caucasian mediterranean middle eastern 11 samples east asian chinese japanese four samples removed nearly heterogeneity table 3 table 3 shows clear differences among three ethnic groups overlap whatsoever allelic frequencies among three groups north europeans east asians differed odds ratios d homozygotes versus positives p 00008 homozygotes versus d positives p 00005 south caucasians also differed east asians odds ratio d homozygotes versus positives p 00003 d homozygotes reduced risk groups particularly east asians heterozygotes increased risk north europeans homozygotes higher risk east asians except bayesian analysis examined heterosis heterozygotes greater risk north europeans comparing di dd ii turn found heterozygotes higher risk d homozygotes odds ratio 125 95 percent confidence interval 108 145 significantly higher homozygotes odds ratio 108 95 percent confidence interval 095 122
0.34448025.16033878.html.plaintext.txt	50	discussion top abstract introduction materials methods results discussion references large meta analysis standards alzheimers disease genetics 39 samples comprising 6037 cases alzheimers disease 12099 elderly controls table 1 found evidence publication bias
0.34448025.16033878.html.plaintext.txt	51	discussion top abstract introduction materials methods results discussion references large meta analysis standards alzheimers disease genetics 39 samples comprising 6037 cases alzheimers disease 12099 elderly controls table 1 found evidence publication bias
0.34448025.16033878.html.plaintext.txt	52	aced homozygotes reduced risk alzheimers disease table 2 three main ethnic groups examined table 3 homozygotes neutral regards alzheimers disease risk table 2 except east asians homozygotes may higher risk table 3 heterozygotes increased risk alzheimers disease overall table 2 mainly north europeans table 3 example heterosis discussed similar results achieved three methods fixed effects random effects bayesian random effects refer materials methods table 2 genotypic comparisons made refer materials methods showed allelic dose effect except east asians table 3 thus allelic comparisons would proved less informative
0.34448025.16033878.html.plaintext.txt	53	aced homozygotes reduced risk alzheimers disease table 2 three main ethnic groups examined table 3 homozygotes neutral regards alzheimers disease risk table 2 except east asians homozygotes may higher risk table 3 heterozygotes increased risk alzheimers disease overall table 2 mainly north europeans table 3 example heterosis discussed similar results achieved three methods fixed effects random effects bayesian random effects refer materials methods table 2 genotypic comparisons made refer materials methods showed allelic dose effect except east asians table 3 thus allelic comparisons would proved less informative
0.34448025.16033878.html.plaintext.txt	54	findings odds ratios close 1 even though significantly different 1 tables 2 3 suggest either linkage disequilibrium true risk factor confounding hidden interaction second possibility discussed regarding former kehoe et al 1 study ace haplotypes gave evidence indel may actual risk factor rather linkage disequilibrium nearby functional polymorphism true risk factor ace haplotype analysis also proved value phenotypes enzyme levels 36 insulin levels myocardial infarction obesity 37 future alzheimers disease studies may better examine polymorphisms regulatory regions rather indel
0.34448025.16033878.html.plaintext.txt	55	findings odds ratios close 1 even though significantly different 1 tables 2 3 suggest either linkage disequilibrium true risk factor confounding hidden interaction second possibility discussed regarding former kehoe et al 1 study ace haplotypes gave evidence indel may actual risk factor rather linkage disequilibrium nearby functional polymorphism true risk factor ace haplotype analysis also proved value phenotypes enzyme levels 36 insulin levels myocardial infarction obesity 37 future alzheimers disease studies may better examine polymorphisms regulatory regions rather indel
0.34448025.16033878.html.plaintext.txt	56	overall results consistent kehoe et al 1 1999 also recent meta analyses kehoe et al 11 2003 elkins et al 12 2004 latter report 12 also suggested age difference however although actual ages available mean cohort ages take account different ways defining case ages refer materials methods strongly confounding factor latter problem cannot exclude possibility association might stronger younger cases example aged less 65 years onset less 75 years death
0.34448025.16033878.html.plaintext.txt	57	overall results consistent kehoe et al 1 1999 also recent meta analyses kehoe et al 11 2003 elkins et al 12 2004 latter report 12 also suggested age difference however although actual ages available mean cohort ages take account different ways defining case ages refer materials methods strongly confounding factor latter problem cannot exclude possibility association might stronger younger cases example aged less 65 years onset less 75 years death
0.34448025.16033878.html.plaintext.txt	58	heterogeneity overall results showed heterogeneity table 2 heterogeneity may due differences sample selection eg age gender diagnosis methods eg genotyping may due real differences populations eg race interactions risk factors eg apoe4 examined potential sources heterogeneity found little effect age gender apoe4 status thus confounding initial hypothesis diagnostic genotyping differences contributed heterogeneity former mainly due diagnosis possible alzheimers disease reported poor record confirmation autopsy 38 latter largely due certain genotyping methods may lead underreporting heterozygotes 27 28 shown hardy weinberg analysis
0.34448025.16033878.html.plaintext.txt	59	heterogeneity overall results showed heterogeneity table 2 heterogeneity may due differences sample selection eg age gender diagnosis methods eg genotyping may due real differences populations eg race interactions risk factors eg apoe4 examined potential sources heterogeneity found little effect age gender apoe4 status thus confounding initial hypothesis diagnostic genotyping differences contributed heterogeneity former mainly due diagnosis possible alzheimers disease reported poor record confirmation autopsy 38 latter largely due certain genotyping methods may lead underreporting heterozygotes 27 28 shown hardy weinberg analysis
0.34448025.16033878.html.plaintext.txt	60	however greatest source heterogeneity ethnic differences ethnic stratification removed nearly heterogeneity table 3 clear contrasts among three ethnic groups examined north europeans south caucasians east asians allelic frequencies odds ratios table 3 latter might due differences linkage disequilibrium true risk polymorphism see ethnic differences previously pointed panza et al 17 39 buss et al 40 elkins et al 12 contrasts highlight dangers combining ethnic groups within single cohort even north south europeans indicated panza et al 17 39 unfortunately one cohort african origin united states 41 thus conclusions could drawn africans
0.34448025.16033878.html.plaintext.txt	61	however greatest source heterogeneity ethnic differences ethnic stratification removed nearly heterogeneity table 3 clear contrasts among three ethnic groups examined north europeans south caucasians east asians allelic frequencies odds ratios table 3 latter might due differences linkage disequilibrium true risk polymorphism see ethnic differences previously pointed panza et al 17 39 buss et al 40 elkins et al 12 contrasts highlight dangers combining ethnic groups within single cohort even north south europeans indicated panza et al 17 39 unfortunately one cohort african origin united states 41 thus conclusions could drawn africans
0.34448025.16033878.html.plaintext.txt	62	heterosis deviations hardy weinberg equilibrium common studies ace indel previously pointed buss et al 40 may due either mistyping heterosis several cases disequilibrium indeed compatible mistyping examples disequilibrium north europeans however excess heterozygotes alzheimers disease requires another explanation believe explanation heterosis heterosis occurs heterozygotes show either greater lesser association given trait either group homozygotes case north europeans excess heterozygotes alzheimers disease association heterozygotes alzheimers disease found comings macmurray 42 suggested three explanations heterosis second applied proposes heterosis may follow inadvertent combination two unlike subsets due hidden interaction another unknown risk factor test proposal constructed mathematical model two equal subsets based median split unknown factor x table 4 model illustrates although heterozygotes may intermediate odds ratios subset emerge highest odds ratio subsets combined ie heterosis overall results illustrative model table 4 close present meta analysis table 2 stress however heterosis found north europeans moreover although heterozygotes greater risk d homozygotes odds ratio 125 95 percent confidence interval 108 145 significantly higher risk homozygotes odds ratio 108 95 percent confidence interval 095 122 thus partial heterosis better describes case
0.34448025.16033878.html.plaintext.txt	63	view table table 4 model show heterosis may follow combination two unlike subsets
0.34448025.16033878.html.plaintext.txt	64	hidden interaction partial heterosis north europeans suggests interaction another risk factor alzheimers disease another potential source heterogeneity candidates include cardiovascular risk factors since many also contribute alzheimers disease risk since ace indel associated cardiovascular risk 43 47
0.34448025.16033878.html.plaintext.txt	65	hidden interaction partial heterosis north europeans suggests interaction another risk factor alzheimers disease another potential source heterogeneity candidates include cardiovascular risk factors since many also contribute alzheimers disease risk since ace indel associated cardiovascular risk 43 47
0.34448025.16033878.html.plaintext.txt	66	biologic background full discussion biologic basis associations outside scope mainly analytical study however note associations ace indel nearby polymorphisms various phenotypes including cardiovascular risk 37 43 47 addition ace protein levels raised certain brain regions alzheimers disease 48 50 enzyme reported modify ss amyloid aggregation 51 ace inhibitors reported maintain memory aged rats 52 human patients 53 brain penetrating ace inhibitors associated reduced incidence alzheimers disease elderly hypertensive patients 54 less cognitive decline cases mild moderate alzheimers disease 55 sleegers et al 9 recently provided evidence magnetic resonance imaging increased atrophy hippocampus amygdala nondemented women homozygous acei allele together modest significant increase risk alzheimers disease independent vascular factors d allele associated raised plasma levels ace 2 association thought due linkage disequilibrium nearby polymorphisms 3 36 apparent conflict benefits ace inhibitor therapy associations indel alzheimers disease risk pathology plasma levels ace however influence ace polymorphisms brain levels enzyme yet known cannot assumed reflect levels plasma subject warrants fuller discussion possible detailed discussion given kehoe 56 although need reconsidered perhaps revised light interacting factor factors may emerge future studies
0.34448025.16033878.html.plaintext.txt	67	biologic background full discussion biologic basis associations outside scope mainly analytical study however note associations ace indel nearby polymorphisms various phenotypes including cardiovascular risk 37 43 47 addition ace protein levels raised certain brain regions alzheimers disease 48 50 enzyme reported modify ss amyloid aggregation 51 ace inhibitors reported maintain memory aged rats 52 human patients 53 brain penetrating ace inhibitors associated reduced incidence alzheimers disease elderly hypertensive patients 54 less cognitive decline cases mild moderate alzheimers disease 55 sleegers et al 9 recently provided evidence magnetic resonance imaging increased atrophy hippocampus amygdala nondemented women homozygous acei allele together modest significant increase risk alzheimers disease independent vascular factors d allele associated raised plasma levels ace 2 association thought due linkage disequilibrium nearby polymorphisms 3 36 apparent conflict benefits ace inhibitor therapy associations indel alzheimers disease risk pathology plasma levels ace however influence ace polymorphisms brain levels enzyme yet known cannot assumed reflect levels plasma subject warrants fuller discussion possible detailed discussion given kehoe 56 although need reconsidered perhaps revised light interacting factor factors may emerge future studies
0.34448025.16033878.html.plaintext.txt	68	limitations meta analysis lack information authors limitation obtained full data 84 percent subjects quality diagnosis genotyping varied among studies overall results changed questions taken account considerable heterogeneity initial results however found main sources heterogeneity able remove since cardiovascular factors strong candidates potential interaction ace variants lack data available us factors limitation hope overcome future studies cardiovascular factors might also influenced results selective mortality however d homozygotes slightly increased risk cardiovascular complications 43 47 57 little evidence association reduced life span 57 62 thus influence selective mortality likely small enough provide alternative explanation findings
0.34448025.16033878.html.plaintext.txt	69	limitations meta analysis lack information authors limitation obtained full data 84 percent subjects quality diagnosis genotyping varied among studies overall results changed questions taken account considerable heterogeneity initial results however found main sources heterogeneity able remove since cardiovascular factors strong candidates potential interaction ace variants lack data available us factors limitation hope overcome future studies cardiovascular factors might also influenced results selective mortality however d homozygotes slightly increased risk cardiovascular complications 43 47 57 little evidence association reduced life span 57 62 thus influence selective mortality likely small enough provide alternative explanation findings
0.34448025.16033878.html.plaintext.txt	70	conclusions suggest large study established ace indel marker alzheimers disease risk since found evidence bias found removed main sources heterogeneity excluded various potential interactions significant results remained three ethnic groups examined indel however probably linkage disequilibrium true risk polymorphism 11 marked contrasts among three ethnic groups studied table 3 also found evidence interaction another risk factor north europeans potential interactions factors age gender apoe4 status examined particularly interactions cardiovascular risk factors
0.34448025.16033878.html.plaintext.txt	71	conclusions suggest large study established ace indel marker alzheimers disease risk since found evidence bias found removed main sources heterogeneity excluded various potential interactions significant results remained three ethnic groups examined indel however probably linkage disequilibrium true risk polymorphism 11 marked contrasts among three ethnic groups studied table 3 also found evidence interaction another risk factor north europeans potential interactions factors age gender apoe4 status examined particularly interactions cardiovascular risk factors
0.34448025.16033878.html.plaintext.txt	72	acknowledgments financial support received bristol myers squibb phytopharm plc medical research council norman collisson foundation takayama foundation dr p g kehoe supported gestetner foundation fellowship
0.34448025.16033878.html.plaintext.txt	73	authors thank groups undertaken acealzheimers disease association studies thereby providing data analyses especially thank authors generously responded requests primary data dr v alvarez dr h arboleda dr capurso dr l cook dr m m esiri dr r fellin dr l fernandez novoa dr u finkh dr r c p go dr h gurling dr n helbecque dr m r keikhaee dr c l lendon dr lovestone dr d m mann dr k m mattila dr p mcilroy dr l myllykangas dr f panza dr r perry dr d c rubinsztein dr r scacchi dr d seripa dr h weiner dr c wu dr g zuliani authors particularly grateful dr u finkh colleagues highlighting issue hardy weinberg disequilibrium ace studies 40 dr capurso colleagues 17 39 pointing ethnic differences ace indel frequencies authors also warmly thank dr m pembrey advice genetics dr j marchini advice statistics c aldridge administrative support m g lehmann help mathematical calculations dr j wu chinese translations
0.34448025.16033878.html.plaintext.txt	74	authors thank groups undertaken acealzheimers disease association studies thereby providing data analyses especially thank authors generously responded requests primary data dr v alvarez dr h arboleda dr capurso dr l cook dr m m esiri dr r fellin dr l fernandez novoa dr u finkh dr r c p go dr h gurling dr n helbecque dr m r keikhaee dr c l lendon dr lovestone dr d m mann dr k m mattila dr p mcilroy dr l myllykangas dr f panza dr r perry dr d c rubinsztein dr r scacchi dr d seripa dr h weiner dr c wu dr g zuliani authors particularly grateful dr u finkh colleagues highlighting issue hardy weinberg disequilibrium ace studies 40 dr capurso colleagues 17 39 pointing ethnic differences ace indel frequencies authors also warmly thank dr m pembrey advice genetics dr j marchini advice statistics c aldridge administrative support m g lehmann help mathematical calculations dr j wu chinese translations
0.34448025.16033878.html.plaintext.txt	75	conflict interest none declared
0.34448025.16033878.html.plaintext.txt	76	note added proof two association studies published since submission article kolsch et al neurosci lett 200537737 9 zhang et al dement geriatr cogn disord 20052052 6
0.34448025.16033878.html.plaintext.txt	77	note added proof two association studies published since submission article kolsch et al neurosci lett 200537737 9 zhang et al dement geriatr cogn disord 20052052 6
0.34448025.16033878.html.plaintext.txt	78	references top abstract introduction materials methods results discussion references kehoe pg russ c mcilroy et al variation dcp1 encoding ace associated susceptibility alzheimer disease nat genet 19992171 2crossrefisimedline rigat b hubert c alhenc gelas f et al insertiondeletion polymorphism angiotensin converting enzyme gene accounting half variance serum enzyme levels j clin invest 1990861343 6isimedline tiret l rigat b visvikis et al evidence combined segregation linkage analysis variant angiotensin converting enzyme ace gene controls plasma ace levels j hum genet 199251197 205isimedline nacmias b tedde forleo p et al angiotensin converting enzyme polymorphism sporadic presenilin linked alzheimers disease families abstract neurology 199952 suppl 2a323 wakutani y kowa h kusumi m et al genetic analysis vascular factors alzheimers disease ann n y acad sci 2002977232 8abstractfree full text farrer la sherbatich keryanov sa et al association angiotensin converting enzyme alzheimer disease arch neurol 200057210 14abstractfree full text crawford f abdullah l schinka j et al gender specific association angiotensin converting enzyme gene alzheimers disease neurosci lett 2000280215 19crossrefisimedline kehoe pg katzov h andreasen n et al common variants ace contribute variable age onset alzheimers disease hum genet 2004114478 83crossrefisimedline sleegers k den heijer van dijk ej et al ace gene associated alzheimers disease atrophy hippocampus amygdala neurobiol aging 2005261153 9crossrefisimedline narain y yip murphy et al ace gene alzheimers disease susceptibility j med genet 200037695 7abstractfree full text kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimers disease hum mol genet 200312859 67abstractfree full text elkins js douglas vc johnston sc alzheimer disease risk genetic variation ace meta analysis neurology 200462363 8abstractfree full text camelo d arboleda g yunis jj et al angiotensin converting enzyme alpha 2 macroglobulin gene polymorphisms associated alzheimers disease colombian patients j neurol sci 200421847 51crossrefisimedline fernandez novoa l lombardi vrm seoane et al ace gene alzheimers disease hanin fisher cacabelos r eds new trends alzheimer parkinson related disorders bologna italy monduzzi editore 2004123 6 keikhaee mr najmabadi h pasalar p angiotensin converting enzyme apolipoprotein e genotype alzheimers disease iranian population abstract neurobiol aging 200223suppls404 lendon cl thaker u harris jm et al angiotensin 1 converting enzyme insertion ideletion d polymorphism influence extent amyloid tau pathology patients sporadic alzheimers disease neurosci lett 2002328314 18crossrefisimedline panza f solfrizzi v dintrono et al lack association ace polymorphism alzheimers disease southern italy arch gerontol geriatr suppl 20028239 45crossrefmedline seripa d dal forno g matera mg et al methylenetetrahydrofolate reductase angiotensin converting enzyme gene polymorphisms two genetically diagnostically distinct cohorts alzheimer patients neurobiol aging 200324933 9crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis jama 19972781349 56abstract lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimers disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline egger m davey smith g altman dge systematic reviews health care meta analysis context london united kingdom bmj books 2001 ott breteler mm van harskamp f et al incidence risk dementia rotterdam study j epidemiol 1998147574 80abstract prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimers disease eur j hum genet 20019437 44crossrefisimedline prince j feuk l brookes et al genetic variation ace influences severity alzheimers disease abstract neurobiol aging 200223suppls319crossref mirra ss heyman mckeel d et al consortium establish registry alzheimers disease cerad part ii standardization neuropathologic assessment alzheimers disease neurology 199141479 86abstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology 198434939 44abstract fogarty dg maxwell ap doherty cc et al ace gene typing letter lancet 1994343851isimedline shanmugam v sell kw saha bk mistyping ace heterozygotes pcr methods appl 19933120 1isimedline mantel n haenszel w statistical aspects analysis data retrospective studies disease j natl cancer inst 195922719 48isimedline dersimonian r laird n meta analysis clinical trials control clin trials 19867177 88crossrefisimedline warn de thompson sg spiegelhalter dj bayesian random effects meta analysis trials binary outcomes methods absolute risk difference relative risk scales stat med 2002211601 23crossrefisimedline armitage p statistical methods medical research oxford united kingdom blackwell scientific publications 1983 egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n eng j med 1992327248 54abstract ihaka r gentleman r r language data analysis graphics j comput graph stat 19965299 314 cox r bouzekri n martin et al angiotensin 1 converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol genet 2002112969 77abstractfree full text katzov h bennet kehoe p et al cladistic model ace sequence variation implications myocardial infarction alzheimer disease obesity hum mol genet 2004132647 57abstractfree full text nagy z esiri mm hindley nj et al accuracy clinical operational diagnostic criteria alzheimers disease relation different pathological diagnostic protocols dement geriatr cogn disord 19989219 26crossrefisimedline panza f solfrizzi v dintrono et al shifts angiotensin 1 converting enzyme insertion allele frequency across europe implications alzheimers disease risk j neurol neurosurg psychiatry 2003741159 61free full text buss muller thomsen hock c et al association dcp1 genotype late onset alzheimer disease j med genet 2002114440 5crossrefisimedline perry rt collins js harrell le et al investigation association 13 polymorphisms eight genes southeastern african american alzheimer disease patients compared age matched controls j med genet 2001105332 42crossrefisimedline comings de macmurray jp molecular heterosis review mol genet metab 20007119 31crossrefisimedline samani nj thompson jr otoole l et al meta analysis association deletion allele angiotensin converting enzyme gene myocardial infarction circulation 199694708 12abstractfree full text staessen ja wang jg ginocchio g et al deletioninsertion polymorphism angiotensin converting enzyme gene cardiovascular renal risk j hypertens 1997151579 92crossrefisimedline sharma p meta analysis ace gene ischaemic stroke j neurol neurosurg psychiatry 199864227 30abstractfree full text keavney b mckenzie c parish et al large scale test hypothesised associations angiotensin converting enzyme insertiondeletion polymorphism myocardial infarction 5000 cases 6000 controls lancet 2000355434 42isimedline sayed tabatabaei fa houwing duistermaat jj van duijn cm et al angiotensin converting enzyme gene polymorphism carotid artery wall thickness meta analysis stroke 2003341634 9abstractfree full text arregui perry ek rossor m et al angiotensin converting enzyme alzheimers disease increased activity caudate nucleus cortical areas j neurochem 1982381490 2isimedline barnes nm cheng ch costall b et al angiotensin converting enzyme density increased temporal cortex patients alzheimers disease eur j pharmacol 1991200289 92crossrefisimedline savaskan e hock c olivieri g et al cortical alterations angiotensin converting enzyme angiotensin ii at1 receptor alzheimers dementia neurobiol aging 200122541 6crossrefisimedline hu j igarashi kamata m et al angiotensin converting enzyme degrades alzheimer amyloid beta peptide ab retards ab aggregation deposition fibril formation inhibits cytotoxicity j biol chem 200127647863 8abstractfree full text hirawa n uehara y kawabata y et al long term inhibition renin angiotensin system sustains memory function aged dahl rats hypertension 199934496 502abstractfree full text sudilovsky turnbull b croog sh et al angiotensin converting enzyme memory preclinical clinical data int j neurol 1987 8821 22145 62 ohrui matsui yamaya m et al angiotensin converting enzyme inhibitors incidence alzheimers disease japan j geriatr soc 200452649 50crossrefisimedline ohrui tomita n sato nakagawa et al effects brain penetrating ace inhibitors alzheimer disease progression neurology 2004631324 5free full text kehoe pg renin angiotensin aldosterone system alzheimers disease j renin angiotensin aldosterone syst 2003480 93isimedline agerholm larsen b nordestgaard bg steffensen r et al ace gene polymorphism ischemic heart disease longevity 10150 individuals case referent retrospective cohort study based copenhagen city heart study circulation 1997952358 67abstractfree full text galinsky d tysoe c brayne ce et al analysis apoe eapo c angiotensin converting enzyme methylenetetrahydrofolate reductase genes candidates affecting human longevity atherosclerosis 1997129177 83crossrefisimedline shimokata h yamada y nakagawa m et al distribution geriatric disease related genotypes national institute longevity sciences longitudinal study aging nils lsa j epidemiol 200010suppls46 55medline blanche h cabanne l sahbatou m et al study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline panza f solfrizzi v dintrono et al angiotensin converting enzyme ace gene polymorphism centenarians different allele frequencies north south europe exp gerontol 2003381015 20crossrefisimedline da cruz ib oliveira g taufer m et al angiotensin converting enzyme gene polymorphism two ethnic groups living brazils southern region association age j gerontol biol sci med sci 200358m851 6abstractfree full text alvarez r alvarez v lahoz ch et al angiotensin converting enzyme endothelial nitric oxide synthase dna polymorphisms late onset alzheimers disease j neurol neurosurg psychiatry 199967733 6abstractfree full text carbonell j allen r kalsi g et al variation dcp1 gene encoding angiotensin converting enzyme ace associated increased susceptibility alzheimers disease psychiatr genet 20031347 50crossrefisimedline chapman j wang n treves ta et al ace mthfr factor v leiden apoe polymorphisms patients vascular alzheimers dementia stroke 1998291401 4abstractfree full text cheng cy hong cj liu hc et al study association alzheimers disease angiotensin converting enzyme gene polymorphism using dna lymphocytes eur neurol 20024726 9crossrefisimedline hu j miyatake f aizu y et al angiotensin converting enzyme genotype associated alzheimer disease japanese population neurosci lett 199927765 7crossrefisimedline isbir agachan b yilmaz h et al angiotensin converting enzyme gene polymorphism alzheimers disease cell biochem funct 200018141 233co2 ytta m et al dipeptidyl carboxypeptidase 1 dcp1 butyrylcholinesterase bche gene interactions apolipoprotein e 4 allele risk factors alzheimers disease parkinsons disease coexisting alzheimer pathology j med genet 200037766 70abstractfree full text monastero r caldarella r mannino m et al lack association angiotensin converting enzyme polymorphism sporadic alzheimers disease neurosci lett 2002335147 9crossrefisimedline myllykangas l polvikoski sulkava r et al cardiovascular risk factors alzheimers disease genetic association study population aged 85 neurosci lett 2000292195 8crossrefisimedline palumbo b cadini d nocentini g et al angiotensin converting enzyme deletion allele different kinds dementia disorders neurosci lett 199926797 100crossrefisimedline richard f fromentin david ricolfi f et al angiotensin converting enzyme gene susceptibility factor dementia neurology 2001561593 5abstractfree full text scacchi r de bernardini l mantuano e et al dna polymorphisms apolipoprotein b angiotensin 1 converting enzyme genes relationships lipid levels italian patients vascular dementia alzheimers disease dement geriatr cogn disord 19989186 90crossrefisimedline wu c zhou d guan z et al association angiotensin converting enzyme gene polymorphism chinese late onset alzheimer disease chinese zhonghua yi xue yi chuan xue za zhi 200219401 4medline yang jd feng g zhang j et al association angiotensin converting enzyme gene late onset alzheimers disease han chinese neurosci lett 200029541 4crossrefisimedline zuliani g ble zanca r et al genetic polymorphisms older subjects vascular alzheimers dementia acta neurol scand 2001103304 8crossrefisimedline american psychiatric association diagnostic statistical manual mental disorders dsm iv 4th ed washington dc american psychiatric association 1994 khachaturian zs diagnosis alzheimers disease arch neurol 1985421097 105crossrefisimedline
0.34448025.16033878.html.plaintext.txt	79	references top abstract introduction materials methods results discussion references kehoe pg russ c mcilroy et al variation dcp1 encoding ace associated susceptibility alzheimer disease nat genet 19992171 2crossrefisimedline rigat b hubert c alhenc gelas f et al insertiondeletion polymorphism angiotensin converting enzyme gene accounting half variance serum enzyme levels j clin invest 1990861343 6isimedline tiret l rigat b visvikis et al evidence combined segregation linkage analysis variant angiotensin converting enzyme ace gene controls plasma ace levels j hum genet 199251197 205isimedline nacmias b tedde forleo p et al angiotensin converting enzyme polymorphism sporadic presenilin linked alzheimers disease families abstract neurology 199952 suppl 2a323 wakutani y kowa h kusumi m et al genetic analysis vascular factors alzheimers disease ann n y acad sci 2002977232 8abstractfree full text farrer la sherbatich keryanov sa et al association angiotensin converting enzyme alzheimer disease arch neurol 200057210 14abstractfree full text crawford f abdullah l schinka j et al gender specific association angiotensin converting enzyme gene alzheimers disease neurosci lett 2000280215 19crossrefisimedline kehoe pg katzov h andreasen n et al common variants ace contribute variable age onset alzheimers disease hum genet 2004114478 83crossrefisimedline sleegers k den heijer van dijk ej et al ace gene associated alzheimers disease atrophy hippocampus amygdala neurobiol aging 2005261153 9crossrefisimedline narain y yip murphy et al ace gene alzheimers disease susceptibility j med genet 200037695 7abstractfree full text kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimers disease hum mol genet 200312859 67abstractfree full text elkins js douglas vc johnston sc alzheimer disease risk genetic variation ace meta analysis neurology 200462363 8abstractfree full text camelo d arboleda g yunis jj et al angiotensin converting enzyme alpha 2 macroglobulin gene polymorphisms associated alzheimers disease colombian patients j neurol sci 200421847 51crossrefisimedline fernandez novoa l lombardi vrm seoane et al ace gene alzheimers disease hanin fisher cacabelos r eds new trends alzheimer parkinson related disorders bologna italy monduzzi editore 2004123 6 keikhaee mr najmabadi h pasalar p angiotensin converting enzyme apolipoprotein e genotype alzheimers disease iranian population abstract neurobiol aging 200223suppls404 lendon cl thaker u harris jm et al angiotensin 1 converting enzyme insertion ideletion d polymorphism influence extent amyloid tau pathology patients sporadic alzheimers disease neurosci lett 2002328314 18crossrefisimedline panza f solfrizzi v dintrono et al lack association ace polymorphism alzheimers disease southern italy arch gerontol geriatr suppl 20028239 45crossrefmedline seripa d dal forno g matera mg et al methylenetetrahydrofolate reductase angiotensin converting enzyme gene polymorphisms two genetically diagnostically distinct cohorts alzheimer patients neurobiol aging 200324933 9crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis jama 19972781349 56abstract lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimers disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline egger m davey smith g altman dge systematic reviews health care meta analysis context london united kingdom bmj books 2001 ott breteler mm van harskamp f et al incidence risk dementia rotterdam study j epidemiol 1998147574 80abstract prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimers disease eur j hum genet 20019437 44crossrefisimedline prince j feuk l brookes et al genetic variation ace influences severity alzheimers disease abstract neurobiol aging 200223suppls319crossref mirra ss heyman mckeel d et al consortium establish registry alzheimers disease cerad part ii standardization neuropathologic assessment alzheimers disease neurology 199141479 86abstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology 198434939 44abstract fogarty dg maxwell ap doherty cc et al ace gene typing letter lancet 1994343851isimedline shanmugam v sell kw saha bk mistyping ace heterozygotes pcr methods appl 19933120 1isimedline mantel n haenszel w statistical aspects analysis data retrospective studies disease j natl cancer inst 195922719 48isimedline dersimonian r laird n meta analysis clinical trials control clin trials 19867177 88crossrefisimedline warn de thompson sg spiegelhalter dj bayesian random effects meta analysis trials binary outcomes methods absolute risk difference relative risk scales stat med 2002211601 23crossrefisimedline armitage p statistical methods medical research oxford united kingdom blackwell scientific publications 1983 egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n eng j med 1992327248 54abstract ihaka r gentleman r r language data analysis graphics j comput graph stat 19965299 314 cox r bouzekri n martin et al angiotensin 1 converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol genet 2002112969 77abstractfree full text katzov h bennet kehoe p et al cladistic model ace sequence variation implications myocardial infarction alzheimer disease obesity hum mol genet 2004132647 57abstractfree full text nagy z esiri mm hindley nj et al accuracy clinical operational diagnostic criteria alzheimers disease relation different pathological diagnostic protocols dement geriatr cogn disord 19989219 26crossrefisimedline panza f solfrizzi v dintrono et al shifts angiotensin 1 converting enzyme insertion allele frequency across europe implications alzheimers disease risk j neurol neurosurg psychiatry 2003741159 61free full text buss muller thomsen hock c et al association dcp1 genotype late onset alzheimer disease j med genet 2002114440 5crossrefisimedline perry rt collins js harrell le et al investigation association 13 polymorphisms eight genes southeastern african american alzheimer disease patients compared age matched controls j med genet 2001105332 42crossrefisimedline comings de macmurray jp molecular heterosis review mol genet metab 20007119 31crossrefisimedline samani nj thompson jr otoole l et al meta analysis association deletion allele angiotensin converting enzyme gene myocardial infarction circulation 199694708 12abstractfree full text staessen ja wang jg ginocchio g et al deletioninsertion polymorphism angiotensin converting enzyme gene cardiovascular renal risk j hypertens 1997151579 92crossrefisimedline sharma p meta analysis ace gene ischaemic stroke j neurol neurosurg psychiatry 199864227 30abstractfree full text keavney b mckenzie c parish et al large scale test hypothesised associations angiotensin converting enzyme insertiondeletion polymorphism myocardial infarction 5000 cases 6000 controls lancet 2000355434 42isimedline sayed tabatabaei fa houwing duistermaat jj van duijn cm et al angiotensin converting enzyme gene polymorphism carotid artery wall thickness meta analysis stroke 2003341634 9abstractfree full text arregui perry ek rossor m et al angiotensin converting enzyme alzheimers disease increased activity caudate nucleus cortical areas j neurochem 1982381490 2isimedline barnes nm cheng ch costall b et al angiotensin converting enzyme density increased temporal cortex patients alzheimers disease eur j pharmacol 1991200289 92crossrefisimedline savaskan e hock c olivieri g et al cortical alterations angiotensin converting enzyme angiotensin ii at1 receptor alzheimers dementia neurobiol aging 200122541 6crossrefisimedline hu j igarashi kamata m et al angiotensin converting enzyme degrades alzheimer amyloid beta peptide ab retards ab aggregation deposition fibril formation inhibits cytotoxicity j biol chem 200127647863 8abstractfree full text hirawa n uehara y kawabata y et al long term inhibition renin angiotensin system sustains memory function aged dahl rats hypertension 199934496 502abstractfree full text sudilovsky turnbull b croog sh et al angiotensin converting enzyme memory preclinical clinical data int j neurol 1987 8821 22145 62 ohrui matsui yamaya m et al angiotensin converting enzyme inhibitors incidence alzheimers disease japan j geriatr soc 200452649 50crossrefisimedline ohrui tomita n sato nakagawa et al effects brain penetrating ace inhibitors alzheimer disease progression neurology 2004631324 5free full text kehoe pg renin angiotensin aldosterone system alzheimers disease j renin angiotensin aldosterone syst 2003480 93isimedline agerholm larsen b nordestgaard bg steffensen r et al ace gene polymorphism ischemic heart disease longevity 10150 individuals case referent retrospective cohort study based copenhagen city heart study circulation 1997952358 67abstractfree full text galinsky d tysoe c brayne ce et al analysis apoe eapo c angiotensin converting enzyme methylenetetrahydrofolate reductase genes candidates affecting human longevity atherosclerosis 1997129177 83crossrefisimedline shimokata h yamada y nakagawa m et al distribution geriatric disease related genotypes national institute longevity sciences longitudinal study aging nils lsa j epidemiol 200010suppls46 55medline blanche h cabanne l sahbatou m et al study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline panza f solfrizzi v dintrono et al angiotensin converting enzyme ace gene polymorphism centenarians different allele frequencies north south europe exp gerontol 2003381015 20crossrefisimedline da cruz ib oliveira g taufer m et al angiotensin converting enzyme gene polymorphism two ethnic groups living brazils southern region association age j gerontol biol sci med sci 200358m851 6abstractfree full text alvarez r alvarez v lahoz ch et al angiotensin converting enzyme endothelial nitric oxide synthase dna polymorphisms late onset alzheimers disease j neurol neurosurg psychiatry 199967733 6abstractfree full text carbonell j allen r kalsi g et al variation dcp1 gene encoding angiotensin converting enzyme ace associated increased susceptibility alzheimers disease psychiatr genet 20031347 50crossrefisimedline chapman j wang n treves ta et al ace mthfr factor v leiden apoe polymorphisms patients vascular alzheimers dementia stroke 1998291401 4abstractfree full text cheng cy hong cj liu hc et al study association alzheimers disease angiotensin converting enzyme gene polymorphism using dna lymphocytes eur neurol 20024726 9crossrefisimedline hu j miyatake f aizu y et al angiotensin converting enzyme genotype associated alzheimer disease japanese population neurosci lett 199927765 7crossrefisimedline isbir agachan b yilmaz h et al angiotensin converting enzyme gene polymorphism alzheimers disease cell biochem funct 200018141 233co2 ytta m et al dipeptidyl carboxypeptidase 1 dcp1 butyrylcholinesterase bche gene interactions apolipoprotein e 4 allele risk factors alzheimers disease parkinsons disease coexisting alzheimer pathology j med genet 200037766 70abstractfree full text monastero r caldarella r mannino m et al lack association angiotensin converting enzyme polymorphism sporadic alzheimers disease neurosci lett 2002335147 9crossrefisimedline myllykangas l polvikoski sulkava r et al cardiovascular risk factors alzheimers disease genetic association study population aged 85 neurosci lett 2000292195 8crossrefisimedline palumbo b cadini d nocentini g et al angiotensin converting enzyme deletion allele different kinds dementia disorders neurosci lett 199926797 100crossrefisimedline richard f fromentin david ricolfi f et al angiotensin converting enzyme gene susceptibility factor dementia neurology 2001561593 5abstractfree full text scacchi r de bernardini l mantuano e et al dna polymorphisms apolipoprotein b angiotensin 1 converting enzyme genes relationships lipid levels italian patients vascular dementia alzheimers disease dement geriatr cogn disord 19989186 90crossrefisimedline wu c zhou d guan z et al association angiotensin converting enzyme gene polymorphism chinese late onset alzheimer disease chinese zhonghua yi xue yi chuan xue za zhi 200219401 4medline yang jd feng g zhang j et al association angiotensin converting enzyme gene late onset alzheimers disease han chinese neurosci lett 200029541 4crossrefisimedline zuliani g ble zanca r et al genetic polymorphisms older subjects vascular alzheimers dementia acta neurol scand 2001103304 8crossrefisimedline american psychiatric association diagnostic statistical manual mental disorders dsm iv 4th ed washington dc american psychiatric association 1994 khachaturian zs diagnosis alzheimers disease arch neurol 1985421097 105crossrefisimedline
0.3493169.9384602.html.plaintext.txt	0	estimation genetic contribution presenilin 1 2 mutations population based study presenile alzheimer disease estimation genetic contribution presenilin 1 2 mutations population based study presenile alzheimer disease marc cruts1 cornelia m van duijn2 hubert backhovens1 marleen van den broeck1 anita wehnert1 sally serneels1 robin sherrington3 michael hutton4 john hardy4 peter h st george hyslop3 albert hofman2 christine van broeckhoven1
0.3493169.9384602.html.plaintext.txt	1	estimation genetic contribution presenilin 1 2 mutations population based study presenile alzheimer disease estimation genetic contribution presenilin 1 2 mutations population based study presenile alzheimer disease marc cruts1 cornelia m van duijn2 hubert backhovens1 marleen van den broeck1 anita wehnert1 sally serneels1 robin sherrington3 michael hutton4 john hardy4 peter h st george hyslop3 albert hofman2 christine van broeckhoven1
0.3493169.9384602.html.plaintext.txt	2	1laboratory neurogenetics flanders interuniversity institute biotechnology vib born bunge foundation bbs university antwerp uia department biochemistry antwerpen belgium 2department epidemiology biostatistics erasmus university rotterdam netherlands 3centre research neurodegenerative diseases department medicine medical biophysics university toronto toronto canada 4neurogenetics laboratory mayo clinic jacksonville fl usa
0.3493169.9384602.html.plaintext.txt	3	received august 1 1997 revised accepted october 2 1997
0.3493169.9384602.html.plaintext.txt	4	two closely related genes presenilins ps located chromosomes 14q243 1q421 identified autosomal dominant alzheimer disease ad onset age 65 years presenile ad performed systematic mutation analysis coding 5 non coding exons ps 1 ps 2 population based epidemiological series 101 unrelated familial sporadic presenile ad cases familial cases included 10 patients autosomal dominant ad families sampled linkage analysis studies patients mutations amyloid precursor protein gene app previously excluded four different ps 1 missense mutations identified six familial cases two autosomal dominant cases three mutations resulted onset ages 55 years one segregating autosomal dominant family mean onset age 64 years range 50 78 years one ps 2 mutation identified sporadic case onset age 62 years mutation data provided estimates ps 1 ps 2 mutation frequencies presenile ad 6 1 respectively family history accounted mutation frequencies ps 1 9 familial cases 18 autosomal dominant cases polymorphisms detected promoter 5 non coding region ps 1 intronic exonic sequences ps 2 useful genetic association studies introduction
0.3493169.9384602.html.plaintext.txt	5	alzheimer disease ad common cause senile dementia fourth leading cause death western societies ad neurodegenerative disorder central nervous system characterized progressive loss memory intellectual functioning due appearance brain two major lesions senile plaques neurofibrillary tangles exact biochemical pathway leading neurodegeneration still unknown ad cases first symptoms memory dysfunction behavior changes become apparent age 65 years late onset senile ad however many cases disease starts earlier life early onset presenile ad indications disease presenile ad cases different observed senile ad cases apart severe pathology rapid clinical progression senile presenile ad genetic etiology however genetic cases frequent among presenile ad cases review see 1 also several ad families documented segregate presenile ad autosomal dominant manner families positional cloning approach employed identify ad genes review see 1 date three ad genes known mutated lead presenile ad amyloid precursor protein gene app chromosome 21 21q211 2 presenilin 1 gene ps 1 chromosome 14 14q2433 presenilin 2 gene ps 2 chromosome 1 1q421 4 5 although normal function amyloid precursor protein app unknown mutations demonstrated alter endoproteolysis app 42 amino acid long form amyloid beta abeta42 produced 6 rapid deposition abeta42 ad brains early morphological event ad pathology also normal pathological functions presenilin proteins ps 1 ps 2 unknown review see 7 since constitute integral membrane proteins six eight transmembrane domains tm one large hydrophilic loop hl 8 9 similar functions ps 1 ps 2 predicted remarkably mutations ps 1 ps 2 also produce abeta42 suggesting ps mutations app mutations lead ad pathology common biochemical pathway
0.3493169.9384602.html.plaintext.txt	6	alzheimer disease ad common cause senile dementia fourth leading cause death western societies ad neurodegenerative disorder central nervous system characterized progressive loss memory intellectual functioning due appearance brain two major lesions senile plaques neurofibrillary tangles exact biochemical pathway leading neurodegeneration still unknown ad cases first symptoms memory dysfunction behavior changes become apparent age 65 years late onset senile ad however many cases disease starts earlier life early onset presenile ad indications disease presenile ad cases different observed senile ad cases apart severe pathology rapid clinical progression senile presenile ad genetic etiology however genetic cases frequent among presenile ad cases review see 1 also several ad families documented segregate presenile ad autosomal dominant manner families positional cloning approach employed identify ad genes review see 1 date three ad genes known mutated lead presenile ad amyloid precursor protein gene app chromosome 21 21q211 2 presenilin 1 gene ps 1 chromosome 14 14q2433 presenilin 2 gene ps 2 chromosome 1 1q421 4 5 although normal function amyloid precursor protein app unknown mutations demonstrated alter endoproteolysis app 42 amino acid long form amyloid beta abeta42 produced 6 rapid deposition abeta42 ad brains early morphological event ad pathology also normal pathological functions presenilin proteins ps 1 ps 2 unknown review see 7 since constitute integral membrane proteins six eight transmembrane domains tm one large hydrophilic loop hl 8 9 similar functions ps 1 ps 2 predicted remarkably mutations ps 1 ps 2 also produce abeta42 suggesting ps mutations app mutations lead ad pathology common biochemical pathway
0.3493169.9384602.html.plaintext.txt	7	app seven different mutations identified autosomal dominant families presenile ad ad related phenotypes 6 mutations occur exons 16 17 encoding abeta proteolysis product app however extensive mutation analyses shown mutations app rare since segregate 5 presenile ad families 1 since ps genes identified recently review see 7 extensive mutation analyses yet performed however initial estimates based linkage analysis studies suggested 70 presenile ad families linked chromosome 14 10 later mutation ps 1 found chromosome 14 linked ad family 3 11 12 date 42 different missense mutations one frame splice site mutation ps 1 reported 82 families world wide 13 mutation screenings ps 1 presenile ad families selected basis linkage chromosome 14 indicated ps 1 mutations contribute less 30 50 initially estimated 14 15 possible explanation lower mutation frequency ps 1 may initial mutation data biased towards finding ps 1 mutations since families analyzed included genome wide search ad genes known linked chromosome 14 one mutation reported proven non familial ad case 16 however mutation studies sporadic ad cases performed
0.3493169.9384602.html.plaintext.txt	8	app seven different mutations identified autosomal dominant families presenile ad ad related phenotypes 6 mutations occur exons 16 17 encoding abeta proteolysis product app however extensive mutation analyses shown mutations app rare since segregate 5 presenile ad families 1 since ps genes identified recently review see 7 extensive mutation analyses yet performed however initial estimates based linkage analysis studies suggested 70 presenile ad families linked chromosome 14 10 later mutation ps 1 found chromosome 14 linked ad family 3 11 12 date 42 different missense mutations one frame splice site mutation ps 1 reported 82 families world wide 13 mutation screenings ps 1 presenile ad families selected basis linkage chromosome 14 indicated ps 1 mutations contribute less 30 50 initially estimated 14 15 possible explanation lower mutation frequency ps 1 may initial mutation data biased towards finding ps 1 mutations since families analyzed included genome wide search ad genes known linked chromosome 14 one mutation reported proven non familial ad case 16 however mutation studies sporadic ad cases performed
0.3493169.9384602.html.plaintext.txt	9	initial linkage studies indicated ps 2 mutations far less frequent ps 1 mutations 5 apart one ps 2 mutation identified chromosome 1 linked group volga german ad families one ps 2 mutation identified date 5 17 however contrast ps 1 families onset ages ps 2 families highly variable usually later life 13 therefore cannot excluded ps 2 families may missed since presenile ad families earlier onset ages likely ascertained linkage analysis studies since clear inheritance patterns date mutation reports ps 2 non familial presenile ad cases published however ps 2 less intensively investigated mutations ps 1
0.3493169.9384602.html.plaintext.txt	10	initial linkage studies indicated ps 2 mutations far less frequent ps 1 mutations 5 apart one ps 2 mutation identified chromosome 1 linked group volga german ad families one ps 2 mutation identified date 5 17 however contrast ps 1 families onset ages ps 2 families highly variable usually later life 13 therefore cannot excluded ps 2 families may missed since presenile ad families earlier onset ages likely ascertained linkage analysis studies since clear inheritance patterns date mutation reports ps 2 non familial presenile ad cases published however ps 2 less intensively investigated mutations ps 1
0.3493169.9384602.html.plaintext.txt	11	study aimed evaluating genetic contributions ps 1 ps 2 mutations presenile ad autosomal dominant familial sporadic cases overcome several biases mentioned used unique sample 101 unrelated familial sporadic presenile ad cases ascertained population based manner netherlands 18 19 sample contained 11 autosomal dominant 56 familial 34 sporadic presenile ad cases mean onset age 567 plus minus 54 years range 45 64 years lower 60 years 71 cases lower 50 years 10 cases autosomal dominant ad families probands onset age 65 years however four families mean onset age 65 years addition analyzed families 10 autosomal dominant presenile ad cases included population based study 20 cases mutations exons 16 17 app gene previously excluded 19 20 one family shown linked chromosome 14 20
0.3493169.9384602.html.plaintext.txt	12	study aimed evaluating genetic contributions ps 1 ps 2 mutations presenile ad autosomal dominant familial sporadic cases overcome several biases mentioned used unique sample 101 unrelated familial sporadic presenile ad cases ascertained population based manner netherlands 18 19 sample contained 11 autosomal dominant 56 familial 34 sporadic presenile ad cases mean onset age 567 plus minus 54 years range 45 64 years lower 60 years 71 cases lower 50 years 10 cases autosomal dominant ad families probands onset age 65 years however four families mean onset age 65 years addition analyzed families 10 autosomal dominant presenile ad cases included population based study 20 cases mutations exons 16 17 app gene previously excluded 19 20 one family shown linked chromosome 14 20
0.3493169.9384602.html.plaintext.txt	13	table 1 intronic pcr primers flanking coding 5 non coding exons ps 1 ps 2 ps 1 ps 2 exon primer sequence size bp exon primer sequence size bp 1a s182ex1a 3 ttctccccgcaatcgtttctccag 297 1 ps 2ex1 3 tgttagcagcggtgtttg 248 s182ex1a 4 gcccatgtccgcggtgccttcc ps 2ex1 4 tctgctcggagggatggac 1b s182ex1b 3 aggaggggcggcccgtttctcg 523 2 ps 2ex2 1 cagggccagggggaggaa 303 s182ex1b 4 agcctctgccaccaccgnaggatc ps 2ex2 2 aaaagcaggttgggagtcac 2 s182ex2 3 tggatgacctggtgaaatcctatt 223 3 ps 2ex3 1 gtcctccactgcctttgtctcac 328 s182ex2 4 cagaaaacaaagcctcttgaggtt ps 2ex3 2 cttcccttctccctcccgcatcag 3 s182ex3 1 acaaagttctgtttttctttccc 247 4 52ps 2x4 aaaaatccgtgcattacat 395 s182ex3 2 cagcatttctcagaggtgagg 3ps 2x4 gctggttgtgagctgcaggtacagtg 4 s182ex4 1 cgttaccttgattctgctga 371 5 ps 2 ex5 1 agcctcgaggagcagtcag 241 s182ex4 2 gacatgctgtaaagaaaagcc ps 2 ex5 2 gcagacggagagaagcgt 5 s182ex5 3 gattggtgagttggggaaaagtg 335 6 5ps 2x6 ggtatcagtctcaggatcatggg 265 s182ex5 4 atacccaaccataagaagaacagg 3ps 2x6 tggggaagactggagctcgatg 6 s182ex6 3 ggttgtgggacctgttaatt 149 7 ps 2 ex7 1 gtaaagagggccaggttggg 387 s182ex6 4 ttaattctgaaagacagaccc ps 2 ex7 2 gtgcagcactggggacgattt 7 s182ex7 1 ggagccatcacattattctaaa 326 8 52ps 2x8 gggcaggctcttcttcaggg 251 s182ex7 2 aacaaattatcagtcttgggttt 3ps 2x8 gaaagccacggccaggaag 8 s182ex8 1 ttacaagtttagcccatacatttt 215 9 ps 2ex9 3 accgcctgagacgtgaacctt 235 s182ex8 2 tcaagttcccgataaattctac ps 2ex9 4 tccctctgcccctcctgaact 9 s182ex9 1 tgtgtgtccagtgcttacctg 188 10 5ps 2x10 ctctgaccagctgttgtttc 249 s182ex9 2 tgttagcttataacagtgaccctg 3ps 2x10 agcctccaccctctgtct 10 s182ex10 1 ccagctagttacaatgacagc 345 11 5ps 2x11 ttccattctgtgcacgcctc 244 s182ex10 2 tcaaaaaggttgataatgtagct 3ps 2x11 acctgcccccaccacaatg 11 s182ex11 1 ggttgagtagggcagtgata 275 12 ps 2ex12 3 acaccagggatcaccacgctcac 344 s182ex11 2 ttaaagggactgtgtaatcaaag ps 2ex12 4 tgcctcctcctcaccaagtaaaca 12 s182ex12 1 gtctttcccatcttctccac 199 s182ex12 2 gggattctaaccgcaaatat
0.3493169.9384602.html.plaintext.txt	14	table 2 missense mutations detected ps 1 ps 2 gene exon location mutation family onset age years family historya restriction site change ps 1 4 236c ala79val 1005 53 ad acii bbei bani ehei haeii hinp1i hhai hsp92i kasi nari nlaiv 1087 55 f 1061 58 f 5 344a g tyr115cys 1066 45 ad csp6i rsai 7 692c ala231val 1072 58 f bgli bsp1286i mwoi 9 953a g glu318gly 1069 57 f ps 2 4 185g arg62his 1121 62 acii aad autosomal dominant f familial sporadicnucleotide positions relative translation start site ps 1 ps 2 cdna restriction enzymes used study test presence mutation denoted bold fig 1a pedigrees families ps 1 mutation depicted figure 2
0.3493169.9384602.html.plaintext.txt	15	table 3 polymorphisms detected ps 1 ps 2 gene exon location codon allele frequencies restriction site change ps 1 1a 48c 088012 hgai hsp96i sfani 1b 364c 018082 bstxi 8 16a c 054046 alw26i ps 2 3 69c ala23 079021 ddei 3 129c asn43 nd tspri 4 42a g 054046 ncoi nlaiii styi 4 261c his87 046054 bbrpi bsaai eco72i maeii nlaiii nspi taii 5 366g thr122 nd 7 708t c ser236 nd bsshii bstui cag8i hinpi tspri 11 24a g 055045 alui bst71i bstf5i cviji mspa1i pvuii nucleotide position exonic polymorphisms relative translation start site ps 1 ps 2 cdna nucleotide positions intronic polymorphisms relative start end intron allele frequencies determined 118 control individuals using restriction enzymes denoted bold fig 1b nd determined results mutation analysis ps 1 ps 2
0.3493169.9384602.html.plaintext.txt	16	previously complete genomic structure ps 1 ps 2 determined identifying 10 coding exons gene 21 22 order avoid confusion used exon numbering 3 12 ps 1 study introduced clark et al 11 intronic primer pairs designed allowing pcr amplification 10 coding exons ps 1 ps 2 table 1 101 ad patients examined mutations ps 1 ps 2 sscp analysis pcr cycle sequencing
0.3493169.9384602.html.plaintext.txt	17	previously complete genomic structure ps 1 ps 2 determined identifying 10 coding exons gene 21 22 order avoid confusion used exon numbering 3 12 ps 1 study introduced clark et al 11 intronic primer pairs designed allowing pcr amplification 10 coding exons ps 1 ps 2 table 1 101 ad patients examined mutations ps 1 ps 2 sscp analysis pcr cycle sequencing
0.3493169.9384602.html.plaintext.txt	18	ps 1 identified four missense mutations exons 4 5 7 9 respectively one intronic polymorphism intron 8 tables 2 3 fig 1 ala79val mutation identified three patients 1005 1061 1087 table 2 test whether mutation three patients ancestral origin genotyped three simple tandem repeat str markers flanking ps 1 23 24 d14s1028 d14s77 d14s1004 patients shared one common allele allele frequencies calculated among cases respectively 027 005 012 data suggested three patients carrying ala79val mutation might related although closely since genealogy studies indicated familial relationship three mutations occurred none mutations present 118 control individuals polymorphism observed intron 8 identical reported wragg et al 25 allele frequencies determined primer mismatch pcr assay described authors table 3 since sscp pattern intron 8 polymorphism could masked presence mutations sequenced exon 8 cases mutations found
0.3493169.9384602.html.plaintext.txt	19	figure 1 restriction enzyme analyses mutations polymorphisms ps 1 ps 2 pcr amplified exons digested restriction enzymes indicated missense mutations ps 1 ps 2 b polymorphisms ps 1 ps 2
0.3493169.9384602.html.plaintext.txt	20	one patient missense mutation ps 2 detected resulting arg substitution codon 62 exon 4 table 2 fig 1 restriction digestion analysis showed mutation absent patients controls addition sscp sequence analysis exon 4 identified two different polymorphisms intron 3 codon his87 respectively table 3 also sscp patterns observed exons 3 5 7 11 due polymorphisms since nucleotide changes involved intronic variations exonic silent mutations table 3 fig 1 b polymorphism exon 5 thr122 seen one patient represents rare polymorphism also polymorphism exon 7 ser236 rare since seen two patients allele frequencies frequent polymorphisms estimated 118 control individuals restriction enzyme digestion table 3 comparison allele distribution 15 control individuals showed two exon 3 polymorphisms linkage disequilibrium also two exon 4 polymorphisms linkage disequilibrium demonstrated ps 2 polymorphisms exons 3 ala23 4 his87 intron 11 show mendelian inheritance
0.3493169.9384602.html.plaintext.txt	21	complete mutation analysis ps 1 ps 2 developed flanking primers three exons located 5 untranslated region 5 utr ps 1 numbered exons 1a 1b 2 two 5 utr ps 2 21 26 sscp analysis followed pcr cycle sequencing revealed two polymorphisms 5 utr ps 1 mutations table 3 allele frequencies polymorphisms estimated sscp analysis exon 1a restriction digestion exon 1b table 3 fig 1 b mendelian inheritance polymorphisms demonstrated mutations polymorphisms detected 5 utr ps 2
0.3493169.9384602.html.plaintext.txt	22	complete mutation analysis ps 1 ps 2 developed flanking primers three exons located 5 untranslated region 5 utr ps 1 numbered exons 1a 1b 2 two 5 utr ps 2 21 26 sscp analysis followed pcr cycle sequencing revealed two polymorphisms 5 utr ps 1 mutations table 3 allele frequencies polymorphisms estimated sscp analysis exon 1a restriction digestion exon 1b table 3 fig 1 b mendelian inheritance polymorphisms demonstrated mutations polymorphisms detected 5 utr ps 2
0.3493169.9384602.html.plaintext.txt	23	although sscp analysis ps 1 ps 2 negative eight 10 autosomal dominant probands included sample could rule mutations may missed since sensitivity sscp 100 therefore performed mutation analysis ps 1 ps 2 cdna synthesized rna isolated cultured lymphoblasts patient escapee ala79val tyr115cys mutations ps 1 detected segregation analysis
0.3493169.9384602.html.plaintext.txt	24	although sscp analysis ps 1 ps 2 negative eight 10 autosomal dominant probands included sample could rule mutations may missed since sensitivity sscp 100 therefore performed mutation analysis ps 1 ps 2 cdna synthesized rna isolated cultured lymphoblasts patient escapee ala79val tyr115cys mutations ps 1 detected segregation analysis
0.3493169.9384602.html.plaintext.txt	25	six ps 1 mutations occurred patients positive family history presenile ad ps 2 mutation observed sporadic case table 2 two ps 1 mutations present autosomal dominant cases 1005 1066 four ps 1 mutations detected familial cases 1061 1069 1072 1087 fig 2 latter families inheritance pattern consistent autosomal dominant transmission fig 2 however families selected linkage studies since fulfil rigid criteria autosomal dominant ad 1061 1069 1087 showed bilineal transmission ad 1072 20 family 1072 additional family members available ps 1 mutation ala231val shown present risk individuals
0.3493169.9384602.html.plaintext.txt	26	six ps 1 mutations occurred patients positive family history presenile ad ps 2 mutation observed sporadic case table 2 two ps 1 mutations present autosomal dominant cases 1005 1066 four ps 1 mutations detected familial cases 1061 1069 1072 1087 fig 2 latter families inheritance pattern consistent autosomal dominant transmission fig 2 however families selected linkage studies since fulfil rigid criteria autosomal dominant ad 1061 1069 1087 showed bilineal transmission ad 1072 20 family 1072 additional family members available ps 1 mutation ala231val shown present risk individuals
0.3493169.9384602.html.plaintext.txt	27	figure 2 pedigrees families autosomal dominant ad cases familial cases ps 1 mutation observed probands included mutation analysis except families 1005 iii 20 1066 v 2 families 1061 1069 1072 1087 included previous linkage studies 20 symbols circles depict females squares depict males open symbols unaffected individuals filled symbols ad patients partly filled symbols patients diagnosed cva roman numbers left pedigree denote generations numbers patient symbols denote age onset age death dagger arrows indicate probands patients autopsy confirmation ad indicated asterisk
0.3493169.9384602.html.plaintext.txt	28	autosomal dominant families 1005 1066 co segregation mutation presenile ad confirmed restriction enzyme digestion table 2 fig 1 previously used informative families 10 autosomal dominant cases included among 101 cases genetic linkage studies 20 family 1066 mean onset age 42 years linked d14s43 located chromosome 14q243 multipoint lod score z 371 zero recombination 20 family 1005 informative chromosome 14 str markers used discussion
0.3493169.9384602.html.plaintext.txt	29	mutation analysis 10 coding exons well 5 non coding exons ps 1 ps 2 sscp analysis pcr cycle sequencing identified four different missense mutations ps 1 six patients ala79val tyr115cys ala231val glu318gly one missense mutation ps 2 one patient arg62his among 101 unrelated presenile ad cases study one mutations 7 27 novel mutations absent 118 control individuals based mutation data calculated mutation frequency 6 ps 1 1 ps 2 presenile ad since ps 1 mutations occurred familial cases ie cases least one first degree relative ad mutation frequency estimated 9 six 67 cases familial presenile ad cases among familial cases study 11 cases belonging families fulfilling rigid criteria autosomal dominant ad ie three patients two generations clinical diagnosis ad least two cases 20 two autosomal dominant families ps 1 mutation found resulting mutation frequency 18 two 11 cases autosomal dominant presenile ad
0.3493169.9384602.html.plaintext.txt	30	mutation analysis 10 coding exons well 5 non coding exons ps 1 ps 2 sscp analysis pcr cycle sequencing identified four different missense mutations ps 1 six patients ala79val tyr115cys ala231val glu318gly one missense mutation ps 2 one patient arg62his among 101 unrelated presenile ad cases study one mutations 7 27 novel mutations absent 118 control individuals based mutation data calculated mutation frequency 6 ps 1 1 ps 2 presenile ad since ps 1 mutations occurred familial cases ie cases least one first degree relative ad mutation frequency estimated 9 six 67 cases familial presenile ad cases among familial cases study 11 cases belonging families fulfilling rigid criteria autosomal dominant ad ie three patients two generations clinical diagnosis ad least two cases 20 two autosomal dominant families ps 1 mutation found resulting mutation frequency 18 two 11 cases autosomal dominant presenile ad
0.3493169.9384602.html.plaintext.txt	31	since mutation screening ps 1 ps 2 performed sscp analysis cannot exclude estimates mutation frequencies ps 1 ps 2 underestimates sensitivity sscp 100 28 however systematically analyzed pcr amplified exon ps 1 ps 2 together positive controls known mutations presence absence glycerol denaturant mutations ps 1 ps 2 may also masked polymorphisms exonic flanking intronic sequences polymorphic sscp patterns observed sequenced pcr products five 10 cases showing homozygous heterozygous sscp patterns case underlying polymorphism detected confirmed restriction enzyme digestion amplified product efficiency mutation analysis strategy demonstrated detection mutation exon 4 ps 2 one patient unique sscp pattern different polymorphic sscp patterns observed exon 4 also sequence analysis polymorphic pcr products exon 8 ps 1 identified mutations
0.3493169.9384602.html.plaintext.txt	32	since mutation screening ps 1 ps 2 performed sscp analysis cannot exclude estimates mutation frequencies ps 1 ps 2 underestimates sensitivity sscp 100 28 however systematically analyzed pcr amplified exon ps 1 ps 2 together positive controls known mutations presence absence glycerol denaturant mutations ps 1 ps 2 may also masked polymorphisms exonic flanking intronic sequences polymorphic sscp patterns observed sequenced pcr products five 10 cases showing homozygous heterozygous sscp patterns case underlying polymorphism detected confirmed restriction enzyme digestion amplified product efficiency mutation analysis strategy demonstrated detection mutation exon 4 ps 2 one patient unique sscp pattern different polymorphic sscp patterns observed exon 4 also sequence analysis polymorphic pcr products exon 8 ps 1 identified mutations
0.3493169.9384602.html.plaintext.txt	33	onset age ps 1 mutation cases varied 45 58 years three mutations ala79val ala231val glu318gly onset ages 55 years table 2 ps 1 mutations reported far onset ages 35 55 years 29 however majority mutations located exons 5 8 coding part tm ii large hl tm vi 13 mutations predicted interfere alpha helical structure tm ii proteolytic processing ps 1 occurring hl vi 7 ps 1 mutations identified study located n terminal region ala79val exon 4 tm v ala231val exon 7 middle part hl vi glu318gly exon 9 likely mutations milder effect ps 1 functioning possibly amino acid changes semi conserved ala79val ala231val located functionally less important region glu318gly glu318 mutation located region ps 1 less conserved ps 2 ps species 13 also co segregation glu318gly mutation ad could demonstrated since relatives family 1069 available high variability onset age observed ps 1 family 1005 segregating ala79val mutation mean onset age family 64 years ranging 55 78 years one mutation carrier disease yet fully penetrant age 76 years possibly onset age family modulated genetic andor environmental factors respect important note non penetrant case apoe epsilon3epsilon3 genotype may delayed onset age 30 however apoe studies larger samples ps 1 cases families needed conclude apoe genotype modulates expression ps 1 mutations also effect apoe genotype onset age observed chromosome 14 linked ad families ps 1 mutations leading early onset ages severe phenotypes 31 another possibility ps 1 linked phenotype modulated polymorphism ps 2 mutations ps 1 ps 2 act together express disease phenotype digenic effect however sscp analysis well rt pcr analysis ps 2 cdna detect sequence alterations ps 2 family 1005 also particular interest since family several patients identified cerebrovascular accidents cva fig 2 however none carried ps 1 mutation indicating cvas family related presenile ad contrast previous three ps 1 mutations tyr115cys mutation exon 5 corresponding hl detected chromosome 14 linked family 1066 mean onset age 42 years range 39 49 years 20 latter provides evidence earlier mutation studies may indeed biased towards finding ps 1 mutations resulting earlier onset ages severe phenotypes
0.3493169.9384602.html.plaintext.txt	34	onset age ps 1 mutation cases varied 45 58 years three mutations ala79val ala231val glu318gly onset ages 55 years table 2 ps 1 mutations reported far onset ages 35 55 years 29 however majority mutations located exons 5 8 coding part tm ii large hl tm vi 13 mutations predicted interfere alpha helical structure tm ii proteolytic processing ps 1 occurring hl vi 7 ps 1 mutations identified study located n terminal region ala79val exon 4 tm v ala231val exon 7 middle part hl vi glu318gly exon 9 likely mutations milder effect ps 1 functioning possibly amino acid changes semi conserved ala79val ala231val located functionally less important region glu318gly glu318 mutation located region ps 1 less conserved ps 2 ps species 13 also co segregation glu318gly mutation ad could demonstrated since relatives family 1069 available high variability onset age observed ps 1 family 1005 segregating ala79val mutation mean onset age family 64 years ranging 55 78 years one mutation carrier disease yet fully penetrant age 76 years possibly onset age family modulated genetic andor environmental factors respect important note non penetrant case apoe epsilon3epsilon3 genotype may delayed onset age 30 however apoe studies larger samples ps 1 cases families needed conclude apoe genotype modulates expression ps 1 mutations also effect apoe genotype onset age observed chromosome 14 linked ad families ps 1 mutations leading early onset ages severe phenotypes 31 another possibility ps 1 linked phenotype modulated polymorphism ps 2 mutations ps 1 ps 2 act together express disease phenotype digenic effect however sscp analysis well rt pcr analysis ps 2 cdna detect sequence alterations ps 2 family 1005 also particular interest since family several patients identified cerebrovascular accidents cva fig 2 however none carried ps 1 mutation indicating cvas family related presenile ad contrast previous three ps 1 mutations tyr115cys mutation exon 5 corresponding hl detected chromosome 14 linked family 1066 mean onset age 42 years range 39 49 years 20 latter provides evidence earlier mutation studies may indeed biased towards finding ps 1 mutations resulting earlier onset ages severe phenotypes
0.3493169.9384602.html.plaintext.txt	35	one ps 2 mutation arg62his observed sporadic ad case onset age 62 years two published ps 2 mutations identified autosomal dominant families presenile ad tm ii tm v ps 2 4 5 mutated arg62 codon conserved human ps 1 ps mammalian species located region n terminal domain generally conserved ps 1 ps 2 caenorhabditis elegans homolog sel 12 32 also mutation conserved amino acid substitution therefore cannot excluded ps 2 mutation rare polymorphism related ad pathogenesis since patient also apoe epsilon3epsilon4 genotype may increased risk developing ad 30
0.3493169.9384602.html.plaintext.txt	36	one ps 2 mutation arg62his observed sporadic ad case onset age 62 years two published ps 2 mutations identified autosomal dominant families presenile ad tm ii tm v ps 2 4 5 mutated arg62 codon conserved human ps 1 ps mammalian species located region n terminal domain generally conserved ps 1 ps 2 caenorhabditis elegans homolog sel 12 32 also mutation conserved amino acid substitution therefore cannot excluded ps 2 mutation rare polymorphism related ad pathogenesis since patient also apoe epsilon3epsilon4 genotype may increased risk developing ad 30
0.3493169.9384602.html.plaintext.txt	37	conclusion mutation data showed ps 1 ps 2 mutations rare genetic causes presenile ad general also frequency ps 1 mutations autosomal dominant ad families 18 less frequent initially estimated mutations identified exons 16 17 app cases 33 suggesting ad genes must exist possible fraction cases may attributed presence apoe epsilon4 allele previous study population based sample demonstrated risk developing presenile ad significantly increased apoe epsilon4 homozygotes independent family history apoe epsilon4 heterozygotes family history positive 33 sample 101 cases 19 apoe epsilon4 homozygotes 31 familial apoe epsilon4 heterozygotes
0.3493169.9384602.html.plaintext.txt	38	conclusion mutation data showed ps 1 ps 2 mutations rare genetic causes presenile ad general also frequency ps 1 mutations autosomal dominant ad families 18 less frequent initially estimated mutations identified exons 16 17 app cases 33 suggesting ad genes must exist possible fraction cases may attributed presence apoe epsilon4 allele previous study population based sample demonstrated risk developing presenile ad significantly increased apoe epsilon4 homozygotes independent family history apoe epsilon4 heterozygotes family history positive 33 sample 101 cases 19 apoe epsilon4 homozygotes 31 familial apoe epsilon4 heterozygotes
0.3493169.9384602.html.plaintext.txt	39	contrast previous reports 29 observed several ps 1 mutations leading ad onset ages 55 years also one ps 1 mutations identified autosomal dominant family mean onset age 64 years range 55 78 years identification ps 1 mutations predicts ps 1 mutations even milder effects ps 1 functioning may present senile ad particular importance since genetic association intronic ps 1 polymorphism senile ad reported 25 although association could replicated studies possibly association result functionally relevant sequence variation elsewhere ps 1 gene preliminary data obtained sequence analysis failed demonstrate sequence variations coding region ps 1 25 however promoter 5 non coding region ps 1 examined since sequences became available recently respect identification us two polymorphisms 5 non coding region ps 1 interest since polymorphisms may used genetic association studies test whether ps 1 also susceptibility gene senile andor presenile ad also intronic exonic polymorphisms identified ps 2 useful test role gene ad analysis yet performed materials methods subjects
0.3493169.9384602.html.plaintext.txt	40	contrast previous reports 29 observed several ps 1 mutations leading ad onset ages 55 years also one ps 1 mutations identified autosomal dominant family mean onset age 64 years range 55 78 years identification ps 1 mutations predicts ps 1 mutations even milder effects ps 1 functioning may present senile ad particular importance since genetic association intronic ps 1 polymorphism senile ad reported 25 although association could replicated studies possibly association result functionally relevant sequence variation elsewhere ps 1 gene preliminary data obtained sequence analysis failed demonstrate sequence variations coding region ps 1 25 however promoter 5 non coding region ps 1 examined since sequences became available recently respect identification us two polymorphisms 5 non coding region ps 1 interest since polymorphisms may used genetic association studies test whether ps 1 also susceptibility gene senile andor presenile ad also intronic exonic polymorphisms identified ps 2 useful test role gene ad analysis yet performed materials methods subjects
0.3493169.9384602.html.plaintext.txt	41	patients clinical diagnosis ad onset age 65 years made period january 1980 july 1987 living metropolitan rotterdam four northern provinces ascertained 18 clinical diagnosis ad independently confirmed two neurologists using standardized protocol according nincds adrda criteria ad 34 total 198 patients participated study 18 onset age defined age memory problems behavior changes first noted cases considered familial least one first degree relative suffered dementia percentage familial cases total sample presenile ad patients 48 18 33 familial cases pedigree considered segregate autosomal dominant ad least three patients dementia reported two generations least two patients detailed medical records clinical diagnosis ad 18 33
0.3493169.9384602.html.plaintext.txt	42	patients clinical diagnosis ad onset age 65 years made period january 1980 july 1987 living metropolitan rotterdam four northern provinces ascertained 18 clinical diagnosis ad independently confirmed two neurologists using standardized protocol according nincds adrda criteria ad 34 total 198 patients participated study 18 onset age defined age memory problems behavior changes first noted cases considered familial least one first degree relative suffered dementia percentage familial cases total sample presenile ad patients 48 18 33 familial cases pedigree considered segregate autosomal dominant ad least three patients dementia reported two generations least two patients detailed medical records clinical diagnosis ad 18 33
0.3493169.9384602.html.plaintext.txt	43	blood samples drawn 100 randomly selected ad patients 33 detailed data family history disease collected 18 affected unaffected relatives 17 families visited home blood drawn relatives assessed family history disease risk factors ad memory performance 20 blood samples obtained 118 control individuals matched age within 5 years place residence controls drawn randomly population register municipality patient 33 cognitive status control individuals tested none showed symptoms dementia time study leukocytes collected total blood patients relatives permanent lymphoblast cell lines obtained transformation using ebstein barr virus dna extracted total blood cultured lymphoblasts using standard phenolchloroform dna extraction procedure
0.3493169.9384602.html.plaintext.txt	44	blood samples drawn 100 randomly selected ad patients 33 detailed data family history disease collected 18 affected unaffected relatives 17 families visited home blood drawn relatives assessed family history disease risk factors ad memory performance 20 blood samples obtained 118 control individuals matched age within 5 years place residence controls drawn randomly population register municipality patient 33 cognitive status control individuals tested none showed symptoms dementia time study leukocytes collected total blood patients relatives permanent lymphoblast cell lines obtained transformation using ebstein barr virus dna extracted total blood cultured lymphoblasts using standard phenolchloroform dna extraction procedure
0.3493169.9384602.html.plaintext.txt	45	initial genetic analyses 100 cases included nine autosomal dominant cases however recently risk individual 1066 v 2 fig 2 diagnosed probable ad included study bringing total number cases 101 mutation analysis exons 16 17 app excluded presence app mutations cases 33 informative families 10 autosomal dominant cases used linkage analysis studies chromosome 14 19 21 markers 20 family 1066 mean onset age 42 years conclusively linked chromosome 14 two others excluded results informative since linkage analysis studies performed presenile ad locus chromosome 1 identified families analyzed linkage chromosome 1 markers polymerase chain reaction pcr analyses
0.3493169.9384602.html.plaintext.txt	46	initial genetic analyses 100 cases included nine autosomal dominant cases however recently risk individual 1066 v 2 fig 2 diagnosed probable ad included study bringing total number cases 101 mutation analysis exons 16 17 app excluded presence app mutations cases 33 informative families 10 autosomal dominant cases used linkage analysis studies chromosome 14 19 21 markers 20 family 1066 mean onset age 42 years conclusively linked chromosome 14 two others excluded results informative since linkage analysis studies performed presenile ad locus chromosome 1 identified families analyzed linkage chromosome 1 markers polymerase chain reaction pcr analyses
0.3493169.9384602.html.plaintext.txt	47	200 ng dna amplified 25 microl reaction mixture containing 20 pmol primer 02 mm dntps 02 u taq dna polymerase gibco brl gaithersburg md 10 mm mgcl2 75 mm tris hcl ph 90 20 mm nh42so4 001 tween 20 pcr amplification consisted 30 cycles 90 94 degrees c 90 empirically defined optimal annealing temperature 90 72 degrees c
0.3493169.9384602.html.plaintext.txt	48	pcr sscp analyses intronic pcr primers used amplify exons flanking intronic sequences ps 1 ps 2 table 1 pcr amplification products heat denatured cooled ice separated using two different electrophoresis systems coding exons ps 1 analyzed 1 x hydrolink mde gel jtbaker phillipsburg without 10 glycerol electrophoresis 20 h 800 v 4 degrees c glycerol room temperature without glycerol sscpheteroduplex patterns visualized using silver staining alternatively non coding exons ps 1 exons ps 2 analyzed multiphorii electrophoresis system pharmacia biotech uppsala sweden using excellgel precast polyacrylamide gels 1 x hydrolink mde gels containing 5 glycerol electrophoresis 600 v 2 5 h depending product sizes sscp patterns visualized using silver staining sscp analyses exons 5 8 11 ps 1 performed presence positive control samples ile143thr met146leu his163arg ala246glu leu286val gly384ala cys410tyr mutations 3 23 aberrant sscp patterns observed sequences fragments determined using cycle sequencing pcr amplification products pretreated 10 u exonuclease 2 u shrimp alkaline phosphatase remove excess pcr primers nucleotides pcr amplification product 5 microl used template cycle sequencing reaction using abi prism dye terminator cycle sequencing core kit applied biosystems foster city ca according suppliers protocol using primers pcr amplification sequences analyzed abi 373a automated dna sequencer
0.3493169.9384602.html.plaintext.txt	49	pcr sscp analyses intronic pcr primers used amplify exons flanking intronic sequences ps 1 ps 2 table 1 pcr amplification products heat denatured cooled ice separated using two different electrophoresis systems coding exons ps 1 analyzed 1 x hydrolink mde gel jtbaker phillipsburg without 10 glycerol electrophoresis 20 h 800 v 4 degrees c glycerol room temperature without glycerol sscpheteroduplex patterns visualized using silver staining alternatively non coding exons ps 1 exons ps 2 analyzed multiphorii electrophoresis system pharmacia biotech uppsala sweden using excellgel precast polyacrylamide gels 1 x hydrolink mde gels containing 5 glycerol electrophoresis 600 v 2 5 h depending product sizes sscp patterns visualized using silver staining sscp analyses exons 5 8 11 ps 1 performed presence positive control samples ile143thr met146leu his163arg ala246glu leu286val gly384ala cys410tyr mutations 3 23 aberrant sscp patterns observed sequences fragments determined using cycle sequencing pcr amplification products pretreated 10 u exonuclease 2 u shrimp alkaline phosphatase remove excess pcr primers nucleotides pcr amplification product 5 microl used template cycle sequencing reaction using abi prism dye terminator cycle sequencing core kit applied biosystems foster city ca according suppliers protocol using primers pcr amplification sequences analyzed abi 373a automated dna sequencer
0.3493169.9384602.html.plaintext.txt	50	sequence variations ps 1 ps 2 analyzed restriction enzyme digestion amplified products involved creation abolition restriction enzyme recognition site also intron 8 polymorphism ps 1 analyzed bamhi digestion described 25 genomic pcr amplification products digested 3 h using 5 u corresponding restriction enzyme tables 2 3 appropriate reaction temperature restriction fragments separated 15 3 agarose gel depending allele sizes visualized uv transilluminator etbr staining
0.3493169.9384602.html.plaintext.txt	51	sequence variations ps 1 ps 2 analyzed restriction enzyme digestion amplified products involved creation abolition restriction enzyme recognition site also intron 8 polymorphism ps 1 analyzed bamhi digestion described 25 genomic pcr amplification products digested 3 h using 5 u corresponding restriction enzyme tables 2 3 appropriate reaction temperature restriction fragments separated 15 3 agarose gel depending allele sizes visualized uv transilluminator etbr staining
0.3493169.9384602.html.plaintext.txt	52	apoe genotype scored pcr amplification genomic dna using published primers 35 standard pcr 35 cycles digestion 5 u hhai 3 h 37 degrees c alleles separated excellgel precast polyacrylamide gels described visualized using silver staining
0.3493169.9384602.html.plaintext.txt	53	apoe genotype scored pcr amplification genomic dna using published primers 35 standard pcr 35 cycles digestion 5 u hhai 3 h 37 degrees c alleles separated excellgel precast polyacrylamide gels described visualized using silver staining
0.3493169.9384602.html.plaintext.txt	54	strs d14s1028 d14s77 d14s1008 amplified standard pcr using published primer sets one fluorescently labeled alleles separated 6 polyacrylamide gel containing 8 m urea analyzed abi 373a automated dna sequencer using genescan 672 software applied biosystems cdna sequence analysis
0.3493169.9384602.html.plaintext.txt	55	strs d14s1028 d14s77 d14s1008 amplified standard pcr using published primer sets one fluorescently labeled alleles separated 6 polyacrylamide gel containing 8 m urea analyzed abi 373a automated dna sequencer using genescan 672 software applied biosystems cdna sequence analysis
0.3493169.9384602.html.plaintext.txt	56	approximately 107 lymphoblast cells homogenized presence 1 ml trizol gibco brl rna isolated chloroform extraction precipitated isopropanol centrifugation 10 min microfuge pellet washed 75 etoh dissolved 20 microl depc treated h2o first strand cdna synthesis performed random primers using superscript pre amplification kit gibco brl described protocol supplied kit rna removed adding 2 u rnase h incubating 20 min 37 degrees c standard pcr amplification 30 cycles performed using 100 ng first strand cdna template ps 1 cdna pcr amplified using primer pairs 917892 901111r 1017852 3 sequence amplification products determined cycle sequencing described sequencing primers published 3 23 ps 2 cdna pcr amplified using primer pairs stm2 67 5 aaccagcgctgccctctttgaa 3 5 aggatgacccacgcggaccactc 3 stm2 89 5 ctaccccaccctcttgctgactgt 3 5 ctccccgccctaatctgaccttct 3 cycle sequencing performed using primers primer 1021 5 5 cagaggatggagagaacac 3 stm2 6 5 aaccagcgctgccctctttgaa 3 stm2 1 5 atcgtggtggtagcc 3 stm2 2 5 gttatgaccatcttcttgg 3 stm2 4 5 tgtgctgtgtcccaaagg 3 ps2 1742as 5 tccaatgaaaattccctgc 3 sequence ps 2 cdna determined cycle sequencing described acknowledgements
0.3493169.9384602.html.plaintext.txt	57	approximately 107 lymphoblast cells homogenized presence 1 ml trizol gibco brl rna isolated chloroform extraction precipitated isopropanol centrifugation 10 min microfuge pellet washed 75 etoh dissolved 20 microl depc treated h2o first strand cdna synthesis performed random primers using superscript pre amplification kit gibco brl described protocol supplied kit rna removed adding 2 u rnase h incubating 20 min 37 degrees c standard pcr amplification 30 cycles performed using 100 ng first strand cdna template ps 1 cdna pcr amplified using primer pairs 917892 901111r 1017852 3 sequence amplification products determined cycle sequencing described sequencing primers published 3 23 ps 2 cdna pcr amplified using primer pairs stm2 67 5 aaccagcgctgccctctttgaa 3 5 aggatgacccacgcggaccactc 3 stm2 89 5 ctaccccaccctcttgctgactgt 3 5 ctccccgccctaatctgaccttct 3 cycle sequencing performed using primers primer 1021 5 5 cagaggatggagagaacac 3 stm2 6 5 aaccagcgctgccctctttgaa 3 stm2 1 5 atcgtggtggtagcc 3 stm2 2 5 gttatgaccatcttcttgg 3 stm2 4 5 tgtgctgtgtcccaaagg 3 ps2 1742as 5 tccaatgaaaattccctgc 3 sequence ps 2 cdna determined cycle sequencing described acknowledgements
0.3493169.9384602.html.plaintext.txt	58	work described study financed part fund scientific research flanders belgium fwo flemish biotechnology programme dwtc interuniversity attractionpoles european biotech grant ct96 0743 american health assistance foundation grants netherlands organization scientific research nwo thank drs wim schulte teun tanja rob haaxma arie lameris rolf saan assisting case diagnoses helen de bruijn micheline de haes jeanette kammen hilda kornman hanneke van meurs caroline valkenburg genealogy studies marc cruts post doctoral fellow fwo references 1 van broeckhovenc 1995 molecular genetics alzheimer disease identification genes gene mutations eur neurol 35 8 19 medline abstract
0.3493169.9384602.html.plaintext.txt	59	work described study financed part fund scientific research flanders belgium fwo flemish biotechnology programme dwtc interuniversity attractionpoles european biotech grant ct96 0743 american health assistance foundation grants netherlands organization scientific research nwo thank drs wim schulte teun tanja rob haaxma arie lameris rolf saan assisting case diagnoses helen de bruijn micheline de haes jeanette kammen hilda kornman hanneke van meurs caroline valkenburg genealogy studies marc cruts post doctoral fellow fwo references 1 van broeckhovenc 1995 molecular genetics alzheimer disease identification genes gene mutations eur neurol 35 8 19 medline abstract
0.3493169.9384602.html.plaintext.txt	60	6 hardyj 1997 amyloid presenilins alzheimer disease trends neurosci 20 154 159 medline abstract
0.3493169.9384602.html.plaintext.txt	61	11 alzheimers disease collaborative group clarkrf huttonm fuldnerra froelichs karrane talbotc crookr lendonc priharg hec korenblatk martineza wraggm busfieldf behrensmi myersa nortonj morrisj mehtan pearsonc lincolnc bakerm duffk zehrc perez turj houldenh ruiza ossaj loperaf arcosm madrigall collingej humphreysc ashwortha sarners foxn harveyr kennedya roquesp clinert philipsca venterjc forselll axelmank liliusl johnstonj cowburnr viitanenm windbladb kosikk haltiam poyhonenm dicksond mannd nearyd snowdonj lantosp lannfeltl rossorm robertsgw adamsmd hardyj goatea 1995 structure presenilin 1 s182 gene identification six novel mutations early onset ad families nature genet 11 219 222
0.3493169.9384602.html.plaintext.txt	62	29 van broeckhovenc 1995 presenilins alzheimer disease nature genet 11 230 232 medline abstract
0.3493169.9384602.html.plaintext.txt	63	correspondence addressed tel 32 3 8202601 fax 32 3 8202541 email cvbroeckuiaacbe
0.3493169.9384602.html.plaintext.txt	64	correspondence addressed tel 32 3 8202601 fax 32 3 8202541 email cvbroeckuiaacbe
0.35055456.9285791.html.plaintext.txt	0	altered metabolism familial alzheimers disease linked amyloid precursor protein variants yeast artificial chromosome transgenic mice altered metabolism familial alzheimers disease linked amyloid precursor protein variants yeast artificial chromosome transgenic mice bruce lamb linda m call1 hilda h slunt2 kimberly bardel ann m lawler1 christopher b eckman3 steven g younkin3 greg holtz4 steven l wagner4 donald l price2 sangram sisodia2 john d gearhart1
0.35055456.9285791.html.plaintext.txt	1	department genetics case western reserve university 10900 euclid avenue cleveland oh 44106 usa 1developmental genetics laboratory departments gynecology obstetrics physiology 2neuropathology laboratory department pathology johns hopkins university school medicine baltimore md 21287 usa 3mayo clinic jacksonville jacksonville fl 32224 usa 4sibia neurosciences inc la jolla ca 92037 usa
0.35055456.9285791.html.plaintext.txt	2	received april 15 1997 revised accepted june 27 1997
0.35055456.9285791.html.plaintext.txt	3	missense mutations beta amyloid precursor protein gene app co segregate small subset autosomal dominant familial alzheimers disease fad cases wherein deposition 39 43 amino acid beta amyloid abeta peptide neurodegeneration principal neuropathological hallmarks accurately examine effect missense mutations app metabolism abeta production vivo introduced yeast artificial chromosomes yacs containing entire 400 kbp human app gene encoding app harboring either asparagine lysine leucine methionine fad substitution codons 670 671 appk670nm671l isoleucine valine fad substitution codon 717 appv717i combination substitutions transgenic mice demonstrate relative yac transgenic mice expressing wild type app high levels abeta peptides detected brains yac transgenic mice expressing human appk670nm671l associated concomitant diminution levels alpha secretase generated soluble app derivatives moreover levels longer abeta peptides species terminating amino acids 4243 elevated yac transgenic mice expressing human appv717i mice prove valuable detailed analysis vivo effects app fad mutations variety tissues throughout aging testing therapeutic agents specifically alter app metabolism abeta production introduction
0.35055456.9285791.html.plaintext.txt	4	missense mutations beta amyloid precursor protein gene app co segregate small subset autosomal dominant familial alzheimers disease fad cases wherein deposition 39 43 amino acid beta amyloid abeta peptide neurodegeneration principal neuropathological hallmarks accurately examine effect missense mutations app metabolism abeta production vivo introduced yeast artificial chromosomes yacs containing entire 400 kbp human app gene encoding app harboring either asparagine lysine leucine methionine fad substitution codons 670 671 appk670nm671l isoleucine valine fad substitution codon 717 appv717i combination substitutions transgenic mice demonstrate relative yac transgenic mice expressing wild type app high levels abeta peptides detected brains yac transgenic mice expressing human appk670nm671l associated concomitant diminution levels alpha secretase generated soluble app derivatives moreover levels longer abeta peptides species terminating amino acids 4243 elevated yac transgenic mice expressing human appv717i mice prove valuable detailed analysis vivo effects app fad mutations variety tissues throughout aging testing therapeutic agents specifically alter app metabolism abeta production introduction
0.35055456.9285791.html.plaintext.txt	5	alzheimers disease ad common cause dementia elderly major source disability death genetic investigations identified several etiologies ad reviewed 1 including dosage imbalance chromosome 21 occurs syndrome ds mutations beta amyloid precursor protein gene app chromosome 21 presenilin 1 gene chromosome 14 presenilin 2 gene chromosome 1 autosomal dominant early onset familial ad fad inheritance apolipoprotein e4 allele chromosome 19 genetic risk factor late onset fad sporadic ad principal cytological hallmark ad cases parenchymal deposits beta amyloid abeta 39 43 amino acid peptide derived app 2
0.35055456.9285791.html.plaintext.txt	6	alzheimers disease ad common cause dementia elderly major source disability death genetic investigations identified several etiologies ad reviewed 1 including dosage imbalance chromosome 21 occurs syndrome ds mutations beta amyloid precursor protein gene app chromosome 21 presenilin 1 gene chromosome 14 presenilin 2 gene chromosome 1 autosomal dominant early onset familial ad fad inheritance apolipoprotein e4 allele chromosome 19 genetic risk factor late onset fad sporadic ad principal cytological hallmark ad cases parenchymal deposits beta amyloid abeta 39 43 amino acid peptide derived app 2
0.35055456.9285791.html.plaintext.txt	7	app gene encompasses 18 exons 400 kbp dna gives rise least four tissue specific alternatively spliced transcripts encode proteins 695 714 751 770 amino acids 3 7 app type integral membrane glycoprotein unknown function matures constitutive secretory pathway processed several pathways including cleavage alpha secretase position 16 abeta resulting secretion app ectodomain thus precluding abeta formation degradation endosomal lysosomal pathways cleavage beta gamma secretases n c termini abeta respectively resulting production secretion abeta peptides reviewed 8 missense mutations app occur small subset 5 individuals early onset fad two large related fad pedigrees sweden 9 double mutation codons 670 671 app 770 results substitution lysine asparagine methionine leucine appk670nm671l 12 fad pedigrees 10 16 mutations within transmembrane domain lead substitutions either isoleucine phenylalanine glycine valine residue 717 app 770 appv717i appv717f appv717g
0.35055456.9285791.html.plaintext.txt	8	app gene encompasses 18 exons 400 kbp dna gives rise least four tissue specific alternatively spliced transcripts encode proteins 695 714 751 770 amino acids 3 7 app type integral membrane glycoprotein unknown function matures constitutive secretory pathway processed several pathways including cleavage alpha secretase position 16 abeta resulting secretion app ectodomain thus precluding abeta formation degradation endosomal lysosomal pathways cleavage beta gamma secretases n c termini abeta respectively resulting production secretion abeta peptides reviewed 8 missense mutations app occur small subset 5 individuals early onset fad two large related fad pedigrees sweden 9 double mutation codons 670 671 app 770 results substitution lysine asparagine methionine leucine appk670nm671l 12 fad pedigrees 10 16 mutations within transmembrane domain lead substitutions either isoleucine phenylalanine glycine valine residue 717 app 770 appv717i appv717f appv717g
0.35055456.9285791.html.plaintext.txt	9	figure 1 introduction mutations app yacs es cells mutation m introduced vitro given dna sequence contained yac trpi ura3 arms cloned plasmid p680 30 contains yeast leu2 cyh2 genes cutting plasmid dna unique site r one side mutation well introduction linear molecule yeast containing yac selection leu transformants result targeted integration plasmid corresponding genomic sequence yac b subsequent selection cyhr transformants results excision plasmid generation wt mutated sequence c high molecular weight dna yeast strain containing app yac four representative es transformants see table 1 digested hindiii transferred nylon membranes hybridized human alu repetitive element 5 right shown sizes molecular weight markers kbp d cytoplasmic rna es transformants subjected rt pcr analysis appropriate mouse mapp human happ plasmid cdna controls 5 right shown sizes expected human 568 bp mouse 516 bp productsfig
0.35055456.9285791.html.plaintext.txt	10	studies transfected cells provided enormous insights mechanisms whereby fad mutations affect app processing abeta production example cells expressing appk670nm671l secrete higher levels abeta containing peptides compared cells expressing wild type wt app 17 19 concomitantly alpha secretase generated soluble app derivatives diminished 17 addition cells expressing app717 substitutions specifically secrete elevated levels longer abeta peptides 20 extending residues 42 andor 43 abeta1 4243 evidence abeta1 4243 highly pathogenic abeta species derives biophysical studies showing highly fibrillogenic nature peptide immunocytochemical studies brains ad ds individuals demonstrating abeta1 4243 peptides deposited relatively early disease 21 24
0.35055456.9285791.html.plaintext.txt	11	studies transfected cells provided enormous insights mechanisms whereby fad mutations affect app processing abeta production example cells expressing appk670nm671l secrete higher levels abeta containing peptides compared cells expressing wild type wt app 17 19 concomitantly alpha secretase generated soluble app derivatives diminished 17 addition cells expressing app717 substitutions specifically secrete elevated levels longer abeta peptides 20 extending residues 42 andor 43 abeta1 4243 evidence abeta1 4243 highly pathogenic abeta species derives biophysical studies showing highly fibrillogenic nature peptide immunocytochemical studies brains ad ds individuals demonstrating abeta1 4243 peptides deposited relatively early disease 21 24
0.35055456.9285791.html.plaintext.txt	12	numerous standard transgenic mice generated express various wt mutant app cdnas gene fragments variety promoters reviewed 25 see also 26 28 although studies revealed app transgenic mice develop age related abeta deposits specifically accurately examined effect regulated expression appk670nm671l appv717i metabolism app abeta vivo contrast efforts designed introduce entire 400 kbp human app gene harboring fad mutations germline transgenic mice thus allowing proper spatial temporal expression mutant app appropriate splice donor acceptor sites needed generate entire spectrum alternatively spliced app transcripts encoded proteins 650 kbp yeast artificial chromosome yac containing app gene mutagenized using homologous recombination strategy yeast introduced mouse embryonic stem es cells lipid mediated transfection finally transferred mouse germline brain peripheral tissues mutant app yac transgenic mice high levels human app mrna protein expressed manner mirrors spatial temporal expression pattern endogenous mouse app gene products furthermore elevated levels abeta peptides detected brains yac transgenic mice expressing human appk670nm671l concomitant decrease levels soluble alpha secretase generated app derivatives compared mice expressing similar levels wt app finally demonstrate elevated levels longer abeta peptides detected yac transgenic mice expressing human appv717i results mutagenesis app yacs
0.35055456.9285791.html.plaintext.txt	13	numerous standard transgenic mice generated express various wt mutant app cdnas gene fragments variety promoters reviewed 25 see also 26 28 although studies revealed app transgenic mice develop age related abeta deposits specifically accurately examined effect regulated expression appk670nm671l appv717i metabolism app abeta vivo contrast efforts designed introduce entire 400 kbp human app gene harboring fad mutations germline transgenic mice thus allowing proper spatial temporal expression mutant app appropriate splice donor acceptor sites needed generate entire spectrum alternatively spliced app transcripts encoded proteins 650 kbp yeast artificial chromosome yac containing app gene mutagenized using homologous recombination strategy yeast introduced mouse embryonic stem es cells lipid mediated transfection finally transferred mouse germline brain peripheral tissues mutant app yac transgenic mice high levels human app mrna protein expressed manner mirrors spatial temporal expression pattern endogenous mouse app gene products furthermore elevated levels abeta peptides detected brains yac transgenic mice expressing human appk670nm671l concomitant decrease levels soluble alpha secretase generated app derivatives compared mice expressing similar levels wt app finally demonstrate elevated levels longer abeta peptides detected yac transgenic mice expressing human appv717i results mutagenesis app yacs
0.35055456.9285791.html.plaintext.txt	14	appk670nm671l appv717i fad mutations introduced yac containing entire wt 400 kb human app gene 250 kbp flanking sequences multiple neomycin resistance expression cassettes yac vector arm homologous recombination yeast 29 briefly genomic sequences containing app exons 16 17 mutagenized subcloned screening app yac genomic sub library exon specific pcr products mutations exons 16 appk670nm671l 17 appv717i introduced respective genomic fragments using pcr based mutagenesis strategies subcloned yeast vector p680 p680 contains yeast leu2 gene permits growth absence leucine cyh2 gene confers sensitivity cycloheximide 30 finally two step gene replacement performed yeast introduce mutated app genomic sequences 650 kbp app yac fig 1 b yacs containing mutated app genomic sequences identified restriction digestion sequencing exon specific pcr products integrity mutant yacs confirmed restriction digestion southern analysis pulsed field gel electrophoresis yeast genomic dna data shown intact yacs identified containing appk670nm671l appv717i fad mutations separately mutations together
0.35055456.9285791.html.plaintext.txt	15	appk670nm671l appv717i fad mutations introduced yac containing entire wt 400 kb human app gene 250 kbp flanking sequences multiple neomycin resistance expression cassettes yac vector arm homologous recombination yeast 29 briefly genomic sequences containing app exons 16 17 mutagenized subcloned screening app yac genomic sub library exon specific pcr products mutations exons 16 appk670nm671l 17 appv717i introduced respective genomic fragments using pcr based mutagenesis strategies subcloned yeast vector p680 p680 contains yeast leu2 gene permits growth absence leucine cyh2 gene confers sensitivity cycloheximide 30 finally two step gene replacement performed yeast introduce mutated app genomic sequences 650 kbp app yac fig 1 b yacs containing mutated app genomic sequences identified restriction digestion sequencing exon specific pcr products integrity mutant yacs confirmed restriction digestion southern analysis pulsed field gel electrophoresis yeast genomic dna data shown intact yacs identified containing appk670nm671l appv717i fad mutations separately mutations together
0.35055456.9285791.html.plaintext.txt	16	table 1 mutant app yac es clones colonya mutation expressionb alu profilec copy nod germline 5 3 py89e wild type nd 1 yes j12 k670nm671l v717i nd 4 5 j16 k670nm671l nd 1 j122 k670nm671l 1 j138 k670nm671l v717i 5 6 j146 v717i 3 4 j158 k670nm671l v717i 2 j180 v717i 2 j188 v717i nd nd yes j196 k670nm671l v717i 1 yes r117 k670nm671l v717i 6 8 yes r130 v717i 2 yes r138 v717i 6 8 yes r140 k670nm671l 6 8 yes r146 k670nm671l v717i 12 16 aan additional 21 j1 eight r1 es clones contained majority mutant app yac injected mouse blastocysts brelative amounts app mrna determined rt pcr 5cintactness alu repetitive element profile determined southern blot analysis 5dcopy number determined southern blot analysis app exon 7 probe recognizes mouse human app egenerated previous study 5 introduction mutated app yacs es cells mice
0.35055456.9285791.html.plaintext.txt	17	results transfection studies mutant app yacs presented table 1 purified concentrated mutated app yac dna introduced j1 r1 es cells lipid mediated transfection suspension cultures generating 83 48 g418r lines respectively twenty one j1 13 r1 lines positive majority yac pcr including app promoter exon 7 exon 16 exon 17 alu repetitive elementpcr data shown copy number integrity app yacs resulting es lines table 1 determined extensive restriction analysis hybridization app data shown human alu probes fig 1 c respectively integration yacs containing mutated app sequences confirmed pcr restriction analysis expression human app mrna determined reverse transcription pcr rt pcr analysis fig 1 d degenerate primers span first six exons mousehuman app mrna 5 several lines subsequently introduced mouse blastocysts numerous chimeras ranging 10 90 es cell contribution generated date five separate lines transmitted es dna germline app expression mutant yac transgenic mice
0.35055456.9285791.html.plaintext.txt	18	results transfection studies mutant app yacs presented table 1 purified concentrated mutated app yac dna introduced j1 r1 es cells lipid mediated transfection suspension cultures generating 83 48 g418r lines respectively twenty one j1 13 r1 lines positive majority yac pcr including app promoter exon 7 exon 16 exon 17 alu repetitive elementpcr data shown copy number integrity app yacs resulting es lines table 1 determined extensive restriction analysis hybridization app data shown human alu probes fig 1 c respectively integration yacs containing mutated app sequences confirmed pcr restriction analysis expression human app mrna determined reverse transcription pcr rt pcr analysis fig 1 d degenerate primers span first six exons mousehuman app mrna 5 several lines subsequently introduced mouse blastocysts numerous chimeras ranging 10 90 es cell contribution generated date five separate lines transmitted es dna germline app expression mutant yac transgenic mice
0.35055456.9285791.html.plaintext.txt	19	expression human app examined several mutant app yac transgenic mice including line j196 contains appk670nm671l appv717i mutations line r140 contains appk670nm671l mutation rt pcr analysis degenerate primers span first six exons mousehuman app mrna 5 revealed j196 line containing single copy mutant app yac expressed human app mrna levels similar endogenous mouse app mrna brain fig 2 lane 6 peripheral tissues fig 2 lanes 9 12 15 line r140 containing 6 8 copies mutant app yac expressed human app mrna levels 2 3 fold endogenous app mrna tissues examined fig 2 lanes 7 10 13 16 additional rt pcr experiments 5 degenerate primers flank common alternatively spliced app exons 7 8 demonstrated levels transcripts encode human app 695 751 770 selected tissues paralleled levels alternatively spliced mouse app transcripts transgenic lines examined data shown app processing mutant yac transgenic mice
0.35055456.9285791.html.plaintext.txt	20	expression human app examined several mutant app yac transgenic mice including line j196 contains appk670nm671l appv717i mutations line r140 contains appk670nm671l mutation rt pcr analysis degenerate primers span first six exons mousehuman app mrna 5 revealed j196 line containing single copy mutant app yac expressed human app mrna levels similar endogenous mouse app mrna brain fig 2 lane 6 peripheral tissues fig 2 lanes 9 12 15 line r140 containing 6 8 copies mutant app yac expressed human app mrna levels 2 3 fold endogenous app mrna tissues examined fig 2 lanes 7 10 13 16 additional rt pcr experiments 5 degenerate primers flank common alternatively spliced app exons 7 8 demonstrated levels transcripts encode human app 695 751 770 selected tissues paralleled levels alternatively spliced mouse app transcripts transgenic lines examined data shown app processing mutant yac transgenic mice
0.35055456.9285791.html.plaintext.txt	21	expression human app related derivatives brains mutant app yac transgenic mice examined western blot analysis demonstrate membrane fractions brains line j196 accumulation full length mutant human app recognized antibody ct 15 specific terminal 15 amino acids mouse human app fig 3 lane 3 essentially indistinguishable level wt human app 5 yac transgenic line py89 fig 3 lane 2 however levels 135 kda fragment likely represents beta secretase generated c terminal peptide extending n terminus abeta end app cytoplasmic tail slightly elevated membrane fractions j196 line fig 3 b lane 3 relative brains animals expressing wt human app fig 3 b lane 2 whereas 12 kda fragment likely represents alpha secretase generated c terminal fragment remains unchanged
0.35055456.9285791.html.plaintext.txt	22	expression human app related derivatives brains mutant app yac transgenic mice examined western blot analysis demonstrate membrane fractions brains line j196 accumulation full length mutant human app recognized antibody ct 15 specific terminal 15 amino acids mouse human app fig 3 lane 3 essentially indistinguishable level wt human app 5 yac transgenic line py89 fig 3 lane 2 however levels 135 kda fragment likely represents beta secretase generated c terminal peptide extending n terminus abeta end app cytoplasmic tail slightly elevated membrane fractions j196 line fig 3 b lane 3 relative brains animals expressing wt human app fig 3 b lane 2 whereas 12 kda fragment likely represents alpha secretase generated c terminal fragment remains unchanged
0.35055456.9285791.html.plaintext.txt	23	figure 2 analysis app mrna expression mutant app yac transgenic mice total rna brain lanes 5 7 kidney lanes 8 10 testes lanes 11 13 heart lanes 14 16 2 month old control mouse ctl mouse line j196 containing appk670nm671 appv717i mutations mouse line r140 containing appk670nm671 mutation subjected rt pcr analysis appropriate mouse mapp human happ template controls lanes 1 3 sense primer 32p labeled experiments gel dried bands quantitated phosphorimaging technology line j196 produces roughly equivalent amounts mouse human app mrna brain line r140 produces 3 fold higher levels human app mrna relative mouse app mrna right shown sizes expected human 568 bp mouse 516 bp productsfig
0.35055456.9285791.html.plaintext.txt	24	figure 3 soluble cell associated app derived molecules app yac transgenic mouse brain soluble s2 fraction cell associated p2 fraction protein extracts brains 3 month old control ctl lane 1 wild type wt line py89 lane 2 mutant line j196 containing appk670nm671 appv717i mutations line r140 containing appk670nm671 mutation lanes 3 4 app yac transgenic mice 5 subjected western blot analysis 1736 p2 extracts subjected sds page tris tricine page b visualized antibody ct 15 recognizing c terminal 15 amino acids mouse human app s2 extracts c subjected sds page visualized antibody p2 1 recognizing epitope n terminus human app right shown approximate sizes kda
0.35055456.9285791.html.plaintext.txt	25	data consistent earlier demonstration cultured cells expressing appk670nm671l accumulate elevated levels c terminal 135 kda fragment generated following cleavage beta secretase 17 reinforcing view also document amount beta secretase generated fragment accumulates high levels line r140 mice overexpressing high levels human appk670nm671l fig 3 b lane 4 interestingly steady state levels full length human app line r140 fig 3 lane 4 3 fold higher endogenous app fig 3 lane 1 finding parallels rt pcr studies shown figure 2
0.35055456.9285791.html.plaintext.txt	26	data consistent earlier demonstration cultured cells expressing appk670nm671l accumulate elevated levels c terminal 135 kda fragment generated following cleavage beta secretase 17 reinforcing view also document amount beta secretase generated fragment accumulates high levels line r140 mice overexpressing high levels human appk670nm671l fig 3 b lane 4 interestingly steady state levels full length human app line r140 fig 3 lane 4 3 fold higher endogenous app fig 3 lane 1 finding parallels rt pcr studies shown figure 2
0.35055456.9285791.html.plaintext.txt	27	analysis soluble app derivatives apps brains mutant app line j196 fig 3 c lane 3 wt app line py89 fig 3 c lane 2 using antibody specific epitopes n terminus human app failed reveal significant difference total apps lines however commensurate elevation beta secretase generated c terminal fragments brain line r140 observed elevated levels accumulated apps fig 3 c lane 4 extended analysis examine levels alpha secretase generated soluble derivatives lines j196 py89 expressing essentially identical levels mutant wt human app respectively western blot analysis soluble fractions s2 brains revealed 50 decrease steady state levels alpha secretase generated human apps derivatives j196 line relative line py89 fig 4 despite demonstration total levels apps appeared unchanged mutant wt transgenic lines fig 3 c
0.35055456.9285791.html.plaintext.txt	28	figure 4 levels alpha secretase cleaved app mutant app yac transgenic mouse brain soluble s2 fraction extracts brains 4 month old control ctl lanes 7 8 wild type wt line py89 lanes 4 5 mutant line j196 containing appk670nm671 appv717i mutations lanes 6 9 app yac transgenic mice 5 alpha secretase cleaved app standards lanes 1 3 subjected western blot analysis parallel blots visualized antibody 6e10 recognizing alpha secretase cleaved human app 32 horseradish peroxidase tagged antibody data shown full length app blots quantified 125i labeled protein revealed 40 50 reduction alpha secretase cleaved products mutant line j196 relative wt normalized full length app signal right shown approximate sizes molecular weight markers kda
0.35055456.9285791.html.plaintext.txt	29	although decreased alpha secretase processing mutantappk670nm671l appears surprising data fully consistent earlier cellular transfection studies documented one effect appk670nm671l mutation enhance cleavage beta secretase site golgi compartment 17 result fraction app molecules would normally cleared alpha secretase plasma membrane would effectively disabled prior action beta secretase hence medium cells expressing appk670nm671l level alpha secretase derivatives considerably diminished relative medium cells expressing similar levels wt app abeta production mutant app yac transgenic mice
0.35055456.9285791.html.plaintext.txt	30	although decreased alpha secretase processing mutantappk670nm671l appears surprising data fully consistent earlier cellular transfection studies documented one effect appk670nm671l mutation enhance cleavage beta secretase site golgi compartment 17 result fraction app molecules would normally cleared alpha secretase plasma membrane would effectively disabled prior action beta secretase hence medium cells expressing appk670nm671l level alpha secretase derivatives considerably diminished relative medium cells expressing similar levels wt app abeta production mutant app yac transgenic mice
0.35055456.9285791.html.plaintext.txt	31	levels abeta quantified using sandwich enzyme linked immunosorbent assays elisas 20 analysis brain homogenates demonstrated increase amount total soluble abeta proportion longer abeta1 4243 mutant app j196 line compared wt app line py89 fig 5 abetax 4243 40 total abeta line j196 compared 20 line py89 moreover dramatic increase total abeta abeta1 4243 species observed line r140 preliminary studies 35smethionine labeled primary cortical neuronal cultures immunoprecipitation abeta conditioned medium revealed substantial increase abeta mutant app line j196 relative wt app line py89 control cultures data shown vivo results similar obtained cell culture experiments human plasma suggest effect appk670nm671l fad mutation enhance beta secretase cleavage resulting increased production secretion abeta appv717i mutation appears influence processing gamma secretase site manner elevates levels secreted abeta1 4243
0.35055456.9285791.html.plaintext.txt	32	levels abeta quantified using sandwich enzyme linked immunosorbent assays elisas 20 analysis brain homogenates demonstrated increase amount total soluble abeta proportion longer abeta1 4243 mutant app j196 line compared wt app line py89 fig 5 abetax 4243 40 total abeta line j196 compared 20 line py89 moreover dramatic increase total abeta abeta1 4243 species observed line r140 preliminary studies 35smethionine labeled primary cortical neuronal cultures immunoprecipitation abeta conditioned medium revealed substantial increase abeta mutant app line j196 relative wt app line py89 control cultures data shown vivo results similar obtained cell culture experiments human plasma suggest effect appk670nm671l fad mutation enhance beta secretase cleavage resulting increased production secretion abeta appv717i mutation appears influence processing gamma secretase site manner elevates levels secreted abeta1 4243
0.35055456.9285791.html.plaintext.txt	33	figure 5 levels various abeta peptides app yac transgenic mouse brain brain extracts 3 month old control wild type wt line py89 mutant line j196 containing appk670nm671 appv717i mutations line r140 containing appk670nm671 mutation app yac transgenic mice 5 subjected sensitive sandwich elisa detects various abeta peptides shown total abeta abetax 4243 levels expressed pmolg relative control standardized peptides discussion
0.35055456.9285791.html.plaintext.txt	34	abeta principal component parenchymal amyloid deposits ad derived integral membrane glycoprotein app several mutations identified app gene co segregate affected individuals fad pedigrees reviewed 1 although multiple app transgenic mice generated attempts develop animal models ad reviewed 25 see also 26 28 molecular mechanisms involved altered app metabolism abeta deposition individuals fad linked mutations app fully clarified present report provides insight theeffects appk670nm671l appv717i fad mutations app metabolism abeta production vivo setting mimics conditions occurring individuals fad mutations generated lines transgenic mice contain entire human app gene carried 650 kbp yac theappk670nm671l mutation appv717i mutation mutations together mice mutant human app transcripts proteins expressed spatial temporal patterns similar endogenous mouse products brain peripheral tissues western blot analysis sensitive elisas whole brain homogenates demonstrated mice expressing appk670nm671l cell associated c terminal app fragments containing abeta domain abeta peptides elevated concomitant reduction levels release alpha secretase cleaved app products mice expressing appv717i hand accumulated elevated levels longer abeta1 4243 species brain
0.35055456.9285791.html.plaintext.txt	35	abeta principal component parenchymal amyloid deposits ad derived integral membrane glycoprotein app several mutations identified app gene co segregate affected individuals fad pedigrees reviewed 1 although multiple app transgenic mice generated attempts develop animal models ad reviewed 25 see also 26 28 molecular mechanisms involved altered app metabolism abeta deposition individuals fad linked mutations app fully clarified present report provides insight theeffects appk670nm671l appv717i fad mutations app metabolism abeta production vivo setting mimics conditions occurring individuals fad mutations generated lines transgenic mice contain entire human app gene carried 650 kbp yac theappk670nm671l mutation appv717i mutation mutations together mice mutant human app transcripts proteins expressed spatial temporal patterns similar endogenous mouse products brain peripheral tissues western blot analysis sensitive elisas whole brain homogenates demonstrated mice expressing appk670nm671l cell associated c terminal app fragments containing abeta domain abeta peptides elevated concomitant reduction levels release alpha secretase cleaved app products mice expressing appv717i hand accumulated elevated levels longer abeta1 4243 species brain
0.35055456.9285791.html.plaintext.txt	36	one additional consideration yac transgenic experiments presence additional genes carried app yac might alter effect fad mutations expressed dosage imbalance initial experiments exon trapping 650 kbp app yac revealed presence five additional exons encode app jjyeh btlamb jdgearhart unpublished observations four theses exons reveal substantial identity sequences database one trapped exon 103 nt revealed complete identity bp 167 269 exon 2 amino acid residues 1 25 human transcription factor gabpa e4tf1 60 gene genbank accession d13318 consistent localization gene chromosome 21q212 31 32 transcription factor contains ets related dna binding domain binds dna cggaaag sequences forms heterodimers polypeptides 33 although remains unclear whether entire gabpa gene present 650 kbp app yac biochemical abnormalities observed mutant app yac transgenic mice likely reflect property unique mutant app polypeptide dosage imbalance gabpa generated wt mutant app yac transgenic mice express app similar level ie wt line py89 mutant line j196
0.35055456.9285791.html.plaintext.txt	37	one additional consideration yac transgenic experiments presence additional genes carried app yac might alter effect fad mutations expressed dosage imbalance initial experiments exon trapping 650 kbp app yac revealed presence five additional exons encode app jjyeh btlamb jdgearhart unpublished observations four theses exons reveal substantial identity sequences database one trapped exon 103 nt revealed complete identity bp 167 269 exon 2 amino acid residues 1 25 human transcription factor gabpa e4tf1 60 gene genbank accession d13318 consistent localization gene chromosome 21q212 31 32 transcription factor contains ets related dna binding domain binds dna cggaaag sequences forms heterodimers polypeptides 33 although remains unclear whether entire gabpa gene present 650 kbp app yac biochemical abnormalities observed mutant app yac transgenic mice likely reflect property unique mutant app polypeptide dosage imbalance gabpa generated wt mutant app yac transgenic mice express app similar level ie wt line py89 mutant line j196
0.35055456.9285791.html.plaintext.txt	38	summary results suggest vivo fad mutations influence app processing manner leading increased levels highly amyloidogenic peptide abeta1 4243 mice expressing appk670nm671 accumulate increased levels abeta peptides mice expressing appv717i selectively accumulate elevated levels abeta1 4243 view vitro aggregation immunocytochemical studies suggested abeta1 4243 highly amyloidogenic deposited early disease process enthusiastic app yac mice described herein develop amyloid deposits associated lesions described mice expressing fad linked app transgenes 26 28 addition yac transgenic mice allow accurate examination effects fad mutations app processing variety cell types neurons astrocytes glia blood vessels etc well alterations neuronal physiology behavior throughout aging finally results suggest yac transgenic strategy allow stringent testing roles early onset presenilin fad mutations amyloidogenesis examine potential interactive effects different early onset fad gene mutations materials methods yac manipulations
0.35055456.9285791.html.plaintext.txt	39	summary results suggest vivo fad mutations influence app processing manner leading increased levels highly amyloidogenic peptide abeta1 4243 mice expressing appk670nm671 accumulate increased levels abeta peptides mice expressing appv717i selectively accumulate elevated levels abeta1 4243 view vitro aggregation immunocytochemical studies suggested abeta1 4243 highly amyloidogenic deposited early disease process enthusiastic app yac mice described herein develop amyloid deposits associated lesions described mice expressing fad linked app transgenes 26 28 addition yac transgenic mice allow accurate examination effects fad mutations app processing variety cell types neurons astrocytes glia blood vessels etc well alterations neuronal physiology behavior throughout aging finally results suggest yac transgenic strategy allow stringent testing roles early onset presenilin fad mutations amyloidogenesis examine potential interactive effects different early onset fad gene mutations materials methods yac manipulations
0.35055456.9285791.html.plaintext.txt	40	human app genomic sub library constructed pulsed field gel electrophoresis fractionation isolation 650 kbp app yac followed digestion saci ligation saci digested lambda phage zapii stratagene exon 16 17 app genomic clones isolated screening sub library 229 bp exon 16 9 319 bp exon 17 product 13 yielding 42 35 kbp genomic clones respectively clones converted plasmids restriction maps generated 18 kbp hindiii fragment containing exon 16 3 kbp ecori fragment containing exon 17 subcloned bluescript stratagene appk670nm671 appv717i mutations introduced exon 16 17 genomic subclones respectively pcr mutagenesis primary pcr performed internal mutagenic primers 5 gagatctctgaagtgaatctggatgcagaattccgac 3 complement appk670nm671 mutation 5 ggacagtgatcatcatcaccttg 3 complement appv717i mutation along external vector primers secondary pcr performed external primers alone products subcloned yeast recombination plasmid p680 provided phieter johns hopkins medical institutions presence mutations confirmed dna sequencing acci site upstream exon 17 genomic clone converted stui site addition linkers
0.35055456.9285791.html.plaintext.txt	41	human app genomic sub library constructed pulsed field gel electrophoresis fractionation isolation 650 kbp app yac followed digestion saci ligation saci digested lambda phage zapii stratagene exon 16 17 app genomic clones isolated screening sub library 229 bp exon 16 9 319 bp exon 17 product 13 yielding 42 35 kbp genomic clones respectively clones converted plasmids restriction maps generated 18 kbp hindiii fragment containing exon 16 3 kbp ecori fragment containing exon 17 subcloned bluescript stratagene appk670nm671 appv717i mutations introduced exon 16 17 genomic subclones respectively pcr mutagenesis primary pcr performed internal mutagenic primers 5 gagatctctgaagtgaatctggatgcagaattccgac 3 complement appk670nm671 mutation 5 ggacagtgatcatcatcaccttg 3 complement appv717i mutation along external vector primers secondary pcr performed external primers alone products subcloned yeast recombination plasmid p680 provided phieter johns hopkins medical institutions presence mutations confirmed dna sequencing acci site upstream exon 17 genomic clone converted stui site addition linkers
0.35055456.9285791.html.plaintext.txt	42	plasmids containing mutagenized sequences linearized stui cuts upstream exon 16 17 introduced wt app yac two step gene replacement yeast described 30 presence mutations determined restriction digestion exon specific pcr products confirmed dna sequencing southern blot analysis mutated yac dna purified essentially described 5 second dimension electrophoresis step 4 nu sieve low melting point agarose fmc concentrate yac dna 34 cell culture blastocyst injections
0.35055456.9285791.html.plaintext.txt	43	plasmids containing mutagenized sequences linearized stui cuts upstream exon 16 17 introduced wt app yac two step gene replacement yeast described 30 presence mutations determined restriction digestion exon specific pcr products confirmed dna sequencing southern blot analysis mutated yac dna purified essentially described 5 second dimension electrophoresis step 4 nu sieve low melting point agarose fmc concentrate yac dna 34 cell culture blastocyst injections
0.35055456.9285791.html.plaintext.txt	44	j1 kindly provided rjaenisch whitehead institute r1 kindly provided jrossant university toronto es cells maintained standard techniques grown mitotically inactivated neor primary embryonic fibroblasts presence leukemia inhibitory factor transfection 1 ml isolated yac dna gently mixed 50 mug lipofectin brl polystyrene tubes allowed complex 45 min room temperature lipid dna complexes added 5 106 es cells resuspended 9 ml optimem brl placed 10 cm bacterial dishes incubated 4 h 37oc plated onto 10 cm tissue culture dishes feeders g418 250 mugml selection initiated following day continued 11 days injection dissociated es cells c57bl6j blastocysts matings resultant chimeras carried essentially described 35 genomic dna isolated es cells mouse tails analyzed pcr southern blot variety probes previously described 5 rna protein analysis
0.35055456.9285791.html.plaintext.txt	45	rna isolated es cells mouse tissues rt pcr performed first six exons across alternatively spliced exons mousehuman app described previously 5 protein extracts immunoblots prepared described 17 36 sandwich elisas specific abeta1 40 versus abeta1 4243 performed described 20 acknowledgements
0.35055456.9285791.html.plaintext.txt	46	rna isolated es cells mouse tissues rt pcr performed first six exons across alternatively spliced exons mousehuman app described previously 5 protein extracts immunoblots prepared described 17 36 sandwich elisas specific abeta1 40 versus abeta1 4243 performed described 20 acknowledgements
0.35055456.9285791.html.plaintext.txt	47	abeta beta amyloid abeta1 4243 abeta extending residue 42 43 ad alzheimers disease app amyloid precursor protein apps soluble app derivatives appk670nm671l app asparagine lysine leucine methionine substitution codons 670671 appv717i app isoleucine valine substitution codon 717 es embryonic stem fad familial alzheimers disease wt wild type yac yeast artificial chromosome references 1 tanzire kovacsdm kimt w moirrd guenettesy wascow 1996 gene defects responsible familial alzheimers disease neurobiol dis 3 159 168
0.35055456.9285791.html.plaintext.txt	48	35 bradleya 1987 production analysis chimeric mice robertsonej ed teratocarcinomas embryonic stem cells practical approach irl press oxford uk pp 113 151
0.35055456.9285791.html.plaintext.txt	49	correspondence addressed tel 1 216 368 2979 fax 1 216 368 3432 email btlpocwruedu
0.35055456.9285791.html.plaintext.txt	50	correspondence addressed tel 1 216 368 2979 fax 1 216 368 3432 email btlpocwruedu
0.35055456.9285791.html.plaintext.txt	51	page maintained oup admin last updated wed aug 13 155216 bst 1997 part oup journals world wide web service copyright oxford university press 1996
0.35055456.9285791.html.plaintext.txt	52	page maintained oup admin last updated wed aug 13 155216 bst 1997 part oup journals world wide web service copyright oxford university press 1996
0.3514349.9575200.html.plaintext.txt	0	subcellular distribution turnover presenilins transfected cells jimin zhang david e kang weiming xia masayasu okochi hiroshi mori dennis j selkoe edward h koo
0.3514349.9575200.html.plaintext.txt	1	subcellular distribution turnover presenilins transfected cells jimin zhang david e kang weiming xia masayasu okochi hiroshi mori dennis j selkoe edward h koo
0.3514349.9575200.html.plaintext.txt	2	departments neurology pathology harvard medical school center neurologic diseases brigham womens hospital boston massachusetts 02115 department neurosciences university california san diego la jolla california 92093 department molecular biology tokyo institute psychiatry tokyo 156 japan
0.3514349.9575200.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.3514349.9575200.html.plaintext.txt	4	mechanisms mutations presenilin 1 ps1 presenilin 2 ps2 result alzheimers disease phenotype unclear full length ps1 ps2 processed stable proteolytic fragments biosynthesis transfected cells ps1 ps2 localized immunocytochemistry endoplasmic reticulum er golgi compartments previous studies could differentiate full length presenilin proteins fragments carried subcellular fractionation cells stably transfected ps1 ps2 determine localization full length presenilins fragments full length ps1 ps2 principally distributed er fractions whereas n c terminal fragments localized predominantly golgi fractions cells expressing ps1 mutant lacking exon 9 e9 observed full length molecules present er golgi fractions turnover rate considerably slower e9 holoprotein apparently due decreased degradation within er results suggest full length presenilin proteins primarily er resident molecules undergo endoproteolysis within er fragments subsequently transported golgi compartment turnover rate much slower full length presenilin er
0.3514349.9575200.html.plaintext.txt	5	mechanisms mutations presenilin 1 ps1 presenilin 2 ps2 result alzheimers disease phenotype unclear full length ps1 ps2 processed stable proteolytic fragments biosynthesis transfected cells ps1 ps2 localized immunocytochemistry endoplasmic reticulum er golgi compartments previous studies could differentiate full length presenilin proteins fragments carried subcellular fractionation cells stably transfected ps1 ps2 determine localization full length presenilins fragments full length ps1 ps2 principally distributed er fractions whereas n c terminal fragments localized predominantly golgi fractions cells expressing ps1 mutant lacking exon 9 e9 observed full length molecules present er golgi fractions turnover rate considerably slower e9 holoprotein apparently due decreased degradation within er results suggest full length presenilin proteins primarily er resident molecules undergo endoproteolysis within er fragments subsequently transported golgi compartment turnover rate much slower full length presenilin er
0.3514349.9575200.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references
0.3514349.9575200.html.plaintext.txt	7	alzheimers disease ad1 major age related dementing disorder usually occurs sporadically elderly population subset cases familial ad fad occurs inherited autosomal dominant disease mutations three different genes associated familial form ad reviewed ref 1 first fad gene amyloid precursor protein app precursor amyloid protein major component senile plaques seen brains ad individuals genes presenilin 1 ps1 chromosome 14 2 presenilin 2 ps2 chromosome 1 3 4 account majority early onset cases fad
0.3514349.9575200.html.plaintext.txt	8	alzheimers disease ad1 major age related dementing disorder usually occurs sporadically elderly population subset cases familial ad fad occurs inherited autosomal dominant disease mutations three different genes associated familial form ad reviewed ref 1 first fad gene amyloid precursor protein app precursor amyloid protein major component senile plaques seen brains ad individuals genes presenilin 1 ps1 chromosome 14 2 presenilin 2 ps2 chromosome 1 3 4 account majority early onset cases fad
0.3514349.9575200.html.plaintext.txt	9	ps1 ps2 functionally homologous c elegans sel 12 molecule 5 6 hydrophobic proteins cross membrane 6 8 times 7 8 transfected cells ps1 ps2 holoprotein rapidly turned half life 1 h 9 10 however transfected cells brain tissue stable n ntf c terminal fragments ctf apparently generated endoproteolysis full length presenilin molecules 9 11 12 immunolocalization studies presenilins transfected cells demonstrated predominant endoplasmic reticulum er golgi distribution 13 14 localization pattern similar regardless whether antibodies generated either n c terminal epitopes raising possibility ntfs ctfs remain proximity however studies cannot distinguish full length presenilin molecules stable fragments app also located er golgi direct indirect interaction presenilins may contribute production longer forms amyloid peptide 15 17 thus knowledge processing trafficking presenilin molecules important understanding pathways production
0.3514349.9575200.html.plaintext.txt	10	ps1 ps2 functionally homologous c elegans sel 12 molecule 5 6 hydrophobic proteins cross membrane 6 8 times 7 8 transfected cells ps1 ps2 holoprotein rapidly turned half life 1 h 9 10 however transfected cells brain tissue stable n ntf c terminal fragments ctf apparently generated endoproteolysis full length presenilin molecules 9 11 12 immunolocalization studies presenilins transfected cells demonstrated predominant endoplasmic reticulum er golgi distribution 13 14 localization pattern similar regardless whether antibodies generated either n c terminal epitopes raising possibility ntfs ctfs remain proximity however studies cannot distinguish full length presenilin molecules stable fragments app also located er golgi direct indirect interaction presenilins may contribute production longer forms amyloid peptide 15 17 thus knowledge processing trafficking presenilin molecules important understanding pathways production
0.3514349.9575200.html.plaintext.txt	11	role endoproteolysis presenilin maturation function remains defined interestingly ps1 fad mutation lacking exon 9 e9 results absence conventional endoproteolysis 12 nevertheless functionally replace egg laying defect resulting c elegans sel 12 mutant 5 date neither subcellular distribution holoprotein fragments compartment endoproteolytic cleavage occurs known define distribution full length forms stable fragments ps1 ps2 carried subcellular fractionation stably transfected cells results indicate full length ps1 ps2 located mainly er n c terminal fragments located principally golgi turnover rate e9 mutant ps1 protein slower wild type wt ps1 holoprotein concomitantly steady state subcellular distribution e9 ps1 extends er golgi fractions finally pulse chase experiments combined subcellular fractionation suggested endoproteolytic cleavage ps1 takes place er
0.3514349.9575200.html.plaintext.txt	12	role endoproteolysis presenilin maturation function remains defined interestingly ps1 fad mutation lacking exon 9 e9 results absence conventional endoproteolysis 12 nevertheless functionally replace egg laying defect resulting c elegans sel 12 mutant 5 date neither subcellular distribution holoprotein fragments compartment endoproteolytic cleavage occurs known define distribution full length forms stable fragments ps1 ps2 carried subcellular fractionation stably transfected cells results indicate full length ps1 ps2 located mainly er n c terminal fragments located principally golgi turnover rate e9 mutant ps1 protein slower wild type wt ps1 holoprotein concomitantly steady state subcellular distribution e9 ps1 extends er golgi fractions finally pulse chase experiments combined subcellular fractionation suggested endoproteolytic cleavage ps1 takes place er
0.3514349.9575200.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references
0.3514349.9575200.html.plaintext.txt	14	ps1 ps2 stably transfected cells chinese hamster ovary cho cells stably transfected wt mutant m146l c410y ps1 wt mutant n141i ps2 described previously 10 17 cdnas encoding wt e9 ps1 subcloned ecdysone inducible mammalian expression vector pind invitrogen transfected human embryonic kidney 293 cells previously transfected pvgrxr construct encodes regulatory ecdysone receptor ecr293 invitrogen stable cell lines selected zeocin g418 resistance ps1 expression induced overnight treatment 00625 10 microm muristerone
0.3514349.9575200.html.plaintext.txt	15	ps1 ps2 stably transfected cells chinese hamster ovary cho cells stably transfected wt mutant m146l c410y ps1 wt mutant n141i ps2 described previously 10 17 cdnas encoding wt e9 ps1 subcloned ecdysone inducible mammalian expression vector pind invitrogen transfected human embryonic kidney 293 cells previously transfected pvgrxr construct encodes regulatory ecdysone receptor ecr293 invitrogen stable cell lines selected zeocin g418 resistance ps1 expression induced overnight treatment 00625 10 microm muristerone
0.3514349.9575200.html.plaintext.txt	16	antibodies ps1 polyclonal antibodies j27 4627 raised residues 27 42 457 467 ps1 respectively previously characterized 9 10 ps1 monoclonal antibody psn2 generated synthetic peptide corresponding residues 31 56 ps1 18 ps2 polyclonal antibody 1209 raised glutathione transferase bacterial fusion protein encompassing residues 1 70 ps2 polyclonal antibody ct15 raised last 15 residues c terminus app 19 additional polyclonal antibodies included calnexin stressgen rat nak atpase upstate biotechnology inc lake placid ny plus monoclonal antibody nak atpase america bioresearch co
0.3514349.9575200.html.plaintext.txt	17	antibodies ps1 polyclonal antibodies j27 4627 raised residues 27 42 457 467 ps1 respectively previously characterized 9 10 ps1 monoclonal antibody psn2 generated synthetic peptide corresponding residues 31 56 ps1 18 ps2 polyclonal antibody 1209 raised glutathione transferase bacterial fusion protein encompassing residues 1 70 ps2 polyclonal antibody ct15 raised last 15 residues c terminus app 19 additional polyclonal antibodies included calnexin stressgen rat nak atpase upstate biotechnology inc lake placid ny plus monoclonal antibody nak atpase america bioresearch co
0.3514349.9575200.html.plaintext.txt	18	pulse chase experiments confluent cho 293 cells incubated methionine deficient medium 1 h followed pulse labeling 200 microciml 35smethionine 20 min cells either lysed immediately chased regular medium 1 8 h cells collected fractionated described
0.3514349.9575200.html.plaintext.txt	19	pulse chase experiments confluent cho 293 cells incubated methionine deficient medium 1 h followed pulse labeling 200 microciml 35smethionine 20 min cells either lysed immediately chased regular medium 1 8 h cells collected fractionated described
0.3514349.9575200.html.plaintext.txt	20	subcellular fractionation cultured cho 293 cells detached confluent cultures grown 15 cm dishes 20 mm edta ice cold phosphate buffered saline cells pelleted resuspended homogenization buffer 10 mm hepes ph 74 1 mm edta 0 25 m sucrose supplemented protease inhibitor mixture cells disrupted using 10 strokes dounce homogenizer followed four passages 25 gauge needle nuclei unbroken cells pelleted centrifugation 3000 x g 10 min pellets resuspended 15 ml homogenization buffer centrifuged 3000 x g 10 min postnuclear supernatants centrifugation steps combined centrifuged 80000 x g 1 h vesicle pellet resuspended 08 ml homogenization buffer operations carried 4 degrees c cell line analyzed 2 5 times representative experiments shown results
0.3514349.9575200.html.plaintext.txt	21	subcellular fractionation cultured cho 293 cells detached confluent cultures grown 15 cm dishes 20 mm edta ice cold phosphate buffered saline cells pelleted resuspended homogenization buffer 10 mm hepes ph 74 1 mm edta 0 25 m sucrose supplemented protease inhibitor mixture cells disrupted using 10 strokes dounce homogenizer followed four passages 25 gauge needle nuclei unbroken cells pelleted centrifugation 3000 x g 10 min pellets resuspended 15 ml homogenization buffer centrifuged 3000 x g 10 min postnuclear supernatants centrifugation steps combined centrifuged 80000 x g 1 h vesicle pellet resuspended 08 ml homogenization buffer operations carried 4 degrees c cell line analyzed 2 5 times representative experiments shown results
0.3514349.9575200.html.plaintext.txt	22	viscosity gradient medium major determinant sedimentation rate addition subcellular organelles osmotically sensitive osmotic activity gradient medium particularly important thus although sucrose glycerol ficoll widely used gradient fractionation cellular membranes ideal osmolality viscosity optiprep 60 wv life technologies inc ready made solution iodixanol 55 2 hydroxy 1 3 propanediyl bisacetylamino bisnn bis23 dihydroxypropyl 246 triiodo 13 benzenecarboxamide advantage using iodixanol gradient osmolality viscosity remain relatively constant changes density gradient mild iso osmotic condition organelles endosomes isolated intact without loss water density gradient increases gradient stock solution 50 iodixanol prepared diluting 025 m sucrose 6 mm edta 60 mm hepes ph 74 51 ratio linear gradients 1 20 iodixanol formed using gradient maker resuspended vesicle preparations loaded top gradient centrifuged beckman sw41 rotor 200000 x g 3 h 4 degrees c sequential 1 ml fractions collected bottom gradient subcellular markers calnexin galactosyltransferase nak atpase analyzed gradient preparation
0.3514349.9575200.html.plaintext.txt	23	viscosity gradient medium major determinant sedimentation rate addition subcellular organelles osmotically sensitive osmotic activity gradient medium particularly important thus although sucrose glycerol ficoll widely used gradient fractionation cellular membranes ideal osmolality viscosity optiprep 60 wv life technologies inc ready made solution iodixanol 55 2 hydroxy 1 3 propanediyl bisacetylamino bisnn bis23 dihydroxypropyl 246 triiodo 13 benzenecarboxamide advantage using iodixanol gradient osmolality viscosity remain relatively constant changes density gradient mild iso osmotic condition organelles endosomes isolated intact without loss water density gradient increases gradient stock solution 50 iodixanol prepared diluting 025 m sucrose 6 mm edta 60 mm hepes ph 74 51 ratio linear gradients 1 20 iodixanol formed using gradient maker resuspended vesicle preparations loaded top gradient centrifuged beckman sw41 rotor 200000 x g 3 h 4 degrees c sequential 1 ml fractions collected bottom gradient subcellular markers calnexin galactosyltransferase nak atpase analyzed gradient preparation
0.3514349.9575200.html.plaintext.txt	24	immunoprecipitation western blotting subcellular fractions collected linear iodixanol gradients lysed addition nonidet p 40 final concentration 1 immunoprecipitations whole cell lysates iodixanol gradient fractions performed described previously 10 resultant immunoprecipitates resuspended laemmli sample buffer separated 8 16 sds polyacrylamide gel electrophoresis transferred either polyvinylidene difluoride supported nitrocellulose membranes samples pulse chase experiments transferred membranes following fractionation quantitated directly phosphor imaging western blotting carried antibodies indicated experiment primary antibodies visualized either 125i conjugated secondary antibody peroxidase conjugated secondary antibody detected super signal enhanced chemiluminescence pierce signals quantitated phosphor imaging densitometry respectively
0.3514349.9575200.html.plaintext.txt	25	immunoprecipitation western blotting subcellular fractions collected linear iodixanol gradients lysed addition nonidet p 40 final concentration 1 immunoprecipitations whole cell lysates iodixanol gradient fractions performed described previously 10 resultant immunoprecipitates resuspended laemmli sample buffer separated 8 16 sds polyacrylamide gel electrophoresis transferred either polyvinylidene difluoride supported nitrocellulose membranes samples pulse chase experiments transferred membranes following fractionation quantitated directly phosphor imaging western blotting carried antibodies indicated experiment primary antibodies visualized either 125i conjugated secondary antibody peroxidase conjugated secondary antibody detected super signal enhanced chemiluminescence pierce signals quantitated phosphor imaging densitometry respectively
0.3514349.9575200.html.plaintext.txt	26	galactosyltransferase assay 14 galactosyltransferase assay performed iodixanol fractions according method bretz staubli 20 addition 3hgalactose onto oligosaccharides acceptor protein ovomucoid measured
0.3514349.9575200.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references
0.3514349.9575200.html.plaintext.txt	28	subcellular fractionation iodixanol gradient cho cells stably transfected ps1 wt m146l c410y ps2 wt n141i 293 cells stably transfected ps1 wt e9 ecdysone inducible system analyzed subcellular fractionation subcellular vesicles separated 1 20 continuous iodixanol gradients described materials methods er rich fractions found expected bottom gradient using antibody well characterized er marker protein calnexin 21 fig 1 b calnexin reactive er vesicles enriched fractions 1 4 golgi containing fractions identified assaying 14 galactosyltransferase trans golgi enzyme 20 principally found fractions 4 7 fig 1 b immunoreactivity nak atpase marker plasma membrane found top gradient ie fractions 9 12 although lesser amounts immunoreactivity also present mid density region fractions 5 8 shown latter reactivity derived molecules transiting golgi additional marker cho cells stably expressing wt app751 fractionated analyzed blotting antibody ct15 c terminus app expected immature primarily n glycosylated forms app appeared er rich fractions fractions 1 4 fig 1c whereas mature n plus o glycosylated forms app appeared golgi rich fractions 4 7 data indicate er golgi plasma membrane fractions effectively separated 1 20 iodixanol gradients
0.3514349.9575200.html.plaintext.txt	29	subcellular fractionation iodixanol gradient cho cells stably transfected ps1 wt m146l c410y ps2 wt n141i 293 cells stably transfected ps1 wt e9 ecdysone inducible system analyzed subcellular fractionation subcellular vesicles separated 1 20 continuous iodixanol gradients described materials methods er rich fractions found expected bottom gradient using antibody well characterized er marker protein calnexin 21 fig 1 b calnexin reactive er vesicles enriched fractions 1 4 golgi containing fractions identified assaying 14 galactosyltransferase trans golgi enzyme 20 principally found fractions 4 7 fig 1 b immunoreactivity nak atpase marker plasma membrane found top gradient ie fractions 9 12 although lesser amounts immunoreactivity also present mid density region fractions 5 8 shown latter reactivity derived molecules transiting golgi additional marker cho cells stably expressing wt app751 fractionated analyzed blotting antibody ct15 c terminus app expected immature primarily n glycosylated forms app appeared er rich fractions fractions 1 4 fig 1c whereas mature n plus o glycosylated forms app appeared golgi rich fractions 4 7 data indicate er golgi plasma membrane fractions effectively separated 1 20 iodixanol gradients
0.3514349.9575200.html.plaintext.txt	30	view larger version 25k fig 1 distribution major subcellular markers app continuous 1 20 iodixanol gradients representative results subcellular fractionation cho cells 293 cells b shown distribution calnexin determined immunoblotting distribution 14 galactosyltransferase determined enzyme activity assay results expressed percentages respective signals fraction sum fractions er marker calnexin primarily located fractions 1 4 golgi marker galactosyltransferase distributed mainly fractions 4 8 c subcellular distribution app determined cho cells stably transfected app751 following fractionation sds polyacrylamide gel electrophoresis samples immunoblotted app c terminal antibody ct15 immature app isoforms present er rich fractions 1 4 whereas mature forms app appeared primarily golgi rich fractions 4 7
0.3514349.9575200.html.plaintext.txt	31	subcellular distribution ps1 ps2 determine distribution ps1 performed western blot analysis gradient fractions ps1 stably transfected cho cells antibody j27 raised n terminus ps1 recognized 45 kda ps1 holoprotein derived transgene mainly gradient fractions 1 4 co localized er marker calnexin fig 2 b contrast major n terminal endoproteolytic fragment 29 kda consistently localized lighter fractions toward middle gradient principally fractions 4 7 fig 2 b similarly major c terminal fragment 18 kda distributed fractions 3 8 fig 2 c d ps1 ntf ctf colocalized golgi marker 14 galactosyl transferase fractionation stable transfectants expressing ps1 missense mutations m146l c410y showed significant differences wt ps1 subcellular distribution holoprotein n c terminal fragments shown
0.3514349.9575200.html.plaintext.txt	32	subcellular distribution ps1 ps2 determine distribution ps1 performed western blot analysis gradient fractions ps1 stably transfected cho cells antibody j27 raised n terminus ps1 recognized 45 kda ps1 holoprotein derived transgene mainly gradient fractions 1 4 co localized er marker calnexin fig 2 b contrast major n terminal endoproteolytic fragment 29 kda consistently localized lighter fractions toward middle gradient principally fractions 4 7 fig 2 b similarly major c terminal fragment 18 kda distributed fractions 3 8 fig 2 c d ps1 ntf ctf colocalized golgi marker 14 galactosyl transferase fractionation stable transfectants expressing ps1 missense mutations m146l c410y showed significant differences wt ps1 subcellular distribution holoprotein n c terminal fragments shown
0.3514349.9575200.html.plaintext.txt	33	view larger version 23k fig 2 subcellular distribution ps1 stably transfected cho cells representative experiment fractions immunoblotted either n terminal antibody j27 b c terminal antibody 4627 c d signal full length ps1 ntf ctf fraction expressed percentage sum fractions b d ps1 holoprotein found mainly gradient fractions 1 4 co localized er marker calnexin 29 kda major ntf located principally fractions 4 7 similarly 18 kda major ctf distributed fractions 3 8 ntf ctf colocalized golgi marker 14 galactosyltransferase respective experiments
0.3514349.9575200.html.plaintext.txt	34	next examined cho cells stably transfected ps2 cdna using gradient fractionation blotting ps2 n terminal antibody antibody 1209 full length ps2 molecules detected characteristic 50 kda band principally er rich fractions 3 4 fig 3 b whereas n terminal fragment localized primarily golgi rich fractions 5 8 moreover seen ps1 mutations distribution n141i mutant form ps2 identical wt ps2 data shown therefore subcellular distribution ps2 proteolytic fragment similar obtained ps1 fragments
0.3514349.9575200.html.plaintext.txt	35	next examined cho cells stably transfected ps2 cdna using gradient fractionation blotting ps2 n terminal antibody antibody 1209 full length ps2 molecules detected characteristic 50 kda band principally er rich fractions 3 4 fig 3 b whereas n terminal fragment localized primarily golgi rich fractions 5 8 moreover seen ps1 mutations distribution n141i mutant form ps2 identical wt ps2 data shown therefore subcellular distribution ps2 proteolytic fragment similar obtained ps1 fragments
0.3514349.9575200.html.plaintext.txt	36	view larger version 43k fig 3 subcellular distribution ps2 cho cells expressing wt ps2 fractionated iodixanol gradients immunoblotted ps2 n terminal antibody 1509 signal full length ps2 ntf fraction expressed percentage sum fractions b similar ps1 50 kda full length ps2 molecules found principally er fractions 3 5 whereas 33 kda major ntf localized primarily golgi fractions 5 8
0.3514349.9575200.html.plaintext.txt	37	293 cells expressing wt ps1 showed pattern distribution holoprotein stable fragments similar seen cho transfected cells although tendency golgi fractions distributed larger number lighter fractions however e9 mutant protein undergo conventional endoproteolytic cleavage 12 widely distributed throughout gradient fractions fig 4 b extension e9 ps1 lighter golgi fractions result overexpression result seen muristerone reduced cell line match level expression seen wt ps1 transfected 293 cells fig 4 b expected observed conventional proteolytic fragments e9 ps1 protein furthermore reported 22 level n terminal fragment derived endogenous ps1 decreased e9 ps1 expression increased higher muristerone induction fig 4a distribution ntf wt ps1 e9 transfected cell lines latter without induction identical case latter cells ntf derived endogenous ps1 therefore subcellular distribution transgene derived ps1 fragments altered transfection overexpression
0.3514349.9575200.html.plaintext.txt	38	293 cells expressing wt ps1 showed pattern distribution holoprotein stable fragments similar seen cho transfected cells although tendency golgi fractions distributed larger number lighter fractions however e9 mutant protein undergo conventional endoproteolytic cleavage 12 widely distributed throughout gradient fractions fig 4 b extension e9 ps1 lighter golgi fractions result overexpression result seen muristerone reduced cell line match level expression seen wt ps1 transfected 293 cells fig 4 b expected observed conventional proteolytic fragments e9 ps1 protein furthermore reported 22 level n terminal fragment derived endogenous ps1 decreased e9 ps1 expression increased higher muristerone induction fig 4a distribution ntf wt ps1 e9 transfected cell lines latter without induction identical case latter cells ntf derived endogenous ps1 therefore subcellular distribution transgene derived ps1 fragments altered transfection overexpression
0.3514349.9575200.html.plaintext.txt	39	view larger version 28k fig 4 subcellular distribution wt e9 mutant ps1 293 cells stably expressing wt e9 ps1 induced overnight 0 1 microm muristerone followed iodixanol fractionation immunoblotting ps1 n terminal monoclonal antibody psn2 cells induced amount muristerone indicated left signals wt e9 ps1 cells induced 1 microm 0125 microm muristerone respectively quantitated fraction expressed percentage total signal mutant e9 holoprotein contrast wt ps1 extended er golgi fractions note levels ntf derived endogenous ps1 decreased e9 expression increased higher muristerone induction
0.3514349.9575200.html.plaintext.txt	40	e9 mutant ps1 longer half life reported transfected full length presenilin mainly located er shown short half life n c terminal fragments mainly located golgi shown substantially longer half life 9 22 futhermore results showed e9 protein extending er golgi rich lighter fractions distinctly different subcellular distribution compared wt ps1 holoprotein determine whether e9 mutant different turnover rate wt e9 ps1 stably transfected 293 cells pulse labeled 20 min chased 0 1 2 4 8 h half life wt ps1 1 h average approximately 50 min multiple experiments holoprotein 8 h ntf fig 5 b hand half life e9 consistently twice long wt ps1 holoprotein fig 5 b steady state conditions documented experiments described e9 protein also present golgi fractions stable proteolytic fragments derived endogenous ps1 located surprisingly distribution e9 mutant ps1 substantially altered chase period fig 5c 4 h profile e9 protein similar seen earlier time points ie predominantly er fractions whereas virtually labeled ps1 wt holoprotein remaining cell fig 5c therefore diminished degradation within er appears account large part prolonged half life e9 rather shift proteins golgi fractions turnover rate may slowed
0.3514349.9575200.html.plaintext.txt	41	e9 mutant ps1 longer half life reported transfected full length presenilin mainly located er shown short half life n c terminal fragments mainly located golgi shown substantially longer half life 9 22 futhermore results showed e9 protein extending er golgi rich lighter fractions distinctly different subcellular distribution compared wt ps1 holoprotein determine whether e9 mutant different turnover rate wt e9 ps1 stably transfected 293 cells pulse labeled 20 min chased 0 1 2 4 8 h half life wt ps1 1 h average approximately 50 min multiple experiments holoprotein 8 h ntf fig 5 b hand half life e9 consistently twice long wt ps1 holoprotein fig 5 b steady state conditions documented experiments described e9 protein also present golgi fractions stable proteolytic fragments derived endogenous ps1 located surprisingly distribution e9 mutant ps1 substantially altered chase period fig 5c 4 h profile e9 protein similar seen earlier time points ie predominantly er fractions whereas virtually labeled ps1 wt holoprotein remaining cell fig 5c therefore diminished degradation within er appears account large part prolonged half life e9 rather shift proteins golgi fractions turnover rate may slowed
0.3514349.9575200.html.plaintext.txt	42	view larger version 35k fig 5 half life wt e9 mutant ps1 overnight induction 1 microm wt ps1 0125 microm e9 muristerone cells pulse labeled chased 0 8 h aliquot cells time point lysed immunoprecipitated n terminal antibody j27 signal time point chase period shown quantitated expressed percentage time 0 b experiment half life wt ps1 e9 40 80 min respectively c immunoprecipitation j27 antibody performed fraction iodixanol separation time 0 1 4 h chase note distributions wt ps1 e9 holoprotein substantially changed 0 4 h chase gradient fractions showed longer half life e9 due primarily diminished turnover protein er fractions distribution ntf arrowhead ps1 wt cells shifted dense lighter fractions chase period top ntf derived endogenous ps1 e9 cells appear 4 h time point bottom
0.3514349.9575200.html.plaintext.txt	43	closer inspection ntf generated pulse chase period showed time 0 small amounts labeled ntf detected ps1 wt cell line fig 5c surprisingly time point distribution ntf virtually identical full length protein ie peak signal fractions 3 4 1 h chase levels labeled ntf increased distributed widely extending lighter fractions finally 4 h chase labeled ntf predominantly within golgi enriched fractions similar seen steady state conditions findings indicated initial cleavage ps1 occurred er proteolytic fragments subsequently transported golgi similar localization labeled ntf golgi fractions seen e9 cell line 4 h chase time representing fragments derived endogenous ps1 fig 5c interestingly endogenous ntf e9 cell line visible 4 h time point suggesting delay formation proteolytic species
0.3514349.9575200.html.plaintext.txt	44	discussion top abstract introduction materials methods results discussion references
0.3514349.9575200.html.plaintext.txt	45	mechanisms mutations ps1 ps2 result early onset ad phenotype unclear hypothesized selective increase production release amyloidogenic a42 result presenilin mutations key factor pathogenesis fad 10 23 26 present intracellular compartment presenilin interacts directly indirectly app unknown study analyzed subcellular distribution presenilins transfected cells results showed ps1 ps2 similarly distributed holoproteins principally located er stable ps1 ps2 fragments principally located golgi e9 ps1 mutation results broader distribution protein er golgi rich fractions well prolonged turnover rate due diminished degradation within er results also indicate endoproteolysis generate stable n c terminal fragments occurs er
0.3514349.9575200.html.plaintext.txt	46	mechanisms mutations ps1 ps2 result early onset ad phenotype unclear hypothesized selective increase production release amyloidogenic a42 result presenilin mutations key factor pathogenesis fad 10 23 26 present intracellular compartment presenilin interacts directly indirectly app unknown study analyzed subcellular distribution presenilins transfected cells results showed ps1 ps2 similarly distributed holoproteins principally located er stable ps1 ps2 fragments principally located golgi e9 ps1 mutation results broader distribution protein er golgi rich fractions well prolonged turnover rate due diminished degradation within er results also indicate endoproteolysis generate stable n c terminal fragments occurs er
0.3514349.9575200.html.plaintext.txt	47	previous immunolocalization studies transfected cells demonstrated ps1 ps2 located er golgi 13 14 studies however could distinguish signals derived full length protein versus stable ntfs ctfs therefore carried subcellular fractionations cho 293 cells stably transfected ps1 ps2 determine localization full length presenilin fragments results showed full length ps1 ps2 distributed dense fractions colocalized er marker calnexin stable ntf ctf distributed predominantly lighter fractions colocalized golgi marker galactosyltransferase activity gradient fractions er golgi fractions overlapped represent distinct populations also cannot exclude possibility organelles containing presenilins may co purify gradient fractions therefore studies determine predominant localization presenilin protein species compartments lesser amounts protein locations cannot excluded examine nuclear localization presenilins reported recently 27 nonetheless clear subcellular separation full length presenilins stable fragments noteworthy known whether normal physiological function presenilin provided full length molecules proteolytic fragments
0.3514349.9575200.html.plaintext.txt	48	previous immunolocalization studies transfected cells demonstrated ps1 ps2 located er golgi 13 14 studies however could distinguish signals derived full length protein versus stable ntfs ctfs therefore carried subcellular fractionations cho 293 cells stably transfected ps1 ps2 determine localization full length presenilin fragments results showed full length ps1 ps2 distributed dense fractions colocalized er marker calnexin stable ntf ctf distributed predominantly lighter fractions colocalized golgi marker galactosyltransferase activity gradient fractions er golgi fractions overlapped represent distinct populations also cannot exclude possibility organelles containing presenilins may co purify gradient fractions therefore studies determine predominant localization presenilin protein species compartments lesser amounts protein locations cannot excluded examine nuclear localization presenilins reported recently 27 nonetheless clear subcellular separation full length presenilins stable fragments noteworthy known whether normal physiological function presenilin provided full length molecules proteolytic fragments
0.3514349.9575200.html.plaintext.txt	49	study subcellular distributions two ps1 mutations m146l c410y n141i ps2 mutation similar respective wt presenilins therefore mutations overtly alter presenilin trafficking contrast noncleavable e9 ps1 mutant localized larger number gradient fractions distributed er golgi fractions addition shown recently 22 pulse chase studies showed turnover rate e9 mutant protein considerably slower wt ps1 holoprotein initially speculated transport e9 golgi compartment stable presenilin fragments located may underlie decrease turnover rate mutant protein species however pulse chase labeling combined subcellular fractionation showed significant pool pulse labeled e9 protein remained intact within er time wt ps1 holoprotein completely degraded result suggests reduced proteolytic degradation e9 within er responsible increased half life molecule time small fraction undegraded protein together endogenous ntf ctf found golgi compartment
0.3514349.9575200.html.plaintext.txt	50	study subcellular distributions two ps1 mutations m146l c410y n141i ps2 mutation similar respective wt presenilins therefore mutations overtly alter presenilin trafficking contrast noncleavable e9 ps1 mutant localized larger number gradient fractions distributed er golgi fractions addition shown recently 22 pulse chase studies showed turnover rate e9 mutant protein considerably slower wt ps1 holoprotein initially speculated transport e9 golgi compartment stable presenilin fragments located may underlie decrease turnover rate mutant protein species however pulse chase labeling combined subcellular fractionation showed significant pool pulse labeled e9 protein remained intact within er time wt ps1 holoprotein completely degraded result suggests reduced proteolytic degradation e9 within er responsible increased half life molecule time small fraction undegraded protein together endogenous ntf ctf found golgi compartment
0.3514349.9575200.html.plaintext.txt	51	previous studies consistently shown inverse relationship e9 expression endogenous ntf levels 22 26 suggesting mutant holoprotein competes normal cleavage endogenous ps1 study increasing expression e9 mutant protein muristerone induction similarly led progressively lower levels endogenous ps1 stable fragments interestingly pulse chasefractionation studies appearance labeled endogenous fragments delayed therefore production ntf proteolysis endogenous ps1 affected quantitatively kinetically presence e9 mutant protein competition likely occur er e9 appeared largely degraded compartment
0.3514349.9575200.html.plaintext.txt	52	previous studies consistently shown inverse relationship e9 expression endogenous ntf levels 22 26 suggesting mutant holoprotein competes normal cleavage endogenous ps1 study increasing expression e9 mutant protein muristerone induction similarly led progressively lower levels endogenous ps1 stable fragments interestingly pulse chasefractionation studies appearance labeled endogenous fragments delayed therefore production ntf proteolysis endogenous ps1 affected quantitatively kinetically presence e9 mutant protein competition likely occur er e9 appeared largely degraded compartment
0.3514349.9575200.html.plaintext.txt	53	study also provides evidence constitutive endoproteolysis ps1 generate stable ntf ctf occurs er pulse chase experiments combined subcellular fractionation showed initial pool labeled ntf albeit low levels located predominantly er fractions similar labeled holoprotein chase period however amount labeled ntf increased consistent precursor product relationship full length protein species fragments within er importantly ntf seen distribute lighter fractions chase 4 h chase labeled ntf distributed predominantly golgi enriched fractions similar seen steady state taken together observations provide compelling evidence constitutive endoproteolysis ps1 occurs initially er compartment
0.3514349.9575200.html.plaintext.txt	54	study also provides evidence constitutive endoproteolysis ps1 generate stable ntf ctf occurs er pulse chase experiments combined subcellular fractionation showed initial pool labeled ntf albeit low levels located predominantly er fractions similar labeled holoprotein chase period however amount labeled ntf increased consistent precursor product relationship full length protein species fragments within er importantly ntf seen distribute lighter fractions chase 4 h chase labeled ntf distributed predominantly golgi enriched fractions similar seen steady state taken together observations provide compelling evidence constitutive endoproteolysis ps1 occurs initially er compartment
0.3514349.9575200.html.plaintext.txt	55	notable exception e9 mutation subcellular distribution ps1 m146l c410y ps2 n141i mutations indistinguishable wt ps1 ps2 respectively since presenilin mutations reported show selective increase a42 production 10 17 results suggest perturbations er golgi processing level cannot explain mutants alter a42 generation like presenilins maturation app exocytic pathway occurs er golgi compartments thus colocalization app presenilins subcellular compartments leads possibility interaction two molecules reported transfected cells 15 17 using subcellular fractionation recently detected increased levels a42 er golgi fractions cells expressing mutant presenilins 16 observations suggest understanding molecular interactions app presenilins well proteins within cellular compartments important resolving mechanisms ad pathogenesis
0.3514349.9575200.html.plaintext.txt	56	notable exception e9 mutation subcellular distribution ps1 m146l c410y ps2 n141i mutations indistinguishable wt ps1 ps2 respectively since presenilin mutations reported show selective increase a42 production 10 17 results suggest perturbations er golgi processing level cannot explain mutants alter a42 generation like presenilins maturation app exocytic pathway occurs er golgi compartments thus colocalization app presenilins subcellular compartments leads possibility interaction two molecules reported transfected cells 15 17 using subcellular fractionation recently detected increased levels a42 er golgi fractions cells expressing mutant presenilins 16 observations suggest understanding molecular interactions app presenilins well proteins within cellular compartments important resolving mechanisms ad pathogenesis
0.3514349.9575200.html.plaintext.txt	57	thank drs victor hsu rick mitchell helpful discussions technical advice dr alison goate e9 cdna
0.3514349.9575200.html.plaintext.txt	58	work supported national institutes health grants ag 12376 ns 01812 e h k ag 05134 ag 12749 d j afar beeson award e h k grants aid scientific research priority areas h mthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3514349.9575200.html.plaintext.txt	59	correspondence addressed present address dept neurosciences 0691 university california san diego la jolla ca 92093 0691
0.3514349.9575200.html.plaintext.txt	60	1 abbreviations used ad alzheimers disease fad familial alzheimers disease ps1 presenilin 1 ps2 presenilin 2 er endoplasmic reticulum app amyloid precursor protein wt wild type e9 ps1 mutant lacking exon 9 amyloid peptide ntf n terminal endoproteolytic fragment ctf c terminal endoproteolytic fragment cho chinese hamster ovary
0.3514349.9575200.html.plaintext.txt	61	references top abstract introduction materials methods results discussion references selkoe d j 1997 science 275 630 631free full text sherrington r rogaev e liang y rogaeva e levesque g ikeda m chi h lin c li g holman k tsuda mar l foncin j f bruni c montesi m p sorbi rainero pinessi l nee l chumakov pollen d roses d fraser p e rommens j m st george hyslop p h 1995 nature 375 754 760crossrefmedline order article via infotrieve levy lahad e wasco w poorkaj p romano d m oshima j pettingell h yu c jondro p d schmidt d wang k crowley c fu y h guenette y galas d nemens e wijsman e m bird d schellenberg g d tanzi r e 1995 science 269 973 977medline order article via infotrieve rogaev e sherrington r rogaeva e levesque g ikeda m liang y chi h lin c holamn k tsuda mar l sorbi nacmias b piacentini amaducci l chumakov cohen d lannfelt l fraser p e rommens j m st george hyslop p h 1995 nature 376 775 778crossrefmedline order article via infotrieve baumeister r leimer u zweckbronner jakubek c grunberg j haass c 1997 genes function 1 149 159medline order article via infotrieve levitan d doyle g brousseau d lee m k thinakaran g slunt h h sisodia greenwald 1996 proc natl acad sci u 93 14940 14944abstractfree full text doan thinakaran g borchelt d r slunt h h ratovitski podlisny m selkoe d j seeger m gandy e price d l sisodia 1996 neuron 17 1023 1030medline order article via infotrieve lehmann chiesa r harris d 1997 j biol chem 272 12047 12051abstractfree full text podlisny m b citron m amarante p sherrington r xia w zhang j diehl levesque g fraser p haass c koo e h m seubert p st george hyslop p teplow d b selkoe d j 1997 neurobiol dis 3 325 337crossrefmedline order article via infotrieve xia w zhang j kholodenko d citron m podlisny m b teplow d b haass c seubert p koo e h selkoe d j 1997 j biol chem 272 7977 7982abstractfree full text kim w pettingell w h hallmark o g moir r d wasco w tanzi r e 1997 j biol chem 272 11006 11010abstractfree full text thinakaran g borchelt d r lee m k slunt h h spitzer l kim g rotovitsky davenport f nordstedt c seeger m hardy j levey gandy e jenkins n copeland n g price d l sisodia 1996 neuron 17 181 190medline order article via infotrieve kovacs d m fausett h j page k j kim w moir r d merriam d e hollister r d hallmark o g mancini r felsenstein k m human b tanzi r e wasco w 1996 nature med 2 224 229medline order article via infotrieve de strooper b beullens m contreras b levesque l craessaerts k cordell b moechars d bollen m fraser p st george hyslop p van leuven f 1997 j biol chem 272 3590 3598abstractfree full text weidemann paliga k durrwang u czech c evin g masters c l beyreuther k 1997 nat med 3 328 332medline order article via infotrieve xia w zhang j ostaszewski b seubert p koo e h selkoe d j 1997 soc neurosci abstr 23 294 xia w zhang j perez r koo e h selkoe d j 1997 proc natl acad sci u 94 8208 8213abstractfree full text okochi m ishii k usami m sahara n kametani f tanaka k fraser p e ikeda m saunders m hendriks l shoji nee l e martin j j vanbroeckhoven c st george hyslop p h roses d mori h 1997 febs lett 418 162 166crossrefmedline order article via infotrieve sisodia koo e h hoffman p n perry g price d l 1993 j neurosci 13 3136 3142abstract bretz r staubli w 1977 eur j biochem 77 181 192medline order article via infotrieve le steiner j l ferrell g shaker j c sifers r n 1994 j biol chem 269 7514 7519abstractfree full text ratovitski slunt h h thinakaran g price d l sisodia borchelt d r 1997 j biol chem 272 24536 24541abstractfree full text scheuner d eckman c jensen m song x citron m suzuki n bird d hardy j hutton m kukull w larson e levy lahad e viitanen m peskind e poorkaj p schellenberg g tanzi r wasco w lannfelt l selkoe d younkin 1996 nat med 2 864 870medline order article via infotrieve duff k eckman c zehr c yu x prada c m perez tur j hutton m buee l hairgaya y morgan d gordon m n holcomb l refolo l zenk b hardy j younkin 1996 nature 383 710 713crossrefmedline order article via infotrieve citron m westaway d xia w carlson g diehl levesque g johnson wood k lee m seubert p davis kholodenko d motter r sherrington r perry b yao h strome r lieberburg rommens j kim schenk d fraser p st george hyslop p selkoe d j 1997 nature med 3 67 72medline order article via infotrieve borchelt d r thinakaran g eckman c b lee m k davenport f ratovitski prada c m kim g seekins yager d slunt h h wang r seeger m levey gandy e copeland n g jenkins n price d l younkin g sisodia 1996 neuron 17 1005 1013medline order article via infotrieve li j xu m zhou h ma j potter h 1997 cell 90 917 927medline order article via infotrieve
0.3514349.9575200.html.plaintext.txt	62	copyright 1998 american society biochemistry molecular biology inc
0.36325452.16103124.html.plaintext.txt	0	secretase independent mechanism signal transduction amyloid precursor protein matthew r hass bruce yankner1
0.36325452.16103124.html.plaintext.txt	1	department neurology division neuroscience childrens hospital harvard medical school boston massachusetts 02115
0.36325452.16103124.html.plaintext.txt	2	received publication march 15 2005 revised form august 8 2005
0.36325452.16103124.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references proposed secretase mediated release amyloid precursor protein app intracellular domain aicd results nuclear translocation signaling complex adaptor protein fe65 histone acetyltransferase tip60 show app fe65 activate transcription gal4 tip60 reporter presenilin 12 deficient cells lacking generation aicd app fe65 also activated transcription presence secretase inhibitors prevent amyloid peptide production human embryonic kidney 293 sh sy5y cells contrast transcriptionally active notch intracellular domain expression aicd activate transcription alternative mechanism app signal transduction suggested identification essential cyclin dependent kinase cdk phosphorylation sites tip60 mutation tip60 phosphorylation sites treatment cdk inhibitor roscovitine blocked ability app signal tip60 moreover app stabilized tip60 cdk dependent phosphorylation subcellular fractionation confocal immunofluorescence showed app recruited tip60 membrane compartments thus app may signal nucleus secretase independent mechanism involves membrane sequestration phosphorylation tip60
0.36325452.16103124.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references proposed secretase mediated release amyloid precursor protein app intracellular domain aicd results nuclear translocation signaling complex adaptor protein fe65 histone acetyltransferase tip60 show app fe65 activate transcription gal4 tip60 reporter presenilin 12 deficient cells lacking generation aicd app fe65 also activated transcription presence secretase inhibitors prevent amyloid peptide production human embryonic kidney 293 sh sy5y cells contrast transcriptionally active notch intracellular domain expression aicd activate transcription alternative mechanism app signal transduction suggested identification essential cyclin dependent kinase cdk phosphorylation sites tip60 mutation tip60 phosphorylation sites treatment cdk inhibitor roscovitine blocked ability app signal tip60 moreover app stabilized tip60 cdk dependent phosphorylation subcellular fractionation confocal immunofluorescence showed app recruited tip60 membrane compartments thus app may signal nucleus secretase independent mechanism involves membrane sequestration phosphorylation tip60
0.36325452.16103124.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references amyloid precursor protein app2 played central role alzheimer disease research ever since pathogenic mutations discovered within app decade ago app type 1 transmembrane protein resembles cell surface receptor 1 studies app biology focused primarily proteolytic processing app undergoes two separate proteolytic pathways termed non amyloidogenic amyloidogenic pathways reviewed ref 2 non amyloidogenic pathway app first cleaved secretase generating c terminal transmembrane fragment c83 amyloidogenic pathway involves cleavage secretase bace generating c terminal fragment c99 cleaved secretase generate amyloid peptide c50app intracellular domain aicd fragment series proteolytic events ectodomain shedding followed intramembrane cleavage reminiscent processing notch receptor following binding ligands reviewed ref 3 app notch require presenilins secretase cleavage within membrane 4 7
0.36325452.16103124.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references amyloid precursor protein app2 played central role alzheimer disease research ever since pathogenic mutations discovered within app decade ago app type 1 transmembrane protein resembles cell surface receptor 1 studies app biology focused primarily proteolytic processing app undergoes two separate proteolytic pathways termed non amyloidogenic amyloidogenic pathways reviewed ref 2 non amyloidogenic pathway app first cleaved secretase generating c terminal transmembrane fragment c83 amyloidogenic pathway involves cleavage secretase bace generating c terminal fragment c99 cleaved secretase generate amyloid peptide c50app intracellular domain aicd fragment series proteolytic events ectodomain shedding followed intramembrane cleavage reminiscent processing notch receptor following binding ligands reviewed ref 3 app notch require presenilins secretase cleavage within membrane 4 7
0.36325452.16103124.html.plaintext.txt	7	pathogenic autosomal dominant mutations app presenilins lead increased generation fibrillogenic peptide a42 forms amyloid plaques one hallmark pathogenic lesions alzheimer disease reviewed refs 8 9 moreover neurotoxic vitro vivo 10 11 observations led amyloid hypothesis proposes accumulation brain causes neurodegeneration dementia alzheimer disease however despite significant effort spent investigating properties app biological function reason cleavage remain enigmatic evidence app plays role cell adhesion axonal transport neurite outgrowth recently signal transduction 12 18
0.36325452.16103124.html.plaintext.txt	8	suggested app may signal mechanism similar notch receptor intracellular tail released presenilin secretase translocates nucleus activates transcription idea supported observation app together adaptor protein fe65 could activate transcriptional activity histone acetyltransferase tip60 18 thus presenilins may mediate regulated intramembrane proteolysis number transmembrane proteins release soluble intracellular domains carry signaling functions reviewed refs 19 20
0.36325452.16103124.html.plaintext.txt	9	suggested app may signal mechanism similar notch receptor intracellular tail released presenilin secretase translocates nucleus activates transcription idea supported observation app together adaptor protein fe65 could activate transcriptional activity histone acetyltransferase tip60 18 thus presenilins may mediate regulated intramembrane proteolysis number transmembrane proteins release soluble intracellular domains carry signaling functions reviewed refs 19 20
0.36325452.16103124.html.plaintext.txt	10	adaptor protein fe65 contains three protein interaction domains ww domain binds proline rich sequences two c terminal phosphotyrosine binding domains interact tip60 app respectively 18 21 fe65 app placed within biological pathway caenorhabditis elegans respective mutants similar pharyngeal pumping phenotypes 22 expression fe65 lead stabilization nuclear translocation aicd may induce apoptosis tip60 23 25 48 addition tip60 histone acetyltransferase activity implicated regulation gene expression dna repair 26 28 however mechanism underlying ability app regulate tip60 mediated transcription determined study provide evidence contrast notch app able activate transcription tip60 independently secretase cleavage recruiting tip60 membrane leading tip60 activation cyclin dependent kinase mediated phosphorylation followed nuclear translocation tip60 fe65 activation transcription
0.36325452.16103124.html.plaintext.txt	11	adaptor protein fe65 contains three protein interaction domains ww domain binds proline rich sequences two c terminal phosphotyrosine binding domains interact tip60 app respectively 18 21 fe65 app placed within biological pathway caenorhabditis elegans respective mutants similar pharyngeal pumping phenotypes 22 expression fe65 lead stabilization nuclear translocation aicd may induce apoptosis tip60 23 25 48 addition tip60 histone acetyltransferase activity implicated regulation gene expression dna repair 26 28 however mechanism underlying ability app regulate tip60 mediated transcription determined study provide evidence contrast notch app able activate transcription tip60 independently secretase cleavage recruiting tip60 membrane leading tip60 activation cyclin dependent kinase mediated phosphorylation followed nuclear translocation tip60 fe65 activation transcription
0.36325452.16103124.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references cell lines treatments embryonic stem cells cultured 37 degrees c 5 co2 atmosphere dulbeccos modified eagles medium supplemented 15 fetal bovine serum 292 microgml l glutamine 100 unitsml penicillin 100 microgml streptomycin 100 microm nonessential amino acids 1 mm sodium pyruvate 100 units leukemia inhibitory factor 0008 2 mercaptoethanol human embryonic kidney 293 hek 293 sh sy5y cells cultured dulbeccos modified eagles medium supplemented 10 fetal bovine serum 292 microgml l glutamine 100 unitsml penicillin 100 microgml streptomycin 1 mm sodium pyruvate cells treated 10 microm roscovitine sigma 20 microm benzyloxycarbonyl vad fluoromethyl ketone sigma 20 nm leptomycin b lc laboratories secretase inhibitors wpe ii 72 wpe iii 31c obtained michael wolfe cells treated 500 nm 5 microm respectively 25 times ic50 values dephosphorylation assay 5 microl calf intestinal alkaline phosphatase new england biolabs inc h2o added 40 microl sample plus 5 microl ne buffer 3 followed incubation 1 h 37 degrees c reaction stopped addition 50 microl 2x sample buffer
0.36325452.16103124.html.plaintext.txt	13	view larger version 33k figure 1 app signaling require secretase cleavage contrast notch signaling wild type wt es ps ko cells cotransfected triplicate pfr luciferase prl tk gal4 tip60 fe65 app ps1 plasmids indicated approximately 24 h transfection cells collected dual luciferase reporter assays performed b wild type es ps ko cells cotransfected triplicate hes1 luciferase prl tk mnotche ps1 nicd indicated luciferase assays performed 24 h post transfection c wild type es ps ko cells transfected pcdna mock appwt c50aicd appsw plasmids cells harvested 24 h transfection separated 10 20 tristricine gel western blotted antibody c8 directed app c terminal domain
0.36325452.16103124.html.plaintext.txt	14	view larger version 33k figure 1 app signaling require secretase cleavage contrast notch signaling wild type wt es ps ko cells cotransfected triplicate pfr luciferase prl tk gal4 tip60 fe65 app ps1 plasmids indicated approximately 24 h transfection cells collected dual luciferase reporter assays performed b wild type es ps ko cells cotransfected triplicate hes1 luciferase prl tk mnotche ps1 nicd indicated luciferase assays performed 24 h post transfection c wild type es ps ko cells transfected pcdna mock appwt c50aicd appsw plasmids cells harvested 24 h transfection separated 10 20 tristricine gel western blotted antibody c8 directed app c terminal domain
0.36325452.16103124.html.plaintext.txt	15	transfection plasmids cells transfected using lipo fectamine 2000 invitrogen following manufacturers protocol basically cell medium replaced opti mem followed addition mixture opti mem dna lipo fectamine 2000 cells incubated 37 degrees c 3 5 h time equivalent volume medium added along appropriate drug treatments plasmids used follows pm tip60 gal4 tip60 pcmv fe65 pcmv myc fe65 128 711 obtained c sudhof pcmv app695wt pcdna c50 pcdna c50 myc pcdna ha tip60 pcdna ha tip60s8690a obtained khochbin pm gal4 tip60wt generated subcloning hemagglutinin ha tip60 cutting pm ha tip60 vectors ecori xbai pm gal4 tip60s8690a generated subcloning ha tip60 cutting pm ha tip60 vectors ecori xbai prk ps1wt pfr luciferase stratagene prl tk renilla promega hes1 luciferase mnotche pcdna nicd pcdna3 empty vector normalize total dna
0.36325452.16103124.html.plaintext.txt	16	transfection plasmids cells transfected using lipo fectamine 2000 invitrogen following manufacturers protocol basically cell medium replaced opti mem followed addition mixture opti mem dna lipo fectamine 2000 cells incubated 37 degrees c 3 5 h time equivalent volume medium added along appropriate drug treatments plasmids used follows pm tip60 gal4 tip60 pcmv fe65 pcmv myc fe65 128 711 obtained c sudhof pcmv app695wt pcdna c50 pcdna c50 myc pcdna ha tip60 pcdna ha tip60s8690a obtained khochbin pm gal4 tip60wt generated subcloning hemagglutinin ha tip60 cutting pm ha tip60 vectors ecori xbai pm gal4 tip60s8690a generated subcloning ha tip60 cutting pm ha tip60 vectors ecori xbai prk ps1wt pfr luciferase stratagene prl tk renilla promega hes1 luciferase mnotche pcdna nicd pcdna3 empty vector normalize total dna
0.36325452.16103124.html.plaintext.txt	17	transactivation assays cells plated onto 24 well plates transfected 70 80 confluent three wells transfected per treatment optimized dna concentrations signaling assay 293 cells 02 microg pfr luciferase 005 microg prl tk 02 microg pm gal4 tip60 02 microg pcmv myc fe65 128 711 01 microg pcmv app695wt per well pcmv myc fe65 128 711 plasmid used shown previously act similarly full length fe65 18 hands required lower amount dna allow activation reporter tip60 additionally construct myc tag facilitated confirmation equivalent expression western blotting different conditions approximately 20 24 h transfection cells lysed promega passive lysis buffer assays performed dual luciferase kit promega according protocol recommended manufacturer luciferase activity read wallac victor model 1420 multilabel counter control transfection efficiency activity firefly luciferase reporter driven gal4 promoter normalized activity renilla luciferase reporter prl tk fold induction determined average three wells per treatment normalized average signal reporter alone wells
0.36325452.16103124.html.plaintext.txt	18	transactivation assays cells plated onto 24 well plates transfected 70 80 confluent three wells transfected per treatment optimized dna concentrations signaling assay 293 cells 02 microg pfr luciferase 005 microg prl tk 02 microg pm gal4 tip60 02 microg pcmv myc fe65 128 711 01 microg pcmv app695wt per well pcmv myc fe65 128 711 plasmid used shown previously act similarly full length fe65 18 hands required lower amount dna allow activation reporter tip60 additionally construct myc tag facilitated confirmation equivalent expression western blotting different conditions approximately 20 24 h transfection cells lysed promega passive lysis buffer assays performed dual luciferase kit promega according protocol recommended manufacturer luciferase activity read wallac victor model 1420 multilabel counter control transfection efficiency activity firefly luciferase reporter driven gal4 promoter normalized activity renilla luciferase reporter prl tk fold induction determined average three wells per treatment normalized average signal reporter alone wells
0.36325452.16103124.html.plaintext.txt	19	antibodies anti ha antibody obtained sigma detect tip60 used antibody n1 kind gift john lough 29 paul greengard generously provided anti fe65 antibody 30 used rabbit antibody c8 directed app c terminus anti antibodies 159 6e10 used immunoprecipitation immunoblotting respectively anti lamin b2 antibody obtained zymed laboratories inc purchased anti actin antibody oncogene science mouse monoclonal antibody 56c6 lab vision corp used neprilysin secondary antibodies purchased jackson immunoresearch laboratories inc
0.36325452.16103124.html.plaintext.txt	20	antibodies anti ha antibody obtained sigma detect tip60 used antibody n1 kind gift john lough 29 paul greengard generously provided anti fe65 antibody 30 used rabbit antibody c8 directed app c terminus anti antibodies 159 6e10 used immunoprecipitation immunoblotting respectively anti lamin b2 antibody obtained zymed laboratories inc purchased anti actin antibody oncogene science mouse monoclonal antibody 56c6 lab vision corp used neprilysin secondary antibodies purchased jackson immunoresearch laboratories inc
0.36325452.16103124.html.plaintext.txt	21	subcellular fractionation cells collected phosphate buffered saline 90 confluent pelleted centrifugation 1000 x g 10 min washed buffer 10 mm hepes koh 15 mm mgcl2 10 mm kcl 05 mm dithiothreitol 1 mm edta 1 mm egta 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture roche applied science centrifuged 1000 x g 10 min cells swelled 10 min buffer followed 20x dounce homogenization glass pestle nuclei pelleted centrifugation 1000 x g 10 min pellet supernatant separated pellet lysed deoxycholate containing radioimmune precipitation assay buffer ripa doc plus phosphatase inhibitors 50 mm naf 5 mm na2p2o7 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture saved nuclear fraction supernatant combined 011 volume buffer b 03 m hepes koh 14 m kcl 003 m mgcl2 1 mm edta 1 mm egta 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture followed ultracentrifugation 100000 x g 1 h pellet resuspended ripa doc phosphatase protease inhibitors saved membrane fraction supernatant saved cytoplasmic fraction
0.36325452.16103124.html.plaintext.txt	22	subcellular fractionation cells collected phosphate buffered saline 90 confluent pelleted centrifugation 1000 x g 10 min washed buffer 10 mm hepes koh 15 mm mgcl2 10 mm kcl 05 mm dithiothreitol 1 mm edta 1 mm egta 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture roche applied science centrifuged 1000 x g 10 min cells swelled 10 min buffer followed 20x dounce homogenization glass pestle nuclei pelleted centrifugation 1000 x g 10 min pellet supernatant separated pellet lysed deoxycholate containing radioimmune precipitation assay buffer ripa doc plus phosphatase inhibitors 50 mm naf 5 mm na2p2o7 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture saved nuclear fraction supernatant combined 011 volume buffer b 03 m hepes koh 14 m kcl 003 m mgcl2 1 mm edta 1 mm egta 1 microm microcystin 1 mm navo4 complete protease inhibitor mixture followed ultracentrifugation 100000 x g 1 h pellet resuspended ripa doc phosphatase protease inhibitors saved membrane fraction supernatant saved cytoplasmic fraction
0.36325452.16103124.html.plaintext.txt	23	view larger version 37k figure 2 secretase inhibitors affect app signaling aicd transcriptional activity upper panel b hek 293 sh sy5y cells respectively cotransfected triplicate pfr luciferase prl tk gal4 tip60 fe65 app c50 myc indicated 3 h secretase inhibitor wpe ii 72 72 i72 500 nm added luciferase assays performed cell lysates 24 h transfection lower panel cell lysates western blotted app antibody c8 actin loading control c hek 293 cells stably expressing appsw hek 293 sh sy5y cells transiently transfected tip60 fe65 appwt incubated presence absence control secretase inhibitor wpe ii 72 500 nm immunoprecipitated antibody 159 western blotted antibody 6e10 d hek 293 cells transfected wild type tip60 tip60wt tip60s86as90a mutant tip60s8690a together fe65 app indicated tip60 immunoprecipitated ip anti ha antibody co immunoprecipitated app detected western blotting antibody c8
0.36325452.16103124.html.plaintext.txt	24	view larger version 37k figure 2 secretase inhibitors affect app signaling aicd transcriptional activity upper panel b hek 293 sh sy5y cells respectively cotransfected triplicate pfr luciferase prl tk gal4 tip60 fe65 app c50 myc indicated 3 h secretase inhibitor wpe ii 72 72 i72 500 nm added luciferase assays performed cell lysates 24 h transfection lower panel cell lysates western blotted app antibody c8 actin loading control c hek 293 cells stably expressing appsw hek 293 sh sy5y cells transiently transfected tip60 fe65 appwt incubated presence absence control secretase inhibitor wpe ii 72 500 nm immunoprecipitated antibody 159 western blotted antibody 6e10 d hek 293 cells transfected wild type tip60 tip60wt tip60s86as90a mutant tip60s8690a together fe65 app indicated tip60 immunoprecipitated ip anti ha antibody co immunoprecipitated app detected western blotting antibody c8
0.36325452.16103124.html.plaintext.txt	25	transgenic mice cortices hippocampi dissected 3 month old 2 year old tg2576 app transgenic mice used two animals genotype age brain samples subjected fractionation described briefly brain samples washed phosphate buffered saline swelled buffer 10 min followed dounce homogenization glass pestle nuclei pelleted centrifugation 1000 x g 10 min supernatant combined 011 volume buffer b ultracentrifuged 100000 x g 1 h pellet resuspended ripa doc used membrane fraction western blot analysis
0.36325452.16103124.html.plaintext.txt	26	transgenic mice cortices hippocampi dissected 3 month old 2 year old tg2576 app transgenic mice used two animals genotype age brain samples subjected fractionation described briefly brain samples washed phosphate buffered saline swelled buffer 10 min followed dounce homogenization glass pestle nuclei pelleted centrifugation 1000 x g 10 min supernatant combined 011 volume buffer b ultracentrifuged 100000 x g 1 h pellet resuspended ripa doc used membrane fraction western blot analysis
0.36325452.16103124.html.plaintext.txt	27	immunoprecipitation western blotting co immunoprecipitation experiments protein lysates precleared protein g sepharose amersham biosciences 1 h 4 degrees c followed overnight incubation immunoprecipitating antibodies next morning fresh protein g sepharose added rocked 4 degrees c 2 h followed three washes ripa doc anti ha antibody immunoprecipitations phosphate buffered saline antibody 159 immunoprecipitations proteins eluted beads boiling 2x sample buffer 5 min immunoprecipitationwestern blot experiments hek 293 sh sy5y cells transiently transfected tip60 fe65 app 20e2 appsw expressing hek 293 stable cell line incubated 48 24 h respectively condition medium secretase inhibitor added beginning conditioning final concentration 500 nm 25 times ic50 value transient transfection additional secretase inhibitor added 24 h 125 times ic50 value compensate turnover inhibitor conditioned medium collected spun 1000 rpm 10 min remove cellular debris anti antibody 159 added conditioned medium rocked overnight 4 degrees c next morning protein sepharose amersham biosciences added rocked 4 degrees c 2 h protein sepharose washed three times phosphate buffered saline eluted beads 2x sample buffer boiled 5 min experiments app stabilization tip60 cells collected 24 h post transfection using promega passive lysis buffer lysates clarified centrifugation 10000 x g 10 min equivalent cell lysates loaded onto gel western blotting
0.36325452.16103124.html.plaintext.txt	28	immunoprecipitation western blotting co immunoprecipitation experiments protein lysates precleared protein g sepharose amersham biosciences 1 h 4 degrees c followed overnight incubation immunoprecipitating antibodies next morning fresh protein g sepharose added rocked 4 degrees c 2 h followed three washes ripa doc anti ha antibody immunoprecipitations phosphate buffered saline antibody 159 immunoprecipitations proteins eluted beads boiling 2x sample buffer 5 min immunoprecipitationwestern blot experiments hek 293 sh sy5y cells transiently transfected tip60 fe65 app 20e2 appsw expressing hek 293 stable cell line incubated 48 24 h respectively condition medium secretase inhibitor added beginning conditioning final concentration 500 nm 25 times ic50 value transient transfection additional secretase inhibitor added 24 h 125 times ic50 value compensate turnover inhibitor conditioned medium collected spun 1000 rpm 10 min remove cellular debris anti antibody 159 added conditioned medium rocked overnight 4 degrees c next morning protein sepharose amersham biosciences added rocked 4 degrees c 2 h protein sepharose washed three times phosphate buffered saline eluted beads 2x sample buffer boiled 5 min experiments app stabilization tip60 cells collected 24 h post transfection using promega passive lysis buffer lysates clarified centrifugation 10000 x g 10 min equivalent cell lysates loaded onto gel western blotting
0.36325452.16103124.html.plaintext.txt	29	immunocytochemistry sh sy5y cells plated onto coverslips 24 well plates 2 days prior transfection cells transfected ha tip60 alone fe65 app described incubated 24 h cells fixed 4 paraformaldehyde 20 min permeabilized 02 triton x 100 10 min blocked 10 donkey serum 1 h followed overnight incubation anti ha antibody antibody c8 detect tip60 app respectively next day used cy3 conjugated anti mouse antibody label tip60 cy2 conjugated anti rabbit antibody label app finally hoechst stain included first wash label nuclei images taken zeiss confocal microscope
0.36325452.16103124.html.plaintext.txt	30	immunocytochemistry sh sy5y cells plated onto coverslips 24 well plates 2 days prior transfection cells transfected ha tip60 alone fe65 app described incubated 24 h cells fixed 4 paraformaldehyde 20 min permeabilized 02 triton x 100 10 min blocked 10 donkey serum 1 h followed overnight incubation anti ha antibody antibody c8 detect tip60 app respectively next day used cy3 conjugated anti mouse antibody label tip60 cy2 conjugated anti rabbit antibody label app finally hoechst stain included first wash label nuclei images taken zeiss confocal microscope
0.36325452.16103124.html.plaintext.txt	31	view larger version 36k figure 3 app signaling independent caspase cleavage regulate neprilysin levels b hek 293 cells wild type wt es ps ko cells respectively cotransfected pfr luciferase luc prl tk gal4 tip60 fe65 app indicated cells treated 4 h post transfection secretase inhibitor wpe ii 72 i72 500 nm caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone zvad20 microm luciferase assays performed 24 h transfection c whole cell lysates two independent wild type es pbd6 pbd8 two ps ko bd8 bd35 cell lines probed neprilysin reprobed actin d bd8 ps ko cells transfected ps1 lysates collected 24 h later western blotted duplicate neprilysin presenilin app c terminal fragments e bd8 ps ko cells transfected either c50 c50 myc alone tip60 fe65 24 h cells harvested western blotted neprilysin actin c50 myc expression c50 expression confirmed darker exposure data shown
0.36325452.16103124.html.plaintext.txt	32	view larger version 36k figure 3 app signaling independent caspase cleavage regulate neprilysin levels b hek 293 cells wild type wt es ps ko cells respectively cotransfected pfr luciferase luc prl tk gal4 tip60 fe65 app indicated cells treated 4 h post transfection secretase inhibitor wpe ii 72 i72 500 nm caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone zvad20 microm luciferase assays performed 24 h transfection c whole cell lysates two independent wild type es pbd6 pbd8 two ps ko bd8 bd35 cell lines probed neprilysin reprobed actin d bd8 ps ko cells transfected ps1 lysates collected 24 h later western blotted duplicate neprilysin presenilin app c terminal fragments e bd8 ps ko cells transfected either c50 c50 myc alone tip60 fe65 24 h cells harvested western blotted neprilysin actin c50 myc expression c50 expression confirmed darker exposure data shown
0.36325452.16103124.html.plaintext.txt	33	results top abstract introduction materials methods results discussion references app signaling presenilin deficient cells activation notch signaling pathway requires secretase cleavage presenilins release notch intracellular domain nicd translocates nucleus activates target genes determine whether app could signal nucleus similar mechanism utilized embryonic stem es cells deficient presenilin 1 presenilin 2 presenilin 12 knockout ps ko cells cells deficient secretase cleavage app secrete 6 address potential signaling function app used gal4 tip60 fusion construct previously shown activate gal4 luciferase reporter upon cotransfection fe65 app 18 physiological system measuring signaling ability app compared app gal4 assays rely fusion artificial dna binding domain app reported previously 18 significant transactivation gal4 tip60 occurred upon coexpression fe65 app fig 1a app signaling reduced 45 ps ko cells relative wild type es cells rescued upon expression presenilin 1 ps1 fig 1a secretase inhibitor reduced app signaling wild type cells level comparable ps ko cells data shown ps ko cells resistant secretase inhibitor consistent lack secretase activity cells however app retained ability activate tip60 absence presenilins suggesting secretase cleavage app required activation tip60 contrasts notch signaling completely inhibited ps ko cells fig 1b results confirmed two independently derived wild type presenilin deficient cell lines indicating presenilin independent app signaling unique property individual presenilin deficient cell line results suggest app may signal mechanism distinct notch pathway despite similar mechanisms proteolytic processing
0.36325452.16103124.html.plaintext.txt	34	results top abstract introduction materials methods results discussion references app signaling presenilin deficient cells activation notch signaling pathway requires secretase cleavage presenilins release notch intracellular domain nicd translocates nucleus activates target genes determine whether app could signal nucleus similar mechanism utilized embryonic stem es cells deficient presenilin 1 presenilin 2 presenilin 12 knockout ps ko cells cells deficient secretase cleavage app secrete 6 address potential signaling function app used gal4 tip60 fusion construct previously shown activate gal4 luciferase reporter upon cotransfection fe65 app 18 physiological system measuring signaling ability app compared app gal4 assays rely fusion artificial dna binding domain app reported previously 18 significant transactivation gal4 tip60 occurred upon coexpression fe65 app fig 1a app signaling reduced 45 ps ko cells relative wild type es cells rescued upon expression presenilin 1 ps1 fig 1a secretase inhibitor reduced app signaling wild type cells level comparable ps ko cells data shown ps ko cells resistant secretase inhibitor consistent lack secretase activity cells however app retained ability activate tip60 absence presenilins suggesting secretase cleavage app required activation tip60 contrasts notch signaling completely inhibited ps ko cells fig 1b results confirmed two independently derived wild type presenilin deficient cell lines indicating presenilin independent app signaling unique property individual presenilin deficient cell line results suggest app may signal mechanism distinct notch pathway despite similar mechanisms proteolytic processing
0.36325452.16103124.html.plaintext.txt	35	view larger version 31k figure 4 cdk phosphorylation tip60 required app dependent transactivation stabilization tip60 b luciferase assays performed hek 293 wild type es cells respectively transfected gal4 tip60 tip60wt gal4 tip60s86as90a tip60s8690a together fe65 app cells treated cdk inhibitor roscovitine rosc 20 microm indicated 24 h luc luciferase c shown phosphorylation tip60 hek 293 cells cotransfected wild type tip60 tip60wt tip60s86as90a tip60s8690a alone fe65 app cells harvested 24 h post transfection equivalent amounts lysate protein incubated absence presence calf intestinal alkaline phosphatase cip western blotted anti tip60 antibody n1 d app dependent stabilization tip60 requires cdk phosphorylation wild type es hek 293 cells cotransfected wild type tip60 tip60s86as90a fe65 app treated roscovitine 20 microm
0.36325452.16103124.html.plaintext.txt	36	view larger version 31k figure 4 cdk phosphorylation tip60 required app dependent transactivation stabilization tip60 b luciferase assays performed hek 293 wild type es cells respectively transfected gal4 tip60 tip60wt gal4 tip60s86as90a tip60s8690a together fe65 app cells treated cdk inhibitor roscovitine rosc 20 microm indicated 24 h luc luciferase c shown phosphorylation tip60 hek 293 cells cotransfected wild type tip60 tip60wt tip60s86as90a tip60s8690a alone fe65 app cells harvested 24 h post transfection equivalent amounts lysate protein incubated absence presence calf intestinal alkaline phosphatase cip western blotted anti tip60 antibody n1 d app dependent stabilization tip60 requires cdk phosphorylation wild type es hek 293 cells cotransfected wild type tip60 tip60s86as90a fe65 app treated roscovitine 20 microm
0.36325452.16103124.html.plaintext.txt	37	confirmed presenilin deficient cells fail generate detectable levels c50 fragment corresponding aicd probed lysates either wild type es ps ko cells transfected plasmids encoding wild type app appwt c50aicd appsw immunoblot analyses wild type cells expressing appwt appsw antibody raised app c terminus showed band 6 kda comigrated transfected c50aicd fig 1c however ps ko cells expressing appwt appsw show clear 6 kda band although band appeared ps ko cells transfected c50aicd plasmid thus app able activate tip60 mechanism require secretase generation c50aicd
0.36325452.16103124.html.plaintext.txt	38	confirmed presenilin deficient cells fail generate detectable levels c50 fragment corresponding aicd probed lysates either wild type es ps ko cells transfected plasmids encoding wild type app appwt c50aicd appsw immunoblot analyses wild type cells expressing appwt appsw antibody raised app c terminus showed band 6 kda comigrated transfected c50aicd fig 1c however ps ko cells expressing appwt appsw show clear 6 kda band although band appeared ps ko cells transfected c50aicd plasmid thus app able activate tip60 mechanism require secretase generation c50aicd
0.36325452.16103124.html.plaintext.txt	39	confirmed presenilins required notch signaling contrast app signaling require presenilins expressed activated notch construct mnotche encodes truncated notch 1 protein retaining transmembrane domain together notch 1 responsive hes1 luciferase reporter mnotche able drive significant transactivation hes1 reporter wild type cells signaling ability absent ps ko cells fig 1b consistent previous reports 6 7 expression presenilin ps ko cells rescued ability mnotche activate hes1 reporter fig 1b shows lack notch signaling presenilin deficient cells due solely lack presenilin dependent secretase cleavage mnotche illustrating point similar level transactivation obtained upon expression soluble nicd wild type presenilin deficient cells fig 1b demonstrating cell lines similarly competent signal transduction results suggest presenilin deficient cells cannot carry signaling requires secretase activity yet cells support app mediated activation tip60 thus app may signal alternative mechanism
0.36325452.16103124.html.plaintext.txt	40	confirmed presenilins required notch signaling contrast app signaling require presenilins expressed activated notch construct mnotche encodes truncated notch 1 protein retaining transmembrane domain together notch 1 responsive hes1 luciferase reporter mnotche able drive significant transactivation hes1 reporter wild type cells signaling ability absent ps ko cells fig 1b consistent previous reports 6 7 expression presenilin ps ko cells rescued ability mnotche activate hes1 reporter fig 1b shows lack notch signaling presenilin deficient cells due solely lack presenilin dependent secretase cleavage mnotche illustrating point similar level transactivation obtained upon expression soluble nicd wild type presenilin deficient cells fig 1b demonstrating cell lines similarly competent signal transduction results suggest presenilin deficient cells cannot carry signaling requires secretase activity yet cells support app mediated activation tip60 thus app may signal alternative mechanism
0.36325452.16103124.html.plaintext.txt	41	secretase independence app signaling confirm surprising secretase independent mode app signaling performed similar assays hek 293 sh sy5y cells expected observed significant transactivation upon coexpression fe65 app fig 2 b treatment secretase inhibitor wpe ii 72 25 times ic50 value significantly affect app tip60 signaling hek 293 sh sy5y cells fig 2 b concentration secretase inhibitor greatly decreased production fig 2c markedly increased accumulation app c terminal fragments fig 2a lower panel secretase independence app signaling confirmed using another secretase inhibitor wpe iii 31c hek 293 sh sy5y cells data shown results confirm app nuclear signaling tip60 occur independently secretase cleavage
0.36325452.16103124.html.plaintext.txt	42	secretase independence app signaling confirm surprising secretase independent mode app signaling performed similar assays hek 293 sh sy5y cells expected observed significant transactivation upon coexpression fe65 app fig 2 b treatment secretase inhibitor wpe ii 72 25 times ic50 value significantly affect app tip60 signaling hek 293 sh sy5y cells fig 2 b concentration secretase inhibitor greatly decreased production fig 2c markedly increased accumulation app c terminal fragments fig 2a lower panel secretase independence app signaling confirmed using another secretase inhibitor wpe iii 31c hek 293 sh sy5y cells data shown results confirm app nuclear signaling tip60 occur independently secretase cleavage
0.36325452.16103124.html.plaintext.txt	43	view larger version 51k figure 5 app recruits tip60 membrane compartment vitro vivo hek 293 cells transfected wild type tip60 tip60wt alone fe65 app 24 h transfection cells subjected subcellular fractionation nuclear cytoplasmic membrane fractions fractions western blotted tip60 showed membrane recruitment coexpression fe65 app western blotting nuclear protein lamin b2 confirmed lack nuclear contamination membrane fraction b similar results observed endogenous tip60 hek 293 cells stably expressing app c cortices hippocampi isolated app transgenic littermate control wild type wt mice either 3 months young 2 years old age cortical hippocampal samples fractionated western blotting performed tip60
0.36325452.16103124.html.plaintext.txt	44	view larger version 51k figure 5 app recruits tip60 membrane compartment vitro vivo hek 293 cells transfected wild type tip60 tip60wt alone fe65 app 24 h transfection cells subjected subcellular fractionation nuclear cytoplasmic membrane fractions fractions western blotted tip60 showed membrane recruitment coexpression fe65 app western blotting nuclear protein lamin b2 confirmed lack nuclear contamination membrane fraction b similar results observed endogenous tip60 hek 293 cells stably expressing app c cortices hippocampi isolated app transgenic littermate control wild type wt mice either 3 months young 2 years old age cortical hippocampal samples fractionated western blotting performed tip60
0.36325452.16103124.html.plaintext.txt	45	examine role aicd signal transduction pathway replaced app signaling assay c50 construct hek 293 cells c50 essentially signaling ability fig 2a upper panel contrast signaling competent notch derived nicd fig 1b moreover observed c50 dominant negative effect decreased app signaling coexpressed app fig 2a upper panel immunoblot analysis lysates showed equivalent levels app expression fig 2a lower panel similar results obtained app signaling assays wild type es ps ko cells data shown results suggest c50aicd activate transcription tip60 rather acts dominant negative protein signaling pathway
0.36325452.16103124.html.plaintext.txt	46	examine role aicd signal transduction pathway replaced app signaling assay c50 construct hek 293 cells c50 essentially signaling ability fig 2a upper panel contrast signaling competent notch derived nicd fig 1b moreover observed c50 dominant negative effect decreased app signaling coexpressed app fig 2a upper panel immunoblot analysis lysates showed equivalent levels app expression fig 2a lower panel similar results obtained app signaling assays wild type es ps ko cells data shown results suggest c50aicd activate transcription tip60 rather acts dominant negative protein signaling pathway
0.36325452.16103124.html.plaintext.txt	47	suggested app may able carry signal transduction cleavage caspases cleavage site within cytoplasmic c terminal domain 31 32 address possibility used pan caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone another series luciferase assays hek 293 cells inhibiting caspase activity benzyloxycarbonyl vad fluoromethyl ketone failed significantly affect ability app activate tip60 fig 3a notably still effect app signaling secretase caspase inhibitors added together similar results observed wild type es ps ko cells fig 3b thus app retains ability activate tip60 signaling absence cleavage either secretase caspases
0.36325452.16103124.html.plaintext.txt	48	suggested app may able carry signal transduction cleavage caspases cleavage site within cytoplasmic c terminal domain 31 32 address possibility used pan caspase inhibitor benzyloxycarbonyl vad fluoromethyl ketone another series luciferase assays hek 293 cells inhibiting caspase activity benzyloxycarbonyl vad fluoromethyl ketone failed significantly affect ability app activate tip60 fig 3a notably still effect app signaling secretase caspase inhibitors added together similar results observed wild type es ps ko cells fig 3b thus app retains ability activate tip60 signaling absence cleavage either secretase caspases
0.36325452.16103124.html.plaintext.txt	49	recent study identified degrading enzyme neprilysin potential transcriptional target c50aicd 33 attempted confirm results using wild type es ps ko cell lines observed significant cell line variability levels endogenous neprilysin correlate presenilin genotype fig 3c indicating variation related presenilin expression furthermore attempted elevate neprilysin levels ps ko cells overexpression ps1 c50 c50 myc observe reproducible changes neprilysin levels upon expression plasmids 24 h transfection fig 3 d e confirmed ps1 c50 myc expressed western blotting fig 3 d e moreover confirmed transfected ps1 functional rescued accumulation app c terminal fragments observed absence secretase cleavage app fig 3d similar results observed hek 293 cells transfected c50 c50 myc data shown results suggest neprilysin may transcriptional target c50aicd
0.36325452.16103124.html.plaintext.txt	50	recent study identified degrading enzyme neprilysin potential transcriptional target c50aicd 33 attempted confirm results using wild type es ps ko cell lines observed significant cell line variability levels endogenous neprilysin correlate presenilin genotype fig 3c indicating variation related presenilin expression furthermore attempted elevate neprilysin levels ps ko cells overexpression ps1 c50 c50 myc observe reproducible changes neprilysin levels upon expression plasmids 24 h transfection fig 3 d e confirmed ps1 c50 myc expressed western blotting fig 3 d e moreover confirmed transfected ps1 functional rescued accumulation app c terminal fragments observed absence secretase cleavage app fig 3d similar results observed hek 293 cells transfected c50 c50 myc data shown results suggest neprilysin may transcriptional target c50aicd
0.36325452.16103124.html.plaintext.txt	51	complex formation tip60 fe65 app shown holo app membrane spanning c terminal fragments rather c50aicd may mediate signaling investigated whether tip60 forms complex holo app tip60 co immunoprecipitated holo app fig 2d presence holo app suggests tip60 may form complex app membrane compartment rather nucleus suggested previously 18 even longer exposures unable detect significant levels app c terminal fragments aicd tip60 immunoprecipitates suggesting tip60 forms complex holo app coexpression fe65 along tip60 app increased complex formation tip60 app fig 2d results suggest tip60 forms complex holo app presumably membrane support hypothesis app may signal mechanism involves membrane recruitment tip60 rather nuclear translocation aicd
0.36325452.16103124.html.plaintext.txt	52	complex formation tip60 fe65 app shown holo app membrane spanning c terminal fragments rather c50aicd may mediate signaling investigated whether tip60 forms complex holo app tip60 co immunoprecipitated holo app fig 2d presence holo app suggests tip60 may form complex app membrane compartment rather nucleus suggested previously 18 even longer exposures unable detect significant levels app c terminal fragments aicd tip60 immunoprecipitates suggesting tip60 forms complex holo app coexpression fe65 along tip60 app increased complex formation tip60 app fig 2d results suggest tip60 forms complex holo app presumably membrane support hypothesis app may signal mechanism involves membrane recruitment tip60 rather nuclear translocation aicd
0.36325452.16103124.html.plaintext.txt	53	view larger version 66k figure 6 colocalization app tip60 sh sy5y cells cotransfected tip60 alone c fe65 app d f fixed permeabilized 24 h post transfection tip60 visualized antibody ha tag cy3 conjugated secondary antibody red app visualized antibody c8 cy2 conjugated secondary antibody green nucleus labeled hoechst dye
0.36325452.16103124.html.plaintext.txt	54	view larger version 66k figure 6 colocalization app tip60 sh sy5y cells cotransfected tip60 alone c fe65 app d f fixed permeabilized 24 h post transfection tip60 visualized antibody ha tag cy3 conjugated secondary antibody red app visualized antibody c8 cy2 conjugated secondary antibody green nucleus labeled hoechst dye
0.36325452.16103124.html.plaintext.txt	55	role cyclin dependent kinase cdk phosphorylation tip60 signaling app activate tip60 pathway require secretase cleavage app considered whether app signaling involves activation kinase cascades two cdk sites recently identified tip60 serines 86 90 34 examine role phosphorylation sites app tip60 signaling fused gal4 dna binding domain tip60 mutant serines 86 90 converted alanines assessed activity tip60 mutant luciferase reporter assays transfected hek 293 cells tip60 mutant could activated coexpression fe65 app contrast strong transactivation observed wild type tip60 fig 4a confirm requirement cdk phosphorylation tip60 app signal transduction tested cdk inhibitor roscovitine cdk inhibition roscovitine significantly decreased ability app activate tip60 fig 4a similar results observed es cells fig 4b thus phosphorylation tip60 serines 86 90 cdks contributes transcriptional signaling tip60 phosphorylation mutant able co immunoprecipitate app efficiently wild type tip60 coexpressed fe65 fig 2d thus inability app activate tip60 mutant unlikely due effect complex formation app tip60
0.36325452.16103124.html.plaintext.txt	56	role cyclin dependent kinase cdk phosphorylation tip60 signaling app activate tip60 pathway require secretase cleavage app considered whether app signaling involves activation kinase cascades two cdk sites recently identified tip60 serines 86 90 34 examine role phosphorylation sites app tip60 signaling fused gal4 dna binding domain tip60 mutant serines 86 90 converted alanines assessed activity tip60 mutant luciferase reporter assays transfected hek 293 cells tip60 mutant could activated coexpression fe65 app contrast strong transactivation observed wild type tip60 fig 4a confirm requirement cdk phosphorylation tip60 app signal transduction tested cdk inhibitor roscovitine cdk inhibition roscovitine significantly decreased ability app activate tip60 fig 4a similar results observed es cells fig 4b thus phosphorylation tip60 serines 86 90 cdks contributes transcriptional signaling tip60 phosphorylation mutant able co immunoprecipitate app efficiently wild type tip60 coexpressed fe65 fig 2d thus inability app activate tip60 mutant unlikely due effect complex formation app tip60
0.36325452.16103124.html.plaintext.txt	57	stabilization phosphorylated forms tip60 app fe65 determined whether app facilitates tip60 phosphorylation wild type phosphorylation mutant tip60 construct cotransfected fe65 app hek 293 cells fig 4c treatment cell lysates calf intestinal alkaline phosphatase led condensation multiple tip60 bands single faster migrating form suggesting slower migrating forms phosphorylated forms tip60 tip60 mutant migrated lower apparent molecular mass compared wild type tip60 consistent lack phosphorylation tip60 cdk sites alkaline phosphatase treatment also led condensation tip60 mutant bands single faster migrating form comigrated dephosphorylated wild type tip60 indicating additional phosphorylation sites yet identified coexpression tip60 fe65 app led markedly enhanced levels slowest migrating phosphorylated forms wild type tip60 fig 4c densitometric analysis blot showed 73 increase slowest migrating band relative fastest migrating form tip60 fe65 app affect tip60 cdk phosphorylation mutant suggesting act specifically increase phosphorylation cdk sites coexpression app fe65 also led significant phosphorylation tip60 cdk sites es cells fig 4d confirm phosphorylation event mediated cdks tested cdk inhibitor roscovitine increase phosphorylation tip60 mediated fe65 app completely blocked cdk inhibitor roscovitine fig 4d results indicate app fe65 potentiate cdk mediated phosphorylation tip60 thereby activating nuclear signaling
0.36325452.16103124.html.plaintext.txt	58	stabilization phosphorylated forms tip60 app fe65 determined whether app facilitates tip60 phosphorylation wild type phosphorylation mutant tip60 construct cotransfected fe65 app hek 293 cells fig 4c treatment cell lysates calf intestinal alkaline phosphatase led condensation multiple tip60 bands single faster migrating form suggesting slower migrating forms phosphorylated forms tip60 tip60 mutant migrated lower apparent molecular mass compared wild type tip60 consistent lack phosphorylation tip60 cdk sites alkaline phosphatase treatment also led condensation tip60 mutant bands single faster migrating form comigrated dephosphorylated wild type tip60 indicating additional phosphorylation sites yet identified coexpression tip60 fe65 app led markedly enhanced levels slowest migrating phosphorylated forms wild type tip60 fig 4c densitometric analysis blot showed 73 increase slowest migrating band relative fastest migrating form tip60 fe65 app affect tip60 cdk phosphorylation mutant suggesting act specifically increase phosphorylation cdk sites coexpression app fe65 also led significant phosphorylation tip60 cdk sites es cells fig 4d confirm phosphorylation event mediated cdks tested cdk inhibitor roscovitine increase phosphorylation tip60 mediated fe65 app completely blocked cdk inhibitor roscovitine fig 4d results indicate app fe65 potentiate cdk mediated phosphorylation tip60 thereby activating nuclear signaling
0.36325452.16103124.html.plaintext.txt	59	view larger version 20k figure 7 shuttling tip60 nucleus cytoplasm app signaling identification two potential nuclear localization sequences nls within tip60 conserved mouse rat human orthologs additionally conserved potential nuclear export sequence indicated b hek 293 cells cotransfected pfr luciferase prl tk gal4 tip60 fe65 app cells treated nuclear export inhibitor leptomycin b 20 nm luciferase assays performed 24 transfection
0.36325452.16103124.html.plaintext.txt	60	view larger version 20k figure 7 shuttling tip60 nucleus cytoplasm app signaling identification two potential nuclear localization sequences nls within tip60 conserved mouse rat human orthologs additionally conserved potential nuclear export sequence indicated b hek 293 cells cotransfected pfr luciferase prl tk gal4 tip60 fe65 app cells treated nuclear export inhibitor leptomycin b 20 nm luciferase assays performed 24 transfection
0.36325452.16103124.html.plaintext.txt	61	app recruits tip60 membrane compartments determined subcellular localization tip60 fe65 app complex performing subcellular fractionation hek 293 cells expressing tip60 substantial portion tip60 present nuclear fraction whether fe65 app coexpressed fig 5a expected based previous studies 18 however upon expression fe65 app marked redistribution tip60 membrane fraction fig 5a nuclear protein lamin b2 present nuclear fraction detectable membrane fraction suggesting membrane associated tip60 due nuclear contamination determined whether endogenous tip60 recruited membrane app purpose utilized control hek 293 cells hek 293 cells stably expressing appwt observed overexpressed tip60 endogenous tip60 immunoreactivity nuclear fraction control app expressing cells fig 5b however app expressing cells substantial tip60 immunoreactivity membrane fraction observed control cells appwt expressing cells showed 10 fold increase membrane associated tip60 compared control cells overexpress app 2 fold increase total cellular tip60 thus endogenous tip60 recruited membrane app lack lamin b2 signal membrane fractions suggests tip60 immunoreactivity membrane fraction due nuclear contamination
0.36325452.16103124.html.plaintext.txt	62	app recruits tip60 membrane compartments determined subcellular localization tip60 fe65 app complex performing subcellular fractionation hek 293 cells expressing tip60 substantial portion tip60 present nuclear fraction whether fe65 app coexpressed fig 5a expected based previous studies 18 however upon expression fe65 app marked redistribution tip60 membrane fraction fig 5a nuclear protein lamin b2 present nuclear fraction detectable membrane fraction suggesting membrane associated tip60 due nuclear contamination determined whether endogenous tip60 recruited membrane app purpose utilized control hek 293 cells hek 293 cells stably expressing appwt observed overexpressed tip60 endogenous tip60 immunoreactivity nuclear fraction control app expressing cells fig 5b however app expressing cells substantial tip60 immunoreactivity membrane fraction observed control cells appwt expressing cells showed 10 fold increase membrane associated tip60 compared control cells overexpress app 2 fold increase total cellular tip60 thus endogenous tip60 recruited membrane app lack lamin b2 signal membrane fractions suggests tip60 immunoreactivity membrane fraction due nuclear contamination
0.36325452.16103124.html.plaintext.txt	63	determined whether app recruits tip60 membrane vivo performing subcellular fractionation wild type app transgenic mouse brains tip60 levels compared membrane fractions cortices hippocampi wild type tg2576 app transgenic mice either 3 months old prior plaque formation 2 years old amyloid plaque load high significantly tip60 appeared membrane fractions app transgenic samples compared age matched wild type control samples fig 5c however tip60 also detected membrane fractions wild type mice particularly hippocampus suggesting membrane sequestration occurs physiological conditions purity membrane fractions confirmed absence nuclear protein lamin b2 results suggest app recruits tip60 membrane compartments consistent formation tip60 complex transmembrane form app
0.36325452.16103124.html.plaintext.txt	64	determined whether app recruits tip60 membrane vivo performing subcellular fractionation wild type app transgenic mouse brains tip60 levels compared membrane fractions cortices hippocampi wild type tg2576 app transgenic mice either 3 months old prior plaque formation 2 years old amyloid plaque load high significantly tip60 appeared membrane fractions app transgenic samples compared age matched wild type control samples fig 5c however tip60 also detected membrane fractions wild type mice particularly hippocampus suggesting membrane sequestration occurs physiological conditions purity membrane fractions confirmed absence nuclear protein lamin b2 results suggest app recruits tip60 membrane compartments consistent formation tip60 complex transmembrane form app
0.36325452.16103124.html.plaintext.txt	65	colocalization tip60 app effect app tip60 localization also examined confocal immunofluorescence microscopy neuroblastoma sh sy5y cells transfected ha tip60 alone fig 6 c fe65 app d f tip60 labeled anti ha antibody app labeled antibody c8 raised app c terminal domain nucleus visualized staining hoechst dye tip60 expressed alone localized nucleus shown colocalization nuclear hoechst dye fig 6c coexpression tip60 fe65 app led dramatic change localization tip60 tip60 appearing outside nucleus fig 6f moreover substantial colocalization tip60 app cell surface fig 6f app excluded nucleus expected fig 6d presence non transfected cells labeled indicated specificity tip60 app labeling results consistent formation tip60 fe65 app complex membrane confirm results subcellular fractionation
0.36325452.16103124.html.plaintext.txt	66	colocalization tip60 app effect app tip60 localization also examined confocal immunofluorescence microscopy neuroblastoma sh sy5y cells transfected ha tip60 alone fig 6 c fe65 app d f tip60 labeled anti ha antibody app labeled antibody c8 raised app c terminal domain nucleus visualized staining hoechst dye tip60 expressed alone localized nucleus shown colocalization nuclear hoechst dye fig 6c coexpression tip60 fe65 app led dramatic change localization tip60 tip60 appearing outside nucleus fig 6f moreover substantial colocalization tip60 app cell surface fig 6f app excluded nucleus expected fig 6d presence non transfected cells labeled indicated specificity tip60 app labeling results consistent formation tip60 fe65 app complex membrane confirm results subcellular fractionation
0.36325452.16103124.html.plaintext.txt	67	shuttling tip60 nucleus cytoplasm results suggest app recruits tip60 membrane activates phosphorylation complex formation fe65 investigated whether tip60 contains nuclear localization export sequences could mediate tip60 shuttling nucleus cytoplasm psortii program identified two potential nuclear localization sequences within tip60 short basic nuclear localization sequence starting amino acid 184 pgrkrks type 1 bipartite nuclear localization sequence beginning amino acid 295 rkgtisffeidgrknks nuclear localization sequences completely conserved mouse rat human tip60 proteins also identified potential nuclear export sequence lttlpvlyl conforms classic lx2 3livfmx2 3lxli motif completely conserved mouse rat human tip60 proteins 35 raises possibility active transport tip60 nucleus may required interaction tip60 app may followed nuclear translocation transcriptional activation determine whether nuclear export required tip60 activation used crm1 nuclear export inhibitor leptomycin b gal4 tip60 luciferase assay treatment leptomycin b greatly suppressed ability app activate tip60 fig 7b thus nuclear export tip60 factor required app able activate transcription tip60 results support model tip60 actively shuttles cytoplasm nucleus enabling activation app fe65 membrane
0.36325452.16103124.html.plaintext.txt	68	shuttling tip60 nucleus cytoplasm results suggest app recruits tip60 membrane activates phosphorylation complex formation fe65 investigated whether tip60 contains nuclear localization export sequences could mediate tip60 shuttling nucleus cytoplasm psortii program identified two potential nuclear localization sequences within tip60 short basic nuclear localization sequence starting amino acid 184 pgrkrks type 1 bipartite nuclear localization sequence beginning amino acid 295 rkgtisffeidgrknks nuclear localization sequences completely conserved mouse rat human tip60 proteins also identified potential nuclear export sequence lttlpvlyl conforms classic lx2 3livfmx2 3lxli motif completely conserved mouse rat human tip60 proteins 35 raises possibility active transport tip60 nucleus may required interaction tip60 app may followed nuclear translocation transcriptional activation determine whether nuclear export required tip60 activation used crm1 nuclear export inhibitor leptomycin b gal4 tip60 luciferase assay treatment leptomycin b greatly suppressed ability app activate tip60 fig 7b thus nuclear export tip60 factor required app able activate transcription tip60 results support model tip60 actively shuttles cytoplasm nucleus enabling activation app fe65 membrane
0.36325452.16103124.html.plaintext.txt	69	view larger version 20k figure 8 model app mediated activation tip60 app recruits tip60 membrane adaptor protein fe65 facilitates phosphorylation stabilization tip60 cdks resulting tip60 activation followed dissociation complex nuclear translocation tip60 fe65 leading transcriptional activation tip60 target genes ptb phosphotyrosine binding domain
0.36325452.16103124.html.plaintext.txt	70	view larger version 20k figure 8 model app mediated activation tip60 app recruits tip60 membrane adaptor protein fe65 facilitates phosphorylation stabilization tip60 cdks resulting tip60 activation followed dissociation complex nuclear translocation tip60 fe65 leading transcriptional activation tip60 target genes ptb phosphotyrosine binding domain
0.36325452.16103124.html.plaintext.txt	71	discussion top abstract introduction materials methods results discussion references experiments indicate app activate tip60 mediated transcription absence presenilin mediated secretase cleavage contrary current dogma contrasts notch signaling secretase cleavage required activate transcription target genes results obtained es cells ps ko mice lacking detectable secretase activity additionally shown cell lines app retained ability activate tip60 presence secretase inhibitors concentrations prevent production generation c50aicd fragment findings suggest alternative model app signaling holo app recruits tip60 membrane induce tip60 phosphorylation complex formation fe65 leading activation signal transduction fig 8 phosphorylation event appears carried cdk signaling could blocked mutating known cdk sites tip60 cdk inhibitor roscovitine key aspect model signaling role app may lie ability recruit proteins microdomain membrane particular kinases cdk5 active
0.36325452.16103124.html.plaintext.txt	72	discussion top abstract introduction materials methods results discussion references experiments indicate app activate tip60 mediated transcription absence presenilin mediated secretase cleavage contrary current dogma contrasts notch signaling secretase cleavage required activate transcription target genes results obtained es cells ps ko mice lacking detectable secretase activity additionally shown cell lines app retained ability activate tip60 presence secretase inhibitors concentrations prevent production generation c50aicd fragment findings suggest alternative model app signaling holo app recruits tip60 membrane induce tip60 phosphorylation complex formation fe65 leading activation signal transduction fig 8 phosphorylation event appears carried cdk signaling could blocked mutating known cdk sites tip60 cdk inhibitor roscovitine key aspect model signaling role app may lie ability recruit proteins microdomain membrane particular kinases cdk5 active
0.36325452.16103124.html.plaintext.txt	73	model app signaling propose differs canonical notch signaling pathway app signals via activation cytoplasmic proteins post translational modifications rather providing intracellular domain activate transcription difference critical another group 36 found c50aicd fragment unable activate transcription contrast transcriptional activity nicd moreover results indicate overexpressed c50aicd acts dominant negative protein inhibit app tip60 signaling however secretase cleavage appears facilitate signaling es cells presumably release fe65 tip60 complex membrane one potential secretase independent mechanism dissociation fe65 tip60 app membrane could phosphorylation app threonine 668 shown decrease interaction fe65 app 37 interestingly cdk5 shown phosphorylate app site 38 raising possibility cdk5 could play dual role activating tip60 releasing complex membrane
0.36325452.16103124.html.plaintext.txt	74	model app signaling propose differs canonical notch signaling pathway app signals via activation cytoplasmic proteins post translational modifications rather providing intracellular domain activate transcription difference critical another group 36 found c50aicd fragment unable activate transcription contrast transcriptional activity nicd moreover results indicate overexpressed c50aicd acts dominant negative protein inhibit app tip60 signaling however secretase cleavage appears facilitate signaling es cells presumably release fe65 tip60 complex membrane one potential secretase independent mechanism dissociation fe65 tip60 app membrane could phosphorylation app threonine 668 shown decrease interaction fe65 app 37 interestingly cdk5 shown phosphorylate app site 38 raising possibility cdk5 could play dual role activating tip60 releasing complex membrane
0.36325452.16103124.html.plaintext.txt	75	one difference notch app processing app undergoes constitutive ectodomain shedding secretase cleavage whereas notch undergoes ectodomain shedding following ligand binding thus difficult understand app signaling could regulated occurs constitutively findings indicate one mechanism regulation pathway activity cdks particularly intriguing altered activity cdk5 already implicated alzheimer disease 39 40 furthermore cdk5 activator p35 membrane associated suggesting cdk5 could specifically phosphorylate tip60 recruited membrane app
0.36325452.16103124.html.plaintext.txt	76	one difference notch app processing app undergoes constitutive ectodomain shedding secretase cleavage whereas notch undergoes ectodomain shedding following ligand binding thus difficult understand app signaling could regulated occurs constitutively findings indicate one mechanism regulation pathway activity cdks particularly intriguing altered activity cdk5 already implicated alzheimer disease 39 40 furthermore cdk5 activator p35 membrane associated suggesting cdk5 could specifically phosphorylate tip60 recruited membrane app
0.36325452.16103124.html.plaintext.txt	77	number potential target genes c50aicd reported recently one intriguing potential target degrading enzyme neprilysin reported responsive c50aicd presenilin deficient cells 33 observe reproducible regulation neprilysin expression ps1 c50 moreover observed considerable variation neprilysin levels es cell lines strictly correlate presenilin genotype also attempted verify two proposed target genes tip60 kai1 manganese super oxide dismutase 27 41 hands reporter constructs containing promoters two genes responsive tip60 fe65 app various combinations constructs another recent study suggested fusion protein citrine c50aicd increases expression number genes including app bace tip60 glycogen synthase kinase 3 kai1 42 unable confirm results transfection hek 293 cells c50 c50 myc could reflect different activity reported citrine fusion protein overall able confirm proposed c50aicd target genes aware time work needs done delineate app signaling pathway primary importance identification endogenous target genes affected app progress area may hindered thus far focus aicd transcriptionally active form
0.36325452.16103124.html.plaintext.txt	78	number potential target genes c50aicd reported recently one intriguing potential target degrading enzyme neprilysin reported responsive c50aicd presenilin deficient cells 33 observe reproducible regulation neprilysin expression ps1 c50 moreover observed considerable variation neprilysin levels es cell lines strictly correlate presenilin genotype also attempted verify two proposed target genes tip60 kai1 manganese super oxide dismutase 27 41 hands reporter constructs containing promoters two genes responsive tip60 fe65 app various combinations constructs another recent study suggested fusion protein citrine c50aicd increases expression number genes including app bace tip60 glycogen synthase kinase 3 kai1 42 unable confirm results transfection hek 293 cells c50 c50 myc could reflect different activity reported citrine fusion protein overall able confirm proposed c50aicd target genes aware time work needs done delineate app signaling pathway primary importance identification endogenous target genes affected app progress area may hindered thus far focus aicd transcriptionally active form
0.36325452.16103124.html.plaintext.txt	79	relevance app signaling alzheimer disease unclear however shown many pathogenic mutations presenilins actually decrease notch signaling 4 43 45 moreover presenilin deficient mice exhibit neurodegenerative phenotype 46 additionally recent study showed familial alzheimer disease mutations app inhibit signaling app gal4 vp16 fusion 47 thus alterations app signaling could potentially play role pathogenesis alzheimer disease
0.36325452.16103124.html.plaintext.txt	80	relevance app signaling alzheimer disease unclear however shown many pathogenic mutations presenilins actually decrease notch signaling 4 43 45 moreover presenilin deficient mice exhibit neurodegenerative phenotype 46 additionally recent study showed familial alzheimer disease mutations app inhibit signaling app gal4 vp16 fusion 47 thus alterations app signaling could potentially play role pathogenesis alzheimer disease
0.36325452.16103124.html.plaintext.txt	81	overall data provide evidence app signaling novel mechanism require secretase cleavage presenilins involves recruitment signaling factors membrane facilitate phosphorylation complex formation mechanism would allow signaling regulated multiple ways activity cdks shuttling tip60 nucleus cytoplasm possibly secretase activity may modulate activation even though required
0.36325452.16103124.html.plaintext.txt	82	overall data provide evidence app signaling novel mechanism require secretase cleavage presenilins involves recruitment signaling factors membrane facilitate phosphorylation complex formation mechanism would allow signaling regulated multiple ways activity cdks shuttling tip60 nucleus cytoplasm possibly secretase activity may modulate activation even though required
0.36325452.16103124.html.plaintext.txt	83	footnotes work supported national institutes health grants ag17974 ns030352 b y fellowship national institutes health training grant ag0022 m r h costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.36325452.16103124.html.plaintext.txt	84	1 correspondence addressed dept neurology childrens hospital enders 460 300 longwood ave boston ma 02115 tel 617 355 7220 fax 617 730 1953 e mail bruceyankneratchildrensharvardedu u d
0.36325452.16103124.html.plaintext.txt	85	1 correspondence addressed dept neurology childrens hospital enders 460 300 longwood ave boston ma 02115 tel 617 355 7220 fax 617 730 1953 e mail bruceyankneratchildrensharvardedu u d
0.36325452.16103124.html.plaintext.txt	86	2 abbreviations used app amyloid precursor protein bace beta site app cleaving enzyme appsw app containing swedish mutation appwt wild type app aicd app intracellular domain amyloid peptide hek 293 human embryonic kidney 293 ha hemagglutinin nicd notch intracellular domain es embryonic stem ps ko presenilin 12 knockout ps1 presenilin 1 cdk cyclin dependent kinase tricine n 2 hydroxy 11 bishydroxymethylethylglycine ripa doc deoxychelate containing radioimmune precipitation assay buffer
0.36325452.16103124.html.plaintext.txt	87	acknowledgments thank shyan yuan kao providing aicd plasmids changiz geula menglan yuan assistance matthew salanga help confocal microscopy tao lu frank lee helpful discussion
0.36325452.16103124.html.plaintext.txt	88	references top abstract introduction materials methods results discussion references kang j lemaire h g unterbeck salbaum j m masters c l grzeschik k h multhaup g beyreuther k muller hill b 1987 nature 325 733 736crossrefmedline order article via infotrieve lichtenthaler f haass c 2004 j clin investig 113 1384 1387abstractfree full text selkoe d kopan r 2003 annu rev neurosci 26 565 597crossrefmedline order article via infotrieve song w nadeau p yuan m yang x shen j yankner b 1999 proc natl acad sci u 96 6959 6963abstractfree full text de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 398 518 522crossrefmedline order article via infotrieve zhang z nadeau p song w donoviel d yuan m bernstein yankner ba 2000 nat cell biol 2 463 465crossrefmedline order article via infotrieve herreman serneels l annaert w collen d schoonjans l de strooper b 2000 nat cell biol 2 461 462crossrefmedline order article via infotrieve tanzi r e bertram l 2005 cell 120 545 555crossrefmedline order article via infotrieve sisodia st george hyslop p h 2002 nat rev neurosci 3 281 290crossrefmedline order article via infotrieve yankner b 1996 neuron 16 921 932crossrefmedline order article via infotrieve geula c wu c k saroff d lorenzo yuan m yankner b 1998 nat med 4 827 831crossrefmedline order article via infotrieve breen k c bruce m anderton b h 1991 j neurosci res 28 90 100crossrefmedline order article via infotrieve chen m yankner b 1991 neurosci lett 125 223 226crossrefmedline order article via infotrieve kamal almenar queralt leblanc j f roberts e goldsteain l 2001 nature 414 643 648crossrefmedline order article via infotrieve leblanc c kovacs d m chen h y villare f tykocinski m autilio gambetti l gambetti p 1992 j neurosci res 31 635 645crossrefmedline order article via infotrieve jin l w ninomiya h roch j m schubert d masliah e otero d saitoh 1994 j neurosci 14 5461 5470abstract qiu w q ferreira miller c koo e h selkoe d j 1995 j neurosci 15 2157 2167abstract cao x sudhof c 2001 science 293 115 201abstractfree full text ebinu j o yankner b 2002 neuron 34 499 502crossrefmedline order article via infotrieve koo e kopan r 2004 nat med 10 s26 s33crossrefmedline order article via infotrieve fiore f zambrano n minopoli g donini v duilio russo 1995 j biol chem 270 30853 30856abstractfree full text zambrano n bimonte m arbucci gianni d russo bazzicalupo p 2002 j cell sci 115 1411 1422abstractfree full text kimberly w zheng j b guenette y selkoe d j 2001 j biol chem 276 40288 40292abstractfree full text kinoshita whelan c m smith c j berezovska o hyman b 2002 j neurochem 82 839 847crossrefmedline order article via infotrieve kinoshita whelan c m berezovska o hyman b 2002 j biol chem 277 28530 28536abstractfree full text gaughan l brady m e cook neal d e robson c n 2001 j biol chem 276 46841 46848abstractfree full text baek h ohgi k rose d w koo e h glass c k rosenfeld m g 2002 cell 110 55 67crossrefmedline order article via infotrieve ikura ogrzko v v grigoriev m groisman r wang j horikoshi m scully r qin j nakatani y 2000 cell 102 463 473crossrefmedline order article via infotrieve mcallister d merlo x lough j 2002 gene amst 289 169 176crossrefmedline order article via infotrieve sabo l lanier l m ikin f khorkova o sahasrabudhe greengard p buxbaum j d 1999 j biol chem 274 7952 7957abstractfree full text kim h kim e m lee j p park c h kim seo j h chang k yu e jeong j chong y h suh y h 2003 faseb j 17 1951 1953abstractfree full text zambrano n gianni d bruni p passaro f telese f russo 2004 j biol chem 279 16161 16169abstractfree full text pardossi piquard r petit kawarai sunyach c alves da costa c vincent b ring dadamio l shen j muller u st george hyslop p checler f 2005 neuron 46 541 554crossrefmedline order article via infotrieve lemercier c legube g caron c louwagie m garin j trouche d khochbin 2003 j biol chem 278 4713 4718abstractfree full text la cour gupta r rapack k skriver k poulsen f m brunak 2003 nucleic acids res 31 393 396abstractfree full text cao x sudhof c 2004 j biol chem 279 24601 24611abstractfree full text ando k iijima k elliott j kirino y suzuki 2001 j biol chem 276 40353 40361abstractfree full text iijima k ando k takeda satoh y seki itohara greengard p kirino y nairn c suzuki 2000 j neurochem 75 1085 1091crossrefmedline order article via infotrieve patrick g n zukerberg l nikolic m de la monte dikkes p tsai l h 1999 nature 402 615 622crossrefmedline order article via infotrieve lee m kwon y li m peng j friedlander r m tsai l h 2000 nature 405 360 364crossrefmedline order article via infotrieve creaven m hans f mutskov v col e caron c dimitrov khochbin 1999 biochemistry 38 8826 8830crossrefmedline order article via infotrieve von rotz r c kohli b m bosset j meier m suzuki nitsch r m konietzko u 2004 j cell sci 117 4435 4448abstractfree full text moehlmann e winkler e xia x edbauer d murrell j capell kaether c zheng h ghetti b haass c steiner h 2002 proc natl acad sci u 99 8025 8030abstractfree full text chen f gu y j hasegawa h ruan x arawaka fraser p westaway d mount h st george hyslop p 2002 j biol chem 277 36521 36526abstractfree full text schroeter e h ilagan m x brunkan l hecimovic li y xu m lewis h d saxena m de strooper b coonrod tomita iwatsubo moore c l goate wolfe m shearman m kopan r 2003 proc natl acad sci u 100 13075 13080abstractfree full text saura c choi y beglopoulos v malkani zhang d shankaranarayana rao b chattarji kelleher r j iii kandel e r duff k kirkwood shen j 2004 neuron 42 23 36crossrefmedline order article via infotrieve wiley j c hudson m kanning k c schecterson l c bothwell m 2005 j neurochem 94 1189 1201crossrefmedline order article via infotrieve passer b pellegrini l russo c siegal r m lenardo m j schettini g bachmann m tabaton m dadamio l 2000 j alzheimers dis 2 289 301medline order article via infotrieve
0.37338918.11978763.html.plaintext.txt	0	identification novel family presenilin homologues chris p ponting1 mike hutton2 andrew nyborg2 matthew baker2 karen jansen2 todd e golde2
0.37338918.11978763.html.plaintext.txt	1	identification novel family presenilin homologues chris p ponting1 mike hutton2 andrew nyborg2 matthew baker2 karen jansen2 todd e golde2
0.37338918.11978763.html.plaintext.txt	2	1mrc functional genetics unit university oxford department human anatomy genetics south parks road oxford ox1 3qx uk 2mayo clinic jacksonville department neuroscience 4500 san pablo road jacksonville fl 32224 usa
0.37338918.11978763.html.plaintext.txt	3	abstract top abstract introduction results discussion materials methods references presenilin 1 presenilin 2 polytopic membrane proteins whose genes mutated individuals alzheimers disease presenilins shown influence limited proteolysis amyloid ss protein precursor app notch erbb4 proposed secretases perform terminal cleavage app model two conserved apparently intramembranous aspartic acids participate catalysis highly sequence similar presenilin homologues known plants invertebrates vertebrates work used combination different sequence database search methods identify new family proteins homologous presenilins members family term presenilin homologues psh significant sequence similarities presenilins also possess two conserved aspartic acid residues within adjacent predicted transmembrane segments psh family found throughout eukaryotes fungi well plants animals archaea five pshs detectable human genome three possess protease associated domains consistent proposed protease function pss based findings propose pss pshs represent different sub branches larger family polytopic membrane associated aspartyl proteases
0.37338918.11978763.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references presenilin 1 presenilin 2 polytopic membrane proteins whose genes mutated individuals alzheimers disease presenilins shown influence limited proteolysis amyloid ss protein precursor app notch erbb4 proposed secretases perform terminal cleavage app model two conserved apparently intramembranous aspartic acids participate catalysis highly sequence similar presenilin homologues known plants invertebrates vertebrates work used combination different sequence database search methods identify new family proteins homologous presenilins members family term presenilin homologues psh significant sequence similarities presenilins also possess two conserved aspartic acid residues within adjacent predicted transmembrane segments psh family found throughout eukaryotes fungi well plants animals archaea five pshs detectable human genome three possess protease associated domains consistent proposed protease function pss based findings propose pss pshs represent different sub branches larger family polytopic membrane associated aspartyl proteases
0.37338918.11978763.html.plaintext.txt	5	introduction top abstract introduction results discussion materials methods references presenilin 1 ps1 presenilin 2 ps2 members evolutionarily conserved family polytopic membrane proteins thought span membrane six eight times reviewed 1 presenilins initially identified genetic linkage analysis families autosomal dominant forms alzheimers disease ad date numerous mutations chromosome 14 encoded ps1 gene several chromosome 1 encoded ps2 gene linked rare forms familial ad see httpwwwalzforumorgmembersresourcespresmutationsindexhtml
0.37338918.11978763.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references presenilin 1 ps1 presenilin 2 ps2 members evolutionarily conserved family polytopic membrane proteins thought span membrane six eight times reviewed 1 presenilins initially identified genetic linkage analysis families autosomal dominant forms alzheimers disease ad date numerous mutations chromosome 14 encoded ps1 gene several chromosome 1 encoded ps2 gene linked rare forms familial ad see httpwwwalzforumorgmembersresourcespresmutationsindexhtml
0.37338918.11978763.html.plaintext.txt	7	studies pss role development ad led appreciation regulate number diverse functions cell pss shown play role proteolytic processing amyloid ss protein precursor app app family members 23 notch notch family members 45 erbb4 6 cases pss appear required permit release cytoplasmic tail proteins membrane bound stub generated ectodomain cleavage holoprotein significantly inhibition release membrane bound stub proteins alters signaling cascades appear mediated translocation cytoplasmic tail nucleus 6 8 pss also shown interact wide array different proteins implicated ip3 mediated release endoplasmic reticulum er calcium 9 capacitative calcium entry 1011 ss catenin signaling 12 14 protein trafficking 15
0.37338918.11978763.html.plaintext.txt	8	studies pss role development ad led appreciation regulate number diverse functions cell pss shown play role proteolytic processing amyloid ss protein precursor app app family members 23 notch notch family members 45 erbb4 6 cases pss appear required permit release cytoplasmic tail proteins membrane bound stub generated ectodomain cleavage holoprotein significantly inhibition release membrane bound stub proteins alters signaling cascades appear mediated translocation cytoplasmic tail nucleus 6 8 pss also shown interact wide array different proteins implicated ip3 mediated release endoplasmic reticulum er calcium 9 capacitative calcium entry 1011 ss catenin signaling 12 14 protein trafficking 15
0.37338918.11978763.html.plaintext.txt	9	much work pss focused role processing app 1 pss shown influence final cleavage step release approximately 4 kda amyloid ss protein ass app proteolysis referred secretase cleavage event generates ass membrane stub app turn produced previous hydrolysis app holoprotein membrane bound aspartyl protease referred ss secretase significantly secretase generates ass peptides varying lengths two species interest peptides 40 amino acids ass40 42 amino acids ass42 cases studied date mutant pss increase relative level ass42 production longer ass42 aggregates rapidly forms ass previously shown increased ad linked mutations app studies implicated pss modulators secretase cleavage also convinced many ad field longer form ass critical ad pathogenesis 16
0.37338918.11978763.html.plaintext.txt	10	much work pss focused role processing app 1 pss shown influence final cleavage step release approximately 4 kda amyloid ss protein ass app proteolysis referred secretase cleavage event generates ass membrane stub app turn produced previous hydrolysis app holoprotein membrane bound aspartyl protease referred ss secretase significantly secretase generates ass peptides varying lengths two species interest peptides 40 amino acids ass40 42 amino acids ass42 cases studied date mutant pss increase relative level ass42 production longer ass42 aggregates rapidly forms ass previously shown increased ad linked mutations app studies implicated pss modulators secretase cleavage also convinced many ad field longer form ass critical ad pathogenesis 16
0.37338918.11978763.html.plaintext.txt	11	subsequent initial studies ad linked ps mutations three lines evidence emerged support direct role ps secretase cleavage app well secretase cleavage regulates release cytoplasmic tails notch erbb4 first genetic level pss appear essential cleavage ps1 knockout markedly inhibits secretase cleavage 34 whereas ps2 knockout apparent effect secretase activity 17 probably owing compensation widely expressed ps1 however combined ps1ps2 knockout completely abolishes secretase activity 1819 second biochemical evidence also supports identification pss secretases pss co fractionate secretase activity high molecular weight complex vitro activity recovered pellet immunoprecipitation antibodies ps1 20 addition mutation two absolutely conserved aspartate residues d257 d385 ps1 d263 d366 ps2 results pss act dominant negative fashion least respect secretase activity 2122 leads hypothesis pss represent novel class intramembranous cleaving diaspartyl proteases hypothesis supported inhibitor studies 2324 third four groups able show inhibitors secretase activity bind varying degrees specificity ps1 ps2 25 28 collectively experiments indicate compounds including properties protease inhibitors bind pss moreover given two groups specifically designed inhibitors transition state analogues aspartyl proteases certainly appears despite lack demonstrable homology known aspartyl proteases pss may
0.37338918.11978763.html.plaintext.txt	12	subsequent initial studies ad linked ps mutations three lines evidence emerged support direct role ps secretase cleavage app well secretase cleavage regulates release cytoplasmic tails notch erbb4 first genetic level pss appear essential cleavage ps1 knockout markedly inhibits secretase cleavage 34 whereas ps2 knockout apparent effect secretase activity 17 probably owing compensation widely expressed ps1 however combined ps1ps2 knockout completely abolishes secretase activity 1819 second biochemical evidence also supports identification pss secretases pss co fractionate secretase activity high molecular weight complex vitro activity recovered pellet immunoprecipitation antibodies ps1 20 addition mutation two absolutely conserved aspartate residues d257 d385 ps1 d263 d366 ps2 results pss act dominant negative fashion least respect secretase activity 2122 leads hypothesis pss represent novel class intramembranous cleaving diaspartyl proteases hypothesis supported inhibitor studies 2324 third four groups able show inhibitors secretase activity bind varying degrees specificity ps1 ps2 25 28 collectively experiments indicate compounds including properties protease inhibitors bind pss moreover given two groups specifically designed inhibitors transition state analogues aspartyl proteases certainly appears despite lack demonstrable homology known aspartyl proteases pss may
0.37338918.11978763.html.plaintext.txt	13	recently primary sequence encompassing one aspartate residues d385 ps1 d366 ps2 pss proposed similar region type iv prepilin peptidases contain catalytic aspartate residue 2930 sequence motif similarity common feature spanning membrane several times suggests pss bacterial signal peptidases may distinct members novel class intramembranous proteases despite local sequence similarities pss type iv prepilin peptidases demonstrably homologous order investigate whether pss possess hitherto unappreciated divergent homologues undertook searches protein nucleotide sequence databases using psi blast 31 hidden markov model package 32 searches revealed family sequences significant similarities presenilins observation may assist elucidating molecular cellular functions pss
0.37338918.11978763.html.plaintext.txt	14	recently primary sequence encompassing one aspartate residues d385 ps1 d366 ps2 pss proposed similar region type iv prepilin peptidases contain catalytic aspartate residue 2930 sequence motif similarity common feature spanning membrane several times suggests pss bacterial signal peptidases may distinct members novel class intramembranous proteases despite local sequence similarities pss type iv prepilin peptidases demonstrably homologous order investigate whether pss possess hitherto unappreciated divergent homologues undertook searches protein nucleotide sequence databases using psi blast 31 hidden markov model package 32 searches revealed family sequences significant similarities presenilins observation may assist elucidating molecular cellular functions pss
0.37338918.11978763.html.plaintext.txt	15	results top abstract introduction results discussion materials methods references human ps1 ps2 sequences compared non redundant database nr using psi blast 31 e value threshold 2x10 3 search revealed mouse sequence unknown function geninfo code 12849450 marginally similar albeit non significant statistics ps1 ps2 e18 23 respectively 2 search rounds mouse sequence compared nr evident one large family proteins representatives among fungi plants arthropods nematode worms vertebrates archaea family showed three intriguing similarities pss first families transmembrane tm proteins whose sequences aligned almost throughout entire lengths fig 1 second contain conserved yd ghgd pal motifs h represents hydrophobic residue collinear arrangement figs 1 2 third yd ghgd motifs pss include candidate active site aspartic acid residues 21 unusual present within predicted adjacent tm segments
0.37338918.11978763.html.plaintext.txt	16	results top abstract introduction results discussion materials methods references human ps1 ps2 sequences compared non redundant database nr using psi blast 31 e value threshold 2x10 3 search revealed mouse sequence unknown function geninfo code 12849450 marginally similar albeit non significant statistics ps1 ps2 e18 23 respectively 2 search rounds mouse sequence compared nr evident one large family proteins representatives among fungi plants arthropods nematode worms vertebrates archaea family showed three intriguing similarities pss first families transmembrane tm proteins whose sequences aligned almost throughout entire lengths fig 1 second contain conserved yd ghgd pal motifs h represents hydrophobic residue collinear arrangement figs 1 2 third yd ghgd motifs pss include candidate active site aspartic acid residues 21 unusual present within predicted adjacent tm segments
0.37338918.11978763.html.plaintext.txt	17	view larger version 225k figure 1 multiple sequence alignment presenilins pss top ps homologues pshs represented using chroma httpwwwlgndirectcoukchroma 75 consensus alignment sequences made using 8 transmembrane tm model pss ps1 ps2 amino acids substituted individuals familial alzheimers disease httpwwwalzforumorgmembersresourcespresmutations shown white red amino acid changes due non synonymous single nucleotide polymorphisms human psh2 psh3 shown white blue amino acid substitution ala pro psh3 prior putative active site residue containing lglgd motif might deleterious function aspartic acids thought active site residues shown white magenta indicated positions seven predicted eight tm segments pss shown correspond seven tm segments pshs numbers parentheses represent numbers amino acids excised alignment represents gap geninfo numbers amino acid limits sequences shown following alignment proteins asterisks contain n terminal protease associated pa domains protein andor gene names shown followed species abbreviations af archaeoglobus fulgidus arabidopsis thaliana ce caenorhabditis elegans dm drosophila melanogaster dr danio rerio zebrafish hl helix lucorum mollusc hs homo sapiens hsp halobacterium sp nrc 1 sp schizosaccharomyces pombe ta thermoplasma acidophilum tv thermoplasma volcanium xl xenopus laevis
0.37338918.11978763.html.plaintext.txt	18	view larger version 225k figure 1 multiple sequence alignment presenilins pss top ps homologues pshs represented using chroma httpwwwlgndirectcoukchroma 75 consensus alignment sequences made using 8 transmembrane tm model pss ps1 ps2 amino acids substituted individuals familial alzheimers disease httpwwwalzforumorgmembersresourcespresmutations shown white red amino acid changes due non synonymous single nucleotide polymorphisms human psh2 psh3 shown white blue amino acid substitution ala pro psh3 prior putative active site residue containing lglgd motif might deleterious function aspartic acids thought active site residues shown white magenta indicated positions seven predicted eight tm segments pss shown correspond seven tm segments pshs numbers parentheses represent numbers amino acids excised alignment represents gap geninfo numbers amino acid limits sequences shown following alignment proteins asterisks contain n terminal protease associated pa domains protein andor gene names shown followed species abbreviations af archaeoglobus fulgidus arabidopsis thaliana ce caenorhabditis elegans dm drosophila melanogaster dr danio rerio zebrafish hl helix lucorum mollusc hs homo sapiens hsp halobacterium sp nrc 1 sp schizosaccharomyces pombe ta thermoplasma acidophilum tv thermoplasma volcanium xl xenopus laevis
0.37338918.11978763.html.plaintext.txt	19	view larger version 19k figure 2 schematic representations predicted transmembrane topologies presenilin 1 human psh2 contains protease associated pa domain topology predictions made basis identifications signal peptides pa domains pshs 8 tm model ps topologies pink stars represent putative active site aspartic acid residues pss pshs red triangles represent conserved palp motifs
0.37338918.11978763.html.plaintext.txt	20	view larger version 19k figure 2 schematic representations predicted transmembrane topologies presenilin 1 human psh2 contains protease associated pa domain topology predictions made basis identifications signal peptides pa domains pshs 8 tm model ps topologies pink stars represent putative active site aspartic acid residues pss pshs red triangles represent conserved palp motifs
0.37338918.11978763.html.plaintext.txt	21	order investigate whether newly identified protein family homologous pss constructed multiple sequence alignment compared global hidden markov model 32 derived alignment second non redundant database nrdb90 results showed presenilins represented highest scoring sequences including plant presenilin arabidopsis thaliana gene product at2g29900 whose sequence similarity family significant e53x10 3 significant sequence similarities demonstrate eukaryotic archaeal proteins represent novel family presenilin homologues pshs
0.37338918.11978763.html.plaintext.txt	22	order investigate whether newly identified protein family homologous pss constructed multiple sequence alignment compared global hidden markov model 32 derived alignment second non redundant database nrdb90 results showed presenilins represented highest scoring sequences including plant presenilin arabidopsis thaliana gene product at2g29900 whose sequence similarity family significant e53x10 3 significant sequence similarities demonstrate eukaryotic archaeal proteins represent novel family presenilin homologues pshs
0.37338918.11978763.html.plaintext.txt	23	five distinct psh genes evident human genome sequence psh genes found fungi saccharomyces cerevisiae archaea archaeoglobus fulgidus first time ps homologues detected eukaryotes plants animals prokaryotes
0.37338918.11978763.html.plaintext.txt	24	five distinct psh genes evident human genome sequence psh genes found fungi saccharomyces cerevisiae archaea archaeoglobus fulgidus first time ps homologues detected eukaryotes plants animals prokaryotes
0.37338918.11978763.html.plaintext.txt	25	predicted presence expressed sequence tag est database human psh rt pcr experiments confirm pshs expressed humans fig 3 pcr products amplified human brain cdna library h4 cdna experiments h4 mrna treated dnase remove trace dna contamination prior reverse transcription non reverse transcribed dnase treated rna used control show product originated mrna genomic dna contamination thus like pshs intronless psh2 mrna expressed full length cdnas homologue also amplified h4 cell cdna data shown
0.37338918.11978763.html.plaintext.txt	26	view larger version 29k figure 3 rt pcr analysis psh1 5 human brain h4 neuroglioma cells ps1 5 transcripts expressed brain h4 cells non quantitative studies appears psh2 likely expressed lower levels pshs indicates cdna rt indicates h4 mrna treated dnase reverse transcribed brain refers amplification brain cdna library h4 refers rt pcr h4 mrna authenticity products verified sequencing
0.37338918.11978763.html.plaintext.txt	27	view larger version 29k figure 3 rt pcr analysis psh1 5 human brain h4 neuroglioma cells ps1 5 transcripts expressed brain h4 cells non quantitative studies appears psh2 likely expressed lower levels pshs indicates cdna rt indicates h4 mrna treated dnase reverse transcribed brain refers amplification brain cdna library h4 refers rt pcr h4 mrna authenticity products verified sequencing
0.37338918.11978763.html.plaintext.txt	28	proximity psh2 mapt gene codes microtubule associated protein tau chromosome 17 suggested might candidate gene variant ftdp 17 occurs families lack tau pathology obvious mutations tau 33 35 sequence analysis therefore performed probands four families frontotemporal dementia ftd similar clinical pathological phenotypes tau negative families however case ftd family large enough confirm linkage chromosome 17 addition psh2 sequenced control samples h1h1 h2h2 mapt genotypes identify single nucleotide polymorphisms snps linkage disequilibrium haplotypes adjacent mapt gene analysis demonstrated psh2 highly polymorphic 12 snps detected nine alter encoded amino acid sequence table 1 nine psh2 snps apparently complete linkage disequilibrium h1h2 haplotypes adjacent mapt gene however none snps obviously pathogenic four ftd families since present control individuals segregate disease r123q e209k
0.37338918.11978763.html.plaintext.txt	29	proximity psh2 mapt gene codes microtubule associated protein tau chromosome 17 suggested might candidate gene variant ftdp 17 occurs families lack tau pathology obvious mutations tau 33 35 sequence analysis therefore performed probands four families frontotemporal dementia ftd similar clinical pathological phenotypes tau negative families however case ftd family large enough confirm linkage chromosome 17 addition psh2 sequenced control samples h1h1 h2h2 mapt genotypes identify single nucleotide polymorphisms snps linkage disequilibrium haplotypes adjacent mapt gene analysis demonstrated psh2 highly polymorphic 12 snps detected nine alter encoded amino acid sequence table 1 nine psh2 snps apparently complete linkage disequilibrium h1h2 haplotypes adjacent mapt gene however none snps obviously pathogenic four ftd families since present control individuals segregate disease r123q e209k
0.37338918.11978763.html.plaintext.txt	30	view table table 1 snps identified sequence analysis psh2 discussion top abstract introduction results discussion materials methods references newly identified pshs could aligned entire lengths pss encompassing ps tm segments 2 8 fig 2 despite apparent lack tm segment 1 appear membrane topology pss consequence signal peptide sequences regions highly conserved two families include putative active site aspartic acid residues also tm sequences palp motif reported obligatory stabilization complex formation secretase activities presenilins 36 several animal plant pshs found contain n terminal protease associated pa domains often co occur peptidase domains 37 consistent hypothesis pshs also homology pss possess peptidase function
0.37338918.11978763.html.plaintext.txt	31	five human psh genes psh1 gene neighbors locus chromosome 12q24 linkage bipolar risk 38 psh2 proximal gene mapt gene encoding tau protein chromosome 17q2131 hyperphosphorylated forms tau often found brains patients ad mapt mutations associated frontotemporal dementia parkinsonism linked chromosome 17 ftdp 17 3940 one hand close proximity ps homologue gene whose dysfunction intimately associated neurodegenerative conditions might coincidental hand close proximity 50 kb genes might significant since sequence analysis revealed multiple nine snps psh2 complete linkage disequilibrium extended h1h2 haplotypes mapt gene 41 h1 haplotype genetic risk factor development sporadic tauopathies progressive supranuclear palsy 41 cortical basal degeneration 42 addition location psh2 might relevant families described ftdp 17 lacking tau pathology without obvious mutations mapt gene 33 35 sequencing psh2 multiple mapt mutation negative ftd families similar clinical pathological phenotypes ftdp 17 families thus far failed reveal evidence pathogenic mutations however none sequenced tau negative ftd families large enough demonstrate linkage chromosome 17q thus cannot exclude psh2 candidate gene tau negative ftdp 17 remaining three psh genes chromosomes 20q1121 19p133 15q212
0.37338918.11978763.html.plaintext.txt	32	five human psh genes psh1 gene neighbors locus chromosome 12q24 linkage bipolar risk 38 psh2 proximal gene mapt gene encoding tau protein chromosome 17q2131 hyperphosphorylated forms tau often found brains patients ad mapt mutations associated frontotemporal dementia parkinsonism linked chromosome 17 ftdp 17 3940 one hand close proximity ps homologue gene whose dysfunction intimately associated neurodegenerative conditions might coincidental hand close proximity 50 kb genes might significant since sequence analysis revealed multiple nine snps psh2 complete linkage disequilibrium extended h1h2 haplotypes mapt gene 41 h1 haplotype genetic risk factor development sporadic tauopathies progressive supranuclear palsy 41 cortical basal degeneration 42 addition location psh2 might relevant families described ftdp 17 lacking tau pathology without obvious mutations mapt gene 33 35 sequencing psh2 multiple mapt mutation negative ftd families similar clinical pathological phenotypes ftdp 17 families thus far failed reveal evidence pathogenic mutations however none sequenced tau negative ftd families large enough demonstrate linkage chromosome 17q thus cannot exclude psh2 candidate gene tau negative ftdp 17 remaining three psh genes chromosomes 20q1121 19p133 15q212
0.37338918.11978763.html.plaintext.txt	33	pshs appear widely expressed since represented numerous ests diverse tissues cell lines significantly even though intronless psh2 might predicted non translated pseudogene resulting retrotransposition ancestral psh mrna fact appear expressed least mrna level initial non quantitative rt pcr experiments expression psh2 appeared lower pshs rigorous analysis relative expression levels needed determine relative abundance psh transcripts
0.37338918.11978763.html.plaintext.txt	34	pshs appear widely expressed since represented numerous ests diverse tissues cell lines significantly even though intronless psh2 might predicted non translated pseudogene resulting retrotransposition ancestral psh mrna fact appear expressed least mrna level initial non quantitative rt pcr experiments expression psh2 appeared lower pshs rigorous analysis relative expression levels needed determine relative abundance psh transcripts
0.37338918.11978763.html.plaintext.txt	35	identification novel family ps homologues likely lead insights ps function evolution inference pss diaspartyl peptidase function pshs plausible however perhaps unlikely pshs cleave known ps substrates since psh family represented among archaea eukaryotes appear arisen considerably appearance pss ass notch erbb4 moreover double knockout ps1 ps2 appears sufficient abolish secretase cleavage app notch 1819 case additional experiments need conducted determine whether pshs cleave known secretase substrates based apparent expression brain unlikely known secretase substrates major substrates pshs however shown enzyme families identification wider repertoire pspsh family members may facilitate greater understanding molecular cellular functions biomedically important family particular given interest developing secretase inhibitors target pss potential therapeutic agents ad 1 information gathered studying protein family may offer important insights potential catalytic mechanisms substrate specificities ps psh aid development inhibitors
0.37338918.11978763.html.plaintext.txt	36	identification novel family ps homologues likely lead insights ps function evolution inference pss diaspartyl peptidase function pshs plausible however perhaps unlikely pshs cleave known ps substrates since psh family represented among archaea eukaryotes appear arisen considerably appearance pss ass notch erbb4 moreover double knockout ps1 ps2 appears sufficient abolish secretase cleavage app notch 1819 case additional experiments need conducted determine whether pshs cleave known secretase substrates based apparent expression brain unlikely known secretase substrates major substrates pshs however shown enzyme families identification wider repertoire pspsh family members may facilitate greater understanding molecular cellular functions biomedically important family particular given interest developing secretase inhibitors target pss potential therapeutic agents ad 1 information gathered studying protein family may offer important insights potential catalytic mechanisms substrate specificities ps psh aid development inhibitors
0.37338918.11978763.html.plaintext.txt	37	materials methods top abstract introduction results discussion materials methods references bioinformatic methods known ps sequences compared non redundant protein sequence database nr ftpftpncbinlmnihgovpubblastdbnr 808 320 sequences using psi blast 31 e value threshold 2x10 3 e value expect value given alignment score x represents number alignments scores x higher expected purely chance database search similar psi blast searches determined extent protein family homologous mouse sequence geninfo code 12849450 multiple sequence alignment familys sequences constructed using clustal w 43 manually adjusted minimize gap positions within secondary structures hidden markov model alignment constructed using hmmer 32 compared second non redundant protein sequence database nrdb90 ftpftpebiacukpubdatabasesnrdb90 392 089 sequences
0.37338918.11978763.html.plaintext.txt	38	members psh sequence family detected searching non redundant nucleotide sequence nt ftpftpncbinlmnihgovpubblastdbnt expressed sequence tag ftpftpncbinlmnihgovpubblastdbest databases using blast positions psh genes human genome determined using blat httpgenomecseucsceducgibinhgblatcommandstart signal peptides detected using signalp httpwwwcbsdtudkservicessignalp co occurring domains identified using pfam httpwwwsangeracukpfam transmembrane topologies pss pshs predicted using algorithms tmhmm httpwwwcbsdtudkservicestmhmm tmpred httpwwwchembnetorgsoftwaretmpredformhtml
0.37338918.11978763.html.plaintext.txt	39	rt pcr rna extracted h4 human neuroglioma cells using rneasy rna extraction kit qiagen chatsworth ca according manufacturers instructions rna treated dnase using dna free kit ambion austin tx cdna synthesized 5 microg rna using superscript reverse transcriptase invitrogen carlsbad ca also according manufacturers instruction whole brain cdna library purchased invitrogen pcr performed taq dna polymerase invitrogen hybaid mbs 02g thermocycler using touchdown program following cycling parameters 10 cycles annealing 60 degrees c followed 25 cycles annealing 55 degrees c primers pcr reactions shown table 2 pcr products analyzed 2 nusieve gel biowhittaker rockland
0.37338918.11978763.html.plaintext.txt	40	rt pcr rna extracted h4 human neuroglioma cells using rneasy rna extraction kit qiagen chatsworth ca according manufacturers instructions rna treated dnase using dna free kit ambion austin tx cdna synthesized 5 microg rna using superscript reverse transcriptase invitrogen carlsbad ca also according manufacturers instruction whole brain cdna library purchased invitrogen pcr performed taq dna polymerase invitrogen hybaid mbs 02g thermocycler using touchdown program following cycling parameters 10 cycles annealing 60 degrees c followed 25 cycles annealing 55 degrees c primers pcr reactions shown table 2 pcr products analyzed 2 nusieve gel biowhittaker rockland
0.37338918.11978763.html.plaintext.txt	41	view table table 2 pcr primers amplification psh pcr sequence analysis primers designed generate three separate products product 1 amplified using primers 1f 3r giving 1126 bp product sequenced 1f 1r 2f 2r 3f 3r product 2 generated using primers 3f 5r giving 1088 bp product sequenced 3f 4f 4r 5r product 3 generated using primers 5f 7r giving 852 bp product sequenced 5f 6f 6r 7r primer sequences shown table 3 reactions contained 50 ng genomic dna 50 microl mixture containing 20 pmol primer 02 mm dntps 1 unit taq buffer q solution qiagen california uk amplifications performed oil free hybaid touchdown thermal cyclers hybaid cambridge uk conditions 35 cycles 94 degrees c 30 60 degrees c 50 degrees c touchdown annealing 30 72 degrees c 45 final extension 72 degrees c 10 min products purified using qiaquick pcr purification kit qiagen ca 100 ng product sequenced directions using big dye kit perkin elmer sequencing performed abi377 automated sequencer processed using factura sequence navigator software perkin elmer
0.37338918.11978763.html.plaintext.txt	42	view table table 3 pcr internal sequencing primers
0.37338918.11978763.html.plaintext.txt	43	footnotes correspondence addressed tel 44 1865 272175 fax 44 1865 282651 email chrispontingatanatoxacuk
0.37338918.11978763.html.plaintext.txt	44	references top abstract introduction results discussion materials methods references 1 golde te younkin sg 2001 presenilins therapeutic targets treatment alzheimers disease trends mol med 7 264 269isimedline
0.37338918.11978763.html.plaintext.txt	45	40 hutton m 2000 molecular genetics chromosome 17 tauopathies ann ny acad sci 920 63 73abstractfree full text
0.37662143.11823322.html.plaintext.txt	0	genotype phenotype alzheimers disease clive holmes mrcpsych
0.37662143.11823322.html.plaintext.txt	1	thornhill research unit university southampton moorgreen hospital botley road west end southampton so30 3jb uk
0.37662143.11823322.html.plaintext.txt	2	background patients alzheimers disease show wide variation clinical phenotype genetic research largely concerned role mutations common variants risk factors disease genetic factors also influence clinical phenotype
0.37662143.11823322.html.plaintext.txt	3	background patients alzheimers disease show wide variation clinical phenotype genetic research largely concerned role mutations common variants risk factors disease genetic factors also influence clinical phenotype
0.37662143.11823322.html.plaintext.txt	4	aims examine evidence genetic factors influence clinical expression disease addition influencing risk
0.37662143.11823322.html.plaintext.txt	5	method selective review made key literature
0.37662143.11823322.html.plaintext.txt	6	results mutations three genes coding amyloid precursor protein presenilin 1 presenilin 2 common variation 4 another gene apoe shown lead earlier development disease recently genetic association twin studies suggested role genetic factors development aspects clinical phenotype notably appearance non cognitive symptoms
0.37662143.11823322.html.plaintext.txt	7	results mutations three genes coding amyloid precursor protein presenilin 1 presenilin 2 common variation 4 another gene apoe shown lead earlier development disease recently genetic association twin studies suggested role genetic factors development aspects clinical phenotype notably appearance non cognitive symptoms
0.37662143.11823322.html.plaintext.txt	8	conclusions alzheimers disease genetic variation influences number aspects clinical phenotype
0.37662143.11823322.html.plaintext.txt	9	early family twin studies indicated number genes important part play development alzheimers disease variation genes including rare mutations common polymorphisms appears confer increased risk development disease however apparent increased risk may largely explained effects genetic variation clinical phenotype alzheimers disease particularly age disease presents recently proposed genetic variation may also explain features clinical phenotype including development non cognitive symptoms
0.37662143.11823322.html.plaintext.txt	10	early family twin studies indicated number genes important part play development alzheimers disease variation genes including rare mutations common polymorphisms appears confer increased risk development disease however apparent increased risk may largely explained effects genetic variation clinical phenotype alzheimers disease particularly age disease presents recently proposed genetic variation may also explain features clinical phenotype including development non cognitive symptoms
0.37662143.11823322.html.plaintext.txt	11	clearest evidence genetic contribution aetiology alzheimers disease existence families disease transmitted clear autosomal dominant pattern study one large pedigrees revealed transmission generation generation single point mutation gene amyloid precursor protein app found chromosome 21 family members developing early onset alzheimers disease studies families led discovery point mutations gene later presence mutations two genes encoding presenilin 1 ps 1 presenilin 2 ps 2 found chromosomes 14 1 respectively date 12 alzheimers disease related mutations discovered app gene 69 mutations ps 1 gene 5 mutations ps 2 gene significantly research suggests different mutations three genes lead common result increase ss a4 peptide fragment app forms core neuritic plaques found brains people alzheimers disease
0.37662143.11823322.html.plaintext.txt	12	clearest evidence genetic contribution aetiology alzheimers disease existence families disease transmitted clear autosomal dominant pattern study one large pedigrees revealed transmission generation generation single point mutation gene amyloid precursor protein app found chromosome 21 family members developing early onset alzheimers disease studies families led discovery point mutations gene later presence mutations two genes encoding presenilin 1 ps 1 presenilin 2 ps 2 found chromosomes 14 1 respectively date 12 alzheimers disease related mutations discovered app gene 69 mutations ps 1 gene 5 mutations ps 2 gene significantly research suggests different mutations three genes lead common result increase ss a4 peptide fragment app forms core neuritic plaques found brains people alzheimers disease
0.37662143.11823322.html.plaintext.txt	13	findings immense importance terms elucidating biological pathogenesis alzheimers diease important recognise three causal genes may account 30 50 autosomal dominant early onset cases around 10 familial early onset cases cruts et al 1998 thus given majority cases 95 alzheimers disease occurs age 60 years clear genetic mutations make small contribution risk developing disease general
0.37662143.11823322.html.plaintext.txt	14	findings immense importance terms elucidating biological pathogenesis alzheimers diease important recognise three causal genes may account 30 50 autosomal dominant early onset cases around 10 familial early onset cases cruts et al 1998 thus given majority cases 95 alzheimers disease occurs age 60 years clear genetic mutations make small contribution risk developing disease general
0.37662143.11823322.html.plaintext.txt	15	inheritance late onset alzheimers disease complex early onset form cross sectional studies presence positive family history late onset alzheimers disease consistent risk factor subjects late onset form clear autosomal dominant pattern inheritance rare twin family studies suggest polygenic multifactorial mode inheritance consequence elucidation genetic risk factors late onset alzheimers disease requires different methods used early onset disease simple mendelian patterns inheritance association studies far dominated genetics late onset alzheimers disease studies look variation frequency allele samples unrelated patients late onset alzheimers disease compared unrelated control subjects studies resulted number candidate genes proposed importance risk factors late onset alzheimers disease include associations variation genes encoding low density lipoprotein vldl receptor ps 1 intronic mutation associated early onset alzheimers disease butyrylcholinesterase angiotensin 1 converting enzyme 1 antichymotrypsin human leucocyte antigen hla complex 2 macroglobulin low density lipoprotein like receptor serotonin transporter interleukin 1 typically interest candidates diminished independent replication forthcoming little evidence remains important role genetic variation vldl receptor ps 1 1 antichymotrypsin genes development late onset alzheimers disease candidate genes still advocates remain hotly disputed
0.37662143.11823322.html.plaintext.txt	16	inheritance late onset alzheimers disease complex early onset form cross sectional studies presence positive family history late onset alzheimers disease consistent risk factor subjects late onset form clear autosomal dominant pattern inheritance rare twin family studies suggest polygenic multifactorial mode inheritance consequence elucidation genetic risk factors late onset alzheimers disease requires different methods used early onset disease simple mendelian patterns inheritance association studies far dominated genetics late onset alzheimers disease studies look variation frequency allele samples unrelated patients late onset alzheimers disease compared unrelated control subjects studies resulted number candidate genes proposed importance risk factors late onset alzheimers disease include associations variation genes encoding low density lipoprotein vldl receptor ps 1 intronic mutation associated early onset alzheimers disease butyrylcholinesterase angiotensin 1 converting enzyme 1 antichymotrypsin human leucocyte antigen hla complex 2 macroglobulin low density lipoprotein like receptor serotonin transporter interleukin 1 typically interest candidates diminished independent replication forthcoming little evidence remains important role genetic variation vldl receptor ps 1 1 antichymotrypsin genes development late onset alzheimers disease candidate genes still advocates remain hotly disputed
0.37662143.11823322.html.plaintext.txt	17	recently results number linkage studies become available methods used linkage studies complex non mendelian diseases late onset alzheimers disease less powerful used early onset form however studies reveal areas interest genome might later explored association studies complete genomic screen series multiplex families affected late onset alzheimers disease revealed five regions interest chromosomes 4 6 12 19 20 excluding effects apoe4 locus maximum log likelihood ratio lod score study occurred region located short arm chromosome 12 pericak vance et al 1997 however two subsequent studies following similar methods blacker et al 1998 wu et al 1998 unable confirm linkage area large sibpair study kehoe et al 1999 revealed many possible loci showing linkage late onset alzheimers disease include loci chromosomes 1 5 9 10 12 14 19 close apoe 21 close app gene currently main focus attention chromosome 10 two independent studies showing evidence susceptibility locus region ertekin taner et al 2000 myers et al 2000 however clear large number loci implicated disagreement studies predicted areas interest findings demonstrate limitations approach also serve emphasise polygenic nature late onset alzheimers disease exploration areas association studies positional candidate approach likely dominate genetics alzheimers disease future
0.37662143.11823322.html.plaintext.txt	18	recently results number linkage studies become available methods used linkage studies complex non mendelian diseases late onset alzheimers disease less powerful used early onset form however studies reveal areas interest genome might later explored association studies complete genomic screen series multiplex families affected late onset alzheimers disease revealed five regions interest chromosomes 4 6 12 19 20 excluding effects apoe4 locus maximum log likelihood ratio lod score study occurred region located short arm chromosome 12 pericak vance et al 1997 however two subsequent studies following similar methods blacker et al 1998 wu et al 1998 unable confirm linkage area large sibpair study kehoe et al 1999 revealed many possible loci showing linkage late onset alzheimers disease include loci chromosomes 1 5 9 10 12 14 19 close apoe 21 close app gene currently main focus attention chromosome 10 two independent studies showing evidence susceptibility locus region ertekin taner et al 2000 myers et al 2000 however clear large number loci implicated disagreement studies predicted areas interest findings demonstrate limitations approach also serve emphasise polygenic nature late onset alzheimers disease exploration areas association studies positional candidate approach likely dominate genetics alzheimers disease future
0.37662143.11823322.html.plaintext.txt	19	genetic risk factors advocated role development late onset alzheimers disease least controversial remains increased risk associated possession one copies apoe4 allele coding apolipoprotein e apoe variant 4 significantly importance apoe4 determined using positional candidate gene approach since finding studies artiga et al 1998 bullido et al 1998 lambert et al 1998 also suggested association number polymorphisms within transcriptional regulatory region apoe gene late onset alzheimers disease independent apoe 4 status based data suggested two independent mechanisms risk late onset alzheimers disease modified apoe gene first variations coding regions alter functional properties apoe second presence promoter variants result quantitative differences apoe expression artiga et al 1998 however hypothesis controversial recent studies helisalmi et al 1999 zurutuza et al 2000 failed support independence apoe promoter variants development alzheimers disease
0.37662143.11823322.html.plaintext.txt	20	genetic risk factors advocated role development late onset alzheimers disease least controversial remains increased risk associated possession one copies apoe4 allele coding apolipoprotein e apoe variant 4 significantly importance apoe4 determined using positional candidate gene approach since finding studies artiga et al 1998 bullido et al 1998 lambert et al 1998 also suggested association number polymorphisms within transcriptional regulatory region apoe gene late onset alzheimers disease independent apoe 4 status based data suggested two independent mechanisms risk late onset alzheimers disease modified apoe gene first variations coding regions alter functional properties apoe second presence promoter variants result quantitative differences apoe expression artiga et al 1998 however hypothesis controversial recent studies helisalmi et al 1999 zurutuza et al 2000 failed support independence apoe promoter variants development alzheimers disease
0.37662143.11823322.html.plaintext.txt	21	genetic influences clinical phenotype
0.37662143.11823322.html.plaintext.txt	22	age onset families carrying mutations app gene ages onset largely within range 40 65 years date app mutation carrier reported unaffected beyond age 67 years families carrying mutations ps 1 gene earliest ages onset fall largely within range 35 55 years although one family member recently recorded onset 24 years wisniewski et al 1998 mutations largely associated early onset familial alzheimers disease least two mutations ala79val his163tyr observed late onset alzheimers disease may non penetrant cruts et al 1998 families carrying mutations ps 2 gene ages onset largely within range 40 70 years thus show overlap late onset alzheimers disease penetrance high may 100 least two reported cases non penetrance age 80 years bird et al 1996
0.37662143.11823322.html.plaintext.txt	23	age onset families carrying mutations app gene ages onset largely within range 40 65 years date app mutation carrier reported unaffected beyond age 67 years families carrying mutations ps 1 gene earliest ages onset fall largely within range 35 55 years although one family member recently recorded onset 24 years wisniewski et al 1998 mutations largely associated early onset familial alzheimers disease least two mutations ala79val his163tyr observed late onset alzheimers disease may non penetrant cruts et al 1998 families carrying mutations ps 2 gene ages onset largely within range 40 70 years thus show overlap late onset alzheimers disease penetrance high may 100 least two reported cases non penetrance age 80 years bird et al 1996
0.37662143.11823322.html.plaintext.txt	24	familial influence age onset late onset alzheimers disease may substantial thus one study affected sib pairs suggests shared familial effects may account 40 variance tunstall et al 2000 indeed studies shown late onset disease age onset approximately 6 years earlier individuals carry two copies apoe4 allele compared non carriers led suggestion apoe4 allele risk factor alzheimers disease mainly old age alzheimers disease death competing risks factor leading earlier age onset alzheimers disease elderly hence development disease prior death associated alzheimers disease evidence confirming hypothesis come large study approximately 5000 individuals meyer et al 1998 study showed clear decline relative risk developing late onset alzheimers disease subjects increasing age clear plateau beyond new cases disease reported age plateau reached earlier carriers apoe4 allele thus appears clear apoe4 allele predominant effect determining individual develops late onset alzheimers disease meyer et al 1998
0.37662143.11823322.html.plaintext.txt	25	familial influence age onset late onset alzheimers disease may substantial thus one study affected sib pairs suggests shared familial effects may account 40 variance tunstall et al 2000 indeed studies shown late onset disease age onset approximately 6 years earlier individuals carry two copies apoe4 allele compared non carriers led suggestion apoe4 allele risk factor alzheimers disease mainly old age alzheimers disease death competing risks factor leading earlier age onset alzheimers disease elderly hence development disease prior death associated alzheimers disease evidence confirming hypothesis come large study approximately 5000 individuals meyer et al 1998 study showed clear decline relative risk developing late onset alzheimers disease subjects increasing age clear plateau beyond new cases disease reported age plateau reached earlier carriers apoe4 allele thus appears clear apoe4 allele predominant effect determining individual develops late onset alzheimers disease meyer et al 1998
0.37662143.11823322.html.plaintext.txt	26	non cognitive features genetic risk factors alzheimers disease associated non cognitive symptoms one might anticipate subjects family history disease increased frequency symptoms likewise one would expect association known genetic risk factors alzheimers disease including genes app ps 1 ps 2 apoe 4 allele symptoms alzheimers disease
0.37662143.11823322.html.plaintext.txt	27	non cognitive features genetic risk factors alzheimers disease associated non cognitive symptoms one might anticipate subjects family history disease increased frequency symptoms likewise one would expect association known genetic risk factors alzheimers disease including genes app ps 1 ps 2 apoe 4 allele symptoms alzheimers disease
0.37662143.11823322.html.plaintext.txt	28	fact appears little consistent evidence association either positive family history alzheimers disease variation known candidate genes increase frequency non cognitive symptoms occurring first time within disease thus seems unlikely major genetic risk factors development late onset alzheimers disease substantial role play development non cognitive symptoms within late onset disease however mean symptoms genetic basis since genes may influence phenotypic expression disease without involved directly aetiology indeed early studies shown evidence association positive family history depressive illness increase frequency depressive symptoms occurring first time within alzheimers disease pearlson et al 1990 early findings supported sib pair study tunstall et al 2000 showing familial factors role development depressive illness late onset alzheimers disease addition small study also suggests role familial factors wide variety non cognitive symptoms including agitation aggression psychosis
0.37662143.11823322.html.plaintext.txt	29	fact appears little consistent evidence association either positive family history alzheimers disease variation known candidate genes increase frequency non cognitive symptoms occurring first time within disease thus seems unlikely major genetic risk factors development late onset alzheimers disease substantial role play development non cognitive symptoms within late onset disease however mean symptoms genetic basis since genes may influence phenotypic expression disease without involved directly aetiology indeed early studies shown evidence association positive family history depressive illness increase frequency depressive symptoms occurring first time within alzheimers disease pearlson et al 1990 early findings supported sib pair study tunstall et al 2000 showing familial factors role development depressive illness late onset alzheimers disease addition small study also suggests role familial factors wide variety non cognitive symptoms including agitation aggression psychosis
0.37662143.11823322.html.plaintext.txt	30	direct approach also adopted whereby common genetic polymorphisms previously showing associations neuropsychiatric conditions found associated non cognitive symptoms late onset alzheimers disease example one study holmes et al 1998 people late onset alzheimers disease found association common polymorphic variations 5 ht2a 5 ht2c serotonin receptor genes 102 tc cys23ser polymorphisms respectively previously implicated schizophrenia bipolar affective disorder psychotic symptoms alzheimers disease associations found presence c102 allele presence visual auditory hallucinations presence ser23 allele visual hallucinations another study sweet et al 1998 found evidence suggest association psychosis aggression patients alzheimers disease carry common polymorphisms dopamine receptor genes drd1 drd3 studies need replicated suggest common receptor polymorphisms may role genesis psychotic non cognitive symptoms implicated genetic risk factors late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	31	direct approach also adopted whereby common genetic polymorphisms previously showing associations neuropsychiatric conditions found associated non cognitive symptoms late onset alzheimers disease example one study holmes et al 1998 people late onset alzheimers disease found association common polymorphic variations 5 ht2a 5 ht2c serotonin receptor genes 102 tc cys23ser polymorphisms respectively previously implicated schizophrenia bipolar affective disorder psychotic symptoms alzheimers disease associations found presence c102 allele presence visual auditory hallucinations presence ser23 allele visual hallucinations another study sweet et al 1998 found evidence suggest association psychosis aggression patients alzheimers disease carry common polymorphisms dopamine receptor genes drd1 drd3 studies need replicated suggest common receptor polymorphisms may role genesis psychotic non cognitive symptoms implicated genetic risk factors late onset alzheimers disease
0.37662143.11823322.html.plaintext.txt	32	cognitive decline study date looked rates decline carriers app ps 1 ps 2 mutations patients late onset alzheimers disease positive family history alzheimers disease show evidence increased rates decline majority studies also failed show relationships possession apoe4 allele increased rates decline lack association interesting since implies genetic factors may determine disease starts rate degeneration clearly caution required interpreting negative finding may associations always difficult establish large number confounding factors may influence cognitive deterioration well difficulties use psychometric scales short periods indeed study craft et al 1998 suggested increased rate cognitive decline apoe4 carriers may detectable using long follow period
0.37662143.11823322.html.plaintext.txt	33	cognitive decline study date looked rates decline carriers app ps 1 ps 2 mutations patients late onset alzheimers disease positive family history alzheimers disease show evidence increased rates decline majority studies also failed show relationships possession apoe4 allele increased rates decline lack association interesting since implies genetic factors may determine disease starts rate degeneration clearly caution required interpreting negative finding may associations always difficult establish large number confounding factors may influence cognitive deterioration well difficulties use psychometric scales short periods indeed study craft et al 1998 suggested increased rate cognitive decline apoe4 carriers may detectable using long follow period
0.37662143.11823322.html.plaintext.txt	34	duration mean duration illness families ps 1 mutations significantly shorter range 58 68 years families ps 2 range 44 108 years app mutations range 90 16 years reflecting severity ps 1 associated alzheimers disease studies late onset alzheimers disease suggest duration illness tends longer people positive family history carriers apoe4 allele however since shown relationship longer holds true confounding effects age onset taken account thus late onset alzheimers disease increased survival directly related earlier age onset influenced number factors exclusively genetic
0.37662143.11823322.html.plaintext.txt	35	clinical implications limitations
0.37662143.11823322.html.plaintext.txt	36	clinical implications number genes implicated risk factors development alzheimers disease variation genes appears major effect determining disease develop aspects clinical phenotype notably non cognitive symptoms also influenced genetic variation
0.37662143.11823322.html.plaintext.txt	37	clinical implications number genes implicated risk factors development alzheimers disease variation genes appears major effect determining disease develop aspects clinical phenotype notably non cognitive symptoms also influenced genetic variation
0.37662143.11823322.html.plaintext.txt	38	limitations number risk genes yet identified influence unknown genes clinical phenotype yet undetermined influence genetic variation non cognitive symptoms relatively unexplored
0.37662143.11823322.html.plaintext.txt	39	limitations number risk genes yet identified influence unknown genes clinical phenotype yet undetermined influence genetic variation non cognitive symptoms relatively unexplored
0.37662143.11823322.html.plaintext.txt	40	received publication may 16 2000 revision received may 14 2001 accepted publication may 23 2001
0.37662143.11823322.html.plaintext.txt	41	received publication may 16 2000 revision received may 14 2001 accepted publication may 23 2001
0.37662143.11823322.html.plaintext.txt	42	highlights issue elizabeth walsh bjp 2002 180 0 full text
0.37662143.11823322.html.plaintext.txt	43	old age psychiatry alistair burns ian g mckeith bjp 2002 180 97 98 full text
0.37812415.15613480.html.plaintext.txt	0	intracellular retention caveolin 1 presenilin deficient cells douglas r wood jeffrey nye ned j c lamb anne fernandez magali kitzmann
0.37812415.15613480.html.plaintext.txt	1	department urology northwestern university chicago illinois 60611 johnson johnson pharmaceutical research development titusville new jersey 08560 cell biology unit institut de genetique humaine upr 1142 cnrs 141 rue de la cardonille montpellier cedex 05 f34396 muscle stem cells facio scapulo humeral dystrophy unit centre de recherche en biochimie macromoleculaire fre 2593 1919 route de mende 34293 montpellier cedex 5 france
0.37812415.15613480.html.plaintext.txt	2	received publication september 9 2004 revised form december 1 2004
0.37812415.15613480.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references mutations genes encoding presenilins ps1 ps2 responsible majority early onset familial alzheimers disease ps critical component secretase responsible intramembranous cleavage amyloid precursor protein notch physiological functions assigned ps without clear identification mechanisms underlying multiple biological roles early embryonic lethality ps1 ps2 double knock ps12 null mice prevents evaluation physiological roles ps investigate new functions presenilins performed proteomic approach using cells derived ps12 null blastocysts wild type controls identified presenilin dependent cell surface binding albumin binding albumin depends intact caveolae cellular surface abnormal caveolin 1 localization ps12 null cells associated loss caveolae absence caveolin 1 expression within lipid rafts expressing ps1 ps2 intracellular form notch1 ps12 null cells restored normal caveolin 1 localization demonstrating presenilins required subcellular trafficking caveolin 1 independently notch activity despite expression caveolin 1 ps1 within lipid raft enriched fractions sucrose density centrifugation wild type cells direct interaction two proteins detected implying presenilins affect caveolin 1 trafficking indirect manner conclude presenilins required caveolae formation controlling transport intracellular caveolin 1 plasma membrane
0.37812415.15613480.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references mutations genes encoding presenilins ps1 ps2 responsible majority early onset familial alzheimers disease ps critical component secretase responsible intramembranous cleavage amyloid precursor protein notch physiological functions assigned ps without clear identification mechanisms underlying multiple biological roles early embryonic lethality ps1 ps2 double knock ps12 null mice prevents evaluation physiological roles ps investigate new functions presenilins performed proteomic approach using cells derived ps12 null blastocysts wild type controls identified presenilin dependent cell surface binding albumin binding albumin depends intact caveolae cellular surface abnormal caveolin 1 localization ps12 null cells associated loss caveolae absence caveolin 1 expression within lipid rafts expressing ps1 ps2 intracellular form notch1 ps12 null cells restored normal caveolin 1 localization demonstrating presenilins required subcellular trafficking caveolin 1 independently notch activity despite expression caveolin 1 ps1 within lipid raft enriched fractions sucrose density centrifugation wild type cells direct interaction two proteins detected implying presenilins affect caveolin 1 trafficking indirect manner conclude presenilins required caveolae formation controlling transport intracellular caveolin 1 plasma membrane
0.37812415.15613480.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references secretase activity responsible cleavage transmembrane domain amyloid precursor protein app1 releasing amyloid peptide app intracellular domain major component amyloid plaques characteristic alzheimers disease ad presenilins pss active core secretase 1 2 different molecular components secretase complex identified include addition pss nicastrin aph1 pen 2 3
0.37812415.15613480.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references secretase activity responsible cleavage transmembrane domain amyloid precursor protein app1 releasing amyloid peptide app intracellular domain major component amyloid plaques characteristic alzheimers disease ad presenilins pss active core secretase 1 2 different molecular components secretase complex identified include addition pss nicastrin aph1 pen 2 3
0.37812415.15613480.html.plaintext.txt	7	ps dependent proteolytic process involved release cytoplasmic domains increasing range type integral membrane receptors notch 4 6 erbb 4 7 e cadherin 8 others pss addition role secretase catalytic subunits important function subcellular trafficking selected group proteins app trk receptor 9 nicastrin 10 pen 2 11
0.37812415.15613480.html.plaintext.txt	8	ps dependent proteolytic process involved release cytoplasmic domains increasing range type integral membrane receptors notch 4 6 erbb 4 7 e cadherin 8 others pss addition role secretase catalytic subunits important function subcellular trafficking selected group proteins app trk receptor 9 nicastrin 10 pen 2 11
0.37812415.15613480.html.plaintext.txt	9	pss mediate additional physiological functions including roles calcium homeostasis neurite outgrowth apoptosis synaptic plasticity 12 deleting ps1 ps2 genes mice leads early embryonic lethality 13 role presenilins cannot fully examined double knock mice
0.37812415.15613480.html.plaintext.txt	10	pss mediate additional physiological functions including roles calcium homeostasis neurite outgrowth apoptosis synaptic plasticity 12 deleting ps1 ps2 genes mice leads early embryonic lethality 13 role presenilins cannot fully examined double knock mice
0.37812415.15613480.html.plaintext.txt	11	therefore used cells derived ps1 ps2 double null termed ps12 null blastocysts wt controls 14 perform differential proteomic approach identified presenilin dependent defect albumin binding reflecting abnormal caveolae dependent pathway showed caveolin 1 mislocalized ps12 null cells leading abnormal caveolae formation absence caveolin1 lipid rafts overexpression pss ps12 null cells sufficient restore normal caveolin localization function could detect physical interaction presenilins caveolin 1 results imply presenilins responsible indirect manner caveolin 1 transport cell surface form caveolae
0.37812415.15613480.html.plaintext.txt	12	therefore used cells derived ps1 ps2 double null termed ps12 null blastocysts wt controls 14 perform differential proteomic approach identified presenilin dependent defect albumin binding reflecting abnormal caveolae dependent pathway showed caveolin 1 mislocalized ps12 null cells leading abnormal caveolae formation absence caveolin1 lipid rafts overexpression pss ps12 null cells sufficient restore normal caveolin localization function could detect physical interaction presenilins caveolin 1 results imply presenilins responsible indirect manner caveolin 1 transport cell surface form caveolae
0.37812415.15613480.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references materials embryonic day e35 blastocysts flushed wild type ps1 ps2 intercrossed mice 13 m2 medium plated mitotically inhibited feeder cells five days later inner cell mass removed trypsinized plated onto new feeder cells 12 days cells replated onto gelatin coated dishes grown confluent maintained embryonic stem cell media high glucose dulbeccos modified eagles medium 15 fetal bovine serum 2 mm l glutamine 1 penicillinstreptomycin 1x non essential amino acids sodium pyruvate recombinant leukemia inhibitory factor uncoated plates cell line pcr geno typing performed described previously 13 cells named blastocyst derived cells sv40 transformation used generate rapidly growing cell lines described previously 33 cells named sv40 transformed blastocyst derived cells nicd myc6 ps1 ps2 cdna constructs described previously 14 gfp cav1 cdna construct generous gift laboratory dr van deurs sweden
0.37812415.15613480.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references materials embryonic day e35 blastocysts flushed wild type ps1 ps2 intercrossed mice 13 m2 medium plated mitotically inhibited feeder cells five days later inner cell mass removed trypsinized plated onto new feeder cells 12 days cells replated onto gelatin coated dishes grown confluent maintained embryonic stem cell media high glucose dulbeccos modified eagles medium 15 fetal bovine serum 2 mm l glutamine 1 penicillinstreptomycin 1x non essential amino acids sodium pyruvate recombinant leukemia inhibitory factor uncoated plates cell line pcr geno typing performed described previously 13 cells named blastocyst derived cells sv40 transformation used generate rapidly growing cell lines described previously 33 cells named sv40 transformed blastocyst derived cells nicd myc6 ps1 ps2 cdna constructs described previously 14 gfp cav1 cdna construct generous gift laboratory dr van deurs sweden
0.37812415.15613480.html.plaintext.txt	15	two dimensional gel electrophoresis total protein extracts wt ps12 null ps12 null cells transiently transfected presenilin 1 cdna blastocyst derived sv40 transformed blastocyst derived cells analyzed two dimensional electrophoresis method ofarrell ampholine mixture used first dimension electrofocusing gel composed 60 wv ampholine ph 5 7 40 ampholine ph 3 10 second dimension performed sds 12 polyacrylamide gels gels stained coomassie blue bsa sequenced maldi tof mass spectrometer carol beach university kentucky
0.37812415.15613480.html.plaintext.txt	16	two dimensional gel electrophoresis total protein extracts wt ps12 null ps12 null cells transiently transfected presenilin 1 cdna blastocyst derived sv40 transformed blastocyst derived cells analyzed two dimensional electrophoresis method ofarrell ampholine mixture used first dimension electrofocusing gel composed 60 wv ampholine ph 5 7 40 ampholine ph 3 10 second dimension performed sds 12 polyacrylamide gels gels stained coomassie blue bsa sequenced maldi tof mass spectrometer carol beach university kentucky
0.37812415.15613480.html.plaintext.txt	17	endocytosis assays blastocyst derived ps12 null cells wt controls grown complete medium 25 mm glass coverslips cells 75 80 confluent medium replaced 2 ml complete medium containing fitc conjugated albumin sigma final concentration 10 microgml cells incubated 37 degrees c 5 30 min washed pbs fixed 37 formaldehyde 10 min cells washed 20 min pbs mounted slide virtually identical experiments carried fitc conjugated transferrin 10 microgml sigma ps12 null cells grown 60 mm tissue culture dishes transiently transfected presenilin 1 presenilin 2 cdna using lipofectamine plus invitrogen according manufacturers instructions transfected cells plated 25 mm coverslips 6 well plates 24 h fitc albumin uptake examined transfected cells 36 h initial transfection cells transfected presenilin 1 presenilin 2 detected immunostaining anti presenilin 1 pab oncogene anti presenilin 2 pab oncogene respectively texas red conjugated secondary antibody jackson immunoresearch
0.37812415.15613480.html.plaintext.txt	18	endocytosis assays blastocyst derived ps12 null cells wt controls grown complete medium 25 mm glass coverslips cells 75 80 confluent medium replaced 2 ml complete medium containing fitc conjugated albumin sigma final concentration 10 microgml cells incubated 37 degrees c 5 30 min washed pbs fixed 37 formaldehyde 10 min cells washed 20 min pbs mounted slide virtually identical experiments carried fitc conjugated transferrin 10 microgml sigma ps12 null cells grown 60 mm tissue culture dishes transiently transfected presenilin 1 presenilin 2 cdna using lipofectamine plus invitrogen according manufacturers instructions transfected cells plated 25 mm coverslips 6 well plates 24 h fitc albumin uptake examined transfected cells 36 h initial transfection cells transfected presenilin 1 presenilin 2 detected immunostaining anti presenilin 1 pab oncogene anti presenilin 2 pab oncogene respectively texas red conjugated secondary antibody jackson immunoresearch
0.37812415.15613480.html.plaintext.txt	19	immunofluorescence microscopy transfected untransfected blastocyst derived ps12 null cells wt controls plated 18 mm glass coverslips fisher fixed 10 min pbs containing 37 formaldehyde rinsed pbs incubated 2 min permeabilization buffer pbs 01 triton x 100 cells washed pbs incubated 10 min blocking buffer pbs 05 bsa labeled corresponding antibodies anti flag mab m2 sigma anti caveolin 1 pab transduction laboratories anti ps1 pab h70 sc biotechnology anti myc mab 9e10 rinsing pbs secondary antibody alexa 488 alexa 555 donkey anti mouse alexa conjugated donkey anti rabbit molecular probes added period 30 min confocal fluorescence microscope olympus north western university molecular pharmacology biological chemistry prof r j millers laboratory used visualization fitc bsa fitc transferrin fig 2 fig 3b fluorescence microscope leica drma2 institut de genetique humaine used visualization bound secondary antibodies fig 4 micro injection experiments performed described previously 34
0.37812415.15613480.html.plaintext.txt	20	immunofluorescence microscopy transfected untransfected blastocyst derived ps12 null cells wt controls plated 18 mm glass coverslips fisher fixed 10 min pbs containing 37 formaldehyde rinsed pbs incubated 2 min permeabilization buffer pbs 01 triton x 100 cells washed pbs incubated 10 min blocking buffer pbs 05 bsa labeled corresponding antibodies anti flag mab m2 sigma anti caveolin 1 pab transduction laboratories anti ps1 pab h70 sc biotechnology anti myc mab 9e10 rinsing pbs secondary antibody alexa 488 alexa 555 donkey anti mouse alexa conjugated donkey anti rabbit molecular probes added period 30 min confocal fluorescence microscope olympus north western university molecular pharmacology biological chemistry prof r j millers laboratory used visualization fitc bsa fitc transferrin fig 2 fig 3b fluorescence microscope leica drma2 institut de genetique humaine used visualization bound secondary antibodies fig 4 micro injection experiments performed described previously 34
0.37812415.15613480.html.plaintext.txt	21	view larger version 70k fig 2 defect caveolae dependent endocytosis ps12 null cells blastocyst derived wt ps12 null cells incubated normal medium supplemented fitc albumin left panel fitc transferrin right panel 5 30 min 37 degrees c cells rinsed pbs formaldehyde fixed visualized fluorescence microscopy bar 15 microm
0.37812415.15613480.html.plaintext.txt	22	view larger version 44k fig 3 ps expression restores albumin uptake ps12 null cells total cellular proteins extracted ps12 null cells transiently transfected presenilin 1 cdna sv40 transformed blastocyst derived top blastocyst derived cells bottom separated two dimensional electrophoresis migration first dimension ph 5 ph 7 illustrated arrows localization bsa coomassie stained two dimensional gel ps12 null cells overexpressing ps1 shown circles b blastocyst derived ps12 null cells transiently transfected full length cdna encoding ps1 top panel ps2 bottom panel thirty six hours post transfection cells allowed endocytose fitc albumin 30 min cells rinsed pbs formaldehyde fixation immunostaining anti ps1 igg top panel anti ps2 igg bottom panel bar 15 microm
0.37812415.15613480.html.plaintext.txt	23	view larger version 47k fig 4 presenilin dependent localization caveolin 1 blastocyst derived wt ps12 null cells formaldehyde fixed permeabilized subcellular localization endogenous cav1 ii visualized indirect immunofluorescence bar 5 microm blastocyst derived wt ps12 null cells transiently transfected full length cdna encoding gfp cav1 gfp cav1 expressing cells visualized fluorescence microscopy formaldehyde fixation iii iv bar 10 microm b blastocyst derived ps12 null cells transiently transfected full length cdna encoding flag ps2 v vi twenty four hours post transfection cells formaldehyde fixed permeabilized immunostained anti flag igg v anti caveolin 1 igg vi bar 5 microm ps12 null cells transiently transfected full length cdna encoding gfp cav1 24 hours post transfection full length cdna encoding ps1 vii viii myc nicd ix x microinjected gfp cav1 positive ps12 null cells sixteen hours post microinjection cells formaldehyde fixed permeabilized immunostained anti ps1 igg vii anti myc igg ix bar 15 microm
0.37812415.15613480.html.plaintext.txt	24	electron microscopy morphological experiments blastocyst derived ps12 null cells wt controls trypsinized collected centrifugation cell pellet fixed phosphate buffer containing 35 glutaraldehyde overnight 4 degrees c cells rinsed phosphate buffer post fixed 2 osmic acid 1 h room temperature dehydrated embedded cut onto grids thin sections 85 nm leica reichert ultracut e collected different levels block counterstained uranyl acetate lead citrate visualization photography hitachi 7100 transmission electron microscope em performed centre regional dimagerie cellulaire montpellier france
0.37812415.15613480.html.plaintext.txt	25	electron microscopy morphological experiments blastocyst derived ps12 null cells wt controls trypsinized collected centrifugation cell pellet fixed phosphate buffer containing 35 glutaraldehyde overnight 4 degrees c cells rinsed phosphate buffer post fixed 2 osmic acid 1 h room temperature dehydrated embedded cut onto grids thin sections 85 nm leica reichert ultracut e collected different levels block counterstained uranyl acetate lead citrate visualization photography hitachi 7100 transmission electron microscope em performed centre regional dimagerie cellulaire montpellier france
0.37812415.15613480.html.plaintext.txt	26	isolation caveolin enriched membrane cem immunoblot assays cems prepared detergent extraction cellular proteins centrifugation discontinuous sucrose gradients essentially described 21 blastocyst derived ps12 null cells wt controls grown 100 mm diameter dishes 2 x 107 cells used prepare cems cells washed twice 10 ml ice cold phosphate buffered saline scraped 2 ml mbst buffer 25 mm mes 150 mm nacl 1 triton x 100 protease inhibitors mixture roche applied science homogenized loose fitting dounce homogenizer 20 strokes extract adjusted 40 sucrose addition 2 ml 80 sucrose mbs lacking triton x 100 placed bottom ultracentrifuge tube discontinuous sucrose gradient formed overlaying solution 4 ml 38 sucrose 4 ml 5 sucrose mbs tubes centrifuged 31000 rpm sw41 ti rotor 17 h 4 degrees c 12 fractions 1 ml collected manually top gradient determine distribution different proteins within gradients 200 microl fraction precipitated ethanol resuspended 20 microl 1x laemmli buffer subjected sds page 10 acrylamide gels followed western blot analyses primary antibodies used follows anti ps1 pab h70 sc biotechnology anti cav1 pab n20 sc biotechnology anti adaptin mab transduction laboratories anti bip mab transduction laboratories anti flotillin 1 mab transduction laboratories horseradish peroxidase conjugated anti mouse igg anti rabbit secondary antibody 12000 dilution amersham biosciences used visualize bound primary antibodies chemiluminescence substrate santa cruz biotechnology
0.37812415.15613480.html.plaintext.txt	27	isolation caveolin enriched membrane cem immunoblot assays cems prepared detergent extraction cellular proteins centrifugation discontinuous sucrose gradients essentially described 21 blastocyst derived ps12 null cells wt controls grown 100 mm diameter dishes 2 x 107 cells used prepare cems cells washed twice 10 ml ice cold phosphate buffered saline scraped 2 ml mbst buffer 25 mm mes 150 mm nacl 1 triton x 100 protease inhibitors mixture roche applied science homogenized loose fitting dounce homogenizer 20 strokes extract adjusted 40 sucrose addition 2 ml 80 sucrose mbs lacking triton x 100 placed bottom ultracentrifuge tube discontinuous sucrose gradient formed overlaying solution 4 ml 38 sucrose 4 ml 5 sucrose mbs tubes centrifuged 31000 rpm sw41 ti rotor 17 h 4 degrees c 12 fractions 1 ml collected manually top gradient determine distribution different proteins within gradients 200 microl fraction precipitated ethanol resuspended 20 microl 1x laemmli buffer subjected sds page 10 acrylamide gels followed western blot analyses primary antibodies used follows anti ps1 pab h70 sc biotechnology anti cav1 pab n20 sc biotechnology anti adaptin mab transduction laboratories anti bip mab transduction laboratories anti flotillin 1 mab transduction laboratories horseradish peroxidase conjugated anti mouse igg anti rabbit secondary antibody 12000 dilution amersham biosciences used visualize bound primary antibodies chemiluminescence substrate santa cruz biotechnology
0.37812415.15613480.html.plaintext.txt	28	results top abstract introduction experimental procedures results discussion references order identify new functions presenilins used differential proteomic approach fig 1 compared two dimensional profile total extracts wt ps12 null cells proteins interest expressed wt cells absent ps12 null cells performed differential proteomic approach sv40 transformed blastocyst derived cells fig 1a blastocyst derived cells fig 1b several proteins corresponded chosen criteria among strongly expressed protein common blastocyst derived cells sv40 counterpart protein sequenced maldi tof mass spectrometer identified bovine serum albumin bsa result shows defect endocytosis andor binding albumin fetal bovine serum absence presenilins
0.37812415.15613480.html.plaintext.txt	29	view larger version 37k fig 1 bsa differentially boundendocytosed wt ps12 null cells total cellular protein extracted wt ps12 cells sv40 transformed blastocyst derived blastocyst derived cells b separated two dimensional electrophoresis migration first dimension ph 5 ph 7 illustrated arrows localization bsa coomassiestained two dimensional gel wt cells shown circles
0.37812415.15613480.html.plaintext.txt	30	caveolae deficient endothelial cells show defects uptake transport albumin vivo 15 caveolin 1 null mouse embryonic fibroblasts show defects endocytosis albumin transferrin 16 caveolae mediated endocytosis endothelial cells stimulated binding albumin specific albumin binding protein localized caveolae 17 therefore defect endocytosis andor binding albumin observed ps12 null cells fig 1 could linked abnormal caveolae dependent pathway
0.37812415.15613480.html.plaintext.txt	31	caveolae deficient endothelial cells show defects uptake transport albumin vivo 15 caveolin 1 null mouse embryonic fibroblasts show defects endocytosis albumin transferrin 16 caveolae mediated endocytosis endothelial cells stimulated binding albumin specific albumin binding protein localized caveolae 17 therefore defect endocytosis andor binding albumin observed ps12 null cells fig 1 could linked abnormal caveolae dependent pathway
0.37812415.15613480.html.plaintext.txt	32	next examined ability wt ps12 null cells bindendocytose fluorescent tracer fitc albumin fig 2 shows ps12 null cells left panel failed accumulate fitc albumin even 30 min continuous incubation contrast wt cells showing cell surface labeling fitc albumin within 5 min incubation ensure lack expression presenilins globally affect ligand bindingendocytosis also examined intracellular uptake second fluorescent tracer fitc transferrin known endocytosed via clathrin coated pits shown fig 2 right panel fitc transferrin rapidly endocytosed wt ps12 null cells thus ps12 null cells show selective defect caveolae mediated ligand binding reminiscent observed caveolin 1 deficient cells 16
0.37812415.15613480.html.plaintext.txt	33	ensure defect caveolae dependent endocytosis observed ps12 null cells specifically lack ps proteins examined whether transient expression presenilin cdna sufficient restore albumin binding ps12 null cells shown fig 3a two dimensional gel profile proteins ps12 null cells re expressing ps1 comparable corresponding wt cells see fig 1 presence bsa detected coomassie stained two dimensional gels either sv40 transformed blastocyst derived ps12 null cells top blastocyst derived ps12 null cells bottom overexpressing ps1 confirmed result restoring efficient fitc albumin uptake blastocyst derived ps12 null cells expressing either ps1 fig 3b top panel ps2 fig 3b bottom panel results show caveolae functionality dependent upon either ps1 ps2 expression
0.37812415.15613480.html.plaintext.txt	34	phenotype observed ps12 null cells figs 1 2 3 reminiscent one observed caveolin1 deficient cells 16 wondered caveolin 1 expressed ps12 null cells western blotting able detect caveolin 1 expression ps12 null cells2 decided investigate caveolin1 regulated ps12 null cells comparison wt cells employed following three distinct methods address issue first explored caveolin1 localization immunofluorescence observed caveolae formation em finally looked association caveolin 1 lipid rafts sucrose density centrifugation
0.37812415.15613480.html.plaintext.txt	35	phenotype observed ps12 null cells figs 1 2 3 reminiscent one observed caveolin1 deficient cells 16 wondered caveolin 1 expressed ps12 null cells western blotting able detect caveolin 1 expression ps12 null cells2 decided investigate caveolin1 regulated ps12 null cells comparison wt cells employed following three distinct methods address issue first explored caveolin1 localization immunofluorescence observed caveolae formation em finally looked association caveolin 1 lipid rafts sucrose density centrifugation
0.37812415.15613480.html.plaintext.txt	36	order evaluate caveolin 1 cav1 distribution wt ps12 null cells performed indirect immunofluorescence experiments fig 4 wt cells endogenous caveolin 1 predominantly localized plasma membrane typical caveolae associated punctated staining fig 4a whereas ps12 null cells endogenous caveolin 1 showed pronounced punctated perinuclear localization fig 4a ii altered localization caveolin 1 ps12 null cells also observed forced expression gfp cav1 fig 4a iv endogenous caveolin 22 result shows intracellular retention caveolin 1 ps12 null cells evaluate caveolin 1 membrane localization ps dependent examined transient expression presenilin 2 cdna sufficient induce change caveolin 1 localization shown fig 4b transient expression flag presenilin 2 v ps12 null cells induced redistribution endogenous caveolin 1 perinuclear localization vi micro injection ps1 cdna gfp cav1 positive ps12 null cells fig 4b vii allowed gfp cav1 relocalized wt cells viii contrast noticeable changes gfp cav1 localization observed microinjection notch nicd fig 4b ix construct gfp cav1 positive ps12 null cells fig 4b x results show caveolin 1 mislocalized ps12 null cells even though ps12 null mice phenotypes attributable loss notch 1 function 13 presenilins involved subcellular localization caveolin 1 independently notch activity
0.37812415.15613480.html.plaintext.txt	37	expression caveolin 1 cells lacking caveolae causes de novo formation caveolae whereas ablation mislocalization caveolin 1 expression causes loss caveolae 18 20 wondered ps12 null cells showing mislocalized caveolin 1 still able form caveolae caveolae well defined organelles forming flask shaped necks plasma membrane easily distinguishable electron microscopy presence caveolae ps12 null cells investigated em found marked reduced number caveolae plasma membrane presenilin deficient cells fig 5b comparison wt cells fig 5a addition 20 ps12 null cells showed caveolae plasma membrane compared 100 wt cells2 data show presenilins involved caveolae formation
0.37812415.15613480.html.plaintext.txt	38	expression caveolin 1 cells lacking caveolae causes de novo formation caveolae whereas ablation mislocalization caveolin 1 expression causes loss caveolae 18 20 wondered ps12 null cells showing mislocalized caveolin 1 still able form caveolae caveolae well defined organelles forming flask shaped necks plasma membrane easily distinguishable electron microscopy presence caveolae ps12 null cells investigated em found marked reduced number caveolae plasma membrane presenilin deficient cells fig 5b comparison wt cells fig 5a addition 20 ps12 null cells showed caveolae plasma membrane compared 100 wt cells2 data show presenilins involved caveolae formation
0.37812415.15613480.html.plaintext.txt	39	view larger version 73k fig 5 lack caveolae ps12 null cells transmission electron microscopy wt ps12 null b cells arrows indicate plasma membrane caveolae bar 150 nm
0.37812415.15613480.html.plaintext.txt	40	caveolae subset specialized liquid ordered domains referred lipid rafts caveolae isolated insolubility triton x 100 sedimentation low density fractions sucrose gradients 21 performed isolation cem wt ps12 null cell proteins see experimental procedures shown previously caveolae enriched fractions isolated manner exclude markers caveolae membranes golgi apparatus mitochondria endoplasmic reticulum 22 23 distribution bip adaptin non raft proteins localized er trans golgi respectively also examined monitor contamination cem er trans golgi membranes fig 6 flotillins described new family proteins associated caveolae 24 expected fig 6a flotillin 1 expression restricted fractions 4 5 cem implying extraction triton x 100 yielded good separation lipid rafts bip adaptin detected cem fractions caveolin 1 expression restricted cem also found fractions wt cells shown previously 25 27 ps1 also concentrated raft fractions caveolin 1 expression detected fraction 5 wt cells fig 6a ps12 null cells fig 6b ps12 null cells caveolin 1 present fraction 7 high density fractions fractions 9 12 triton x 100 soluble proteins result shows absence presenilins caveolin 1 detected low density fractions normally enriched caveolae fractions 4 5 supporting fact caveolae form surprisingly flotillin 1 expression longer associated lipid rafts ps12 null cells implying caveolae also lipid rafts may affected deficiency presenilins expression
0.37812415.15613480.html.plaintext.txt	41	caveolae subset specialized liquid ordered domains referred lipid rafts caveolae isolated insolubility triton x 100 sedimentation low density fractions sucrose gradients 21 performed isolation cem wt ps12 null cell proteins see experimental procedures shown previously caveolae enriched fractions isolated manner exclude markers caveolae membranes golgi apparatus mitochondria endoplasmic reticulum 22 23 distribution bip adaptin non raft proteins localized er trans golgi respectively also examined monitor contamination cem er trans golgi membranes fig 6 flotillins described new family proteins associated caveolae 24 expected fig 6a flotillin 1 expression restricted fractions 4 5 cem implying extraction triton x 100 yielded good separation lipid rafts bip adaptin detected cem fractions caveolin 1 expression restricted cem also found fractions wt cells shown previously 25 27 ps1 also concentrated raft fractions caveolin 1 expression detected fraction 5 wt cells fig 6a ps12 null cells fig 6b ps12 null cells caveolin 1 present fraction 7 high density fractions fractions 9 12 triton x 100 soluble proteins result shows absence presenilins caveolin 1 detected low density fractions normally enriched caveolae fractions 4 5 supporting fact caveolae form surprisingly flotillin 1 expression longer associated lipid rafts ps12 null cells implying caveolae also lipid rafts may affected deficiency presenilins expression
0.37812415.15613480.html.plaintext.txt	42	view larger version 30k fig 6 raft dissociation cav1 flotillin 1 ps12 null cells blastocyst derived wt ps12 null b cells lysed 1 triton subjected flotation sucrose density gradient centrifugation equal volumes precipitated fraction analyzed western blotting antibodies bip adaptin ada cav1 ps1 flotillin 1 caveolin1 flotillin 1 mark low buoyant density lipid raft fractions non raft proteins resident er bip trans golgi ada adaptin recovered heavier fractions
0.37812415.15613480.html.plaintext.txt	43	order determine molecular mechanism responsible caveolin 1 mislocalization ps12 null cells tested presenilin 1 caveolin 1 able interact one another despite co expression caveolin 1 ps1 lipid rafts fig 6a able detect interaction endogenous presenilin 1 caveolin 1 immunoprecipitation wt cells2 either total extract cem fractions
0.37812415.15613480.html.plaintext.txt	44	order determine molecular mechanism responsible caveolin 1 mislocalization ps12 null cells tested presenilin 1 caveolin 1 able interact one another despite co expression caveolin 1 ps1 lipid rafts fig 6a able detect interaction endogenous presenilin 1 caveolin 1 immunoprecipitation wt cells2 either total extract cem fractions
0.37812415.15613480.html.plaintext.txt	45	altogether results show ps1 ps2 expression required correct localization caveolin 1 caveolae plasma membrane absence presenilins may affect proteins directly implicated caveolin 1 sorting
0.37812415.15613480.html.plaintext.txt	46	discussion top abstract introduction experimental procedures results discussion references paper performed differential proteomic approach using blastocyst derived wt ps12 null cells order identify new roles presenilins beyond alzheimers disease using approach identified presenilin dependent caveolin 1 localization leading absence caveolae presenilins missing caveolin 1 added list proteins presenilin dependent trafficking
0.37812415.15613480.html.plaintext.txt	47	discussion top abstract introduction experimental procedures results discussion references paper performed differential proteomic approach using blastocyst derived wt ps12 null cells order identify new roles presenilins beyond alzheimers disease using approach identified presenilin dependent caveolin 1 localization leading absence caveolae presenilins missing caveolin 1 added list proteins presenilin dependent trafficking
0.37812415.15613480.html.plaintext.txt	48	observed intracellular retention caveolin 1 ps12 null cells fig 4 perinuclear localization caveolin 1 ps12 null cells partially co localized adaptin immunofluorescence2 experiments caveolin 1 broadly distributed adaptin precise localization caveolin 1 absence presenilins needs investigation
0.37812415.15613480.html.plaintext.txt	49	mechanism presenilins chaperone proteins allow correct caveolin 1 localization caveolae formation involve complex caveolin 1 presenilin independent notch 1 signaling fig 4 flotillin 1 always targets lipid raftcaveolae fractions independent presence caveolin 28 thus absence flotillin 1 lipid raft fractions ps12 null cells caveolin 1 mislocalization implying mechanism presenilins transport raft proteins lipid rafts global may directly affect common protein involved targeting raft associated proteins lipid rafts lipid rafts multifunctional organelles playing important roles variety cellular processes work pointed important new role presenilins
0.37812415.15613480.html.plaintext.txt	50	neurons form caveolae form lipid rafts caveolae type structures app found membrane fractions caveolae like properties 29 suggesting caveolae type structures might important manifestation ad moreover targeting secretase lipid rafts shown regulate site processing app 30 presenilins found highly enriched caveolin 3 positive caveolae astrocytes surrounding senile plaques 31 recently secretase complex shown localized lipid raft microdomains post golgi endosomes 32 thus postulate neurons presenilins may implicated trafficking proteins flotillin 1 responsible lipid raft formation lipid rafts would form best environment secretase activity better understanding secretase complex formed transported cell membrane may lead development new pharmacological strategies specifically target cleavage app delay progress ad
0.37812415.15613480.html.plaintext.txt	51	neurons form caveolae form lipid rafts caveolae type structures app found membrane fractions caveolae like properties 29 suggesting caveolae type structures might important manifestation ad moreover targeting secretase lipid rafts shown regulate site processing app 30 presenilins found highly enriched caveolin 3 positive caveolae astrocytes surrounding senile plaques 31 recently secretase complex shown localized lipid raft microdomains post golgi endosomes 32 thus postulate neurons presenilins may implicated trafficking proteins flotillin 1 responsible lipid raft formation lipid rafts would form best environment secretase activity better understanding secretase complex formed transported cell membrane may lead development new pharmacological strategies specifically target cleavage app delay progress ad
0.37812415.15613480.html.plaintext.txt	52	footnotes work supported human frontier science program long term fellowship lt 000522000 m m k arc grant 4459 n j c l costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.37812415.15613480.html.plaintext.txt	53	correspondence addressed crbm fre2593 1919 route de mende 34293 montpellier cedex 5 france tel 33 467 61 33 62 fax 33 4 67 52 15 59 e mail magalikitzmannatcrbmcnrsfr u d
0.37812415.15613480.html.plaintext.txt	54	1 abbreviations used app amyloid precursor protein ad alzheimers disease ps presenilin ps12 null cells derived ps1 ps2 double null mice bsa bovine serum albumin cav caveolin nicd notch 1 intracellular domain cem caveolin enriched membrane wt wild type pbs phosphate buffered saline gfp green fluorescent protein mab monoclonal antibody pab polyclonal antibody fitc fluorescein isothiocyanate bsa bovine serum albumin maldi tof matrix assisted laser desorption ionization time flight mes 4 morpholineethanesulfonic acid er endoplasmic reticulum cav1 caveolin 1
0.37812415.15613480.html.plaintext.txt	55	acknowledgments thank ayuan zhan technical assistance laboratory dr van deurs gfp cav1 cdna thank florence tribillac chantal cazevieille centre regional dimagerie cellulaire montpellier proficiency electron microscopy carol beach university kentucky proficiency protein sequencing
0.37812415.15613480.html.plaintext.txt	56	references top abstract introduction experimental procedures results discussion references herreman sermeels l annaert w collen d schoonjans l de strooper b 2000 nat cell biol 2 461 462crossrefmedline order article via infotrieve zhang z nadeau p song w donoviel d yuan m bernstein yankner b 2000 nat cell biol 2 463 465crossrefmedline order article via infotrieve francis r mcgrath g zhang j ruddy d sym m apfeld m nicoll m maxwell m hai b ellis m c parks l xu w li j gurney m myers r l himes c hiebsch r ruble c nye j curtis d 2002 dev cell 3 85 97medline order article via infotrieve de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 388 518 522crossref struhl g greenwald l 1999 nature 398 522 525crossrefmedline order article via infotrieve ye y lukinova n fortini m e 1999 nature 398 525 529crossrefmedline order article via infotrieve ni c y murphy m p golde e carpenter g 2001 science 294 2179 2181abstractfree full text marambaud p shioi j serban g georgakopoulos sarner nagy v baki l wen p efthimipoulos shao z wisniewski robakis n k 2002 embo j 21 48 56 naruse thinakaran g luo j j kusiak j w tomita iwatsubo qian x ginty d d price d l borchelt d r wong p c sisodia 1998 neuron 21 1213 1221medline order article via infotrieve herreman van gassen g bentahir m nyabi o craessaerts k mueller u annaert w de strooper b 2003 j cell sci 116 1127 1136abstractfree full text wang h luo w j zhang y w li y m thinakaran g greengard p xu h 2004 j biol chem 279 40560 40566abstractfree full text sisodia kim h thinakaran g 1999 j hum genet 65 7 12crossrefmedline order article via infotrieve donoviel d b hadjantonakis k ikeda m zheng h hyslop p bernstein 1999 genes dev 13 2801 2810abstractfree full text berechid b e kitzmann m foltz d r roach h seiffert d thompson l olson r e bernstein donoviel d b nye j 2002 j biol chem 277 8154 8165abstractfree full text schubert w frank p g razani b park d chow c w lisanti m p 2001 j biol chem 276 48619 48622abstractfree full text razani b engelman j wang x b schubert w zhang x l marks c b macaluso f russell r g li m pestell r g di vizio d hou h kneitz b lagaud g n christ g j edelmann w lisanti m p 2001 j biol chem 276 38121 38138abstractfree full text ghitescu l fixman simionescu m simionescu n 1986 j cell biol 102 1304 1311abstract fra m williamson e simons k parton r g 1995 proc natl acad sci u 92 8655 8659abstractfree full text lee h park d razani b russell r g pestell r g lisanti m p 2002 j pathol 161 1357 1369abstractfree full text zhao y y liu y stan r v fan l gu y dalton n chu p h peterson k ross j chien k r 2002 proc natl acad sci u 99 11375 11380abstractfree full text bilderback r grigsby r j dobrowsky r 1997 j biol chem 272 10922 10927abstractfree full text lisanti m p scherer p e vidugiriene j tang z hermanowski vosatka tu y h cook r f sargiacomo m 1994 j cell biol 126 111 126abstract song k tang z li lisanti m p 1997 j biol chem 272 4398 4403abstractfree full text bickel p e scherer p e schnitzer j e oh p lisanti m p lodish h f 1997 j biol chem 272 13793 13802abstractfree full text lee j liyanage u bickel p e xia w lansbury p jr kosik k 1998 nat med 4 730 734medline order article via infotrieve morishima kawashima m ihara y 1998 biochemistry 37 15247 15253crossrefmedline order article via infotrieve riddell d r christie g hussain dingwall c 2001 curr biol 11 1288 1293crossrefmedline order article via infotrieve capozza f cohen w cheung m w razani b sotgia f schubert w battista m lee h frank p g lisanti m p 2004 j physiol press bouillot c prochiantz rougon g allinquant b 1996 j biol chem 271 7640 7644abstractfree full text cordy j m hussain dingwall c hooper n m turner j 2003 proc natl acad sci u 100 11735 11740abstractfree full text nishiyama k trapp b d ikezu ransohoff r m tomita iwatsubo kanazawa hsiao k k lisanti m p okamoto 1999 j neurosci 19 6538 6548abstractfree full text vetrivel k cheng h lin w sakurai li nukina n wong p c xu h thinakaran g 2004 j biol chem 279 44945 44954abstractfree full text palacino j j berechid b e alexander p eckman c younkin nye j wolozin b 2000 j biol chem 275 215 222abstractfree full text lazaro j b kitzmann m poul m vandromme m lamb n j fernandez 1997 j cell sci 110 1251 1260abstractfree full text
0.38811842.14976159.html.plaintext.txt	0	law mass action applied neurodegenerative disease hypothesis concerning etiology pathogenesis complex diseases andrew singleton amanda myers john hardy
0.38811842.14976159.html.plaintext.txt	1	laboratory neurogenetics national institute aging national institutes health building 10 room 6c103 msc1589 bethesda md 20892 usa
0.38811842.14976159.html.plaintext.txt	2	received january 2 2004 revised february 3 2004 accepted february 9 2004
0.38811842.14976159.html.plaintext.txt	3	abstract top abstract introduction diseases methodological considerations conclusions predictions references loci underlying autosomal dominant forms neurodegenerative disease identified prion mutations cause gerstmann straussler syndrome hereditary creuzfeldt jakob disease tau mutations cause autosomal dominant frontal temporal dementia synuclein mutations cause autosomal dominant parkinsons disease cases pathogenic mutation protein deposited diseased tissue cases whole protein deposited alzheimers disease mutations app presenilin 1 2 cause autosomal dominant disease substrate proteases respectively responsible production deposited peptide ass thus cases mutations lead disease mechanism involves deposition process briefly review remarkably predictable biology also point seems sporadic forms diseases predisposed genetic variability loci strongly suggesting quantity normal protein produced influences risk sporadic forms disease evidence assertion strongest parkinsons disease pd genetic variability synuclein expression affects risk developing disease although oldest evidence notion increased expression normal sequence protein lead disease comes observation alzheimers disease trisomy 21 cases observations make predictions concerning etiology pathogenesis neurodegenerative diseases general
0.38811842.14976159.html.plaintext.txt	4	abstract top abstract introduction diseases methodological considerations conclusions predictions references loci underlying autosomal dominant forms neurodegenerative disease identified prion mutations cause gerstmann straussler syndrome hereditary creuzfeldt jakob disease tau mutations cause autosomal dominant frontal temporal dementia synuclein mutations cause autosomal dominant parkinsons disease cases pathogenic mutation protein deposited diseased tissue cases whole protein deposited alzheimers disease mutations app presenilin 1 2 cause autosomal dominant disease substrate proteases respectively responsible production deposited peptide ass thus cases mutations lead disease mechanism involves deposition process briefly review remarkably predictable biology also point seems sporadic forms diseases predisposed genetic variability loci strongly suggesting quantity normal protein produced influences risk sporadic forms disease evidence assertion strongest parkinsons disease pd genetic variability synuclein expression affects risk developing disease although oldest evidence notion increased expression normal sequence protein lead disease comes observation alzheimers disease trisomy 21 cases observations make predictions concerning etiology pathogenesis neurodegenerative diseases general
0.38811842.14976159.html.plaintext.txt	5	introduction top abstract introduction diseases methodological considerations conclusions predictions references last 15 years remarkable progress understanding etiology autosomal dominant neurodegenerative diseases loci underlying autosomal dominant forms creuzfeldt jakob disease 1 frontal temporal dementia 2 parkinsons disease identified 3 case underlying locus encoded protein often deposited disease creuzfeldt jakob disease prion protein frontal temporal dementia tau parkinsons disease synuclein alzheimers disease situation little complex deposited peptide ass derived fragment app protein metabolized secretase complex key component complex presenilins mutations either app presenilin 1 2 lead disease 4 6
0.38811842.14976159.html.plaintext.txt	6	introduction top abstract introduction diseases methodological considerations conclusions predictions references last 15 years remarkable progress understanding etiology autosomal dominant neurodegenerative diseases loci underlying autosomal dominant forms creuzfeldt jakob disease 1 frontal temporal dementia 2 parkinsons disease identified 3 case underlying locus encoded protein often deposited disease creuzfeldt jakob disease prion protein frontal temporal dementia tau parkinsons disease synuclein alzheimers disease situation little complex deposited peptide ass derived fragment app protein metabolized secretase complex key component complex presenilins mutations either app presenilin 1 2 lead disease 4 6
0.38811842.14976159.html.plaintext.txt	7	findings well established driven therapeutics research especially allowed development animal models diseases well defined therapeutic targets 7 examples precise pathologic species protein obscure one debated whether deposits intermediate species oligomer responsible extensively investigated balance recent data favoring smaller intermediate species toxic entities 8 however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.38811842.14976159.html.plaintext.txt	8	findings well established driven therapeutics research especially allowed development animal models diseases well defined therapeutic targets 7 examples precise pathologic species protein obscure one debated whether deposits intermediate species oligomer responsible extensively investigated balance recent data favoring smaller intermediate species toxic entities 8 however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.38811842.14976159.html.plaintext.txt	9	studying autosomal dominant forms diseases researchers hope gain insight common sporadic forms mechanistic perspective certainly case however perhaps surprisingly last 4 years become clear case many diseases least haplotype mendelian pathogenic locus influences disease risk sporadic disease
0.38811842.14976159.html.plaintext.txt	10	studying autosomal dominant forms diseases researchers hope gain insight common sporadic forms mechanistic perspective certainly case however perhaps surprisingly last 4 years become clear case many diseases least haplotype mendelian pathogenic locus influences disease risk sporadic disease
0.38811842.14976159.html.plaintext.txt	11	review briefly summarise data make predictions concerning etiology pathogenesis neurodegenerative diseases first though worth noting haplotypic association means mechanistic perspective absence coding changes haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.38811842.14976159.html.plaintext.txt	12	review briefly summarise data make predictions concerning etiology pathogenesis neurodegenerative diseases first though worth noting haplotypic association means mechanistic perspective absence coding changes haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.38811842.14976159.html.plaintext.txt	13	diseases top abstract introduction diseases methodological considerations conclusions predictions references prion diseases prion gene two common coding variants caucasian populations one prion m129 prion v129 910 long recognized homozygosity codon 129 predisposes sporadic disease presumably necessity prion prion interactions symmetry considerations 910 however addition well established risk recent genetic data shown prion haplotype confers additional risk idiopathic disease 11 clearly suggesting genetic variability prion expression contributes disease risk genetic data establish whether high expressors low expressors susceptible since prion knockout mice completely resistant disease 12 parsimonious expect express high levels prion protein homozygotes codon 129 susceptible disease
0.38811842.14976159.html.plaintext.txt	14	diseases top abstract introduction diseases methodological considerations conclusions predictions references prion diseases prion gene two common coding variants caucasian populations one prion m129 prion v129 910 long recognized homozygosity codon 129 predisposes sporadic disease presumably necessity prion prion interactions symmetry considerations 910 however addition well established risk recent genetic data shown prion haplotype confers additional risk idiopathic disease 11 clearly suggesting genetic variability prion expression contributes disease risk genetic data establish whether high expressors low expressors susceptible since prion knockout mice completely resistant disease 12 parsimonious expect express high levels prion protein homozygotes codon 129 susceptible disease
0.38811842.14976159.html.plaintext.txt	15	alzheimers disease extensive sequencing app gene late onset alzheimers disease failed identify mutations 13 however analysis data sibpairs affected late onset alzheimers disease consistently suggested app locus form disease 1415 suggests genetic variability app locus contributes disease risk although precise variability identified finding consistent longstanding observation individuals trisomy 21 inevitably develop alzheimer pathology fifth decade 16 however cases syndrome caused triplication chromosome 21 distal app gene develop alzheimers disease 17 thus three copies app gene leads alzheimer pathology fifth decade yet unidentified genetic variability app locus appears contribute disease risk
0.38811842.14976159.html.plaintext.txt	16	alzheimers disease extensive sequencing app gene late onset alzheimers disease failed identify mutations 13 however analysis data sibpairs affected late onset alzheimers disease consistently suggested app locus form disease 1415 suggests genetic variability app locus contributes disease risk although precise variability identified finding consistent longstanding observation individuals trisomy 21 inevitably develop alzheimer pathology fifth decade 16 however cases syndrome caused triplication chromosome 21 distal app gene develop alzheimers disease 17 thus three copies app gene leads alzheimer pathology fifth decade yet unidentified genetic variability app locus appears contribute disease risk
0.38811842.14976159.html.plaintext.txt	17	frontal temporal dementia tangle diseases mutations tau gene cause many cases autosomal dominant frontal temporal dementia tau pathology many sporadic diseases tau pathology occurs usually tangles also pick bodies argyrophilic grains 18 two genetic haplotype clades caucasian populations designated h1 h2 differ intron sizes promoter sequence wobble bases 19 h1 haplotype frequency 75 caucasians thus h1 homozygotes constitute 60 populations however individuals one three sporadic tau diseases progressive supranuclear palsy 19 corticobasal degeneration 20 argyrophilic grain disease 21 although picks disease 22 guam disease 23 show robust association h1 homozygosity frequency h1 homozygotes 95 data show clearly variability either tau expression tau splicing variability contribute disease risk case difficult determine whether control splicing control expression key variable indeed clear many mutations lead mendelian disease altering alternate splicing 224
0.38811842.14976159.html.plaintext.txt	18	frontal temporal dementia tangle diseases mutations tau gene cause many cases autosomal dominant frontal temporal dementia tau pathology many sporadic diseases tau pathology occurs usually tangles also pick bodies argyrophilic grains 18 two genetic haplotype clades caucasian populations designated h1 h2 differ intron sizes promoter sequence wobble bases 19 h1 haplotype frequency 75 caucasians thus h1 homozygotes constitute 60 populations however individuals one three sporadic tau diseases progressive supranuclear palsy 19 corticobasal degeneration 20 argyrophilic grain disease 21 although picks disease 22 guam disease 23 show robust association h1 homozygosity frequency h1 homozygotes 95 data show clearly variability either tau expression tau splicing variability contribute disease risk case difficult determine whether control splicing control expression key variable indeed clear many mutations lead mendelian disease altering alternate splicing 224
0.38811842.14976159.html.plaintext.txt	19	parkinsons diseaselewy body dementia mutations synuclein gene cause autosomal dominant parkinsons disease synuclein primary component lewy bodies pathognomic feature parkinsons disease 25 genetic variability synuclein promoter contributes risk sporadic parkinsons disease 2627 associated promoter allele stronger promoter 28 perhaps convincingly triplication whole synuclein locus causes autosomal dominant parkinsons diseaselewy body dementia onset age fourth decade 29 duplication locus leads disease fifth decade 30 thus parkinsons disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplications locus causing mendelian disease onset age determined precise dose protein studies cell lines affected individuals kindreds reveal amount synuclein produced correlates disease singleton et al unpublished data 31
0.38811842.14976159.html.plaintext.txt	20	parkinsons diseaselewy body dementia mutations synuclein gene cause autosomal dominant parkinsons disease synuclein primary component lewy bodies pathognomic feature parkinsons disease 25 genetic variability synuclein promoter contributes risk sporadic parkinsons disease 2627 associated promoter allele stronger promoter 28 perhaps convincingly triplication whole synuclein locus causes autosomal dominant parkinsons diseaselewy body dementia onset age fourth decade 29 duplication locus leads disease fifth decade 30 thus parkinsons disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplications locus causing mendelian disease onset age determined precise dose protein studies cell lines affected individuals kindreds reveal amount synuclein produced correlates disease singleton et al unpublished data 31
0.38811842.14976159.html.plaintext.txt	21	methodological considerations top abstract introduction diseases methodological considerations conclusions predictions references problems assessment haplotypic expression rigorous assessment impact haplotypic variation quantitative gene expression splicing surprisingly difficult problem 32 usual method test variability control expression tie artificial arbitrary reporter construct bacterially derived reporter gene measure transient effect expression tumor derived cell line clearly experiments unlikely yield data direct relevance subtle effects variation gene expression development allele specific gene expression methods 3334 offers hope subtle effects studied although methods arduous require access large numbers well maintained human brain specimens 33
0.38811842.14976159.html.plaintext.txt	22	methodological considerations top abstract introduction diseases methodological considerations conclusions predictions references problems assessment haplotypic expression rigorous assessment impact haplotypic variation quantitative gene expression splicing surprisingly difficult problem 32 usual method test variability control expression tie artificial arbitrary reporter construct bacterially derived reporter gene measure transient effect expression tumor derived cell line clearly experiments unlikely yield data direct relevance subtle effects variation gene expression development allele specific gene expression methods 3334 offers hope subtle effects studied although methods arduous require access large numbers well maintained human brain specimens 33
0.38811842.14976159.html.plaintext.txt	23	conclusions predictions top abstract introduction diseases methodological considerations conclusions predictions references diseases referred thus strong evidence frank mutations pathologic locus cause autosomal dominant disease protein deposition genetic variability expression normal protein contributes risk idiopathic disease alzheimers disease deposited protein peptide fragment primary locus mutations cleaving enzyme also lead disease simple observations lead predictions mutant wild type proteins quantitatively different qualitatively different properties cases diseases protein deposition part process polyglutamine diseases als genetic variability promoter gene considered factor influencing applicable risk sporadic disease age onset familial disease see 35 suggestions might also case huntingtons disease polyglutamine diseases deposited fragment cleaved precursor molecule genetic variability cleaving proteases interactors influence stability assessed risk factor loci loci impact risk diseases general may merely cause effect altering levels primary proteins either transcription factors responsible protein breakdown
0.38811842.14976159.html.plaintext.txt	24	conclusions predictions top abstract introduction diseases methodological considerations conclusions predictions references diseases referred thus strong evidence frank mutations pathologic locus cause autosomal dominant disease protein deposition genetic variability expression normal protein contributes risk idiopathic disease alzheimers disease deposited protein peptide fragment primary locus mutations cleaving enzyme also lead disease simple observations lead predictions mutant wild type proteins quantitatively different qualitatively different properties cases diseases protein deposition part process polyglutamine diseases als genetic variability promoter gene considered factor influencing applicable risk sporadic disease age onset familial disease see 35 suggestions might also case huntingtons disease polyglutamine diseases deposited fragment cleaved precursor molecule genetic variability cleaving proteases interactors influence stability assessed risk factor loci loci impact risk diseases general may merely cause effect altering levels primary proteins either transcription factors responsible protein breakdown
0.38811842.14976159.html.plaintext.txt	25	findings unexpected perhaps chemists know power law mass action perhaps surprised us may profound implications determining risks neurodegenerative disease 36 course one therapeutic approach cases therefore would aim reduce concentrations toxic proteins relevant tissue compartment either decreased production increased breakdown
0.38811842.14976159.html.plaintext.txt	26	findings unexpected perhaps chemists know power law mass action perhaps surprised us may profound implications determining risks neurodegenerative disease 36 course one therapeutic approach cases therefore would aim reduce concentrations toxic proteins relevant tissue compartment either decreased production increased breakdown
0.38811842.14976159.html.plaintext.txt	27	acknowledgements work supported nianih intramural programme
0.38811842.14976159.html.plaintext.txt	28	footnotes correspondence addressed tel 1 3014513829 fax 1 3014800335 email hardyjatmailnihgov
0.38811842.14976159.html.plaintext.txt	29	footnotes correspondence addressed tel 1 3014513829 fax 1 3014800335 email hardyjatmailnihgov
0.38811842.14976159.html.plaintext.txt	30	references top abstract introduction diseases methodological considerations conclusions predictions references owen f poulter m lofthouse r collinge j crow tj risby d baker hf ridley rm hsiao k prusiner sb 1989 insertion prion protein gene familial creutzfeldt jakob disease lancet 1 51 52crossref
0.38811842.14976159.html.plaintext.txt	31	rogaeva e 2002 solved unsolved mysteries genetics early onset alzheimers disease neuromol med 2 1 10crossref
0.38811842.14976159.html.plaintext.txt	32	hutton m 2000 missing tau mutation identified ann neurol 47 417 41833co2 2linktypedoi crossrefmedline
0.3937268.11487570.html.plaintext.txt	0	pathogenic app mutations near secretase cleavage site differentially affect ass secretion app c terminal fragment stability chris de jonghe cary esselens1 samir kumar singh katleen craessaerts1 sally serneels frederic checler2 wim annaert1 christine van broeckhoven bart de strooper1
0.3937268.11487570.html.plaintext.txt	1	laboratory neurogenetics department molecular genetics flanders interuniversity institute biotechnology university antwerp belgium 1laboratory neuronal cell biology department human genetics flanders interuniversity institute biotechnology university leuven belgium 2institut de pharmacologie moleculaire et cellulaire du centre national de la recherche scientifique valbonne france
0.3937268.11487570.html.plaintext.txt	2	received april 5 2001 revised accepted june 5 2001
0.3937268.11487570.html.plaintext.txt	3	abstract top abstract introduction results discussion materials methods references release amyloid ss ass amyloid precursor protein app requires cleavages ss secretases plays crucial role alzheimer disease ad pathogenesis missense mutations app gene causing familial ad clustered around ss particular secretase cleavage sites systematically compare primary neurons effect app processing series clinical app mutations two characterized located close proximity secretase cleavage site confirm extend previous observations showing mutations t714i v715m v715a i716v v717i v717l affect secretase cleavage causing increased relative ratio ass42 ass40 taking advantage extended series app mutations able demonstrate inverse correlation ratios age onset disease different families addition subset mutations caused accumulation app c terminal fragments indicating mutations also influence stability app c terminal fragments however unlikely fragments contribute significantly disease process
0.3937268.11487570.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references release amyloid ss ass amyloid precursor protein app requires cleavages ss secretases plays crucial role alzheimer disease ad pathogenesis missense mutations app gene causing familial ad clustered around ss particular secretase cleavage sites systematically compare primary neurons effect app processing series clinical app mutations two characterized located close proximity secretase cleavage site confirm extend previous observations showing mutations t714i v715m v715a i716v v717i v717l affect secretase cleavage causing increased relative ratio ass42 ass40 taking advantage extended series app mutations able demonstrate inverse correlation ratios age onset disease different families addition subset mutations caused accumulation app c terminal fragments indicating mutations also influence stability app c terminal fragments however unlikely fragments contribute significantly disease process
0.3937268.11487570.html.plaintext.txt	5	introduction top abstract introduction results discussion materials methods references mutations amyloid precursor protein app gene first recognized cause early onset autosomal dominant alzheimer disease ad since initial report pathogenic app mutation 1 10 different app mutations identified limited number early onset ad families 2 10 cvan broeckhoven unpublished data mutations cluster near proteolytic cleavage sites app shown affect release amyloidss ass 6 811 18 cvan broeckhoven unpublished data release ass involves successive cleavages ss secretase bace secretase bace cleaves app residues 671 672 codon numbering app770 isoform residues 681 682 19 leading secretion app ectodomain sappss extracellular medium retention 12 kda cell bound c terminal fragment ctfss c99 cleavage ctfss secretase predominantly occurring residues 711 712 40 cleavage lesser extent residues 713 714 42 cleavage results secretion respectively 40 42 amino acid ass peptide ass40 ass42 remaining 55 57 residue long ctf ctf c5557 aidapp intracellular domain rapidly degraded pcupers wannaert bde stooper manuscript submitted publication present extremely low levels vitro 2021 vivo 22 function fragment remains elusive alternatively app cleaved within ass sequence secretase leading secretion app ectodomain sapp retention 10 kda ctf ctf c83 subsequent cleavage ctf secretase leads production 3 kda n truncated amyloid peptide named p3
0.3937268.11487570.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references mutations amyloid precursor protein app gene first recognized cause early onset autosomal dominant alzheimer disease ad since initial report pathogenic app mutation 1 10 different app mutations identified limited number early onset ad families 2 10 cvan broeckhoven unpublished data mutations cluster near proteolytic cleavage sites app shown affect release amyloidss ass 6 811 18 cvan broeckhoven unpublished data release ass involves successive cleavages ss secretase bace secretase bace cleaves app residues 671 672 codon numbering app770 isoform residues 681 682 19 leading secretion app ectodomain sappss extracellular medium retention 12 kda cell bound c terminal fragment ctfss c99 cleavage ctfss secretase predominantly occurring residues 711 712 40 cleavage lesser extent residues 713 714 42 cleavage results secretion respectively 40 42 amino acid ass peptide ass40 ass42 remaining 55 57 residue long ctf ctf c5557 aidapp intracellular domain rapidly degraded pcupers wannaert bde stooper manuscript submitted publication present extremely low levels vitro 2021 vivo 22 function fragment remains elusive alternatively app cleaved within ass sequence secretase leading secretion app ectodomain sapp retention 10 kda ctf ctf c83 subsequent cleavage ctf secretase leads production 3 kda n truncated amyloid peptide named p3
0.3937268.11487570.html.plaintext.txt	7	presenilin ps proteins required secretase mediated cleavage app since deletion ps1 gene inhibits ass generation 23 moreover finding mutagenesis critical aspartate residues d257 d385 ps1 causes reduced ass secretion accumulation appctfs led hypothesis ps1 may exert aspartyl protease activity might identical secretase 24 addition app mutations ps interferes secretase activity way production highly amyloidogenic ass42 increased 25 consequently leading hypothesis ad etiology amyloid cascade hypothesis 26 stating increased ass42 secretion represents gain misfunction
0.3937268.11487570.html.plaintext.txt	8	presenilin ps proteins required secretase mediated cleavage app since deletion ps1 gene inhibits ass generation 23 moreover finding mutagenesis critical aspartate residues d257 d385 ps1 causes reduced ass secretion accumulation appctfs led hypothesis ps1 may exert aspartyl protease activity might identical secretase 24 addition app mutations ps interferes secretase activity way production highly amyloidogenic ass42 increased 25 consequently leading hypothesis ad etiology amyloid cascade hypothesis 26 stating increased ass42 secretion represents gain misfunction
0.3937268.11487570.html.plaintext.txt	9	however reported recently app v715m mutation affects ass40 rather ass42 secretion 7 moreover artifical putative active site d257a ps1 mutant causes accumulation appctfs without concomitant reduction ass secretion indicating accumulation appctfs necessarily direct consequence decreased ass production 27
0.3937268.11487570.html.plaintext.txt	10	however reported recently app v715m mutation affects ass40 rather ass42 secretion 7 moreover artifical putative active site d257a ps1 mutant causes accumulation appctfs without concomitant reduction ass secretion indicating accumulation appctfs necessarily direct consequence decreased ass production 27
0.3937268.11487570.html.plaintext.txt	11	recently several novel mutations clustered secretase processing site app identified 6 10 compare relative effects secretase cleavage expressed human app695 without clinical mutants t714i v715m v715a i716v v717i v717l primary cultures cortical neurones analysed full scope app metabolites demonstrate mutations lead significantly increased relative ass42ass40 concentrations level increase inversely correlated age onset ad furthermore c terminal app mutations also influenced turnover appctfs resulting accumulation appctfs
0.3937268.11487570.html.plaintext.txt	12	recently several novel mutations clustered secretase processing site app identified 6 10 compare relative effects secretase cleavage expressed human app695 without clinical mutants t714i v715m v715a i716v v717i v717l primary cultures cortical neurones analysed full scope app metabolites demonstrate mutations lead significantly increased relative ass42ass40 concentrations level increase inversely correlated age onset ad furthermore c terminal app mutations also influenced turnover appctfs resulting accumulation appctfs
0.3937268.11487570.html.plaintext.txt	13	results top abstract introduction results discussion materials methods references effect ass secretion systematically analysed effect series clinical mutations near secretase cleavage site app end expressed human wild type app app containing either austrian t714i 8 french v715m 7 german v715a cvan broeckhoven unpublished data florida i716v 6 indiana v717l 9 london v717i 1 mutation primary cultures neurons specifically immunoprecipitated ass40 ass42 conditioned medium using antibody fca3340 antibody fca3542 respectively 28 app c terminal mutations exception v715m increased ass1 42 secretion fig 1 increase ass1 42 ranged 154 fold t714i 271 fold v717l fig 1c accompanied increase n truncated ass isoforms ending residue 42 assx 42 isoforms run gels doublet bands fig 1b presumably generated alternative ss secretase activity amino acid residue 11 1929 secretase activity amino acid residue 17 30 ass sequence ass1 40 hand decreased mutations t714i v715m v715a mutations reduce ass1 40 secretion drastically 20 30 55 wild type levels respectively v717i v717l mutations affect ass40 secretion lesser extent i716v mutation apparently effect ass40 secretion fig 1c secretion n truncated ass40 isoforms assx 40 decreased extent comparable ass1 40
0.3937268.11487570.html.plaintext.txt	14	results top abstract introduction results discussion materials methods references effect ass secretion systematically analysed effect series clinical mutations near secretase cleavage site app end expressed human wild type app app containing either austrian t714i 8 french v715m 7 german v715a cvan broeckhoven unpublished data florida i716v 6 indiana v717l 9 london v717i 1 mutation primary cultures neurons specifically immunoprecipitated ass40 ass42 conditioned medium using antibody fca3340 antibody fca3542 respectively 28 app c terminal mutations exception v715m increased ass1 42 secretion fig 1 increase ass1 42 ranged 154 fold t714i 271 fold v717l fig 1c accompanied increase n truncated ass isoforms ending residue 42 assx 42 isoforms run gels doublet bands fig 1b presumably generated alternative ss secretase activity amino acid residue 11 1929 secretase activity amino acid residue 17 30 ass sequence ass1 40 hand decreased mutations t714i v715m v715a mutations reduce ass1 40 secretion drastically 20 30 55 wild type levels respectively v717i v717l mutations affect ass40 secretion lesser extent i716v mutation apparently effect ass40 secretion fig 1c secretion n truncated ass40 isoforms assx 40 decreased extent comparable ass1 40
0.3937268.11487570.html.plaintext.txt	15	view larger version 54k figure 1 effect app c terminal mutations ass secretion primary neuronal cultures transduced recombinant sfv expressing indicated app mutants cells metabolically labelled 35smethionine 4 h culture media collected immunoprecipitation antibodies fca3340 1200 specifically recognizing ass40 fca3542 1200 specifically recognizing ass42 b performed culture media precipitates separated 4 12 sds nupage detection radioactive bands performed using phosphorimaging c values expressed relative wild type arbitrarily set equal 1 represent means plus minus sem three experiments p 005 p 00001
0.3937268.11487570.html.plaintext.txt	16	view larger version 54k figure 1 effect app c terminal mutations ass secretion primary neuronal cultures transduced recombinant sfv expressing indicated app mutants cells metabolically labelled 35smethionine 4 h culture media collected immunoprecipitation antibodies fca3340 1200 specifically recognizing ass40 fca3542 1200 specifically recognizing ass42 b performed culture media precipitates separated 4 12 sds nupage detection radioactive bands performed using phosphorimaging c values expressed relative wild type arbitrarily set equal 1 represent means plus minus sem three experiments p 005 p 00001
0.3937268.11487570.html.plaintext.txt	17	hence ass1 42ass1 40 ratio compared wild type app arbitrarily set equal 1 mutation ratio increased app mutations increase ranges 189 fold v717i 820 fold t714i fig 2a moreover ass1 42ass1 40 ratio correlates inversely r 084 mean age onset different mutations httpmolgen wwwuiaacbeadmutations fig 2b
0.3937268.11487570.html.plaintext.txt	18	view larger version 20k figure 2 effect app c terminal mutations ass42ass40 ratio primary neuronal cultures transduced recombinant sfv expressing indicated app mutants secretion ass1 42 ass1 40 measured described figure 1 mean ass1 42ass1 40 ratio calculated three independent experiments compared wild type arbitrarily set equal 1 p 01 p 005 p 00001 b inversely linear relationship ass42ass40 ratio mean age onset ad mean age onset calculated mutation including data available families httpmolgen wwwuiaacbeadmutations also indicated age onset range number patients n
0.3937268.11487570.html.plaintext.txt	19	view larger version 20k figure 2 effect app c terminal mutations ass42ass40 ratio primary neuronal cultures transduced recombinant sfv expressing indicated app mutants secretion ass1 42 ass1 40 measured described figure 1 mean ass1 42ass1 40 ratio calculated three independent experiments compared wild type arbitrarily set equal 1 p 01 p 005 p 00001 b inversely linear relationship ass42ass40 ratio mean age onset ad mean age onset calculated mutation including data available families httpmolgen wwwuiaacbeadmutations also indicated age onset range number patients n
0.3937268.11487570.html.plaintext.txt	20	effect secretion sapp immunoprecipitated secreted app ectodomain conditioned medium neurons transduced sfv expressing wild type mutant app using antibody 207 significant differences levels sapp mutants wild type app observed data shown agreement assumption mutations mainly affect secretase processing app
0.3937268.11487570.html.plaintext.txt	21	effect secretion sapp immunoprecipitated secreted app ectodomain conditioned medium neurons transduced sfv expressing wild type mutant app using antibody 207 significant differences levels sapp mutants wild type app observed data shown agreement assumption mutations mainly affect secretase processing app
0.3937268.11487570.html.plaintext.txt	22	effect generation appctfs ctfs ctf ctfss remain associated cells ss secretase cleavage app immunoprecipitated using antibody b114 directed last 20 amino acids cytoplasmic domain app mutations codons 714 t714i 717 v717i v717l caused increased levels appctfs 141 217 fold mutations codons 715 v715a v715m 716 i716v displayed similar even slightly decreased levels appctfs compared wild type app fig 3
0.3937268.11487570.html.plaintext.txt	23	effect generation appctfs ctfs ctf ctfss remain associated cells ss secretase cleavage app immunoprecipitated using antibody b114 directed last 20 amino acids cytoplasmic domain app mutations codons 714 t714i 717 v717i v717l caused increased levels appctfs 141 217 fold mutations codons 715 v715a v715m 716 i716v displayed similar even slightly decreased levels appctfs compared wild type app fig 3
0.3937268.11487570.html.plaintext.txt	24	view larger version 50k figure 3 effect c terminal app mutations production appctfs primary neuronal cultures transduced recombinant sfv expressing indicated app mutations cells metabolically labelled 35smethionine 4 h cells washed lysed immunoprecipitation antibody b114 1200 app cytoplasmic tail performed cell lysates precipitates separated 4 12 sds nupage detection radioactive material performed using phosphorimaging b data expressed relative wild type represent means plus minus sem indicated number n experiments p 001
0.3937268.11487570.html.plaintext.txt	25	view larger version 50k figure 3 effect c terminal app mutations production appctfs primary neuronal cultures transduced recombinant sfv expressing indicated app mutations cells metabolically labelled 35smethionine 4 h cells washed lysed immunoprecipitation antibody b114 1200 app cytoplasmic tail performed cell lysates precipitates separated 4 12 sds nupage detection radioactive material performed using phosphorimaging b data expressed relative wild type represent means plus minus sem indicated number n experiments p 001
0.3937268.11487570.html.plaintext.txt	26	investigated whether accumulation appctfs observed t714i mutation consequence reduced degradation increased production therefore pulse chase experiments performed turnover rate wild type mutant ctfs assessed appreciated figure 4a b turnover rate app holoprotein less identical wild type mutant app contrast turnover rates wild type appctfs appi716vctfs faster turnover rates appctfs containing t714i v717i mutation fig 4b three hours pulse labeling level appctfs clearly decreasing wild type app appctfs continue accumulate t714i v717i mutation degradation rate i716v mutant appctfs identical wild type
0.3937268.11487570.html.plaintext.txt	27	investigated whether accumulation appctfs observed t714i mutation consequence reduced degradation increased production therefore pulse chase experiments performed turnover rate wild type mutant ctfs assessed appreciated figure 4a b turnover rate app holoprotein less identical wild type mutant app contrast turnover rates wild type appctfs appi716vctfs faster turnover rates appctfs containing t714i v717i mutation fig 4b three hours pulse labeling level appctfs clearly decreasing wild type app appctfs continue accumulate t714i v717i mutation degradation rate i716v mutant appctfs identical wild type
0.3937268.11487570.html.plaintext.txt	28	view larger version 18k figure 4 pulse chase analysis wild type mutant full length app primary neuronal cultures transduced recombinant sfv expressing indicated app mutations cells pulse labelled 35smethionine 30 min followed chase period 0 240 min cell extracts immunoprecipitated using antibody b114 1200 separated using 4 12 sds nupage detection radioactive material performed using phosphorimaging quantification radioactive bands shown app holoprotein b appctfs radioactive signals normalized signal obtained app holoprotein time zero data representative two independent experiments
0.3937268.11487570.html.plaintext.txt	29	view larger version 18k figure 4 pulse chase analysis wild type mutant full length app primary neuronal cultures transduced recombinant sfv expressing indicated app mutations cells pulse labelled 35smethionine 30 min followed chase period 0 240 min cell extracts immunoprecipitated using antibody b114 1200 separated using 4 12 sds nupage detection radioactive material performed using phosphorimaging quantification radioactive bands shown app holoprotein b appctfs radioactive signals normalized signal obtained app holoprotein time zero data representative two independent experiments
0.3937268.11487570.html.plaintext.txt	30	discussion top abstract introduction results discussion materials methods references common feature app c terminal mutations tested current study significant increase relative ratio ass42 ass40 far largest increase 820 fold observed t714i mutant corroborating previous data hek 293 cells 8 striking mutant also clinically aggressive one displays unusually early age onset 34 years compared app mutations interesting test mutant app transgenic mice anticipating rapid development amyloid plaques disease animals importantly systematically analysing extended series c terminal app mutants single neuronal expression paradigm able demonstrate first time clear inverse correlation ass42ass40 ratio age onset app mutations strongly supports variant amyloid peptide hypothesis mentioned app v717i families age onset apparently modulated apoe genotype apoe4 decreasing apoe2 increasing age onset 3132 app mutations found single families apoe data sparse allow analysis apoe effect age onset httpmolgen wwwuiaacbeadmutations correlation data also contrast observation ps1 families age onset inversely correlated ass42 secretion 33 35 families age onset also influenced apoe genotype 36 remarkably observed correlation holds true relative levels ass42 ass40 considered completely clear absolute amounts ass42 correlate age onset disease protective role ass40 seems unlikely since ass40 levels correlated age onset disease data shown
0.3937268.11487570.html.plaintext.txt	31	discussion top abstract introduction results discussion materials methods references common feature app c terminal mutations tested current study significant increase relative ratio ass42 ass40 far largest increase 820 fold observed t714i mutant corroborating previous data hek 293 cells 8 striking mutant also clinically aggressive one displays unusually early age onset 34 years compared app mutations interesting test mutant app transgenic mice anticipating rapid development amyloid plaques disease animals importantly systematically analysing extended series c terminal app mutants single neuronal expression paradigm able demonstrate first time clear inverse correlation ass42ass40 ratio age onset app mutations strongly supports variant amyloid peptide hypothesis mentioned app v717i families age onset apparently modulated apoe genotype apoe4 decreasing apoe2 increasing age onset 3132 app mutations found single families apoe data sparse allow analysis apoe effect age onset httpmolgen wwwuiaacbeadmutations correlation data also contrast observation ps1 families age onset inversely correlated ass42 secretion 33 35 families age onset also influenced apoe genotype 36 remarkably observed correlation holds true relative levels ass42 ass40 considered completely clear absolute amounts ass42 correlate age onset disease protective role ass40 seems unlikely since ass40 levels correlated age onset disease data shown
0.3937268.11487570.html.plaintext.txt	32	level secretase processing different mutations apparently slightly different effects mutations codons 714 t714i 715 v715a v715m appear primarily affect 40 cleavage cause decreased secretion ass40 mutations codons 716 i716v 717 v717i v717l predominantly affect 42 cleavage increase ass42 secretion hence pathogenic app mutations exert largest effect cleavage site located two three residues n terminal substitution fig 5a suggests residues p3 p4 positions particular importance exposure scissile bounds catalytic sites secretase proteases remarkably drastic decreases ass40 secretion observed mutations codons 714 715 clearly accompanied large increase ass42 secretion however demonstrated previously app t714i mutation 8 ass isoforms ending residues 39 38 lesser extent 37 may counterbalance decrease ass40 overall follows ratio ass42 ass40 best indicator severity disease patients app mutations
0.3937268.11487570.html.plaintext.txt	33	level secretase processing different mutations apparently slightly different effects mutations codons 714 t714i 715 v715a v715m appear primarily affect 40 cleavage cause decreased secretion ass40 mutations codons 716 i716v 717 v717i v717l predominantly affect 42 cleavage increase ass42 secretion hence pathogenic app mutations exert largest effect cleavage site located two three residues n terminal substitution fig 5a suggests residues p3 p4 positions particular importance exposure scissile bounds catalytic sites secretase proteases remarkably drastic decreases ass40 secretion observed mutations codons 714 715 clearly accompanied large increase ass42 secretion however demonstrated previously app t714i mutation 8 ass isoforms ending residues 39 38 lesser extent 37 may counterbalance decrease ass40 overall follows ratio ass42 ass40 best indicator severity disease patients app mutations
0.3937268.11487570.html.plaintext.txt	34	view larger version 17k figure 5 helicoidal model app positions mutated residues relative cleavage sites secretase displayed amino acid numbering indicated app holoprotein 712 718 ass 41 48 arrows residue number indicate effect mutation secretion corresponding ass isoform b top view spatial model putative helical conformation adapted lichtenthaler et al 38 part transmembrane region app near secretase cleavage site shown residues mutated mainly affect 40 cleavage bold line fully encircled residues mutated affect predominantly 42 cleavage dashed line encircled dashes note types residues located opposite sides helix separated bold dashed line
0.3937268.11487570.html.plaintext.txt	35	unexpectedly app c terminal mutations also influence levels appctfs t714i v717i v717l mutations cause accumulation appctfs neurons whereas v715a v715m i716v mutations significant effect appctf levels ss secretase generated appctfs increase approximately extent elevation clearly accompanied increased secretion sapp indicating accumulation appctfs direct result increased ss secretase processing app increased levels appctfs could also result reduced secretase activity 23 could envisaged presence c terminal app mutation reduces secretase activity since ass40 major ass isoform produced specific reduction 40 cleavage could theoretically explain accumulation appctfs maintaining ass42 levels pathogenic level however app mutations drastically decreased ass40 secretion v715a v715m display appctf accumulation whereas others v717i v717l significantly affect ass40 secretion accumulated appctfs therefore effect latter mutations appctf metabolism must occur independently secretase cleavage step pulse chase data indicated reduced turnover rate mutant ctfs suggesting app mutations affect secretase processing also catabolic pathways degrade fragments accumulation appctfs shown swedish london app mutants k670nm671l v717i v717f v717g 37 agreement findings mcphie et al 37 proposed appctfss linked signalling transduction pathway accumulation appctfss speculated disrupt pathway leading cytoskeletal abnormalities neurodegeneration however data show accumulation appctfs consistent feature app mutants causing ad fact mutations v717i i716v result similar mean age onset whereas appctfs accumulate former latter therefore accumulation appctfs likely less important factor overall pathogenesis disease would interest investigate different mutations pathological level brain patients unfortunately material yet available patients mutations cause appctf accumulation ie mutations positions 715 716 app sequence
0.3937268.11487570.html.plaintext.txt	36	unexpectedly app c terminal mutations also influence levels appctfs t714i v717i v717l mutations cause accumulation appctfs neurons whereas v715a v715m i716v mutations significant effect appctf levels ss secretase generated appctfs increase approximately extent elevation clearly accompanied increased secretion sapp indicating accumulation appctfs direct result increased ss secretase processing app increased levels appctfs could also result reduced secretase activity 23 could envisaged presence c terminal app mutation reduces secretase activity since ass40 major ass isoform produced specific reduction 40 cleavage could theoretically explain accumulation appctfs maintaining ass42 levels pathogenic level however app mutations drastically decreased ass40 secretion v715a v715m display appctf accumulation whereas others v717i v717l significantly affect ass40 secretion accumulated appctfs therefore effect latter mutations appctf metabolism must occur independently secretase cleavage step pulse chase data indicated reduced turnover rate mutant ctfs suggesting app mutations affect secretase processing also catabolic pathways degrade fragments accumulation appctfs shown swedish london app mutants k670nm671l v717i v717f v717g 37 agreement findings mcphie et al 37 proposed appctfss linked signalling transduction pathway accumulation appctfss speculated disrupt pathway leading cytoskeletal abnormalities neurodegeneration however data show accumulation appctfs consistent feature app mutants causing ad fact mutations v717i i716v result similar mean age onset whereas appctfs accumulate former latter therefore accumulation appctfs likely less important factor overall pathogenesis disease would interest investigate different mutations pathological level brain patients unfortunately material yet available patients mutations cause appctf accumulation ie mutations positions 715 716 app sequence
0.3937268.11487570.html.plaintext.txt	37	finally propose molecular model integrates observations one presumes helical conformation transmembraneous part app 38 fig 5b mutations residues 714 715 primarily affect 40 secretase cleavage located one side helix whereas mutations residues 716 717 predominantly affect 42 secretase cleavage located opposite side noted mutations residues 714 717 leading accumulation appctfs located one side helix whereas mutations residues 715 716 lead accumulation appctfs side fig 5b recent unpublished data wannaert bde strooper demonstrated region app spanning currently investigated clinical mutations involved direct binding app ps1 speculate therefore investigated clinical mutations cause subtle changes binding interaction ps1 app therefore mainly affect exposure scissile bonds catalytic site secretase abnormal accumulation appctfs observed app mutants could also fit hypothesis since ps1 d257a catalytic site mutant leads accumulation appctfs without concomitant reduction ass production 27
0.3937268.11487570.html.plaintext.txt	38	finally propose molecular model integrates observations one presumes helical conformation transmembraneous part app 38 fig 5b mutations residues 714 715 primarily affect 40 secretase cleavage located one side helix whereas mutations residues 716 717 predominantly affect 42 secretase cleavage located opposite side noted mutations residues 714 717 leading accumulation appctfs located one side helix whereas mutations residues 715 716 lead accumulation appctfs side fig 5b recent unpublished data wannaert bde strooper demonstrated region app spanning currently investigated clinical mutations involved direct binding app ps1 speculate therefore investigated clinical mutations cause subtle changes binding interaction ps1 app therefore mainly affect exposure scissile bonds catalytic site secretase abnormal accumulation appctfs observed app mutants could also fit hypothesis since ps1 d257a catalytic site mutant leads accumulation appctfs without concomitant reduction ass production 27
0.3937268.11487570.html.plaintext.txt	39	materials methods top abstract introduction results discussion materials methods references preparation recombinant semliki forest virus austrian t714i 8 german v715a cvan broeckhoven unpublished data french v715m 7 florida i716v 6 indiana v717l 9 mutations introduced human wild type app cdna 695 isoform site directed mutagenesis using appropriate oligonucleotides quick change mutagenesis system stratagene la jolla ca mutant app cdna subsequently cloned smai site psfv 1 gibco brl bethesda md recombinant semliki forest viruses produced described 39
0.3937268.11487570.html.plaintext.txt	40	materials methods top abstract introduction results discussion materials methods references preparation recombinant semliki forest virus austrian t714i 8 german v715a cvan broeckhoven unpublished data french v715m 7 florida i716v 6 indiana v717l 9 mutations introduced human wild type app cdna 695 isoform site directed mutagenesis using appropriate oligonucleotides quick change mutagenesis system stratagene la jolla ca mutant app cdna subsequently cloned smai site psfv 1 gibco brl bethesda md recombinant semliki forest viruses produced described 39
0.3937268.11487570.html.plaintext.txt	41	primary neuronal cultures primary cortical neurons isolated e14 embryonic mice described 39 briefly dissection brain dissociation cells trypsinization cells plated poly lysine coated dishes incubated neurobasal medium b27 supplement proliferation non neuronal cells prevented adding 5 microm cytosine arabinoside
0.3937268.11487570.html.plaintext.txt	42	primary neuronal cultures primary cortical neurons isolated e14 embryonic mice described 39 briefly dissection brain dissociation cells trypsinization cells plated poly lysine coated dishes incubated neurobasal medium b27 supplement proliferation non neuronal cells prevented adding 5 microm cytosine arabinoside
0.3937268.11487570.html.plaintext.txt	43	transduction primary neurons recombinant sfv diluted 110 conditioned culture medium added 3 5 day old primary cortical neurons 1 h medium replaced normal culture medium transduction continued 2 h medium replaced methionine free medium containing 100 microci 35smethionine icn irvine ca 4 h metabolic labelling culture supernatants collected cells washed pbs finally lysed dip buffer 20 mm tris hcl ph 74 150 mm nacl 1 triton x 100 1 sodium deoxycholate 01 sds containing protease inhibitors 5 mm edta 100 uml trasylol 1 microgml pepstatin
0.3937268.11487570.html.plaintext.txt	44	transduction primary neurons recombinant sfv diluted 110 conditioned culture medium added 3 5 day old primary cortical neurons 1 h medium replaced normal culture medium transduction continued 2 h medium replaced methionine free medium containing 100 microci 35smethionine icn irvine ca 4 h metabolic labelling culture supernatants collected cells washed pbs finally lysed dip buffer 20 mm tris hcl ph 74 150 mm nacl 1 triton x 100 1 sodium deoxycholate 01 sds containing protease inhibitors 5 mm edta 100 uml trasylol 1 microgml pepstatin
0.3937268.11487570.html.plaintext.txt	45	pulse chase neurons transduced recombinant sfv described neurons pulse labeled 100 microci 35smethionine 30 min chased 60 120 240 min cell extracts processed described
0.3937268.11487570.html.plaintext.txt	46	pulse chase neurons transduced recombinant sfv described neurons pulse labeled 100 microci 35smethionine 30 min chased 60 120 240 min cell extracts processed described
0.3937268.11487570.html.plaintext.txt	47	immunoprecipitation sds page antibodies directed ass 4g8 1200 senetek napa ca recognizes total ass fca3340 1200 specifically recognizes ass40 28 fca3542 1200 specifically recognizes ass42 28 secreted ectodomain app antibody 207 1200 40 added culture supernatants immune complexes recovered protein g sepharose antibody b114 used precipitate ss c terminal fragments app cell extracts 41 immunoprecipitated material resolved 4 12 nupage gel novex invitrogen carlsbad ca run mes buffer intensity radioactive bands quantified using phosphoimager molecular dynamics sunnyvale ca imagequant software package quantitative data normalized signal obtained corresponding app holoprotein compensate variations expression culture dishes different app mutants used
0.3937268.11487570.html.plaintext.txt	48	immunoprecipitation sds page antibodies directed ass 4g8 1200 senetek napa ca recognizes total ass fca3340 1200 specifically recognizes ass40 28 fca3542 1200 specifically recognizes ass42 28 secreted ectodomain app antibody 207 1200 40 added culture supernatants immune complexes recovered protein g sepharose antibody b114 used precipitate ss c terminal fragments app cell extracts 41 immunoprecipitated material resolved 4 12 nupage gel novex invitrogen carlsbad ca run mes buffer intensity radioactive bands quantified using phosphoimager molecular dynamics sunnyvale ca imagequant software package quantitative data normalized signal obtained corresponding app holoprotein compensate variations expression culture dishes different app mutants used
0.3937268.11487570.html.plaintext.txt	49	acknowledgements work supported fund scientific research flanders fwo interuniversitary attraction poles iuap p417 cdj wa postdoctoral fellows fwo
0.3937268.11487570.html.plaintext.txt	50	footnotes correspondence addressed tel 32 16 346227 fax 32 16 347181 email admedkuleuvenacbe
0.3937268.11487570.html.plaintext.txt	51	footnotes correspondence addressed tel 32 16 346227 fax 32 16 347181 email admedkuleuvenacbe
0.3937268.11487570.html.plaintext.txt	52	correspondence addressed tel 32 16 346227 fax 32 16 347181 email admedkuleuvenacbe
0.3937268.11487570.html.plaintext.txt	53	correspondence addressed tel 32 16 346227 fax 32 16 347181 email admedkuleuvenacbe
0.3937268.11487570.html.plaintext.txt	54	references top abstract introduction results discussion materials methods references 1 goate chartier harlin mc mullan m brown j crawford f fidani l giuffra l haynes irving n james l et al 1991 segregation missense mutation amyloid precursor protein gene familial alzheimer disease nature 349 704 706isimedline
0.41595346.15367492.html.plaintext.txt	0	reduced kiaa0471 mrna expression alzheimers patients new candidate gene product linked disease lluisa de yebra1 rosa adroer1 nuria de gregorio rocasolano2 rafael blesa3 ramon trullas2 nicole mahy1
0.41595346.15367492.html.plaintext.txt	1	1unitat de bioquimica institut dinvestigacions biomediques august pi sunyer idibaps facultat de medicina universitat de barcelona ccasanova 143 08036 barcelona spain 2unitat de neurobiologia institut dinvestigacions biomediques de barcelona csic institut dinvestigacions biomediques august pi sunyer idibaps crossello 161 08036 barcelona spain 3servei de neurologia hospital de la santa creu sant pau cst antoni m claret 167 08025 barcelona spain
0.41595346.15367492.html.plaintext.txt	2	received may 13 2004 revised july 6 2004 accepted september 4 2004
0.41595346.15367492.html.plaintext.txt	3	abstract top abstract introduction results discussion materials methods references alzheimers disease ad phenotype complexity raises question whether genetic features remain unknown although percentage patients familial cases linked mutations amyloid precursor protein presenilin 1 presenilin 2 genes remainder considered mainly sporadic late onset cases complex etiology however changes gene expression genetic features individual clearly contribute develop illness consequently paper focused identification new genes expression altered ad used technique differential display reverse transcriptase polymerase chain reaction ddrt pcr order study gene expression differences brain tissue patients advanced stage ad studying medial septum hippocampus brain areas found inhibition kiaa0471 gene expression three six ad patients including one presenilin 1 gene mutation gene encodes large protein presents predicted form 95 homology idn4 ggtr sequences results may provide significant clues understanding molecular mechanisms underlying septohippocampal neurodegeneration addition may open new area research diagnostic therapeutic tools relevance also considered
0.41595346.15367492.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references alzheimers disease ad phenotype complexity raises question whether genetic features remain unknown although percentage patients familial cases linked mutations amyloid precursor protein presenilin 1 presenilin 2 genes remainder considered mainly sporadic late onset cases complex etiology however changes gene expression genetic features individual clearly contribute develop illness consequently paper focused identification new genes expression altered ad used technique differential display reverse transcriptase polymerase chain reaction ddrt pcr order study gene expression differences brain tissue patients advanced stage ad studying medial septum hippocampus brain areas found inhibition kiaa0471 gene expression three six ad patients including one presenilin 1 gene mutation gene encodes large protein presents predicted form 95 homology idn4 ggtr sequences results may provide significant clues understanding molecular mechanisms underlying septohippocampal neurodegeneration addition may open new area research diagnostic therapeutic tools relevance also considered
0.41595346.15367492.html.plaintext.txt	5	introduction top abstract introduction results discussion materials methods references although alzheimers disease ad one common illnesses modern society affecting 10 population 65 years molecular bases disease remain unclear familial forms account 5 total number cases linked mutations three different genes amyloid precursor protein app gene chromosome 21 1 presenilin 1 ps1 gene chromosome 14 23 presenilin 2 ps2 gene chromosome 1 45 nevertheless well accepted genetic profiles predispose individuals suffer illness others case apolipoprotein 4 apoe allele demonstrated susceptibility gene ad 6
0.41595346.15367492.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references although alzheimers disease ad one common illnesses modern society affecting 10 population 65 years molecular bases disease remain unclear familial forms account 5 total number cases linked mutations three different genes amyloid precursor protein app gene chromosome 21 1 presenilin 1 ps1 gene chromosome 14 23 presenilin 2 ps2 gene chromosome 1 45 nevertheless well accepted genetic profiles predispose individuals suffer illness others case apolipoprotein 4 apoe allele demonstrated susceptibility gene ad 6
0.41595346.15367492.html.plaintext.txt	7	septohippocampal system plays important role memory cognition affected ad patients characterized reduction cholinergic activity significant atrophy medial septum diagonal band broca ms dbb correlates grade cognitive memory deficits 7 pathological changes arise diseases mostly believed driven changes gene expression 8 10 aim study disentangle different pattern genetic expression characterize ad medial septum hippocampus
0.41595346.15367492.html.plaintext.txt	8	septohippocampal system plays important role memory cognition affected ad patients characterized reduction cholinergic activity significant atrophy medial septum diagonal band broca ms dbb correlates grade cognitive memory deficits 7 pathological changes arise diseases mostly believed driven changes gene expression 8 10 aim study disentangle different pattern genetic expression characterize ad medial septum hippocampus
0.41595346.15367492.html.plaintext.txt	9	differential display reverse transcriptase polymerase chain reaction ddrt pcr technique quite unique potential visualize expressed genes eukaryotic cell systematic non biased sequence dependent manner using multiple primer combinations 11 thus technique allows searching genes differentially expressed specific disease ddrt pcr used laboratory identify new genes involved ad report kiaa0471 gene differentially expressed human brain several ad patients including one ps1 mutation
0.41595346.15367492.html.plaintext.txt	10	differential display reverse transcriptase polymerase chain reaction ddrt pcr technique quite unique potential visualize expressed genes eukaryotic cell systematic non biased sequence dependent manner using multiple primer combinations 11 thus technique allows searching genes differentially expressed specific disease ddrt pcr used laboratory identify new genes involved ad report kiaa0471 gene differentially expressed human brain several ad patients including one ps1 mutation
0.41595346.15367492.html.plaintext.txt	11	results top abstract introduction results discussion materials methods references brain samples six ad patients including one ps1 mutation three age matched controls compared table 1 observe one cdna fragment differentially expressed 15 arbitrary primers combination different 3 anchored primers needed fig 1 represents analysis 37 total mrna according formula p1 097n n corresponds number arbitrary primers 12 band disappeared hippocampus septum three six ad patients including one ps1 mutation present three analyzed controls results confirmed reproducing experiments duplicate rna isolation step validating observed pattern expression suggesting depth characterization identified gene warranted addition found differences band intensities could confirmed therefore discarded
0.41595346.15367492.html.plaintext.txt	12	results top abstract introduction results discussion materials methods references brain samples six ad patients including one ps1 mutation three age matched controls compared table 1 observe one cdna fragment differentially expressed 15 arbitrary primers combination different 3 anchored primers needed fig 1 represents analysis 37 total mrna according formula p1 097n n corresponds number arbitrary primers 12 band disappeared hippocampus septum three six ad patients including one ps1 mutation present three analyzed controls results confirmed reproducing experiments duplicate rna isolation step validating observed pattern expression suggesting depth characterization identified gene warranted addition found differences band intensities could confirmed therefore discarded
0.41595346.15367492.html.plaintext.txt	13	view table figure 1 differential display analysis gene expression ad total rna extracted hippocampus septum post mortem ad control patients autoradiogram shows band pattern obtained 33pdatp labeled differential display reactions performed duplicate using 5 aagctttttttttttg 3 anchored primer h t11g 5 aagcttcctctat 3 random arbitrary primer h ap53 arrow indicates band corresponding cdna fragment differentially expressed ad patients indicates alzheimers patients controls ad patients alzheimers disease ad patient mutation ps1 gene c controls two brain areas analyzed per case hippocampus 1 septum 3 different lanes numbered 1 30 every two lanes correspond duplicated sample patient e included figure gives results similar patients b d
0.41595346.15367492.html.plaintext.txt	14	excising bands interest reverse northern dot blot performed gave several positive clones confirmed differences expression fig 2a nucleotide sequence representative clones 1 4 identical fig 2b confirm differences northern blot analysis performed ad patients fig 2c basis known sequences genbank database fragment sequence presented high homology 98 e 166 homo sapiens gene product kiaa0471 sequence mrna part human brain cdna library included japanese protein database huge human unidentified gene encoded 13 huge database human large proteins aims predict primary structures sequences human large cdnas 4 kb particular cdna clones capable coding large proteins 50 kda 14 kiaa0471 6834 bp gene located chromosome 1 maps 1q24 q25 region 5309 bp 3 utr
0.41595346.15367492.html.plaintext.txt	15	view larger version 55k figure 2 confirmation differentially expressed cdnas reverse northern dot blot cdna differential band represented figure 1 lane 5 candidate cdna another band showing different intensity ddrt gel control cdna excised reamplified ligated pcr trap cloning vector pcr five picked colonies c1 c2 c3 c4 c5 blotted onto duplicated filters one pair filters hybridized 32p labeled cdna control individual pair filters hybridized 32p labeled cdna ad patient c1 c4 clones corresponding candidate cdna present marked differences hybridization control ad mrna probes b nucleotide sequence candidate clone cdna fragment cdna inserts candidate 1 4 clones showing differential expression sequenced nucleotide sequence clones identical sequence primers used differential gene display analysis underlined hhindiii site 5 end primers c northern blot analysis showing overexpression kiaa0471 ad patients hippocampus septum different patients used two lanes pair show hippocampus h septum one patient equal amounts 20 microglane total rna septum hippocampus isolated studied brain area run 13 agarose gel transferred nylon filters filters hybridized 32p labeled kiaa0471 cdna fragment identified differential display blot also rehybridized ss actin probe control
0.41595346.15367492.html.plaintext.txt	16	view larger version 55k figure 2 confirmation differentially expressed cdnas reverse northern dot blot cdna differential band represented figure 1 lane 5 candidate cdna another band showing different intensity ddrt gel control cdna excised reamplified ligated pcr trap cloning vector pcr five picked colonies c1 c2 c3 c4 c5 blotted onto duplicated filters one pair filters hybridized 32p labeled cdna control individual pair filters hybridized 32p labeled cdna ad patient c1 c4 clones corresponding candidate cdna present marked differences hybridization control ad mrna probes b nucleotide sequence candidate clone cdna fragment cdna inserts candidate 1 4 clones showing differential expression sequenced nucleotide sequence clones identical sequence primers used differential gene display analysis underlined hhindiii site 5 end primers c northern blot analysis showing overexpression kiaa0471 ad patients hippocampus septum different patients used two lanes pair show hippocampus h septum one patient equal amounts 20 microglane total rna septum hippocampus isolated studied brain area run 13 agarose gel transferred nylon filters filters hybridized 32p labeled kiaa0471 cdna fragment identified differential display blot also rehybridized ss actin probe control
0.41595346.15367492.html.plaintext.txt	17	discussion top abstract introduction results discussion materials methods references changes gene expression may contribute explain part high percentage 95 sporadic forms alzheimer clear etiology ddrt pcr method powerful technique identifying differentially expressed transcripts two tissues cell types interest 15 main objective apply technique identify new genes responsible expression changes involved ad order carry analyzed human brain samples alzheimers patients age matched controls whose medical history fully documented fact limited number samples extremely well qualified patients followed approach avoid false results associated variations patient conditions related agonal state tissue ph terminal medical conditions 16 differences expression could due differences cellular composition samples blocks hippocampus septum accurately obtained area shown cdna bands profiles displayed samples limited differences age post mortem interval affect study
0.41595346.15367492.html.plaintext.txt	18	discussion top abstract introduction results discussion materials methods references changes gene expression may contribute explain part high percentage 95 sporadic forms alzheimer clear etiology ddrt pcr method powerful technique identifying differentially expressed transcripts two tissues cell types interest 15 main objective apply technique identify new genes responsible expression changes involved ad order carry analyzed human brain samples alzheimers patients age matched controls whose medical history fully documented fact limited number samples extremely well qualified patients followed approach avoid false results associated variations patient conditions related agonal state tissue ph terminal medical conditions 16 differences expression could due differences cellular composition samples blocks hippocampus septum accurately obtained area shown cdna bands profiles displayed samples limited differences age post mortem interval affect study
0.41595346.15367492.html.plaintext.txt	19	important consider besides working problems human samples fact human brain thought greatest complexity gene expression region body 17 obtained clear sharp ddrt gels improving image bands compared previously reported studies 1819
0.41595346.15367492.html.plaintext.txt	20	identified one cdna expressed septum hippocampus several alzheimers patients including one ps1 mutation necessary screen 35 total mrna observe difference ad gene expression transcript could important among total genes potentially associated ad differential mrna identified kiaa0471 stage kiaa0471 mrna cannot directly associated known protein based predicted coding region would translated soluble large protein length 370 amino acids 20 molecular weight 43 kda predicted protein presents least 95 homology h sapiens aminoacid sequences idn4 ggtr membrane protein protein associated precancerous lesions hepatocellular carcinoma embl bioinformatic harvester recent experiments ddrt pcr reported upregulation kiaa0471 gene products 7 12 cases esophageal tumors 21 studies predicted kiaa proteins indicate multiple domains may participate intricate framework assembly protein complexes predicted functions mainly implied cell communicationsignaling cell structuremotility nucleic acid management 22 would agreement increased kiaa0471 expression proliferative cells reduction neuronal loss associated neurodegeneration true absence kiaa0471 expression evidenced results may directly involved pathogenesis septohippocampal lesion presented ad present studies directly conducted determine entire sequences human kiaa proteins together biological functions help better understand involvement variety diseases 23
0.41595346.15367492.html.plaintext.txt	21	identified one cdna expressed septum hippocampus several alzheimers patients including one ps1 mutation necessary screen 35 total mrna observe difference ad gene expression transcript could important among total genes potentially associated ad differential mrna identified kiaa0471 stage kiaa0471 mrna cannot directly associated known protein based predicted coding region would translated soluble large protein length 370 amino acids 20 molecular weight 43 kda predicted protein presents least 95 homology h sapiens aminoacid sequences idn4 ggtr membrane protein protein associated precancerous lesions hepatocellular carcinoma embl bioinformatic harvester recent experiments ddrt pcr reported upregulation kiaa0471 gene products 7 12 cases esophageal tumors 21 studies predicted kiaa proteins indicate multiple domains may participate intricate framework assembly protein complexes predicted functions mainly implied cell communicationsignaling cell structuremotility nucleic acid management 22 would agreement increased kiaa0471 expression proliferative cells reduction neuronal loss associated neurodegeneration true absence kiaa0471 expression evidenced results may directly involved pathogenesis septohippocampal lesion presented ad present studies directly conducted determine entire sequences human kiaa proteins together biological functions help better understand involvement variety diseases 23
0.41595346.15367492.html.plaintext.txt	22	lack expression kiaa0471 gene ps1 mutation patient could additional factor contributes explain early onset dementia andor early death possible genetic association presenilin 2 kiaa0471 ad cannot discarded genes map long arm chromosome 1 1q24 q25 kiaa0471 1q31 q42 ps2 ad mutations chromosome result individuals wide range age onset 24 also shown results special instability 1q chromosome also suggested presentation genetic abnormalities leading gliomas oligodendrogliomas astrocytomas 25 ependymomas 26 hand well characterized diseases sometimes appear linked genetic mutations loci kiaa0471 maps 1q24 q25 case type 2 diabetes 27 immunoglobulin nephropathy 28 hereditary prostate cancer 1 29 present direct relationship ad established diseases except recently recognized association among hyperinsulinemia diabetes ad 30 insulin degrading enzyme activity ss amyloid peptides 31 33 therefore knowledge function kiaa0471 protein future could elucidate possible relationship deficiency kiaa0471 showed male individuals though one ad woman included study study necessary disentangle whether link gender
0.41595346.15367492.html.plaintext.txt	23	lack expression kiaa0471 gene ps1 mutation patient could additional factor contributes explain early onset dementia andor early death possible genetic association presenilin 2 kiaa0471 ad cannot discarded genes map long arm chromosome 1 1q24 q25 kiaa0471 1q31 q42 ps2 ad mutations chromosome result individuals wide range age onset 24 also shown results special instability 1q chromosome also suggested presentation genetic abnormalities leading gliomas oligodendrogliomas astrocytomas 25 ependymomas 26 hand well characterized diseases sometimes appear linked genetic mutations loci kiaa0471 maps 1q24 q25 case type 2 diabetes 27 immunoglobulin nephropathy 28 hereditary prostate cancer 1 29 present direct relationship ad established diseases except recently recognized association among hyperinsulinemia diabetes ad 30 insulin degrading enzyme activity ss amyloid peptides 31 33 therefore knowledge function kiaa0471 protein future could elucidate possible relationship deficiency kiaa0471 showed male individuals though one ad woman included study study necessary disentangle whether link gender
0.41595346.15367492.html.plaintext.txt	24	work needed determine causes lack expression among could due mutation kiaa0471 gene results altered missing mrna upstream effect simply ulterior suppresion mrna production another factor downstream effect moment beginning new assays using microchips dna probes specific antibodies predicted kiaa047 protein new attempts aimed understand difference gene expression found study using ddrt pcr technique study incidence kiaa0471 mrna deficit alzheimers patients wide population sample brain tissue blood give key information better diagnosis disease future
0.41595346.15367492.html.plaintext.txt	25	work needed determine causes lack expression among could due mutation kiaa0471 gene results altered missing mrna upstream effect simply ulterior suppresion mrna production another factor downstream effect moment beginning new assays using microchips dna probes specific antibodies predicted kiaa047 protein new attempts aimed understand difference gene expression found study using ddrt pcr technique study incidence kiaa0471 mrna deficit alzheimers patients wide population sample brain tissue blood give key information better diagnosis disease future
0.41595346.15367492.html.plaintext.txt	26	conclusion found first time strong reduction kiaa0471 gene expression several ad patients including one ps1 mutation predicted defective protein presents 95 homology idn4 ggtr sequences identification new genetic defect may give new clues explain pathogenesis ad process new starting point design rational diagnostic therapeutic tools
0.41595346.15367492.html.plaintext.txt	27	conclusion found first time strong reduction kiaa0471 gene expression several ad patients including one ps1 mutation predicted defective protein presents 95 homology idn4 ggtr sequences identification new genetic defect may give new clues explain pathogenesis ad process new starting point design rational diagnostic therapeutic tools
0.41595346.15367492.html.plaintext.txt	28	materials methods top abstract introduction results discussion materials methods references tissue samples brain post mortem septal hippocampal samples table 1 nine patients obtained local neurological tissue bank serveis cientifico tecnics universitat de barcelona spain approval appropriate medical ethic committee neuropathological assessment established bank neuropathologist according braak newel criteria 3435 blocks hippocampus septum extracted area brain bank performed histological characterization ensure similarity post mortem intervals pmi ranged 415 15 h three patients two men one woman mean age death 547 plus minus 79 years pmi 11 plus minus 26 h present brain pathology used controls six patients five men one woman mean age death 678 plus minus 36 years pmi 67 plus minus 09 h suffered ad one ad patients presented ps1 mutation v89l 36 cases cerebrospinal fluid ph measured autopsy indicator strips index agonal state mean result 7 range 6 8 considered appropriate pieces septal hippocampal regions frozen separately 80 degrees c rna extraction
0.41595346.15367492.html.plaintext.txt	29	materials methods top abstract introduction results discussion materials methods references tissue samples brain post mortem septal hippocampal samples table 1 nine patients obtained local neurological tissue bank serveis cientifico tecnics universitat de barcelona spain approval appropriate medical ethic committee neuropathological assessment established bank neuropathologist according braak newel criteria 3435 blocks hippocampus septum extracted area brain bank performed histological characterization ensure similarity post mortem intervals pmi ranged 415 15 h three patients two men one woman mean age death 547 plus minus 79 years pmi 11 plus minus 26 h present brain pathology used controls six patients five men one woman mean age death 678 plus minus 36 years pmi 67 plus minus 09 h suffered ad one ad patients presented ps1 mutation v89l 36 cases cerebrospinal fluid ph measured autopsy indicator strips index agonal state mean result 7 range 6 8 considered appropriate pieces septal hippocampal regions frozen separately 80 degrees c rna extraction
0.41595346.15367492.html.plaintext.txt	30	rna extraction rna extracted 100 mg studied brain area hippocampus septum using tripure isolation reagent boehringer manheim germany treated dnase genhunter nashville tn usa briefly tissue samples sliced homogenized tripure aqueous organic phases separated centrifugation addition chloroform merck darmstadt germany aqueous rna solution precipitated isopropyl alcohol scharlau chemie spain rinsed 75 ethanol resuspended water quantification concentrations spectrophotometry total rna samples kept frozen 80 degrees c ethanol precipitates
0.41595346.15367492.html.plaintext.txt	31	rna extraction rna extracted 100 mg studied brain area hippocampus septum using tripure isolation reagent boehringer manheim germany treated dnase genhunter nashville tn usa briefly tissue samples sliced homogenized tripure aqueous organic phases separated centrifugation addition chloroform merck darmstadt germany aqueous rna solution precipitated isopropyl alcohol scharlau chemie spain rinsed 75 ethanol resuspended water quantification concentrations spectrophotometry total rna samples kept frozen 80 degrees c ethanol precipitates
0.41595346.15367492.html.plaintext.txt	32	gene expression analysis used differential display technique ddrt pcr described liang pardee 1112 study gene expression first strand cdna synthesis pcr amplification labeled 33pdatp labeled performed using rna image kit genhunter basically 02 microg total rna reverse transcribed using anchored oligo dt h t11v va g c aliquot generated cdna corresponding 1 ng total rna amplified pcr anchored oligo dt used cdna reaction arbitrary primer pcr reactions performed always duplicate pcr products resolved electrophoresis using 6 denaturing polyacrylamide gel gel dried 3mm whatman paper 2 h vacuum 80 degrees c exposed overnight x omat ar film eastman kodak co rochester ny usa film put top dried gel marked needle punches order locate gel bands identified film film developed cdna displays showed differences band intensities repeated rna isolation step order ensure results avoid false positives cdna bands interest corresponding human samples excised gel reamplified pcr set primers pcr conditions used mrna display higher concentration dntps ligated pcr trap cloning vector genhunter pcr trap vector includes tetracycline dependent positive selection plasmids dna inserts thus recombinant plasmids show antibiotic resistance ligated plasmids transformed gh competent cells plated lb plates containing 20 microgml tetracycline
0.41595346.15367492.html.plaintext.txt	33	gene expression analysis used differential display technique ddrt pcr described liang pardee 1112 study gene expression first strand cdna synthesis pcr amplification labeled 33pdatp labeled performed using rna image kit genhunter basically 02 microg total rna reverse transcribed using anchored oligo dt h t11v va g c aliquot generated cdna corresponding 1 ng total rna amplified pcr anchored oligo dt used cdna reaction arbitrary primer pcr reactions performed always duplicate pcr products resolved electrophoresis using 6 denaturing polyacrylamide gel gel dried 3mm whatman paper 2 h vacuum 80 degrees c exposed overnight x omat ar film eastman kodak co rochester ny usa film put top dried gel marked needle punches order locate gel bands identified film film developed cdna displays showed differences band intensities repeated rna isolation step order ensure results avoid false positives cdna bands interest corresponding human samples excised gel reamplified pcr set primers pcr conditions used mrna display higher concentration dntps ligated pcr trap cloning vector genhunter pcr trap vector includes tetracycline dependent positive selection plasmids dna inserts thus recombinant plasmids show antibiotic resistance ligated plasmids transformed gh competent cells plated lb plates containing 20 microgml tetracycline
0.41595346.15367492.html.plaintext.txt	34	reverse northern dot blot reverse northern dot blot used verify differences expression cdna fragments identified previously differential display tetracycline resistant colonies randomly picked plate lysed 50 microl lysis buffer te buffer ph 80 01 tween 20 cloned cdna fragments amplified using primers flanking cloning site vector pcr products individually dot blotted onto duplicate nylon membranes hybond xl amersham pharmacia biotech uk using microfiltration system uv crosslinking membranes 2 h 80 degrees c probed total 32pcdna probes prepared 20 microg total rna isolated septum alzheimers patient without band interest septum control presents band probes labeled 32pdctp 3000 cimmol amersham pharmacia biotech equal counts 5 10x106 cpm cdna probes case alzheimers patients controls heat denatured used probe duplicate blots
0.41595346.15367492.html.plaintext.txt	35	reverse northern dot blot reverse northern dot blot used verify differences expression cdna fragments identified previously differential display tetracycline resistant colonies randomly picked plate lysed 50 microl lysis buffer te buffer ph 80 01 tween 20 cloned cdna fragments amplified using primers flanking cloning site vector pcr products individually dot blotted onto duplicate nylon membranes hybond xl amersham pharmacia biotech uk using microfiltration system uv crosslinking membranes 2 h 80 degrees c probed total 32pcdna probes prepared 20 microg total rna isolated septum alzheimers patient without band interest septum control presents band probes labeled 32pdctp 3000 cimmol amersham pharmacia biotech equal counts 5 10x106 cpm cdna probes case alzheimers patients controls heat denatured used probe duplicate blots
0.41595346.15367492.html.plaintext.txt	36	northern blot cdna overexpression confirmed reverse northern dot blot northern blots performed verify whether selected cdnas represent overexpression single mrna total rna isolated using tripure isolation reagent boehringer without dnase treatment denatured rna 20 microg total rna brain samples electrophoresed 13 agarose gels transferred nylon membrane hybond xl amersham pharmacia biotech rna fixed membrane baking 2 h 80 degrees c hybridization 32p labeled probes washing conditions performed following membrane manufacturer indications filters exposed biomax films amersham pharmacia biotech intensifying screens 12 48 h 80 degrees c
0.41595346.15367492.html.plaintext.txt	37	northern blot cdna overexpression confirmed reverse northern dot blot northern blots performed verify whether selected cdnas represent overexpression single mrna total rna isolated using tripure isolation reagent boehringer without dnase treatment denatured rna 20 microg total rna brain samples electrophoresed 13 agarose gels transferred nylon membrane hybond xl amersham pharmacia biotech rna fixed membrane baking 2 h 80 degrees c hybridization 32p labeled probes washing conditions performed following membrane manufacturer indications filters exposed biomax films amersham pharmacia biotech intensifying screens 12 48 h 80 degrees c
0.41595346.15367492.html.plaintext.txt	38	preparation kiaa0471 ss actin probes kiaa0471 probe used northern blot analysis corresponds fragment 456 bp obtained pcr amplification positive clone identified reverse northern dot blot pcr product directly purified using qiaquick pcr purification kit qiagen previous confirmation size agarose gel ss actin probe obtained digestion puc19 vector containing 19 kb pair human ss actin insert bamhi sites digested product electrophoresed agarose purified using qiaquick gel extraction kit qiagen probes 32p labeled using ready go dna labeling beads amersham pharmacia biotech
0.41595346.15367492.html.plaintext.txt	39	preparation kiaa0471 ss actin probes kiaa0471 probe used northern blot analysis corresponds fragment 456 bp obtained pcr amplification positive clone identified reverse northern dot blot pcr product directly purified using qiaquick pcr purification kit qiagen previous confirmation size agarose gel ss actin probe obtained digestion puc19 vector containing 19 kb pair human ss actin insert bamhi sites digested product electrophoresed agarose purified using qiaquick gel extraction kit qiagen probes 32p labeled using ready go dna labeling beads amersham pharmacia biotech
0.41595346.15367492.html.plaintext.txt	40	sequencing cdna database searches nucleotide alignment cdna sequencing obtained miniprep purification sequencing reactions performed big dye terminator kit abi prism applied byosistems usa dna sequencing done using abi prism 377 fluorescent sequencing instrument serveis cientifico tecnics universitat de barcelona database searches sequence comparisons performed using blast fasta search servers national center biotechnology information ncbi european bioinformatics institute ebi respectively
0.41595346.15367492.html.plaintext.txt	41	sequencing cdna database searches nucleotide alignment cdna sequencing obtained miniprep purification sequencing reactions performed big dye terminator kit abi prism applied byosistems usa dna sequencing done using abi prism 377 fluorescent sequencing instrument serveis cientifico tecnics universitat de barcelona database searches sequence comparisons performed using blast fasta search servers national center biotechnology information ncbi european bioinformatics institute ebi respectively
0.41595346.15367492.html.plaintext.txt	42	acknowledgements acknowledge banc de teixits neurologravegics serveis cientifico tecnics universitat de barcelona research supported dursi 2001sgr00380 ministerio de sanidad v 2003 redg167b o red cien idibaps isciii rtic c0306
0.41595346.15367492.html.plaintext.txt	43	acknowledgements acknowledge banc de teixits neurologravegics serveis cientifico tecnics universitat de barcelona research supported dursi 2001sgr00380 ministerio de sanidad v 2003 redg167b o red cien idibaps isciii rtic c0306
0.41595346.15367492.html.plaintext.txt	44	footnotes correspondence addressed tel 34 934024525 fax 34 934035882 email lluisadeyebraatubedu
0.41595346.15367492.html.plaintext.txt	45	footnotes correspondence addressed tel 34 934024525 fax 34 934035882 email lluisadeyebraatubedu
0.41595346.15367492.html.plaintext.txt	46	references top abstract introduction results discussion materials methods references goate chartier harlin mc mullan m brown j crawford f fidani l giuffra l haynes irving n james l et al 1991 segregation missense mutation amyloid precursor protein gene familial alzheimers disease nature 349 704 706crossrefisimedline
0.41595346.15367492.html.plaintext.txt	47	article abstract free full text pdf versions article 13212607 recent ddh293v1 alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager request permissions google scholar articles de yebra l articles mahy n pubmed pubmed citation articles de yebra l articles mahy n online issn 1460 2083 print issn 0964 6906 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.43037122.11266476.html.plaintext.txt	0	notch wnt signaling meet presenilin hub bart de stroopera wim annaerta center human genetics neuronal cell biology laboratory katholieke universiteit leuven flanders interuniversitary institute biotechnology 3000 leuven belgium
0.43037122.11266476.html.plaintext.txt	1	correspondence bart de strooper center human genetics neuronal cell biology laboratory ku leuven flanders interuniversitary institute biotechnology herestraat 49 3000 leuven belgium tel32 16 346227 fax32 16 347181 e mailbartdestrooperatmedkuleuvenacbe u d
0.43037122.11266476.html.plaintext.txt	2	presenilins pss1 part molecular machinery responsible cleaving proteins like ss amyloid precursor protein app notch plane membrane annaert de strooper 1999 mutations ps1 one major causes familiar alzheimers disease pss also involved regulating wntss catenin signaling pathway exactly remains highly controversial issue full discussion see wwwalzforumorgmembersforumsjournalcateninindexhtml issue soriano et al 2001 provide results tip scales definitively favor concept ps1 operates negative regulator wntss catenin signaling pathway
0.43037122.11266476.html.plaintext.txt	3	presenilins pss1 part molecular machinery responsible cleaving proteins like ss amyloid precursor protein app notch plane membrane annaert de strooper 1999 mutations ps1 one major causes familiar alzheimers disease pss also involved regulating wntss catenin signaling pathway exactly remains highly controversial issue full discussion see wwwalzforumorgmembersforumsjournalcateninindexhtml issue soriano et al 2001 provide results tip scales definitively favor concept ps1 operates negative regulator wntss catenin signaling pathway
0.43037122.11266476.html.plaintext.txt	4	ss catenin neural plakophilin related armadillo protein nprap also called catenin p0071 previously known bind large cytoplasmic loop domain ps1 see wwwalzforumorgmembersforumsjournalcateninindexhtml proteins characterized repeats armadillo motif 42 amino acid sequence involved protein protein interactions however function ss catenin fairly well established one pool ss catenin bound cell membrane cell adhesion molecule e cadherin provides link actin cytoskeleton second pool located cytoplasm complex axin adenomatous polyposis coli apc glycogen synthase kinase 3ss gsk 3ss phosphorylation ss catenin gsk 3ss promotes binding ss transducing repeat containing protein ss trcp f box protein part e2e3 ubiquitin ligase complex maniatis 1999 upon ubiquitination ss catenin becomes rapidly degraded proteasome fig 1 binding soluble ligand wnt membrane receptor frizzled inhibits gsk 3ss via pathway involving casein kinases protein disheveled results accumulation unphosphorylated ss catenin cytoplasm subsequent translocation cell nucleus ss catenin binds members leftcf cell specific transcription factor 1 family transcriptional regulators activates wnt target genes like cyclin d1 c myc metalloproteases thus finely tuned balance three ss catenin pools cell membrane cytoplasm nucleus determines final outcome wnt signaling pathway fig 1 detailed overview see www stanfordedurnussewntwindowhtml
0.43037122.11266476.html.plaintext.txt	5	view larger version 55k figure 1 presenilin notch wnt signaling pathways schematic outline signaling pathways horizontal arrows indicate possible negative cross talk ss cat ss catenin ss trcp ss transducing repeats containing protein apc adenomatous polyposis coli ax axin csl cbf1 suh lag1 dvl disheveled frz frizzled gsk glycogen synthase kinase nicd notch intracellular domain tcf cell specific transcription factor 1 ub ubiquitin details see text
0.43037122.11266476.html.plaintext.txt	6	view larger version 55k figure 1 presenilin notch wnt signaling pathways schematic outline signaling pathways horizontal arrows indicate possible negative cross talk ss cat ss catenin ss trcp ss transducing repeats containing protein apc adenomatous polyposis coli ax axin csl cbf1 suh lag1 dvl disheveled frz frizzled gsk glycogen synthase kinase nicd notch intracellular domain tcf cell specific transcription factor 1 ub ubiquitin details see text
0.43037122.11266476.html.plaintext.txt	7	however functional relevance ps ss catenin interaction investigated contradictory results obtained ps1 appeared either stabilize zhang et al 1998 destabilize ss catenin kang et al 1999 remarkably clinical ps mutations cause alzheimers disease also affected ss catenin stability positively negatively given contradictory results remains unclear extent observations contribute understanding disease see wwwalzforumorgmembersforumsjournalcateninindexhtml attempt avoid methodological confusion soriano et al 2001 careful overexpress proteins use primary cultures large transformed cultures ps1 knockout fibroblasts apply rigorous controls use several functional assays make point convincingly demonstrate ss catenin accumulates cytoplasmic pool leftcf gene transcription becomes activated absence ps1 conclusion presenilin negative regulator wntss catenin pathway gains considerable support recent vivo studies drosophila melanogaster showing accumulation armadillo drosophila homologue ss catenin observed ps deficient blastoderm embryos noll et al 2000 genetic screen suppressors armadillo phenotype yielded drosophila ps cox et al 2000
0.43037122.11266476.html.plaintext.txt	8	however functional relevance ps ss catenin interaction investigated contradictory results obtained ps1 appeared either stabilize zhang et al 1998 destabilize ss catenin kang et al 1999 remarkably clinical ps mutations cause alzheimers disease also affected ss catenin stability positively negatively given contradictory results remains unclear extent observations contribute understanding disease see wwwalzforumorgmembersforumsjournalcateninindexhtml attempt avoid methodological confusion soriano et al 2001 careful overexpress proteins use primary cultures large transformed cultures ps1 knockout fibroblasts apply rigorous controls use several functional assays make point convincingly demonstrate ss catenin accumulates cytoplasmic pool leftcf gene transcription becomes activated absence ps1 conclusion presenilin negative regulator wntss catenin pathway gains considerable support recent vivo studies drosophila melanogaster showing accumulation armadillo drosophila homologue ss catenin observed ps deficient blastoderm embryos noll et al 2000 genetic screen suppressors armadillo phenotype yielded drosophila ps cox et al 2000
0.43037122.11266476.html.plaintext.txt	9	important question ps1 affects ss catenin stability since ps1 bind gsk 3ss tempting speculate provides scaffold phosphorylation ss catenin kang et al 1999 interestingly ss catenin interaction site ps1 contains consensus sequence phosphorylation gsk 3ss kirchenbaum et al 2000 suggesting interaction regulated interaction ss catenin axinapcgsk 3ss complex however data soriano et al 2001 appears ps1 needed phosphorylation ss catenin since phosphorylated ss catenin species accumulate ps1 deficient cells furthermore presence proteasome inhibitor mg132 fewer ubiquitinated ss catenin species observed ps1 deficient cells wild type cells soriano et al 2001 instead results suggest ps1 needed ubiquitination ss catenin see noll et al 2000 raise intriguing questions concerning relationship ps1 ubiquitin ligase machinery proteasome fig 1
0.43037122.11266476.html.plaintext.txt	10	important question ps1 affects ss catenin stability since ps1 bind gsk 3ss tempting speculate provides scaffold phosphorylation ss catenin kang et al 1999 interestingly ss catenin interaction site ps1 contains consensus sequence phosphorylation gsk 3ss kirchenbaum et al 2000 suggesting interaction regulated interaction ss catenin axinapcgsk 3ss complex however data soriano et al 2001 appears ps1 needed phosphorylation ss catenin since phosphorylated ss catenin species accumulate ps1 deficient cells furthermore presence proteasome inhibitor mg132 fewer ubiquitinated ss catenin species observed ps1 deficient cells wild type cells soriano et al 2001 instead results suggest ps1 needed ubiquitination ss catenin see noll et al 2000 raise intriguing questions concerning relationship ps1 ubiquitin ligase machinery proteasome fig 1
0.43037122.11266476.html.plaintext.txt	11	ps1 also involved notch 1 signaling pathway notch 1 belongs family large type integral membrane receptors involved cell fate decisions upon ligand binding notch becomes proteolytically processed intracellular domain translocates nucleus binds transcription regulators csl family induces expression notch target genes fig 1 ps1 functions proteolytic complex needed generate intramembranous cleavage notch unlike cleavage app kopan goate 2000 embryonic lethal phenotype mice ps1 genes inactivated largely explained deficiencies notch signaling system therefore physiological relevance ss cateninps1 connection mammals remained somewhat speculative however discussed soriano et al 2001 mice specifically lack expression ps1 skin generated zheng h unpublished results mice develop spectrum skin tumors suggestive increased ss catenin activity concept ps1 may act repressor pathway adulthood
0.43037122.11266476.html.plaintext.txt	12	ps1 also involved notch 1 signaling pathway notch 1 belongs family large type integral membrane receptors involved cell fate decisions upon ligand binding notch becomes proteolytically processed intracellular domain translocates nucleus binds transcription regulators csl family induces expression notch target genes fig 1 ps1 functions proteolytic complex needed generate intramembranous cleavage notch unlike cleavage app kopan goate 2000 embryonic lethal phenotype mice ps1 genes inactivated largely explained deficiencies notch signaling system therefore physiological relevance ss cateninps1 connection mammals remained somewhat speculative however discussed soriano et al 2001 mice specifically lack expression ps1 skin generated zheng h unpublished results mice develop spectrum skin tumors suggestive increased ss catenin activity concept ps1 may act repressor pathway adulthood
0.43037122.11266476.html.plaintext.txt	13	inhibitory cross talk notch wnt signaling pathways previously thought occur level notch extracellular domain binding wnt wesley 1999 level notch intracellular domain binding disheveled axelrod et al 1996 ps1 seems provide third level interaction could theoretically occur deleting cytoplasmic loop domain ps1 annihilates binding ss catenin whereas proteolytic cleavage notch app maintained saura et al 2000 soriano et al 2001 function ps1 ss catenin turnover thus separated function secretase processing many biological questions worm caenorhabditis elegans could shed light matter wu et al 1998 provided evidence protein encoded sel 10 suppressor notch signaling pathway associates functionally physically sel 12 worms homologue human ps sel10 related cdc4 family f boxwd40 repeat containing proteins proteins part e3 enzymes ubiquitin ligation pathway appear function adapters recruit target proteins complex containing e2 ubiquitin conjugating enzyme maniatis 1999 30 mammalian homologues including ss trcp identified winston et al 1999 challenge find whether ps1 provides scaffold ss trcp members f box protein family ubiquitin ligase substrates like ss catenin also important establish whether current findings extended proteins bind ps eg nprap p0071 conclusion ps1 involved least two proteolytic machines regulating signal transduction cascades regulated intramembrane proteolysis notch app one hand brown et al 2000 regulated protein degradation ss catenin wnt signaling pathway noll et al 2000 soriano et al 2001
0.43037122.11266476.html.plaintext.txt	14	1 abbreviations used paper ss trcp ss transducing repeats containing protein apc adenomatous polyposis coli app ss amyloid precursor protein gsk glycogen synthase kinase nicd notch intracellular domain ps presenilin tcf cell specific transcription factor 1
0.43037122.11266476.html.plaintext.txt	15	acknowledgements top acknowledgements references
0.43037122.11266476.html.plaintext.txt	16	apologize colleagues able cite relevant work editorial constraints
0.43037122.11266476.html.plaintext.txt	17	submitted 19 january 2001 accepted 24 january 2001
0.43037122.11266476.html.plaintext.txt	18	references top acknowledgements references
0.43437973.11884509.html.plaintext.txt	0	notch membrane bound transcription factor raphael kopan
0.43437973.11884509.html.plaintext.txt	1	department molecular biology pharmacology washington university school medicine st louis mo 63110 usa
0.43437973.11884509.html.plaintext.txt	2	introduction top introduction panel panel b panel c references notch signaling simple complex simple secondary messengers required notch directly report nucleus contact ligand plasma membrane notch acts membranebound transcription factor released response ligand binding two proteases acting sequentially freed intracellular domain enters nucleus interacts dna bound protein activate transcription selected targets notch signaling complex regulates astonishingly large number cellular decisions development artavanis tsakonas et al 1999 adult milner bigas 1999 addition regulation notch proteolysis complex involving array accessory proteins whose functions elucidated recently kramer 2001 mumm kopan 2000 finally genetic experiments indicate notch may also separate proteolysis independent function membrane acts together wnt affect developmental competence brennan et al 1999a ramain et al 2001
0.43437973.11884509.html.plaintext.txt	3	introduction top introduction panel panel b panel c references notch signaling simple complex simple secondary messengers required notch directly report nucleus contact ligand plasma membrane notch acts membranebound transcription factor released response ligand binding two proteases acting sequentially freed intracellular domain enters nucleus interacts dna bound protein activate transcription selected targets notch signaling complex regulates astonishingly large number cellular decisions development artavanis tsakonas et al 1999 adult milner bigas 1999 addition regulation notch proteolysis complex involving array accessory proteins whose functions elucidated recently kramer 2001 mumm kopan 2000 finally genetic experiments indicate notch may also separate proteolysis independent function membrane acts together wnt affect developmental competence brennan et al 1999a ramain et al 2001
0.43437973.11884509.html.plaintext.txt	4	poster panel summarizes proteins notch signal transduction pathway biochemical functions proposed panel b outlines events occur response ligand binding regulation transcription return basal state panel c speculative pathway independent core components presented
0.43437973.11884509.html.plaintext.txt	5	poster panel summarizes proteins notch signal transduction pathway biochemical functions proposed panel b outlines events occur response ligand binding regulation transcription return basal state panel c speculative pathway independent core components presented
0.43437973.11884509.html.plaintext.txt	6	panel top introduction panel panel b panel c references core elements notch signaling system include notch receptor dsl ligands delta serratejagged drosophila vertebrates lag 2 c elegans csl dna binding proteins cbf1rbpjk vertebrates suppressor hairless drosophila lag 1 c elegans target genes known first identified members hes hairyenhancer split family basic helix loop helix transcriptional regulators illustrated notch proteins ligands contain extracellular egf epidermal growth factor like repeats repeats 11 12 notch pink interact dsl domain ligands pink egf repeats delta like ligands continuous whereas serrate like ligands interspersed short linker sequences notch modified golgi glycosyltransferase called fringe blair 2000 specific fucose modified egf repeats fringe expressed subset cells notch hyperactivated fringe expressing nonexpressing territories abut forming boundary irvine rauskolb 2001 wu rao 1999 notch secreted cell surface furin convertase dependent step logeat et al 1998 lnr linnotch repeat red domain maintains association polypeptides resulting furin cleavage site 1 s1 intracellular domain contains ram23 domain ram enhances interaction csl protein notch intracellular domain nicd contains nuclear localization signals nls cdc 10ankyrin repeat domain ank mediates interactions csl proteins domain rich proline glutamate serine threonine residues pest also shown neuralized e3 ubiquitin ligase presenilin intramembrane cleaving protease clip huppert kopan 2001 nicastrin protein interacts presenilin required plasma membrane localization stabilization presenilin kopan goate 2002 presenilin nicastrin part secretase activity contributing alzheimers disease kopan goate 2000 metalloprotease cell surface also required notch signaling mumm kopan 2000 nucleus csl binds smrt silencing mediator retinoid thyroid hormone receptor skip ski related protein proteins facilitate nuclear localization csl zhou hayward 2001 together histone deacetylase hdac repress transcription target genes mumm kopan 2000 drosophila csl interacts hairless c terminalbinding protein ctbp mediate repression see panel 5 morel et al 2001 basal state cells notch inactive absent
0.43437973.11884509.html.plaintext.txt	7	panel top introduction panel panel b panel c references core elements notch signaling system include notch receptor dsl ligands delta serratejagged drosophila vertebrates lag 2 c elegans csl dna binding proteins cbf1rbpjk vertebrates suppressor hairless drosophila lag 1 c elegans target genes known first identified members hes hairyenhancer split family basic helix loop helix transcriptional regulators illustrated notch proteins ligands contain extracellular egf epidermal growth factor like repeats repeats 11 12 notch pink interact dsl domain ligands pink egf repeats delta like ligands continuous whereas serrate like ligands interspersed short linker sequences notch modified golgi glycosyltransferase called fringe blair 2000 specific fucose modified egf repeats fringe expressed subset cells notch hyperactivated fringe expressing nonexpressing territories abut forming boundary irvine rauskolb 2001 wu rao 1999 notch secreted cell surface furin convertase dependent step logeat et al 1998 lnr linnotch repeat red domain maintains association polypeptides resulting furin cleavage site 1 s1 intracellular domain contains ram23 domain ram enhances interaction csl protein notch intracellular domain nicd contains nuclear localization signals nls cdc 10ankyrin repeat domain ank mediates interactions csl proteins domain rich proline glutamate serine threonine residues pest also shown neuralized e3 ubiquitin ligase presenilin intramembrane cleaving protease clip huppert kopan 2001 nicastrin protein interacts presenilin required plasma membrane localization stabilization presenilin kopan goate 2002 presenilin nicastrin part secretase activity contributing alzheimers disease kopan goate 2000 metalloprotease cell surface also required notch signaling mumm kopan 2000 nucleus csl binds smrt silencing mediator retinoid thyroid hormone receptor skip ski related protein proteins facilitate nuclear localization csl zhou hayward 2001 together histone deacetylase hdac repress transcription target genes mumm kopan 2000 drosophila csl interacts hairless c terminalbinding protein ctbp mediate repression see panel 5 morel et al 2001 basal state cells notch inactive absent
0.43437973.11884509.html.plaintext.txt	8	panel b top introduction panel panel b panel c references notch signaling starts ligand binding 1 1 although dsl proteins bind notch modified fringe 1 cells expressing fringe 1 ligands show distinct preferences delta prefers fringe modified notch whereas serrate would much rather bind unmodified notch preferences basis notch hyperactivation boundaries fringe expressing nonexpressing territories
0.43437973.11884509.html.plaintext.txt	9	panel b top introduction panel panel b panel c references notch signaling starts ligand binding 1 1 although dsl proteins bind notch modified fringe 1 cells expressing fringe 1 ligands show distinct preferences delta prefers fringe modified notch whereas serrate would much rather bind unmodified notch preferences basis notch hyperactivation boundaries fringe expressing nonexpressing territories
0.43437973.11884509.html.plaintext.txt	10	despite associated presenilin complex notch cannot cleaved since extracellular domain somehow blocks presenilin activity ligand binding neuralized adds ubiquitin intracellular domain delta triggers endocytosis 2 kramer 2001 ligand endocytosis triggers conformational change notch permits metalloproteases cleave near membrane second site s2 extracellular domain trans endocytosed ligand expressing cell 3 parks et al 2000 event permits presenilin cleave notch third site s3 located within transmembrane domain 4 mumm kopan 2000 nicd free translocate nucleus cells expressing notch ligand ligand interferes process unknown mechanism interference may relieved neuralized protein targets delta degradation kramer 2001
0.43437973.11884509.html.plaintext.txt	11	despite associated presenilin complex notch cannot cleaved since extracellular domain somehow blocks presenilin activity ligand binding neuralized adds ubiquitin intracellular domain delta triggers endocytosis 2 kramer 2001 ligand endocytosis triggers conformational change notch permits metalloproteases cleave near membrane second site s2 extracellular domain trans endocytosed ligand expressing cell 3 parks et al 2000 event permits presenilin cleave notch third site s3 located within transmembrane domain 4 mumm kopan 2000 nicd free translocate nucleus cells expressing notch ligand ligand interferes process unknown mechanism interference may relieved neuralized protein targets delta degradation kramer 2001
0.43437973.11884509.html.plaintext.txt	12	nucleus nicd converts csl transcriptional repressor transcriptional activator 5 8 current understanding proposes conversion occurs direct protein protein interactions notch intracellular domain skip csl leads smrthdac dissociation reviewed mumm kopan 2000 alone sufficient express target genes notchcsl recruit histone acetylases hats assist chromatin remodeling mastermindlag 3 activate additional targets metabolism nicd nucleus controlled phosphorylation ubiquitination e3 ubiquitin ligase sel 10 gupta rossi et al 2001 oberg et al 2001 wu et al 2001 sudx cornell et al 1999 nicd degradation resets cell prepares next round notch signaling
0.43437973.11884509.html.plaintext.txt	13	nucleus nicd converts csl transcriptional repressor transcriptional activator 5 8 current understanding proposes conversion occurs direct protein protein interactions notch intracellular domain skip csl leads smrthdac dissociation reviewed mumm kopan 2000 alone sufficient express target genes notchcsl recruit histone acetylases hats assist chromatin remodeling mastermindlag 3 activate additional targets metabolism nicd nucleus controlled phosphorylation ubiquitination e3 ubiquitin ligase sel 10 gupta rossi et al 2001 oberg et al 2001 wu et al 2001 sudx cornell et al 1999 nicd degradation resets cell prepares next round notch signaling
0.43437973.11884509.html.plaintext.txt	14	panel c top introduction panel panel b panel c references another activity notch independent dsl ligands csl proteins observed drosophila myogenesis neurogenesis brennan et al 1999a ramain et al 2001 rusconi corbin 1999 evidence existence signaling axis drosophila compelling although still earlier phase discovery compared notchcsl axis ab therefore many arrows panel describe genetic interactions rather biochemical mechanism
0.43437973.11884509.html.plaintext.txt	15	two specific regions notch required activity abruptex region notch egf repeats 17 29 dark blue brennan et al 1997 brennan et al 1999b ramain et al 2001 region c terminal ank repeats contains pest domain brennan et al 1997 ramain et al 2001 region previously shown bind dishevelled dsh dsh mediator wnt signals downstream frizzled frz receptors huelsken birchmeier 2001 drosophila neurogenesis csl dependent notch signals restrict neural competence small number cells within equivalence group kopan turner 1996 newly recognized role notch acts prevent cells acquiring neural myogenic competence earlier development although unclear notch mediates effect many additional proteins involved activity requires deltex cytoplasmic ring finger protein ramain et al 2001 kinase gsk3ss sgg brennan et al 1999b ramain et al 2001 deltex csl appear antagonistic possibly compete ank domain notch cytoplasmic notch activity may require proteolysis 11 however determined yet whether presenilin proteases required deltex dependent notch activity wnt acts block notch either directly via abruptex domain wesley saez 2000 1 2 likely indirectly stimulating dsh block gsk3 circumvent deltexnotch interaction 12 interference notchdeltex activity dsh requires dsh binding region notch deletions region abruptex mutations render notch constitutive repressor neural competence 2 ramain et al 2001 removal notch wingless restores competence suggesting role wnt acquisition neural myogenic competence antagonize notch
0.43437973.11884509.html.plaintext.txt	16	clear proteins facilitating inhibition competence described time biochemical mechanism proposed process similar wntnotch interactions organisms yet discovered casting doubt generality observations importance abruptex mutations recognized early name given even realized locus identical notch biochemical explanation complex genetic behavior abruptex mutations still lacking recent observations may begin provide answer
0.43437973.11884509.html.plaintext.txt	17	clear proteins facilitating inhibition competence described time biochemical mechanism proposed process similar wntnotch interactions organisms yet discovered casting doubt generality observations importance abruptex mutations recognized early name given even realized locus identical notch biochemical explanation complex genetic behavior abruptex mutations still lacking recent observations may begin provide answer
0.43437973.11884509.html.plaintext.txt	18	references top introduction panel panel b panel c references
0.4394662.14559775.html.plaintext.txt	0	fine mapping catenin gene quantitative trait locus chromosome 10 late onset alzheimers disease pedigrees nilufer ertekin taner1 james ronald1 hideaki asahara1 linda younkin1 maria hella1 shushant jain1 eugene gnida1 samuel younkin1 daniel fadale1 yasumasa ohyagi2 adam singleton1 leah scanlin1 mariza de andrade3 ronald petersen4 neill graff radford5 michael hutton1 steven younkin1
0.4394662.14559775.html.plaintext.txt	1	1department neuroscience mayo clinic jacksonville jacksonville fl usa 2department neurology neurological institute graduate school medical sciences kyushu university fukuoka japan 3department health sciences research division biostatistics mayo clinic rochester rochester mn usa 4department neurology mayo clinic rochester rochester mn usa 5department neurology mayo clinic jacksonville jacksonville fl usa
0.4394662.14559775.html.plaintext.txt	2	received july 29 2003 revised september 23 2003 accepted october 7 2003
0.4394662.14559775.html.plaintext.txt	3	abstract top abstract introduction results discussion subjects methods references using plasma amyloid ss protein ass42 levels intermediate quantitative phenotype late onset alzheimers disease load previously obtained significant linkage 80 cm chromosome 10 linkage region obtained independently study affected load sib pairs together two studies provide strong evidence novel load locus chromosome 10 acts increase ass42 vr22 large 17 mb gene located 80 cm encodes catenin binding partner ss catenin makes vr22 attractive candidate gene ss catenin interacts presenilin 1 many mutations elevate ass42 cause early onset familial ad identified two intronic vr22 snps 4360 4783 strong linkage disequilibrium ld showed highly significant association p00001 00006 plasma ass42 10 extended load families association clearly contributed linkage 80 cm lod scores decreased linkage analysis performed conditional upon vr22 association association replicated another independent set 12 load families p004 4783 p008 4360 bounding association region using multiple snps showed vr22 confirmed gene within region association findings indicate vr22 variants influence ass42 contribute previously reported linkage plasma ass42 load families
0.4394662.14559775.html.plaintext.txt	4	abstract top abstract introduction results discussion subjects methods references using plasma amyloid ss protein ass42 levels intermediate quantitative phenotype late onset alzheimers disease load previously obtained significant linkage 80 cm chromosome 10 linkage region obtained independently study affected load sib pairs together two studies provide strong evidence novel load locus chromosome 10 acts increase ass42 vr22 large 17 mb gene located 80 cm encodes catenin binding partner ss catenin makes vr22 attractive candidate gene ss catenin interacts presenilin 1 many mutations elevate ass42 cause early onset familial ad identified two intronic vr22 snps 4360 4783 strong linkage disequilibrium ld showed highly significant association p00001 00006 plasma ass42 10 extended load families association clearly contributed linkage 80 cm lod scores decreased linkage analysis performed conditional upon vr22 association association replicated another independent set 12 load families p004 4783 p008 4360 bounding association region using multiple snps showed vr22 confirmed gene within region association findings indicate vr22 variants influence ass42 contribute previously reported linkage plasma ass42 load families
0.4394662.14559775.html.plaintext.txt	5	introduction top abstract introduction results discussion subjects methods references late onset alzheimers disease load complex genetic disorder 1 onset defined 60 65 years age twin studies suggested much 74 risk load may due genetic factors 23 well established apoe plays important role genetics load 45 recent study estimated however four additional loci make contribution variance load age onset effect size similar greater apoe 6 given heterogeneity likely least five loci contribute substantially genetics load surprising large number single gene association studies performed far failed identify variants associate reproducibly load reasons failure replication possible gene gene gene environment interactions difficult account poor study design
0.4394662.14559775.html.plaintext.txt	6	introduction top abstract introduction results discussion subjects methods references late onset alzheimers disease load complex genetic disorder 1 onset defined 60 65 years age twin studies suggested much 74 risk load may due genetic factors 23 well established apoe plays important role genetics load 45 recent study estimated however four additional loci make contribution variance load age onset effect size similar greater apoe 6 given heterogeneity likely least five loci contribute substantially genetics load surprising large number single gene association studies performed far failed identify variants associate reproducibly load reasons failure replication possible gene gene gene environment interactions difficult account poor study design
0.4394662.14559775.html.plaintext.txt	7	several groups 7 9 suggested quantitative intermediate phenotypes may useful unraveling complex genetics disorders load clinical disease states load likely result uncertain complex sequence pathophysiologic events whereas intermediate phenotypes may directly related action set genes easily identified thus identification genes variants contribute specific intermediate phenotypes may tractable way identify least genes contribute diseases governed complex genetics optimize utility approach important select intermediate phenotypes highly heritable close biological link disease question
0.4394662.14559775.html.plaintext.txt	8	several groups 7 9 suggested quantitative intermediate phenotypes may useful unraveling complex genetics disorders load clinical disease states load likely result uncertain complex sequence pathophysiologic events whereas intermediate phenotypes may directly related action set genes easily identified thus identification genes variants contribute specific intermediate phenotypes may tractable way identify least genes contribute diseases governed complex genetics optimize utility approach important select intermediate phenotypes highly heritable close biological link disease question
0.4394662.14559775.html.plaintext.txt	9	studies focused levels amyloid ss protein ass specifically ass42 quantitative intermediate phenotype load ass secreted protein 10 12 derived set large precursor proteins collectively referred amyloid ss protein precursor secreted ass produced virtually cells readily detected human plasma cerebrospinal fluid secreted ass forty amino acids ass40 small fraction 5 10 two additional amino acids carboxyl terminus ass42 13 15 brains patients ad large amount ass aggregates deposited senile plaques much form highly insoluble amyloid fibrils make definite diagnosis ad large numbers senile plaques neurofibrillary tangles must demonstrated brain autopsy 16 load patients large amount ass deposited senile plaques ends ass42 one third cases ass ending ass42 essentially form ass deposited one third predominant form one third large amount ass40 also deposited 17 worth noting synthetic ass40 ass42 spontaneously assemble amyloid fibrils vitro ass42 forms amyloid fibrils far rapidly ass40 1819 brain high levels app mrna concentration ass cerebrospinal fluid 50 times higher plasma mixed fetal brain cultures produce far ass types cultured cells 122021 thus likely senile plaques form specifically brain ass levels higher brain organs
0.4394662.14559775.html.plaintext.txt	10	studies focused levels amyloid ss protein ass specifically ass42 quantitative intermediate phenotype load ass secreted protein 10 12 derived set large precursor proteins collectively referred amyloid ss protein precursor secreted ass produced virtually cells readily detected human plasma cerebrospinal fluid secreted ass forty amino acids ass40 small fraction 5 10 two additional amino acids carboxyl terminus ass42 13 15 brains patients ad large amount ass aggregates deposited senile plaques much form highly insoluble amyloid fibrils make definite diagnosis ad large numbers senile plaques neurofibrillary tangles must demonstrated brain autopsy 16 load patients large amount ass deposited senile plaques ends ass42 one third cases ass ending ass42 essentially form ass deposited one third predominant form one third large amount ass40 also deposited 17 worth noting synthetic ass40 ass42 spontaneously assemble amyloid fibrils vitro ass42 forms amyloid fibrils far rapidly ass40 1819 brain high levels app mrna concentration ass cerebrospinal fluid 50 times higher plasma mixed fetal brain cultures produce far ass types cultured cells 122021 thus likely senile plaques form specifically brain ass levels higher brain organs
0.4394662.14559775.html.plaintext.txt	11	app presenilin 1 presenilin 2 genes many fully penetrant mutations cause early onset familial ad eofad 22 25 apart early onset causation specific mutations eofad clinically pathologically indistinguishable load others shown eofad mutations increase ass42 sometimes increase ass40 well 1526 30 importantly observed plasma ass42 elevations eofad patients young cognitively normal carriers eofad mutations 31 also observed ass42 elevations plasma non demented relatives load patients ages 20 65 32 importantly elevations associated apoe4 allele variants eofad genes 32 finally mayeux et al 33 found longitudinal study unrelated elderly individuals subsequently developed ad higher plasma levels ass42 remained free dementia collectively findings show ass42 closely linked ad investigate heritability plasma ass analyzed extended load families found plasma ass40 ass42 levels substantial heritability 34
0.4394662.14559775.html.plaintext.txt	12	app presenilin 1 presenilin 2 genes many fully penetrant mutations cause early onset familial ad eofad 22 25 apart early onset causation specific mutations eofad clinically pathologically indistinguishable load others shown eofad mutations increase ass42 sometimes increase ass40 well 1526 30 importantly observed plasma ass42 elevations eofad patients young cognitively normal carriers eofad mutations 31 also observed ass42 elevations plasma non demented relatives load patients ages 20 65 32 importantly elevations associated apoe4 allele variants eofad genes 32 finally mayeux et al 33 found longitudinal study unrelated elderly individuals subsequently developed ad higher plasma levels ass42 remained free dementia collectively findings show ass42 closely linked ad investigate heritability plasma ass analyzed extended load families found plasma ass40 ass42 levels substantial heritability 34
0.4394662.14559775.html.plaintext.txt	13	given findings level plasma ass42 likely useful intermediate quantitative phenotype load performed variance components linkage analysis trait group extended load pedigrees analysis showed significant linkage locus 80 cm chromosome 10 35 linkage region obtained independently study affected load sib pairs 36 together two studies provide strong evidence novel load locus chromosome 10 acts increase ass42 sib pair group estimated effect locus equivalent apoe suggesting likely major risk factor load third group found linkage downstream region chromosome 10 focused insulin degrading enzyme ide possible candidate gene region 37 recently fourth group using age onset quantitative phenotype ad parkinsons disease pd families found suggestive linkage chromosome 10 133 135 cm 38
0.4394662.14559775.html.plaintext.txt	14	given findings level plasma ass42 likely useful intermediate quantitative phenotype load performed variance components linkage analysis trait group extended load pedigrees analysis showed significant linkage locus 80 cm chromosome 10 35 linkage region obtained independently study affected load sib pairs 36 together two studies provide strong evidence novel load locus chromosome 10 acts increase ass42 sib pair group estimated effect locus equivalent apoe suggesting likely major risk factor load third group found linkage downstream region chromosome 10 focused insulin degrading enzyme ide possible candidate gene region 37 recently fourth group using age onset quantitative phenotype ad parkinsons disease pd families found suggestive linkage chromosome 10 133 135 cm 38
0.4394662.14559775.html.plaintext.txt	15	important advantage variance components approach employed candidate genes identified likely effect ass42 evaluated systematically determine much various within gene variants contribute linkage study analyzed vr22 variants contribute linkage signal chromosome 10 location function make vr22 strong candidate gene located 80 cm peak previously reported linkage signal vr22 encodes novel catenin catenin recently cloned jannsens et al 39 catenins interact closely ss catenin play important role intercellular adhesion strong intercellular adhesion depends linkage cadherins actin cytoskeleton via ss catenin complex catenin closely homologous n catenin neuron specific e catenin expressed tissues catenin expressed high levels testis heart also expressed human mouse brain 39 catenin overall sequence identity 56 58 e n catenin respectively importantly jannsens et al 39 shown catenin interacts ss catenin functionally effective fashion makes vr22 strong functional candidate ss catenin interacts presenilin 1 40 many mutations increase ass42 262931 cause early onset familial ad 24 zhang et al 40 shown loss signalling ss catenin pathway leads enhanced neuronal vulnerability ass addition ss catenin presenilin forms complex leads stabilization former destabilization complex leads ss catenin degradation enhanced neuronal apoptosis presenilin mutations shown lead destabilization ss catenin presenilin complex degradation ss catenin enhanced ass production given catenins provide link ss catenin binding counterparts presenilins actin cytoskeleton possible postulate mutations catenins could lead disruption stability ss catenin presenilin complex resulting enhanced neuronal vulnerability cells ass increased ass production
0.4394662.14559775.html.plaintext.txt	16	important advantage variance components approach employed candidate genes identified likely effect ass42 evaluated systematically determine much various within gene variants contribute linkage study analyzed vr22 variants contribute linkage signal chromosome 10 location function make vr22 strong candidate gene located 80 cm peak previously reported linkage signal vr22 encodes novel catenin catenin recently cloned jannsens et al 39 catenins interact closely ss catenin play important role intercellular adhesion strong intercellular adhesion depends linkage cadherins actin cytoskeleton via ss catenin complex catenin closely homologous n catenin neuron specific e catenin expressed tissues catenin expressed high levels testis heart also expressed human mouse brain 39 catenin overall sequence identity 56 58 e n catenin respectively importantly jannsens et al 39 shown catenin interacts ss catenin functionally effective fashion makes vr22 strong functional candidate ss catenin interacts presenilin 1 40 many mutations increase ass42 262931 cause early onset familial ad 24 zhang et al 40 shown loss signalling ss catenin pathway leads enhanced neuronal vulnerability ass addition ss catenin presenilin forms complex leads stabilization former destabilization complex leads ss catenin degradation enhanced neuronal apoptosis presenilin mutations shown lead destabilization ss catenin presenilin complex degradation ss catenin enhanced ass production given catenins provide link ss catenin binding counterparts presenilins actin cytoskeleton possible postulate mutations catenins could lead disruption stability ss catenin presenilin complex resulting enhanced neuronal vulnerability cells ass increased ass production
0.4394662.14559775.html.plaintext.txt	17	results top abstract introduction results discussion subjects methods references association vr22 snps plasma ass42 initial assessment vr22 examined three snps 4825 ca 4783 ag 4360 tc intron exons 10 11 snps table 1 spanned 465 bp genotyped 10 extended load families previously analyzed linkage 35 order minimize age dementia related environmental effects plasma ass42 levels performed analyses 20 65 year age group previous studies 3435 effect three vr22 snps analyzed encoding covariate testing effect variance plasma ass42 regression style approach implemented solar table 1 control effect linkage linkage component included null alternative models tested 4360 tc 4783 ag snps strong linkage disequilibrium showed strong association p00001 00006 respectively 4825 snp showed marginal association p006 table 1 three snps also examined second set 12 additional load families table 1 34 vr22 4783 snp showed significant association p004 vr22 4360 snp yielded marginal association p008 vr22 4825 snp yield significant association p098 additional smaller dataset 22 families combined significance association reached p59x10 6 4783 21x10 6 4360 snps table 1 figure 1 depicts box plots 10logass42 levels 22 families stratified significant vr22 4360 snp genotypes consistent association results genotype dependent effect plasma ass levels observed 4360 tt genotype associated highest ass42 levels ct intermediate levels cc lowest levels
0.4394662.14559775.html.plaintext.txt	18	results top abstract introduction results discussion subjects methods references association vr22 snps plasma ass42 initial assessment vr22 examined three snps 4825 ca 4783 ag 4360 tc intron exons 10 11 snps table 1 spanned 465 bp genotyped 10 extended load families previously analyzed linkage 35 order minimize age dementia related environmental effects plasma ass42 levels performed analyses 20 65 year age group previous studies 3435 effect three vr22 snps analyzed encoding covariate testing effect variance plasma ass42 regression style approach implemented solar table 1 control effect linkage linkage component included null alternative models tested 4360 tc 4783 ag snps strong linkage disequilibrium showed strong association p00001 00006 respectively 4825 snp showed marginal association p006 table 1 three snps also examined second set 12 additional load families table 1 34 vr22 4783 snp showed significant association p004 vr22 4360 snp yielded marginal association p008 vr22 4825 snp yield significant association p098 additional smaller dataset 22 families combined significance association reached p59x10 6 4783 21x10 6 4360 snps table 1 figure 1 depicts box plots 10logass42 levels 22 families stratified significant vr22 4360 snp genotypes consistent association results genotype dependent effect plasma ass levels observed 4360 tt genotype associated highest ass42 levels ct intermediate levels cc lowest levels
0.4394662.14559775.html.plaintext.txt	19	view table figure 1 dose dependent effect vr22 4360 snp plasma ass42 levels extended load families box plots depicting median middle part box 25th percentile lower limit box 75th percentile upper limit box 10th percentile lower end line 90th percentile upper end line 10logass42 levels 20 65 year old family members 22 load families plots depicted separately vr22 4360 genotypes tt red ct green cc blue
0.4394662.14559775.html.plaintext.txt	20	determine snps region vr22 gene show stronger association analyzed 10 additional snps total 13 snps analyzed region spanning 88 kb table 2 hcv3096482 hcv11295092 snps 88 kb region linkage disequilibrium many snps region showed nominally significant association none showed association stronger observed 4360 4783 table 1
0.4394662.14559775.html.plaintext.txt	21	determine snps region vr22 gene show stronger association analyzed 10 additional snps total 13 snps analyzed region spanning 88 kb table 2 hcv3096482 hcv11295092 snps 88 kb region linkage disequilibrium many snps region showed nominally significant association none showed association stronger observed 4360 4783 table 1
0.4394662.14559775.html.plaintext.txt	22	view table table 2 p values association plasma ass42 20 65 year old subjects extended load families bounding association vr22 snps plasma ass42 bound region vr22 43604783 association evaluated total 49 additional snps spaced either side 4360 4783 snps snps selected several groups designed span entire vr22 gene 250 kb intervals well region 3 vr22 known exons vr22 433 kb median away closest snp closest snp group mean538 kb 22 149 kb given extent ld human genome estimated different studies anywhere 10 100 kb 41 45 extent one genomic region predictable priori possible miss association signals due variants snp groups however given size vr22 extent coverage throughout outside gene association signals identify 4360 4783 vr22 snps well bounded within vr22 snp genotyping design three six snps analyzed group linkage disequilibrium significantly associating 4360 snp snps analyzed 22 combined families fig 2a using covariate style regression approach snp analyzed association plasma ass42 10 12 22 combined load families table 2 fig 2b
0.4394662.14559775.html.plaintext.txt	23	view larger version 18k figure 2 boundaries vr22 43604783 association marker marker linkage disequilibrium snps analyzed respect 4360 snp horizontal line shows position 17 mb vr22 gene dashed line shows d075 b marker phenotype plasma ass42 association horizontal line shows position 17 mb vr22 gene dashed line shows p005
0.4394662.14559775.html.plaintext.txt	24	view larger version 18k figure 2 boundaries vr22 43604783 association marker marker linkage disequilibrium snps analyzed respect 4360 snp horizontal line shows position 17 mb vr22 gene dashed line shows d075 b marker phenotype plasma ass42 association horizontal line shows position 17 mb vr22 gene dashed line shows p005
0.4394662.14559775.html.plaintext.txt	25	3 5 sides strongly associating 4360 snp ld flanking snps fell essentially baseline levels within large vr22 gene 5 side snp association ass42 also decreased baseline levels within vr22 gene fig 2b 3 side significance snp association decreased 2 orders magnitude 00001 4360 003 significantly associated snp nearest snp group hcv1380042 fig 2b table 2 association baseline levels 3 side 1 000 kb 3 margin vr22
0.4394662.14559775.html.plaintext.txt	26	3 5 sides strongly associating 4360 snp ld flanking snps fell essentially baseline levels within large vr22 gene 5 side snp association ass42 also decreased baseline levels within vr22 gene fig 2b 3 side significance snp association decreased 2 orders magnitude 00001 4360 003 significantly associated snp nearest snp group hcv1380042 fig 2b table 2 association baseline levels 3 side 1 000 kb 3 margin vr22
0.4394662.14559775.html.plaintext.txt	27	bounding approach effectively limits region potential association 3 5 sides 4360 within vr22 thus data provide strong evidence association 4360 4783 snps plasma ass42 due variants vr22 gene
0.4394662.14559775.html.plaintext.txt	28	bounding approach effectively limits region potential association 3 5 sides 4360 within vr22 thus data provide strong evidence association 4360 4783 snps plasma ass42 due variants vr22 gene
0.4394662.14559775.html.plaintext.txt	29	given total 51 snps genotyped issue multiple testing raised many snps linkage disequilibrium therefore independent one another fig 2b therefore simple bonferroni correction assumption 51 independent tests overly conservative study nonetheless even bonferroni correction applied 4783 4360 snps still significant 10 families p003 0005 22 combined families p00003 00001 association smaller set 12 families longer significant overly conservative correction p2 4 4783 4360 respectively nonetheless inclusion analysis leads improved evidence association
0.4394662.14559775.html.plaintext.txt	30	given total 51 snps genotyped issue multiple testing raised many snps linkage disequilibrium therefore independent one another fig 2b therefore simple bonferroni correction assumption 51 independent tests overly conservative study nonetheless even bonferroni correction applied 4783 4360 snps still significant 10 families p003 0005 22 combined families p00003 00001 association smaller set 12 families longer significant overly conservative correction p2 4 4783 4360 respectively nonetheless inclusion analysis leads improved evidence association
0.4394662.14559775.html.plaintext.txt	31	contribution vr22 association linkage 80 cm next investigated contribution vr22 43604783 association linkage previously reported initial linkage findings obtained using seven markers covering 14 cm chromosome 10 analyze entirety chromosome 10 genotyped 26 additional markers spanning 165 cm 10 load families 10 families combined best two point lod scores obtained 4783 262 4360 217 peak described multipoint lod scores broadened flattened considerably incorporation additional markers maximum multipoint lod score continued 80 cm fig 3
0.4394662.14559775.html.plaintext.txt	32	contribution vr22 association linkage 80 cm next investigated contribution vr22 43604783 association linkage previously reported initial linkage findings obtained using seven markers covering 14 cm chromosome 10 analyze entirety chromosome 10 genotyped 26 additional markers spanning 165 cm 10 load families 10 families combined best two point lod scores obtained 4783 262 4360 217 peak described multipoint lod scores broadened flattened considerably incorporation additional markers maximum multipoint lod score continued 80 cm fig 3
0.4394662.14559775.html.plaintext.txt	33	view larger version 11k figure 3 effect vr22 snp 4360 multipoint lod scores mls load families effect vr22 4360 linkage plasma ass42 10 load families black line linkage gray line linkage conditional upon association vr22 4360 snp multipoint ibds used analyses generated using 31 markers described text
0.4394662.14559775.html.plaintext.txt	34	view larger version 11k figure 3 effect vr22 snp 4360 multipoint lod scores mls load families effect vr22 4360 linkage plasma ass42 10 load families black line linkage gray line linkage conditional upon association vr22 4360 snp multipoint ibds used analyses generated using 31 markers described text
0.4394662.14559775.html.plaintext.txt	35	reason broader flatter peak fine mapping analysis may several fold first utilized mcmc mibd estimation implemented simwalk2 package 4647 multipoint linkage results presented paper opposed regression based mibd estimation algorithm implemented solar used original paper 34 see also subjects methods second genotyping additional markers leads information regarding recombination could potentially lead decrease original linkage signal obtained fewer markers third utilizing larger number markers increases likelihood map genotyping errors despite implementation strict genotype quality control measures indeed others also found fine mapping markers lead lowering original lod scores obtained lesser number markers 4849
0.4394662.14559775.html.plaintext.txt	36	reason broader flatter peak fine mapping analysis may several fold first utilized mcmc mibd estimation implemented simwalk2 package 4647 multipoint linkage results presented paper opposed regression based mibd estimation algorithm implemented solar used original paper 34 see also subjects methods second genotyping additional markers leads information regarding recombination could potentially lead decrease original linkage signal obtained fewer markers third utilizing larger number markers increases likelihood map genotyping errors despite implementation strict genotype quality control measures indeed others also found fine mapping markers lead lowering original lod scores obtained lesser number markers 4849
0.4394662.14559775.html.plaintext.txt	37	evaluate extent 4360 4783 snps functional snps associated tightly linked pair account linkage observed repeated linkage analysis regressing effect vr22 4360 association including covariate linkage model regressing effect snp multipoint linkage signal diminished substantially 10 combined families fig 3 marked diminution lod scores indicates substantial proportion linkage signal plasma ass42 accounted vr22 4360 association residual linkage signal persisted regressing vr22 4360 association indicates likely additional variants contribute linkage though residual signal may also due random variation diminution maximum multipoint lod scores upon inclusion 4360 snp covariate also evident comparison variance component model excludes covariate table 3b one includes table 3c p value major gene effect maximum multipoint locus goes 0004 016 trend observed twopoint linkage 4360 snp assessed without including 4360 covariate table 3d e p value major gene 4360 locus loses significance p0009 p0038
0.4394662.14559775.html.plaintext.txt	38	evaluate extent 4360 4783 snps functional snps associated tightly linked pair account linkage observed repeated linkage analysis regressing effect vr22 4360 association including covariate linkage model regressing effect snp multipoint linkage signal diminished substantially 10 combined families fig 3 marked diminution lod scores indicates substantial proportion linkage signal plasma ass42 accounted vr22 4360 association residual linkage signal persisted regressing vr22 4360 association indicates likely additional variants contribute linkage though residual signal may also due random variation diminution maximum multipoint lod scores upon inclusion 4360 snp covariate also evident comparison variance component model excludes covariate table 3b one includes table 3c p value major gene effect maximum multipoint locus goes 0004 016 trend observed twopoint linkage 4360 snp assessed without including 4360 covariate table 3d e p value major gene 4360 locus loses significance p0009 p0038
0.4394662.14559775.html.plaintext.txt	39	view table table 3 variance components models depicting effect 4360 snp multipoint twopoint linkage discussion top abstract introduction results discussion subjects methods references study analyzed vr22 gene chromosome 10 determine functional snps contribute linkage signal plasma ass42 previously reported extended load families found two vr22 snps 4360 4783 showed significant robust association plasma ass42 20 65 year old family members extended load families two snps 423 bp apart strong ld give virtually identical results 4360 4783 snps located 177 kb intron exons 10 11 distance 14 kb exon 11 identified 11 additional snps within 6 kb 43604783 eight intron exons 10 11 three intron exons 11 12 none snps gave significant association 43604783 careful bounding showed large 17 mb vr22 gene confirmed gene within region 43604783 association analyses 4360 used covariate null linkage models reduced multipoint lod score indicating vr22 43604783 association contributes linkage large reduction observed 10 families analyzed suggests 43604783 association contributes substantially linkage signal observed families presence residual linkage regressing effect vr22 4360 snp indicates however 4360 association entirely account linkage thus data provide substantial evidence vr22 variants contribute linkage signal previously reported though residual linkage signal may due random variation could also indicate may additional variants contribute linkage whether variants large vr22 gene nearby genes remains determined
0.4394662.14559775.html.plaintext.txt	40	since intronic snps located 14 kb nearest exon 4360 4783 unlikely functional effect association ass42 presumably occurs ld one several functional vr22 snps sequencing vr22 exons reported vr22 transcript 39 failed identify potentially functional snps could account 43604783 association possible functional snps affect splicing known alternatively spliced exons strong ld 43604783
0.4394662.14559775.html.plaintext.txt	41	since intronic snps located 14 kb nearest exon 4360 4783 unlikely functional effect association ass42 presumably occurs ld one several functional vr22 snps sequencing vr22 exons reported vr22 transcript 39 failed identify potentially functional snps could account 43604783 association possible functional snps affect splicing known alternatively spliced exons strong ld 43604783
0.4394662.14559775.html.plaintext.txt	42	basic premise studying plasma ass42 intermediate phenotype genes variants influence plasma ass42 genes variants influence risk load results reported useful identify vr22 gene variants influence plasma ass42 thereby increasing likelihood vr22 gene one genes 80 cm region chromosome 10 variants influence risk load important unanswered question well effect snp plasma ass42 correlate effect ad phenotype unlikely change plasma ass42 caused specific genetic variant directly increases risk ad increased risk ad probably produced related effect variant within brain thus conceivable perhaps even likely specific variant strong influence plasma ass42 may sometimes little influence ad phenotype vice versa thoroughly studying several genes elucidating effects entire set functional variants plasma ass42 ad phenotypes question answered may effects two phenotypes correlate well variants genes poorly others
0.4394662.14559775.html.plaintext.txt	43	basic premise studying plasma ass42 intermediate phenotype genes variants influence plasma ass42 genes variants influence risk load results reported useful identify vr22 gene variants influence plasma ass42 thereby increasing likelihood vr22 gene one genes 80 cm region chromosome 10 variants influence risk load important unanswered question well effect snp plasma ass42 correlate effect ad phenotype unlikely change plasma ass42 caused specific genetic variant directly increases risk ad increased risk ad probably produced related effect variant within brain thus conceivable perhaps even likely specific variant strong influence plasma ass42 may sometimes little influence ad phenotype vice versa thoroughly studying several genes elucidating effects entire set functional variants plasma ass42 ad phenotypes question answered may effects two phenotypes correlate well variants genes poorly others
0.4394662.14559775.html.plaintext.txt	44	results reported indicate vr22 variants significantly associate plasma ass42 account substantial portion linkage signal chromosome 10 additional analysis needed identify entire set functional variants account ass42 linkage 80 cm identified important test effects ass production vr22 gene function biological experiments well determine whether functional variants modify risk ad
0.4394662.14559775.html.plaintext.txt	45	results reported indicate vr22 variants significantly associate plasma ass42 account substantial portion linkage signal chromosome 10 additional analysis needed identify entire set functional variants account ass42 linkage 80 cm identified important test effects ass production vr22 gene function biological experiments well determine whether functional variants modify risk ad
0.4394662.14559775.html.plaintext.txt	46	subjects methods top abstract introduction results discussion subjects methods references subjects collected 10 extended load families composed 292 individuals 205 ages 20 65 four families collected via load patient extremely high plasma ass42 andor ass40 levels extremes top 10th percentile 545 ad patients analyzed remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently except one family distinction extreme non extreme families made priori family collection based plasma ass42 levels proband detailed collection strategies family profiles families provided elsewhere 3435 addition 10 families 12 independent extended load pedigrees collected additional pedigrees proband first degree relative load patient elevated plasma ass levels 34 contributed 88 subjects ages 20 65 study approved appropriate institutional review board appropriate informed consent obtained participants
0.4394662.14559775.html.plaintext.txt	47	subjects methods top abstract introduction results discussion subjects methods references subjects collected 10 extended load families composed 292 individuals 205 ages 20 65 four families collected via load patient extremely high plasma ass42 andor ass40 levels extremes top 10th percentile 545 ad patients analyzed remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently except one family distinction extreme non extreme families made priori family collection based plasma ass42 levels proband detailed collection strategies family profiles families provided elsewhere 3435 addition 10 families 12 independent extended load pedigrees collected additional pedigrees proband first degree relative load patient elevated plasma ass levels 34 contributed 88 subjects ages 20 65 study approved appropriate institutional review board appropriate informed consent obtained participants
0.4394662.14559775.html.plaintext.txt	48	microsatellite genotyping dna extracted peripheral blood leukocytes using routine methods genotypes microsatellites obtained using abi 377 3100 sequencers associated genescangenotyper software packages single nucleotide polymorphisms snps genotyped using taqman chemistry software designing primers probes implemented within abi prism 7900 ht sequence detection system pedigree structure phenotypic genotypic information maintained pedsys httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml 50 also produced output files analyses performed solar explained order location 27 chromosome 10 microsatellite markers determined marshfield linkage map two markers d10s1435 d10s1211 locations marshfield linkage map 51 placed linkage map according location estimates obtained map o mat program httpcompgenrutgersedumapomat 52 two snps found vr22 gene also used markers linkage analysis snps 4360tc 4783ag located 61137462 61137039 bp respectively chromosome 10 genomic map celera database httpwwwceleracom two snps placed linkage map based approximate centimorgan locations estimated physical maps
0.4394662.14559775.html.plaintext.txt	49	microsatellite genotyping dna extracted peripheral blood leukocytes using routine methods genotypes microsatellites obtained using abi 377 3100 sequencers associated genescangenotyper software packages single nucleotide polymorphisms snps genotyped using taqman chemistry software designing primers probes implemented within abi prism 7900 ht sequence detection system pedigree structure phenotypic genotypic information maintained pedsys httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml 50 also produced output files analyses performed solar explained order location 27 chromosome 10 microsatellite markers determined marshfield linkage map two markers d10s1435 d10s1211 locations marshfield linkage map 51 placed linkage map according location estimates obtained map o mat program httpcompgenrutgersedumapomat 52 two snps found vr22 gene also used markers linkage analysis snps 4360tc 4783ag located 61137462 61137039 bp respectively chromosome 10 genomic map celera database httpwwwceleracom two snps placed linkage map based approximate centimorgan locations estimated physical maps
0.4394662.14559775.html.plaintext.txt	50	identification genotyping snps vr22 genomic mrna sequences initially obtained national center biotechnology information ncbi web site using genomic contig nt008663 af091606 order identify snps primers designed cover known exons 7 kb intronic region exons 10 11 load cases elderly control subjects family members extended load pedigrees sequenced identify polymorphisms initial sequencing vr22 exons 7 kb intronic region identified three snps intronic 7 kb region 4825 4783 4360 subsequently many additional snps vr22 flanking genes identified using celera database aim cover region using snp groups located every 250 kb group composed 3 5 snps separated 1 5 kb total 51 snps including vr22 4360 4783 genotyped throughout vr22 3 anxa2p3 5 sirt1 flanking genes snps within group found strong ld snp locations obtained celera sequence map
0.4394662.14559775.html.plaintext.txt	51	identification genotyping snps vr22 genomic mrna sequences initially obtained national center biotechnology information ncbi web site using genomic contig nt008663 af091606 order identify snps primers designed cover known exons 7 kb intronic region exons 10 11 load cases elderly control subjects family members extended load pedigrees sequenced identify polymorphisms initial sequencing vr22 exons 7 kb intronic region identified three snps intronic 7 kb region 4825 4783 4360 subsequently many additional snps vr22 flanking genes identified using celera database aim cover region using snp groups located every 250 kb group composed 3 5 snps separated 1 5 kb total 51 snps including vr22 4360 4783 genotyped throughout vr22 3 anxa2p3 5 sirt1 flanking genes snps within group found strong ld snp locations obtained celera sequence map
0.4394662.14559775.html.plaintext.txt	52	variance components analysis employed variance components methodology implemented software package solar 5354 estimate heritability plasma ass42 levels perform linkage association analyses detect quantitative trait loci qtls affect variance ass42 extended load families method described detail elsewhere 5354 estimates amount variance quantitative trait due particular genetic locus q2 residual genetic factors g2 individual specific random environmental factors e2 based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.4394662.14559775.html.plaintext.txt	53	variance components analysis employed variance components methodology implemented software package solar 5354 estimate heritability plasma ass42 levels perform linkage association analyses detect quantitative trait loci qtls affect variance ass42 extended load families method described detail elsewhere 5354 estimates amount variance quantitative trait due particular genetic locus q2 residual genetic factors g2 individual specific random environmental factors e2 based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.4394662.14559775.html.plaintext.txt	54	matrix probabilities pair individuals share genetic material identical descent given chromosomal location estimated genetic marker data 2 matrix kinship coefficients describing polygenic factors identity matrix describing sporadic environmental factors
0.4394662.14559775.html.plaintext.txt	55	addition effect shared environment h2 variance trait also estimated including household matrix model matrix whose ijth element equal 1 individuals j share specified environment 0 otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma ass42 included household matrix models since almost individuals family measured one batch household matrix included element1 individuals extended family 0 otherwise realize probably overly conservative since shared family household effect employed account potential batch batch variance assay overlaps kinship effect 55 inclusion household matrix almost certainly overcorrects batch batch variance underestimates shared genetic effect reason performed heritability linkage analyses without household matrix model multipoint results shown figures 2 3 include household matrix analyses without household matrix yielded slightly better lod scores higher heritabilities general
0.4394662.14559775.html.plaintext.txt	56	addition effect shared environment h2 variance trait also estimated including household matrix model matrix whose ijth element equal 1 individuals j share specified environment 0 otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma ass42 included household matrix models since almost individuals family measured one batch household matrix included element1 individuals extended family 0 otherwise realize probably overly conservative since shared family household effect employed account potential batch batch variance assay overlaps kinship effect 55 inclusion household matrix almost certainly overcorrects batch batch variance underestimates shared genetic effect reason performed heritability linkage analyses without household matrix model multipoint results shown figures 2 3 include household matrix analyses without household matrix yielded slightly better lod scores higher heritabilities general
0.4394662.14559775.html.plaintext.txt	57	scalars q2 g2 h2 e2 estimated using maximum likelihood heritability estimations compared environmental model q2 g2 fixed zero h2 e2 estimated polygenic model g2 h2 e2 estimated linkage analyses performed comparing polygenic model linkage model q2 also estimated difference two log10 likelihoods models produces lod score equivalent classical lod score linkage analysis incorporated sex age age2 sexage sexage2 covariates heritability estimations none covariates significant p 005 therefore excluded multipoint linkage analysis
0.4394662.14559775.html.plaintext.txt	58	scalars q2 g2 h2 e2 estimated using maximum likelihood heritability estimations compared environmental model q2 g2 fixed zero h2 e2 estimated polygenic model g2 h2 e2 estimated linkage analyses performed comparing polygenic model linkage model q2 also estimated difference two log10 likelihoods models produces lod score equivalent classical lod score linkage analysis incorporated sex age age2 sexage sexage2 covariates heritability estimations none covariates significant p 005 therefore excluded multipoint linkage analysis
0.4394662.14559775.html.plaintext.txt	59	order minimize age dementia related environmental effects plasma ass42 levels performed analyses 20 65 year age group previous studies 3435 since variance components methods based underlying assumption quantitative trait analyzed normal distribution 10logass42 levels used phenotypes extreme outliers plasma ass levels plus minus 4 standard deviations beyond mean excluded analyses thus 10logass42 phenotype analyzed normal distribution plasma ass measurements done using well established sandwich elisa system described previously 15 samples measured duplicate elisa plate included samples five volunteers results five standard samples used normalize values obtained reduce plate plate day day variance
0.4394662.14559775.html.plaintext.txt	60	order minimize age dementia related environmental effects plasma ass42 levels performed analyses 20 65 year age group previous studies 3435 since variance components methods based underlying assumption quantitative trait analyzed normal distribution 10logass42 levels used phenotypes extreme outliers plasma ass levels plus minus 4 standard deviations beyond mean excluded analyses thus 10logass42 phenotype analyzed normal distribution plasma ass measurements done using well established sandwich elisa system described previously 15 samples measured duplicate elisa plate included samples five volunteers results five standard samples used normalize values obtained reduce plate plate day day variance
0.4394662.14559775.html.plaintext.txt	61	identity descent probability estimations identity descent ibd probabilities genotyped marker estimated using pairwise likelihood based estimation method implemented solar 53 ibd estimates used obtain twopoint lod scores multipoint ibd probabilities also estimated centimorgan pair adjacent markers using markov chain monte carlo mcmc multipoint ibd estimation approach implemented simwalk2 package 4647 mcmc process run twice default length 1000 replicates second time doubling process length multipoint linkage analyses using mibd matrices done using variance components methodology implemented solar results using shorter longer runs similar results latter presented given computation time increases marker number two upstream markers yielded evidence linkage datasets two markers d10s1435 d10s189 omitted mibd estimations two major differences mibd estimations utilized previous report linkage chromosome 10 current study 35 results previous linkage obtained result genotyping seven markers 13 cm region current study utilizes 31 markers spread 283 1653 cm chromosome 10 second mibd estimation approaches used previous current studies different mcmc approach implemented simwalk2 4647 utilized study different mibd probability estimation algorithm implemented solar approach utilized initial analysis seven chromosome 10 markers sobel et al 47 demonstrated significant differences results obtained two methods using dataset concluded multipoint mcmc approach yielded accurate mibd probability estimates inter marker loci reason utilized mcmc approach study
0.4394662.14559775.html.plaintext.txt	62	identity descent probability estimations identity descent ibd probabilities genotyped marker estimated using pairwise likelihood based estimation method implemented solar 53 ibd estimates used obtain twopoint lod scores multipoint ibd probabilities also estimated centimorgan pair adjacent markers using markov chain monte carlo mcmc multipoint ibd estimation approach implemented simwalk2 package 4647 mcmc process run twice default length 1000 replicates second time doubling process length multipoint linkage analyses using mibd matrices done using variance components methodology implemented solar results using shorter longer runs similar results latter presented given computation time increases marker number two upstream markers yielded evidence linkage datasets two markers d10s1435 d10s189 omitted mibd estimations two major differences mibd estimations utilized previous report linkage chromosome 10 current study 35 results previous linkage obtained result genotyping seven markers 13 cm region current study utilizes 31 markers spread 283 1653 cm chromosome 10 second mibd estimation approaches used previous current studies different mcmc approach implemented simwalk2 4647 utilized study different mibd probability estimation algorithm implemented solar approach utilized initial analysis seven chromosome 10 markers sobel et al 47 demonstrated significant differences results obtained two methods using dataset concluded multipoint mcmc approach yielded accurate mibd probability estimates inter marker loci reason utilized mcmc approach study
0.4394662.14559775.html.plaintext.txt	63	tests association initially tested association snps plasma ass42 10 extended load families using regression based covariate approach variance components paradigm implemented computer program solar 53 order control effect linkage included linkage component q2 null alternative models tested used multipoint ibd matrix yielded maximum multipoint lod score 80 cm 10 extended load families multipoint ibd probabilities matrix estimated simwalk using genetic marker information described
0.4394662.14559775.html.plaintext.txt	64	tests association initially tested association snps plasma ass42 10 extended load families using regression based covariate approach variance components paradigm implemented computer program solar 53 order control effect linkage included linkage component q2 null alternative models tested used multipoint ibd matrix yielded maximum multipoint lod score 80 cm 10 extended load families multipoint ibd probabilities matrix estimated simwalk using genetic marker information described
0.4394662.14559775.html.plaintext.txt	65	test effect specific snp genotypes used measured genotype approach included copy number snp allele covariate analysis regressed plasma ass42 phenotype covariate individual measured genotype approach classical test differences trait mean genotype described theoretically previously 5657 approach also utilized previous association studies snps various quantitative traits extended families 5859 individuals xx xy yy snp genotype used covariate takes value 0 1 2 respectively formulation assumes snp additive qtl model includes covariate tested model include determine effect quantitative trait interest twice difference natural log likelihoods two models distributed 2 distribution 1 degree freedom order test association beyond linkage residual genetic household effects three components included null alternative models first tested association snps ass42 10 load families previously used describe linkage chromosome 10 35 order control effect linkage residual genetic effects household effects group estimated effect snp background model included 80 cm multipoint identity descent matrix well kinship household matrices tested snp association ass42 second independent set 12 load families also analyzed combined group 22 families
0.4394662.14559775.html.plaintext.txt	66	test effect specific snp genotypes used measured genotype approach included copy number snp allele covariate analysis regressed plasma ass42 phenotype covariate individual measured genotype approach classical test differences trait mean genotype described theoretically previously 5657 approach also utilized previous association studies snps various quantitative traits extended families 5859 individuals xx xy yy snp genotype used covariate takes value 0 1 2 respectively formulation assumes snp additive qtl model includes covariate tested model include determine effect quantitative trait interest twice difference natural log likelihoods two models distributed 2 distribution 1 degree freedom order test association beyond linkage residual genetic household effects three components included null alternative models first tested association snps ass42 10 load families previously used describe linkage chromosome 10 35 order control effect linkage residual genetic effects household effects group estimated effect snp background model included 80 cm multipoint identity descent matrix well kinship household matrices tested snp association ass42 second independent set 12 load families also analyzed combined group 22 families
0.4394662.14559775.html.plaintext.txt	67	linkage analysis conditional upon association conditional linkage analysis accounts association functional polymorphism one strong ld linkage locus decrease eliminate linkage signal 5859 reason performed linkage analysis conditional association strongly associating snp 4360tc performed test estimating proportion variance due linkage background model included snp covariate comparing linkage model excluded covariate
0.4394662.14559775.html.plaintext.txt	68	linkage analysis conditional upon association conditional linkage analysis accounts association functional polymorphism one strong ld linkage locus decrease eliminate linkage signal 5859 reason performed linkage analysis conditional association strongly associating snp 4360tc performed test estimating proportion variance due linkage background model included snp covariate comparing linkage model excluded covariate
0.4394662.14559775.html.plaintext.txt	69	analysis linkage disequilibrium measured linkage disequilibrium ld snps haplotype groups within 22 extended load families using gold program 60 used expectation maximization algorithm slatkin excoffier 61 determine various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient d 62 algorithm determines ld founders married ins ld estimated vr22 4360 snp snps
0.4394662.14559775.html.plaintext.txt	70	analysis linkage disequilibrium measured linkage disequilibrium ld snps haplotype groups within 22 extended load families using gold program 60 used expectation maximization algorithm slatkin excoffier 61 determine various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient d 62 algorithm determines ld founders married ins ld estimated vr22 4360 snp snps
0.4394662.14559775.html.plaintext.txt	71	acknowledgements grateful frederick pishotta computer support thomas dyer southwest foundation biomedical research providing us scripts obtaining solar compatible mibd files simwalk acknowledge mayo clinic adrc employees help collection samples grateful individuals participated study without work would possible study supported nih grants ag18023 sgy ag06656 sgy ag20903 net grant american federation aging research grant pd01062 net robert clarice smith fellowship net
0.4394662.14559775.html.plaintext.txt	72	acknowledgements grateful frederick pishotta computer support thomas dyer southwest foundation biomedical research providing us scripts obtaining solar compatible mibd files simwalk acknowledge mayo clinic adrc employees help collection samples grateful individuals participated study without work would possible study supported nih grants ag18023 sgy ag06656 sgy ag20903 net grant american federation aging research grant pd01062 net robert clarice smith fellowship net
0.4394662.14559775.html.plaintext.txt	73	footnotes correspondence addressed mayo clinic jacksonville 4500 san pablo road birdsall 2 jacksonville fl 32224 usa tel 1 9049537356 fax 1 9049537370 email younkinstevenatmayoedu
0.4394662.14559775.html.plaintext.txt	74	footnotes correspondence addressed mayo clinic jacksonville 4500 san pablo road birdsall 2 jacksonville fl 32224 usa tel 1 9049537356 fax 1 9049537370 email younkinstevenatmayoedu
0.4394662.14559775.html.plaintext.txt	75	authors wish known opinion first two authors regarded joint first authors
0.4394662.14559775.html.plaintext.txt	76	references top abstract introduction results discussion subjects methods references schellenberg gd dsouza poorkaj p 2000 genetics alzheimers disease curr psych rep 2 158 164
0.44692016.11134059.html.plaintext.txt	0	minireview role presenilins secretase activity michael wolfe christian haass
0.44692016.11134059.html.plaintext.txt	1	center neurologic diseases harvard medical school brigham womens hospital boston massachusetts 02115 ludwig maximilians university munich adolf butenandt institute department biochemistry schillerstrasse 44 d 80336 muenchen germany
0.44692016.11134059.html.plaintext.txt	2	introduction top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	3	aphorism basic biological research lays groundwork solving important biomedical problems however reverse true well focusing problems human disease lead important new insights intricacies nature research alzheimers disease ad1 provides case study latter race identify molecular players involved pathogenesis unveiled unexpected fascinating aspects protease biochemistry proteolysis dependent signal transduction 40 42 residue amyloid peptide implicated early pathogenic events lead ad peptide carved amyloid precursor protein app secretases fig 1a 1 two proteases considered important drug targets search inhibitors production within pharmaceutical companies gone years even though secretases remained unknown recently last year secretase identified new membrane tethered member aspartyl protease family 2 6 finding greatly facilitate drug discovery secretases prevent formation cleaving middle amyloid domain 7 shown members adam family disintegrin metalloprotease 8 9 time mysterious secretase giving secrets well
0.44692016.11134059.html.plaintext.txt	4	aphorism basic biological research lays groundwork solving important biomedical problems however reverse true well focusing problems human disease lead important new insights intricacies nature research alzheimers disease ad1 provides case study latter race identify molecular players involved pathogenesis unveiled unexpected fascinating aspects protease biochemistry proteolysis dependent signal transduction 40 42 residue amyloid peptide implicated early pathogenic events lead ad peptide carved amyloid precursor protein app secretases fig 1a 1 two proteases considered important drug targets search inhibitors production within pharmaceutical companies gone years even though secretases remained unknown recently last year secretase identified new membrane tethered member aspartyl protease family 2 6 finding greatly facilitate drug discovery secretases prevent formation cleaving middle amyloid domain 7 shown members adam family disintegrin metalloprotease 8 9 time mysterious secretase giving secrets well
0.44692016.11134059.html.plaintext.txt	5	view larger version 55k fig 1 proteolytic processing app notch ectodomain shedding secretase generates 83 99 residue membrane associated c terminal fragments c83 c99 respectively metalloproteases tace adam 10 appear secretases secretase membrane tethered aspartyl protease c83 c99 processed secretase hydrolyzes substrates middle transmembrane regions form p3 c83 c99 notch processed furin like protease producing heterodimeric species trafficked cell surface ligand binding notch ectodomain shed tace remaining membrane associated c terminus next cut within transmembrane region secretase like protease b topology proteolytic processing presenilins presenilins possess eight transmembrane regions snipped middle hydrophobic domain large cytosolic loop tm 6 tm 7 producing stable heterodimers unidentified presenilinase psase two conserved aspartates one tm 6 one tm 7 required heterodimer formation secretase cleavage app notch leading hypothesis presenilins proteases activated autoproteolysis ntf n terminal fragment ctf c terminal fragment familial alzheimers disease generation highly amyloidogenic a42 top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	6	genetic studies families susceptible autosomal dominant early onset 60 years ad underscore importance formation disease process 10 11 several different missense mutations app gene chromosome 21 cause familial ad fad mutations found immediately near secretase processing sites lys asnmet leu double mutation near secretase cleavage site found swedish pedigree leads increased production a40 a42 12 indeed purified secretase cuts peptide substrates swedish mutation better peptides based wild type sequence 2 4 6 several fad causing mutations app near secretase processing site also affect production cases mutations alter specificity protease leading increases 42 residue variant 13 14 findings bolstered amyloid hypothesis ad pathogenesis a42 particularly prone fibril formation 15 protein initially deposited neuritic plaques characterize disease 16 genes encoding polytopic presenilin 1 presenilin 2 ps1 ps2 found chromosomes 14 1 respectively later identified major loci fad 17 18 mutations presenilins likewise found increase a42 production transfected cell lines 19 21 transgenic animals 19 20 22 human plasma 23 thus presenilins somehow modulate secretase activity fact deletion ps1 mice dramatically reduced secretase activity 24 knockout ps1 ps2 resulted complete abolition app processing event 25 26 demonstrating presenilins absolutely required proteolysis secretase
0.44692016.11134059.html.plaintext.txt	7	genetic studies families susceptible autosomal dominant early onset 60 years ad underscore importance formation disease process 10 11 several different missense mutations app gene chromosome 21 cause familial ad fad mutations found immediately near secretase processing sites lys asnmet leu double mutation near secretase cleavage site found swedish pedigree leads increased production a40 a42 12 indeed purified secretase cuts peptide substrates swedish mutation better peptides based wild type sequence 2 4 6 several fad causing mutations app near secretase processing site also affect production cases mutations alter specificity protease leading increases 42 residue variant 13 14 findings bolstered amyloid hypothesis ad pathogenesis a42 particularly prone fibril formation 15 protein initially deposited neuritic plaques characterize disease 16 genes encoding polytopic presenilin 1 presenilin 2 ps1 ps2 found chromosomes 14 1 respectively later identified major loci fad 17 18 mutations presenilins likewise found increase a42 production transfected cell lines 19 21 transgenic animals 19 20 22 human plasma 23 thus presenilins somehow modulate secretase activity fact deletion ps1 mice dramatically reduced secretase activity 24 knockout ps1 ps2 resulted complete abolition app processing event 25 26 demonstrating presenilins absolutely required proteolysis secretase
0.44692016.11134059.html.plaintext.txt	8	secretase carries unusual proteolysis within middle predicted transmembrane domain substrates c99 generated secretase c83 generated alternative processing secretase fig 1a indeed helical conformation secretase cleavage site app explain nearby fad causing mutations specifically increase a42 production mutations immediately adjacent amide bond processed give a42 27 phenylalanine scanning study near secretase cleavage site resulting effects a40 a42 production provided important experimental support idea substrate helical conformation upon initial interaction protease 28 mutagenesis studies likewise indicated secretase loose sequence specificity 29 31
0.44692016.11134059.html.plaintext.txt	9	despite loose sequence specificity secretase nevertheless appears process substrate app specific sites apparent paradox resolved considering distance within membrane key determinant site proteolysis concept together helical model suggests secretase might catalyze intramembranous proteolysis development substrate based inhibitors led indirect characterization secretase inhibition peptidomimetic transition state analogues suggested aspartyl protease mechanism 27 moreover secretase appears loose sequence specificity peptidomimetic inhibitors displays substrates 27 distinctions observed ability given compound block a40 vis vis a42 leading suggestion two species generated different secretases 32 33 presenilins secretases top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	10	despite loose sequence specificity secretase nevertheless appears process substrate app specific sites apparent paradox resolved considering distance within membrane key determinant site proteolysis concept together helical model suggests secretase might catalyze intramembranous proteolysis development substrate based inhibitors led indirect characterization secretase inhibition peptidomimetic transition state analogues suggested aspartyl protease mechanism 27 moreover secretase appears loose sequence specificity peptidomimetic inhibitors displays substrates 27 distinctions observed ability given compound block a40 vis vis a42 leading suggestion two species generated different secretases 32 33 presenilins secretases top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	11	findings ps mutations affect a42 generation ps knockouts prevent production raised question presenilins identical secretases presenilins appear bear obvious sequence homology known proteases homology spe 4 caenorhabditis elegans protein apparently involved vesicle transport spermatozoa initially suggested less direct role secretase processing app 17 furthermore overexpression presenilins lead increased secretase activity 20 however presenilins undergo proteolytic processing within hydrophobic region large cytosolic loop transmembrane domain tm 6 tm 7 fig 1b form stable heterodimeric complexes 39 40 studies support eight tm topology presenilins 34 36 although six seven tm topologies also suggested 37 38 heterodimers produced limited levels even upon overexpression holoprotein 39 41 43 may found cell surface 44 expression exogenous presenilins leads replacement endogenous presenilin heterodimers corresponding exogenous heterodimers indicating competition limiting cellular factors needed stabilization endoproteolysis 45
0.44692016.11134059.html.plaintext.txt	12	findings ps mutations affect a42 generation ps knockouts prevent production raised question presenilins identical secretases presenilins appear bear obvious sequence homology known proteases homology spe 4 caenorhabditis elegans protein apparently involved vesicle transport spermatozoa initially suggested less direct role secretase processing app 17 furthermore overexpression presenilins lead increased secretase activity 20 however presenilins undergo proteolytic processing within hydrophobic region large cytosolic loop transmembrane domain tm 6 tm 7 fig 1b form stable heterodimeric complexes 39 40 studies support eight tm topology presenilins 34 36 although six seven tm topologies also suggested 37 38 heterodimers produced limited levels even upon overexpression holoprotein 39 41 43 may found cell surface 44 expression exogenous presenilins leads replacement endogenous presenilin heterodimers corresponding exogenous heterodimers indicating competition limiting cellular factors needed stabilization endoproteolysis 45
0.44692016.11134059.html.plaintext.txt	13	fad causing presenilin mutants likewise processed stable heterodimers one exception missense mutation ps1 leads aberrant splicing exon 9 region encodes endoproteolytic cleavage site 39 41 ps1 e9 variant active presenilin like fad causing presenilin mutants causes increased a42 production 19 46 upon overexpression ps1 e9 rapidly degraded similar unprocessed wild type presenilins however small portion ps1 variant stabilized cells 41 47 forms high molecular weight complex like n c terminal fragments 40 48 suggesting interact limiting cellular factors wild type presenilins observations consistent idea bioactive form presenilin heterodimer hydrophobic region inhibitory domain however several artificial ps variants generated biologically activeinactive independent ability undergo endoproteolysis 49 50 therefore evidence required finally demonstrate role ps endoproteolysis biological pathological function
0.44692016.11134059.html.plaintext.txt	14	fad causing presenilin mutants likewise processed stable heterodimers one exception missense mutation ps1 leads aberrant splicing exon 9 region encodes endoproteolytic cleavage site 39 41 ps1 e9 variant active presenilin like fad causing presenilin mutants causes increased a42 production 19 46 upon overexpression ps1 e9 rapidly degraded similar unprocessed wild type presenilins however small portion ps1 variant stabilized cells 41 47 forms high molecular weight complex like n c terminal fragments 40 48 suggesting interact limiting cellular factors wild type presenilins observations consistent idea bioactive form presenilin heterodimer hydrophobic region inhibitory domain however several artificial ps variants generated biologically activeinactive independent ability undergo endoproteolysis 49 50 therefore evidence required finally demonstrate role ps endoproteolysis biological pathological function
0.44692016.11134059.html.plaintext.txt	15	given characterization secretase aspartyl protease might catalyze unusual intramembranous proteolysis sequences presenilins inspected found contain two conserved aspartates predicted lie within tm 6 tm 7 flanking large cytosolic loop 51 aspartates appear align within membrane secretase cleavage sites app fig 1b mutation either aspartate alanine completely prevented ps1 endoproteolysis asp ala ps1 mutants acted dominant negative manner respect secretase processing app similar effects app processing observed even conservative mutations glutamate 51 asparagine 49 52 made indicating crucial identity two residues aspartates suggesting effects likely misfolding effects corroborated several laboratories seen ps1 ps2 48 49 51 54 although recent study demonstrated tm 7 aspartate may less tolerant mutagenesis compared tm 6 aspartate 55
0.44692016.11134059.html.plaintext.txt	16	given characterization secretase aspartyl protease might catalyze unusual intramembranous proteolysis sequences presenilins inspected found contain two conserved aspartates predicted lie within tm 6 tm 7 flanking large cytosolic loop 51 aspartates appear align within membrane secretase cleavage sites app fig 1b mutation either aspartate alanine completely prevented ps1 endoproteolysis asp ala ps1 mutants acted dominant negative manner respect secretase processing app similar effects app processing observed even conservative mutations glutamate 51 asparagine 49 52 made indicating crucial identity two residues aspartates suggesting effects likely misfolding effects corroborated several laboratories seen ps1 ps2 48 49 51 54 although recent study demonstrated tm 7 aspartate may less tolerant mutagenesis compared tm 6 aspartate 55
0.44692016.11134059.html.plaintext.txt	17	aspartates critical secretase independent role presenilin endoproteolysis aspartate mutation ps1 e9 variant still blocked secretase activity even though endoproteolysis required presenilin variant 51 together results suggested presenilins might catalytic component secretase upon interaction yet unidentified limiting cellular factors presenilin undergoes autoproteolysis via two aspartates two presenilin subunits remain together contributing one aspartate active site secretase issue autoproteolysis however needs investigation heterologous expression worm ps homologue human cells leads functional ps variant cleaved 56 indicating separate presenilinase may least required cleave worm ps presenilins notch processing top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	18	aspartates critical secretase independent role presenilin endoproteolysis aspartate mutation ps1 e9 variant still blocked secretase activity even though endoproteolysis required presenilin variant 51 together results suggested presenilins might catalytic component secretase upon interaction yet unidentified limiting cellular factors presenilin undergoes autoproteolysis via two aspartates two presenilin subunits remain together contributing one aspartate active site secretase issue autoproteolysis however needs investigation heterologous expression worm ps homologue human cells leads functional ps variant cleaved 56 indicating separate presenilinase may least required cleave worm ps presenilins notch processing top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	19	presenilins also critical processing notch receptor signaling molecule crucial cell fate determination embryogenesis 57 translation er notch processed furin like protease resulting heterodimeric receptor shuttled cell surface fig 1a upon interaction cognate ligand ectodomain notch shed metalloprotease apparently identical tumor necrosis factor converting enzyme tace 58 59 interestingly metalloproteases tace adam 10 among identified secretases shed app ectodomain 8 9 membrane associated c terminus cut within postulated transmembrane domain release notch intracellular domain nicd translocates nucleus interacts activates csl cbf1 suh lag 1 family transcription factors 60 nicd formation absolutely required signaling notch receptor knock single point mutation near transmembrane cleavage site notch1 results embryonic lethal phenotype mice virtually identical observed upon knockout entire notch1 protein 61
0.44692016.11134059.html.plaintext.txt	20	presenilins also critical processing notch receptor signaling molecule crucial cell fate determination embryogenesis 57 translation er notch processed furin like protease resulting heterodimeric receptor shuttled cell surface fig 1a upon interaction cognate ligand ectodomain notch shed metalloprotease apparently identical tumor necrosis factor converting enzyme tace 58 59 interestingly metalloproteases tace adam 10 among identified secretases shed app ectodomain 8 9 membrane associated c terminus cut within postulated transmembrane domain release notch intracellular domain nicd translocates nucleus interacts activates csl cbf1 suh lag 1 family transcription factors 60 nicd formation absolutely required signaling notch receptor knock single point mutation near transmembrane cleavage site notch1 results embryonic lethal phenotype mice virtually identical observed upon knockout entire notch1 protein 61
0.44692016.11134059.html.plaintext.txt	21	parallels app notch processing striking cleaved tace also transmembrane regions proteins processed secretase like protease requires presenilins deletion ps1 mice embryonic lethal phenotype similar observed upon knockout notch1 62 63 ps1ps2 double knockout phenotype even similar 64 65 deficiency ps1 dramatically reduces nicd formation 66 complete absence presenilins results total abolition nicd production 25 26 treatment cells secretase inhibitors designed transmembrane cleavage site within app likewise blocks nicd production 66 nuclear translocation 67 reduces notch signaling reporter gene 67 moreover two conserved tm aspartates presenilins required cleavage notch tm domain seen secretase inhibitors expression asp mutant ps1 ps2 results reduction nicd formation translocation signaling 44 54 55 67 thus presenilins catalytic components secretases process app also likely catalytic components related proteases clip transmembrane region notch
0.44692016.11134059.html.plaintext.txt	22	parallels app notch processing striking cleaved tace also transmembrane regions proteins processed secretase like protease requires presenilins deletion ps1 mice embryonic lethal phenotype similar observed upon knockout notch1 62 63 ps1ps2 double knockout phenotype even similar 64 65 deficiency ps1 dramatically reduces nicd formation 66 complete absence presenilins results total abolition nicd production 25 26 treatment cells secretase inhibitors designed transmembrane cleavage site within app likewise blocks nicd production 66 nuclear translocation 67 reduces notch signaling reporter gene 67 moreover two conserved tm aspartates presenilins required cleavage notch tm domain seen secretase inhibitors expression asp mutant ps1 ps2 results reduction nicd formation translocation signaling 44 54 55 67 thus presenilins catalytic components secretases process app also likely catalytic components related proteases clip transmembrane region notch
0.44692016.11134059.html.plaintext.txt	23	subcellular localization presents potential problem idea presenilins could secretases presenilins primarily found er early golgi 68 whereas secretase activity apparently takes place cell surface er golgi 69 74 small amounts presenilin heterodimers however found cell surface complexation membrane associated c terminus notch 44 small amounts presumably bioactive form needed catalysis nevertheless spatial paradox still needs clear resolution another perplexing phenomenon holoproteins app notch form stable complexes presenilins er 75 77 app notch substrates secretase interact presenilin presenilin protease however mentioned membrane associated c terminus notch likewise forms stable complexes 44 app derived c83 c99 also complex presenilins presence secretase inhibitor either critical presenilin aspartate mutated 78 perhaps presenilins mature together app notch unresolved issues site specificity notch cleavage vis vis app although notch appears cleaved within transmembrane region site cleavage close cytosolic edge whereas app secretase site apparently middle membrane either cleavage event though one proteolytic products identified characterizing fragments may clarify issue sequence specificity single val leu change prevents proteolysis notch transmembrane region 60 whereas variety mutations app transmembrane region tolerated secretase examination proteolytic events purified enzyme assays may offer insights resolve problem especially since recent data suggest app also notch endoproteolysis occurs largely independent sequence 79 biochemical evidence presenilins proteases top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	24	subcellular localization presents potential problem idea presenilins could secretases presenilins primarily found er early golgi 68 whereas secretase activity apparently takes place cell surface er golgi 69 74 small amounts presenilin heterodimers however found cell surface complexation membrane associated c terminus notch 44 small amounts presumably bioactive form needed catalysis nevertheless spatial paradox still needs clear resolution another perplexing phenomenon holoproteins app notch form stable complexes presenilins er 75 77 app notch substrates secretase interact presenilin presenilin protease however mentioned membrane associated c terminus notch likewise forms stable complexes 44 app derived c83 c99 also complex presenilins presence secretase inhibitor either critical presenilin aspartate mutated 78 perhaps presenilins mature together app notch unresolved issues site specificity notch cleavage vis vis app although notch appears cleaved within transmembrane region site cleavage close cytosolic edge whereas app secretase site apparently middle membrane either cleavage event though one proteolytic products identified characterizing fragments may clarify issue sequence specificity single val leu change prevents proteolysis notch transmembrane region 60 whereas variety mutations app transmembrane region tolerated secretase examination proteolytic events purified enzyme assays may offer insights resolve problem especially since recent data suggest app also notch endoproteolysis occurs largely independent sequence 79 biochemical evidence presenilins proteases top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	25	advancing understanding secretase role presenilins activity hampered lack isolated enzyme assay recently li et al 80 reported solubilized secretase assay faithfully reproduces properties protease activity observed whole cells isolated microsomes solubilized detergent secretase activity determined measuring production flag tagged version c99 a40 a42 produced ratio seen living cells 91 peptidomimetics blocked a40 a42 formation cells likewise inhibited production species solubilized protease assay separation detergent solubilized material size exclusion chromatography secretase activity coeluted two subunits ps1 remarkably immunoprecipitated ps1 heterodimers also produced flag tagged substrate strongly suggesting presenilins part large secretase complex
0.44692016.11134059.html.plaintext.txt	26	direct evidence presenilins catalytic components secretases recently come affinity labeling studies using transition state analogue inhibitors targeted active site protease shearman et al 80 81 identified peptidomimetic blocks secretase activity ic50 03 nm solubilized protease assay contains hydroxyethyl isostere transition state mimicking moiety found many aspartyl protease inhibitors transition state mimicking alcohol directs compound aspartyl proteases flanking substructures determine specificity photoactivatable versions compound bound covalently presenilin subunits exclusively 82 interestingly installation photoreactive group one end inhibitor led labeling n terminal presenilin subunit whereas installation end resulted tagging c terminal subunit moreover whereas agents label wild type ps1 holoprotein tag ps1 e9 described processed heterodimers nevertheless active similarly esler et al 83 identified peptidomimetic inhibitors containing difluoro alcohol group another type transition state mimicking moiety compounds developed starting substrate based inhibitor designed secretase cleavage site app conversion one analogue reactive bromoacetamide provided affinity reagent likewise bound covalently specifically ps1 subunits cell lysates isolated microsomes whole cells either ps1 subunit labeled could brought antibodies subunit coimmunoprecipitation conditions demonstrating inhibitor bound heterodimeric ps1 seiffert colleagues 84 likewise identified presenilin subunits molecular target novel peptidomimetic secretase inhibitors inhibitors however resemble known transition state mimics clear whether would expected bind active site protease
0.44692016.11134059.html.plaintext.txt	27	taken together results strongly suggest heterodimeric presenilins contain catalytic component secretase inhibitors two three studies transition state analogues targeted active site active site likely ps heterodimeric interface subunits labeled secretase affinity reagents contributes one critical aspartate affinity labeling studies also identify protease responsible transmembrane cleavage notch substrate based secretase inhibitors like used esler et al 83 also block notch proteolysis see findings reinforce amyloid hypothesis ad pathogenesis fad causing mutations identified date accounting 60 fad cases either precursor protein leading app appear located proteases catalyze final step generation presenilins secretases time important target drug development identified although yet clear whether toxic effects blocking cleavage secretase substrates eg notch negate therapeutic effects although presenilins essential proper embryonic development role proteins aging adults known perspective top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	28	taken together results strongly suggest heterodimeric presenilins contain catalytic component secretase inhibitors two three studies transition state analogues targeted active site active site likely ps heterodimeric interface subunits labeled secretase affinity reagents contributes one critical aspartate affinity labeling studies also identify protease responsible transmembrane cleavage notch substrate based secretase inhibitors like used esler et al 83 also block notch proteolysis see findings reinforce amyloid hypothesis ad pathogenesis fad causing mutations identified date accounting 60 fad cases either precursor protein leading app appear located proteases catalyze final step generation presenilins secretases time important target drug development identified although yet clear whether toxic effects blocking cleavage secretase substrates eg notch negate therapeutic effects although presenilins essential proper embryonic development role proteins aging adults known perspective top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references
0.44692016.11134059.html.plaintext.txt	29	discovery presenilins likely secretases raises number fascinating questions respect protease biochemistry well protease evolution carry hydrolysis lipid environment transmembrane regions likely form pore channel like topography polar residues facing inward allow entry interaction catalytic water sequestered active site two dimensional fluidity lipid bilayer substrate probably first interacts binding site outer surface protease subsequent conformational changes allowing entry substrate active site within protease interior given conformation substrate upon initial interaction protease apparently helix enzyme must mechanism unwinding bending substrate near site cleavage catalytic water protease residues access scissile amide bond
0.44692016.11134059.html.plaintext.txt	30	discovery presenilins likely secretases raises number fascinating questions respect protease biochemistry well protease evolution carry hydrolysis lipid environment transmembrane regions likely form pore channel like topography polar residues facing inward allow entry interaction catalytic water sequestered active site two dimensional fluidity lipid bilayer substrate probably first interacts binding site outer surface protease subsequent conformational changes allowing entry substrate active site within protease interior given conformation substrate upon initial interaction protease apparently helix enzyme must mechanism unwinding bending substrate near site cleavage catalytic water protease residues access scissile amide bond
0.44692016.11134059.html.plaintext.txt	31	origin presenilins intramembrane cleaving proteases clips 85 seems likely certain polytopic integral membrane proteins acquired catalytic residues essential catalysis rather soluble proteases somehow acquired multiple transmembrane domains would explain polytopic membrane proteases bear little sequence homology soluble proteases instance s2p family proteases process membrane bound transcription factors mammals bacteria contains essential hexxh motif consensus sequence number metalloproteases 86 otherwise bear little resemblance metalloproteases similarly presenilins require two conserved aspartates proteolytic function otherwise look like typical aspartyl proteases apparently limited number efficient biochemical solutions problem proteolysis mechanisms conferred polytopic proteases strikingly similar soluble membrane tethered proteases interestingly presenilins contain motif near one critical aspartates also found bacterial type 4 prepilin protease family 50 87 polytopic aspartyl proteases also eight transmembrane domains require two completely conserved aspartates 88 finding supports idea presenilins may indeed polytopic aspartyl proteases
0.44692016.11134059.html.plaintext.txt	32	origin presenilins intramembrane cleaving proteases clips 85 seems likely certain polytopic integral membrane proteins acquired catalytic residues essential catalysis rather soluble proteases somehow acquired multiple transmembrane domains would explain polytopic membrane proteases bear little sequence homology soluble proteases instance s2p family proteases process membrane bound transcription factors mammals bacteria contains essential hexxh motif consensus sequence number metalloproteases 86 otherwise bear little resemblance metalloproteases similarly presenilins require two conserved aspartates proteolytic function otherwise look like typical aspartyl proteases apparently limited number efficient biochemical solutions problem proteolysis mechanisms conferred polytopic proteases strikingly similar soluble membrane tethered proteases interestingly presenilins contain motif near one critical aspartates also found bacterial type 4 prepilin protease family 50 87 polytopic aspartyl proteases also eight transmembrane domains require two completely conserved aspartates 88 finding supports idea presenilins may indeed polytopic aspartyl proteases
0.44692016.11134059.html.plaintext.txt	33	considerable work lies ahead understand presenilins secretases clearly top priority identify critical components secretase complex allowing reconstitution activity development purified enzyme assay assembly complex active secretase allow focused structural functional studies current approach expressing mutant proteins whole cells organisms also understanding 70 different fad mutations presenilins cause specific increases a42 production might shed light deleterious function skewed favor less noxious isoforms understanding suggest novel therapeutic approaches ad also undergird appreciation workings emerging class polytopic membrane proteases footnotes
0.44692016.11134059.html.plaintext.txt	34	considerable work lies ahead understand presenilins secretases clearly top priority identify critical components secretase complex allowing reconstitution activity development purified enzyme assay assembly complex active secretase allow focused structural functional studies current approach expressing mutant proteins whole cells organisms also understanding 70 different fad mutations presenilins cause specific increases a42 production might shed light deleterious function skewed favor less noxious isoforms understanding suggest novel therapeutic approaches ad also undergird appreciation workings emerging class polytopic membrane proteases footnotes
0.44692016.11134059.html.plaintext.txt	35	minireview reprinted 2001 minireview compendium available december 2001
0.44692016.11134059.html.plaintext.txt	36	correspondence may addressed e mail wolfecndbwhharvardedu
0.44692016.11134059.html.plaintext.txt	37	correspondence may addressed e mail chaasspbmmed uni muenchende
0.44692016.11134059.html.plaintext.txt	38	published jbc papers press december 29 2000 doi 101074jbcr000026200
0.44692016.11134059.html.plaintext.txt	39	abbreviations used ad alzheimers disease amyloid peptide app amyloid precursor protein fad familial ad ps presenilin tm transmembrane domain tace tumor necrosis factor converting enzyme nicd notch intracellular domain er endoplasmic reticulum
0.44692016.11134059.html.plaintext.txt	40	references top introduction familial alzheimers disease presenilins secretases presenilins notch biochemical evidence perspective references 1 selkoe d j 1999 nature 399 a23 31crossrefmedline order article via infotrieve 2 vassar r bennett b d babu khan kahn mendiaz e denis p teplow d b ross amarante p loeloff r et al 1999 science 286 735 741abstractfree full text 3 sinha anderson j p barbour r basi g caccavello r davis d doan m dovey h f frigon n hong j et al 1999 nature 402 537 540crossrefmedline order article via infotrieve 4 yan r bienkowski m j shuck m e miao h tory m c pauley m brashier j r stratman n c mathews w r buhl e et al 1999 nature 402 533 537crossrefmedline order article via infotrieve 5 hussain powell d howlett d r tew d g meek d chapman c gloger murphy k e southa c d ryan d m et al 1999 mol cell neurosci 14 419 427crossrefmedline order article via infotrieve 6 lin x koelsch g wu downs d dashti tang j 2000 proc natl acad sci u 97 1456 1460abstractfree full text 7 esch f keim p beattie e c blacher r w culwell r oltersdorf mcclure d ward p j 1990 science 248 1122 1124medline order article via infotrieve 8 lammich kojro e postina r gilbert pfeiffer r jasionowski m haass c fahrenholz f 1999 proc natl acad sci u 96 3922 3927abstractfree full text 9 buxbaum j d liu k n luo y slack j l stocking k l peschon j j johnson r castner b j cerretti d p black r 1998 j biol chem 273 27765 27767abstractfree full text 10 hardy j 1997 trends neurosci 20 154 159crossrefmedline order article via infotrieve 11 selkoe d j 1997 science 275 630 631free full text 12 citron m oltersdorf haass c mcconlogue l hung y seubert p vigo pelfrey c lieberburg selkoe d j 1992 nature 360 672 674crossrefmedline order article via infotrieve 13 suzuki n cheung cai x d odaka otvos l jr eckman c golde e younkin g 1994 science 264 1336 1340medline order article via infotrieve 14 tamaoka odaka ishibashi y usami m sahara n suzuki n nukina n mizusawa h shoji kanazawa mori h 1994 j biol chem 269 32721 32724abstractfree full text 15 jarrett j berger e p lansbury p jr 1993 biochemistry 32 4693 4697medline order article via infotrieve 16 iwatsubo odaka suzuki n mizusawa h nukina n ihara y 1994 neuron 13 45 53medline order article via infotrieve 17 sherrington r rogaev e liang y rogaeva e levesque g ikeda m chi h lin c li g holman k et al 1995 nature 375 754 760crossrefmedline order article via infotrieve 18 levy lahad e wasco w poorkaj p romano d m oshima j pettingell w h yu c e jondro p d schmidt d wang k et al 1995 science 269 973 977medline order article via infotrieve 19 borchelt d r thinakaran g eckman c b lee m k davenport f ratovitsky prada c m kim g seekins yager d et al 1996 neuron 17 1005 1013medline order article via infotrieve 20 citron m westaway d xia w carlson g diehl levesque g johnson wood k lee m seubert p davis et al 1997 nat med 3 67 72medline order article via infotrieve 21 tomita maruyama k saido c kume h shinozaki k tokuhiro capell walter j grunberg j haass c iwatsubo obata k 1997 proc natl acad sci u 94 2025 2030abstractfree full text 22 duff k eckman c zehr c yu x prada c m perez tur j hutton m buee l harigaya y yager d morgan d gordon m n holcomb l refolo l zenk b hardy j younkin 1996 nature 383 710 713crossrefmedline order article via infotrieve 23 scheuner d eckman c jensen m song x citron m suzuki n bird d hardy j hutton m kukull w et al 1996 nat med 2 864 870medline order article via infotrieve 24 de strooper b saftig p craessaerts k vanderstichele h guhde g annaert w von figura k van leuven f 1998 nature 391 387 390crossrefmedline order article via infotrieve 25 herreman serneels l annaert w collen d schoonjans l de strooper b 2000 nat cell biol 2 461 462crossrefmedline order article via infotrieve 26 zhang z nadeau p song w donoviel d yuan m bernstein yankner b 2000 nat cell biol 2 463 465crossrefmedline order article via infotrieve 27 wolfe m xia w moore c l leatherwood d d ostaszewski b donkor o selkoe d j 1999 biochemistry 38 4720 4727crossrefmedline order article via infotrieve 28 lichtenthaler f wang r grimm h uljon n masters c l beyreuther k 1999 proc natl acad sci u 96 3053 3058abstractfree full text 29 tischer e cordell b 1996 j biol chem 271 21914 21919abstractfree full text 30 maruyama k tomita shinozaki k kume h asada h saido c ishiura iwatsubo obata k 1996 biochem biophys res commun 227 730 735crossrefmedline order article via infotrieve 31 lichtenthaler f ida n multhaup g masters c l beyreuther k 1997 biochemistry 36 15396 15403crossrefmedline order article via infotrieve 32 citron m diehl gordon g biere l seubert p selkoe d j 1996 proc natl acad sci u 93 13170 13175abstractfree full text 33 klafki h abramowski d swoboda r paganetti p staufenbiel m 1996 j biol chem 271 28655 28659abstractfree full text 34 doan thinakaran g borchelt d r slunt h h ratovitsky podlisny m selkoe d j seeger m gandy e price d l sisodia 1996 neuron 17 1023 1030medline order article via infotrieve 35 li x greenwald 1996 neuron 17 1015 1021medline order article via infotrieve 36 li x greenwald 1998 proc natl acad sci u 95 7109 7114abstractfree full text 37 lehmann chiesa r harris d 1997 j biol chem 272 12047 12051abstractfree full text 38 dewji n n singer j 1997 proc natl acad sci u 94 14025 14030abstractfree full text 39 thinakaran g borchelt d r lee m k slunt h h spitzer l kim g ratovitsky davenport f nordstedt c seeger m et al 1996 neuron 17 181 190medline order article via infotrieve 40 capell grunberg j pesold b diehlmann citron m nixon r beyreuther k selkoe d j haass c 1998 j biol chem 273 3205 3211abstractfree full text 41 ratovitski slunt h h thinakaran g price d l sisodia borchelt d r 1997 j biol chem 272 24536 24541abstractfree full text 42 podlisny m b citron m amarante p sherrington r xia w zhang j diehl levesque g fraser p haass c et al 1997 neurobiol dis 3 325 337crossrefmedline order article via infotrieve 43 steiner h capell pesold b citron m kloetzel p m selkoe d j romig h mendla k haass c 1998 j biol chem 273 32322 32331abstractfree full text 44 ray w j yao m mumm j schroeter e h saftig p wolfe m selkoe d j kopan r goate m 1999 j biol chem 274 36801 36807abstractfree full text 45 thinakaran g harris c l ratovitski davenport f slunt h h price d l borchelt d r sisodia 1997 j biol chem 272 28415 28422abstractfree full text 46 steiner h romig h grim m g philipp u pesold b citron m baumeister r haass c 1999 j biol chem 274 7615 7618abstractfree full text 47 zhang j kang d e xia w okochi m mori h selkoe d j koo e h 1998 j biol chem 273 12436 12442abstractfree full text 48 yu g chen f nishimura m steiner h tandon kawarai arawaka supala song y q rogaeva e et al 2000 j biol chem 275 27348 27353abstractfree full text 49 steiner h romig h pesold b philipp u baader m citron m loetscher h jacobsen h haass c 1999 biochemistry 38 14600 14605crossrefmedline order article via infotrieve 50 steiner h kostka m romig h basset g pesold b hardy j capell meyn l grim m g baumeister r fechteler k haass c 2000 nat cell biol 2 848 851crossrefmedline order article via infotrieve 51 wolfe m xia w ostaszewski b l diehl kimberly w selkoe d j 1999 nature 398 513 517crossrefmedline order article via infotrieve 52 leimer u lun k romig h walter j grunberg j brand m haass c 1999 biochemistry 38 13602 13609crossrefmedline order article via infotrieve 53 kimberly w xia w rahmati wolfe m selkoe d j 2000 j biol chem 275 3173 3178abstractfree full text 54 steiner h duff k capell romig h grim m g lincoln hardy j yu x picciano m fechteler k et al 1999 j biol chem 274 28669 28673abstractfree full text 55 capell steiner h romig h keck baader m grim m g baumeister r haass c 2000 nat cell biol 2 205 211crossrefmedline order article via infotrieve 56 okochi m eimer bottcher baumeister r romig h walter j capell steiner h haass c 2000 j biol chem 275 40925 40932abstractfree full text 57 artavanis tsakonas rand m d lake r j 1999 science 284 770 776abstractfree full text 58 brou c logeat f gupta n bessia c lebail o doedens j r cumano roux p black r israel 2000 mol cell 5 207 216medline order article via infotrieve 59 mumm j schroeter e h saxena m griesemer tian x pan d j ray w j kopan r 2000 mol cell 5 197 206medline order article via infotrieve 60 schroeter e h kisslinger j kopan r 1998 nature 393 382 386crossrefmedline order article via infotrieve 61 huppert le schroeter e h mumm j saxena m milner l kopan r 2000 nature 405 966 970crossrefmedline order article via infotrieve 62 wong p c zheng h chen h becher m w sirinathsinghji d j trumbauer m e chen h y price d l van der ploeg l h sisodia 1997 nature 387 288 292crossrefmedline order article via infotrieve 63 shen j bronson r chen d f xia w selkoe d j tonegawa 1997 cell 89 629 639medline order article via infotrieve 64 herreman hartmann d annaert w saftig p craessaerts k serneels l umans l schrijvers v checler f vanderstichele h et al 1999 proc natl acad sci u 96 11872 11877abstractfree full text 65 donoviel d b hadjantonakis k ikeda m zheng h hyslop p bernstein 1999 genes dev 13 2801 2810abstractfree full text 66 de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 398 518 522crossrefmedline order article via infotrieve 67 berezovska o jack c mclean p aster j c hicks c xia w wolfe m kimberly w weinmaster g selkoe d j hyman b 2000 j neurochem 75 583 593crossrefmedline order article via infotrieve 68 annaert w g levesque l craessaerts k dierinck snellings g westaway d george hyslop p cordell b fraser p de strooper b 1999 j cell biol 147 277 294abstractfree full text 69 haass c koo e h mellon hung y selkoe d j 1992 nature 357 500 503crossrefmedline order article via infotrieve 70 higaki j quon d zhong z cordell b 1995 neuron 14 651 659medline order article via infotrieve 71 hartmann bieger c bruhl b tienari p j ida n allsop d roberts g w masters c l dotti c g unsicker k beyreuther k 1997 nat med 3 1016 1020medline order article via infotrieve 72 cook d g forman m sung j c leight kolson d l iwatsubo lee v m doms r w 1997 nat med 3 1021 1023medline order article via infotrieve 73 perez r g soriano hayes j d ostaszewski b xia w selkoe d j chen x stokin g b koo e h 1999 j biol chem 274 18851 18856abstractfree full text 74 wild bode c yamazaki capell leimer u steiner h ihara y haass c 1997 j biol chem 272 16085 16088abstractfree full text 75 xia w zhang j perez r koo e h selkoe d j 1997 proc natl acad sci u 94 8208 8213abstractfree full text 76 weidemann paliga k durrwang u czech c evin g masters c l beyreuther k 1997 nat med 3 328 332medline order article via infotrieve 77 ray w j yao m nowotny p mumm j zhang w wu j y kopan r goate m 1999 proc natl acad sci u 96 3263 3268abstractfree full text 78 xia w ray w j ostaszewski b l rahmati kimberly w wolfe m zhang j goate m selkoe d j 2000 proc natl acad sci u 97 9299 9304abstractfree full text 79 struhl g adachi 2000 mol cell 6 625 636medline order article via infotrieve 80 li y m lai m xu m huang q dimuzio mower j sardana m k shi x p yin k c shafer j gardell j 2000 proc natl acad sci u 97 6138 6143abstractfree full text 81 shearman m beher d clarke e e lewis h d harrison hunt p nadin smith l stevenson g castro j l 2000 biochemistry 39 8698 8704crossrefmedline order article via infotrieve 82 li y m xu m lai m huang q castro j l dimuzio mower j harrison lellis c nadin neduvelil j g register r b sardana m k shearman m smith l shi x p yin k c shafer j gardell j 2000 nature 405 689 694crossrefmedline order article via infotrieve 83 esler w p kimberly w ostaszewski b l diehl moore c l tsai j y rahmati xia w selkoe d j wolfe m 2000 nat cell biol 2 428 434crossrefmedline order article via infotrieve 84 seiffert d bradley j d rominger c m rominger d h yang f meredith j e jr wang q roach h thompson l spitz m et al 2000 j biol chem 275 34086 34091abstractfree full text 85 wolfe m de los angeles j miller d d xia w selkoe d j 1999 biochemistry 38 11223 11230crossrefmedline order article via infotrieve 86 rawson r b zelenski n g nijhawan d ye j sakai j hasan m chang y brown m goldstein j l 1997 mol cell 1 47 57medline order article via infotrieve 87 steiner h haass c 2001 nat rev mol cell biol press 88 lapointe c f taylor r k 2000 j biol chem 275 1502 1510abstractfree full text
0.44692016.11134059.html.plaintext.txt	41	copyright 2001 american society biochemistry molecular biology inc
0.45364788.15322109.html.plaintext.txt	0	sequence length c terminus pen 2 critical intermolecular interactions function presenilin complexes hiroshi hasegawa nobuo sanjo fusheng chen yong jun gu cortney shier agnes petit toshitaka kawarai taiichi katayama stephen d schmidt paul m mathews gerold schmitt ulms paul e fraser peter st george hyslop
0.45364788.15322109.html.plaintext.txt	1	centre research neurodegenerative diseases university toronto west toronto ontario m5s 3h2 canada new york university medical centernathan kline institute new york new york 10962 department medicine medical biophysics university toronto west toronto ontario m5s 3h2 canada department medicine division neurology university health networktoronto western hospital toronto ontario m5s 3h2 canada
0.45364788.15322109.html.plaintext.txt	2	received publication june 7 2004 revised form august 10 2004
0.45364788.15322109.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references presenilin 1 presenilin 2 nicastrin aph 1 pen 2 form high molecular weight complexes play pivotal role cleavage various type transmembrane proteins including amyloid precursor protein specific function pen 2 unclear explore function intermolecular interactions conducted deletion mutagenesis studies series conserved residues c terminus pen 2 studies suggest 1 presence amino acid sequence conserved dylsf domain c terminus pen 2 residues 90 94 critical binding pen 2 components presenilin complex 2 overall length exposed c terminus critical functional secretase activity
0.45364788.15322109.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references presenilin 1 presenilin 2 nicastrin aph 1 pen 2 form high molecular weight complexes play pivotal role cleavage various type transmembrane proteins including amyloid precursor protein specific function pen 2 unclear explore function intermolecular interactions conducted deletion mutagenesis studies series conserved residues c terminus pen 2 studies suggest 1 presence amino acid sequence conserved dylsf domain c terminus pen 2 residues 90 94 critical binding pen 2 components presenilin complex 2 overall length exposed c terminus critical functional secretase activity
0.45364788.15322109.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references presenilin proteins ps1 ps2 evolutionarily conserved polytopic transmembrane proteins required regulated intramembranous proteolysis several type 1 transmembrane proteins including amyloid precursor protein app1 notch receptor p75 1 4 several different lines evidence revealed presenilins form high molecular weight complexes least three proteins aph 1 pen 2 nicastrin 5 9 proteins required functional intramembranous proteolytic activity 10 result null mutations suppression expression genes results loss regulated intramembranous endoproteolysis app termed secretase cleavage notch termed s3 cleavage type 1 transmembrane protein substrates conversely clinical missense mutations ps1 ps2 associated familial alzheimers disease 11 12 selected experimental missense mutations nicastrin 6 alter presenilin dependent secretase cleavage app leading overproduction longer proteolytic derivatives app termed amyloid peptide
0.45364788.15322109.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references presenilin proteins ps1 ps2 evolutionarily conserved polytopic transmembrane proteins required regulated intramembranous proteolysis several type 1 transmembrane proteins including amyloid precursor protein app1 notch receptor p75 1 4 several different lines evidence revealed presenilins form high molecular weight complexes least three proteins aph 1 pen 2 nicastrin 5 9 proteins required functional intramembranous proteolytic activity 10 result null mutations suppression expression genes results loss regulated intramembranous endoproteolysis app termed secretase cleavage notch termed s3 cleavage type 1 transmembrane protein substrates conversely clinical missense mutations ps1 ps2 associated familial alzheimers disease 11 12 selected experimental missense mutations nicastrin 6 alter presenilin dependent secretase cleavage app leading overproduction longer proteolytic derivatives app termed amyloid peptide
0.45364788.15322109.html.plaintext.txt	7	pen 2 presenilin enhancer 2 initially identified genetic screen modifiers presenilin homologues caenorhabditis elegans sel 12 hop 1 8 subsequent studies confirmed component high molecular weight presenilin complexes presence within complexes necessary maturation activity 8 13 14 thus loss pen 2 activity associated reduced presenilin levels 8 15 16 reduced presenilin endoproteolysis 13 17 18 loss regulated intramembranous proteolytic s3 cleavage activity 8 analysis primary amino acid sequence pen 2 provides clue function however protein predicted two hydrophobic transmembrane domains 19 20 also series residues hydrophilic c terminus residues 90 101 conserved evolution hypothesize functionally important see fig 1a support one three naturally occurring loss function mutants c elegans stop codon mutation residue trp74 truncates protein near beginning c terminal hydrophilic loop 8 see fig 1 explore hypothesis investigated functional effects mutations c terminal domain data indicate overall length exposed c terminus pen 2 sequence highly conserved dylsf motif within domain important binding pen 2 components presenilin complex proper function complexes nct maturation presenilin endoproteolysis secretion
0.45364788.15322109.html.plaintext.txt	8	pen 2 presenilin enhancer 2 initially identified genetic screen modifiers presenilin homologues caenorhabditis elegans sel 12 hop 1 8 subsequent studies confirmed component high molecular weight presenilin complexes presence within complexes necessary maturation activity 8 13 14 thus loss pen 2 activity associated reduced presenilin levels 8 15 16 reduced presenilin endoproteolysis 13 17 18 loss regulated intramembranous proteolytic s3 cleavage activity 8 analysis primary amino acid sequence pen 2 provides clue function however protein predicted two hydrophobic transmembrane domains 19 20 also series residues hydrophilic c terminus residues 90 101 conserved evolution hypothesize functionally important see fig 1a support one three naturally occurring loss function mutants c elegans stop codon mutation residue trp74 truncates protein near beginning c terminal hydrophilic loop 8 see fig 1 explore hypothesis investigated functional effects mutations c terminal domain data indicate overall length exposed c terminus pen 2 sequence highly conserved dylsf motif within domain important binding pen 2 components presenilin complex proper function complexes nct maturation presenilin endoproteolysis secretion
0.45364788.15322109.html.plaintext.txt	9	view larger version 33k fig 1 alignment pen 2 proteins transmembrane domains indicated underlining arrowheads arrows indicate truncated positions series deletion mutants conserved residues among last six residues b schematic structure wild type series large deletion mutants c mutants dylsf domains substituted alanines underlined d schematic structure aaa ipg kdas deletion mutant residues 100 101 wt wild type
0.45364788.15322109.html.plaintext.txt	10	experimental procedures top abstract introduction experimental procedures results discussion references construction expression plasmids stable cells cdna clone encoding human wild type pen 2 generated pcr human brain cdna library using cdna template constructs encoding n terminal v5 tagged wild type mutant pen 2 obtained pcr using 5 gaattccagctatgggtaagcctatccctaaccctctcctcggtctcgattctacgaacctggagcgagtgtccaat 3 forward primer 5 ctcgagctcagggggtgcccaggggtat 3 wild type pen 2 5 ctcgagctcaccggtagatctggaagat 3 del84 101 5 ctcgagctcacccaagggcaccccagcg 3 del90 101 5 ctcgagctcaggtgaaggagaggtagtc 3 del96 101 reverse primer mutagenesis primers 5 cgctggggtgcccttggggccgccgccgccgccaccatacccctgggcaccccctgactcgag 3 5 cgctggcctgcccttgggaccatacccctgggcaccccctgactcgag 3 used generation constructs encoding aaaaa del90 94 respectively agreement previous reports 8 16 preliminary experiments data shown revealed pen 2 expressed vector included c terminal mychis tag resultant c terminally tagged pen 2 protein stable fully functionally active consequently constructs tagged v5 n terminus following direct sequence verification ligated expression vector pcdna4 invitrogen n terminal v5 tag partially interferes recognition epitope residues 1 26 however transient transfection n terminal v5 tagged wild type pen 2 constructs cells pen 2 expression suppressed rnai see confirmed v5 tagged protein expressed fully complemented loss endogenous pen 2 resulting restoration ps1 endoproteolysis nicastrin maturation production hek293 cells stably expressing appswe transfected plasmids empty vector negative control using lipofectamine invitrogen stable transfectant cells selected 150 microgml zeocin stable pen 2 knock cell line oligonucleotides pen 2 160 180 ligated psup vector oligoengine per manufacturers instruction confirming sequence psuppen 2 160 180 pcdna6v5 vector invitrogen stably transfected hek293 clone stably expressing appswe using lipofectamine selected blasticidin 10 microgml rescue analysis cdna sequence constructs corresponding pen 2 160 180 mutated without changing amino acid sequence using mutagenesis primer 5 gaacagagccaaatcaaaggttacgtatggcgctcagctgtgggcttcctcttc 3 cdna constructs also validated direct nucleotide sequencing
0.45364788.15322109.html.plaintext.txt	11	experimental procedures top abstract introduction experimental procedures results discussion references construction expression plasmids stable cells cdna clone encoding human wild type pen 2 generated pcr human brain cdna library using cdna template constructs encoding n terminal v5 tagged wild type mutant pen 2 obtained pcr using 5 gaattccagctatgggtaagcctatccctaaccctctcctcggtctcgattctacgaacctggagcgagtgtccaat 3 forward primer 5 ctcgagctcagggggtgcccaggggtat 3 wild type pen 2 5 ctcgagctcaccggtagatctggaagat 3 del84 101 5 ctcgagctcacccaagggcaccccagcg 3 del90 101 5 ctcgagctcaggtgaaggagaggtagtc 3 del96 101 reverse primer mutagenesis primers 5 cgctggggtgcccttggggccgccgccgccgccaccatacccctgggcaccccctgactcgag 3 5 cgctggcctgcccttgggaccatacccctgggcaccccctgactcgag 3 used generation constructs encoding aaaaa del90 94 respectively agreement previous reports 8 16 preliminary experiments data shown revealed pen 2 expressed vector included c terminal mychis tag resultant c terminally tagged pen 2 protein stable fully functionally active consequently constructs tagged v5 n terminus following direct sequence verification ligated expression vector pcdna4 invitrogen n terminal v5 tag partially interferes recognition epitope residues 1 26 however transient transfection n terminal v5 tagged wild type pen 2 constructs cells pen 2 expression suppressed rnai see confirmed v5 tagged protein expressed fully complemented loss endogenous pen 2 resulting restoration ps1 endoproteolysis nicastrin maturation production hek293 cells stably expressing appswe transfected plasmids empty vector negative control using lipofectamine invitrogen stable transfectant cells selected 150 microgml zeocin stable pen 2 knock cell line oligonucleotides pen 2 160 180 ligated psup vector oligoengine per manufacturers instruction confirming sequence psuppen 2 160 180 pcdna6v5 vector invitrogen stably transfected hek293 clone stably expressing appswe using lipofectamine selected blasticidin 10 microgml rescue analysis cdna sequence constructs corresponding pen 2 160 180 mutated without changing amino acid sequence using mutagenesis primer 5 gaacagagccaaatcaaaggttacgtatggcgctcagctgtgggcttcctcttc 3 cdna constructs also validated direct nucleotide sequencing
0.45364788.15322109.html.plaintext.txt	12	antibodies following antibodies used study anti pen 2 antibody gift dr thinakaran 17 anti v5 antibody invitrogen anti ps1 n terminal antibody ab14 anti myc antibody invitrogen anti app c terminal antibody residues 676 695 app695 sigma anti app n terminal antibody residues 99 126 app chemicon anti app c terminal antibody 6e10 signet anti aph 1 1 antibody 21 anti nicastrin antibody sigma anti calnexin antibody transduction laboratories anti gm130 antibody transduction laboratories enzyme linked immunosorbent assay studies used antibodies jrfca4010 jrfca4226 jrfatot1 gifts dr marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.45364788.15322109.html.plaintext.txt	13	antibodies following antibodies used study anti pen 2 antibody gift dr thinakaran 17 anti v5 antibody invitrogen anti ps1 n terminal antibody ab14 anti myc antibody invitrogen anti app c terminal antibody residues 676 695 app695 sigma anti app n terminal antibody residues 99 126 app chemicon anti app c terminal antibody 6e10 signet anti aph 1 1 antibody 21 anti nicastrin antibody sigma anti calnexin antibody transduction laboratories anti gm130 antibody transduction laboratories enzyme linked immunosorbent assay studies used antibodies jrfca4010 jrfca4226 jrfatot1 gifts dr marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.45364788.15322109.html.plaintext.txt	14	immunoprecipitation membrane fractions isolated hek293 cells lysed 1 chapso sigma buffer containing 10 glycerol preclearing protein sepharose cl 4b amersham biosciences 1 h cell lysates incubated appropriate antibody immunoprecipitants recovered overnight incubation 4 degrees c protein sepharose cl 4b beads washed three times 1 chapso buffer
0.45364788.15322109.html.plaintext.txt	15	immunoprecipitation membrane fractions isolated hek293 cells lysed 1 chapso sigma buffer containing 10 glycerol preclearing protein sepharose cl 4b amersham biosciences 1 h cell lysates incubated appropriate antibody immunoprecipitants recovered overnight incubation 4 degrees c protein sepharose cl 4b beads washed three times 1 chapso buffer
0.45364788.15322109.html.plaintext.txt	16	cycloheximide treatment stable transfectants empty vector wild type mutant pen 2 constructs incubated presence cycloheximide 30 microgml 6 12 24 h analyzed immunoblotting anti v5 anti pen 2 antibodies
0.45364788.15322109.html.plaintext.txt	17	gradient centrifugation subcellular fractionation membrane fractions isolated hek293 cells described previously 22 applied step gradient consisting 1 ml 30 25 20 15 125 10 75 5 25 vv iodixanol accurate centrifugation 08 ml fractions collected analyzed western blotting specific marker proteins endoplasmic reticulum calnexin golgi gm130 detected using monoclonal antibodies
0.45364788.15322109.html.plaintext.txt	18	assays a40 a42 measured described enzyme linked immunosorbent assay 23 24 using conditioned medium collected pen 2 knock hek293 cells transiently transfected either wild type pen 2 mutant pen 2 empty vector control values a40 a42 compared students test dylsf mutants represent population related mutants fully independent analyzed mutations involving dylsf domain including deletion mutants single population avoid risk false positive results arising multiple comparisons aaa ipg del96 101 kdas del100 101 mutants individually compared wild type pen 2 represent small number tests different hypothesis length c terminus critical
0.45364788.15322109.html.plaintext.txt	19	assays a40 a42 measured described enzyme linked immunosorbent assay 23 24 using conditioned medium collected pen 2 knock hek293 cells transiently transfected either wild type pen 2 mutant pen 2 empty vector control values a40 a42 compared students test dylsf mutants represent population related mutants fully independent analyzed mutations involving dylsf domain including deletion mutants single population avoid risk false positive results arising multiple comparisons aaa ipg del96 101 kdas del100 101 mutants individually compared wild type pen 2 represent small number tests different hypothesis length c terminus critical
0.45364788.15322109.html.plaintext.txt	20	results top abstract introduction experimental procedures results discussion references functional domain analysis explore function conserved residues c terminus pen 2 initially created three overlapping deletion mutants del84 101 del90 101 del96 101 fig 1b cdnas stably transfected hek293 cells stably expressing appswe produced proteins expected molecular weight fig 2a top panel immunoprecipitation ps1 revealed wild type exogenous v5 tagged pen 2 co precipitated ps1 fig 2b panel 1 wild type v5 tagged pen 2 protein also displaced endogenous pen 2 fig 2 panel 2 b panel 2 note n terminal v5 tag partially interferes recognition epitope residues 1 26 v5 tagged endogenous pen 2 peptides easily distinguished differential affinities anti v5 antibodies antibody residues 1 26 pen 2 note also interference anti pen 2 antibody recognition sequence functional effect transient transfection n terminal v5 tagged wild type pen 2 constructs cells endogenous pen 2 expression suppressed rnai see fully complemented loss endogenous pen 2 resulting restoration ps1 endoproteolysis nicastrin maturation production contrast mutant pen 2 deletion residue 96 del96 101 moderately reduced binding exogenous pen 2 ps1 nicastrin aph 1 able partially displace endogenous pen 2 however deletion residues 84 101 90 101 dramatically reduced amount exogenous pen 2 co precipitated ps1 fig 2b panel 1 furthermore overexpressed deletion mutant pen 2 molecules bind ps1 fig 2b panel 1 also failed displace endogenous pen 2 fig 2a panel 2 therefore continued interact co precipitate ps1 fig 2b panel 2 would predicted del84 101 del90 101 co precipitate either aph 1 nicastrin fig 2b panels 4 5 observations suggest c terminus particular residues 90 96 contain highly conserved dylsf motif may either 1 essential stability pen 2 2 essential proper trafficking pen 2 3 involved binding pen 2 components presenilin complex
0.45364788.15322109.html.plaintext.txt	21	view larger version 55k fig 2 expression levels components presenilin complex wild type mutant pen 2 stable transfectant lane 1 mock lane 2 wild type lane 3 del84 101 lane 4 del90 101 lane 5 del96 101 endogenous pen 2 wild type del96 101 pen 2 transfected cells significantly reduced cell lysates panel 2 whereas presenilin panels 3 4 aph 1 panel 5 app panels 6 7 unchanged b binding presenilin panels 1 3 aph 1 panel 4 nicastrin panel 5 del84 101 del90 101 significantly reduced whereas binding del96 101 affected much binding ps1 endogenous pen 2 panel 2 compensates failure binding mutant pen 2 panel 1 del84 101 del90 101 ip immunoprecipitation
0.45364788.15322109.html.plaintext.txt	22	explore whether mutants caused destabilization pen 2 assessed cellular pen 2 levels following cycloheximide blockade protein synthesis hek293 cells endogenous pen 2 wild type pen 2 tagged n terminus del96 101 mutant constructs equivalent stability half life 9 10 h fig 3 contrast del84 101 del90 101 deletion mutants highly unstable half life approximately 4 h result surprising del84 101 del90 101 molecules incorporated presenilin complexes therefore stabilized however also possible proteins might intrinsically unstable simply degraded interact components presenilin complexes exclude possibility transiently expressed v5 tagged wild type mutant pen 2 peptides ps1 ps2 double knock es cells stabilizing influence presenilin complexes present thereby allowing direct comparison intrinsic stability wild type deletion mutant peptides ps1ps2 double knock es cells stability transiently expressed wild type mutant pen 2 proteins equivalently reduced less 4 h confirming mutant pen 2 proteins intrinsically unstable data shown
0.45364788.15322109.html.plaintext.txt	23	explore whether mutants caused destabilization pen 2 assessed cellular pen 2 levels following cycloheximide blockade protein synthesis hek293 cells endogenous pen 2 wild type pen 2 tagged n terminus del96 101 mutant constructs equivalent stability half life 9 10 h fig 3 contrast del84 101 del90 101 deletion mutants highly unstable half life approximately 4 h result surprising del84 101 del90 101 molecules incorporated presenilin complexes therefore stabilized however also possible proteins might intrinsically unstable simply degraded interact components presenilin complexes exclude possibility transiently expressed v5 tagged wild type mutant pen 2 peptides ps1 ps2 double knock es cells stabilizing influence presenilin complexes present thereby allowing direct comparison intrinsic stability wild type deletion mutant peptides ps1ps2 double knock es cells stability transiently expressed wild type mutant pen 2 proteins equivalently reduced less 4 h confirming mutant pen 2 proteins intrinsically unstable data shown
0.45364788.15322109.html.plaintext.txt	24	view larger version 30k fig 3 deletion tagging c terminus accelerate degradation pen 2 proteins stable transfectants expressing mock panel 1 wild type pen 2 tagged n terminus panel 2 wild type pen 2 tagged c terminus panel 3 del84 101 panel 4 del90 101 panel 5 del96 101 panel 6 treated cycloheximide indicated time 0 6 12 24 h endogenous exogenous pen 2 total cell lysates analyzed wt wild type
0.45364788.15322109.html.plaintext.txt	25	explore whether mutants caused mistrafficking pen 2 investigated subcellular distribution endogenous exogenous pen 2 using biochemical fractionation iodixanol gradients study revealed endogenous pen 2 predominantly located intracellular membrane structures especially endoplasmic reticulum colocalizing calnexin golgi network co localizing gm130 fig 4 panel 3 distributions exogenous v5 tagged wild type pen 2 well del84 101 del90 101 del96 101 mutants essentially identical slightly shifted regard distribution endogenous wild type pen 2 presence additional v5 tag andor modest overexpression fig 4 panels 4 7
0.45364788.15322109.html.plaintext.txt	26	explore whether mutants caused mistrafficking pen 2 investigated subcellular distribution endogenous exogenous pen 2 using biochemical fractionation iodixanol gradients study revealed endogenous pen 2 predominantly located intracellular membrane structures especially endoplasmic reticulum colocalizing calnexin golgi network co localizing gm130 fig 4 panel 3 distributions exogenous v5 tagged wild type pen 2 well del84 101 del90 101 del96 101 mutants essentially identical slightly shifted regard distribution endogenous wild type pen 2 presence additional v5 tag andor modest overexpression fig 4 panels 4 7
0.45364788.15322109.html.plaintext.txt	27	view larger version 16k fig 4 deletion c terminus change subcellular distribution total cell lysates stable transfectants expressing mock panel 3 wild type pen 2 tagged n terminus panel 4 del84 101 panel 5 del90 101 panel 6 del96 101 panel 7 fractionated iodixanol gradient fractionation lane 1 25 lane 11 30 gm130 panel 1 calnexin panel 2 used marker protein golgi apparatus endoplasmic reticulum respectively
0.45364788.15322109.html.plaintext.txt	28	previous studies suggested pen 2 plays role presenilin endoproteolysis nicastrin maturation generation 8 13 15 18 several mutants described even stably overexpressed unable displace endogenous pen 2 functional complexes result impossible measure functional properties pen 2 mutants cells expressing endogenous pen 2 circumvent problem created pen 2 knock cells stable expression pen 2 sirna pen 2 knock cells endogenous pen 2 protein moderately clone 10 severely depleted clones 13 17 19 fig 5 top panel agreement previously reported studies using transient sirna expression pen 2 16 18 pen 2 stable knock cells showed significant accumulations immature glycosylated nicastrin fig 5 panel 2 full length ps1 fig 5 panel 3 app ctf fig 5 panel 6 pen 2 knock cells also showed significant reductions amount mature ps1 ntf reductions ps1 ntf levels proportion degree depletion pen 2 expected previous work showing aph 1 stable initial scaffolding molecule 21 aph 1 fig 5 panel 4 full length app fig 5 panel 5 affected pen 2 knockdown however secretion significantly reduced compared mock cells fig 5 panel 7
0.45364788.15322109.html.plaintext.txt	29	previous studies suggested pen 2 plays role presenilin endoproteolysis nicastrin maturation generation 8 13 15 18 several mutants described even stably overexpressed unable displace endogenous pen 2 functional complexes result impossible measure functional properties pen 2 mutants cells expressing endogenous pen 2 circumvent problem created pen 2 knock cells stable expression pen 2 sirna pen 2 knock cells endogenous pen 2 protein moderately clone 10 severely depleted clones 13 17 19 fig 5 top panel agreement previously reported studies using transient sirna expression pen 2 16 18 pen 2 stable knock cells showed significant accumulations immature glycosylated nicastrin fig 5 panel 2 full length ps1 fig 5 panel 3 app ctf fig 5 panel 6 pen 2 knock cells also showed significant reductions amount mature ps1 ntf reductions ps1 ntf levels proportion degree depletion pen 2 expected previous work showing aph 1 stable initial scaffolding molecule 21 aph 1 fig 5 panel 4 full length app fig 5 panel 5 affected pen 2 knockdown however secretion significantly reduced compared mock cells fig 5 panel 7
0.45364788.15322109.html.plaintext.txt	30	view larger version 52k fig 5 pen 2 knock cells fail nct maturation ps endoproteolysis secretion resulting accumulation app ctf mock clones 3 5 pen 2 knock cells clones 10 13 17 19 pen 2 nct ps1 aph 1 app secretion analyzed panels 1 7 respectively
0.45364788.15322109.html.plaintext.txt	31	assess interaction pen 2 deletion mutants del84 101 del90 101 del96 101 nicastrin presenilins aph 1 absence interference endogenous pen 2 transiently expressed deletion mutants pen 2 knock cells expected initial immunoprecipitation experiments reported del84 101 del90 101 mutants bound poorly presenilin components even absence endogenous pen 2 fig 6 lanes 3 4 agreement results reported binding del96 101 mutant nicastrin ps1 aph 1 reduced less severely binding del84 101 del90 101 mutants explore sequence specificity apparently important conserved dylsf domain residues 90 94 created deletion mutant del90 94 series missense mutations either single residues two residues five residues within 90 94 domain mutated alanine fig 1c repeated co immunoprecipitation studies deletion residues 90 94 missense mutation five residues alanine caused dramatic reduction interaction presenilin 1 nicastrin aph 1 fig 6 lanes 10 11 contrast mutation single residue two residues variable generally less severe effects interaction pen 2 components measured co immunoprecipitation fig 6 lanes 6 9
0.45364788.15322109.html.plaintext.txt	32	assess interaction pen 2 deletion mutants del84 101 del90 101 del96 101 nicastrin presenilins aph 1 absence interference endogenous pen 2 transiently expressed deletion mutants pen 2 knock cells expected initial immunoprecipitation experiments reported del84 101 del90 101 mutants bound poorly presenilin components even absence endogenous pen 2 fig 6 lanes 3 4 agreement results reported binding del96 101 mutant nicastrin ps1 aph 1 reduced less severely binding del84 101 del90 101 mutants explore sequence specificity apparently important conserved dylsf domain residues 90 94 created deletion mutant del90 94 series missense mutations either single residues two residues five residues within 90 94 domain mutated alanine fig 1c repeated co immunoprecipitation studies deletion residues 90 94 missense mutation five residues alanine caused dramatic reduction interaction presenilin 1 nicastrin aph 1 fig 6 lanes 10 11 contrast mutation single residue two residues variable generally less severe effects interaction pen 2 components measured co immunoprecipitation fig 6 lanes 6 9
0.45364788.15322109.html.plaintext.txt	33	view larger version 19k fig 6 binding pen 2 components severely disturbed del84 101 del90 101 aaaaa del90 94 mutants moderately del96 101 del100 101 mutants using pen 2 knock cells transiently transfected mock wild type del84 101 del90 101 del96 101 aylsf dalsa eylsf dyaaf aaaaa del90 94 aaa ipg del100 101lanes 1 11 14 15 pulled pen 2 anti ps anti nct anti aph 1 antibody analyzed lane 16 negative control using normal rabbit serum bottom panel shows expression level wild type mutant pen 2 wt wild type ip immunoprecipitation
0.45364788.15322109.html.plaintext.txt	34	assess functional properties pen 2 mutants next examined ability rescue presenilin complex formation maturation pen 2 knock cells transient transfection wild type pen 2 pen 2 knock cells significantly rescued nicastrin maturation ps endoproteolysis secretion fig 7 panels 1 2 5 associated slight reduction app ctf fig 7 panel 4 contrast transient expression aaaaa poly substitution residues 90 94 fig 7 del84 101 fig 8 del90 94 fig 7 del90 101 fig 8 deletion mutants bind efficiently presenilin complex components little ability rescue presenilin complex maturation andor secretion fig 7 panels 1 2 5 sapp unchanged cells fig 7 panel 6 indicating mutants altered app maturation trafficking cleavage secretase effects robust replicated three independent pen 2 knockdown cells contrast profound loss function effects aaaaa del90 94 mutants mutation one two residues dylsf domain caused variable milder reductions nicastrin maturation ps endoproteolysis secretion figs 8 lanes 6 9 9a lanes 6 9 degree reduction commensurate effect mutant interaction presenilin complex components instance conservative mutation dylsf eylsf caused modest reductions binding complex maturation secretion figs 8 lane 8 9 lane 8
0.45364788.15322109.html.plaintext.txt	35	assess functional properties pen 2 mutants next examined ability rescue presenilin complex formation maturation pen 2 knock cells transient transfection wild type pen 2 pen 2 knock cells significantly rescued nicastrin maturation ps endoproteolysis secretion fig 7 panels 1 2 5 associated slight reduction app ctf fig 7 panel 4 contrast transient expression aaaaa poly substitution residues 90 94 fig 7 del84 101 fig 8 del90 94 fig 7 del90 101 fig 8 deletion mutants bind efficiently presenilin complex components little ability rescue presenilin complex maturation andor secretion fig 7 panels 1 2 5 sapp unchanged cells fig 7 panel 6 indicating mutants altered app maturation trafficking cleavage secretase effects robust replicated three independent pen 2 knockdown cells contrast profound loss function effects aaaaa del90 94 mutants mutation one two residues dylsf domain caused variable milder reductions nicastrin maturation ps endoproteolysis secretion figs 8 lanes 6 9 9a lanes 6 9 degree reduction commensurate effect mutant interaction presenilin complex components instance conservative mutation dylsf eylsf caused modest reductions binding complex maturation secretion figs 8 lane 8 9 lane 8
0.45364788.15322109.html.plaintext.txt	36	view larger version 80k fig 7 wild type pen 2 rescue nct maturation ps endoproteolysis secretion aaaaa del90 94 mutant mock lane 1 wild type lane 2 aaaaa lane 3 del90 94 lane 4 mutant transfected pen 2 knock cells clones 10 13 19 nct ps1 pen 2 app ctf secretion sapp panels top bottom conditioned media analyzed wt wild type
0.45364788.15322109.html.plaintext.txt	37	view larger version 45k fig 8 nct maturation ps proteolysis rescued partial substitution mutants dylsf domain aaa ipg mutant del84 101 del90 101 del96 101 aaaaa del90 94 del100 101 kdas nct ps1 pen 2 aph 1 app panels top bottom analyzed pen 2 knock cells transiently transfected mock wild type del84 101 del90 101 del96 101 aylsf dalsa eylsf dyaaf aaaaa del90 94 aaa ipg kdas del100 101lanes 1 11 14 15 18 wt wild type
0.45364788.15322109.html.plaintext.txt	38	view larger version 43k fig 9 secretion fully rescued wild type pen 2 aaa ipg partially rescued partial substitution mutants dylsf domain pen 2 knock cells transiently transfected mock wild type del84 101 del90 101 del96 101 aylsf dalsa eylsf dyaaf aaaaa del90 94 aaa ipg del100 101 kdas lanes 1 11 14 15 18 b secreted condition medium measured enzyme linked immunosorbent assay n 3 independent replications wt wild type
0.45364788.15322109.html.plaintext.txt	39	despite fact del96 101 mutant binds efficiently presenilin complex components remaining pen 2 deletion mutations del96 101 mutant partially rescued presenilin complex maturation function activity equivalent deletion mutations reasoned reduced rescue activity del96 101 mutant despite mild reduction binding could occur specific residues 96 101 domain critical pen 2 activity three highly conserved residues domain ile codon 96 pro codon 97 gly codon 99 alternate possibility absolute length c terminus critical function pen 2 deletion deletions altered property latter possibility supported prior report exogenous wild type c terminally tagged pen 2 failed complement loss function alleles c elegans pen 2 gene 8 earlier observation pen 2 constructs tagged c terminal myc epitopes unstable fig 3 resolve dichotomy made three constructs one alanine missense mutations three conserved residues one four residue kdas c terminal addition one deletion two non conserved c terminal residues aaa ipg kdas del100 101 respectively fig 1d immunoprecipitation experiments following transient expression constructs pen 2 knock hek293 cells revealed aaa ipg mutant bound presenilins complex components comparably wild type pen 2 however kdas del100 101 mutant moderate reduction binding similar magnitude reduction binding del96 101 mutant fig 6 lane 15 del100 101 shown kdas would expected binding assays transient expression aaa ipg mutant nearly completely rescued nicastrin maturation ps endoproteolysis secretion whereas kdas del100 101 mutant minimal effect figs 8 lanes 14 15 18 9a lanes 14 15 18 data indicate addition sequence size conserved dylsf motif residues 90 94 another critical factor nicastrin maturation ps endoproteolysis length c terminus fig 9
0.45364788.15322109.html.plaintext.txt	40	despite fact del96 101 mutant binds efficiently presenilin complex components remaining pen 2 deletion mutations del96 101 mutant partially rescued presenilin complex maturation function activity equivalent deletion mutations reasoned reduced rescue activity del96 101 mutant despite mild reduction binding could occur specific residues 96 101 domain critical pen 2 activity three highly conserved residues domain ile codon 96 pro codon 97 gly codon 99 alternate possibility absolute length c terminus critical function pen 2 deletion deletions altered property latter possibility supported prior report exogenous wild type c terminally tagged pen 2 failed complement loss function alleles c elegans pen 2 gene 8 earlier observation pen 2 constructs tagged c terminal myc epitopes unstable fig 3 resolve dichotomy made three constructs one alanine missense mutations three conserved residues one four residue kdas c terminal addition one deletion two non conserved c terminal residues aaa ipg kdas del100 101 respectively fig 1d immunoprecipitation experiments following transient expression constructs pen 2 knock hek293 cells revealed aaa ipg mutant bound presenilins complex components comparably wild type pen 2 however kdas del100 101 mutant moderate reduction binding similar magnitude reduction binding del96 101 mutant fig 6 lane 15 del100 101 shown kdas would expected binding assays transient expression aaa ipg mutant nearly completely rescued nicastrin maturation ps endoproteolysis secretion whereas kdas del100 101 mutant minimal effect figs 8 lanes 14 15 18 9a lanes 14 15 18 data indicate addition sequence size conserved dylsf motif residues 90 94 another critical factor nicastrin maturation ps endoproteolysis length c terminus fig 9
0.45364788.15322109.html.plaintext.txt	41	discussion top abstract introduction experimental procedures results discussion references data reveal pen 2 plays role nicastrin maturation ps endoproteolysis secretion agreement several previous reports 8 15 16 however data also reveal c terminus important 1 modulating interaction pen 2 presenilin complex components 2 supporting nicastrin maturation ps endoproteolysis 3 supporting secretion intensive mutation analysis suggests sequence dylsf domain absolute length c terminus important activities
0.45364788.15322109.html.plaintext.txt	42	discussion top abstract introduction experimental procedures results discussion references data reveal pen 2 plays role nicastrin maturation ps endoproteolysis secretion agreement several previous reports 8 15 16 however data also reveal c terminus important 1 modulating interaction pen 2 presenilin complex components 2 supporting nicastrin maturation ps endoproteolysis 3 supporting secretion intensive mutation analysis suggests sequence dylsf domain absolute length c terminus important activities
0.45364788.15322109.html.plaintext.txt	43	deletion mutants lesser degree individual missense mutations dylsf domain affect binding pen 2 presenilin complex result also affect presenilin complex assembly maturation secretase activity equivalent degree hand modulation length sequence exposed extreme c terminus pen 2 less impact pen 2 binding complex significant affect presenilin complex maturation secretase activity interpret findings mean 1 amino acid sequence dylsf domain important physical binding pen 2 presenilin complex components 2 absolute length c terminus important pen 2 activity within functional presenilin complexes
0.45364788.15322109.html.plaintext.txt	44	deletion mutants lesser degree individual missense mutations dylsf domain affect binding pen 2 presenilin complex result also affect presenilin complex assembly maturation secretase activity equivalent degree hand modulation length sequence exposed extreme c terminus pen 2 less impact pen 2 binding complex significant affect presenilin complex maturation secretase activity interpret findings mean 1 amino acid sequence dylsf domain important physical binding pen 2 presenilin complex components 2 absolute length c terminus important pen 2 activity within functional presenilin complexes
0.45364788.15322109.html.plaintext.txt	45	dylsf domain conserved homology blast database search however ylsf sequence matches tyrosine based sorting signal yxxlmvif cytoplasmic tail several proteins including mu subunit ap adaptor protein complex tgn38 epidermal growth factor receptor mannose 6 phosphate receptor furin 25 28 tyrosine based sorting motifs proteins responsible targeting proteins various organelles 25 28 although ylsf motifs examples work cytoplasm conceivable dylsf domain pen 2 could also involved targeting pen 2 nascent presenilin complexes may simply binding motif required interaction pen 2 proteins ps1 complex
0.45364788.15322109.html.plaintext.txt	46	dylsf domain conserved homology blast database search however ylsf sequence matches tyrosine based sorting signal yxxlmvif cytoplasmic tail several proteins including mu subunit ap adaptor protein complex tgn38 epidermal growth factor receptor mannose 6 phosphate receptor furin 25 28 tyrosine based sorting motifs proteins responsible targeting proteins various organelles 25 28 although ylsf motifs examples work cytoplasm conceivable dylsf domain pen 2 could also involved targeting pen 2 nascent presenilin complexes may simply binding motif required interaction pen 2 proteins ps1 complex
0.45364788.15322109.html.plaintext.txt	47	fact absolute length sequence c terminus pen 2 critical presenilin complex function affect binding pen 2 complex suggests c terminus may involved maintaining non sequence based spatial interactions eg spatial packing components presenilin complex similar critical sensitivity length c terminus reported ps1 ps2 29 c termini ps1ps2 pen 2 oriented cytoplasm additional experiments needed discern whether c termini two proteins fact interact whether directly third protein however taken together data raise possibility pen 2 might function important linkerspacer molecule maintains spatial interactions various presenilin complex components
0.45364788.15322109.html.plaintext.txt	48	footnotes work supported grants canadian institutes health research howard hughes medical institute canadian genetic diseases network scottish rite charitable foundation canada alzheimer society ontario costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.45364788.15322109.html.plaintext.txt	49	footnotes work supported grants canadian institutes health research howard hughes medical institute canadian genetic diseases network scottish rite charitable foundation canada alzheimer society ontario costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.45364788.15322109.html.plaintext.txt	50	correspondence addressed
0.45364788.15322109.html.plaintext.txt	51	1 abbreviations used app amyloid precursor protein ps presenilin nct nicastrin amyloid peptide chapso 3 3 cholamidopropyldimethylammonio 2 hydroxy 1 propanesulfonic acid
0.45364788.15322109.html.plaintext.txt	52	acknowledgments antibodies jrfca4010 jrfca4226 jrfatot1 gift dr marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.45364788.15322109.html.plaintext.txt	53	acknowledgments antibodies jrfca4010 jrfca4226 jrfatot1 gift dr marc mercken johnson johnson pharmaceutical research developmentjanssen pharmaceutica beerse belgium
0.45364788.15322109.html.plaintext.txt	54	references top abstract introduction experimental procedures results discussion references sisodia st george hyslop p 2002 nat rev neurosci 3 281 290crossrefmedline order article via infotrieve haass c steiner h 2002 trends cell biol 12 556 562crossrefmedline order article via infotrieve selkoe d kopan r 2003 annu rev neurosci 26 565 597crossrefmedline order article via infotrieve de strooper b 2003 neuron 38 9 12medline order article via infotrieve yu g chen f levesque g nishimura m zhang d m levesque l rogaeva e xu d liang y duthie m st george hyslop p fraser p e 1998 j biol chem 273 16470 16475abstractfree full text yu g nishimura m arawaka levitan d zhang l tandon song y q rogaeva e chen f kawarai supala levesque l yu h yang d holmes e milman p liang y zhang d m xu d m sato c rogaev e smith m janus c zhang y aebersold r farrer l sorbi bruni fraser p st george hyslop p 2000 nature 407 48 54crossrefmedline order article via infotrieve goutte c tsunozaki m hale v priess j r 2002 proc natl acad sci u 99 775 779abstractfree full text francis r mcgrath g zhang j ruddy d sym m apfeld j nicoll m maxwell m hai b ellis m c parks l xu w li j gurney m myers r l himes c hiebsch r ruble c nye j curtis d 2002 dev cell 3 85 97medline order article via infotrieve gu y sanjo n chen f hasegawa h petit ruan x li w shier c kawarai schmitt ulms g westaway d st george hyslop p fraser p e 2004 j biol chem 279 31329 31336abstractfree full text edbauer d winkler e regula j pesold b steiner h haass c 2003 nat cell biol 5 486 488crossrefmedline order article via infotrieve sherrington r rogaev e liang y rogaeva e levesque g ikeda m chi h lin c holman k tsuda mar l fraser p e rommens j m st george hyslop p 1995 nature 375 754 760crossrefmedline order article via infotrieve rogaev e sherrington r rogaeva e levesque g ikeda m liang y chi h lin c holman k tsuda mar l sorbi nacmias b piacentini amaducci l chumakov cohen d lannfelt l fraser p e rommens j m st george hyslop p 1995 nature 376 775 778crossrefmedline order article via infotrieve takasugi n tomita hayashi tsuruoka m niimura m takahashi y thinakaran g iwatsubo 2003 nature 422 438 441crossrefmedline order article via infotrieve kimberly w lavoie m j ostaszewski b l ye w wolfe m selkoe d j 2003 proc natl acad sci u 100 6382 6387abstractfree full text steiner h winkler e edbauer d prokop basset g yamasaki kostka m haass c 2002 j biol chem 277 39062 39065abstractfree full text prokop shirotani k edbauer d haass c steiner h crystal morais v fortna r r carlin d pierson c wilson c lee v m doms r w bergman hansson e m pursglove e farmery m r lannfelt l lendahl u lundkvist j naslund j fraering p c lavoie m j ye w ostaszewski b l kimberly w selkoe d j wolfe m lee f shah yu c wigley w c li h lim m pedersen k han w thomas p hao y h yu g pijak d baulac strahle j xia w warriss p d brown n knowles g guo m hong e j fernandes j zipursky l hay b costa j nyabi o bentahir m horre k herreman gottardi littell n van broeckhoven c merchiers p spittaels k annaert w de strooper b kim h ikeuchi sisodia berezovska o ramdya p skoch j bacskai b j hyman b hu y fortini m e 2004 j biol chem 23 23 luo w j wang h li h kim b shah lee h j thinakaran g kim w yu g xu h 2003 j biol chem 278 7850 7854 8abstractfree full text kim h ikeuchi yu c sisodia 2003 j biol chem 278 33992 34002abstractfree full text crystal morais v pierson c pijak d carlin d lee v m doms r w 2003 j biol chem 278 20117 20123 epub 2003 mar 14abstractfree full text bergman hansson e m pursglove e farmery m r lannfelt l lendahl u lundkvist j naslund j fraering p c lavoie m j ye w ostaszewski b l kimberly w selkoe d j wolfe m 2004 j biol chem 279 16744 16753abstractfree full text gu y chen f sanjo n kawarai hasegawa h duthie m li w ruan x luthra mount h tandon fraser p e st george hyslop p 2003 j biol chen 278 7374 7380abstractfree full text chen f yang d petanceska yang tandon yu g rozmahel r ghiso j nishimura m zhang d m kawarai levesque g mills j levesque l song y q rogaeva e westaway d mount h gandy st george hyslop p fraser p e 2000 j biol chem 275 36794 36802abstractfree full text chishti m yang d janus c phinney l horne p pearson j strome r zuker n loukides j french j turner lozza g grilli m kunicki morissette c paquette j gervais f bergeron c fraser p e carlson g st george hyslop p westaway d 2001 j biol chem 276 21562 21570abstractfree full text mclaurin j cecal r kierstead m e tian x phinney l manea m french j e lambermon m h darabie brown m e janus c chishti m horne p westaway d fraser p e mount h przybylski m st george hyslop p 2002 nat med 8 1263 1269crossrefmedline order article via infotrieve boll w rapoport brunner c modis y prehn kirchhausen 2002 traffic 3 590 600crossrefmedline order article via infotrieve dellangelica e c payne g 2001 cell 106 395 398medline order article via infotrieve boll w ohno h songyong z rapoport cantley k c bonifacino js kirchhausen 1996 embo j 15 5789 5795abstract ohno h stewart j fourner m c bosshart h rhee miyatake saito gallusser kirchhausen bonifacino j 1995 science 269 1872 1875medline order article via infotrieve tomita tokuhiro hashimoto aiba k saido c maruyama k iwatsubo 1998 j biol chem 273 21153 21160abstractfree full text
0.46781272.9013610.html.plaintext.txt	0	phosphorylation subcellular localization membrane orientation alzheimers disease associated presenilins
0.46781272.9013610.html.plaintext.txt	1	received publication may 30 1996 revised form october 1 1996
0.46781272.9013610.html.plaintext.txt	2	bart de strooper monique beullens bart contreras lyne levesque katleen craessaerts barbara cordell dieder moechars mathieu bollen paul fraser peter st george hyslop fred van leuven
0.46781272.9013610.html.plaintext.txt	3	bart de strooper monique beullens bart contreras lyne levesque katleen craessaerts barbara cordell dieder moechars mathieu bollen paul fraser peter st george hyslop fred van leuven
0.46781272.9013610.html.plaintext.txt	4	experimental genetics group molecular oncology group center human genetics laboratory biochemistry katholieke universiteit 3000 leuven belgium center research neurodegenerative diseases department medicine neurology medical biophysics university toronto toronto ontario m5s 1a8 canada scios inc sunnyvale california 94043 abstract introduction materials methods results discussion footnotes acknowledgments note added proof references
0.46781272.9013610.html.plaintext.txt	5	experimental genetics group molecular oncology group center human genetics laboratory biochemistry katholieke universiteit 3000 leuven belgium center research neurodegenerative diseases department medicine neurology medical biophysics university toronto toronto ontario m5s 1a8 canada scios inc sunnyvale california 94043 abstract introduction materials methods results discussion footnotes acknowledgments note added proof references
0.46781272.9013610.html.plaintext.txt	6	presenilins 1 2 unglycosylated proteins apparent molecular mass 45 50 kda respectively transfected cos 1 chinese hamster ovary cells colocalize proteins endoplasmic reticulum golgi apparatus transfected untransfected cells cos 1 cells low amounts intact endogeneous presenilin 1 migrating 45 kda detected together relative larger amounts presenilin 1 fragments migrating 18 30 kda presenilins strong tendency form aggregates mass 100 250 kda sds polyacrylamide gel electrophoresis partially resolved denatured sds 37 degrees c instead 95 degrees c sulfation glycosaminoglycan modification acylation presenilins observed proteins posttranslationally phosphorylated serine residues mutations ala 246 glu cys 410 tyr cause alzheimers disease interfere biosynthesis phosphorylation presenilin 1 finally using low concentrations digitonin selectively permeabilize cell membrane endoplasmic reticulum membrane demonstrated two major hydrophilic domains presenilin 1 oriented cytoplasm current investigation documents posttranslational modifications subcellular localization presenilins indicates postulated interactions amyloid precursor protein metabolism occur early compartments biosynthetic pathway
0.46781272.9013610.html.plaintext.txt	7	presenilins 1 2 unglycosylated proteins apparent molecular mass 45 50 kda respectively transfected cos 1 chinese hamster ovary cells colocalize proteins endoplasmic reticulum golgi apparatus transfected untransfected cells cos 1 cells low amounts intact endogeneous presenilin 1 migrating 45 kda detected together relative larger amounts presenilin 1 fragments migrating 18 30 kda presenilins strong tendency form aggregates mass 100 250 kda sds polyacrylamide gel electrophoresis partially resolved denatured sds 37 degrees c instead 95 degrees c sulfation glycosaminoglycan modification acylation presenilins observed proteins posttranslationally phosphorylated serine residues mutations ala 246 glu cys 410 tyr cause alzheimers disease interfere biosynthesis phosphorylation presenilin 1 finally using low concentrations digitonin selectively permeabilize cell membrane endoplasmic reticulum membrane demonstrated two major hydrophilic domains presenilin 1 oriented cytoplasm current investigation documents posttranslational modifications subcellular localization presenilins indicates postulated interactions amyloid precursor protein metabolism occur early compartments biosynthetic pathway
0.46781272.9013610.html.plaintext.txt	8	alzheimers disease major health problem patients suffer progressive dementia caused massive neuronal loss cortical hippocampal areas brain 1 6 neuropathological signs disease tangles amyloid deposits brain parenchyma amyloid deposits brain vasculature cause sporadic form disease still unknown although increased risk associated presence apolipoprotein allele e4 6 7 hand familial early onset alzheimers disease caused point mutations amyloid precursor protein gene chromosome 21 8 presenilin 2 ps21 gene chromosome 1 9 11 frequently presenilin 1 ps1 gene chromosome 14 12 15 amyloid precursor protein app type integral membrane protein precursor amyloid peptide main component senile plaques 1 3 point mutations exons 16 17 app gene cause alterations metabolism app results increased production intracellular a4 amyloid peptide containing carboxyl terminal app fragments increased secretion potentially neurotoxic a4 peptide 1 3 16 63 amino acid residues sequences two presenilins conserved strongly suggests proteins involved similar functions similar pathogenic role alzheimers disease based computer algorithms seven membrane spanning domains defined 9 15 although possibility nine transmembrane domains cannot ruled moment 17 amino terminal domain acidic loop domain located transmembrane domains six seven hydrophilic alternatively spliced 9 13 mutations cause familial alzheimers disease found protein hydrophilic loop constitutes hot spot nine different mutations described date 5 15 biological function presenilins remains essentially unknown interestingly 103 carboxyl terminal amino acid residues ps2 inhibit apoptosis deathtrap assay 18 based homology caenorhabditis elegans proteins roles intracellular protein sorting andor intercellular signal transmission proposed well 19 20
0.46781272.9013610.html.plaintext.txt	9	alzheimers disease major health problem patients suffer progressive dementia caused massive neuronal loss cortical hippocampal areas brain 1 6 neuropathological signs disease tangles amyloid deposits brain parenchyma amyloid deposits brain vasculature cause sporadic form disease still unknown although increased risk associated presence apolipoprotein allele e4 6 7 hand familial early onset alzheimers disease caused point mutations amyloid precursor protein gene chromosome 21 8 presenilin 2 ps21 gene chromosome 1 9 11 frequently presenilin 1 ps1 gene chromosome 14 12 15 amyloid precursor protein app type integral membrane protein precursor amyloid peptide main component senile plaques 1 3 point mutations exons 16 17 app gene cause alterations metabolism app results increased production intracellular a4 amyloid peptide containing carboxyl terminal app fragments increased secretion potentially neurotoxic a4 peptide 1 3 16 63 amino acid residues sequences two presenilins conserved strongly suggests proteins involved similar functions similar pathogenic role alzheimers disease based computer algorithms seven membrane spanning domains defined 9 15 although possibility nine transmembrane domains cannot ruled moment 17 amino terminal domain acidic loop domain located transmembrane domains six seven hydrophilic alternatively spliced 9 13 mutations cause familial alzheimers disease found protein hydrophilic loop constitutes hot spot nine different mutations described date 5 15 biological function presenilins remains essentially unknown interestingly 103 carboxyl terminal amino acid residues ps2 inhibit apoptosis deathtrap assay 18 based homology caenorhabditis elegans proteins roles intracellular protein sorting andor intercellular signal transmission proposed well 19 20
0.46781272.9013610.html.plaintext.txt	10	hypothetical final common pathway pathogenesis genetic sporadic forms alzheimers disease postulated based invariable occurrence amyloid deposits neurofibrillar tangles neurodegeneration affected brains central question thus mutations presenilin genes cause typical neuropathology studies indicating increased production amyloidogenic a4 1 42 peptide fibroblasts obtained patients presenilin mutations would support amyloid hypothesis postulates abnormal a4 amyloid peptide production plaque formation pivotal event pathogenesis disease 2 21 however observed increases a4 1 42 peptide production relatively small suggested relationship presenilin mutations app metabolism corroborated experiments showing directly effect presenilin mutations app processing transfected cells brains transgenic animals moreover aspects app metabolism production carboxyl terminal app fragments 16 investigated greater detail possibility presenilins interact cytoskeleton exert effect via apoptotic pathways disregarded time 18 addition addressing questions basic information needed subcellular localization posttranslational modifications membrane orientation presenilins
0.46781272.9013610.html.plaintext.txt	11	hypothetical final common pathway pathogenesis genetic sporadic forms alzheimers disease postulated based invariable occurrence amyloid deposits neurofibrillar tangles neurodegeneration affected brains central question thus mutations presenilin genes cause typical neuropathology studies indicating increased production amyloidogenic a4 1 42 peptide fibroblasts obtained patients presenilin mutations would support amyloid hypothesis postulates abnormal a4 amyloid peptide production plaque formation pivotal event pathogenesis disease 2 21 however observed increases a4 1 42 peptide production relatively small suggested relationship presenilin mutations app metabolism corroborated experiments showing directly effect presenilin mutations app processing transfected cells brains transgenic animals moreover aspects app metabolism production carboxyl terminal app fragments 16 investigated greater detail possibility presenilins interact cytoskeleton exert effect via apoptotic pathways disregarded time 18 addition addressing questions basic information needed subcellular localization posttranslational modifications membrane orientation presenilins
0.46781272.9013610.html.plaintext.txt	12	used cos 1 cells cho cells express ps1 ps2 well myc tagged ps1 ps1 containing mutations cause familial alzheimers disease biosynthesis transfected untransfected presenilins studied using immunoblotting metabolical labeling immunoprecipitation assays demonstrate transfected presenilins phosphorylated serine residues using immunofluorescence microscopy document association presenilin 1 early compartments biosynthetic pathway demonstrate cytoplasmic orientation two major hydrophilic domains
0.46781272.9013610.html.plaintext.txt	13	used cos 1 cells cho cells express ps1 ps2 well myc tagged ps1 ps1 containing mutations cause familial alzheimers disease biosynthesis transfected untransfected presenilins studied using immunoblotting metabolical labeling immunoprecipitation assays demonstrate transfected presenilins phosphorylated serine residues using immunofluorescence microscopy document association presenilin 1 early compartments biosynthetic pathway demonstrate cytoplasmic orientation two major hydrophilic domains
0.46781272.9013610.html.plaintext.txt	14	cdna coding mouse ps1 human ps1 ps2 ps1 containing ala 246 glu fad1 cys 410 tyr nih2 mutations described 9 12 myc tagged ps1 fragment generated pcr using primers 5 cgggatccattatgacagagttacctgcaccg 3 5 gatcacatgcttggcgccatat 3 sequence coding myc tag underlined fragment used replace naribamhi restriction fragment ps1 psg5 resulting cdna codes ps1 myc tag eqkliseedl immediately initiator methionine confirmed cdna sequencing plasmids containing cdna furin 22 23 reticulonnsp 24 25 kindly provided dr j creemers dr roebroek dr w van de ven center human genetics leuven belgium
0.46781272.9013610.html.plaintext.txt	15	cdna coding mouse ps1 human ps1 ps2 ps1 containing ala 246 glu fad1 cys 410 tyr nih2 mutations described 9 12 myc tagged ps1 fragment generated pcr using primers 5 cgggatccattatgacagagttacctgcaccg 3 5 gatcacatgcttggcgccatat 3 sequence coding myc tag underlined fragment used replace naribamhi restriction fragment ps1 psg5 resulting cdna codes ps1 myc tag eqkliseedl immediately initiator methionine confirmed cdna sequencing plasmids containing cdna furin 22 23 reticulonnsp 24 25 kindly provided dr j creemers dr roebroek dr w van de ven center human genetics leuven belgium
0.46781272.9013610.html.plaintext.txt	16	polyclonal rabbit antisera b13 b14 b15 raised peptide p45 ndnrerqehndrrslc amino terminal domain ps1 12 polyclonal rabbit sera b16 b17 raised peptide p46 egdpeaqrrvsknskc situated hydrophilic loop domain ps1 polyclonal rabbit antiserum 519 raised residues kdgqliytpftedtec antiserum reacts sequence second loop domain ps1 ps2 synthetic peptides p45 p46 manufactured eurogentec liege belgium peptide p519 synthesized solid phase techniques purified reverse phase high pressure liquid chromatography laboratories2 rabbits injected every 2 weeks 100 200 300 microg peptide complete freunds adjuvant coupled keyhole limpet hemocyanin bovine serum albumin pierce solubilized pbs mixed complete freunds adjuvant monoclonal antibody mab ps1 3 reacting peptide rrvsknskynaesteresqdtvaen hydrophilic loop domain ps1 mab 9e10 myc tag 26 kindly provided dr j creemers mabs mon160 161 162 mon148 152 nspreticulon furin described 22 25 mabs immunoglobulin binding protein bip calcium pump serca 2a iid8 purchased respectively stressgen victoria canada affinity bioreagents neshanic station nj
0.46781272.9013610.html.plaintext.txt	17	polyclonal rabbit antisera b13 b14 b15 raised peptide p45 ndnrerqehndrrslc amino terminal domain ps1 12 polyclonal rabbit sera b16 b17 raised peptide p46 egdpeaqrrvsknskc situated hydrophilic loop domain ps1 polyclonal rabbit antiserum 519 raised residues kdgqliytpftedtec antiserum reacts sequence second loop domain ps1 ps2 synthetic peptides p45 p46 manufactured eurogentec liege belgium peptide p519 synthesized solid phase techniques purified reverse phase high pressure liquid chromatography laboratories2 rabbits injected every 2 weeks 100 200 300 microg peptide complete freunds adjuvant coupled keyhole limpet hemocyanin bovine serum albumin pierce solubilized pbs mixed complete freunds adjuvant monoclonal antibody mab ps1 3 reacting peptide rrvsknskynaesteresqdtvaen hydrophilic loop domain ps1 mab 9e10 myc tag 26 kindly provided dr j creemers mabs mon160 161 162 mon148 152 nspreticulon furin described 22 25 mabs immunoglobulin binding protein bip calcium pump serca 2a iid8 purchased respectively stressgen victoria canada affinity bioreagents neshanic station nj
0.46781272.9013610.html.plaintext.txt	18	cell culture metabolic labeling cell extraction immunoprecipitation
0.46781272.9013610.html.plaintext.txt	19	fibroblast cell line designation ag07657 coriell institute unaffected individual fad1 lineage cultured dulbeccos modified eagles medium supplemented 20 fetal bovine serum life technologies inc cos1 cells cultured described previously dulbeccos modified eagles mediumhams f 12 10 fetal bovine serum 27 cho cells stably transfected app770 kindly provided dr b greenberg cephalon west chester pa cultured high glucose dulbeccos modified eagles medium life technologies inc supplemented 01 mm minimal essential medium nonessential amino acids 3 fetal calf serum 250 nm methotrexate
0.46781272.9013610.html.plaintext.txt	20	cos cells transfected using deaedextran 27 cho cells transfected using lipofectamine according instructions manufacturer life technologies inc
0.46781272.9013610.html.plaintext.txt	21	metabolic labeling done 100 microci 35smethionine 250 microci 35ssulfate 60 microci 3hglucosamine 500 microci 3hpalmitic acid 3hmyristic acid 500 microci 32porthophosphateml appropriate culture medium radiolabeled precursors amersham cellular labeling done 4 h unless otherwise specified cell extracts made described previously 27 analysis phosphorylation postnuclear extract prepared using 05 vv triton x 100 tris buffered saline tbs containing proteinase inhibitors 100 unitsml aprotinin 1 microgml pepstatin tyrosine serinethreonine phosphatase inhibitors 1 mm sodium orthovanadate 5 mm edta 5 mm egta 20 mm naf nuclei pelleted centrifugation 14000 rpm 15 min cooled eppendorf centrifuge antisera added cell extracts 1250 dilution antibody antigen complexes collected incubation immobilized protein g pierce overnight 4 degrees c immunoprecipitates washed using tris buffered saline containing 1 vv triton x 100 1 wv deoxycholate 01 wv sds 27 analysis phosphorylation phosphatase inhibitors detailed added buffers
0.46781272.9013610.html.plaintext.txt	22	metabolic labeling done 100 microci 35smethionine 250 microci 35ssulfate 60 microci 3hglucosamine 500 microci 3hpalmitic acid 3hmyristic acid 500 microci 32porthophosphateml appropriate culture medium radiolabeled precursors amersham cellular labeling done 4 h unless otherwise specified cell extracts made described previously 27 analysis phosphorylation postnuclear extract prepared using 05 vv triton x 100 tris buffered saline tbs containing proteinase inhibitors 100 unitsml aprotinin 1 microgml pepstatin tyrosine serinethreonine phosphatase inhibitors 1 mm sodium orthovanadate 5 mm edta 5 mm egta 20 mm naf nuclei pelleted centrifugation 14000 rpm 15 min cooled eppendorf centrifuge antisera added cell extracts 1250 dilution antibody antigen complexes collected incubation immobilized protein g pierce overnight 4 degrees c immunoprecipitates washed using tris buffered saline containing 1 vv triton x 100 1 wv deoxycholate 01 wv sds 27 analysis phosphorylation phosphatase inhibitors detailed added buffers
0.46781272.9013610.html.plaintext.txt	23	phorbol myristic acid phorbol dibutyric acid forskolin okadaic acid staurosporin sigma added cell cultures last 30 min metabolic labeling indicated final concentrations vitro labeling assays immunoprecipitated ps1 ps2 bound protein g beads incubated purified protein kinase c tris buffered saline presence 01 mm 32patp 2 mm mg2 60 min 30 degrees c precipitates washed analyzed sds page gels quantitatively analyzed using phosphorimager molecular dynamics
0.46781272.9013610.html.plaintext.txt	24	phorbol myristic acid phorbol dibutyric acid forskolin okadaic acid staurosporin sigma added cell cultures last 30 min metabolic labeling indicated final concentrations vitro labeling assays immunoprecipitated ps1 ps2 bound protein g beads incubated purified protein kinase c tris buffered saline presence 01 mm 32patp 2 mm mg2 60 min 30 degrees c precipitates washed analyzed sds page gels quantitatively analyzed using phosphorimager molecular dynamics
0.46781272.9013610.html.plaintext.txt	25	immunoblotting experiments cells scraped pbs centrifuged 10 min 1000 rpm solubilized laemmli sample buffer blots stained mab 9e10 myc tag ascites fluid 11000 dilution mab ps1 3 hybridoma supernatant 1100 dilution affinity purified goat anti mouse peroxidase conjugated antibodies 110000 bio rad using sensitive ecl system amersham
0.46781272.9013610.html.plaintext.txt	26	immunoblotting experiments cells scraped pbs centrifuged 10 min 1000 rpm solubilized laemmli sample buffer blots stained mab 9e10 myc tag ascites fluid 11000 dilution mab ps1 3 hybridoma supernatant 1100 dilution affinity purified goat anti mouse peroxidase conjugated antibodies 110000 bio rad using sensitive ecl system amersham
0.46781272.9013610.html.plaintext.txt	27	immunoprecipitated 32p labeled ps size fractionated sds page labeled bands localized autoradiography proteins hydrolyzed 6 n hcl 110 degrees c 90 min hydrolysate supplemented phosphoamino acid standards analyzed two dimensional thin layer electrophoresis ph 19 35 respective dimensions 28 phosphoserine phosphothreonine phosphotyrosine localized using ninhydrin staining radioactive phosphoamino acid residues visualized autoradiography
0.46781272.9013610.html.plaintext.txt	28	immunoprecipitated 32p labeled ps size fractionated sds page labeled bands localized autoradiography proteins hydrolyzed 6 n hcl 110 degrees c 90 min hydrolysate supplemented phosphoamino acid standards analyzed two dimensional thin layer electrophoresis ph 19 35 respective dimensions 28 phosphoserine phosphothreonine phosphotyrosine localized using ninhydrin staining radioactive phosphoamino acid residues visualized autoradiography
0.46781272.9013610.html.plaintext.txt	29	fibroblasts grown coverslips coated mouse collagen iv collaborative biomedical products 1 microgcm2 transfected cos 1 cho cells cultured lab tek chamber slides nunc cells washed twice pbs fixed 4 formaldehyde pbs 10 min room temperature washed three times pbs tbs cells permeabilized 002 vv triton x 100 tbs 20 min 02 wv saponin 10 min washed 01 tween 20 tbs nonspecific binding blocked 02 cold water fish gelatin 2 bovine serum albumin 2 fetal calf serum blocking buffer cells probed affinity purified primary antibody 519 125 immune serum 1400 appropriate fitc tritc conjugated anti mouse anti rat anti rabbit antibodies sigma used 1400 dilution preparations viewed nikon diaphot 300 zeiss axiophot uv microscope digitized immunofluorescence images obtained using lsm419 inverted laser scanning confocal microscope zeiss inc processed using nih image software
0.46781272.9013610.html.plaintext.txt	30	fibroblasts grown coverslips coated mouse collagen iv collaborative biomedical products 1 microgcm2 transfected cos 1 cho cells cultured lab tek chamber slides nunc cells washed twice pbs fixed 4 formaldehyde pbs 10 min room temperature washed three times pbs tbs cells permeabilized 002 vv triton x 100 tbs 20 min 02 wv saponin 10 min washed 01 tween 20 tbs nonspecific binding blocked 02 cold water fish gelatin 2 bovine serum albumin 2 fetal calf serum blocking buffer cells probed affinity purified primary antibody 519 125 immune serum 1400 appropriate fitc tritc conjugated anti mouse anti rat anti rabbit antibodies sigma used 1400 dilution preparations viewed nikon diaphot 300 zeiss axiophot uv microscope digitized immunofluorescence images obtained using lsm419 inverted laser scanning confocal microscope zeiss inc processed using nih image software
0.46781272.9013610.html.plaintext.txt	31	selective permeabilization plasma membrane obtained incubating fixed cells 10 mm pipes buffer ph 68 containing 03 m sucrose 01 m kcl 25 mm mgcl2 1 mm edta 5 microgml digitonin 15 min 4 degrees c 29 cells washed pbs processed rat monoclonal antibody kdel sequence 30 31 used demonstrate permeabilization endoplasmic reticulum membrane
0.46781272.9013610.html.plaintext.txt	32	immunocytochemical localization presenilin 1 endoplasmic reticulum golgi apparatus
0.46781272.9013610.html.plaintext.txt	33	subcellular localization presenilins investigated permeabilized fixed fibroblasts using affinity purified polyclonal antibody 519 raised peptide kdgqliytpftedte conserved sequence second loop domain ps1 ps2 9 12 fine reticular staining cytoplasm pronounced perinuclear staining observed cells fig 1a partially colocalized staining obtained mab bip endoplasmic reticulum marker preabsorption antibody 519 peptide antigen resulted loss staining demonstrating specificity observed signals fig 1c fig 1 immunofluorescent staining ps12 untransfected fibroblasts fibroblasts fixed formaldehyde permeabilized triton x 100 cells incubated affinity purified rabbit antibody 519 loop 2 domain ps12 panel mouse mab bip panel b followed appropriate tritc fitc conjugated secondary antibodies presenilin staining observed cytoplasm reticular pattern partially colocalizes staining obtained mab endoplasmic reticulum marker bip b panel c fibroblasts stained antibody 519 preabsorbed peptide revealed weak background fluorescence view larger version image 32k gif file
0.46781272.9013610.html.plaintext.txt	34	subcellular localization presenilins investigated permeabilized fixed fibroblasts using affinity purified polyclonal antibody 519 raised peptide kdgqliytpftedte conserved sequence second loop domain ps1 ps2 9 12 fine reticular staining cytoplasm pronounced perinuclear staining observed cells fig 1a partially colocalized staining obtained mab bip endoplasmic reticulum marker preabsorption antibody 519 peptide antigen resulted loss staining demonstrating specificity observed signals fig 1c fig 1 immunofluorescent staining ps12 untransfected fibroblasts fibroblasts fixed formaldehyde permeabilized triton x 100 cells incubated affinity purified rabbit antibody 519 loop 2 domain ps12 panel mouse mab bip panel b followed appropriate tritc fitc conjugated secondary antibodies presenilin staining observed cytoplasm reticular pattern partially colocalizes staining obtained mab endoplasmic reticulum marker bip b panel c fibroblasts stained antibody 519 preabsorbed peptide revealed weak background fluorescence view larger version image 32k gif file
0.46781272.9013610.html.plaintext.txt	35	lacelike network seen cos 1 cells transfected plasmids containing cdna ps1 using antiserum b14 peptide ndnrerqehndrrs amino terminal domain ps1 antiserum b16 peptide egdpeaqrrvsknsky hydrophilic loop domain ps1 fig 2 c untransfected cos 1 cells remained negative experimental conditions used probably low levels endogeneous ps present cells see pattern staining observed monoclonal antibody iid8 32 serca 2a ca2 atpase results shown antibodies transfected reticulonnsp fig 2b proteins located endoplasmic reticulum golgi apparatus 24 distribution ps1 reticulonnsp remained identical double transfected cells compare panels b fig 2 transfected app fig 2e transfected furin fig 2d contrast mainly found golgi apparatus shown previously 33 34 similar results obtained cho cells results shown fig 2 immunofluorescent staining ps1 transfected cos cells cos 1 cells double transfected plasmids coding ps1 reticulonnsp b single transfected plasmids coding ps1 amyloid precursor protein furin c d e cells fixed formaldehyde permeabilized saponin immunostaining done antiserum b14 amino terminal domain ps1 b16 loop domain ps1 c mix monoclonal antibodies mon160 162 reticulonnsp b mon148 152 furin d mab 22c11 amyloid precursor protein e followed appropriate tritc conjugated red fitc conjugated green secondary antibodies notice fine reticular pattern obtained ps1 antibodies panels c distributes reticulonnsp panel b double transfected cells panel e demonstrates amyloid precursor protein located mainly golgi apparatus similar furin panel d view larger version image 128k gif file
0.46781272.9013610.html.plaintext.txt	36	biosynthesis presenilins
0.46781272.9013610.html.plaintext.txt	37	metabolic labeling untransfected mock transfected cos 1 cho cells using 35smethionine followed immunoprecipitation cell extracts using antibodies 519 b14 b17 resolution immunoprecipitates sds page yielded signals fig 3a lane 4 prolonged exposures 2 weeks nonspecific signals autoradiography results shown immunoprecipitation detergent extracts cos 1 cells transfected plasmids containing cdna wild type ps1 contrast yielded strong specific signals radiolabeled protein migrating apparent molecular mass 45 kda fig 3a lanes 1 3 diffuse protein bands masses 100 250 kda observed variable extent fig 3a similar results obtained ps2 cdna main ps2 species migrated however slightly slowly ps1 resulting apparent mass 50 kda see unrelated polyclonal antibodies untransfected cells yield bands immunoblots cos 1 cells transfected myc tagged ps1 stained myc tag specific mab 9e10 revealed pronounced smearing fig 3b result clearly demonstrated 100 250 kda protein smears consisted ps protein either associated associated proteins essential similar patterns observed ps1 fad1 ala 246 glu ps1 nih2 cys 410 tyr expressed fig 3a clinical mutations 12 therefore cause major alterations biosynthesis ps1 protein overexpressed cos 1 cells fig 3a independent experiments performed cho cells confirmed completely results results shown fig 3 biosynthesis ps1 protein cos 1 cells panel cos 1 cells transfected constructs containing cdna coding wild type ps1 ps1 wt ps1 fad1 ala 246 glu ps1 nih2 cys 410 tyr expression vector alone psg5 control cells metabolically labeled 35smethionine 4 h cells solubilized ps1 immunoprecipitated antiserum b17 1250 immunoprecipitates resolved 4 20 gradient sds page molecular size markers indicated left kda panel b western blotting cos 1cells transfected ps1 containing amino terminally inserted myc epitope cell extracts electophoresed 4 20 gradient acrylamide gel transferred nitrocellulose membrane mab 9e10 myc epitope used detect ps1 panel c combined immunoprecipitation western blotting ps1 untransfected cos cells detergent extracts 10 x 106 untransfected cos 1 cells made ps1 immunoprecipitated using antiserum b13 n term b17 loop lanes 1 3 5 7 05 x 105 cos 1 cells transfected wild type ps1 added untransfected cells immunoprecipitated material resolved 4 20 gradient sds page transferred nitrocellulose filter filters reacted mab ps1 3 goat anti mouse peroxidase conjugated antibodies lanes 1 4 indicated ps1 3 goat anti mouse peroxidase conjugated antibodies alone lanes 5 8 co mobility intact ps1 indicated arrow right view larger version image 24k gif file
0.46781272.9013610.html.plaintext.txt	38	metabolic labeling untransfected mock transfected cos 1 cho cells using 35smethionine followed immunoprecipitation cell extracts using antibodies 519 b14 b17 resolution immunoprecipitates sds page yielded signals fig 3a lane 4 prolonged exposures 2 weeks nonspecific signals autoradiography results shown immunoprecipitation detergent extracts cos 1 cells transfected plasmids containing cdna wild type ps1 contrast yielded strong specific signals radiolabeled protein migrating apparent molecular mass 45 kda fig 3a lanes 1 3 diffuse protein bands masses 100 250 kda observed variable extent fig 3a similar results obtained ps2 cdna main ps2 species migrated however slightly slowly ps1 resulting apparent mass 50 kda see unrelated polyclonal antibodies untransfected cells yield bands immunoblots cos 1 cells transfected myc tagged ps1 stained myc tag specific mab 9e10 revealed pronounced smearing fig 3b result clearly demonstrated 100 250 kda protein smears consisted ps protein either associated associated proteins essential similar patterns observed ps1 fad1 ala 246 glu ps1 nih2 cys 410 tyr expressed fig 3a clinical mutations 12 therefore cause major alterations biosynthesis ps1 protein overexpressed cos 1 cells fig 3a independent experiments performed cho cells confirmed completely results results shown fig 3 biosynthesis ps1 protein cos 1 cells panel cos 1 cells transfected constructs containing cdna coding wild type ps1 ps1 wt ps1 fad1 ala 246 glu ps1 nih2 cys 410 tyr expression vector alone psg5 control cells metabolically labeled 35smethionine 4 h cells solubilized ps1 immunoprecipitated antiserum b17 1250 immunoprecipitates resolved 4 20 gradient sds page molecular size markers indicated left kda panel b western blotting cos 1cells transfected ps1 containing amino terminally inserted myc epitope cell extracts electophoresed 4 20 gradient acrylamide gel transferred nitrocellulose membrane mab 9e10 myc epitope used detect ps1 panel c combined immunoprecipitation western blotting ps1 untransfected cos cells detergent extracts 10 x 106 untransfected cos 1 cells made ps1 immunoprecipitated using antiserum b13 n term b17 loop lanes 1 3 5 7 05 x 105 cos 1 cells transfected wild type ps1 added untransfected cells immunoprecipitated material resolved 4 20 gradient sds page transferred nitrocellulose filter filters reacted mab ps1 3 goat anti mouse peroxidase conjugated antibodies lanes 1 4 indicated ps1 3 goat anti mouse peroxidase conjugated antibodies alone lanes 5 8 co mobility intact ps1 indicated arrow right view larger version image 24k gif file
0.46781272.9013610.html.plaintext.txt	39	since levels endogeneous ps1 detectable using classical immunoprecipitation sensitive immunological sandwich type assay developed ps1 immunoprecipitated detergent extracts 10 x 106 untransfected cos 1 cells using polyclonal ps1 antisera small amount transfected cells 05 x 105 added positive control samples immunoprecipitates resolved sds page electrophoresis transferred nitrocellulose filter immunoprecipitated ps1 finally detected mab ps1 3 raised peptide rrvsknskynaesteresqdtvae loop domain ps1 weak signals representing intact endogeneous ps1 revealed untransfected cos 1 cells fig 3c lanes 2 4 endogeneous ps1 migrated mobility 45 kda transfected ps1 best seen experiments using amino terminal domain specific antiserum b13 fig 3c lane 2 since mab ps1 3 recognizes epitope carboxyl terminally located hydrophilic loop combination antibodies expected detect mainly intact ps1 fig 3c lane 2 hydrophilic loop specific antiserum b17 contrast relatively pronounced 18 30 kda fragments visualized together intact ps1 fragments represent likely carboxyl terminal fragments presenilin 35 remarkably observed fragments marginally increased cos 1 cells overexpressing ps1 compare lanes 3 lane 4 fig 3c pulse chase experiments transfected cho cells fig 4 c cos 1 cells results shown showed transfected 45 kda ps1 species half life 4 h fragments seen time point assay either amino terminal b13 hydrophilic loop specific b17 antisera app immunoprecipitated cell extracts fig 4b displayed much faster turnover half life 2 h indicating relative high expression ps1 interfere normal turnover app fig 4 pulse chase metabolic labeling ps1 transfected cho cells cho cells expressing stably human app770 transfected ps1 metabolically labeled 35smethionine 10 min methionine free medium incorporated label chased incubation cells complete medium indicated time ps1 immunoprecipitated cell extracts using b13 n term b17 loop antiserum resolved 4 20 gradient sds page panel app consecutively immunoprecipitated cell extracts using antibody 207 45 47 analyzed 6 homogeneous sds page notice difference turnover transfected presenilin 1 transfected app panel c displays quantitative analysis mean plus minus se three independent pulse chase experiments ps1 signals quantitated using phosphorimager points represent fraction ps1 synthesized 10 min pulse remaining period chase indicated results obtained app two experiments also displayed view larger version image 14k gif file
0.46781272.9013610.html.plaintext.txt	40	since levels endogeneous ps1 detectable using classical immunoprecipitation sensitive immunological sandwich type assay developed ps1 immunoprecipitated detergent extracts 10 x 106 untransfected cos 1 cells using polyclonal ps1 antisera small amount transfected cells 05 x 105 added positive control samples immunoprecipitates resolved sds page electrophoresis transferred nitrocellulose filter immunoprecipitated ps1 finally detected mab ps1 3 raised peptide rrvsknskynaesteresqdtvae loop domain ps1 weak signals representing intact endogeneous ps1 revealed untransfected cos 1 cells fig 3c lanes 2 4 endogeneous ps1 migrated mobility 45 kda transfected ps1 best seen experiments using amino terminal domain specific antiserum b13 fig 3c lane 2 since mab ps1 3 recognizes epitope carboxyl terminally located hydrophilic loop combination antibodies expected detect mainly intact ps1 fig 3c lane 2 hydrophilic loop specific antiserum b17 contrast relatively pronounced 18 30 kda fragments visualized together intact ps1 fragments represent likely carboxyl terminal fragments presenilin 35 remarkably observed fragments marginally increased cos 1 cells overexpressing ps1 compare lanes 3 lane 4 fig 3c pulse chase experiments transfected cho cells fig 4 c cos 1 cells results shown showed transfected 45 kda ps1 species half life 4 h fragments seen time point assay either amino terminal b13 hydrophilic loop specific b17 antisera app immunoprecipitated cell extracts fig 4b displayed much faster turnover half life 2 h indicating relative high expression ps1 interfere normal turnover app fig 4 pulse chase metabolic labeling ps1 transfected cho cells cho cells expressing stably human app770 transfected ps1 metabolically labeled 35smethionine 10 min methionine free medium incorporated label chased incubation cells complete medium indicated time ps1 immunoprecipitated cell extracts using b13 n term b17 loop antiserum resolved 4 20 gradient sds page panel app consecutively immunoprecipitated cell extracts using antibody 207 45 47 analyzed 6 homogeneous sds page notice difference turnover transfected presenilin 1 transfected app panel c displays quantitative analysis mean plus minus se three independent pulse chase experiments ps1 signals quantitated using phosphorimager points represent fraction ps1 synthesized 10 min pulse remaining period chase indicated results obtained app two experiments also displayed view larger version image 14k gif file
0.46781272.9013610.html.plaintext.txt	41	posttranslational modification aggregation presenilins
0.46781272.9013610.html.plaintext.txt	42	problem presenilin smears sds page investigated enzymatic digestion immunoprecipitated ps1 ps2 protein glycosidase f 3 milliunits microl o glycanase 60 nanounits microl endoglycosidase h 60 nanounits microl sialidase 100 nanounits microl combinations enzymes affect mobility proteins indicating glycosylation ps1 ps2 occurred results shown digestions heparinase 01 milliunits microl heparitinase 01 milliunits microl chondroitinase ac 5 milliunits microl chondroitinase abc 5 milliunits microl also effect mobility protein smears indicating ps1 modified glycosaminoglycan chains fig 5 negative results independently confirmed metabolic labeling experiments using 3hglucosamine 35so4 radioactive precursors incorporated proteins cell extracts labeled cells signal obtained transfected ps1 immunoprecipitated results shown experiments using 3hpalmitic 3hmyristic acid demonstrated also presenilins incorporate fatty acids fig 5 presenilins modified glycosaminoglycan chains ps1 immunoprecipitated using serum b16 metabolically labeled cos 1 cells transfected wild type ps1 digested heparinase heparitinase chondroitinase abc chondroitinase ac digested material resolved 12 homogeneous sds page activity heparinase heparitinase confirmed using proteoglycans immunopurified fibroblasts 50 activity chondroitinase abc ac demonstrated using test solution chondroitinesulfate clarified addition enzymes molecular size markers indicated left kda view larger version image 39k gif file
0.46781272.9013610.html.plaintext.txt	43	problem presenilin smears sds page investigated enzymatic digestion immunoprecipitated ps1 ps2 protein glycosidase f 3 milliunits microl o glycanase 60 nanounits microl endoglycosidase h 60 nanounits microl sialidase 100 nanounits microl combinations enzymes affect mobility proteins indicating glycosylation ps1 ps2 occurred results shown digestions heparinase 01 milliunits microl heparitinase 01 milliunits microl chondroitinase ac 5 milliunits microl chondroitinase abc 5 milliunits microl also effect mobility protein smears indicating ps1 modified glycosaminoglycan chains fig 5 negative results independently confirmed metabolic labeling experiments using 3hglucosamine 35so4 radioactive precursors incorporated proteins cell extracts labeled cells signal obtained transfected ps1 immunoprecipitated results shown experiments using 3hpalmitic 3hmyristic acid demonstrated also presenilins incorporate fatty acids fig 5 presenilins modified glycosaminoglycan chains ps1 immunoprecipitated using serum b16 metabolically labeled cos 1 cells transfected wild type ps1 digested heparinase heparitinase chondroitinase abc chondroitinase ac digested material resolved 12 homogeneous sds page activity heparinase heparitinase confirmed using proteoglycans immunopurified fibroblasts 50 activity chondroitinase abc ac demonstrated using test solution chondroitinesulfate clarified addition enzymes molecular size markers indicated left kda view larger version image 39k gif file
0.46781272.9013610.html.plaintext.txt	44	sonication boiling samples sds 6 m urea data shown extraction cells presence 5 mm dithiothreitol resolve aggregates fig 6 denaturation immunoprecipitates 37 degrees c instead 95 degrees c reduced aggregates considerably completely fig 6 lane 2 demonstrated aggregates consisted mainly exclusively ps1 radiolabeled species fig 6 also suggested ps aggregates least partially produced processing samples electrophoresis noticed however even freshly prepared material used heating samples avoided protein smears 100 250 kda region remained visible sds page fig 6 fig 6 presenilin aggregates temperature sensitive immunoprecipitated ps1 antiserum b16 transfected cos cells denatured 10 min sds mercapthoethanol 95 degrees c lanes 1 3 37 degrees c lane 2 lane 3 cell extracts prepared presence 5 mm dithiothreitol dtt notice decrease 100 250 kda aggregates slightly increased intensity 45 kda band lane 2 compared lanes 1 3 samples resolved 4 20 sds page view larger version image 28k gif file
0.46781272.9013610.html.plaintext.txt	45	phosphorylation presenilins
0.46781272.9013610.html.plaintext.txt	46	high level serines threonines tyrosines primary amino acid sequences ps1 ps2 suggested possibility ps proteins phosphoproteins 12 13 transfected cos 1 cells fig 7 cho cells fig 8b incorporated 32p presenilins acid hydrolysis immunoprecipitated 32p phosphorylated ps1 ps2 yielded mainly phosphoserine fig 7b longer exposures revealed weak signals phosphothreonine phosphotyrosine never observed phosphorylation ps1 strongly increased ps2 slightly increased treating cells phosphatase inhibitor okadaic acid 300 nm fig 8a okadaic acid inhibits two major classes serinethreonine phosphatases 49 protein kinase c inhibitor staurosporin 300 nm agonists phorbol myristic acid 1 microm phorbol dibutyric acid 1 microm protein kinase agonist forskolin 100 microm effect phosphorylation extent pattern fig 8a attempts phosphorylate immunoprecipitated ps1 vitro using protein kinase protein kinase c remained also negative results shown fig 7 phosphorylation ps1 ps2 serine residues panel transfected cos 1 cells metabolically labeled using 32porthophosphate post nuclear cell extracts prepared see materials methods ps1 ps2 immunoprecipitated antiserum b16 ps1 519 ps2 cos 1 cells transfected psg5 labeled extracted immunoprecipitated antibodies panel b thin layer chromatography hydrolyzed ps1 45 kda ps2 50 kda identifying serine phosphorylated residues mobility phosphoserine phosphothreonine phosphotyrosine y detected ninhydrin staining indicated dotted lines view larger version image 31k gif file
0.46781272.9013610.html.plaintext.txt	47	cytoplasmic orientation amino terminal domain hydrophilic loop domain presenilin 1
0.46781272.9013610.html.plaintext.txt	48	finally addressed issue whether two major hydrophilic domains presenilin 1 ie amino terminal domain hydrophilic loop domain 12 oriented toward cytoplasmic luminal side endoplasmic reticulum current models orientation presenilins membranes based theoretical predictions see discussion domains candidate regions interactions proteins orientation determines whether interaction occurs cytoplasmic endoplasmic reticulum proteins analyze question used low concentrations digitonin selectively permeabilize plasma membrane see materials methods antibodies amino terminal domain antiserum b14 myc tag introduced amino terminus mab 9e10 second loop domain antibody 519 finally hydrophilic loop domain antiserum b16 ps1 monitor permeabilization procedure rat monoclonal antibody luminal endoplasmic reticulum retention signal kdel used 30 31 antibodies amino terminal domain ps1 amino terminally inserted myc tag fig 9a hydrophilic loop fig 9e reacted ps1 digitonin permeabilized cells conditions kdel specific monoclonal antibody result labeling fig 9 e hand antibodies second hydrophilic loop domain 519 reacted ps1 saponin fig 9d digitonin fig 9c used permeabilize cells suggesting luminal localization domain fig 9 cytoplasmic orientation amino terminal domain hydrophilic loop ps1 cos 1 cells transfected ps1myc panels b ps1 wt panels c f permeabilized using digitonin panels c e saponin panels b d f immunostained anti myc mab 9e10 panels b polyclonal antibody 519 second loop domain panels c d polyclonal antibody b16 panels e f rat monoclonal antibody kdel sequence panels f ps1 immunoreactivity observed redyellow staining kdel immunoreactivity green panels b show amino terminus ps1 oriented cytoplasmic side endoplasmic reticulum membrane cells express ps1myc stain strongly amino terminal domain directed 9e10 mab digitonin saponin b permeabilized cells saponin used untransfected cells stained kdel antibody green since reacts endogenous proteins b digitonin used staining observed indicating endoplasmic reticulum membrane permeable antibodies conditions used panels c d similar experiments displayed using antiserum 519 second loop domain staining observed saponin used indicating luminal orientation domain panel d panels e f demonstrate antiserum b16 hydrophilic loop domain ps1 react digitonin e saponin f permeabilized cells indicating cytoplasmic orientation hydrophilic loop view larger version image 91k gif file
0.46781272.9013610.html.plaintext.txt	49	current investigation provides detailed characterization biosynthesis presenilins overexpressed cos 1 cells cho cells results show ps proteins unglycosylated phosphoproteins apparent molecular masses 45 50 kda sds page strong tendency form sds resistant complexes apparent molecular masses 100 250 kda double immunofluorescence studies showed ps1 mainly located endoplasmic reticulum golgi apparatus amino terminal domain hydrophilic loop domain oriented cytoplasmic side
0.46781272.9013610.html.plaintext.txt	50	current investigation provides detailed characterization biosynthesis presenilins overexpressed cos 1 cells cho cells results show ps proteins unglycosylated phosphoproteins apparent molecular masses 45 50 kda sds page strong tendency form sds resistant complexes apparent molecular masses 100 250 kda double immunofluorescence studies showed ps1 mainly located endoplasmic reticulum golgi apparatus amino terminal domain hydrophilic loop domain oriented cytoplasmic side
0.46781272.9013610.html.plaintext.txt	51	localization transfected ps1 endoplasmic reticulum cos 1 cells cho cells simple consequence overexpression protein nonspecific general effects biosynthetic pathway cells first endogeneous presenilins located endoplasmic reticulum untransfected cells demonstrated fig 1a using confocal laser microscopy second using identical transfection conditions app furin found accumulate golgi apparatus demonstrated 33 34 third turnover fig 4 secretory processing app3 cho cells stably expressing human app770 affected transfection ps1 ruling general inhibitory effects protein transport processing hand levels endogeneous presenilin cos 1 cells apparently low combination immunoprecipitation concentrate ps1 detergent extracts 10 x 106 cells followed immunoblotting using mab ps1 3 allowed us detect endogeneous ps1 migrating molecular weight transfected ps1 disadvantage approach antibodies immunoprecipitation step interfere consecutive detection possible ps aggregates immunoblotting step fig 3c assay also precludes dynamic analysis metabolism presenilins using metabolic labeling pulse chase experiments hand allowed us demonstrate presence absence particular antibody epitopes ps1 fragments importantly use hydrophilic loop specific antibodies immunoprecipitation step resulted detection relative large amounts presumably proteolytic fragments ps1 18 30 kda range fig 3c level fragments slightly increased cos 1 cells overexpressed ps1 explains readily detected transfection experiments proteolytic process involved probably easily saturated even inhibited ps overexpression 35 36 data therefore allow us speculate exact nature biological significance process conclude overexpression studies type used suitable study particular aspect presenilin metabolism hand clear untransfected cells fig 3 brain tissue vivo 36 37 contain detectable amounts intact presenilin since endogeneously expressed ps1 mobility transfected ps1 conclusion transfected ps1 ps2 subject glycosylation sulfation glycosaminoglycan modification palmitoylation myristoylation also holds apparently true endogeneous protein posttranslational modifications thereby also excluded contributing formation high molecular mass sds resistant aggregates 100 250 kda sds page electrophoresis aggregates observed variable extent experiments noticed others using cell types brain tissue 36 38 39 since smears detected three different antibodies recognizing three different epitopes myc directed mab using myc tagged ps1 construct aggregates must contain presenilin core proteins alone associated unidentified components denaturation immunoprecipitates 37 degrees c instead 95 degrees c resulted less aggregates increased amounts 45 kda ps1 band fig 3c aggregates therefore probably consist mainly oligomers presenilins unclear whether property form sds resistant aggregates vitro physiological significance vivo immuno electron microscope observations suggest clustering presenilins also occurs endoplasmic reticulum untransfected cells2 envisaged pathological conditions exacerbated aggregation presenilins could become problem context mentioned antibodies ps1 stain amyloid plaques brains alzheimers disease patients 40
0.46781272.9013610.html.plaintext.txt	52	localization transfected ps1 endoplasmic reticulum cos 1 cells cho cells simple consequence overexpression protein nonspecific general effects biosynthetic pathway cells first endogeneous presenilins located endoplasmic reticulum untransfected cells demonstrated fig 1a using confocal laser microscopy second using identical transfection conditions app furin found accumulate golgi apparatus demonstrated 33 34 third turnover fig 4 secretory processing app3 cho cells stably expressing human app770 affected transfection ps1 ruling general inhibitory effects protein transport processing hand levels endogeneous presenilin cos 1 cells apparently low combination immunoprecipitation concentrate ps1 detergent extracts 10 x 106 cells followed immunoblotting using mab ps1 3 allowed us detect endogeneous ps1 migrating molecular weight transfected ps1 disadvantage approach antibodies immunoprecipitation step interfere consecutive detection possible ps aggregates immunoblotting step fig 3c assay also precludes dynamic analysis metabolism presenilins using metabolic labeling pulse chase experiments hand allowed us demonstrate presence absence particular antibody epitopes ps1 fragments importantly use hydrophilic loop specific antibodies immunoprecipitation step resulted detection relative large amounts presumably proteolytic fragments ps1 18 30 kda range fig 3c level fragments slightly increased cos 1 cells overexpressed ps1 explains readily detected transfection experiments proteolytic process involved probably easily saturated even inhibited ps overexpression 35 36 data therefore allow us speculate exact nature biological significance process conclude overexpression studies type used suitable study particular aspect presenilin metabolism hand clear untransfected cells fig 3 brain tissue vivo 36 37 contain detectable amounts intact presenilin since endogeneously expressed ps1 mobility transfected ps1 conclusion transfected ps1 ps2 subject glycosylation sulfation glycosaminoglycan modification palmitoylation myristoylation also holds apparently true endogeneous protein posttranslational modifications thereby also excluded contributing formation high molecular mass sds resistant aggregates 100 250 kda sds page electrophoresis aggregates observed variable extent experiments noticed others using cell types brain tissue 36 38 39 since smears detected three different antibodies recognizing three different epitopes myc directed mab using myc tagged ps1 construct aggregates must contain presenilin core proteins alone associated unidentified components denaturation immunoprecipitates 37 degrees c instead 95 degrees c resulted less aggregates increased amounts 45 kda ps1 band fig 3c aggregates therefore probably consist mainly oligomers presenilins unclear whether property form sds resistant aggregates vitro physiological significance vivo immuno electron microscope observations suggest clustering presenilins also occurs endoplasmic reticulum untransfected cells2 envisaged pathological conditions exacerbated aggregation presenilins could become problem context mentioned antibodies ps1 stain amyloid plaques brains alzheimers disease patients 40
0.46781272.9013610.html.plaintext.txt	53	importantly two point mutations causing alzheimers disease studied ie ps1 ala 246 glu fad1 kindred ps1 cys 410 tyr nih2 kindred alter biosynthesis level expression ps1 protein cos 1 cells cho cells mutations must cause therefore subtle effects possibility interfere fragmentation ps1 shown recently two mutations 35 36 cannot excluded current data analysis brains transgenic mice expressing ps1 ala 246 glu mutant indicate however least mutation interfere proteolytic processing ps14 since ps mutations known date act dominant way pathogenesis alzheimers disease gain function likely evidence fibroblasts derived patients presenilin mutations produce longer forms a4 amyloid peptide suggests mutations exert effect cellular metabolism trafficking amyloid precursor protein 21 localization ps1 early compartments biosynthetic pathway makes unlikely presenilin mutations directly influence andor secretase activity since operate late golgi transport vesicles cell surface endosomes 27 41 43 possibility ps mutants influence balance amyloidogenic non amyloidogenic processing app indirect way changing intracellular trafficking explored polarized madin darby canine kidney cells neurons 16 44 45
0.46781272.9013610.html.plaintext.txt	54	study demonstrates furthermore presenilins phosphorylated serine residues phosphorylation ps1 ps2 evident cos 1 cells cho cells phosphorylation ps1 less intense variable ps2 observation okadaic acid enhanced ps1 phosphorylation suggests ps1 prone phosphatase activity ps2 fig 8a protein kinase c responsible ps phosphorylation since neither stimulation cells phorbol esters purified kinase added immunoprecipitated ps1 ps2 resulted increased labeling therefore unlikely presenilins directly involved regulation app secretion protein kinase c 46 47
0.46781272.9013610.html.plaintext.txt	55	study demonstrates furthermore presenilins phosphorylated serine residues phosphorylation ps1 ps2 evident cos 1 cells cho cells phosphorylation ps1 less intense variable ps2 observation okadaic acid enhanced ps1 phosphorylation suggests ps1 prone phosphatase activity ps2 fig 8a protein kinase c responsible ps phosphorylation since neither stimulation cells phorbol esters purified kinase added immunoprecipitated ps1 ps2 resulted increased labeling therefore unlikely presenilins directly involved regulation app secretion protein kinase c 46 47
0.46781272.9013610.html.plaintext.txt	56	finally showed hydrophilic nh2 terminal major loop domain ps1 exposed cytoplasmic side endoplasmic reticulum membrane digitonin low concentrations selectively permeabilizes cell membrane endoplasmic reticulum membrane 29 antibodies directed toward amino terminal domain ps1 fig 9 displayed similar immunofluorescent staining patterns digitonin saponin permeabilized cells control experiments antibodies luminal epitope ie kdel endoplasmic reticulum retention signal 30 31 showed digitonin permeabilize endoplasmic reticulum membrane major hydrophilic loop domain essentially identical results obtained conclusion therefore two major hydrophilic domains ps1 oriented cytoplasmic side endoplasmic reticulum directs search candidate proteins interacting domains toward cytoplasm consistent conclusion antibodies second loop domain reacted ps1 saponin digitonin permeabilization confirms luminal localization recognized epitope also validates approach used
0.46781272.9013610.html.plaintext.txt	57	finally showed hydrophilic nh2 terminal major loop domain ps1 exposed cytoplasmic side endoplasmic reticulum membrane digitonin low concentrations selectively permeabilizes cell membrane endoplasmic reticulum membrane 29 antibodies directed toward amino terminal domain ps1 fig 9 displayed similar immunofluorescent staining patterns digitonin saponin permeabilized cells control experiments antibodies luminal epitope ie kdel endoplasmic reticulum retention signal 30 31 showed digitonin permeabilize endoplasmic reticulum membrane major hydrophilic loop domain essentially identical results obtained conclusion therefore two major hydrophilic domains ps1 oriented cytoplasmic side endoplasmic reticulum directs search candidate proteins interacting domains toward cytoplasm consistent conclusion antibodies second loop domain reacted ps1 saponin digitonin permeabilization confirms luminal localization recognized epitope also validates approach used
0.46781272.9013610.html.plaintext.txt	58	detailed studies including electron microscopy enzymatic digestion protection assays required settle definitively orientation presenilins endoplasmic reticulum membrane results clarify already two important issues first problem orientation first transmembrane domain ps1 determines fact topology following transmembrane domains 46 positive charge difference 15 carboxyl terminal 15 amino terminal residues flanking first membrane spanning domain suggests luminal orientation amino terminus 48 however several exceptions rule known mainly proteins amino terminal domain contains 17 charged amino acid residues 48 ps1 domain contains 29 charged residues would explain cytoplasmic orientation second issue pointed others 9 13 17 whether two putative hydrophobic stretches ps amino acid sequence flanking hydrophilic loop additionally span membrane would make presenilins nine transmembrane domain proteins data compatible seven transmembrane domain model amino terminal domain hydrophilic loop located cytoplasm fig 10 see also note added proof conclusion current study analyzed biosynthesis subcellular localization presenilins provides basis study cell biology possible interactions integral membrane cytoplasmic proteins app tau implicated pathogenesis alzheimers disease 4 fig 10 localization antibody epitopes orientation ps1 endoplasmic reticulum membrane ps1 inserted endoplasmic reticulum membrane amino terminal nh2 hydrophilic loop domain cytoplasmic side localization peptides used raise different antibodies used study topology ps1 indicated bars sequence see also materials methods note added proof view larger version image 13k gif file
0.46781272.9013610.html.plaintext.txt	59	detailed studies including electron microscopy enzymatic digestion protection assays required settle definitively orientation presenilins endoplasmic reticulum membrane results clarify already two important issues first problem orientation first transmembrane domain ps1 determines fact topology following transmembrane domains 46 positive charge difference 15 carboxyl terminal 15 amino terminal residues flanking first membrane spanning domain suggests luminal orientation amino terminus 48 however several exceptions rule known mainly proteins amino terminal domain contains 17 charged amino acid residues 48 ps1 domain contains 29 charged residues would explain cytoplasmic orientation second issue pointed others 9 13 17 whether two putative hydrophobic stretches ps amino acid sequence flanking hydrophilic loop additionally span membrane would make presenilins nine transmembrane domain proteins data compatible seven transmembrane domain model amino terminal domain hydrophilic loop located cytoplasm fig 10 see also note added proof conclusion current study analyzed biosynthesis subcellular localization presenilins provides basis study cell biology possible interactions integral membrane cytoplasmic proteins app tau implicated pathogenesis alzheimers disease 4 fig 10 localization antibody epitopes orientation ps1 endoplasmic reticulum membrane ps1 inserted endoplasmic reticulum membrane amino terminal nh2 hydrophilic loop domain cytoplasmic side localization peptides used raise different antibodies used study topology ps1 indicated bars sequence see also materials methods note added proof view larger version image 13k gif file
0.46781272.9013610.html.plaintext.txt	60	investigation supported grants fonds voor geneeskundig wetenschappelijk onderzoek fgwo nfwo human frontiers science program hfsp action program biotechnology flemish government vlab flemish institute biotechnology vib katholieke universiteit leuven alzheimers society ontario medical research council canada costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact onderzoeksleider national fund scientific research belgium nfwo correspondence addressed campus gasthuisberg o n 06 3000 leuven belgium fax 32 16 345871 e mail bartdestrooperatmedkuleuvenacbe u d 1 abbreviations used ps2 presenilin 2 ps1 presenilin 1 app amyloid precursor protein mab monoclonal antibody pbs phosphate buffered saline tbs tris buffered saline fitc fluorescein isothiocyanate tritc tetramethylrhodamine isothiocyanate page polyacrylamide gel electrophoresis pipes 14 piperazinediethanesulfonic acid nsp neuroendocrine specific protein 2 p fraser unpublished results 3 b de strooper k craessaerts unpublished results 4 d moechars b de strooper f van leuven unpublished results acknowledgments
0.46781272.9013610.html.plaintext.txt	61	investigation supported grants fonds voor geneeskundig wetenschappelijk onderzoek fgwo nfwo human frontiers science program hfsp action program biotechnology flemish government vlab flemish institute biotechnology vib katholieke universiteit leuven alzheimers society ontario medical research council canada costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact onderzoeksleider national fund scientific research belgium nfwo correspondence addressed campus gasthuisberg o n 06 3000 leuven belgium fax 32 16 345871 e mail bartdestrooperatmedkuleuvenacbe u d 1 abbreviations used ps2 presenilin 2 ps1 presenilin 1 app amyloid precursor protein mab monoclonal antibody pbs phosphate buffered saline tbs tris buffered saline fitc fluorescein isothiocyanate tritc tetramethylrhodamine isothiocyanate page polyacrylamide gel electrophoresis pipes 14 piperazinediethanesulfonic acid nsp neuroendocrine specific protein 2 p fraser unpublished results 3 b de strooper k craessaerts unpublished results 4 d moechars b de strooper f van leuven unpublished results acknowledgments
0.46781272.9013610.html.plaintext.txt	62	gratefully acknowledge contribution expertise materials following scientists b greenberg roebroek j creemers w van de ven g schellenberg geriatric research education clinical center seattle wa
0.46781272.9013610.html.plaintext.txt	63	eight transmembrane model hydrophobic region viii loop domain spanning endoplasmic reticulum membrane also compatible data would result cytoplasmic orientation carboxyl terminal domain ps1
0.46781272.9013610.html.plaintext.txt	64	eight transmembrane model hydrophobic region viii loop domain spanning endoplasmic reticulum membrane also compatible data would result cytoplasmic orientation carboxyl terminal domain ps1
0.47823864.11983636.html.plaintext.txt	0	genetic host factors dementia downs syndrome nicole schupf phd
0.47823864.11983636.html.plaintext.txt	1	laboratory epidemiology new york state institute basic research developmental disabilities staten island
0.47823864.11983636.html.plaintext.txt	2	center columbia university college physicians surgeons new york usa
0.47823864.11983636.html.plaintext.txt	3	correspondence nicole schupf phd new york state institute basic research 1050 forest hill road staten island ny 10314 tel 001 718 494 5301 fax 001 718 494 5395 e mail ns24atcolumbiaedu
0.47823864.11983636.html.plaintext.txt	4	correspondence nicole schupf phd new york state institute basic research 1050 forest hill road staten island ny 10314 tel 001 718 494 5301 fax 001 718 494 5395 e mail ns24atcolumbiaedu
0.47823864.11983636.html.plaintext.txt	5	declaration interest grants iirg 90 067 rg3 96 077 alzheimers association federal grants ag14673 hd35897 p50ag08702 funds new york state office mental retardation developmental disabilities
0.47823864.11983636.html.plaintext.txt	6	presented part blake marsh lecture annual meeting royal college psychiatrists 6 july 2000 edinburgh
0.47823864.11983636.html.plaintext.txt	7	abstract top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references background high risk dementia adults downs syndrome attributed triplication overexpression gene amyloid precursor protein app wide variation age onset must due risk factors
0.47823864.11983636.html.plaintext.txt	8	aims identify factors influence age onset dementia downs syndrome
0.47823864.11983636.html.plaintext.txt	9	method studies factors influence formation beta amyloid ass reviewed including atypical karyotypes susceptibility genotypes gender oestrogen deficiency individual differences ass peptide levels
0.47823864.11983636.html.plaintext.txt	10	results apolipoprotein e 4 allele oestrogen deficiency high levels ass1 42 peptide associated earlier onset dementia atypical karyotypes apolipoprotein e 2 allele associated reduced mortality reduced risk dementia
0.47823864.11983636.html.plaintext.txt	11	conclusions factors influence ass levels rather overexpression app may account differences age onset dementia downs syndrome
0.47823864.11983636.html.plaintext.txt	12	introduction top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references alzheimers disease associated characteristic neuropathology includes deposition extracellular beta amyloid ass neuritic plaques intracellular accumulation neurofibrillary tangles adults downs syndrome high levels ass deposition age 40 years early onset dementia however average age onset clinical dementia 55 years varies widely neuropathological manifestations alzheimers disease downs syndrome attributed triplication expression gene beta amyloid precursor protein app located chromosome 21 factors influencing age onset dementia unresolved factors influence formation deposition ass reviewed including atypical karyotypes susceptibility genotypes gender oestrogen deficiency individual differences ass peptide levels factors modify rate degree ass deposition rather expression app may important determinants risk dementia downs syndrome
0.47823864.11983636.html.plaintext.txt	13	amyloid cascade hypothesis top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references although controversy relative importance plaques versus tangles development alzheimers disease increasing evidence altered metabolism ass peptides amyloid deposition neuritic plaques causes alzheimers disease triggering complex pathological cascade produces dementia ass peptides ass1 40 ass1 42 two major species ass generated app sequential proteolytic cleavage ss secretases enzymes ones involved breakdown app secretase cleaves full length app producing soluble sapp subsequently p3 processing secretase precludes production full length ass peptides anti amyloidogenic younkin 1998
0.47823864.11983636.html.plaintext.txt	14	several lines evidence suggest deposition ass 42 important initial step pathogenesis alzheimers disease ass1 42 aggregates rapidly deposited earlier alzheimers disease plaques ass1 40 iwatsubo et al 1994 mutations gene app presenilin ps12 genes associated early onset familial alzheimers disease selective increase ass1 42 borchelt et al 1996 mann et al 1996 scheuner et al 1996 kosaka et al 1997 younkin 1998 brain levels ass1 42 increase early development alzheimers disease strongly correlated cognitive decline cummings cotman 1995 naslund et al 2000 plasma levels ass1 42 higher elderly people subsequently develop alzheimers disease remain free dementia mayeux et al 1999
0.47823864.11983636.html.plaintext.txt	15	several lines evidence suggest deposition ass 42 important initial step pathogenesis alzheimers disease ass1 42 aggregates rapidly deposited earlier alzheimers disease plaques ass1 40 iwatsubo et al 1994 mutations gene app presenilin ps12 genes associated early onset familial alzheimers disease selective increase ass1 42 borchelt et al 1996 mann et al 1996 scheuner et al 1996 kosaka et al 1997 younkin 1998 brain levels ass1 42 increase early development alzheimers disease strongly correlated cognitive decline cummings cotman 1995 naslund et al 2000 plasma levels ass1 42 higher elderly people subsequently develop alzheimers disease remain free dementia mayeux et al 1999
0.47823864.11983636.html.plaintext.txt	16	virtually individuals downs syndrome neuropathological changes consistent diagnosis alzheimers disease time reach 40 years age including deposition ass diffuse neuritic plaques wisniewski h et al 1995 mann 1988 develop dementia end seventh decade life lai williams 1989 despite nearly universal occurrence alzheimers disease pathology middle age wide variation age onset dementia prevalence alzheimers disease age 65 ranged 30 75 zigman et al 1997 studies shown average age onset dementia 50 55 years range 38 70 years lai williams 1989 prasher krishnan 1993 methodological problems may account variation estimated prevalence alzheimers disease downs syndrome diagnosis alzheimers disease population requires documentation clinically significant decline cognitive adaptive competence previously attained levels performance documentation absence condition might cause declines performance aylward et al 1997 requirements particularly difficult address adults downs syndrome given lifelong intellectual disability wide range premorbid levels performance associated differences level intellectual disability requires specific criteria clinically significant decline indicative dementia level function beginning developed yet consensus set cognitive assessment tasks diagnostic criteria existing cognitive assessment batteries differentiate adults downs syndrome dementia early stages presently diagnoses alzheimers disease adults downs syndrome made clinically relatively late stages disease without systematic cognitive functional testing time
0.47823864.11983636.html.plaintext.txt	17	virtually individuals downs syndrome neuropathological changes consistent diagnosis alzheimers disease time reach 40 years age including deposition ass diffuse neuritic plaques wisniewski h et al 1995 mann 1988 develop dementia end seventh decade life lai williams 1989 despite nearly universal occurrence alzheimers disease pathology middle age wide variation age onset dementia prevalence alzheimers disease age 65 ranged 30 75 zigman et al 1997 studies shown average age onset dementia 50 55 years range 38 70 years lai williams 1989 prasher krishnan 1993 methodological problems may account variation estimated prevalence alzheimers disease downs syndrome diagnosis alzheimers disease population requires documentation clinically significant decline cognitive adaptive competence previously attained levels performance documentation absence condition might cause declines performance aylward et al 1997 requirements particularly difficult address adults downs syndrome given lifelong intellectual disability wide range premorbid levels performance associated differences level intellectual disability requires specific criteria clinically significant decline indicative dementia level function beginning developed yet consensus set cognitive assessment tasks diagnostic criteria existing cognitive assessment batteries differentiate adults downs syndrome dementia early stages presently diagnoses alzheimers disease adults downs syndrome made clinically relatively late stages disease without systematic cognitive functional testing time
0.47823864.11983636.html.plaintext.txt	18	neuropathological manifestations alzheimers disease downs syndrome attributed triplication overexpression gene app located chromosome 21 rumble et al 1989 increased risk dementia downs syndrome may mediated increased substrate cellular production ass peptides recent neuropathological studies shown diffuse plaques prevalent alzheimer type lesion seen individuals downs syndrome age 50 associated dementia diffuse plaques contain non fibrillar amyloid appear younger ages neuritic plaques associated neuronal degeneration appear affect structure function neurons contrast increases numbers neuritic plaques containing substantial amounts fibrillised ass peptides observed adults downs syndrome predominantly 50 years age associated neuronal degeneration loss function wisniewski et al 1995 examination age specific prevalence dementia downs syndrome supports hypothesis clinical manifestations alzheimers disease downs syndrome closely associated development fibrillised plaques lai williams 1989 visser et al 1997 holland et al 1998 lai et al 1999 see fig 1 although prevalence studies employed varying sampling diagnostic methods remarkable agreement across studies risk alzheimers disease increases primarily 50 years age addition adults downs syndrome develop dementia even reach ages presence high densities neuritic plaques presumed thus triplication gene app may serve increase diffuse plaques adults downs syndrome factors distinct app triplication must account individual differences susceptibility formation fibrillised plaques wide range age onset dementia central task epidemiology dementia downs syndrome identify factors may influence risk alzheimers disease accelerating formation ass several avenues investigation suggested existing findings review role atypical karyotypes b genetic susceptibility factors c gender oestrogen deficiency d individual differences ass peptide levels
0.47823864.11983636.html.plaintext.txt	19	neuropathological manifestations alzheimers disease downs syndrome attributed triplication overexpression gene app located chromosome 21 rumble et al 1989 increased risk dementia downs syndrome may mediated increased substrate cellular production ass peptides recent neuropathological studies shown diffuse plaques prevalent alzheimer type lesion seen individuals downs syndrome age 50 associated dementia diffuse plaques contain non fibrillar amyloid appear younger ages neuritic plaques associated neuronal degeneration appear affect structure function neurons contrast increases numbers neuritic plaques containing substantial amounts fibrillised ass peptides observed adults downs syndrome predominantly 50 years age associated neuronal degeneration loss function wisniewski et al 1995 examination age specific prevalence dementia downs syndrome supports hypothesis clinical manifestations alzheimers disease downs syndrome closely associated development fibrillised plaques lai williams 1989 visser et al 1997 holland et al 1998 lai et al 1999 see fig 1 although prevalence studies employed varying sampling diagnostic methods remarkable agreement across studies risk alzheimers disease increases primarily 50 years age addition adults downs syndrome develop dementia even reach ages presence high densities neuritic plaques presumed thus triplication gene app may serve increase diffuse plaques adults downs syndrome factors distinct app triplication must account individual differences susceptibility formation fibrillised plaques wide range age onset dementia central task epidemiology dementia downs syndrome identify factors may influence risk alzheimers disease accelerating formation ass several avenues investigation suggested existing findings review role atypical karyotypes b genetic susceptibility factors c gender oestrogen deficiency d individual differences ass peptide levels
0.47823864.11983636.html.plaintext.txt	20	view larger version 14k fig 1 age specific prevalence dementia adults downs syndrome data lai williams 1989 data visser et al 1997 data lai et al 1999 data holland et al 1998
0.47823864.11983636.html.plaintext.txt	21	view larger version 14k fig 1 age specific prevalence dementia adults downs syndrome data lai williams 1989 data visser et al 1997 data lai et al 1999 data holland et al 1998
0.47823864.11983636.html.plaintext.txt	22	atypical karyotypes top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references evidence case studies adults downs syndrome atypical karyotypes including translocations partial trisomies varying degrees mosaicism associated improved survival decreased risk alzheimers disease prasher et al 1998 presented interesting case 78 year old woman partial trisomy 21 46xxrec21dup q inv21p12q221 conducted comprehensive analysis clinical molecular genetic correlates partial trisomy general appearance suggestive typical downs syndrome phenotype experienced several common age related medical conditions characteristic downs syndrome including hypothyroidism cataracts hypotonia hearing impairment analysis gene sequences chromosome 21 using fluorescent situ hybridisation showed partial trisomy excluded region containing gene app present two copies evidence decline cognitive adaptive competence 5 years preceding death pneumonia evidence alzheimers disease found magnetic resonance imaging neuropathological assessment similarly two reports women downs syndrome 25 86 disomy chromosome 21 respectively chicoine mcguire 1997 w b zigman personal communication 2000 women characteristic downs syndrome phenotype typical age related medical conditions including hypothyroidism cataracts woman 25 disomy chromosome 21 died age 83 following hospitalisation hip fracture free dementia death woman 86 disomy still living age 74 shows evidence dementia based evaluations cognitive adaptive behaviour
0.47823864.11983636.html.plaintext.txt	23	genetic susceptibility factors top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references four genes increase risk alzheimers disease identified mutations three genes app presenilin 1 ps1 presenilin 2 ps2 associated early onset familial forms alzheimers disease transmitted autosomal dominant goate et al 1991 levy lehad et al 1995 sherrington et al 1995 homozygosity common variant ps1 1 allele associated increased risk alzheimers disease studies higuchi et al 1996 kehoe et al 1996 scott et al 1996 wragg et al 1996 one study examined influence ps1 alleles risk dementia downs syndrome study adults downs syndrome significant differences allele frequencies individuals dementia age matched individuals without dementia tyrrell et al 1999
0.47823864.11983636.html.plaintext.txt	24	polymorphisms gene apolipoprotein e apoe associated risk common late onset alzheimers disease onset 65 years age three common variants gene apoe encoded three alleles 2 3 4 numerous cross sectional case control studies patients alzheimers disease found significantly likely peers one copies apoe 4 allele corder et al 1993 mayeux et al 1993 saunders et al 1993 apoe 4 protein may act increasing rate process leads alzheimers disease predisposing greater accumulation ass without alzheimers disease roses et al 1994 hyman et al 1995 polvikoski et al 1995 presence least common allele apoe 2 associated delay disease onset even protection investigators corder et al 1994 roses et al 1994
0.47823864.11983636.html.plaintext.txt	25	polymorphisms gene apolipoprotein e apoe associated risk common late onset alzheimers disease onset 65 years age three common variants gene apoe encoded three alleles 2 3 4 numerous cross sectional case control studies patients alzheimers disease found significantly likely peers one copies apoe 4 allele corder et al 1993 mayeux et al 1993 saunders et al 1993 apoe 4 protein may act increasing rate process leads alzheimers disease predisposing greater accumulation ass without alzheimers disease roses et al 1994 hyman et al 1995 polvikoski et al 1995 presence least common allele apoe 2 associated delay disease onset even protection investigators corder et al 1994 roses et al 1994
0.47823864.11983636.html.plaintext.txt	26	apolipoprotein e downs syndrome relation apoe genotype risk alzheimers disease downs syndrome difficult establish studies consistently found presence apoe 2 allele increases longevity reduces risk dementia role 4 allele controversial hardy et al 1994 royston et al 1994 martins et al 1995 van gool et al 1995 cosgrave et al 1996 lambert et al 1996 schupf et al 1996 prasher et al 1997 schupf et al 1998 sekijima et al 1998 tyrrell et al 1998 lai et al 1999 rubinszstein et al 1999 deb et al 2000 small sample sizes importantly failure consider differences age onset dementia among without 4 allele may account negative findings since effect 4 allele expressed midlife inclusion sufficient numbers adults 50 years age analysis using survival methods adjust age years follow important methodological considerations group used survival methods analysis found presence 4 allele associated earlier onset dementia greater decline adaptive behaviour schupf et al 1996 compared apoe 33 genotype adults downs syndrome 4 allele five times likely develop dementia age 65 one 2 allele developed dementia see fig 2 among affected individuals mean age onset dementia 533 years 4 allele 580 years 33 genotype four studies found increased frequency 4 allele adults downs syndrome dementia compared downs syndrome without dementia martins et al 1995 sekijima et al 1998 rubinsztein et al 1999 deb et al 2000
0.47823864.11983636.html.plaintext.txt	27	apolipoprotein e downs syndrome relation apoe genotype risk alzheimers disease downs syndrome difficult establish studies consistently found presence apoe 2 allele increases longevity reduces risk dementia role 4 allele controversial hardy et al 1994 royston et al 1994 martins et al 1995 van gool et al 1995 cosgrave et al 1996 lambert et al 1996 schupf et al 1996 prasher et al 1997 schupf et al 1998 sekijima et al 1998 tyrrell et al 1998 lai et al 1999 rubinszstein et al 1999 deb et al 2000 small sample sizes importantly failure consider differences age onset dementia among without 4 allele may account negative findings since effect 4 allele expressed midlife inclusion sufficient numbers adults 50 years age analysis using survival methods adjust age years follow important methodological considerations group used survival methods analysis found presence 4 allele associated earlier onset dementia greater decline adaptive behaviour schupf et al 1996 compared apoe 33 genotype adults downs syndrome 4 allele five times likely develop dementia age 65 one 2 allele developed dementia see fig 2 among affected individuals mean age onset dementia 533 years 4 allele 580 years 33 genotype four studies found increased frequency 4 allele adults downs syndrome dementia compared downs syndrome without dementia martins et al 1995 sekijima et al 1998 rubinsztein et al 1999 deb et al 2000
0.47823864.11983636.html.plaintext.txt	28	view larger version 13k fig 2 cumulative incidence dementia adults downs syndrome apolipoprotein e apoe genotype unk unk apoe 34 44 genotypes apoe 33 genotype apoe 22 23 24 genotypes based schupf et al 1996 kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	29	view larger version 13k fig 2 cumulative incidence dementia adults downs syndrome apolipoprotein e apoe genotype unk unk apoe 34 44 genotypes apoe 33 genotype apoe 22 23 24 genotypes based schupf et al 1996 kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	30	results studies apoe genotype adults downs syndrome mixed several studies found apoe 2 allele decreased risk dementia sample sizes small demonstrate significant effect 4 allele hardy et al 1994 royston et al 1994 wisniewski et al 1995 two case control studies adults downs syndrome compared allele frequencies individuals without dementia found significant association apoe genotype alzheimers disease adjust age van gool et al 1995 prasher et al 1997 one large study examined 100 adults downs syndrome 40 70 years age used survival analyses examine age onset dementia apoe genotype lai et al 1999 cumulative incidence dementia age 65 55 apoe 23 genotype 88 apoe 33 genotype 100 4 allele effect 4 allele stronger younger ages consistent findings studies general population effect 4 allele accelerate onset alzheimers disease corder et al 1993 saunders et al 1993 meyer et al 1998 cumulative incidence age 55 071 among 4 allele 040 among apoe 33 genotype authors suggested 4 effect study may attenuated high rates dementia advanced ages concluded effect 4 allele may dependent age study sample
0.47823864.11983636.html.plaintext.txt	31	results studies apoe genotype adults downs syndrome mixed several studies found apoe 2 allele decreased risk dementia sample sizes small demonstrate significant effect 4 allele hardy et al 1994 royston et al 1994 wisniewski et al 1995 two case control studies adults downs syndrome compared allele frequencies individuals without dementia found significant association apoe genotype alzheimers disease adjust age van gool et al 1995 prasher et al 1997 one large study examined 100 adults downs syndrome 40 70 years age used survival analyses examine age onset dementia apoe genotype lai et al 1999 cumulative incidence dementia age 65 55 apoe 23 genotype 88 apoe 33 genotype 100 4 allele effect 4 allele stronger younger ages consistent findings studies general population effect 4 allele accelerate onset alzheimers disease corder et al 1993 saunders et al 1993 meyer et al 1998 cumulative incidence age 55 071 among 4 allele 040 among apoe 33 genotype authors suggested 4 effect study may attenuated high rates dementia advanced ages concluded effect 4 allele may dependent age study sample
0.47823864.11983636.html.plaintext.txt	32	findings consistent reduced ass deposition polvikoski et al 1995 less plaque formation benjamin et al 1994 lippa et al 1994 2 allele acceleration ass pathology 4 allele hymen et al 1995 polvikoski et al 1995 size 4 effect relation presence 4 allele early mortality interaction apoe genotype risk factors dementia downs syndrome gender level learning disability remain resolved require larger older samples analytic procedures provide better adjustment age potential confounders
0.47823864.11983636.html.plaintext.txt	33	findings consistent reduced ass deposition polvikoski et al 1995 less plaque formation benjamin et al 1994 lippa et al 1994 2 allele acceleration ass pathology 4 allele hymen et al 1995 polvikoski et al 1995 size 4 effect relation presence 4 allele early mortality interaction apoe genotype risk factors dementia downs syndrome gender level learning disability remain resolved require larger older samples analytic procedures provide better adjustment age potential confounders
0.47823864.11983636.html.plaintext.txt	34	gender oestrogen deficiency top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references loss gonadal hormones following menopause may important determinant cognitive decline risk alzheimers disease ageing women menopause oestrogen promotes growth prolongs survival cholinergic neurons brain regions serving cognitive function toran allerand et al 1992 increases cholinergic activity antioxidant properties regulates metabolism app protect formation ass jaffe et al 1994 goodman et al 1996 petanceska et al 2000
0.47823864.11983636.html.plaintext.txt	35	human studies data show higher age specific rates alzheimers disease women compared men bachman et al 1993 approximately half risk alzheimers disease women received oestrogen replacement therapy barrett conner kritz silverstein 1993 brenner et al 1994 henderson et al 1994 paganini hill henderson 1994 mortel meyer 1995 tang et al 1996 findings support hypothesis oestrogen deficiency contributes aetiology alzheimers disease contrast randomised controlled clinical trials oestrogen replacement therapy women moderate severe alzheimers disease failed show cognitive improvement suggesting major effect oestrogen delay onset rather reverse cognitive functional decline henderson et al 2000 mulnard et al 2000
0.47823864.11983636.html.plaintext.txt	36	human studies data show higher age specific rates alzheimers disease women compared men bachman et al 1993 approximately half risk alzheimers disease women received oestrogen replacement therapy barrett conner kritz silverstein 1993 brenner et al 1994 henderson et al 1994 paganini hill henderson 1994 mortel meyer 1995 tang et al 1996 findings support hypothesis oestrogen deficiency contributes aetiology alzheimers disease contrast randomised controlled clinical trials oestrogen replacement therapy women moderate severe alzheimers disease failed show cognitive improvement suggesting major effect oestrogen delay onset rather reverse cognitive functional decline henderson et al 2000 mulnard et al 2000
0.47823864.11983636.html.plaintext.txt	37	gender differences effects oestrogen downs syndrome systematically investigated work needed clarify hormonal risk factors may influence onset dementia studies presented results separately men women studies compared women men found conflicting results different studies showing earlier onset raghaven et al 1994 lai et al 1999 later onset farrer et al 1997 schupf et al 1998 difference age onset visser et al 1997 lai williams 1989 gender two studies employed survival methods examine age onset distributions gender adjusting age level learning disability found conflicting results colleagues found men downs syndrome three times likely women develop alzheimers disease age 65 see fig 3a effect gender observed age groups 50 years schupf et al 1998 men women downs syndrome show elevations follicle stimulating hormone fsh luteinising hormone puberty indicative primary gonadal dysfunction appear progress age frequent men women hasen et al 1980 campbell et al 1982 hsiang et al 1987 hestnes et al 1991 thus older men may benefit relative preservation oestrogen proposed account lower risk alzheimers disease men general population contrast another study found women downs syndrome approximately twice likely develop dementia men lai et al 1999 see fig 3b study effect gender seen primarily younger ages studies gender differences largest apoe 33 genotype suggesting high risk associated presence apoe 4 allele mask gender effects basis different results studies gender differences clear
0.47823864.11983636.html.plaintext.txt	38	gender differences effects oestrogen downs syndrome systematically investigated work needed clarify hormonal risk factors may influence onset dementia studies presented results separately men women studies compared women men found conflicting results different studies showing earlier onset raghaven et al 1994 lai et al 1999 later onset farrer et al 1997 schupf et al 1998 difference age onset visser et al 1997 lai williams 1989 gender two studies employed survival methods examine age onset distributions gender adjusting age level learning disability found conflicting results colleagues found men downs syndrome three times likely women develop alzheimers disease age 65 see fig 3a effect gender observed age groups 50 years schupf et al 1998 men women downs syndrome show elevations follicle stimulating hormone fsh luteinising hormone puberty indicative primary gonadal dysfunction appear progress age frequent men women hasen et al 1980 campbell et al 1982 hsiang et al 1987 hestnes et al 1991 thus older men may benefit relative preservation oestrogen proposed account lower risk alzheimers disease men general population contrast another study found women downs syndrome approximately twice likely develop dementia men lai et al 1999 see fig 3b study effect gender seen primarily younger ages studies gender differences largest apoe 33 genotype suggesting high risk associated presence apoe 4 allele mask gender effects basis different results studies gender differences clear
0.47823864.11983636.html.plaintext.txt	39	view larger version 12k fig 3 cumulative incidence dementia adults downs syndrome gender based schupf et al 1998 b based lai et al 1999 kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	40	view larger version 12k fig 3 cumulative incidence dementia adults downs syndrome gender based schupf et al 1998 b based lai et al 1999 kind permission lippincott williams wilkins
0.47823864.11983636.html.plaintext.txt	41	one published study examined influence oestrogen deficiency age onset dementia women downs syndrome cosgrave et al 1999 menstrual profiles risk dementia 143 women downs syndrome studied twelve women postmenopausal diagnosed dementia significant relationship age menopause age onset dementia subsample r057 although sample size small results consistent hypothesis higher endogenous oestrogen levels lower risk dementia decreasing ass peptide levels maintaining cholinergic function critical neuronal populations association age menopause onset dementia confirmed supporting hormonal data provided oestrogen replacement therapy might prove important intervention delay onset dementia
0.47823864.11983636.html.plaintext.txt	42	one published study examined influence oestrogen deficiency age onset dementia women downs syndrome cosgrave et al 1999 menstrual profiles risk dementia 143 women downs syndrome studied twelve women postmenopausal diagnosed dementia significant relationship age menopause age onset dementia subsample r057 although sample size small results consistent hypothesis higher endogenous oestrogen levels lower risk dementia decreasing ass peptide levels maintaining cholinergic function critical neuronal populations association age menopause onset dementia confirmed supporting hormonal data provided oestrogen replacement therapy might prove important intervention delay onset dementia
0.47823864.11983636.html.plaintext.txt	43	individual differences ass peptide levels top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references downs syndrome alzheimers disease deposition ass1 42 precedes appearance ass1 40 iwatsubo et al 1995 ass1 42 predominant species brains young age 50 years individuals downs syndrome ass1 40 deposits observed decade later compared age matched controls general population plasma levels ass1 42 ass1 40 increased adults downs syndrome tokuda et al 1997 mehta et al 1998 one study found increase related dementia status tokuda et al 1997 group studied plasma ass1 42 ass1 40 levels 108 adults downs syndrome without dementia compared plasma levels 64 adults without dementia general population schupf et al 2001 ass1 42 ass1 40 levels significantly higher adults downs syndrome controls general population p00001 highest adults dementia downs syndrome mean plasma levels ass1 42 ass1 40 higher individuals apoe 4 allele without 4 allele regardless dementia status see fig 4 effect apoe 4 allele ass1 42 levels may related acceleration rate amyloid fibril formation ma et al 1994 diminished clearance ass mcnamara et al 1998
0.47823864.11983636.html.plaintext.txt	44	view larger version 9k fig 4 plasma levels ass1 42 ass1 40 adults downs syndrome without dementia apoe genotype 4 allele 4 allele schupf et al 2001 permission elsevier science
0.47823864.11983636.html.plaintext.txt	45	view larger version 9k fig 4 plasma levels ass1 42 ass1 40 adults downs syndrome without dementia apoe genotype 4 allele 4 allele schupf et al 2001 permission elsevier science
0.47823864.11983636.html.plaintext.txt	46	discussion top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references factors influence formation ass apoe 4 allele oestrogen deficiency high levels ass1 42 peptides associated earlier onset dementia downs syndrome factors decrease formation ass apoe 2 allele atypical karyotypes reduce app gene dose associated lower mortality reduced risk dementia important task future work identify sources individual variation premorbid ass levels since 95 people downs syndrome triplication app associated free trisomy overexpression app cannot account differences age onset dementia within population rather joint effects variety factors including reviewed others yet identified must influence development alzheimers disease suggests need focus younger adults downs syndrome identify causes individual differences lifespan development determine begin exert effects
0.47823864.11983636.html.plaintext.txt	47	clinical implications limitations top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references clinical implications onset dementia downs syndrome modified risk factors influence formation deposition beta amyloid well triplication gene amyloid precursor protein investigation risk factor profiles considered part differential diagnosis dementia downs syndrome studies younger adults downs syndrome may help identify causes individual differences development alzheimers disease
0.47823864.11983636.html.plaintext.txt	48	limitations reliable valid cognitive assessment batteries diagnostic criteria required detect dementia early stages improve studies risk factors studies small sample sizes controlled potential confounders modifiers age gender level intellectual disability studies used prevalent rather incident cases may mask effect risk factors disease onset confounding differential survival
0.47823864.11983636.html.plaintext.txt	49	limitations reliable valid cognitive assessment batteries diagnostic criteria required detect dementia early stages improve studies risk factors studies small sample sizes controlled potential confounders modifiers age gender level intellectual disability studies used prevalent rather incident cases may mask effect risk factors disease onset confounding differential survival
0.47823864.11983636.html.plaintext.txt	50	acknowledgments top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references thank collaborators work richard mayeux md warren zigman phd wayne silverman phd benjamin tycko md pankaj mehta phd edmund jenkins phd deborah pang mph bindu patel mph
0.47823864.11983636.html.plaintext.txt	51	references top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references aylward e h burt d b thorpe l u et al 1997 diagnosis dementia individuals intellectual disability journal intellectual disability research 41 152 164medline
0.47823864.11983636.html.plaintext.txt	52	received publication january 5 2001 revision received june 8 2001 accepted publication june 13 2001
0.47823864.11983636.html.plaintext.txt	53	received publication january 5 2001 revision received june 8 2001 accepted publication june 13 2001
0.48003986.14645205.html.plaintext.txt	0	mutant presenilins specifically elevate levels 42 residue ss amyloid peptide vivo evidence augmentation 42 specific secretase joanna l jankowsky1 daniel j fadale3 jeffrey anderson4 guilian m xu1 victoria gonzales1 nancy jenkins5 neal g copeland5 michael k lee1 linda h younkin3 steven l wagner46 steven g younkin3 david r borchelt12
0.48003986.14645205.html.plaintext.txt	1	1department pathology 2department neuroscience johns hopkins university school medicine baltimore md 21205 usa 3mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa 4merck research labs san diego 505 coast boulevard south la jolla ca 92037 usa 5mouse cancer genetics program nci frederick cancer research development center frederick md 21702 usa 6neurogenetics inc 11085 north torrey pines road suite 300 la jolla ca 92037 usa
0.48003986.14645205.html.plaintext.txt	2	1department pathology 2department neuroscience johns hopkins university school medicine baltimore md 21205 usa 3mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa 4merck research labs san diego 505 coast boulevard south la jolla ca 92037 usa 5mouse cancer genetics program nci frederick cancer research development center frederick md 21702 usa 6neurogenetics inc 11085 north torrey pines road suite 300 la jolla ca 92037 usa
0.48003986.14645205.html.plaintext.txt	3	received august 15 2003 accepted november 11 2003
0.48003986.14645205.html.plaintext.txt	4	abstract top abstract introduction results discussion conclusions materials methods supplementary material references amyloid precursor protein app endoproteolytically processed bace1 secretase release amyloid peptides ass40 42 aggregate form senile plaques brains patients alzheimers disease ad c terminus ass4042 generated secretase whose activity dependent upon presenilin ps 1 2 missense mutations ps1 ps2 occur patients early onset familial ad fad previous studies transgenic mice cultured cell models demonstrated fad ps1 variants shift ratio ass40 42 favor ass42 one hypothesis explain outcome mutant ps alters specificity secretase favor production ass42 expense ass40 test hypothesis vivo studied ass40 42 levels series transgenic mice co express swedish mutation app appswe two fad ps1 variants differentially accelerate amyloid pathology brain demonstrate direct correlation concentration ass42 rate amyloid deposition show shift ass42 40 ratios associated expression fad ps1 variants due specific elevation steady state levels ass42 maintaining constant level ass40 data suggest ps1 variants simply alter preferred cleavage site secretase rather complex effects regulation secretase access substrates
0.48003986.14645205.html.plaintext.txt	5	abstract top abstract introduction results discussion conclusions materials methods supplementary material references amyloid precursor protein app endoproteolytically processed bace1 secretase release amyloid peptides ass40 42 aggregate form senile plaques brains patients alzheimers disease ad c terminus ass4042 generated secretase whose activity dependent upon presenilin ps 1 2 missense mutations ps1 ps2 occur patients early onset familial ad fad previous studies transgenic mice cultured cell models demonstrated fad ps1 variants shift ratio ass40 42 favor ass42 one hypothesis explain outcome mutant ps alters specificity secretase favor production ass42 expense ass40 test hypothesis vivo studied ass40 42 levels series transgenic mice co express swedish mutation app appswe two fad ps1 variants differentially accelerate amyloid pathology brain demonstrate direct correlation concentration ass42 rate amyloid deposition show shift ass42 40 ratios associated expression fad ps1 variants due specific elevation steady state levels ass42 maintaining constant level ass40 data suggest ps1 variants simply alter preferred cleavage site secretase rather complex effects regulation secretase access substrates
0.48003986.14645205.html.plaintext.txt	6	introduction top abstract introduction results discussion conclusions materials methods supplementary material references pathology alzheimers disease ad characterized amyloid lesions formed aggregated peptides ss amyloid ass derived amyloid precursor protein app endoproteolytic cleavage bace1 secretase app also substrate endoproteases secretase bace2 collectively cleavages generate range amyloid ass peptides review see 1 pathogenic peptides ass40 42 share common n terminus 1 differ two residues c terminus 2 7 mutations app identified familial ad fad kindreds alter proteins normal processing causing either increased production peptides specific elevation ass42 8 11 longer ass42 peptide prone ass40 aggregate vitro 1213 major species detected immunocytochemically brains ad patients 14
0.48003986.14645205.html.plaintext.txt	7	introduction top abstract introduction results discussion conclusions materials methods supplementary material references pathology alzheimers disease ad characterized amyloid lesions formed aggregated peptides ss amyloid ass derived amyloid precursor protein app endoproteolytic cleavage bace1 secretase app also substrate endoproteases secretase bace2 collectively cleavages generate range amyloid ass peptides review see 1 pathogenic peptides ass40 42 share common n terminus 1 differ two residues c terminus 2 7 mutations app identified familial ad fad kindreds alter proteins normal processing causing either increased production peptides specific elevation ass42 8 11 longer ass42 peptide prone ass40 aggregate vitro 1213 major species detected immunocytochemically brains ad patients 14
0.48003986.14645205.html.plaintext.txt	8	mutations two additional genes presenilin 1 ps1 homolog ps2 also cause early onset fad 15 17 studies vertebrates invertebrates suggest ps1 ps2 components larger protein complex contains nicastrin aph 1 pen 2 18 27 complex either required cofactor secretase activity generates c termini ass40 42 1922 2428 35 deletion ps1 ps2 leads complete loss secretase activity 33 cells deficient ps1 also show abnormalities subcellular trafficking integral membrane proteins including app 3637
0.48003986.14645205.html.plaintext.txt	9	mutations two additional genes presenilin 1 ps1 homolog ps2 also cause early onset fad 15 17 studies vertebrates invertebrates suggest ps1 ps2 components larger protein complex contains nicastrin aph 1 pen 2 18 27 complex either required cofactor secretase activity generates c termini ass40 42 1922 2428 35 deletion ps1 ps2 leads complete loss secretase activity 33 cells deficient ps1 also show abnormalities subcellular trafficking integral membrane proteins including app 3637
0.48003986.14645205.html.plaintext.txt	10	interaction presenilins app first suggested observation plasma patients mutations ps1 higher ratios ass42 relative ass40 patients sporadic ad 38 subsequent work cell models demonstrated co expression fad mutant ps1 app reproduced rise ass42 relative ass40 seen patients ps1 associated ad 39 41 shift ass40 ass42 ratio also found brains transgenic mice co expressing one several fad ps1 mutations m146v m146l a246e m286l swedish mutation app 3942 44 similar shifts steady state ratios mouse ass40 ass42 also noted mice expressing fad variant ps1 45 ps2 46 transgenic mice co expressing mutated ps1 app developed amyloid pathology much earlier mice expressing app acceleration amyloid formation directly correlated change ass40 ass42 ratios 424748 contrast co expression wild type human ps1 mutant human app impact rate amyloid formation 44
0.48003986.14645205.html.plaintext.txt	11	interaction presenilins app first suggested observation plasma patients mutations ps1 higher ratios ass42 relative ass40 patients sporadic ad 38 subsequent work cell models demonstrated co expression fad mutant ps1 app reproduced rise ass42 relative ass40 seen patients ps1 associated ad 39 41 shift ass40 ass42 ratio also found brains transgenic mice co expressing one several fad ps1 mutations m146v m146l a246e m286l swedish mutation app 3942 44 similar shifts steady state ratios mouse ass40 ass42 also noted mice expressing fad variant ps1 45 ps2 46 transgenic mice co expressing mutated ps1 app developed amyloid pathology much earlier mice expressing app acceleration amyloid formation directly correlated change ass40 ass42 ratios 424748 contrast co expression wild type human ps1 mutant human app impact rate amyloid formation 44
0.48003986.14645205.html.plaintext.txt	12	studies dominant negative versions ps1 chemical inhibitors secretase interpreted evidence ps1 may comprise active site secretase complex 283149 52 moreover inhibitors coordinately depress ass40 ass42 production assumed one enzyme complex responsible production peptides 5051 setting fad mutations ps1 might alter ratio ass peptides produced app simply shifting specificity secretase favor cleavage residue 42 40 scenario mutations increase output ass42 accompanied decrease generation ass40
0.48003986.14645205.html.plaintext.txt	13	studies dominant negative versions ps1 chemical inhibitors secretase interpreted evidence ps1 may comprise active site secretase complex 283149 52 moreover inhibitors coordinately depress ass40 ass42 production assumed one enzyme complex responsible production peptides 5051 setting fad mutations ps1 might alter ratio ass peptides produced app simply shifting specificity secretase favor cleavage residue 42 40 scenario mutations increase output ass42 accompanied decrease generation ass40
0.48003986.14645205.html.plaintext.txt	14	current work took advantage recent advances elisa methodology examine ass40 ass42 levels several lines appswe mice co expressing either two fad ps1 variants a246e de9 ps1 variant accelerated rate amyloid deposition differing extents quantifying levels ass40 ass42 brains young pre symptomatic animals found co expression either ps1a246e ps1 de9 appswe transgenic mice specifically increased ass42 levels without altering ass40 data defined direct correlation age amyloid onset ass42 levels based work cultured cell models suggesting mutant ps1 alters production ass42 39 41 conclude changes steady state level peptide transgenic mice likely due alterations processing app suggest fad ps1 variants may increase accessibility bace1 cleaved c terminal fragments app ss ctfs secretase preferentially cleaves residue 42
0.48003986.14645205.html.plaintext.txt	15	current work took advantage recent advances elisa methodology examine ass40 ass42 levels several lines appswe mice co expressing either two fad ps1 variants a246e de9 ps1 variant accelerated rate amyloid deposition differing extents quantifying levels ass40 ass42 brains young pre symptomatic animals found co expression either ps1a246e ps1 de9 appswe transgenic mice specifically increased ass42 levels without altering ass40 data defined direct correlation age amyloid onset ass42 levels based work cultured cell models suggesting mutant ps1 alters production ass42 39 41 conclude changes steady state level peptide transgenic mice likely due alterations processing app suggest fad ps1 variants may increase accessibility bace1 cleaved c terminal fragments app ss ctfs secretase preferentially cleaves residue 42
0.48003986.14645205.html.plaintext.txt	16	results top abstract introduction results discussion conclusions materials methods supplementary material references transgene derived appswe expression lines q2 2 85 c3 3 study used three different lines mice express mohuapp695swe control mouse prion protein promoter 53 mohu app695swe construct encodes mouse sequence throughout extra intracellular regions human sequence within ass domain swedish mutations k594nm595l prior ass n terminus lines q2 2 c3 3 harbor appswe construct previously characterized 53 third line appswe mice used study line 85 expresses identical mohu appswe construct conjunction exon 9 deleted variant human presenilin 1 ps1 de9 54 line produced co injection appswe ps1 de9 vectors controlled prion promoter element following previously reported procedures 55
0.48003986.14645205.html.plaintext.txt	17	results top abstract introduction results discussion conclusions materials methods supplementary material references transgene derived appswe expression lines q2 2 85 c3 3 study used three different lines mice express mohuapp695swe control mouse prion protein promoter 53 mohu app695swe construct encodes mouse sequence throughout extra intracellular regions human sequence within ass domain swedish mutations k594nm595l prior ass n terminus lines q2 2 c3 3 harbor appswe construct previously characterized 53 third line appswe mice used study line 85 expresses identical mohu appswe construct conjunction exon 9 deleted variant human presenilin 1 ps1 de9 54 line produced co injection appswe ps1 de9 vectors controlled prion promoter element following previously reported procedures 55
0.48003986.14645205.html.plaintext.txt	18	immunoblot analysis brain protein separated sds page demonstrated relatively high levels appswe expression lines fig 1 blots probed monoclonal antibody 22c11 detects shared epitope n terminal region mouse human app showed transgenic lines expresses 2 4 fold total app non transgenic animals fig 1b immunoblots probed monoclonal antibody 6e10 detects humanized ass domain transgene product demonstrated appswe protein levels highest brains mice line c3 3 overall expression three lines ranked q2 2 85 c3 3 fig 1a
0.48003986.14645205.html.plaintext.txt	19	view larger version 66k figure 1 transgene derived appswe expression three mouse lines studied human ass specific antibody 6e10 used detect transgene derived app brain homogenates line q2 2 85 c3 3 animals b antibody 22c11 used detect endogenous mouse app amyloid precursor like protein 2 aplp 2 80 non transgenic controls endogenous appaplp 2 transgene derived human appswe lines q2 2 85 c3 3 immunoblot analysis consistently revealed highest appswe expression line c3 3 lowest line q2 2 line 85 falling two lines
0.48003986.14645205.html.plaintext.txt	20	view larger version 66k figure 1 transgene derived appswe expression three mouse lines studied human ass specific antibody 6e10 used detect transgene derived app brain homogenates line q2 2 85 c3 3 animals b antibody 22c11 used detect endogenous mouse app amyloid precursor like protein 2 aplp 2 80 non transgenic controls endogenous appaplp 2 transgene derived human appswe lines q2 2 85 c3 3 immunoblot analysis consistently revealed highest appswe expression line c3 3 lowest line q2 2 line 85 falling two lines
0.48003986.14645205.html.plaintext.txt	21	ps1 a246e ps1 de9 possess different amyloidogenic potentials previous studies 4447 others 424348 shown co expression mutant ps1 appswe accelerate rate amyloid deposition contrast co expression wild type human ps1 even high levels effect rate amyloid deposition 44 extend work compare effects two fad ps1 variants hasten amyloid onset differing degrees shown previously 47 transgenic mice line c3 3 develop amyloid deposits well beyond 18 months age fig 2a c co expression ps1 a246e line n 5 halves time c3 3n 5 mice developing amyloid deposits 9 12 months fig 2d f 47 plaque burden c3 3n 5 mice worsens age 20 24 months hippocampus cortex show high amyloid burdens similar acceleration amyloid deposition noted mice different line ps1 a246e line i2 4 crossed c3 3 mice 44 mice line c3 3 crossed mice expressing exon 9 deleted variant ps1 line 9 56 substantial amyloid deposition visible 6 months age fig 2g 57 ps1 a246e amyloid burdens c3 3ps1 de9 mice increase throughout life fig 2h early appearance amyloid deposits observed offspring c3 3 mice mated two different lines ps1 de9 mice line 9 shown line o 7 data shown confirming effect due ps1 de9 transgene artifact integration site
0.48003986.14645205.html.plaintext.txt	22	ps1 a246e ps1 de9 possess different amyloidogenic potentials previous studies 4447 others 424348 shown co expression mutant ps1 appswe accelerate rate amyloid deposition contrast co expression wild type human ps1 even high levels effect rate amyloid deposition 44 extend work compare effects two fad ps1 variants hasten amyloid onset differing degrees shown previously 47 transgenic mice line c3 3 develop amyloid deposits well beyond 18 months age fig 2a c co expression ps1 a246e line n 5 halves time c3 3n 5 mice developing amyloid deposits 9 12 months fig 2d f 47 plaque burden c3 3n 5 mice worsens age 20 24 months hippocampus cortex show high amyloid burdens similar acceleration amyloid deposition noted mice different line ps1 a246e line i2 4 crossed c3 3 mice 44 mice line c3 3 crossed mice expressing exon 9 deleted variant ps1 line 9 56 substantial amyloid deposition visible 6 months age fig 2g 57 ps1 a246e amyloid burdens c3 3ps1 de9 mice increase throughout life fig 2h early appearance amyloid deposits observed offspring c3 3 mice mated two different lines ps1 de9 mice line 9 shown line o 7 data shown confirming effect due ps1 de9 transgene artifact integration site
0.48003986.14645205.html.plaintext.txt	23	view larger version 100k figure 2 co expression ps1 de9 dramatically accelerates amyloid pathology appswe transgenic mice c mice transgenic appswe line c3 3 develop hippocampal amyloid deposits late ages shown hirano silver stain amyloid plaques absent young middle aged b animals appearing mice 20 months age c d f co expression ps1 a246e accelerates appearance amyloid plaques deposits first observed line c3 3 appsweps1 a246e double transgenic mice 10 13 months age e plaque load worsens age f g co expression ps1 de9 line c3 3 appswe mice hastens appearance pathology double transgenic appsweps1 de9 mice substantial number deposits 6 months age g plaque burden increases progressively time h hippocampus shown panels ease comparison plaques also observed superficial layers anterior cortex concurrent hippocampal onset
0.48003986.14645205.html.plaintext.txt	24	view larger version 100k figure 2 co expression ps1 de9 dramatically accelerates amyloid pathology appswe transgenic mice c mice transgenic appswe line c3 3 develop hippocampal amyloid deposits late ages shown hirano silver stain amyloid plaques absent young middle aged b animals appearing mice 20 months age c d f co expression ps1 a246e accelerates appearance amyloid plaques deposits first observed line c3 3 appsweps1 a246e double transgenic mice 10 13 months age e plaque load worsens age f g co expression ps1 de9 line c3 3 appswe mice hastens appearance pathology double transgenic appsweps1 de9 mice substantial number deposits 6 months age g plaque burden increases progressively time h hippocampus shown panels ease comparison plaques also observed superficial layers anterior cortex concurrent hippocampal onset
0.48003986.14645205.html.plaintext.txt	25	measurements ass levels immunoprecipitation antibodies n terminus ass followed immunoblotting antibodies specific 40 42 termini demonstrated ratio ass40 ass42 varied genotype fig 3a mice expressing appswe ratio 3 1 co expressing ps1a246e decreased ratio 175 1 co expressing ps1de9 dropped ratio 075 1 degree change ass40 ass42 ratios proportional acceleration ass deposition across genotypes fig 3b
0.48003986.14645205.html.plaintext.txt	26	view larger version 15k figure 3 co expressing mutant ps1 shifts ratio ass40 42 quantitative immunoprecipitation immunoblotting see methods used measure ass40 42 ratios brains mice co expressing appswe ps1a246e ps1de9 mice line c3 3 brains contains 2 3 fold ass40 ass42 reported previous work 39 co expression ps1a246e halves ass40 ass42 ratio 175 show expressing ps1de9 c3 3 appswe mice alters ass levels dramatically ass42 becomes dominant species b regression analysis reveals direct correlation age amyloid onset ratio ass40 42 c3 3 transgenic series statistical significance determined two tailed students test
0.48003986.14645205.html.plaintext.txt	27	view larger version 15k figure 3 co expressing mutant ps1 shifts ratio ass40 42 quantitative immunoprecipitation immunoblotting see methods used measure ass40 42 ratios brains mice co expressing appswe ps1a246e ps1de9 mice line c3 3 brains contains 2 3 fold ass40 ass42 reported previous work 39 co expression ps1a246e halves ass40 ass42 ratio 175 show expressing ps1de9 c3 3 appswe mice alters ass levels dramatically ass42 becomes dominant species b regression analysis reveals direct correlation age amyloid onset ratio ass40 42 c3 3 transgenic series statistical significance determined two tailed students test
0.48003986.14645205.html.plaintext.txt	28	evidence highly pathogenic activity ps1 de9 seen extended study mice express lower levels appswe mice line q2 2 develop amyloid pathology 20 months age fig 4a e test whether co expression mutant ps1 could induce plaques non depositing line crossed q2 2 appswe mice animals expressing either ps1 a246e line i2 4 4456 ps1 de9 line 9 5657 despite ability accelerate amyloid deposition line c3 3 mice 44 co expression ps1 a246e line q2 2 produced amyloid pathology brain region 20 months age fig 4b f contrast double transgenic offspring q2 2xps1 de9 developed substantial amyloid pathology mid life fig 4c g deposits probably began 15 18 months time sacrificed 20 months animals considerable burden diffuse compact plaques throughout hippocampus cortex thus ps1 de9 consistently induces earlier pathology appswe transgenic mice ps1 a246e pathogenic enough cause amyloid formation even line appswe animals would otherwise remained free deposits
0.48003986.14645205.html.plaintext.txt	29	evidence highly pathogenic activity ps1 de9 seen extended study mice express lower levels appswe mice line q2 2 develop amyloid pathology 20 months age fig 4a e test whether co expression mutant ps1 could induce plaques non depositing line crossed q2 2 appswe mice animals expressing either ps1 a246e line i2 4 4456 ps1 de9 line 9 5657 despite ability accelerate amyloid deposition line c3 3 mice 44 co expression ps1 a246e line q2 2 produced amyloid pathology brain region 20 months age fig 4b f contrast double transgenic offspring q2 2xps1 de9 developed substantial amyloid pathology mid life fig 4c g deposits probably began 15 18 months time sacrificed 20 months animals considerable burden diffuse compact plaques throughout hippocampus cortex thus ps1 de9 consistently induces earlier pathology appswe transgenic mice ps1 a246e pathogenic enough cause amyloid formation even line appswe animals would otherwise remained free deposits
0.48003986.14645205.html.plaintext.txt	30	view larger version 69k figure 4 co expression ps1 de9 induce plaque formation non depositing line appswe transgenic mice e unlike previously published lines appswe transgenic mice animals line q2 2 never develop amyloid deposits even late ages shown hirano silver stained sections hippocampus cortex e 20 month old animals b f co expression ps1 a246e sufficient induce amyloidosis mice line q2 2 20 months age c g co expression pathogenic ps1 de9 leads formation amyloid plaques q2 2 mice 20 months age diffuse dense core deposits found hippocampus c cortex g age d h line 85 mice appswe ps1 de9 transgenes co injected shown comparison animals express slightly higher levels appswe line q2 2 mice leading earlier onset pathology q2 2xps1de9 plaques abundant hippocampus d cortex h line 85 mice 9 months age
0.48003986.14645205.html.plaintext.txt	31	view larger version 69k figure 4 co expression ps1 de9 induce plaque formation non depositing line appswe transgenic mice e unlike previously published lines appswe transgenic mice animals line q2 2 never develop amyloid deposits even late ages shown hirano silver stained sections hippocampus cortex e 20 month old animals b f co expression ps1 a246e sufficient induce amyloidosis mice line q2 2 20 months age c g co expression pathogenic ps1 de9 leads formation amyloid plaques q2 2 mice 20 months age diffuse dense core deposits found hippocampus c cortex g age d h line 85 mice appswe ps1 de9 transgenes co injected shown comparison animals express slightly higher levels appswe line q2 2 mice leading earlier onset pathology q2 2xps1de9 plaques abundant hippocampus d cortex h line 85 mice 9 months age
0.48003986.14645205.html.plaintext.txt	32	analysis double transgenic mice created co injecting mohu appswe ps1 de9 constructs confirmed amyloidogenic potential ps1 de9 variant animals line 85 express levels appswe intermediate lines c3 3 q2 2 fig 1 however invariably co express ps1de9 line 85 mice develop amyloid deposits far earlier either single transgenic appswe line fig 4d h occasional deposits found line 85 mice young 6 months age 9 months animals significant plaque burden cortex hippocampus fig 4d h thus de9 variant appears highly pathogenic mutation profound effects deposition amyloid peptides despite highly pathogenic activity expression ps1 de9 alone mice sufficient induce amyloid deposits endogenous mouse app shown consistent previous reports fad variant ps1 transgenic mice 48
0.48003986.14645205.html.plaintext.txt	33	analysis double transgenic mice created co injecting mohu appswe ps1 de9 constructs confirmed amyloidogenic potential ps1 de9 variant animals line 85 express levels appswe intermediate lines c3 3 q2 2 fig 1 however invariably co express ps1de9 line 85 mice develop amyloid deposits far earlier either single transgenic appswe line fig 4d h occasional deposits found line 85 mice young 6 months age 9 months animals significant plaque burden cortex hippocampus fig 4d h thus de9 variant appears highly pathogenic mutation profound effects deposition amyloid peptides despite highly pathogenic activity expression ps1 de9 alone mice sufficient induce amyloid deposits endogenous mouse app shown consistent previous reports fad variant ps1 transgenic mice 48
0.48003986.14645205.html.plaintext.txt	34	mutant ps1 specifically increases steady state levels ass42 two independent approaches demonstrated earlier appearance amyloid mice co expressing appswe line c3 3 ps1 a246e line n 5 ps1 de9 line 9 associated change ratio ass40 ass42 favor ass42 fig 3 39 studies however variance efficiency ass peptide captured either immunoprecipitation elisa made difficult distinguish whether ass42 levels increased expense ass40 whether level ass42 increased independently ass40 remained unchanged course study refined elisa approach 58 developed allowed us address issue
0.48003986.14645205.html.plaintext.txt	35	using refined elisa assay studied levels ass peptides brains young pre deposit animals double transgenic lines described fig 5 tissue processed using two step extraction method following sonication 02 diethylamine dea high speed centrifugation soluble ass recovered supernatant pellet re extracted 70 formic acid fa recover remaining insoluble species two fractions assayed separately data total ass calculated addition dea fa fraction values obtained animal noted approximately 50 ass40 extracted dea lower variable percentage ass42 extracted solvent table 1 samples prepared young pre deposit animals especially case mice transgenic appswe believe relative insolubility ass42 due oligomerization peptide rather inherent difference solubility two peptides dea comparisons across genotypes transgenic series therefore focus total ass values rather dea fa soluble fractions accommodate differential solubility two peptides
0.48003986.14645205.html.plaintext.txt	36	view larger version 30k figure 5 mutant ps1 specifically elevates levels ass42 proportionately decreases age deposits first appear appswe transgenic mice levels ass40 42 measured brains mice five distinct genotypes noted graph elisa described materials methods values ass40 42 genotype normalized levels c3 3 single transgenic mice value peptide c3 3 mice set 1 values ass40 42 genotypes related c3 3 mice see table 1 statistical significance among genotypes calculated pair wise using two tailed students test pairs noted brackets figure asterisk denotes significant difference ass40 levels c3 3xps1 a246e c3 3xps1 de9 p 00015 statistical differences ass40 levels within remaining c3 3 pairs contrast levels ass42 significantly increased mice co expressing mutant ps1 b relationship brain concentration ass42 age amyloid onset genotypes analyzed ass42 values normalized levels measured c3 3 single transgenic animals co expression hu ps1de9 induces greatest relative increase ass42 largest decrease age amyloid onset note onset amyloid lesions line q2 2 estimated age plaques appear q2 2xps1de9 animals would difficult observe normal mouse lifespan c levels ass40 42 brains q2 2 appswe mice crossed ps1 mice measured separate elisa assay concentration peptide normalized value measured q2 2 single transgenic mice set 1 c3 3 series co expression ps1a246e ps1de9 q2 2 mice significantly elevated level ass42 without decreasing ass40 asterisk denotes small significant difference ass40 found q2 2xps1 a246e q2 2 none remaining pairs showed significant differences ass40
0.48003986.14645205.html.plaintext.txt	37	view larger version 30k figure 5 mutant ps1 specifically elevates levels ass42 proportionately decreases age deposits first appear appswe transgenic mice levels ass40 42 measured brains mice five distinct genotypes noted graph elisa described materials methods values ass40 42 genotype normalized levels c3 3 single transgenic mice value peptide c3 3 mice set 1 values ass40 42 genotypes related c3 3 mice see table 1 statistical significance among genotypes calculated pair wise using two tailed students test pairs noted brackets figure asterisk denotes significant difference ass40 levels c3 3xps1 a246e c3 3xps1 de9 p 00015 statistical differences ass40 levels within remaining c3 3 pairs contrast levels ass42 significantly increased mice co expressing mutant ps1 b relationship brain concentration ass42 age amyloid onset genotypes analyzed ass42 values normalized levels measured c3 3 single transgenic animals co expression hu ps1de9 induces greatest relative increase ass42 largest decrease age amyloid onset note onset amyloid lesions line q2 2 estimated age plaques appear q2 2xps1de9 animals would difficult observe normal mouse lifespan c levels ass40 42 brains q2 2 appswe mice crossed ps1 mice measured separate elisa assay concentration peptide normalized value measured q2 2 single transgenic mice set 1 c3 3 series co expression ps1a246e ps1de9 q2 2 mice significantly elevated level ass42 without decreasing ass40 asterisk denotes small significant difference ass40 found q2 2xps1 a246e q2 2 none remaining pairs showed significant differences ass40
0.48003986.14645205.html.plaintext.txt	38	view table table 1 normalized fractions brain ass extracted dea formic acid two separate series experiments performed one series compared ass40 ass42 levels brains c3 3 appswe mice levels c3 3xps1 a246e c3 3xps1 de9 appsweps1de9 line 85 q2 2 mice fig 5a table 1 first series values normalized ass levels c3 3 mice graphing relative levels peptide animals revealed addition mutant ps1 increases concentration ass42 without causing proportionate decrease ass40 case conclusion stronger second series mice described even c3 3 series measurements show compared appswe single transgenic mice co expression ps1a246e caused 50 increase ps1 de9 150 increase concentration ass42 without consistently lowering level ass40 mice co expressing ps1de9 variant appswe levels ass42 exceeded ass40 fig 3 hence difficult argue lack change ass40 levels might due far greater abundance ass40 relative ass42
0.48003986.14645205.html.plaintext.txt	39	comparison values ages amyloid deposits first appear genotype suggests immediate relationship fig 5b age onset cross directly correlates concentration ass42 brain correlation extends beyond c3 3 series line 85 mice made co injecting appswe ps1de9 vectors similar c3 3xps1 de9 mice peptide levels age amyloid onset fig 5a b end spectrum q2 2 single transgenic mice accumulate even less ass42 c3 3 single transgenic mice show sign amyloid pathology ages deposits already begun c3 3 animals fig 5a b
0.48003986.14645205.html.plaintext.txt	40	second elisa experiment measured ass levels across q2 2 appswe series q2 2 q2 2xps1 a246e q2 2xps1 de9 concentrations ass values genotype normalized levels q2 2 single transgenic animals found addition mutant ps1 specifically elevates ass42 levels without lowering ass40 levels fig 5c table 1 collectively data demonstrate mutant ps1 present specific increase ass42 without proportionate decrease ass40 data also demonstrate concentration ass42 driving force behind changes rate amyloid deposition occur double transgenic mice
0.48003986.14645205.html.plaintext.txt	41	second elisa experiment measured ass levels across q2 2 appswe series q2 2 q2 2xps1 a246e q2 2xps1 de9 concentrations ass values genotype normalized levels q2 2 single transgenic animals found addition mutant ps1 specifically elevates ass42 levels without lowering ass40 levels fig 5c table 1 collectively data demonstrate mutant ps1 present specific increase ass42 without proportionate decrease ass40 data also demonstrate concentration ass42 driving force behind changes rate amyloid deposition occur double transgenic mice
0.48003986.14645205.html.plaintext.txt	42	transgenic mice expressing ps1 de9 develop cotton wool plaques fad patients de9 mutation associated pathology motor symptoms atypical ad neuropathological examination several patients carrying mutation revealed large loose cotton wool amyloid aggregates cortex relative absence compact dense core deposits 59 63 atypical pathology found ps1 de9 kindreds 6264 indeed observed mice expressing de9 transgene instead appsweps1 de9 double transgenic animals displayed characteristic compact dense cored deposits throughout cortex hippocampus could stained congo red birefringent polarized light fig 6
0.48003986.14645205.html.plaintext.txt	43	transgenic mice expressing ps1 de9 develop cotton wool plaques fad patients de9 mutation associated pathology motor symptoms atypical ad neuropathological examination several patients carrying mutation revealed large loose cotton wool amyloid aggregates cortex relative absence compact dense core deposits 59 63 atypical pathology found ps1 de9 kindreds 6264 indeed observed mice expressing de9 transgene instead appsweps1 de9 double transgenic animals displayed characteristic compact dense cored deposits throughout cortex hippocampus could stained congo red birefringent polarized light fig 6
0.48003986.14645205.html.plaintext.txt	44	view larger version 151k figure 6 congophilic amyloid deposits found mice co expressing ps1 de9 appswe h mice expressing de9 mutation ps1 conjunction mohu appswe develop typical diffuse compact birefringent deposits panel shows congo red stained plaques bright field c e g polarized light b d f h plaques appear qualitatively identical mice high expressing early onset c3 3 low expressing late onset q2 2 lines shown sections 6 month old c3 3xps1 de9 mice b e f 20 month old q2 2xps1 de9 mice c d g h congophilic deposits found cortex d hippocampus e h
0.48003986.14645205.html.plaintext.txt	45	view larger version 151k figure 6 congophilic amyloid deposits found mice co expressing ps1 de9 appswe h mice expressing de9 mutation ps1 conjunction mohu appswe develop typical diffuse compact birefringent deposits panel shows congo red stained plaques bright field c e g polarized light b d f h plaques appear qualitatively identical mice high expressing early onset c3 3 low expressing late onset q2 2 lines shown sections 6 month old c3 3xps1 de9 mice b e f 20 month old q2 2xps1 de9 mice c d g h congophilic deposits found cortex d hippocampus e h
0.48003986.14645205.html.plaintext.txt	46	discussion top abstract introduction results discussion conclusions materials methods supplementary material references studied fad variants ps1 elevate ass levels accelerate amyloid deposition different extents transgenic mice co express mohu appswe comparing ass measurements appsweps1 de9 double transgenic mice animals expressing appswe alone less pathogenic ps1 a246e mutation gained insight mechanisms mutations ps1 cause early onset ad data show fad variants ps1 selectively increase levels ass42 without affecting ass40 levels thus co expression ps1 variants increases amount total ass derived constant level appswe protein suggesting mutant ps1 either directly indirectly makes substrate available processing additional substrate specifically cleaved residue 42 demonstrate small changes levels ass42 considerable impact rate amyloid deposition highlighting potential therapeutic benefit might gained lowering ass42 levels even partially early clinical course ad
0.48003986.14645205.html.plaintext.txt	47	discussion top abstract introduction results discussion conclusions materials methods supplementary material references studied fad variants ps1 elevate ass levels accelerate amyloid deposition different extents transgenic mice co express mohu appswe comparing ass measurements appsweps1 de9 double transgenic mice animals expressing appswe alone less pathogenic ps1 a246e mutation gained insight mechanisms mutations ps1 cause early onset ad data show fad variants ps1 selectively increase levels ass42 without affecting ass40 levels thus co expression ps1 variants increases amount total ass derived constant level appswe protein suggesting mutant ps1 either directly indirectly makes substrate available processing additional substrate specifically cleaved residue 42 demonstrate small changes levels ass42 considerable impact rate amyloid deposition highlighting potential therapeutic benefit might gained lowering ass42 levels even partially early clinical course ad
0.48003986.14645205.html.plaintext.txt	48	amyloid onset determined level ass42 previous studies 4447 others 424348 demonstrated co expression fad associated ps1 variants app transgenic mice shifts ratio ass40 ass42 shift correlates rapid appearance amyloid deposits contrast co expression wild type human ps1 impact rate amyloid formation 44 previous studies two point comparisons one line mice expressing mutant app mice mice expressing one fad ps1 variant present study first analyze different combinations app ps1 variants show distinct courses amyloid pathology data demonstrate age amyloid deposits first appear correlates directly concentration ass42 brain demonstrated mice line q2 2 animals expressing app even co expressing ps1 form amyloid deposits 2 year lifetime co expression ps1 a246e able dramatically accelerate appearance plaques c3 3 appswe transgenic mice effect strong enough induce plaques 20 months age lower expressing q2 2 appswe mice instead plaques observed mice line q2 2 highly pathogenic ps1 de9 variant introduced quantitative elisa analysis mice genotype revealed ps1 variants altered concentration ass42 brain animals expressing either ps1 variant contained ass42 q2 2 single transgenic mice however co expression ps1 de9 led substantially higher ass42 levels ps1 a246e consistent ability induce amyloid formation earlier ps1 a246e
0.48003986.14645205.html.plaintext.txt	49	amyloid onset determined level ass42 previous studies 4447 others 424348 demonstrated co expression fad associated ps1 variants app transgenic mice shifts ratio ass40 ass42 shift correlates rapid appearance amyloid deposits contrast co expression wild type human ps1 impact rate amyloid formation 44 previous studies two point comparisons one line mice expressing mutant app mice mice expressing one fad ps1 variant present study first analyze different combinations app ps1 variants show distinct courses amyloid pathology data demonstrate age amyloid deposits first appear correlates directly concentration ass42 brain demonstrated mice line q2 2 animals expressing app even co expressing ps1 form amyloid deposits 2 year lifetime co expression ps1 a246e able dramatically accelerate appearance plaques c3 3 appswe transgenic mice effect strong enough induce plaques 20 months age lower expressing q2 2 appswe mice instead plaques observed mice line q2 2 highly pathogenic ps1 de9 variant introduced quantitative elisa analysis mice genotype revealed ps1 variants altered concentration ass42 brain animals expressing either ps1 variant contained ass42 q2 2 single transgenic mice however co expression ps1 de9 led substantially higher ass42 levels ps1 a246e consistent ability induce amyloid formation earlier ps1 a246e
0.48003986.14645205.html.plaintext.txt	50	studies ass40 ass42 fibrilization vitro demonstrated formation congophilic fibrils follows second order kinetics long lag phase nucleation seeding phase followed exponential phase fibril formation extinction substrate 12136566 since length lag phase proportional concentration ass peptides 12136566 believe different rates ass deposition observed genotype represent changes rate nucleation seeding ass42 fibrils vivo
0.48003986.14645205.html.plaintext.txt	51	studies ass40 ass42 fibrilization vitro demonstrated formation congophilic fibrils follows second order kinetics long lag phase nucleation seeding phase followed exponential phase fibril formation extinction substrate 12136566 since length lag phase proportional concentration ass peptides 12136566 believe different rates ass deposition observed genotype represent changes rate nucleation seeding ass42 fibrils vivo
0.48003986.14645205.html.plaintext.txt	52	congophilic neuritic amyloid pathology mohu appswexps1de9 mice neuropathological studies brains fad patients ps1 de9 mutation reported number cases contain senile plaques atypical ad unusual cases ass aggregates described cotton wool deposits lack compact dense cores show birefringence stained congo red 59 63 however atypical pathology found ps1 de9 kindreds 6264 indeed mice carrying ps1de9 mutation recapitulate cotton wool plaques de9 fad patients instead lines appsweps1de9 mice examined study develop congophilic neuritic senile plaques fig 6 perhaps extreme concentrations ass needed observe amyloid formation within mouse lifespan artificially drive plaques compact form
0.48003986.14645205.html.plaintext.txt	53	congophilic neuritic amyloid pathology mohu appswexps1de9 mice neuropathological studies brains fad patients ps1 de9 mutation reported number cases contain senile plaques atypical ad unusual cases ass aggregates described cotton wool deposits lack compact dense cores show birefringence stained congo red 59 63 however atypical pathology found ps1 de9 kindreds 6264 indeed mice carrying ps1de9 mutation recapitulate cotton wool plaques de9 fad patients instead lines appsweps1de9 mice examined study develop congophilic neuritic senile plaques fig 6 perhaps extreme concentrations ass needed observe amyloid formation within mouse lifespan artificially drive plaques compact form
0.48003986.14645205.html.plaintext.txt	54	second atypical feature fad caused ps1 de9 mutation frequent appearance spastic paraparesis 596167 affected patients exhibit abnormal gait hyper reflexive lower extremities however kindreds carrying ps1 de9 show motor involvement 62 yet observe evidence diminished motor function line mice expressing ps1 de9 either alone conjunction appswe savonenko et al submitted incomplete penetrance atypical pathology motor dysfunction ps1 de9 kindreds lack features transgenic models suggests modifier locus may influence expression phenotypes humans
0.48003986.14645205.html.plaintext.txt	55	second atypical feature fad caused ps1 de9 mutation frequent appearance spastic paraparesis 596167 affected patients exhibit abnormal gait hyper reflexive lower extremities however kindreds carrying ps1 de9 show motor involvement 62 yet observe evidence diminished motor function line mice expressing ps1 de9 either alone conjunction appswe savonenko et al submitted incomplete penetrance atypical pathology motor dysfunction ps1 de9 kindreds lack features transgenic models suggests modifier locus may influence expression phenotypes humans
0.48003986.14645205.html.plaintext.txt	56	mutant presenilins may recruit new pools substrate secretase pathway elevate production ass42 studies presenilin biology suggest ps1 ps2 compete inclusion larger protein complex contains nicastrin aph 1 pen 2 18 27 complex required active secretase responsible proteolytic processing app generate c termini ass peptides 2833 studies chemical inhibitors secretase shown cleavage app 40 site 42 sites coordinately suppressed suggesting single activity responsible cleavages 505168 70 setting simplest explanation elevation ass42 relative ass40 presence mutant ps1 simple shift enzyme specificity favor cleavage residue 42 net change amount total ass however results indicate expression fad ps1 variants specified increases steady state levels ass42 without altering ass 40 levels expression mutant ps1 thus leads net increase total ass similar finding reported oyama colleagues study mice transgenic ps2 n141i also show specific increase ass42 levels 46
0.48003986.14645205.html.plaintext.txt	57	mutant presenilins may recruit new pools substrate secretase pathway elevate production ass42 studies presenilin biology suggest ps1 ps2 compete inclusion larger protein complex contains nicastrin aph 1 pen 2 18 27 complex required active secretase responsible proteolytic processing app generate c termini ass peptides 2833 studies chemical inhibitors secretase shown cleavage app 40 site 42 sites coordinately suppressed suggesting single activity responsible cleavages 505168 70 setting simplest explanation elevation ass42 relative ass40 presence mutant ps1 simple shift enzyme specificity favor cleavage residue 42 net change amount total ass however results indicate expression fad ps1 variants specified increases steady state levels ass42 without altering ass 40 levels expression mutant ps1 thus leads net increase total ass similar finding reported oyama colleagues study mice transgenic ps2 n141i also show specific increase ass42 levels 46
0.48003986.14645205.html.plaintext.txt	58	experiments cell cultures shown co expression fad ps1 variants app alters ratio ass40 42 medium favor ass42 39 41 cell culture experiments assumed ps1 variants alter production secretion ass42 rather altering clearance catabolism however cell culture paradigms cannot replicate complex architecture signaling patterns neurons brain hippocampal slice cultures kamenetz et al 71 recently demonstrated neuronal activity influence secretion ass extracellular space vivo animal models used studies difficult separate changes production ass changes catabolism however based cell culture studies app processing believe likely increase steady state levels ass42 measured brain tissue mice reflects enhanced production ass42 rather changes stability clearance studies demonstrating absolute requirement ps1 ps2 function active secretase 2833 consistent interpretation
0.48003986.14645205.html.plaintext.txt	59	experiments cell cultures shown co expression fad ps1 variants app alters ratio ass40 42 medium favor ass42 39 41 cell culture experiments assumed ps1 variants alter production secretion ass42 rather altering clearance catabolism however cell culture paradigms cannot replicate complex architecture signaling patterns neurons brain hippocampal slice cultures kamenetz et al 71 recently demonstrated neuronal activity influence secretion ass extracellular space vivo animal models used studies difficult separate changes production ass changes catabolism however based cell culture studies app processing believe likely increase steady state levels ass42 measured brain tissue mice reflects enhanced production ass42 rather changes stability clearance studies demonstrating absolute requirement ps1 ps2 function active secretase 2833 consistent interpretation
0.48003986.14645205.html.plaintext.txt	60	recent reports indicate ps1 required translocation app plasma membrane endosomes secretase cleavage produces extracellular ass thought occur 72 specific mutations ps1 alter movement 73 75 moreover others demonstrated cells deficient ps1 show alterations subcellular trafficking specific membrane proteins 3637 however studies cultured cells suggested full length app preferred substrate secretase instead appears direct substrates secretase c terminal fragments app generated ss secretase fragments full length protein accumulate high levels secretase inhibited 2830313349 52 whether effects detected due changes app trafficking unclear note analysis levels sapp ss soluble ectodomain app generated bace1 failed detect obvious alterations due co expression mutant ps1 supplementaly material fig s1
0.48003986.14645205.html.plaintext.txt	61	recent reports indicate ps1 required translocation app plasma membrane endosomes secretase cleavage produces extracellular ass thought occur 72 specific mutations ps1 alter movement 73 75 moreover others demonstrated cells deficient ps1 show alterations subcellular trafficking specific membrane proteins 3637 however studies cultured cells suggested full length app preferred substrate secretase instead appears direct substrates secretase c terminal fragments app generated ss secretase fragments full length protein accumulate high levels secretase inhibited 2830313349 52 whether effects detected due changes app trafficking unclear note analysis levels sapp ss soluble ectodomain app generated bace1 failed detect obvious alterations due co expression mutant ps1 supplementaly material fig s1
0.48003986.14645205.html.plaintext.txt	62	light foregoing data favor notion ps1 a246e ps1 de9 differing efficiencies place greater amount app ctf substrate contact secretase preferentially cleaves residue 42 mechanism would explain specific elevation ass42 levels absence change ass40 levels moreover scenario could also explain certain natural experimental variants ps1 differentially affect cleavage app ctfs notch another important substrate secretase 32 note ps1nicastrinpen 2aph 1 protein complex responsible delivery substrates secretase proteolysis inhibition ps1 complex either genetically pharmacologically would diminish secretase activity manner indistinguishable inhibiting secretase thus think possible one effects mutant ps1 augment amount substrate presented 42 specific secretase
0.48003986.14645205.html.plaintext.txt	63	light foregoing data favor notion ps1 a246e ps1 de9 differing efficiencies place greater amount app ctf substrate contact secretase preferentially cleaves residue 42 mechanism would explain specific elevation ass42 levels absence change ass40 levels moreover scenario could also explain certain natural experimental variants ps1 differentially affect cleavage app ctfs notch another important substrate secretase 32 note ps1nicastrinpen 2aph 1 protein complex responsible delivery substrates secretase proteolysis inhibition ps1 complex either genetically pharmacologically would diminish secretase activity manner indistinguishable inhibiting secretase thus think possible one effects mutant ps1 augment amount substrate presented 42 specific secretase
0.48003986.14645205.html.plaintext.txt	64	conclusions top abstract introduction results discussion conclusions materials methods supplementary material references studies highlighted small changes production ass42 modulate rate amyloid deposition within limits imposed mouse lifespan small changes ass42 levels make difference appearance absence amyloid pathology show dichotomy determined threshold concentration ass42 minimum surpassed elevations ass42 act hasten onset amyloid aggregation findings suggest even partial reductions ass42 levels pharmacological agents may substantially delay onset amyloid lesions patients risk ad study also first demonstrate presence mutant ps1 results ass42 specifically increasing concentration peptide without altering ass40 suggest mutant ps1 may act recruit new pools app ss ctf substrate secretase favors cleavage residue 42 altering subcellular trafficking app substrates could therefore another therapeutic approach diminish concentration ass42 brains patients ad
0.48003986.14645205.html.plaintext.txt	65	conclusions top abstract introduction results discussion conclusions materials methods supplementary material references studies highlighted small changes production ass42 modulate rate amyloid deposition within limits imposed mouse lifespan small changes ass42 levels make difference appearance absence amyloid pathology show dichotomy determined threshold concentration ass42 minimum surpassed elevations ass42 act hasten onset amyloid aggregation findings suggest even partial reductions ass42 levels pharmacological agents may substantially delay onset amyloid lesions patients risk ad study also first demonstrate presence mutant ps1 results ass42 specifically increasing concentration peptide without altering ass40 suggest mutant ps1 may act recruit new pools app ss ctf substrate secretase favors cleavage residue 42 altering subcellular trafficking app substrates could therefore another therapeutic approach diminish concentration ass42 brains patients ad
0.48003986.14645205.html.plaintext.txt	66	materials methods top abstract introduction results discussion conclusions materials methods supplementary material references generation transgenic mice exception line 85 transgenic mice used study described fully characterized earlier publications transgenes expressed control mouse prion protein promoter moprpxho drives high protein expression neurons astrocytes cns 5357 lines c3 3 q2 2 expressing mousehuman mohu chimeric app695 humanized ass domain harboring swedish k594mn595l mutation described borchelt et al 53 line i2 4 expresses human ps1 a246e described lee et al 56 borchelt et al 44 lines 9 o 7 expressing human ps1 de9 described lee et al 56 mohuappswe line c3 3 ps1a246e line n 5 mice deposited jackson laboratories
0.48003986.14645205.html.plaintext.txt	67	materials methods top abstract introduction results discussion conclusions materials methods supplementary material references generation transgenic mice exception line 85 transgenic mice used study described fully characterized earlier publications transgenes expressed control mouse prion protein promoter moprpxho drives high protein expression neurons astrocytes cns 5357 lines c3 3 q2 2 expressing mousehuman mohu chimeric app695 humanized ass domain harboring swedish k594mn595l mutation described borchelt et al 53 line i2 4 expresses human ps1 a246e described lee et al 56 borchelt et al 44 lines 9 o 7 expressing human ps1 de9 described lee et al 56 mohuappswe line c3 3 ps1a246e line n 5 mice deposited jackson laboratories
0.48003986.14645205.html.plaintext.txt	68	line 85 companion lines 7 26 56 57 described jankowsky et al 55 five lines created co injection chimeric mousehuman appswe human ps1 de9 vectors controlled independent mouse prion protein promoter elements two transgenes co integrated co segregate single locus 55 protein expression transgenic appswe line 85 comparable previously described line 57 55 line 85 mice deposited jackson laboratories
0.48003986.14645205.html.plaintext.txt	69	animals used study maintained hybrid background back crossing c3hejxc57bl6j f1 mice obtained jackson laboratories bar harbor usa offspring genotyped presence transgene pcr amplification genomic dna extracted 1 cm tail clippings described jankowsky et al 55 reactions contained three primers one antisense primer matching sequence within vector also present mouse genomic prp 5 gtg gat acc ccc tcc ccc agc cta gac c one sense primer specific transgene cdna ps1 5 cag gtg gtg gag caa gat g app 5 ccg aga tct ctg aag tga aga tgg atg second sense primer specific genomic prp coding region removed moprp vector 5 cct ctt tgt gac tat gtg gac tga tgt cgg reactions give 750 bp product endogenous prp gene control dna integrity successful amplification transgene positive samples additional band 400 bp app 13 kb ps1
0.48003986.14645205.html.plaintext.txt	70	animals used study maintained hybrid background back crossing c3hejxc57bl6j f1 mice obtained jackson laboratories bar harbor usa offspring genotyped presence transgene pcr amplification genomic dna extracted 1 cm tail clippings described jankowsky et al 55 reactions contained three primers one antisense primer matching sequence within vector also present mouse genomic prp 5 gtg gat acc ccc tcc ccc agc cta gac c one sense primer specific transgene cdna ps1 5 cag gtg gtg gag caa gat g app 5 ccg aga tct ctg aag tga aga tgg atg second sense primer specific genomic prp coding region removed moprp vector 5 cct ctt tgt gac tat gtg gac tga tgt cgg reactions give 750 bp product endogenous prp gene control dna integrity successful amplification transgene positive samples additional band 400 bp app 13 kb ps1
0.48003986.14645205.html.plaintext.txt	71	animals housed microisolator cages unlimited access food water procedures involving animals approved jhu institutional animal care use committee
0.48003986.14645205.html.plaintext.txt	72	animals housed microisolator cages unlimited access food water procedures involving animals approved jhu institutional animal care use committee
0.48003986.14645205.html.plaintext.txt	73	ass peptide analysis quantitative immunoblot quantitation ass levels transgenic mouse brain tissue performed described lesuisse et al 57 briefly hemibrain samples line c3 3 mice homogenized dounce tissue grinder 24 vols pbs containing 1 chaps 1 mm pmsf 5 microgml leupeptin 30 microgml aprotinin 1 microm pepstatin homogenates mixed 30 min 4 degrees c centrifuged 1 h 100 000g supernatants immunoprecipitated monoclonal antibody 26d6 specific ass1 12 recovered peptides separated bicineurea sds page proteins transferred pvdf membrane blotted 26d6 conjugated horseradish peroxidase antibody binding visualized ecl reagent exposed film quantified using scanning laser densitometry compare band densities sample synthetic ass standards run parallel statistics performed one way anova least square difference lsd post test using statistica analysis program statsoft tulsa ok usa
0.48003986.14645205.html.plaintext.txt	74	ass peptide quantitation elisa frozen mouse hemi brains n4 5 per genotype extracted sonication 02 diethylamine dea50 mm nacl concentration 100 mgml centrifugation 100 000g 1 h 4 degrees c supernatant removed saved dea extract pellet sonicated 70 formic acid fa diluted water using volume equal original volume dea centrifugation 100 000g 1 h 4 degrees c supernatant removed saved fa extract
0.48003986.14645205.html.plaintext.txt	75	ass peptide quantitation elisa frozen mouse hemi brains n4 5 per genotype extracted sonication 02 diethylamine dea50 mm nacl concentration 100 mgml centrifugation 100 000g 1 h 4 degrees c supernatant removed saved dea extract pellet sonicated 70 formic acid fa diluted water using volume equal original volume dea centrifugation 100 000g 1 h 4 degrees c supernatant removed saved fa extract
0.48003986.14645205.html.plaintext.txt	76	brain extracts measured sandwich elisa described previously 115876 dea extracts neutralized adding 110 vol 05 m tris hcl ph 68 vortexing briefly neutralized samples prepared elisa 1 10 dilution ec buffer 002 m phosphate buffer ph 7 04 m nacl 2 mm edta 04 block ace dainipponseiyaku suita osaka japan 02 bovine serum albumin 005 chaps 005 sodium azide standard curve used calculate ass concentration dea extracts also performed ec buffer fa extracts neutralized prepared elisa diluting 1 20 1 m tris phosphate buffer tpb ph 11 standard curve fa extracts performed mixture fa tpb samples assayed human ass specific elisa system uses ban50 monoclonal antibody mab epitope ass1 16 capture ba27 bc05 mabs detection ass40 ass42 respectively final ass concentrations expressed picomoles per gram tissue calculated original brain weight measurement prior homogenization
0.48003986.14645205.html.plaintext.txt	77	brain extracts measured sandwich elisa described previously 115876 dea extracts neutralized adding 110 vol 05 m tris hcl ph 68 vortexing briefly neutralized samples prepared elisa 1 10 dilution ec buffer 002 m phosphate buffer ph 7 04 m nacl 2 mm edta 04 block ace dainipponseiyaku suita osaka japan 02 bovine serum albumin 005 chaps 005 sodium azide standard curve used calculate ass concentration dea extracts also performed ec buffer fa extracts neutralized prepared elisa diluting 1 20 1 m tris phosphate buffer tpb ph 11 standard curve fa extracts performed mixture fa tpb samples assayed human ass specific elisa system uses ban50 monoclonal antibody mab epitope ass1 16 capture ba27 bc05 mabs detection ass40 ass42 respectively final ass concentrations expressed picomoles per gram tissue calculated original brain weight measurement prior homogenization
0.48003986.14645205.html.plaintext.txt	78	statistics performed one way anova lsd post test using statistica analysis program statsoft tulsa ok usa
0.48003986.14645205.html.plaintext.txt	79	histology mice euthanized ether inhalation brain removed immersion 4 paraformaldehyde1xbuffered saline pbs fixation 48 h 4 degrees c brains transferred pbs dehydrated alcohol series treated cedarwood oil methylsalicylate embedded paraffin sectioning
0.48003986.14645205.html.plaintext.txt	80	histology mice euthanized ether inhalation brain removed immersion 4 paraformaldehyde1xbuffered saline pbs fixation 48 h 4 degrees c brains transferred pbs dehydrated alcohol series treated cedarwood oil methylsalicylate embedded paraffin sectioning
0.48003986.14645205.html.plaintext.txt	81	hirano silver stain silver impregnation histology performed 10 microm paraffin embedded sections hiranos modification bielschowsky method 7778 briefly sections deparaffinized xylene alcohols tap water placed fresh 20 silver nitrate solution 20 min washing thoroughly distilled water slides immersed 20 silver nitrate solution titrated fresh ammonium hydroxide 20 min slides washed ammonia water individually developed 100 microl developer 20 ml 37 formaldehyde 100 ml distilled water 50 microl concentrated nitric acid 05 g citric acid added 50 ml titrated silver nitrate solution slides rinsed tap water fixed 5 sodium thiosulfate dehydrated alcohols xylene
0.48003986.14645205.html.plaintext.txt	82	hirano silver stain silver impregnation histology performed 10 microm paraffin embedded sections hiranos modification bielschowsky method 7778 briefly sections deparaffinized xylene alcohols tap water placed fresh 20 silver nitrate solution 20 min washing thoroughly distilled water slides immersed 20 silver nitrate solution titrated fresh ammonium hydroxide 20 min slides washed ammonia water individually developed 100 microl developer 20 ml 37 formaldehyde 100 ml distilled water 50 microl concentrated nitric acid 05 g citric acid added 50 ml titrated silver nitrate solution slides rinsed tap water fixed 5 sodium thiosulfate dehydrated alcohols xylene
0.48003986.14645205.html.plaintext.txt	83	congo red stain congo red staining performed according standard techniques deparaffinized slides 10 microm brain sections counterstained hematoxylin rinsed well immersed congo red solution 20 g sodium chloride 100 ml distilled water mixed 5 g congo red sigma st louis mo usa dissolved 400 ml 95 ethanol 30 min without rinsing slides moved aniline blue 75 g aniline blue 5 ml glacial acetic acid 250 ml distilled water dehydrated ethanol xylene
0.48003986.14645205.html.plaintext.txt	84	congo red stain congo red staining performed according standard techniques deparaffinized slides 10 microm brain sections counterstained hematoxylin rinsed well immersed congo red solution 20 g sodium chloride 100 ml distilled water mixed 5 g congo red sigma st louis mo usa dissolved 400 ml 95 ethanol 30 min without rinsing slides moved aniline blue 75 g aniline blue 5 ml glacial acetic acid 250 ml distilled water dehydrated ethanol xylene
0.48003986.14645205.html.plaintext.txt	85	western blotting western blotting assess transgenic app expression q2 2 85 c3 3 lines performed described jankowsky et al 55 briefly 5 50 microg brain homogenate probed 22c11 6e10 antisevnl respectively loaded per lane onto 10 tris glycine sds page gel invitrogen carlsbad ca usa electrophoresed several hours 1xtg sds buffer amresco solon oh usa proteins transferred overnight 045 microm optitran nitrocellulose schleicher schuell keene nh usa 1xtg buffer amresco blots blocked pbs containing 5 non fat dry milk powder incubated 3 h room temperature either antibody 22c11 kind gift drs konrad beyreuther andreas weidemann diluted 1 2000 blocking solution antibody 6e10 signet laboratories dedham ma usa diluted 1 2500 blocking solution sevnl 79 diluted 1 2000 blocking solution blots washed several times pbs containing 01 tween 20 incubated either peroxidase conjugated protein sigma st louis mo usa diluted 1 2000 blocking solution 6e10 mixture peroxidase protein diluted 1 1000 rabbit anti mouse igg chemicon temecula ca usa diluted 1 2000 blocking solution washing several times pbs 01 tween 20 blots developed enhanced chemiluminescence reagent new england nuclear boston ma usa exposed film
0.48003986.14645205.html.plaintext.txt	86	levels ps1 transgene products mice used previously described 394456 steady state levels human ps1 protein various mice used accumulate similar levels 4456
0.48003986.14645205.html.plaintext.txt	87	levels ps1 transgene products mice used previously described 394456 steady state levels human ps1 protein various mice used accumulate similar levels 4456
0.48003986.14645205.html.plaintext.txt	88	supplementary material top abstract introduction results discussion conclusions materials methods supplementary material references supplementary material available hmg online
0.48003986.14645205.html.plaintext.txt	89	acknowledgements thank debbie swing assistance production transgenic mice david fromholt alvin george help mouse genotyping data crosses mohu appswe line c3 3 ps1 de9 line o 7 kindly provided drs shadid zaman flavio kamenetz roberto malinow cold spring harbor laboratory cold spring harbor ny usa grateful drs konrad beyreuther andreas weidemann sharing 22c11 antibody dr robert siman university pennsylvania medical school sharing anti sevnl antibody work funded grants national institute aging drb nia 1 p50 ag 14248 nia 1 p01 ag 98 003 national cancer institute naj ngc alzheimers association drb jlj supported training grant nih 1 t32 ns 07435 funding john douglas french alzheimers foundation american health assistance foundation
0.48003986.14645205.html.plaintext.txt	90	acknowledgements thank debbie swing assistance production transgenic mice david fromholt alvin george help mouse genotyping data crosses mohu appswe line c3 3 ps1 de9 line o 7 kindly provided drs shadid zaman flavio kamenetz roberto malinow cold spring harbor laboratory cold spring harbor ny usa grateful drs konrad beyreuther andreas weidemann sharing 22c11 antibody dr robert siman university pennsylvania medical school sharing anti sevnl antibody work funded grants national institute aging drb nia 1 p50 ag 14248 nia 1 p01 ag 98 003 national cancer institute naj ngc alzheimers association drb jlj supported training grant nih 1 t32 ns 07435 funding john douglas french alzheimers foundation american health assistance foundation
0.48003986.14645205.html.plaintext.txt	91	footnotes correspondence addressed department pathology johns hopkins university school medicine 558 ross research building 720 rutland ave baltimore md 21205 usa tel 1 4105025174 fax 1 4109559777 email drboratjhmiedu
0.48003986.14645205.html.plaintext.txt	92	footnotes correspondence addressed department pathology johns hopkins university school medicine 558 ross research building 720 rutland ave baltimore md 21205 usa tel 1 4105025174 fax 1 4109559777 email drboratjhmiedu
0.48003986.14645205.html.plaintext.txt	93	present addressdivision biology mc 156 29 california institute technology pasadena ca 91125 usa
0.48003986.14645205.html.plaintext.txt	94	references top abstract introduction results discussion conclusions materials methods supplementary material references jankowsky jl savonenko schilling g wang j xu g borchelt dr 2002 transgenic mouse models neurodegenerative disease opportunities therapeutic development curr neurol neurosci rep 2 457 464medline
0.48003986.14645205.html.plaintext.txt	95	duff k 1997 alzheimer transgenic mouse models come age trends neurosci 20 279 280crossrefisimedline
0.48230362.12966028.html.plaintext.txt	0	intramembrane cleaving aspartic proteases disease presenilins signal peptide peptidase homologs bruno martoglio1 todd e golde2
0.48230362.12966028.html.plaintext.txt	1	1institute biochemistry swiss federal institute technology eth eth hoenggerberg 8093 zurich switzerland 2department neuroscience mayo graduate school mayo clinic jacksonville jacksonville fl 32224 usa
0.48230362.12966028.html.plaintext.txt	2	received june 30 2003 accepted august 14 2003
0.48230362.12966028.html.plaintext.txt	3	abstract top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references recent studies demonstrate presenilins pss signal peptide peptidase spp members novel protease family integral membrane proteins may utilize catalytic mechanism similar classic aspartic proteases pepsin renin cathepsin d defining features pss spp ability cleave substrate polypeptides within transmembrane region presence two active site aspartate residues adjacent membrane spanning regions conserved pal motif near cooh terminus pss appear catalytic subunit multiprotein complexes possess secretase activity activity generates amyloid ss peptide ass deposited brain patients alzheimers disease ad pss considered therapeutic targets ad contrast pss active unless part larger complex spp appear require protein co factors requirement hepatitis c virus maturation possible immune modulatory role spp also considered potential therapeutic target four additional psspp homologs identified humans yet functions elucidated herein review recent advances understanding psspp family proteases well discuss aspects intramembrane cleavage well understood
0.48230362.12966028.html.plaintext.txt	4	introduction top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references order accurately reflect catalytic activities proteases referred peptide peptidohydrolases terminology reflects catalytic mechanism water molecule plays essential role cleaving peptide bond recently characterized classic proteases shown active site domain located aqueous environment cytoplasmic lumenal extracellular space thus cleavage peptide bonds buried within hydrophobic interior cellular membrane postulated require either breakdown membrane transport substrate lipid bilayer aqueous environment recent identification several families membrane proteases seem capable cleaving peptide bonds present within lipid bilayer dramatically changed concept transmembrane regions proteins may cleaved 12
0.48230362.12966028.html.plaintext.txt	5	three families proteases carry intramembrane proteolysis recognized 12 though exact catalytic mechanisms remain elusive evidence active site proteases could lie within plane lipid bilayer proteases within family may utilize conserved catalytic mechanisms analogous found classic proteases first family whose prototypic member human site two protease s2p cleaves activates sterol regulatory element binding proteins srebps appears group metalloproteases 3 second family rhomboids whose prototypic member drosophila rhomboid 1 cleaves liberates several egf ligands appears group serine proteases 4 third family whose prototypic members presenilins pss involved cleavage amyloid ss protein precursor app notch appears group aspartic proteases 56 collectively proteases referred intramembrane cleaving proteases clips several reasons great deal attention focused aspartic clip family first prototypic members family human pss therapeutic targets alzheimers disease ad second new member family signal peptide peptidase spp recently identified shown unequivocally possess proteolytic activity biological functions may also make therapeutic target herein discuss recent advances respect presenilinsignal peptide peptidase family clips
0.48230362.12966028.html.plaintext.txt	6	three families proteases carry intramembrane proteolysis recognized 12 though exact catalytic mechanisms remain elusive evidence active site proteases could lie within plane lipid bilayer proteases within family may utilize conserved catalytic mechanisms analogous found classic proteases first family whose prototypic member human site two protease s2p cleaves activates sterol regulatory element binding proteins srebps appears group metalloproteases 3 second family rhomboids whose prototypic member drosophila rhomboid 1 cleaves liberates several egf ligands appears group serine proteases 4 third family whose prototypic members presenilins pss involved cleavage amyloid ss protein precursor app notch appears group aspartic proteases 56 collectively proteases referred intramembrane cleaving proteases clips several reasons great deal attention focused aspartic clip family first prototypic members family human pss therapeutic targets alzheimers disease ad second new member family signal peptide peptidase spp recently identified shown unequivocally possess proteolytic activity biological functions may also make therapeutic target herein discuss recent advances respect presenilinsignal peptide peptidase family clips
0.48230362.12966028.html.plaintext.txt	7	presenilins top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references pss integral membrane proteins 6 8 predicted transmembrane regions first identified genetic linkage analysis families early onset autosomal dominant forms ad 78 pss synthesized 50 kda proteins rapidly endoproteolyzed nh2 30 kda cooh 20 kda terminal fragments remain associated along proteins high molecular weight complex 910 date 100 ad linked mutations found presenilin 1 ps1 several presenilin 2 ps2 11 almost concurrent identification mutations pss genetic causes ad evidence linking pss proteolytic activity referred secretase 12 activity involved production amyloid ss peptide ass precursor app following cleavage app ss secretase secretase cleaves membrane bound cooh terminal app fragment within transmembrane region generating 4 kda ass peptide cognate cooh terminal cleavage product cut membrane heterogeneous multiple ass species produced ranging length 32 42 amino acids 13 prevalent form ass one 40 amino acid residues ass40 typical circumstances ass40 represents 50 ass secreted cell however ass species 42 amino acids ass42 appears play causal role ad pathogenesis date ad linked mutations ps1 ps2 shown increase relative production ass42 even asymptomatic carriers expression mutant ps gene transgenic mice overexpressing human app accelerated accumulation aggregation ass brain 1214
0.48230362.12966028.html.plaintext.txt	8	despite evidence mutations pss altered secretase activity generated ass one readily endorsed idea pss secretases pss bear homology classic proteases thus proposed pss influenced secretase activity indirectly past years genetic biochemical evidence emerged demonstrating pss fact secretases knockout studies ps1 ps2 demonstrated essential role proteins secretase cleavage ps1 knockout decreased secretase activity 80 ps2 knockout little effect combined ps1 ps2 knockout abolished secretase activity 15 18 biochemical studies showed ps1 co fractionates secretase activity high molecular weight complex vitro activity could recovered pellet immunoprecipitation antibodies ps1 19 significantly mutation conserved aspartate residues d257 d385 ps1 d263 d366 ps2 present two adjacent transmembrane regions produced dominant negative forms ps inhibited secretase activity cells 5 studies together inhibitor studies suggested pss might aspartic type proteases 20 finally inhibitors secretase activity shown directly target ps1 ps2 21 24 moreover given two groups specifically designed inhibitors transition state analogs aspartic proteases 2122 certainly appears despite lack demonstrable homology known aspartic proteases ps may
0.48230362.12966028.html.plaintext.txt	9	despite evidence mutations pss altered secretase activity generated ass one readily endorsed idea pss secretases pss bear homology classic proteases thus proposed pss influenced secretase activity indirectly past years genetic biochemical evidence emerged demonstrating pss fact secretases knockout studies ps1 ps2 demonstrated essential role proteins secretase cleavage ps1 knockout decreased secretase activity 80 ps2 knockout little effect combined ps1 ps2 knockout abolished secretase activity 15 18 biochemical studies showed ps1 co fractionates secretase activity high molecular weight complex vitro activity could recovered pellet immunoprecipitation antibodies ps1 19 significantly mutation conserved aspartate residues d257 d385 ps1 d263 d366 ps2 present two adjacent transmembrane regions produced dominant negative forms ps inhibited secretase activity cells 5 studies together inhibitor studies suggested pss might aspartic type proteases 20 finally inhibitors secretase activity shown directly target ps1 ps2 21 24 moreover given two groups specifically designed inhibitors transition state analogs aspartic proteases 2122 certainly appears despite lack demonstrable homology known aspartic proteases ps may
0.48230362.12966028.html.plaintext.txt	10	recent insight components high molecular weight complex contains secretase activity pss offers complete picture secretase three additional proteins required secretase activity cells nicastrin nct aph 2 130 kda type membrane protein originally purified complex 25 two additional proteins aph 1 another integral membrane protein 30 kda multiple transmembrane regions pen 2 small hairpin like protein 12 kda initially isolated genetic screens caenorhabditis elegans 26 together ps three components appear comprise minimal functional secretase complex 27 29 although precise function subunit yet definitively established appears pss catalytic component nct aph 1 pen 2 play various roles stabilization maturation complex also possible accessory proteins involved substrate presentation
0.48230362.12966028.html.plaintext.txt	11	recent insight components high molecular weight complex contains secretase activity pss offers complete picture secretase three additional proteins required secretase activity cells nicastrin nct aph 2 130 kda type membrane protein originally purified complex 25 two additional proteins aph 1 another integral membrane protein 30 kda multiple transmembrane regions pen 2 small hairpin like protein 12 kda initially isolated genetic screens caenorhabditis elegans 26 together ps three components appear comprise minimal functional secretase complex 27 29 although precise function subunit yet definitively established appears pss catalytic component nct aph 1 pen 2 play various roles stabilization maturation complex also possible accessory proteins involved substrate presentation
0.48230362.12966028.html.plaintext.txt	12	biological activities secretase pss extensively reviewed 230 although activities pss distinct protease activity eg stabilization ss catenin many secretase activity regulates notch app signaling promoting release cytoplasmic tail membrane bound fragment precursor clear whether release small peptides ass exoplasmic space demonstrable physiologic function also clear whether secretase cleavage substrates notch app physiologic functions possible secretase cleavage certain substrates may simply mechanism breakdown proteins current list secretase substrates cleavage products putative functions listed table 1
0.48230362.12966028.html.plaintext.txt	13	biological activities secretase pss extensively reviewed 230 although activities pss distinct protease activity eg stabilization ss catenin many secretase activity regulates notch app signaling promoting release cytoplasmic tail membrane bound fragment precursor clear whether release small peptides ass exoplasmic space demonstrable physiologic function also clear whether secretase cleavage substrates notch app physiologic functions possible secretase cleavage certain substrates may simply mechanism breakdown proteins current list secretase substrates cleavage products putative functions listed table 1
0.48230362.12966028.html.plaintext.txt	14	view table table 1 ps secretase substrates signal peptide peptidase top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references second recently identified member aspartic clip family spp higher eukaryotes 31 typical aspartic clip spp predicted multispanning membrane protein containing two putative active site aspartates located centre adjacent transmembrane regions latter feature consistent observed cleavage substrate peptides centre membrane spanning portion addition spp contains two endoglycosidase h sensitive n glycans er retrieval signal kkxx ascribing spp function endoplasmic reticulum er 31
0.48230362.12966028.html.plaintext.txt	15	role spp cell function poorly understood spp substrates identified date represent variety signal peptides viral protein table 2 31 34 unequivocally demonstrate role spp either degradation signal peptides may otherwise accumulate er membrane activation signaling regulatory molecules potential orthologs spp found genomes animals plants fungi bacteria 3135 therefore prime role spp may necessarily clearance membranes signal peptides produced organisms basic mechanism may exist fulfil function may thus speculate spp analogy clips may promote liberation bioactive peptides proteins er membrane generation hla e epitopes humans represents first example spp dependent production bioactive peptide case functions reporter hla e epitopes play key role immune surveillance produced signal sequences antigen presenting mhc class molecules process depends spp 36 epitopes eventually presented cell surface cells recognized natural killer nk cells immune system presentation signal peptide derived epitopes indirect indication probed cell healthy properly synthesized mhc class molecules epitope presentation defective otherwise disturbed eg due virus infection transformation tumor cell impaired cells thought recognized eliminated nk cells 37
0.48230362.12966028.html.plaintext.txt	16	role spp cell function poorly understood spp substrates identified date represent variety signal peptides viral protein table 2 31 34 unequivocally demonstrate role spp either degradation signal peptides may otherwise accumulate er membrane activation signaling regulatory molecules potential orthologs spp found genomes animals plants fungi bacteria 3135 therefore prime role spp may necessarily clearance membranes signal peptides produced organisms basic mechanism may exist fulfil function may thus speculate spp analogy clips may promote liberation bioactive peptides proteins er membrane generation hla e epitopes humans represents first example spp dependent production bioactive peptide case functions reporter hla e epitopes play key role immune surveillance produced signal sequences antigen presenting mhc class molecules process depends spp 36 epitopes eventually presented cell surface cells recognized natural killer nk cells immune system presentation signal peptide derived epitopes indirect indication probed cell healthy properly synthesized mhc class molecules epitope presentation defective otherwise disturbed eg due virus infection transformation tumor cell impaired cells thought recognized eliminated nk cells 37
0.48230362.12966028.html.plaintext.txt	17	view table table 2 spp substrates substrate spectrum spp may restricted classic signal peptides typically short nh2 terminal extensions precursor protein finding spp exploited hepatitis c virus hcv processing viral core protein implies protease may also catalyse intramembrane cleavage membrane anchored proteins similar clips 34 biosynthesis viral proteins hcv infected cells immature hcv core protein transiently anchored er membrane via cooh terminal signal peptide like sequence intramembrane proteolysis spp promotes final processing core protein release er membrane cytosol likewise may speculate proteins anchored er membrane signal peptide like sequence may liberated er membrane activated upon cleavage spp
0.48230362.12966028.html.plaintext.txt	18	presenilin spp similarities differences top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references despite limited areas direct sequence homology pss spp membrane proteins whose sequences aligned almost throughout entire lengths 3135 pss spp share identical active site motifs yd lglgd table 3 addition contain third conserved region pal seems characteristic entire aspartic clip family moreover yd lglgd motifs contain catalytic aspartate residues unusual present within predicted adjacent opposing transmembrane regions similarities pss spp particularly identity active site motifs point common catalytic mechanism indeed series protease inhibitors including aspartic protease transition state analogues targeted active site spp pss inhibited activities 38 enzymes potential targets therapeutic intervention pss treatment ad spp anti hcv therapy challenging task future define compounds conditions selective inhibition either protease
0.48230362.12966028.html.plaintext.txt	19	view table table 3 ps psh family members another common feature one typical many clips ps spp activity appear require prior cleavage substrate remove ectodomain spp substrates first cleaved signal peptidase 33 whereas ps secretase substrates first cleaved shedding proteases eg adam family members ss secretase 39 41 cases studied date initial cleavage essential intramembrane cut occur thus substrate specificity ps secretase spp may determined much priming cleavage respective substrate sequence
0.48230362.12966028.html.plaintext.txt	20	one striking differences pss spp apparent opposite positioning active site motif containing transmembrane regions within plane membrane 3142 positioning correlates opposite orientation respective substrates ps substrates type membrane topology cooh termini facing cytosol whereas spp substrates type ii topology nh2 termini facing cytosol thus appears related proteases inversed proteolytic domains evolved cleavage membrane spanning peptides different topologies
0.48230362.12966028.html.plaintext.txt	21	one striking differences pss spp apparent opposite positioning active site motif containing transmembrane regions within plane membrane 3142 positioning correlates opposite orientation respective substrates ps substrates type membrane topology cooh termini facing cytosol whereas spp substrates type ii topology nh2 termini facing cytosol thus appears related proteases inversed proteolytic domains evolved cleavage membrane spanning peptides different topologies
0.48230362.12966028.html.plaintext.txt	22	despite common features major differences pss spp reconstitution human spp yeast saccharomyces cerevisiae express orthologous signal peptide peptidase suggested human spp require additional proteins activity 31 contrast pss appear require least three additional protein partners activity pss undergo endoproteolytic activation may depend components together additional proteins forms active secretase complex activation complex formation may provide means control proteases intramembrane cleaving activity regulate substrate delivery andor trafficking intracellular site action case spp indication endoproteolysis another activation step nevertheless activity almost certainly regulated fashion spp appear randomly attack membrane proteins er rather protease activity properties substrates may account controlled proteolysis spp 33
0.48230362.12966028.html.plaintext.txt	23	despite common features major differences pss spp reconstitution human spp yeast saccharomyces cerevisiae express orthologous signal peptide peptidase suggested human spp require additional proteins activity 31 contrast pss appear require least three additional protein partners activity pss undergo endoproteolytic activation may depend components together additional proteins forms active secretase complex activation complex formation may provide means control proteases intramembrane cleaving activity regulate substrate delivery andor trafficking intracellular site action case spp indication endoproteolysis another activation step nevertheless activity almost certainly regulated fashion spp appear randomly attack membrane proteins er rather protease activity properties substrates may account controlled proteolysis spp 33
0.48230362.12966028.html.plaintext.txt	24	homologs top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references shortly identification human pss homologs recognized plants invertebrates vertebrates close homologs found c elegans drosophila extensively studied shown function aspartic clips high molecular weight complexes like human pss reviewed 2 recently addition spp number potential aspartic clips less obvious homology pss recognized database searching table 3 313543 proteins identified function referred various names herein referred presenilin homologssignal peptide peptidase like proteases pshsppl although future functional assignment propose would renamed accurately reflect function humans four pshsppls unknown functions recognized pshsppls predicted integral membrane proteins multiple membrane spanning regions contain conserved transmembrane aspartates motifs yd lghgd pal motif near cooh terminus addition several members family contain protease associated domain near nh2 terminus found classic protease domain involved substrate binding 44
0.48230362.12966028.html.plaintext.txt	25	models cleavage top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references although much learned intramembrane cleavage exact manner reactions occur remains mystery conservation putative active site motifs clips classic proteases indicates catalytic mechanism clips likely involves hydrolysis case water must somehow gain entry active site proteases labile bonds within substrates transmembrane region must point exposed activated water molecule figure 1 theoretical models might fulfill two requirements shown first model fig 1a one multiple transmembrane regions protease form hydrophilic pocket groove one face membrane model compatible clip cleavage sites lie close cytosolic lumenal face membrane release cytoplasmic tail app notch however cleavage events generate ass appear occur middle membrane might either require perpendicular movement substrate protease within membrane possibly deep hydrophilic pocket variant model might transmembrane regions clip adopt horseshoe like structure upon association substrate active site channel pore might formed allowing access water site hydrolysis model might require distinct initial binding sites substrate followed transfer active site another model fig 1b might suggested recent data showing pss spp may form dimers vivo one initial binding substrate occurs one active site binding could induce conformational shift resulting merger two subunits together form pore like structure alternatively distinct substrate binding site one subunit could result presentation substrate active site subunit additional models cleavage combine various aspects models possible finally possible given clip may utilize novel mechanism catalysis compatible cleavage peptide bond lipid environment
0.48230362.12966028.html.plaintext.txt	26	view larger version 67k figure 1 possible models cleavage clip several models presented could permit water access active site clip may form shallow deep hydrophilic pocket membrane would allow access water catalytic residues indicated two stars pocket may form upon conformational change induced binding substrate b two units clip may act dimer carry cleavage case substrate binding one clip unit may induce conformational change formation pore containing merged active site
0.48230362.12966028.html.plaintext.txt	27	view larger version 67k figure 1 possible models cleavage clip several models presented could permit water access active site clip may form shallow deep hydrophilic pocket membrane would allow access water catalytic residues indicated two stars pocket may form upon conformational change induced binding substrate b two units clip may act dimer carry cleavage case substrate binding one clip unit may induce conformational change formation pore containing merged active site
0.48230362.12966028.html.plaintext.txt	28	conclusions top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references aspartic clips represent newly recognized biomedically important family proteases intense study pss secretase led development potent inhibitors secretase activity several entered phase trials humans distinct secretase inhibitors overlapping activity spp 38 highly expected many compounds may also target pshsppls thus specificity secretase inhibitors must questioned potential clinical significance secretase inhibitors urgent need increase understanding proteins even experience gained studying pss spp remain difficult task date easily identifiable strategy assured identifying function substrate novel aspartic clips nevertheless inhibitor specificity may prove instrumental inhibitors aspartic clips prove therapeutic utility assignment function development activity assays extremely important
0.48230362.12966028.html.plaintext.txt	29	acknowledgements work supported grants nihnia ns39072 teg center neuroscience zurich znz national competence center research nccr neuronal plasticity repair swiss national science foundation bm
0.48230362.12966028.html.plaintext.txt	30	footnotes correspondence addressed bruno martoglio tel 41 16326347 fax 41 16321269 email brunomartoglioatbcbiolethzch u d todd e golde tel 1 9049532538 fax 1 9049537370 email tgoldeatmayoedu
0.48230362.12966028.html.plaintext.txt	31	references top abstract introduction presenilins signal peptide peptidase presenilin spp similarities homologs models cleavage conclusions references weihofen martoglio b 2003 intramembrane cleaving proteases controlled liberation proteins bioactive peptides trends cell biol 13 71 78crossrefmedline
0.48230362.12966028.html.plaintext.txt	32	de strooper b 2003 aph 1 pen 2 nicastrin presenilin generate active gamma secretase complex neuron 38 9 12medline
0.49538547.12930775.html.plaintext.txt	0	presenilins required formation comma shaped bodies nephrogenesis pei wang12 fred pereira123 duane beasley1 hui zheng124
0.49538547.12930775.html.plaintext.txt	1	presenilins required formation comma shaped bodies nephrogenesis pei wang12 fred pereira123 duane beasley1 hui zheng124
0.49538547.12930775.html.plaintext.txt	2	1 huffington center aging baylor college medicine houston tx 77030 usa 2 department molecular cellular biology baylor college medicine houston tx 77030 usa 3 department otolaryngology baylor college medicine houston tx 77030 usa 4 department molecular human genetics baylor college medicine houston tx 77030 usa
0.49538547.12930775.html.plaintext.txt	3	author correspondence e mail huizatbcmtmcedu u d
0.49538547.12930775.html.plaintext.txt	4	summary top summary introduction materials methods results discussion references mammalian presenilins consist two highly homologous proteins psen1 psen2 share redundant activities notch processing signaling bypass early lethality psen1 psen2 double psen null embryos used human psen1 transgene rescue somite patterning defects psen null animals allow determination function presenilins late embryogenesis report expression human psen1 transgene supported survival psen null embryos perinatal stage however presenilin deficiency kidney led severe nephrogenesis defects virtually comma shaped bodies mature glomeruli formed document mesenchyme induced could progress renal vesicles psen null kidney indicating presenilins essential inductive interactions mesenchyme epithelium transition however renal vesicles failed pattern form proximal tubules glomerular epithelium presenilin dependent signaling competent form notch1 detected mesenchymal derivatives ureteric buds wild type mice consistent obligatory role presenilins notch processing activation active form notch1 downstream target hesr1 absent psen null kidney importantly sustained notch1 signaling required maintenance notch ligand jag1 expression results identify presenilins one determinant renal vesicle patterning developing mouse kidney hypothesize act notch signaling pathway
0.49538547.12930775.html.plaintext.txt	5	summary top summary introduction materials methods results discussion references mammalian presenilins consist two highly homologous proteins psen1 psen2 share redundant activities notch processing signaling bypass early lethality psen1 psen2 double psen null embryos used human psen1 transgene rescue somite patterning defects psen null animals allow determination function presenilins late embryogenesis report expression human psen1 transgene supported survival psen null embryos perinatal stage however presenilin deficiency kidney led severe nephrogenesis defects virtually comma shaped bodies mature glomeruli formed document mesenchyme induced could progress renal vesicles psen null kidney indicating presenilins essential inductive interactions mesenchyme epithelium transition however renal vesicles failed pattern form proximal tubules glomerular epithelium presenilin dependent signaling competent form notch1 detected mesenchymal derivatives ureteric buds wild type mice consistent obligatory role presenilins notch processing activation active form notch1 downstream target hesr1 absent psen null kidney importantly sustained notch1 signaling required maintenance notch ligand jag1 expression results identify presenilins one determinant renal vesicle patterning developing mouse kidney hypothesize act notch signaling pathway
0.49538547.12930775.html.plaintext.txt	6	key words presenilin notch kidney nephrogenesis patterning proximal tubule
0.49538547.12930775.html.plaintext.txt	7	introduction top summary introduction materials methods results discussion references presenilins psen1 psen2 polytopic transmembrane proteins essential process ss amyloid precursor protein app secretase site generate ass40 ass42 peptides constitute major components ss amyloid plaques characteristic alzheimers disease ad de strooper et al 1998 selkoe 1998 autosomal dominant inheritance mutations psen1 psen2 leads familial alzheimers disease mutations known affect secretase activity foster ss amyloid plaque pathology selkoe 1998 similar mechanisms presenilins required proteolytic cleavage notch de strooper et al 1999 molecules crucial various cell fate specification processes activity highly conserved levitan et al 1996 levitan greenwald 1995 struhl greenwald 1999 ye et al 1999 mammalian systems two presenilins play compensatory roles notch signaling pathway revealed gene knockout studies specifically psen1 null mice die pre perinatally exhibiting notch1 associated somite segmentation defect shen et al 1997 wong et al 1997 although psen2 knockout overt impairment psen1 psen2 double psen null embryos die embryonic day 95 e95 complete absence somite patterning resembles complete notch1 loss function precisely notch1 notch4 double knockout phenotypes conlon et al 1995 donoviel et al 1999 herreman et al 1999 krebs et al 2000 redundant activities psen1 psen2 may explanation lack overt organogenesis defects single knockouts early lethal phenotype psen null embryos prevents evaluation potential physiological roles presenilins mid late embryogenesis
0.49538547.12930775.html.plaintext.txt	8	organogenesis highly regulated developmental program involving cell fate decisions pattern formation differentiation mammals organogenesis initiates body axes established kidney organogenesis mice begins e11 involves reciprocal inductive interactions ureteric bud epithelium metanephric mesenchyme tips ureteric bud induce nephrogenic mesenchyme form condensates followed pretubular aggregates undergo mesenchyme epithelium transition met progress polarized epithelia renal vesicles comma shaped bodies saxen 1987 morphogenesis patterning epithelial structures leads formation distal proximal tubules glomerulus latter consists podocytes mesangial cells endothelial cells saxen 1987
0.49538547.12930775.html.plaintext.txt	9	organogenesis highly regulated developmental program involving cell fate decisions pattern formation differentiation mammals organogenesis initiates body axes established kidney organogenesis mice begins e11 involves reciprocal inductive interactions ureteric bud epithelium metanephric mesenchyme tips ureteric bud induce nephrogenic mesenchyme form condensates followed pretubular aggregates undergo mesenchyme epithelium transition met progress polarized epithelia renal vesicles comma shaped bodies saxen 1987 morphogenesis patterning epithelial structures leads formation distal proximal tubules glomerulus latter consists podocytes mesangial cells endothelial cells saxen 1987
0.49538547.12930775.html.plaintext.txt	10	number ductal mesenchymal derived molecules identified loss function studies established crucial roles nephrogenesis httpgolgianaedacukkidhomehtml relevant study ret expressed tips newly formed branches ureteric bud crucial inductive interactions binding ligand gdnf resides condensing mesenchyme moore et al 1996 pachnis et al 1993 schuchardt et al 1994 paired box genes pax2 pax8 expressed various mesenchymal derivatives ureteric bud epithelium dressler et al 1993 plachov et al 1990 rothenpieler dressler 1993 together regulate define nephric lineage bouchard et al 2002 wnt4 documented essential signaling molecule metanephric mesenchyme mesenchymal epithelial cell conversion kispert et al 1998 stark et al 1994 wt1 expressed uninduced mesenchyme podocyte precursor cells shaped bodies mature glomeruli required earliest phase kidney formation armstrong et al 1993 kreidberg et al 1993 winged helix transcription factor bf2 specifically expressed interstitial stromal mesenchyme shown modulate transition condensed mesenchyme tubular epithelium hatini et al 1996
0.49538547.12930775.html.plaintext.txt	11	notch pathway implicated kidney development specifically notch1 notch2 ligands delta like1 dll1 jag1 expressed maturing nephron glomerulus beckers et al 1999 mccright et al 2001 weinmaster et al 1991 weinmaster et al 1992 xenopus pronephros notch signaling proposed involved early determination duct versus tubule fate well controlling tubule patterning mclaughlin et al 2000 furthermore mice hypomorphic expression notch2 exhibit kidney glomerulogenesis defect mccright et al 2001
0.49538547.12930775.html.plaintext.txt	12	notch pathway implicated kidney development specifically notch1 notch2 ligands delta like1 dll1 jag1 expressed maturing nephron glomerulus beckers et al 1999 mccright et al 2001 weinmaster et al 1991 weinmaster et al 1992 xenopus pronephros notch signaling proposed involved early determination duct versus tubule fate well controlling tubule patterning mclaughlin et al 2000 furthermore mice hypomorphic expression notch2 exhibit kidney glomerulogenesis defect mccright et al 2001
0.49538547.12930775.html.plaintext.txt	13	reported earlier restricted expression human psen1 transgene developing brain vertebralspinal column driven human thy 1 promoter could rescue psen1 null patterning defects lethal phenotype qian et al 1998 bypass early lethality psen null embryos bred transgene onto psen1 psen2 double knockout background showed expression human psen1 transgene supported survival psen null embryos perinatal stage however loss presenilins resulted profound nephrogenesis defects prior development comma shaped bodies provide evidence presenilins play important role probably notch signaling pathway patterning renal epithelial structures
0.49538547.12930775.html.plaintext.txt	14	materials methods top summary introduction materials methods results discussion references breeding genotyping psen rescue mice generation genotyping psen1 psen2 null human psen1 transgenic mice previously described donoviel et al 1999 qian et al 1998 wong et al 1997 breeding strategy shown fig 1a mice analyzed study mixed genetic background three strains 129 c57 sjl day vaginal plug observed considered embryonic day e 05 embryos least one wild type allele psen1 gene used littermate controls
0.49538547.12930775.html.plaintext.txt	15	view larger version 44k fig 1 generation morphological biochemical characterization presenilin rescue mice mice carrying single copy human psen1 transgene onto endogenous mouse psen1 psen2 double knockout psen1 psen2 psen1 presenilin rescue background produced three generations breeding outlined b whole mount photographs presenilin rescue embryos mutant along littermates control e135 left p0 right c dramatically reduced kidney size presenilin rescue mutant compared littermate control control d western blot analysis psen1 expression p0 kidneys control lanes 1 2 presenilin rescue mutant lane 3 psen1 null lane 4 documenting absence psen1 expression presenilin rescue kidney lower panel hybridization anti ss actin antibody loading control
0.49538547.12930775.html.plaintext.txt	16	embryonic histology embryos dissected fixed 10 neutral buffered formalin sigma 24 48 hours dehydrated graded alcohols stored 70 ethanol 4 degrees c embryos vacuum embedded paraffin wax sectioned 5 microm stained hematoxylin eosin
0.49538547.12930775.html.plaintext.txt	17	embryonic histology embryos dissected fixed 10 neutral buffered formalin sigma 24 48 hours dehydrated graded alcohols stored 70 ethanol 4 degrees c embryos vacuum embedded paraffin wax sectioned 5 microm stained hematoxylin eosin
0.49538547.12930775.html.plaintext.txt	18	situ hybridization situ hybridization carried using digoxigenin labeled 35sutp labeled antisense riboprobes samples fixed 10 neutral buffered formalin embedded paraffin wax sections cut 5 microm radioactive probes 9 microm nonradioactive probes protocol used radioactive situ essentially published qiu et al 1994 non radioactive situ modified protocol wilkinson employed wilkinson 1992 brief sections dewaxed dehydrated fixed 4 paraformaldehyde pfa 30 minutes room temperature washing pbs sections treated proteinase k 20 microgml 10 minutes refixed pfa washed pbs samples acetylated 20 minutes washed hybridized 50 formamide 20 mm tris hcl ph 80 500 microgml trna 1xdenhardts solution 10 dextran sulfate 300 mm nacl 10 mm napo4 ph 80 5 mm edta 200 ng probeslide overnight 65 degrees c humidified chamber sections washed 40 minutes 05xssc20 formamide 60 degrees c followed treatment rnase 30 minutes 37 degrees c washed 20 minutes 05xssc20 formamide 60 degrees c sections blocked blocking solution 100 mm maleic acid 150 mm nacl 1 boehringer blocking agent 1 hour room temperature incubated alkaline phosphatase conjugated sheep polyclonal antidigoxigenin antibody roche diluted 12000 tbs buffer overnight 4 degrees c washing twice tbs alkaline phosphatase activity detected presence nbtbcip roche
0.49538547.12930775.html.plaintext.txt	19	situ hybridization situ hybridization carried using digoxigenin labeled 35sutp labeled antisense riboprobes samples fixed 10 neutral buffered formalin embedded paraffin wax sections cut 5 microm radioactive probes 9 microm nonradioactive probes protocol used radioactive situ essentially published qiu et al 1994 non radioactive situ modified protocol wilkinson employed wilkinson 1992 brief sections dewaxed dehydrated fixed 4 paraformaldehyde pfa 30 minutes room temperature washing pbs sections treated proteinase k 20 microgml 10 minutes refixed pfa washed pbs samples acetylated 20 minutes washed hybridized 50 formamide 20 mm tris hcl ph 80 500 microgml trna 1xdenhardts solution 10 dextran sulfate 300 mm nacl 10 mm napo4 ph 80 5 mm edta 200 ng probeslide overnight 65 degrees c humidified chamber sections washed 40 minutes 05xssc20 formamide 60 degrees c followed treatment rnase 30 minutes 37 degrees c washed 20 minutes 05xssc20 formamide 60 degrees c sections blocked blocking solution 100 mm maleic acid 150 mm nacl 1 boehringer blocking agent 1 hour room temperature incubated alkaline phosphatase conjugated sheep polyclonal antidigoxigenin antibody roche diluted 12000 tbs buffer overnight 4 degrees c washing twice tbs alkaline phosphatase activity detected presence nbtbcip roche
0.49538547.12930775.html.plaintext.txt	20	immunohistochemical staining psen null littermate control kidneys dissected various developmental stages specified figure legends immunohistochemical staining performed frozen laminin 1 gift d abrahamson paraffin fixed sections others sections blocked 5 goat serum incubated primary antibodies 4 degrees c overnight washed pbs incubated 11000 alexa fluor 488 alexa fluor 594 conjugated secondary antibody molecular probe 1 hour room temperature washed pbs mounted glycerolpbs digital images obtained zeiss microscope axioskop 2 primary antibodies used laminin sigma l9393 e cadherin signal transduction c20820 wt1 santa cruz sc192 cleaved notch1 val1744 cell signaling 2421 cleaved caspase 3 asp175 cell signaling 9661 ncam monoclonal antibody developed jessell troma1 monoclonal antibody developed p brulet obtained developmental studies hybridoma bank
0.49538547.12930775.html.plaintext.txt	21	immunohistochemical staining psen null littermate control kidneys dissected various developmental stages specified figure legends immunohistochemical staining performed frozen laminin 1 gift d abrahamson paraffin fixed sections others sections blocked 5 goat serum incubated primary antibodies 4 degrees c overnight washed pbs incubated 11000 alexa fluor 488 alexa fluor 594 conjugated secondary antibody molecular probe 1 hour room temperature washed pbs mounted glycerolpbs digital images obtained zeiss microscope axioskop 2 primary antibodies used laminin sigma l9393 e cadherin signal transduction c20820 wt1 santa cruz sc192 cleaved notch1 val1744 cell signaling 2421 cleaved caspase 3 asp175 cell signaling 9661 ncam monoclonal antibody developed jessell troma1 monoclonal antibody developed p brulet obtained developmental studies hybridoma bank
0.49538547.12930775.html.plaintext.txt	22	embryonic proliferation apoptosis antibody phosphorylated histone h3 upstate biochemicals used detect mitotic cells wei et al 1999 tunel assay performed described gavrieli et al 1992 sections stained methyl green identify nucleated cells four hundred 600 cells per section counted proportion mitotic apoptotic cells determined fraction total number nucleated cells four kidneysstagegenotype five sectionskidney counted
0.49538547.12930775.html.plaintext.txt	23	kidney organ culture immunohistochemistry embryonic day 125 kidneys isolated cultured memf12 containing 10 fetal bovine serum millicell culture plate insert millipore mediumgas interface 3 days kidneys fixed 2 paraformaldehyde 10 minutes 95 methanol 15 minutes washed pbst phosphate buffered saline 01 m ph 74 01 tween 20 stained whole mount anti pan cytokeratin sigma c2562 wt1 santa cruz sc192 antibodies 4 degrees c overnight washed pbs incubated 11000 alexa fluor 488 alexa fluor 594 conjugated secondary antibody molecular probe 2 hours room temperature washed pbs mounted glycerolpbs viewed zeiss confocal microscope lsm510
0.49538547.12930775.html.plaintext.txt	24	kidney organ culture immunohistochemistry embryonic day 125 kidneys isolated cultured memf12 containing 10 fetal bovine serum millicell culture plate insert millipore mediumgas interface 3 days kidneys fixed 2 paraformaldehyde 10 minutes 95 methanol 15 minutes washed pbst phosphate buffered saline 01 m ph 74 01 tween 20 stained whole mount anti pan cytokeratin sigma c2562 wt1 santa cruz sc192 antibodies 4 degrees c overnight washed pbs incubated 11000 alexa fluor 488 alexa fluor 594 conjugated secondary antibody molecular probe 2 hours room temperature washed pbs mounted glycerolpbs viewed zeiss confocal microscope lsm510
0.49538547.12930775.html.plaintext.txt	25	results top summary introduction materials methods results discussion references morphological histological characterization presenilin rescue mice generate mice carrying human psen1 transgene endogenous mouse psen1 psen2 double knockout psen1 psen2 psen1 presenilin rescue background bred mice heterozygous mouse psen1 positive psen1 psen1 psen1 line 16 4 qian et al 1998 psen2 null psen2 donoviel et al 1999 produce offspring compound heterozygous endogenous presenilins positive psen1 psen1 psen2 psen1 mice crossed twice animals heterozygous psen1 homozygous psen2 psen1 psen2 yield desired mutant genotype psen1 psen2 psen1 fig 1a
0.49538547.12930775.html.plaintext.txt	26	results top summary introduction materials methods results discussion references morphological histological characterization presenilin rescue mice generate mice carrying human psen1 transgene endogenous mouse psen1 psen2 double knockout psen1 psen2 psen1 presenilin rescue background bred mice heterozygous mouse psen1 positive psen1 psen1 psen1 line 16 4 qian et al 1998 psen2 null psen2 donoviel et al 1999 produce offspring compound heterozygous endogenous presenilins positive psen1 psen1 psen2 psen1 mice crossed twice animals heterozygous psen1 homozygous psen2 psen1 psen2 yield desired mutant genotype psen1 psen2 psen1 fig 1a
0.49538547.12930775.html.plaintext.txt	27	reported earlier expression psen1 transgene able rescue somite patterning defect psen1 null mice qian et al 1998 similarly transgene expression restored somite structures completely absent psen null embryos fig 1b donoviel et al 1999 presenilin rescue mutants indistinguishable compared littermate controls prior e125 e135 mutants overtly similar littermates although slightly smaller size difference became dramatic time fig 1b mutants could unambiguously identified eyes lacked pigmentation phenotype subject separate study
0.49538547.12930775.html.plaintext.txt	28	presenilin rescue mutants died within 2 hours birth examination organs revealed p0 kidneys dramatically smaller littermate controls fig 1c suggesting defect kidney development western blot analysis showed psen1 protein could readily detected control kidneys fig 1d lane 12 however detectable psen1 psen2 psen1 rescue mutant fig 1d lane 3 suggests defect due loss presenilins mutant kidney herein referred psen null
0.49538547.12930775.html.plaintext.txt	29	presenilin rescue mutants died within 2 hours birth examination organs revealed p0 kidneys dramatically smaller littermate controls fig 1c suggesting defect kidney development western blot analysis showed psen1 protein could readily detected control kidneys fig 1d lane 12 however detectable psen1 psen2 psen1 rescue mutant fig 1d lane 3 suggests defect due loss presenilins mutant kidney herein referred psen null
0.49538547.12930775.html.plaintext.txt	30	histological analysis various stages kidney development revealed e125 ureteric buds readily identified surrounded condensed mesenchyme control psen null kidneys fig 2ab asterisks result suggests inductive interactions ureteric bud epithelium metanephric mesenchyme proceeded normally absence presenilins however e135 kidney development advanced control evidenced appearance pretubular aggregatesrenal vesicles distinguished upon analysis see fig 4 comma shaped bodies fig 2c thin arrow arrowheads respectively pretubular aggregatesrenal vesicles fig 2d thin arrow could found psen null kidney comma shaped bodies identified result indicates presenilins play critical role progression pretubular aggregatesrenal vesicles towards comma shaped bodies nephrogenesis analysis kidneys later stages e155 p0 supports view mature glomeruli could readily detected controls fig 2eg thick arrows completely absent psen null kidneys fig 2fh kidney defect present another psen rescue line 17 3 data shown therefore conclude phenotype result loss presenilin expression rather transgene integration
0.49538547.12930775.html.plaintext.txt	31	histological analysis various stages kidney development revealed e125 ureteric buds readily identified surrounded condensed mesenchyme control psen null kidneys fig 2ab asterisks result suggests inductive interactions ureteric bud epithelium metanephric mesenchyme proceeded normally absence presenilins however e135 kidney development advanced control evidenced appearance pretubular aggregatesrenal vesicles distinguished upon analysis see fig 4 comma shaped bodies fig 2c thin arrow arrowheads respectively pretubular aggregatesrenal vesicles fig 2d thin arrow could found psen null kidney comma shaped bodies identified result indicates presenilins play critical role progression pretubular aggregatesrenal vesicles towards comma shaped bodies nephrogenesis analysis kidneys later stages e155 p0 supports view mature glomeruli could readily detected controls fig 2eg thick arrows completely absent psen null kidneys fig 2fh kidney defect present another psen rescue line 17 3 data shown therefore conclude phenotype result loss presenilin expression rather transgene integration
0.49538547.12930775.html.plaintext.txt	32	view larger version 146k fig 2 hematoxylin eosin analysis kidney development right column presenilin null mutant left column littermate controls control e125 ab condensed mesenchyme asterisks surrounding ureteric bud could identified psen null mutant b control e135 cd pretubular aggregates arrows could seen control c mutant d advanced structures comma shaped bodies arrowheads could detected control psen null kidney e155 ef p0 gh numerous glomeruli formed control eg arrows structures absent mutant fh scale bar 100 microm
0.49538547.12930775.html.plaintext.txt	33	view larger version 80k fig 4 immunohistochemical characterization renal derivatives double staining anti ncam green anti pan laminin red antibodies e145 ab e165 cd development ncam positive laminin low negative aggregates asterisks ncam laminin positive renal vesicles thin arrows tubules thick arrow present controls psen null mutant b e165 sections labeled anti laminin 1 antibody identified polarized renal epithelium psen null mutant b thin arrow c double staining anti cytokeratin 8 ck8 red ductal anti e cadherin renal ductal green antibodies ab e145 cd e165 ef magnified view highlighted structures cd respectively e cadherin positive cytokeratin 8 negative renal epithelial derivatives could identified either close proximity white arrowheads appear connected ureteric bud terminals thick arrows open arrowheads ef indicate site fusion scale bars part 20 microm ab c parts d c part e 8 microm c parts ef
0.49538547.12930775.html.plaintext.txt	34	analysis inductive interactions kidney organogenesis involves reciprocal inductive interactions ureteric bud epithelium metanephric mesenchyme performed situ hybridization various ductal mesenchymal markers delineate origin defect analysis gdnf bmp7 showed molecules expressed psen null kidneys similar littermate controls data shown suggesting mesenchymal stem cells preserved investigate inductive processes analyzed expression pax2 pax8 wnt4 e125 comparable levels pax2 mesenchymal condensates observed psen null kidney control fig 3a compare b expressions pax8 wnt4 undetectable regardless genotype stage shown e135 levels pax2 fig 3a part f wnt4 fig 3b part b pax8 fig 3c part b clearly detectable mesenchymal derivatives including aggregates arrows psen null kidney however reduced expression genes probably attributed lack differentiation comma shaped bodies dressler et al 1990 plachov et al 1990 stark et al 1994 examination molecules e155 development yielded similar results data shown
0.49538547.12930775.html.plaintext.txt	35	analysis inductive interactions kidney organogenesis involves reciprocal inductive interactions ureteric bud epithelium metanephric mesenchyme performed situ hybridization various ductal mesenchymal markers delineate origin defect analysis gdnf bmp7 showed molecules expressed psen null kidneys similar littermate controls data shown suggesting mesenchymal stem cells preserved investigate inductive processes analyzed expression pax2 pax8 wnt4 e125 comparable levels pax2 mesenchymal condensates observed psen null kidney control fig 3a compare b expressions pax8 wnt4 undetectable regardless genotype stage shown e135 levels pax2 fig 3a part f wnt4 fig 3b part b pax8 fig 3c part b clearly detectable mesenchymal derivatives including aggregates arrows psen null kidney however reduced expression genes probably attributed lack differentiation comma shaped bodies dressler et al 1990 plachov et al 1990 stark et al 1994 examination molecules e155 development yielded similar results data shown
0.49538547.12930775.html.plaintext.txt	36	view larger version 139k fig 3 situ hybridization analysis pax2 wnt4 b pax8 c ret d expression c top panels dark field lower panels corresponding bright field e125 levels pax2 comparable control ac psen null mutant bd e135 reduced pax2 expression observed mutant fh compared control eg also case wnt4 b compare b pax8 c compare b arrows indicate aggregate structures positive markers d e135 ret positive structures similar control psen null mutant b e155 number ret positive tips reduced mutant d compared control c scale bars part 100 microm c d parts ab d part c 100 microm d parts cd
0.49538547.12930775.html.plaintext.txt	37	ret marks tips newly formed ureteric bud branches signaling essential inductive interactions pachnis et al 1993 e135 ret expression comparable control mutant fig 3d compare b indicating primary branching affected loss presenilins stage impaired nephrogenesis unambiguously documented stage result suggests ureteric bud signaling primary cause defect reduced number ret positive tips mutant e155 fig 3d compare c d would thus probably result impaired secondary tertiary branching morphogenesis later stages
0.49538547.12930775.html.plaintext.txt	38	exclude possible contribution stromal mesenchyme defects evaluated stromal mesenchyme marker bf2 expression levels significantly different mutants controls data shown therefore combined data suggest loss presenilins disrupt early inductive interactions nephrogenic phenotype psen null kidney probably due defect intrinsic mesenchyme
0.49538547.12930775.html.plaintext.txt	39	exclude possible contribution stromal mesenchyme defects evaluated stromal mesenchyme marker bf2 expression levels significantly different mutants controls data shown therefore combined data suggest loss presenilins disrupt early inductive interactions nephrogenic phenotype psen null kidney probably due defect intrinsic mesenchyme
0.49538547.12930775.html.plaintext.txt	40	analysis mesenchymal epithelial cell conversion presence mesenchymal condensates aggregates absence comma shaped bodies psen null kidney prompted us examine mesenchyme epithelium transition met neuronal cell adhesion molecule ncam highly expressed mesenchymal derivatives ureteric buds ncam positive structures green readily detected control psen null kidney e145 fig 4a parts ab e165 fig 4a parts cd majority ncam positive structures also positive pan laminin fig 4a red found basement membranes ductal renal epithelia cho et al 1998 data suggest mesenchymal derivatives competent epithelization
0.49538547.12930775.html.plaintext.txt	41	analysis mesenchymal epithelial cell conversion presence mesenchymal condensates aggregates absence comma shaped bodies psen null kidney prompted us examine mesenchyme epithelium transition met neuronal cell adhesion molecule ncam highly expressed mesenchymal derivatives ureteric buds ncam positive structures green readily detected control psen null kidney e145 fig 4a parts ab e165 fig 4a parts cd majority ncam positive structures also positive pan laminin fig 4a red found basement membranes ductal renal epithelia cho et al 1998 data suggest mesenchymal derivatives competent epithelization
0.49538547.12930775.html.plaintext.txt	42	proper expression laminin chain shown crucial epithelial polarization ekblom et al 1990 klein et al 1988 polarized laminin 1 positive renal vesicles readily identifiable psen null kidney fig 4bb arrow epithelial nature mesenchymal derivatives confirmed positive staining e cadherin present ductal renal epithelia green negative cytokeratin 8 ductal epithelium red fig 4c results establish notion presenilins required met
0.49538547.12930775.html.plaintext.txt	43	analysis nephron patterning detailed examination ncam positive structures revealed multiple types identified including laminin low irregular aggregates fig 4a asterisks laminin positive organized renal vesicles lumen fig 4a thin arrows elongated laminin expressing tubules fig 4a part d thick arrow suggesting pretubular aggregates progressed renal vesicles tubules psen null mutant kidney consistent assessment e cadherin positive renal derivatives psen null mutant similar littermate control formed immature tubular structures either close proximity fig 4c part b arrowhead appear connected duct thick arrows d arrowhead f fig 4c characteristics suggest formation distal tubules however contrast control advanced tubules adjoining glomerular clefts could recognized fig 4c part e mutant structures failed undergo differentiation patterning
0.49538547.12930775.html.plaintext.txt	44	analysis nephron patterning detailed examination ncam positive structures revealed multiple types identified including laminin low irregular aggregates fig 4a asterisks laminin positive organized renal vesicles lumen fig 4a thin arrows elongated laminin expressing tubules fig 4a part d thick arrow suggesting pretubular aggregates progressed renal vesicles tubules psen null mutant kidney consistent assessment e cadherin positive renal derivatives psen null mutant similar littermate control formed immature tubular structures either close proximity fig 4c part b arrowhead appear connected duct thick arrows d arrowhead f fig 4c characteristics suggest formation distal tubules however contrast control advanced tubules adjoining glomerular clefts could recognized fig 4c part e mutant structures failed undergo differentiation patterning
0.49538547.12930775.html.plaintext.txt	45	investigate possible defect proximal tubule development psen null kidney performed staining lotus tetragonolobus lectin ltl specific marker proximal tubules cho et al 1998 remarkably although control kidney showed strong staining ltl fig 5a parts ac positive staining could detected ltl mutant fig 5a part bd immunostaining wt1 highly expressed podocyte precursor cells shaped bodies mature glomeruli ryan et al 1995 revealed complete absence wt1 expression psen null kidney well fig 5b thus presenilins absolutely required formation proximal structures including proximal tubules glomeruli
0.49538547.12930775.html.plaintext.txt	46	view larger version 89k fig 5 analysis proximal derivatives lotus tetragonolobus lectin ltl staining revealed complete absence mature proximal tubules psen null mutant bd cd magnified view highlighted structures ab respectively residual positives d probably result background staining blood vessels b double staining anti e cadherin green anti wt1 red antibodies documented lack wt1 expressing podocyte precursors psen null kidney b c whole mount immunostaining kidney organ cultures anti pan cytokeratin green anti wt1 red antibodies cd magnified view highlighted structures ab respectively revealing connection weak cytokeratin positive truncated renal tubules strong cytokeratin positive ureteric bud terminal psen null kidney culture d scale bars parts ab 100 microm parts cd b 20 microm c parts ab 50 microm c parts cd 10 microm
0.49538547.12930775.html.plaintext.txt	47	strengthen vivo findings next studied kidney development organ cultures control psen null kidneys dissected e125 embryos cultured 3 days whole mount immunostaining anti pan cytokeratin antibody documented significant branching control psen null kidneys three days culture fig 5c consistent notion presenilins exert effect primary branching morphogenesis agreement vivo results psen null kidneys devoid wt1 fig 5c part b close examination ureteric bud tips showed psen null culture weak pan cytokeratin positive renal tubules formed least appeared fused ureteric bud strongly positive pan cytokeratin fig 5c part d however compared control fig 5c part c psen null renal derivatives truncated negative wt1 expression fig 5c part d similar results also obtained control kidney cultures treated presenilin secretase inhibitor data shown vitro organ culture experiments thus lend support essential role presenilins patterning differentiation renal epithelial derivatives
0.49538547.12930775.html.plaintext.txt	48	strengthen vivo findings next studied kidney development organ cultures control psen null kidneys dissected e125 embryos cultured 3 days whole mount immunostaining anti pan cytokeratin antibody documented significant branching control psen null kidneys three days culture fig 5c consistent notion presenilins exert effect primary branching morphogenesis agreement vivo results psen null kidneys devoid wt1 fig 5c part b close examination ureteric bud tips showed psen null culture weak pan cytokeratin positive renal tubules formed least appeared fused ureteric bud strongly positive pan cytokeratin fig 5c part d however compared control fig 5c part c psen null renal derivatives truncated negative wt1 expression fig 5c part d similar results also obtained control kidney cultures treated presenilin secretase inhibitor data shown vitro organ culture experiments thus lend support essential role presenilins patterning differentiation renal epithelial derivatives
0.49538547.12930775.html.plaintext.txt	49	effect proliferation apoptosis nephrogenesis analysis cells undergoing active division anti phosphorylated histone h3 antibody showed cell proliferation profile similar mutant kidney control e135 data shown e155 fig 6a parts ab double staining anti ncam fig 6a parts cd cytokeratin 8 antibodies shown indicated proliferation rate renal ductal derivatives respectively also similar however cannot rule possibility minor differences cell proliferation renal structures affected tubule growth patterning presenilin mutant finding unexpected much mesenchymal derivatives required active cell division already formed psen null kidney
0.49538547.12930775.html.plaintext.txt	50	view larger version 111k fig 6 cell proliferation apoptosis analysis left column littermate controls right column presenilin null anti phosphorylated histone h3 used stain mitotic cells ab double staining anti phosphorylated histone h3 red anti ncam green antibodies labeled renal derivatives undergoing active division cd b tunel assay revealed percentage apoptotic cells arrowheads increased dramatically mutant b compared control cd double staining anti cleaved caspase 3 red anti ncam antibodies green showed increased apoptosis ncam positive renal derivatives arrow well cortical mesenchyme arrowheads yellow dots auto fluorescence blood scale bar 50 microm
0.49538547.12930775.html.plaintext.txt	51	measurement apoptosis using tunel assay revealed e135 number apoptotic cells low control psen null kidney appreciable differences could identified data shown however e155 number apoptotic cells significantly higher psen null kidney compared control fig 6b compare b quantitative analysis showed 093 cells apoptotic control percentage apoptotic cells reached 634 psen null apoptotic cells widespread majority localized peripherial mesenchyme fig 6b part b arrowheads enhanced general apoptosis would contribute reduced kidney size psen null mutant
0.49538547.12930775.html.plaintext.txt	52	measurement apoptosis using tunel assay revealed e135 number apoptotic cells low control psen null kidney appreciable differences could identified data shown however e155 number apoptotic cells significantly higher psen null kidney compared control fig 6b compare b quantitative analysis showed 093 cells apoptotic control percentage apoptotic cells reached 634 psen null apoptotic cells widespread majority localized peripherial mesenchyme fig 6b part b arrowheads enhanced general apoptosis would contribute reduced kidney size psen null mutant
0.49538547.12930775.html.plaintext.txt	53	using co immunostaining detect activated form caspase 3 ncam fig 6b parts cd able evaluate apoptotic profile renal structures similar control pretubular aggregates renal vesicles psen null exhibited caspase 3 activity however high caspase 3 staining observed ncam positive tubular structures psen null kidney fig 6bd arrow similar tunel staining cortical mesenchyme also showed higher caspase 3 activation fig 6b part d arrowheads overall results suggest defective patterning immature distal tubules absence presenilins leads attenuation nephrogenesis enhanced apoptosis
0.49538547.12930775.html.plaintext.txt	54	using co immunostaining detect activated form caspase 3 ncam fig 6b parts cd able evaluate apoptotic profile renal structures similar control pretubular aggregates renal vesicles psen null exhibited caspase 3 activity however high caspase 3 staining observed ncam positive tubular structures psen null kidney fig 6bd arrow similar tunel staining cortical mesenchyme also showed higher caspase 3 activation fig 6b part d arrowheads overall results suggest defective patterning immature distal tubules absence presenilins leads attenuation nephrogenesis enhanced apoptosis
0.49538547.12930775.html.plaintext.txt	55	analysis notch pathway molecules kidney development impaired notch signal transduction considered leading mechanism somite patterning defect psen null mice assessed expression notch pathway molecules e145 psen null kidneys first examined cell types exhibiting presenilin secretase activity immunostaining antibody recognizes psen cleaved activated form notch1 notch intracellular domain nicd fig 7a co staining anti cytokeratin 8 antibody ck8 marked ductal derivatives nicd expressed background ureteric bud epithelium control psen null samples fig 7a control kidney nicd immunoreactivity could detected pretubular aggregatesrenal vesicles fig 7aa comma shaped bodies data shown psen null kidney devoid nicd although pretubular aggregates present fig 7a part b notch activation correlated expression downstream target hesr1 hey1 mouse genome informatics kokubo et al 1999 control fig 7b part contrast hesr1 expression cannot detected psen null mutant fig 7bb consistent obligatory role presenilins notch processing signaling residual signal probably results staining blood vessels also express hesr1 results support idea presenilin mediated nephrogenic signal derived mesenchyme presenilin dependent notch activation signaling mechanism operation
0.49538547.12930775.html.plaintext.txt	56	view larger version 100k fig 7 notch pathway analysis control left psen null right kidneys immunohistochemical staining presenilin dependent nicd green expression ureteric bud marked cytokeratin 8 ck8 red b d situ hybridization analysis notch downstream target hesr1 b notch ligands jag1 c dll1 d e145 except c parts cd e165 thin arrows indicate pretubular aggregatesrenal vesicles arrowheads indicate comma shaped bodies scale bars 20 microm b 100 microm b d
0.49538547.12930775.html.plaintext.txt	57	next investigated notch ligands jag1 dll1 expression situ hybridization e145 jag1 expressed condensed mesenchyme fig 7c part ab asterisks expression turned pretubular aggregates psen null kidney control fig 7c part ab arrows comma shaped bodies control kidney fig 7c part arrowhead interestingly e165 although jag1 strongly expressed control kidney fig 7c part c arrowhead expression almost undetectable mutant fig 7c part d loss jag1 caused absence mesenchymal derivatives ncam positive pretubular aggregates renal vesicles could readily identified psen null stage fig 4a part d therefore result suggests notch signaling required maintenance jag1 expression kidney organogenesis
0.49538547.12930775.html.plaintext.txt	58	situ hybridization analysis another notch ligand dll1 showed contrast jag1 dll1 expressed condensed mesenchyme pretubular aggregates dll1 positive staining could seen comma shaped bodies control kidney fig 7d part arrowheads dll1 expression could detected psen null stages nephrogenesis fig 7d part b negative staining could attributed lack dll induction caused defective notch signaling absence comma shaped bodies psen null mutant kidney interesting note dll1 expression seems restricted specific region comma shaped bodies fig 7d part arrowheads although fate cells clear similar nicd hesr1 notch ligands expressed ureteric bud supporting cell autonomous mechanism presenilin dependent notch signaling within mesenchyme
0.49538547.12930775.html.plaintext.txt	59	situ hybridization analysis another notch ligand dll1 showed contrast jag1 dll1 expressed condensed mesenchyme pretubular aggregates dll1 positive staining could seen comma shaped bodies control kidney fig 7d part arrowheads dll1 expression could detected psen null stages nephrogenesis fig 7d part b negative staining could attributed lack dll induction caused defective notch signaling absence comma shaped bodies psen null mutant kidney interesting note dll1 expression seems restricted specific region comma shaped bodies fig 7d part arrowheads although fate cells clear similar nicd hesr1 notch ligands expressed ureteric bud supporting cell autonomous mechanism presenilin dependent notch signaling within mesenchyme
0.49538547.12930775.html.plaintext.txt	60	discussion top summary introduction materials methods results discussion references role presenilins nephrogenesis histological examination various stages kidney development showed presenilin deficiency affect reciprocal inductive interactions ureteric bud epithelium metanephric mesenchyme e125 mutant kidney indistinguishable littermate controls evidenced formation condensed mesenchyme surrounding ureteric buds however difference became apparent e135 control kidney undergoes development form pretubular aggregates renal vesicles comma shaped bodies pretubular aggregates renal vesicles found psen null kidney situ hybridization analyses kidney development markers revealed gdnf bmp7 normally expressed psen null kidney data shown demonstrating uninduced mesenchyme affected loss presenilins positive staining pax2 pax8 wnt4 mutant established metanephric mesenchyme competent receiving signals ureteric bud form condensates aggregates last fact ret marker newly formed ureteric bud tips expressed similarly control mutant e135 suggests presenilins exert direct effect primary branching morphogenesis reduced levels mesenchymal markers pax2 pax8 wnt4 mutant e135 e155 likely caused absence comma shaped bodies combined effect led impaired secondary tertiary branching evidenced decreased number ret positive tips mutant e155 notion supported kidney organ culture experiments loss presenilins affected branching minor fashion formation glomeruli completely blocked limited secondary tertiary branching increased apoptotic cell death later stages may turn result failed progression nephrogenesis psen null kidney results combined finding presenilin secretase activity restricted mesenchymal derivatives support role presenilins differentiation pretubular aggregates renal vesicles towards comma shaped bodies within mesenchyme
0.49538547.12930775.html.plaintext.txt	61	progression pretubular aggregates comma shaped bodies requires conversion patterning mesenchymal cells highly organized polarized epithelia analysis cell adhesion molecules extracellular matrix proteins ncam e cadherin revealed renal vesicles tubular derivatives partially formed psen null kidney importantly laminin stained renal structures suggesting developed polarized cells basement membranes thus presenilins essential mesenchyme epithelium transition however despite formation apparent fusion e cadherin positive distal renal tubule structures bud epithelium mature proximal tubules glomeruli completely absent psen null kidney conclusion supported negative binding ltl lack expression wt1 respectively data conclude presenilins play indispensable role patterning differentiation renal vesicles leading proximal tubules glomeruli
0.49538547.12930775.html.plaintext.txt	62	progression pretubular aggregates comma shaped bodies requires conversion patterning mesenchymal cells highly organized polarized epithelia analysis cell adhesion molecules extracellular matrix proteins ncam e cadherin revealed renal vesicles tubular derivatives partially formed psen null kidney importantly laminin stained renal structures suggesting developed polarized cells basement membranes thus presenilins essential mesenchyme epithelium transition however despite formation apparent fusion e cadherin positive distal renal tubule structures bud epithelium mature proximal tubules glomeruli completely absent psen null kidney conclusion supported negative binding ltl lack expression wt1 respectively data conclude presenilins play indispensable role patterning differentiation renal vesicles leading proximal tubules glomeruli
0.49538547.12930775.html.plaintext.txt	63	contrast inductive interactions met current understanding nephron patterning limited candidate regulatory mechanisms tubule patterning molecules cadherins differentially regulated various renal epithelial compartments cho et al 1998 however gene knockout studies supported clear function molecules nephron patterning dahl et al 2002 dressler 2002 mah et al 2000 presenilins represent one first examples molecules play essential role patterning differentiation renal vesicle derivatives
0.49538547.12930775.html.plaintext.txt	64	contrast inductive interactions met current understanding nephron patterning limited candidate regulatory mechanisms tubule patterning molecules cadherins differentially regulated various renal epithelial compartments cho et al 1998 however gene knockout studies supported clear function molecules nephron patterning dahl et al 2002 dressler 2002 mah et al 2000 presenilins represent one first examples molecules play essential role patterning differentiation renal vesicle derivatives
0.49538547.12930775.html.plaintext.txt	65	role presenilins notch signaling nephrogenesis presenilins indispensable processing signaling notch activity highly conserved likely accounts role presenilins somite patterning donoviel et al 1999 takahashi et al 2000 analysis showed presenilin secretase activated form notch1 nicd notch downstream target hesr1 ligands dll1 jag1 expressed mesenchymal derivatives expressions critically impaired psen null kidneys thus notch pathway particularly signaling notch1 may underlying mediator presenilin activity kidney development noteworthy mice expressing hypomorphic allele notch2 exhibit kidney glomerulogenesis defects mccright et al 2001 four mammalian notch proteins presenilin substrates vitro saxena et al 2001 defective notch2 mediated pathway may also account psen null kidney phenotype however presence glomeruli notch2 mutant kidneys albeit structurally abnormal indicates notch2 functions downstream tubule patterning mccright et al 2001
0.49538547.12930775.html.plaintext.txt	66	role presenilins notch signaling nephrogenesis presenilins indispensable processing signaling notch activity highly conserved likely accounts role presenilins somite patterning donoviel et al 1999 takahashi et al 2000 analysis showed presenilin secretase activated form notch1 nicd notch downstream target hesr1 ligands dll1 jag1 expressed mesenchymal derivatives expressions critically impaired psen null kidneys thus notch pathway particularly signaling notch1 may underlying mediator presenilin activity kidney development noteworthy mice expressing hypomorphic allele notch2 exhibit kidney glomerulogenesis defects mccright et al 2001 four mammalian notch proteins presenilin substrates vitro saxena et al 2001 defective notch2 mediated pathway may also account psen null kidney phenotype however presence glomeruli notch2 mutant kidneys albeit structurally abnormal indicates notch2 functions downstream tubule patterning mccright et al 2001
0.49538547.12930775.html.plaintext.txt	67	although essential role presenilins notch signaling well established regulation affects notch ligand expression subject controversy support lateral inhibition model loss notch signaling resulting presenilin deficiency leads ectopic overexpression ligand donoviel et al 1999 handler et al 2000 others suggest presenilin mediated notch signaling necessary proper induction ligand takahashi et al 2000 differences may caused part variations systems study ligand expression seems subjected strict temporal spatial cell type specific regulation
0.49538547.12930775.html.plaintext.txt	68	although essential role presenilins notch signaling well established regulation affects notch ligand expression subject controversy support lateral inhibition model loss notch signaling resulting presenilin deficiency leads ectopic overexpression ligand donoviel et al 1999 handler et al 2000 others suggest presenilin mediated notch signaling necessary proper induction ligand takahashi et al 2000 differences may caused part variations systems study ligand expression seems subjected strict temporal spatial cell type specific regulation
0.49538547.12930775.html.plaintext.txt	69	kidney development detailed examination expression patterns jag1 dll1 yielded interesting findings
0.49538547.12930775.html.plaintext.txt	70	1 jag1 expressed condensed mesenchyme expression detected pretubular aggregates renal vesicles distinct jag1 staining pattern similar control psen null kidneys e145 suggesting transition condensed mesenchyme pretubular aggregates depend presenilins interestingly although pretubular aggregates renal vesicles still exist psen null mutant e165 jag1 expression lost data suggest sustained notch activation necessary maintenance jag1 expression nephrogenesis
0.49538547.12930775.html.plaintext.txt	71	1 jag1 expressed condensed mesenchyme expression detected pretubular aggregates renal vesicles distinct jag1 staining pattern similar control psen null kidneys e145 suggesting transition condensed mesenchyme pretubular aggregates depend presenilins interestingly although pretubular aggregates renal vesicles still exist psen null mutant e165 jag1 expression lost data suggest sustained notch activation necessary maintenance jag1 expression nephrogenesis
0.49538547.12930775.html.plaintext.txt	72	2 contrast jag1 dll1 message cannot detected pretubular aggregates control kidney dll1 expression seems restricted specific region comma shaped bodies e145 although origin cells known spatiotemporally restricted expression pattern may imply functional significance indeed somite patterning caudally restricted expression dll1 shown important prefiguring somite identity proper dll1 induction requires presenilin dependent notch signaling takahashi et al 2000 equally possible however absence dll1 expression could also due physical lack comma shaped bodies psen null kidney
0.49538547.12930775.html.plaintext.txt	73	2 contrast jag1 dll1 message cannot detected pretubular aggregates control kidney dll1 expression seems restricted specific region comma shaped bodies e145 although origin cells known spatiotemporally restricted expression pattern may imply functional significance indeed somite patterning caudally restricted expression dll1 shown important prefiguring somite identity proper dll1 induction requires presenilin dependent notch signaling takahashi et al 2000 equally possible however absence dll1 expression could also due physical lack comma shaped bodies psen null kidney
0.49538547.12930775.html.plaintext.txt	74	besides notch app numerous proteins reported substrates presenilin dependent proteolysis lammich et al 2002 marambaud et al 2002 ni et al 2001 although physiological significance clear impaired processing molecules cannot excluded potential mechanism kidney defects processing independent mechanisms psen1 shown interact ss catenin facilitate turnover kang et al 2002 xia et al 2002 therefore possible deregulation ss catenin pathway psen null may contribute kidney phenotype wnt pathway implicated inductive phase kidney development dressler 2002 essentially unaffected psen null addition created mice deletion exon 10 endogenous psen1 essential ss catenin interaction homozygous exon 10 deleted mice crossed onto psen2 null background viable exhibit kidney defects hz unpublished observations thus argue potential ss catenin involvement psen null kidney
0.49538547.12930775.html.plaintext.txt	75	addition kidney patterning defect psen1 psen2 double null embryos display abnormalities noticeably defects heart looping vascular remodeling donoviel et al 1999 herreman et al 1999 defects apparently corrected human psen1 transgene presumably early expression mesoderm relevant cell derivatives indeed human thy 1 promoter shown active endothelial cells gordon et al 1987 expression hesr1 although absent developing nephrons psen null kidney detected blood vessels analysis mechanisms leading phenotypes currently ongoing
0.49538547.12930775.html.plaintext.txt	76	summary using novel presenilin rescue system identified novel function presenilins nephrogenesis specifically presenilins indispensable patterning renal epithelial structures form mature proximal tubules glomeruli loss presenilins associated failed progression renal vesicles comma shaped bodies molecular level reveal obligatory role presenilins activation notch signaling maintenance notch ligand jag1 expression mesenchymal derivatives kidney development
0.49538547.12930775.html.plaintext.txt	77	summary using novel presenilin rescue system identified novel function presenilins nephrogenesis specifically presenilins indispensable patterning renal epithelial structures form mature proximal tubules glomeruli loss presenilins associated failed progression renal vesicles comma shaped bodies molecular level reveal obligatory role presenilins activation notch signaling maintenance notch ligand jag1 expression mesenchymal derivatives kidney development
0.49538547.12930775.html.plaintext.txt	78	acknowledgments probes antibody mainly donated r johnson dll1 jag1 hesr1 y furuta bpm7 bf2 b hogan gdnf f constantini ret d abrahamson anti laminin 1 antibody m shearman h lewis provided us presenilin secretase inhibitor grateful r kopan h cheng advice nicd immunostaining sharing results prior publication thank zaidi x chen z yu expert technical support j xu image assistance valuable inputs j miner r johnson j rosen r davis tsai m justice x wu greatly appreciated work supported grants nih ns40039 ag20670 alzheimers association iirg 00 221 hz new scholar ellison medical foundation
0.49538547.12930775.html.plaintext.txt	79	acknowledgments probes antibody mainly donated r johnson dll1 jag1 hesr1 y furuta bpm7 bf2 b hogan gdnf f constantini ret d abrahamson anti laminin 1 antibody m shearman h lewis provided us presenilin secretase inhibitor grateful r kopan h cheng advice nicd immunostaining sharing results prior publication thank zaidi x chen z yu expert technical support j xu image assistance valuable inputs j miner r johnson j rosen r davis tsai m justice x wu greatly appreciated work supported grants nih ns40039 ag20670 alzheimers association iirg 00 221 hz new scholar ellison medical foundation
0.49538547.12930775.html.plaintext.txt	80	references top summary introduction materials methods results discussion references
0.49538547.12930775.html.plaintext.txt	81	related articles development
0.49538547.12930775.html.plaintext.txt	82	role notch kidney development development 2003 130 2003 full text
0.49586895.12808018.html.plaintext.txt	0	intramembrane proteolysis presenilin presenilin like proteases weiming xia michael wolfe
0.49586895.12808018.html.plaintext.txt	1	center neurologic diseases brigham womens hospital harvard medical school boston ma 02115 usa e mail wxiaatricsbwhharvardedu u d mwolfeatricsbwhharvardedu u d
0.49586895.12808018.html.plaintext.txt	2	summary top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references regulated intramembrane proteolysis novel mechanism involving proteases hydrolyze substrates hydrophobic environment presenilin ps 1 ps 2 required intramembrane cleavage increasing number type membrane proteins including amyloid precursor protein alzheimers disease notch receptor signals differentiation development mutagenesis affinity labeling biochemical isolation reconstitution cells reveal ps complex co factors nicastrin aph 1 pen 2 apparently contains active site secretase novel membrane aspartyl protease addition related aspartyl proteases identified include members type 4 prepilin peptidase family bacteria known proteases carry gd motif conserved ps group multi pass membrane proteins found eukaryotes also contain yd lgxgd motifs two transmembrane domains conserved ps postulated constitute aspartyl protease active site among signal peptide peptidase spp cleaves remnant signal peptides derived signal peptidase mediated ectodomain shedding spp cuts type ii membrane proteins illustrating ps like proteases play key role intramembrane proteolysis single pass membrane proteins oriented either direction
0.49586895.12808018.html.plaintext.txt	3	key words presenilin secretase signal peptide peptidase amyloid alzheimers disease
0.49586895.12808018.html.plaintext.txt	4	introduction top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references deposition amyloid ss protein ass form neuritic plaques primary pathological lesion alzheimers disease ad mounting evidence points 38 43 residue ass initiator pathogenesis molecular bystander strong evidence hypothesis comes genetics early onset dominant forms familial ad fad caused mutations amyloid precursor protein app presenilin 1 ps1 presenilin 2 ps2 mutations affect ass production 42 residue form ass ass42 predominant ass species deposited limbic association cortices sporadic familial ad patients gravina et al 1995 iwatsubo et al 1994 lemere et al 1996 mann et al 1996a mann et al 1996b increased amounts ass42 produced stably transfected cells transgenic mice overexpressing mutant presenilin ps genes borchelt et al 1996 citron et al 1997 duff et al 1996 xia et al 1997 plasma mutant gene carriers scheuner et al 1996 mutations ps genes account 50 early onset fad levy lahad et al 1995 rogaev et al 1995 sherrington et al 1995 although fad cases represent minority ad cases mechanism ps mutations affect ass production cause fad provide insight pathogenesis treatment sporadic ad well
0.49586895.12808018.html.plaintext.txt	5	production ass app involves sequential proteolysis ss secretases cleavage secretase heterogeneous generates c terminal variations ass fad mutations ps increase ass42 levels particular ps must affect selectivity secretase deletion ps1 mice lethal producing major disruption somite segmentation shen et al 1997 wong et al 1997 neurogenesis impaired massive neuronal loss observed specific regions shen et al 1997 developmental abnormalities embryonic lethality rescued wild type fad mutant ps1 davis et al 1998 qian et al 1998 indicates disease causing ps mutants least partially functional cleavage app secretase cultured ps1 knockout neurons markedly inhibited de strooper et al 1998 herreman et al 2000 zhang et al 2000 ps ps2 neurons produce undetectable levels secreted ass clearly demonstrates ps required secretase activity ass generation
0.49586895.12808018.html.plaintext.txt	6	production ass app involves sequential proteolysis ss secretases cleavage secretase heterogeneous generates c terminal variations ass fad mutations ps increase ass42 levels particular ps must affect selectivity secretase deletion ps1 mice lethal producing major disruption somite segmentation shen et al 1997 wong et al 1997 neurogenesis impaired massive neuronal loss observed specific regions shen et al 1997 developmental abnormalities embryonic lethality rescued wild type fad mutant ps1 davis et al 1998 qian et al 1998 indicates disease causing ps mutants least partially functional cleavage app secretase cultured ps1 knockout neurons markedly inhibited de strooper et al 1998 herreman et al 2000 zhang et al 2000 ps ps2 neurons produce undetectable levels secreted ass clearly demonstrates ps required secretase activity ass generation
0.49586895.12808018.html.plaintext.txt	7	studies inhibitors shown secretase characteristics aspartyl protease shearman et al 2000 wolfe et al 1999a identification two conserved aspartate residues transmembrane tm domains 6 7 ps critical secretase activity d257 d385 ps1 provided conceptual basis novel hypothesis ps aspartyl secretase wolfe et al 1999b either aspartate residue ps1 wolfe et al 1999b ps2 kimberly et al 2000 steiner et al 1999 mutated secretase activity blocked ass levels significantly reduced cultured cells also observed transgenic mice overexpressing aspartate d257a mutant ps1 xia et al 2001 evidence summarized suggests ps aspartyl protease entire class ps like proteases involved intramembrane proteolysis type ii membrane proteins
0.49586895.12808018.html.plaintext.txt	8	ps active site secretase top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references ps1 ps2 467 448 residue polypeptides respectively share 60 sequence similarity full length ps undergoes endoproteolysis form stable n terminal ntf c terminal ctf fragments remain associated borchelt et al 1996 capell et al 1998 thinakaran et al 1996 transition state analogue secretase inhibitors designed target active site protease efficiently decrease ass generation vivo vitro bind members ps ntf ctf heterodimeric complex suggests active site lies two associated fragments esler et al 2000 li et al 2000 although aspartyl protease inhibitor pepstatin binds full length ps ntf ctf complexes evin et al 2001 potent secretase inhibitors bind associated ntf ctf full length ps esler et al 2000 li et al 2000 seiffert et al 2000 inhibitors bind ps1e9 ps1 variant lacks processing site nevertheless functional li et al 2000 findings suggest conformational change ps caused endoproteolysis deletion processing site produces active protease susceptible exogenous inhibitors
0.49586895.12808018.html.plaintext.txt	9	besides endoproteolysis ps form functional ntf ctf association components apparently also critical secretase activity investigation ps containing high molecular weight hmw complex indicates additional cofactors intimately associate ps form active secretase complex nicastrin initially identified ps1 co immunoprecipitates yu et al 2000 binds specifically immobilized transition state analogue secretase inhibitor esler et al 2002 nicastrin ps1 ntf ctf capable binding immobilized secretase inhibitor conditions also maintain secretase activity conditions disrupting association proteins inhibitor also render complex inactive common anti ps1 antibodies anti nicastrin antibodies precipitate functional secretase complex esler et al 2002 although glycosylation nicastrin absolutely required secretase activity herreman et al 2003 mainly mature form nicastrin identified hmw secretase complex levels nicastrin cells closely correlate ps levels arawaka et al 2002 kimberly et al 2002 leem et al 2002 tomita et al 2002 yang et al 2002 reduction ps levels leads concomitant reduction nicastrin levels downregulation nicastrin expression decreases levels stabilized ps molecules thus reduction amount either protein decreases ass generation edbauer et al 2002
0.49586895.12808018.html.plaintext.txt	10	besides endoproteolysis ps form functional ntf ctf association components apparently also critical secretase activity investigation ps containing high molecular weight hmw complex indicates additional cofactors intimately associate ps form active secretase complex nicastrin initially identified ps1 co immunoprecipitates yu et al 2000 binds specifically immobilized transition state analogue secretase inhibitor esler et al 2002 nicastrin ps1 ntf ctf capable binding immobilized secretase inhibitor conditions also maintain secretase activity conditions disrupting association proteins inhibitor also render complex inactive common anti ps1 antibodies anti nicastrin antibodies precipitate functional secretase complex esler et al 2002 although glycosylation nicastrin absolutely required secretase activity herreman et al 2003 mainly mature form nicastrin identified hmw secretase complex levels nicastrin cells closely correlate ps levels arawaka et al 2002 kimberly et al 2002 leem et al 2002 tomita et al 2002 yang et al 2002 reduction ps levels leads concomitant reduction nicastrin levels downregulation nicastrin expression decreases levels stabilized ps molecules thus reduction amount either protein decreases ass generation edbauer et al 2002
0.49586895.12808018.html.plaintext.txt	11	presenilin involved intramembranous processing app also processing signaling notch receptor kopan goate 2002 proper notch signaling critical wide variety cell fate determinations embryonic development adulthood notch type integral membrane protein large extracellular domain single transmembrane domain intracellular domain translation receptor proteolyzed trans golgi part maturation heterodimeric cell surface receptor notch suffers second proteolysis result ligand activation leading shedding extracellular domain receptor remaining membrane bound c terminal stub subsequently cleaved within transmembrane domain release notch intracellular domain translocates nucleus regulates gene expression final intramembrane proteolysis mediated multi component secretase complex fortini 2002
0.49586895.12808018.html.plaintext.txt	12	presenilin involved intramembranous processing app also processing signaling notch receptor kopan goate 2002 proper notch signaling critical wide variety cell fate determinations embryonic development adulthood notch type integral membrane protein large extracellular domain single transmembrane domain intracellular domain translation receptor proteolyzed trans golgi part maturation heterodimeric cell surface receptor notch suffers second proteolysis result ligand activation leading shedding extracellular domain receptor remaining membrane bound c terminal stub subsequently cleaved within transmembrane domain release notch intracellular domain translocates nucleus regulates gene expression final intramembrane proteolysis mediated multi component secretase complex fortini 2002
0.49586895.12808018.html.plaintext.txt	13	genetic screening proteins cause notch like defects interact presenilin nicastrin orthologues c elegans sel 12 aph 2 respectively identified two multipass transmembrane proteins aph 1 anterior pharynx defective pen 2 presenilin enhancer francis et al 2002 goutte et al 2002 c elegans aph 1 human orthologues predicted contain seven membrane spanning regions closely associated sel 12ps aph 2nicastrin c eleganshumans aph 1 apparently facilitates localization aph 2 cell surface c elegans embryos aph 2 remains er like compartments close nucleus aph 1 mutant embryos goutte et al 2002 phenotype aph 1 mutant embryos similar embryos possessing defective sel 12 indicating aph 1 sel 12 ps may act together proper function aph 2 nicastrin goutte et al 2002
0.49586895.12808018.html.plaintext.txt	14	genetic screening proteins cause notch like defects interact presenilin nicastrin orthologues c elegans sel 12 aph 2 respectively identified two multipass transmembrane proteins aph 1 anterior pharynx defective pen 2 presenilin enhancer francis et al 2002 goutte et al 2002 c elegans aph 1 human orthologues predicted contain seven membrane spanning regions closely associated sel 12ps aph 2nicastrin c eleganshumans aph 1 apparently facilitates localization aph 2 cell surface c elegans embryos aph 2 remains er like compartments close nucleus aph 1 mutant embryos goutte et al 2002 phenotype aph 1 mutant embryos similar embryos possessing defective sel 12 indicating aph 1 sel 12 ps may act together proper function aph 2 nicastrin goutte et al 2002
0.49586895.12808018.html.plaintext.txt	15	genetic screening notch pathway components c elegans confirmed aph 1 regulator secretase also revealed additional component pen 2 francis et al 2002 pen 2 two predicted tm domains contain known protease motif carry signal peptide interestingly chromosomal location chromosome 19 close apoe gene apoe4 allele major risk factor associated ad inactivation aph 1 pen 2 cultured drosophila cells significantly reduces secretase cleavage app notch ps ntf ctf levels also reduced francis et al 2002 mammalian cells pen 2 protein levels significantly reduced absence ps downregulation nicastrin synthesis similarly causes reduction pen 2 levels downregulation pen 2 synthesis likewise decreases levels stabilized ps molecules mature nicastrin concomitant reduction secretase activity steiner et al 2002 reduction aph 1 levels mammalian cells also reduces secretase activity lee et al 2002b recent studies demonstrated aph 1 pen 2 nicastrin directly associate ps gu et al 2003 luo et al 2003 kimberly et al 2003 overexpression four proteins enhances secretase activity edbauer et al 2003 kimberly et al 2003 takasugi et al 2003 increased levels aph 1 pen 2 ps1 facilitate ps heterodimer formation well glycosylation nicastrin edbauer et al 2003 kimberly et al 2003 takasugi et al 2003 thus nicastrin aph 1 pen 2 regulate one another indispensable secretase activity although reconstitution ps nicastrin aph 1 pen 2 yeast leads ps endoproteolysis assaicd production edbauer et al 2003 definitive evidence ps protease requires vitro reconstitution assays using purified ps substrate
0.49586895.12808018.html.plaintext.txt	16	genetic screening notch pathway components c elegans confirmed aph 1 regulator secretase also revealed additional component pen 2 francis et al 2002 pen 2 two predicted tm domains contain known protease motif carry signal peptide interestingly chromosomal location chromosome 19 close apoe gene apoe4 allele major risk factor associated ad inactivation aph 1 pen 2 cultured drosophila cells significantly reduces secretase cleavage app notch ps ntf ctf levels also reduced francis et al 2002 mammalian cells pen 2 protein levels significantly reduced absence ps downregulation nicastrin synthesis similarly causes reduction pen 2 levels downregulation pen 2 synthesis likewise decreases levels stabilized ps molecules mature nicastrin concomitant reduction secretase activity steiner et al 2002 reduction aph 1 levels mammalian cells also reduces secretase activity lee et al 2002b recent studies demonstrated aph 1 pen 2 nicastrin directly associate ps gu et al 2003 luo et al 2003 kimberly et al 2003 overexpression four proteins enhances secretase activity edbauer et al 2003 kimberly et al 2003 takasugi et al 2003 increased levels aph 1 pen 2 ps1 facilitate ps heterodimer formation well glycosylation nicastrin edbauer et al 2003 kimberly et al 2003 takasugi et al 2003 thus nicastrin aph 1 pen 2 regulate one another indispensable secretase activity although reconstitution ps nicastrin aph 1 pen 2 yeast leads ps endoproteolysis assaicd production edbauer et al 2003 definitive evidence ps protease requires vitro reconstitution assays using purified ps substrate
0.49586895.12808018.html.plaintext.txt	17	bacterial proteases ps conserved active site motif top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references catalytic apparatus classical aspartyl protease consists two aspartic acid residues two aspartate residues coordinate water molecule activating cleavage peptide bonds unlike serine cysteine proteases aspartyl proteases use nucleophilic attack part mechanism thus covalent intermediate formed enzyme substrate beynon salvesen 2001 ps lacks classic dtsg motif aspartyl protease conserved d257 d385 residues may either critical aspartyl protease activity hmw secretase complex constitute active site novel aspartyl protease carry classic dtsg motif studies bacterial aspartyl proteases shown multi pass type 4 prepilin peptidases tfpp likewise lack dtsg motif conserved gd motif also conserved presenilins includes second critical aspartate residue d385 ps1 d385a g384p g384k mutations ps1 block proteolysis app notch tm region fad causing mutation position ps1 g384a instead causes six fold increase ass42 generation compared wild type ps1 expressing cells prevent proteolysis notch tm domain steiner et al 2000 conserved gd motif lies tm7 ps1 motif likewise found c terminal side active site bacterial tfpp mutation aspartate residue gd motif blocks ability remove leader peptides certain substrates lapointe taylor 2000 although primary sequences ps tfpp highly similar overall similar requirement aspartate containing motifs proteolysis bacteria humans suggests tfpp ps novel polytopic membrane aspartyl proteases steiner et al 2000
0.49586895.12808018.html.plaintext.txt	18	ps homologues putative protease activity top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references database searches ps homologues led identification another group multipass transmembrane proteins contain aspartyl protease like domains similar proposed ps ponting et al 2002 except tm1 domain ps sequences ps homologues termed pshs loosely align ps sequence proteins thus appear topologies similar ps yd motif tm6 lgxgd motif tm7 containing two key aspartate residues conserved almost reported pshs addition known ps proteins contain proline alanine leucine proline palp motif starting p433 amino acid numbering based human ps1 c terminus mutation first proline palp domain ps leads destabilization ps high molecular weight complex tomita et al 2001 interestingly palp domain also conserved pshs several animal plant pshs also contain n terminal protease associated pa domains often co occur peptidase domains mahon bateman 2000 ponting et al 2002
0.49586895.12808018.html.plaintext.txt	19	rogaev colleagues independently found group ps like proteins collectively name impas intramembrane protease associated activity imps grigorenko et al 2002 example imp1 identical psh3 encoded gene located chromosome 20 furthermore sequence imp1psh3 identical signal peptide peptidase spp protease involved cleaving signal peptide remnants grigorenko et al 2002 ponting et al 2002 weihofen et al 2002 see
0.49586895.12808018.html.plaintext.txt	20	signal peptide peptidase ps like aspartyl protease top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references spp membrane topology like ps weihofen et al 2002 signal peptides cleaved pre proteins signal peptidase remnant signal peptides anchored er membrane become substrates spp human spp predicted seven tm domains n terminus facing er c terminus facing cytoplasm fig 1 active site motif yd located center tm 4 whereas active site motif lgxgd located center tm 5 cdna encoding human spp expressed yeast spp activity microsomal vesicles solubilized chaps weihofen et al 2002 detergent capable solubilizing secretase activity esler et al 2002 vitro spp mediated cleavage substrate clearly demonstrated critical role conserved aspartates spp mutation d265 lgxgd motif prevents cleavage substrate addition specific inhibitor spp tbl4k reversibly binds active site protease completely blocks vitro spp proteolytic activity indeed weihofen et al used photocrosslinkable version inhibitor purify identify spp weihofen et al 2002 therefore spp represents novel class ps like aspartyl protease
0.49586895.12808018.html.plaintext.txt	21	view larger version 26k fig 1 signal peptide peptidase presenilin like aspartyl protease human spp seven tm domains n terminus facing er lumen c terminus facing cytoplasm active site motif yd located center tm domain 4 corresponding active site motif lgxgd located center adjacent tm domain 5 human ps eight tm domains n c termini facing cytoplasm corresponding active motifs located center tm domains 6 7 reverse orientation ps spp involved intramembrane proteolysis type ii substrates respectively conserved pall spp palp ps motifs c terminus also shown
0.49586895.12808018.html.plaintext.txt	22	substrates type ii membrane proteins top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references ps predicted eight tm domains n terminus tm6 tm7 loop c terminus oriented towards cytoplasm fig 1 doan et al 1996 li greenwald 1998 thus orientation tm6 contains yd motif lumen cytoplasm orientation tm7 contains lgxgd motif cytoplasm lumen contrasts orientations tm regions containing yd lgxgd motifs spp consistent orientations respective substrates fig 1 spp substrates signal peptides type ii membrane proteins whose n termini face cytoplasm whereas secretase substrates type membrane proteins whose c termini facing cytoplasm known secretase substrates app notch erbb 4 e cadherin cd44 lrp nectin1 type membrane proteins cleaved tm domains ps dependent manner fig 2 cleavage sites fully characterized others remain determined products secretase mediated cleavage characterized case app notch substrates cut middle tm domains residue close interface membrane cytoplasm cleavages inhibited secretase inhibitors fully dependent ps de strooper et al 1999 okochi et al 2002 cases secretase substrates one product best fully characterized erbb 4 undergoes secretase cleavage residue a672 conserved residue v673 several residues membrane cytoplasm boundary lee et al 2002a ni et al 2001 cleavage e cadherin occurs residues l731 r732 apparently right membrane cytoplasm interface marambaud et al 2002 cd44 cleaved fashion similar app cleavage occurs middle tm domain residues a278 l279 releasing ass like molecule cd44 ss another cleavage releases cd44 intracellular domain cd44 icd lammich et al 2002 ectodomain shedding full length low density lipoprotein receptor related protein lrp may et al 2002 nectin 1 kim et al 2002 case leads formation membrane bound c terminal fragment followed ps dependent secretase like cleavage tm domain release intracellular domain although lrp nectin 1 conserved valine residue close membrane cytoplasm boundary actual cleavage sites lrp nectin 1 yet determined none known ps secretase substrates appears cleaved pshs since secretase cleavage substrates occur ps1 ps2 cells
0.49586895.12808018.html.plaintext.txt	23	view larger version 22k fig 2 type membrane proteins substrates ps mediated secretase cleavage app notch erbb 4 e cadherin cd44 lrp nectin1 type membrane proteins app notch cd44 cleaved middle tm domains residue close interface membrane cytoplasm red arrows cleavage erbb 4 occurs several residues membrane cytoplasm boundary cleavage e cadherin occurs right interface lrp nectin 1 undergo proteolysis tm domain release intracellular domain ectodomain shedding fl membrane proteins blue arrow required subsequent intramembrane proteolysis mediated ps
0.49586895.12808018.html.plaintext.txt	24	studies spp substrates signal peptides indicate valine residue close interface membrane cytoplasm required cleavage lemberg martoglio 2002 although spp cleave signal peptides hormone prolactin human polymorphic mhc class molecules calreticulin viral proteins vesicular stomatitis virus g protein vsvg fails cleave signal peptides human cytomegalovirus glycoprotein ul40 rnase sequence comparison substrates suggests residues tendency disrupt helix tm domain required spp cleavage importantly signal peptidase cleavage pre proteins form signal peptide prerequisite spp cleavage consistent requirement ectodomain shedding secretase substrates type ii membrane proteins thus undergo ectodomain shedding prerequisite secretaseps spp mediated intramembrane proteolysis
0.49586895.12808018.html.plaintext.txt	25	studies spp substrates signal peptides indicate valine residue close interface membrane cytoplasm required cleavage lemberg martoglio 2002 although spp cleave signal peptides hormone prolactin human polymorphic mhc class molecules calreticulin viral proteins vesicular stomatitis virus g protein vsvg fails cleave signal peptides human cytomegalovirus glycoprotein ul40 rnase sequence comparison substrates suggests residues tendency disrupt helix tm domain required spp cleavage importantly signal peptidase cleavage pre proteins form signal peptide prerequisite spp cleavage consistent requirement ectodomain shedding secretase substrates type ii membrane proteins thus undergo ectodomain shedding prerequisite secretaseps spp mediated intramembrane proteolysis
0.49586895.12808018.html.plaintext.txt	26	conclusion top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references although majority experimental results support idea ps aspartyl protease definitive evidence vitro reconstitution assays using purified ps substrate needed approach complicated owing existence least three necessary co factors protease activity nicastrin aph 1 pen 2 although functions co factors extensive investigation database searches protease motifs revealed candidates protease domains co factors contrast relatives ps emerged potential proteases carrying unique putative active site motifs two tm domains proteins appear function without need co factors tfpps example known proteases carrying conserved gd motif ps primary sequences tfpps share similarity ps multipass psh impas tm proteins share sequence similarity ps possessing yd lgxgd motifs postulated active site spp psh3imp1 ps like membrane topology protease activity although ectodomain shedding substrates ps secretasespp necessary prerequisite subsequent proteolysis detailed molecular events involved proteolysis tm domains clear secretase substrates discovered related molecules examined possible cleavage ps like proteases searches yd lgxgd motifs genome sequences may also reveal additional ps like proteases similar spp biochemical characterization proteases help us elucidate molecular mechanism intramembrane proteolysis
0.49586895.12808018.html.plaintext.txt	27	acknowledgments studies discussed review supported part alzheimers association nih ns 41355 nih ag 17574 msw nih ag 17593 wx
0.49586895.12808018.html.plaintext.txt	28	references top summary introduction ps active site bacterial proteases ps homologues putative signal peptide peptidase ps substrates type conclusion references
0.49586895.12808018.html.plaintext.txt	29	intra membrane proteolysis jcs 2003 116 1401 full text
0.49589044.12668626.html.plaintext.txt	0	two suppressors sel 12 encode c2h2 zinc finger proteins regulate presenilin transcription caenorhabditis elegans bernard lakowski stefan eimer christine gobel andreas bottcher babett wagler ralf baumeister
0.49589044.12668626.html.plaintext.txt	1	abi department biochemistry laboratory molecular neurogenetics ludwig maximilians universitaet schillerstr 44 d 80336 munich germany present address department neuroscience pasteur institute paris france
0.49589044.12668626.html.plaintext.txt	2	abi department biochemistry laboratory molecular neurogenetics ludwig maximilians universitaet schillerstr 44 d 80336 munich germany present address department neuroscience pasteur institute paris france
0.49589044.12668626.html.plaintext.txt	3	author correspondence e mail ralfbaumeisteratpbmmeduni muenchende u d
0.49589044.12668626.html.plaintext.txt	4	summary top summary introduction materials methods results discussion references mutations presenilin genes associated familial alzheimers disease humans affect lin 12notch signaling organisms tested far loss sel 12 presenilin activity caenorhabditis elegans results completely penetrant egg laying defect screens extragenic suppressors sel 12 egg laying defect isolated mutations least five genes report cloning characterization spr 3 spr 4 encode large basic c2h2 zinc finger proteins suppression sel 12 spr 3 spr 4 requires activity second presenilin gene hop 1 mutations spr 3 spr 4 de repress hop 1 transcription early larval stages hop 1 expression normally nearly undetectable sel 12 hop 1 functionally redundant suggests mutations spr 3 spr 4 bypass need one presenilin stage specifically de repressing transcription spr 3 spr 4 code proteins similar human restnrsf re1 silencing transcription factorneural restrictive silencing factor transcriptional repressors spr genes encode proteins homologous components corest co repressor complex interacts rest inhat inhibitor acetyltransferase co repressor complex data suggest spr genes may function mechanism involves transcriptional repression hop 1 locus
0.49589044.12668626.html.plaintext.txt	5	summary top summary introduction materials methods results discussion references mutations presenilin genes associated familial alzheimers disease humans affect lin 12notch signaling organisms tested far loss sel 12 presenilin activity caenorhabditis elegans results completely penetrant egg laying defect screens extragenic suppressors sel 12 egg laying defect isolated mutations least five genes report cloning characterization spr 3 spr 4 encode large basic c2h2 zinc finger proteins suppression sel 12 spr 3 spr 4 requires activity second presenilin gene hop 1 mutations spr 3 spr 4 de repress hop 1 transcription early larval stages hop 1 expression normally nearly undetectable sel 12 hop 1 functionally redundant suggests mutations spr 3 spr 4 bypass need one presenilin stage specifically de repressing transcription spr 3 spr 4 code proteins similar human restnrsf re1 silencing transcription factorneural restrictive silencing factor transcriptional repressors spr genes encode proteins homologous components corest co repressor complex interacts rest inhat inhibitor acetyltransferase co repressor complex data suggest spr genes may function mechanism involves transcriptional repression hop 1 locus
0.49589044.12668626.html.plaintext.txt	6	key words presenilin alzheimers disease genetic suppression transcription regulation
0.49589044.12668626.html.plaintext.txt	7	introduction top summary introduction materials methods results discussion references presenilins class polytopic proteins found throughout plant animal kingdoms part high molecular weight complexes containing additional components including aph 2nicastrin aph 1 pen 2 capell et al 1998 francis et al 2002 li et al 2000 thinakaran et al 1998 yu et al 1998 complex assembles maturates er golgi subsequently transported cell membrane required intra membranous proteolytic cleavage certain type transmembrane proteins include amyloid precursor protein app notch type receptors de strooper et al 1999 de strooper et al 1998 fortini 2001 proposed presenilins provide aspartyl protease activity responsible secretase cleavage involved generating ss amyloid fragments app steiner et al 2000 wolfe et al 1999
0.49589044.12668626.html.plaintext.txt	8	introduction top summary introduction materials methods results discussion references presenilins class polytopic proteins found throughout plant animal kingdoms part high molecular weight complexes containing additional components including aph 2nicastrin aph 1 pen 2 capell et al 1998 francis et al 2002 li et al 2000 thinakaran et al 1998 yu et al 1998 complex assembles maturates er golgi subsequently transported cell membrane required intra membranous proteolytic cleavage certain type transmembrane proteins include amyloid precursor protein app notch type receptors de strooper et al 1999 de strooper et al 1998 fortini 2001 proposed presenilins provide aspartyl protease activity responsible secretase cleavage involved generating ss amyloid fragments app steiner et al 2000 wolfe et al 1999
0.49589044.12668626.html.plaintext.txt	9	mutations either human presenilin genes psen1 psen2 dominant cause early onset alzheimers disease result increase ratio 42 amino acid variant 40 amino acid variant ss amyloid alter total amount presenilin dependent secretase cleavage reviewed selkoe 2001 42 amino acid variant ss amyloid highly insoluble tends aggregate nucleating senile plaques found brains individuals alzheimers disease reviewed sisodia st george hyslop 2002
0.49589044.12668626.html.plaintext.txt	10	mutations either human presenilin genes psen1 psen2 dominant cause early onset alzheimers disease result increase ratio 42 amino acid variant 40 amino acid variant ss amyloid alter total amount presenilin dependent secretase cleavage reviewed selkoe 2001 42 amino acid variant ss amyloid highly insoluble tends aggregate nucleating senile plaques found brains individuals alzheimers disease reviewed sisodia st george hyslop 2002
0.49589044.12668626.html.plaintext.txt	11	presenilin activity also required s3 cleavage notch receptors ligand binding struhl adachi 1998 like secretase cleavage app cleavage occurs within transmembrane domain releases notch intracellular domain nicd release nicd essential notch signaling liberated nicd fragment enters nucleus interacts transcription factor csl cbp suppressor hairless lag 1 de strooper et al 1999 song et al 1999 additional co activators sel 8lag 3 mastermind doyle et al 2000 freyer et al 2002 petcherski kimble 2000
0.49589044.12668626.html.plaintext.txt	12	presenilin activity also required s3 cleavage notch receptors ligand binding struhl adachi 1998 like secretase cleavage app cleavage occurs within transmembrane domain releases notch intracellular domain nicd release nicd essential notch signaling liberated nicd fragment enters nucleus interacts transcription factor csl cbp suppressor hairless lag 1 de strooper et al 1999 song et al 1999 additional co activators sel 8lag 3 mastermind doyle et al 2000 freyer et al 2002 petcherski kimble 2000
0.49589044.12668626.html.plaintext.txt	13	c elegans genome encodes three presenilin genes sel 12 hop 1 spe 4 homologous human psen1 psen2 spe 4 divergent member presenilin family appears specific role spermatogenesis arduengo et al 1998 lhernault arduengo 1992 two presenilins much similar human homologs absolutely essential signaling two c elegans notch type receptors lin 12 glp 1 levitan greenwald 1995 li greenwald 1997 westlund et al 1999 absence sel 12 hop 1 genes leads completely penetrant lethal phenotype resembles either complete loss glp 1 complete loss lin 12 signaling exact phenotype depends double mutants constructed sel 12 hop 1 partial maternal effects westlund et al 1999 mutations hop 1 obvious phenotype mutations sel 12 lead egg laying defect egl levitan greenwald 1995 westlund et al 1999 sel 12 hop 1 seem largely overlapping roles hop 1 rescue sel 12 egl defect expressed sel 12 promoter li greenwald 1997 westlund et al 1999 sequence also function presenilins evolutionarily conserved human presenilins psen1 psen2 also rescue sel 12 egl defect expressed control appropriate promoters baumeister et al 1997 levitan et al 1996
0.49589044.12668626.html.plaintext.txt	14	order understand biological role presenilins studying sel 12 gene c elegans mutations sel 12 first identified ability suppress lin 12 gain function mutation levitan greenwald 1995 suggests sel 12 mutations reduce lin 12 signaling sel 12 protein normally facilitates lin 12 signaling levitan greenwald 1995 however mutations sel 12 completely eliminate lin 12 signaling presumably owing residual presenilin activity supplied hop 1 li greenwald 1997 westlund et al 1999 different levels lin 12 activity required control least five post embryonic signaling events eimer et al 2002a sel 12 null mutants two affected varying degree eimer et al 2002a cinar et al 2001 indicates presenilin activity supplied hop 1 sufficient lin 12 signaling events lin 12 signaling events appear sensitive presenilin dosage others eimer et al 2002a
0.49589044.12668626.html.plaintext.txt	15	elucidate function sel 12 gene one study mutations bypass need sel 12 mutations four genes sel 10 spr 1 spr 2 spr 5 already shown suppress sel 12 egg laying defect mutations sel 10 first found screen genes suppress weak lin 12 loss function mutant hubbard et al 1997 sel 10 similar yeast gene cdc4 acts e3 ubiquitin ligase targets intracellular domains lin 12 glp 1 proteins degradation gupta rossi et al 2001 hubbard et al 1997 sel 10 mutations also weakly suppress mutations sel 12 completely bypass need sel 12 screen similar one reported wen et al identified four genes strongly suppress egl defect sel 12 suppressors presenilin described cloning characterization one spr 2 wen et al 2000 mutations spr 2 almost completely bypass need sel 12 biochemical role spr 2 presently unclear may affect chromatin structure andor transcription wen et al 2000
0.49589044.12668626.html.plaintext.txt	16	elucidate function sel 12 gene one study mutations bypass need sel 12 mutations four genes sel 10 spr 1 spr 2 spr 5 already shown suppress sel 12 egg laying defect mutations sel 10 first found screen genes suppress weak lin 12 loss function mutant hubbard et al 1997 sel 10 similar yeast gene cdc4 acts e3 ubiquitin ligase targets intracellular domains lin 12 glp 1 proteins degradation gupta rossi et al 2001 hubbard et al 1997 sel 10 mutations also weakly suppress mutations sel 12 completely bypass need sel 12 screen similar one reported wen et al identified four genes strongly suppress egl defect sel 12 suppressors presenilin described cloning characterization one spr 2 wen et al 2000 mutations spr 2 almost completely bypass need sel 12 biochemical role spr 2 presently unclear may affect chromatin structure andor transcription wen et al 2000
0.49589044.12668626.html.plaintext.txt	17	paper report results several screens strong suppressors sel 12 isolation 25 independent mutations mutations lie several complementation groups identified wen et al well additional genes indicating neither screen reached saturation also report cloning characterization two suppressor genes spr 3 spr 4 code c2h2 zinc finger proteins similar transcriptional repressors restnrsf spr 3 spr 4 mutants bypass need sel 12 upregulating transcription presenilin hop 1 two presenilin suppressors also identified screen spr 1 spr 5 encode proteins coresthdac complex eimer et al 2002b jarriault greenwald 2002 interacts rest propose spr proteins assemble one repressor complexes normally repress hop 1 locus early larval stages mutations components complexes remove repressor activity leading higher basal level hop 1 presenilin activity
0.49589044.12668626.html.plaintext.txt	18	paper report results several screens strong suppressors sel 12 isolation 25 independent mutations mutations lie several complementation groups identified wen et al well additional genes indicating neither screen reached saturation also report cloning characterization two suppressor genes spr 3 spr 4 code c2h2 zinc finger proteins similar transcriptional repressors restnrsf spr 3 spr 4 mutants bypass need sel 12 upregulating transcription presenilin hop 1 two presenilin suppressors also identified screen spr 1 spr 5 encode proteins coresthdac complex eimer et al 2002b jarriault greenwald 2002 interacts rest propose spr proteins assemble one repressor complexes normally repress hop 1 locus early larval stages mutations components complexes remove repressor activity leading higher basal level hop 1 presenilin activity
0.49589044.12668626.html.plaintext.txt	19	materials methods top summary introduction materials methods results discussion references general handling mutations used worms handled according standard procedures sulston hodgkin 1988 grown 20 degrees c unless otherwise stated following mutations used
0.49589044.12668626.html.plaintext.txt	20	materials methods top summary introduction materials methods results discussion references general handling mutations used worms handled according standard procedures sulston hodgkin 1988 grown 20 degrees c unless otherwise stated following mutations used
0.49589044.12668626.html.plaintext.txt	21	lg hop 1lg1501 dpy 5e61 ego 1om71 unc 55e1170 spr 4ar208 daf 8e1393 unc 75e950 unc 101m1 unc 59e261 lg v dpy 11e224 unc 76e911 lg x sel 12ar171 ar131 by125 lg1401 dpy 23e830 spr 3ar209 lon 2e678 mndp31 mndp32
0.49589044.12668626.html.plaintext.txt	22	lg hop 1lg1501 dpy 5e61 ego 1om71 unc 55e1170 spr 4ar208 daf 8e1393 unc 75e950 unc 101m1 unc 59e261 lg v dpy 11e224 unc 76e911 lg x sel 12ar171 ar131 by125 lg1401 dpy 23e830 spr 3ar209 lon 2e678 mndp31 mndp32
0.49589044.12668626.html.plaintext.txt	23	mutations obtained caenorhabditis genetics center except sel 12ar131 sel 12ar171 spr 3ar209 spr 4ar208 kindly provided iva greenwald hop 1lg1501 described wittenburg et al wittenburg et al 2000 sel 12by125 sel 12lg1401 described eimer et al eimer et al 2002a
0.49589044.12668626.html.plaintext.txt	24	isolation mutants ethylmethanesulfonate ems ultra violet lighttetramethylpsoralen uvtmp mutagenesis carried according published procedures anderson 1995 sulston hodgkin 1988 mutator screen presented another paper eimer et al 2002b looked one ems 16000 haploid genomes one uvtmp screen 8000 haploid genomes dominant suppressor mutations identify screened recessive suppressor mutations similar manner wen et al wen et al 2000 mutants retained spr sel 12ar171 double mutants displayed essentially wild type egg laying behavior vast majority progeny 90 become egl mutations outcrossed five times phenotypic analysis type screen mutagens used number haploid genomes screened mutations identified follows
0.49589044.12668626.html.plaintext.txt	25	isolation mutants ethylmethanesulfonate ems ultra violet lighttetramethylpsoralen uvtmp mutagenesis carried according published procedures anderson 1995 sulston hodgkin 1988 mutator screen presented another paper eimer et al 2002b looked one ems 16000 haploid genomes one uvtmp screen 8000 haploid genomes dominant suppressor mutations identify screened recessive suppressor mutations similar manner wen et al wen et al 2000 mutants retained spr sel 12ar171 double mutants displayed essentially wild type egg laying behavior vast majority progeny 90 become egl mutations outcrossed five times phenotypic analysis type screen mutagens used number haploid genomes screened mutations identified follows
0.49589044.12668626.html.plaintext.txt	26	ems 24300 by105 by107 by108 by109 by112 by113 by114 by116 by117 by119 uvtmp 41600 by118 by128 by129 by130 by131 by132 by133 by134 by135 by136 by137 by139 by140
0.49589044.12668626.html.plaintext.txt	27	ems 24300 by105 by107 by108 by109 by112 by113 by114 by116 by117 by119 uvtmp 41600 by118 by128 by129 by130 by131 by132 by133 by134 by135 by136 by137 by139 by140
0.49589044.12668626.html.plaintext.txt	28	mutator generated mutations 9600 by101 by110
0.49589044.12668626.html.plaintext.txt	29	complementation tests complementation tests done according standard procedures sulston hodgkin 1988 assignment complementation groups follows
0.49589044.12668626.html.plaintext.txt	30	complementation tests complementation tests done according standard procedures sulston hodgkin 1988 assignment complementation groups follows
0.49589044.12668626.html.plaintext.txt	31	spr 1 by133 spr 3 ar209 by108 by109 by110 by131bydf1 by135 by136 by137 spr 4 ar208 by105 by107 by112 by114 by129 by130 by132 spr 5 by101 by113 by119 by128 by134 by139 uncharacterized by116 by117 by118 by140
0.49589044.12668626.html.plaintext.txt	32	genetic mapping suppressor mutations genetically mapped using standard techniques sulston hodgkin 1988 maintaining possible spr mutation homozygous sel 12ar171 background position spr 4 refined single nucleotide polymorphism snp mapping carried essentially described jakubowski kornfeld 1999
0.49589044.12668626.html.plaintext.txt	33	genetic mapping suppressor mutations genetically mapped using standard techniques sulston hodgkin 1988 maintaining possible spr mutation homozygous sel 12ar171 background position spr 4 refined single nucleotide polymorphism snp mapping carried essentially described jakubowski kornfeld 1999
0.49589044.12668626.html.plaintext.txt	34	transgenic rescue spr 3 spr 4 injected strain sel 12ar171 spr 3by108 rescue spr 3 strain spr 4by105 sel 12ar171 rescue spr 4 looked anti suppressor activity injection mixes ie restoration sel 12 phenotype test clones pcr products injected 20 ng microl 100 ng microl prf4 rol 6 20 ng microl pby218 ttx 3gfp hobert et al 1997 co injection markers
0.49589044.12668626.html.plaintext.txt	35	transgenic rescue spr 3 spr 4 injected strain sel 12ar171 spr 3by108 rescue spr 3 strain spr 4by105 sel 12ar171 rescue spr 4 looked anti suppressor activity injection mixes ie restoration sel 12 phenotype test clones pcr products injected 20 ng microl 100 ng microl prf4 rol 6 20 ng microl pby218 ttx 3gfp hobert et al 1997 co injection markers
0.49589044.12668626.html.plaintext.txt	36	gene structures spr 3 spr 4 sequenced two spr 3 cdnas yk64e9 yk247c5 kindly provided yuji kohara found two cdnas similar structure yet yk247c5 additional intron largest exon gene however staged northern blots see fig 2 fig 4a rt pcr developmental stage single transcript similar length yk64e9 could detected data shown process sequencing cdnas also discovered sequencing error genomic sequence cosmids f46h6 c07a12 near 5 end spr 3 put first atg frame data shown error communicated c elegans sequencing consortium genomic sequence updated determine 5 end spr 3 transcript performed pcr random primed cdna library kindly provided bob barstead using sl1 sl2 forward primers spieth et al 1993 gene specific reverse primers rb1080 catacttgacggcatcatcgg rb1079 catctgcttctcgctcgagaatcg found spr 3 trans spliced sl1 sl2 sl1 specific product sequenced found start 5 5ends two sequenced cdnas predicted splice acceptor site
0.49589044.12668626.html.plaintext.txt	37	gene structures spr 3 spr 4 sequenced two spr 3 cdnas yk64e9 yk247c5 kindly provided yuji kohara found two cdnas similar structure yet yk247c5 additional intron largest exon gene however staged northern blots see fig 2 fig 4a rt pcr developmental stage single transcript similar length yk64e9 could detected data shown process sequencing cdnas also discovered sequencing error genomic sequence cosmids f46h6 c07a12 near 5 end spr 3 put first atg frame data shown error communicated c elegans sequencing consortium genomic sequence updated determine 5 end spr 3 transcript performed pcr random primed cdna library kindly provided bob barstead using sl1 sl2 forward primers spieth et al 1993 gene specific reverse primers rb1080 catacttgacggcatcatcgg rb1079 catctgcttctcgctcgagaatcg found spr 3 trans spliced sl1 sl2 sl1 specific product sequenced found start 5 5ends two sequenced cdnas predicted splice acceptor site
0.49589044.12668626.html.plaintext.txt	38	view larger version 45k fig 2 positional cloning spr 3 three factor mapping spr 3 mapped interval dpy 23e840 lon 2 outside duplication mndp32 see table s1 httpdevbiologistsorgsupplemental note spr 3 previously mapped dpy 3 unc 2 close unc 2 wen et al 2000 b rescue spr 3 spr 3 rescued cosmid f46h6 partially overlapping cosmid c07a12 shown thick bars cosmid c07a12 extends right orfs f46h6 named indicated lines arrows two spr 3 alleles generated uvtmp mutagenesis large rearrangements bydf1 deletes 31 kb cosmid f46h6 by136 complex rearrangement affects promoter c07a125 injecting series restriction fragments subclones pcr products see thick bars f46h6 minimal rescuing region narrowed 41 kb fragment using rb950 cagtatacaactacgctctcc rb951 atccaacactcctaagtccg contains c07a125 open reading frame number lines rescued indicated right construct c northern blot rna n2 sel 12ar171 7 spr 3 alleles sel 12ar171 background probed spr 3 cdna message detectable strains harboring either two large rearrangements bydf1 spr 3by136
0.49589044.12668626.html.plaintext.txt	39	view larger version 71k fig 4 expression pattern spr 3 stage specific expression spr 3 transcript ama 1 shown control e eggs l1 l4 first fourth larval stages adult bc spr 3egfp promoter fusion expressed broadly throughout animal spr 3 expressed uniformly eggs b broadly adult c strong expression pharynx de expression gst myc tagged spr 3 baculovirus construct expressed insect sf9 cells detected fluorescein isothiocyanate coupled goat anti mouse secondary antibody d fluorescent e propidium iodide staining cells
0.49589044.12668626.html.plaintext.txt	40	determine structure spr 4 sequenced nearly full length cdna yk646c12 entirety found matched predicted gene c09h61 z81466 except yk646c12 lacks first five nucleotides orf last exon starts six nucleotides 3 annotated c09h61 cdna yk1178d11 uses weak acceptor last exon annotated wormbase httpwwwwormbaseorg spr 4 appears alternatively spliced two transcripts encode identical proteins except difference two amino acids region 17th 18th zinc fingers fig 5c
0.49589044.12668626.html.plaintext.txt	41	determine structure spr 4 sequenced nearly full length cdna yk646c12 entirety found matched predicted gene c09h61 z81466 except yk646c12 lacks first five nucleotides orf last exon starts six nucleotides 3 annotated c09h61 cdna yk1178d11 uses weak acceptor last exon annotated wormbase httpwwwwormbaseorg spr 4 appears alternatively spliced two transcripts encode identical proteins except difference two amino acids region 17th 18th zinc fingers fig 5c
0.49589044.12668626.html.plaintext.txt	42	view larger version 50k fig 5 cloning spr 4 genetic position spr 4 see table s1 httpdevbiologistsorgsupplemental b physical map near c09h61 spr 4 mapped close right byp7 snp v120a11s1at186 u d extent 12 kb pvuii rescuing fragment shown c predicted spr 4 protein aligned 5 end c28g14 3 end g28g44 identical amino acids highlighted black similar amino acids highlighted gray 18 putative c2h2 zinc fingers spr 4 underlined regions could act nuclear localization signals boxed two amino acids present alternatively spliced form spr 4 overlined labeled mutations indicated asterisk d alignment spr 4 rest homo sapiens identical amino acids highlighted black similar amino acids highlighted gray
0.49589044.12668626.html.plaintext.txt	43	comparisons predicted caenorhabditis briggsae genes access unpublished draft genomic sequence caenorhabditis briggsae available welcome trust sanger institute httpwwwsangeracukprojectscbriggsae genome sequencing center washington university st louis httpgenomewustleduprojectscbriggsae local synteny c elegans c briggsae preliminary prediction c briggsae genes viewed wormbase httpwwwwormbaseorg
0.49589044.12668626.html.plaintext.txt	44	c briggase spr 3 gene identified possible spr 3 homolog c briggsae contig c010301474 purified total c briggsae mixed stage rna qiagen rnaeasy kit according manufacturers instructions qiagen hilden determine gene structure performed rt pcr various combinations primers amplified pcr product using primers rb1627 tacttgccacttgtgtccaag rb1629 tggtgaacttttcaccagcg reverse transcribed first strand cdnas generated primer rb1629 pcr product sequenced found contain central 3 regions c briggsae spr 3 gene
0.49589044.12668626.html.plaintext.txt	45	expression constructs spr 3egfp promoter fusion made cloning egfp spr 3 atg behind 4 kb spr 3 promoter sequence construct also contained spr 3 3utr translational fusion constructs made inserting egfp rescuing genomic construct either atg n terminal fusion taa stop codon c terminal fusion transgenic lines generated constructs rescue spr 3 detectable gfp fluorescence baculovirus expression construct made inserting spr 3 cdna transfer vector pby1296 eimer et al 2002b fusing gst myc tag n terminally spr 3 resulting construct co transformed along linearized baculogold dna becton dickinsonpharmingen sf9 cells generate recombinant viruses
0.49589044.12668626.html.plaintext.txt	46	expression constructs spr 3egfp promoter fusion made cloning egfp spr 3 atg behind 4 kb spr 3 promoter sequence construct also contained spr 3 3utr translational fusion constructs made inserting egfp rescuing genomic construct either atg n terminal fusion taa stop codon c terminal fusion transgenic lines generated constructs rescue spr 3 detectable gfp fluorescence baculovirus expression construct made inserting spr 3 cdna transfer vector pby1296 eimer et al 2002b fusing gst myc tag n terminally spr 3 resulting construct co transformed along linearized baculogold dna becton dickinsonpharmingen sf9 cells generate recombinant viruses
0.49589044.12668626.html.plaintext.txt	47	rnai feeding subcloned 27 kb hindiiixhoi fragment cdna yk356a2 kindly provided y kohara l4440 ppd12936 kindly provided fire cut hindiiixhoi generate c28g14 rnai feeding vector full length hop 1 cdna amplified pcr cloned smainoti fragment l4440 creating pby1575 genes transiently inactivated rnai feeding e coli strain ht115de3 expressing double stranded rna gene interest timmons et al 2001 timmons fire 1998 dsrna expression induced described kamath et al 2001 worms transferred l4 larvae onto seeded plates containing 50 microgml ampicillin 1 mm iptg 24 hours parental worm transferred new plate also containing ampicillin iptg progeny second rnai plate scored relevant phenotypes case sel 12ar171 animals parental worms kept first rnai plate died bag worm phenotype last progeny scored rnai phenotype
0.49589044.12668626.html.plaintext.txt	48	rnai feeding subcloned 27 kb hindiiixhoi fragment cdna yk356a2 kindly provided y kohara l4440 ppd12936 kindly provided fire cut hindiiixhoi generate c28g14 rnai feeding vector full length hop 1 cdna amplified pcr cloned smainoti fragment l4440 creating pby1575 genes transiently inactivated rnai feeding e coli strain ht115de3 expressing double stranded rna gene interest timmons et al 2001 timmons fire 1998 dsrna expression induced described kamath et al 2001 worms transferred l4 larvae onto seeded plates containing 50 microgml ampicillin 1 mm iptg 24 hours parental worm transferred new plate also containing ampicillin iptg progeny second rnai plate scored relevant phenotypes case sel 12ar171 animals parental worms kept first rnai plate died bag worm phenotype last progeny scored rnai phenotype
0.49589044.12668626.html.plaintext.txt	49	northern blots rna isolated mixed stage plates staged plates prepared rnaeasy kit according manufacturers instructions qiagen hilden northern blots 5 microg total rna per lane denatured 65 degrees c 5 minutes loaded onto 08 agarose rna gel gel run overnight separate fragments blotted onto hybond n membranes according sambrook sambrook 1989 l1 northern blots 20 microg total rna used per lane probes labeled 32p dctp using megaprime labeling kit according manufacturers instructions amersham freiburg germany blots hybridized washed according procedure church gilbert 1984 65 degrees c northern blots probed ama 1 specific probe johnstone barry 1996 loading control blot first made blot 5 microg per lane total rna probed ama 1 used results probing adjust amount rna loaded obtain equal amounts mrna per lane quantification relative transcript levels blots placed storage phosphor screen molecular dynamics several days read storm 860 scanner molecular dynamics intensity bands determined using imagequant version 42 molecular dynamics using user method volume quantitation volumes adjusted background intensity
0.49589044.12668626.html.plaintext.txt	50	northern blots rna isolated mixed stage plates staged plates prepared rnaeasy kit according manufacturers instructions qiagen hilden northern blots 5 microg total rna per lane denatured 65 degrees c 5 minutes loaded onto 08 agarose rna gel gel run overnight separate fragments blotted onto hybond n membranes according sambrook sambrook 1989 l1 northern blots 20 microg total rna used per lane probes labeled 32p dctp using megaprime labeling kit according manufacturers instructions amersham freiburg germany blots hybridized washed according procedure church gilbert 1984 65 degrees c northern blots probed ama 1 specific probe johnstone barry 1996 loading control blot first made blot 5 microg per lane total rna probed ama 1 used results probing adjust amount rna loaded obtain equal amounts mrna per lane quantification relative transcript levels blots placed storage phosphor screen molecular dynamics several days read storm 860 scanner molecular dynamics intensity bands determined using imagequant version 42 molecular dynamics using user method volume quantitation volumes adjusted background intensity
0.49589044.12668626.html.plaintext.txt	51	staged northern blots worms synchronized l1 stage alkaline hypochlorite treatment sulston hodgkin 1988 synchronized l1 larvae spotted onto 9 cm plates seeded op50 allowed grow 6 hours 18 hours 30 hours 42 hours 54 hours l1 l2 l3 l4 young adult stages respectively worms inspected visually harvesting confirm worms correct stage
0.49589044.12668626.html.plaintext.txt	52	staged northern blots worms synchronized l1 stage alkaline hypochlorite treatment sulston hodgkin 1988 synchronized l1 larvae spotted onto 9 cm plates seeded op50 allowed grow 6 hours 18 hours 30 hours 42 hours 54 hours l1 l2 l3 l4 young adult stages respectively worms inspected visually harvesting confirm worms correct stage
0.49589044.12668626.html.plaintext.txt	53	results top summary introduction materials methods results discussion references sel 12 suppressor screen isolate mutations bypass need sel 12 performed several screens suppressors egg laying defect sel 12ar171 mutants using chemical ems uvtmp genetic eimer et al 2002b mutagenesis protocols different screens chosen induce range types mutations get alleles restriction fragment length polymorphisms rflps recovered dominant suppressor isolate 25 strong recessive suppressor mutations twenty 25 mutations fall three complementation groups defined alleles by108 by105 by101 by101 mapped right arm chromosome unc 101 unc 59 near unc 59 by105 mapped genetically cluster lgi daf 8 unc 55 by108 mapped lgx dpy 23 lon 2 see table s1 httpdevbiologistsorgsupplemental
0.49589044.12668626.html.plaintext.txt	54	subsequently wen et al identified four suppressors presenilin spr genes similar screen described cloning characterization one spr 2 wen et al 2000 wen et al mapped spr 1 spr 2 spr 3 spr 4 chromosomes v iv x respectively complementation analysis spr 3ar209 spr 4ar208 kindly provided greenwald new york determined by108 by105 alleles spr 3 spr 4 respectively consequently defined new gene spr 5 reference allele by101 eimer et al 2002b examined remaining five suppressor mutations found screens see could spr 1 spr 2 alleles none remaining five alleles mutation coding region spr 2 however by133 showed close linkage dpy 11 chromosome v mapped similar region spr 1 see table s1 httpdevbiologistsorgsupplemental spr 1 recently cloned jarriault greenwald 2002 found by133 contains mutation gene eimer et al 2002b remaining four suppressor mutations pursued detail complementation tests define three additional genes data shown fact found spr 2 alleles found mutations genes identified wen et al 2000 indicates saturation reached either screen rest paper report cloning characterization two major complementation groups spr 3 spr 4
0.49589044.12668626.html.plaintext.txt	55	spr 3 spr 4 potently specifically suppress sel 12 roughly 75 sel 12ar171 adult animals display protruding vulva pvl fig 1 defect strongly correlated presumably caused mis specification lineage eimer et al 2002a almost sel 12 animals retain many eggs uterus egg laying defective egl phenotype eggs hatch develop within mother leading terminal bag worms bag phenotype fig 1 egl defect severely limits number progeny generated table 1 mutations spr 3 completely suppress aspects sel 12 egg laying defect fig 1 sel 12ar171 spr 3 double mutants also display nearly wild type brood size table 1 indicating spr 3 mutations restore normal egg laying behavior normal fertility also respond neurotransmitters stimulate egg laying data shown spr 4 mutations however lead less completely penetrant suppression sel 12 phenotype alleles 5 spr 4 sel 12ar171 animals still become egl fig 1 egl phenotype similar sel 12ar171 except pvl animals seen suggests remaining egl animals least part sel 12 phenotype rescued however spr 4 sel 12ar171 double mutant animals lay eggs display nearly wild type brood size table 1 mutations spr 3 spr 4 also suppress sel 12 alleles tested ar131 by125 lg1401 spr 3 ar131 spr 4 table 1 data shown mutations spr 3 spr 4 obvious phenotype except perhaps slightly reduced brood size table 1 data shown spr 3 examined clear null mutation by131 also known bydf1 detail surprisingly even mutation 31 kb deletion deletes five genes including spr 3 upstream downstream neighbor fig 2b obvious phenotype table 1 data shown indicating none deleted genes essential taken together results show spr 3 spr 4 potent specific suppressors sel 12 able suppress aspects sel 12 phenotype
0.49589044.12668626.html.plaintext.txt	56	spr 3 spr 4 potently specifically suppress sel 12 roughly 75 sel 12ar171 adult animals display protruding vulva pvl fig 1 defect strongly correlated presumably caused mis specification lineage eimer et al 2002a almost sel 12 animals retain many eggs uterus egg laying defective egl phenotype eggs hatch develop within mother leading terminal bag worms bag phenotype fig 1 egl defect severely limits number progeny generated table 1 mutations spr 3 completely suppress aspects sel 12 egg laying defect fig 1 sel 12ar171 spr 3 double mutants also display nearly wild type brood size table 1 indicating spr 3 mutations restore normal egg laying behavior normal fertility also respond neurotransmitters stimulate egg laying data shown spr 4 mutations however lead less completely penetrant suppression sel 12 phenotype alleles 5 spr 4 sel 12ar171 animals still become egl fig 1 egl phenotype similar sel 12ar171 except pvl animals seen suggests remaining egl animals least part sel 12 phenotype rescued however spr 4 sel 12ar171 double mutant animals lay eggs display nearly wild type brood size table 1 mutations spr 3 spr 4 also suppress sel 12 alleles tested ar131 by125 lg1401 spr 3 ar131 spr 4 table 1 data shown mutations spr 3 spr 4 obvious phenotype except perhaps slightly reduced brood size table 1 data shown spr 3 examined clear null mutation by131 also known bydf1 detail surprisingly even mutation 31 kb deletion deletes five genes including spr 3 upstream downstream neighbor fig 2b obvious phenotype table 1 data shown indicating none deleted genes essential taken together results show spr 3 spr 4 potent specific suppressors sel 12 able suppress aspects sel 12 phenotype
0.49589044.12668626.html.plaintext.txt	57	view larger version 14k fig 1 mutations spr 3 spr 4 potently suppress egg laying defect sel 12 mutants percentage animals exhibit protruding vulva pvl black bar egg laying defect egl gray bar die internal hatching bag white bar shown wild type n2 sel 12 three separate alleles spr 3 spr 4 sel 12ar171 background number animals examined n2 100 ar171 95 by108 97 by109 99 by110 99 by105 92 by130 95 by132 87
0.49589044.12668626.html.plaintext.txt	58	view table table 1 brood size spr 3 spr 4 mutants
0.49589044.12668626.html.plaintext.txt	59	spr 3 c2h2 zinc finger protein genetic mapping placed spr 3 chromosome x dpy 23e840 lon 2e678 close dpy 23 fig 2a dpy 23e840 roughly 100 kb deletion left right breakpoints cosmids c15h3 f02e8 respectively g garriga personal communication started sequentially injecting sequenced cosmids f02e8 right spr 3 completely rescued cosmid f46h6 partially overlapping cosmid c07a12 fig 2b injected series purified restriction fragments subclones pcr products f46h6 fig 2b injected products containing entirety predicted gene c07a125 produced complete rescue spr 3 fig 2b table 1 data shown minimal rescuing fragment narrowed 41 kb containing c07a125 predicted open reading frame
0.49589044.12668626.html.plaintext.txt	60	spr 3 encodes novel basic protein predicted pi91 684 amino acids recognizable domains spr 3 seven putative c2h2 zinc finger several regions may act nuclear localization signals fig 3ab spr 3 alleles ar209 by108 by110 by137 amino acid stop codon mutations various positions protein fig 3b by135 mutation single base pair deletion shifts frame amino acid 183 truncates protein 210 amino acids by109 mutation c596y transition second cysteine sixth zinc finger indicating finger essential spr 3 function by131 deletion 31069 bases position 3052 f46h6 position 6698 c07a12 single base pair insertion mutation deletes f46h62dgk 2 f46h64 f46h61rhi 1 c07a125spr 3 part c07a127 clearly null spr 3 function fig 2b by131 deletes several genes renamed bydf1 combination pcr southern blotting sequencing determined alterations coding sequence by136 however by136 complex promoter rearrangement c07a125 data shown using northern analysis single transcript detectable by108 by109 by110 by135 by137 lanes nearly wild type levels although transcript detectable bydf1 by136 fig 2c indicating by136 also null spr 3 function
0.49589044.12668626.html.plaintext.txt	61	view larger version 51k fig 3 structure spr 3 c elegans c briggsae determined structure c elegans spr 3 3 end c briggsae homolog black boxes indicate location predicted c2h2 zinc fingers gray boxes indicate locations sequences might act nuclear localization signals region confirmed structure c elegans c briggsae transcripts similar b alignment c elegans partial c briggsae sequences spr 3 also shown region 5 determined sequence c briggsae spr 3 similar zinc fingers 1 2 c elegans spr 3 gene predicted part c briggsae spr 3 gene identical amino acids highlighted black similar amino acids indicated gray predicted zinc fingers underlined regions containing sequences could act nuclear localization signals boxed positions point mutations shown asterisk c alignment zinc finger regions spr 3 rest homo sapiens identical amino acids highlighted black similar gray gaps alignment indicated hyphens gaps segments spr 3 indicated blank spaces
0.49589044.12668626.html.plaintext.txt	62	spr 3 broadly expressed nuclearly localized spr 3 transcript expressed stages different levels message present high amounts eggs l2 adult stages weakly expressed l1 l3 l4 stages fig 4a determine expression pattern spr 3 made promoter fusion egfp construct broadly expressed embryo larval stages adult fig 4bc expressed sf9 insect cells using baculovirus expression system spr 3 localized nucleus fig 4de attempts purify spr 3 insect cells failed spr 3 remained nuclear fraction even dnase treatment high salt extraction data shown therefore likely spr 3 present nuclear subcompartment attached nuclear periphery
0.49589044.12668626.html.plaintext.txt	63	spr 3 broadly expressed nuclearly localized spr 3 transcript expressed stages different levels message present high amounts eggs l2 adult stages weakly expressed l1 l3 l4 stages fig 4a determine expression pattern spr 3 made promoter fusion egfp construct broadly expressed embryo larval stages adult fig 4bc expressed sf9 insect cells using baculovirus expression system spr 3 localized nucleus fig 4de attempts purify spr 3 insect cells failed spr 3 remained nuclear fraction even dnase treatment high salt extraction data shown therefore likely spr 3 present nuclear subcompartment attached nuclear periphery
0.49589044.12668626.html.plaintext.txt	64	spr 3 gene evolved rapidly unable identify clear homologs spr 3 sequence databases understand better regions protein could important function tried identify homologs c briggsae closest known relative c elegans blaxter et al 1998 using rt pcr isolated large fragment transcript determined similar exonintron structure spr 3 c elegans see fig 3ab however c briggsae gene 22 identical 45 similar c elegans spr 3 see fig 3b similarity confined zinc finger regions predicted 5 end c briggsae spr 3 gene significantly diverged c elegans spr 3 however predicted n terminal region c briggsae spr 3 region similar zinc fingers 1 2 c elegans spr 3 fig 3b
0.49589044.12668626.html.plaintext.txt	65	spr 3 gene evolved rapidly unable identify clear homologs spr 3 sequence databases understand better regions protein could important function tried identify homologs c briggsae closest known relative c elegans blaxter et al 1998 using rt pcr isolated large fragment transcript determined similar exonintron structure spr 3 c elegans see fig 3ab however c briggsae gene 22 identical 45 similar c elegans spr 3 see fig 3b similarity confined zinc finger regions predicted 5 end c briggsae spr 3 gene significantly diverged c elegans spr 3 however predicted n terminal region c briggsae spr 3 region similar zinc fingers 1 2 c elegans spr 3 fig 3b
0.49589044.12668626.html.plaintext.txt	66	spr 3 similar transcriptional repressors fact spr 3 weakly conserved c briggsae similarity largely confined zinc finger domains suggests regions zinc fingers little selective pressure zinc fingers nuclear localization signals may functional domains protein case would expect mutations result amino acid substitutions would phenotypic consequences consistent one eight spr 3 alleles missense mutation mutation affects conserved cysteine one zinc fingers spr 3 contains three pairs adjacent zinc fingers one lone zinc finger separated non conserved linkers therefore analyze zinc finger regions protein concatenated sequences zinc fingers along short linkers tandem fingers searched databases similarity sequence similar many c2h2 zinc finger proteins similar members rest family transcriptional repressors fig 3c suggests spr 3 may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	67	spr 3 similar transcriptional repressors fact spr 3 weakly conserved c briggsae similarity largely confined zinc finger domains suggests regions zinc fingers little selective pressure zinc fingers nuclear localization signals may functional domains protein case would expect mutations result amino acid substitutions would phenotypic consequences consistent one eight spr 3 alleles missense mutation mutation affects conserved cysteine one zinc fingers spr 3 contains three pairs adjacent zinc fingers one lone zinc finger separated non conserved linkers therefore analyze zinc finger regions protein concatenated sequences zinc fingers along short linkers tandem fingers searched databases similarity sequence similar many c2h2 zinc finger proteins similar members rest family transcriptional repressors fig 3c suggests spr 3 may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	68	spr 4 belongs family c2h2 proteins related transcriptional repressors spr 4 mapped unc 55 daf 8 lgi close right single nucleotide polymorphism snp vl20a11s1at186 u d cosmid f18c12 fig 5ab near point gene c09h61 greatest similarity c elegans c07a125 fig 5b probing spr 4 alleles southern blot yk18b7 c09h61 cdna could identify clear polymorphisms two uvtmp generated spr 4 alleles by130 by132 data shown injection either two cosmids overlap c09h6 f34g10 c48b11 gave partial rescue spr 4 data shown cosmids contain 12 kb pvuii fragment contains entire coding region c09h61 2 kb 3 sequence well 45 kb 5 sequence extending almost next gene upstream fig 5b subcloned pvuii fragment f34g10 pbsiisk cut pvuii found rescues spr 4 well original cosmids data shown
0.49589044.12668626.html.plaintext.txt	69	spr 4 belongs family c2h2 proteins related transcriptional repressors spr 4 mapped unc 55 daf 8 lgi close right single nucleotide polymorphism snp vl20a11s1at186 u d cosmid f18c12 fig 5ab near point gene c09h61 greatest similarity c elegans c07a125 fig 5b probing spr 4 alleles southern blot yk18b7 c09h61 cdna could identify clear polymorphisms two uvtmp generated spr 4 alleles by130 by132 data shown injection either two cosmids overlap c09h6 f34g10 c48b11 gave partial rescue spr 4 data shown cosmids contain 12 kb pvuii fragment contains entire coding region c09h61 2 kb 3 sequence well 45 kb 5 sequence extending almost next gene upstream fig 5b subcloned pvuii fragment f34g10 pbsiisk cut pvuii found rescues spr 4 well original cosmids data shown
0.49589044.12668626.html.plaintext.txt	70	spr 4 codes large protein 1309 amino acids fig 5c containing 18 c2h2 zinc finger domains one zinc fingers labeled znf7 threshold pfam httpwwwcgrkisepfam region highly conserved c briggsae data shown indicating may represent functional domain possible splice variant also suggested based sequence yk1178d11 cdna see materials methods spr 4 also predicted nuclearly localized contains several nuclear localization signals nls including bipartite nls identified mutations three spr 4 alleles fig 5c by130 contains 64 bp deletion 8 bp insertion position 1165 message deletion shifts frame amino acid 389 truncates predicted protein position 404 fig 5c by112 allele q97stop mutation fig 5c southern analysis by132 contains 500 bp deletion near 3 end gene data shown
0.49589044.12668626.html.plaintext.txt	71	spr 4 codes large protein 1309 amino acids fig 5c containing 18 c2h2 zinc finger domains one zinc fingers labeled znf7 threshold pfam httpwwwcgrkisepfam region highly conserved c briggsae data shown indicating may represent functional domain possible splice variant also suggested based sequence yk1178d11 cdna see materials methods spr 4 also predicted nuclearly localized contains several nuclear localization signals nls including bipartite nls identified mutations three spr 4 alleles fig 5c by130 contains 64 bp deletion 8 bp insertion position 1165 message deletion shifts frame amino acid 389 truncates predicted protein position 404 fig 5c by112 allele q97stop mutation fig 5c southern analysis by132 contains 500 bp deletion near 3 end gene data shown
0.49589044.12668626.html.plaintext.txt	72	spr 4 clear homologs c briggsae data shown distantly related nematodes pristionchus pacificus ai989188 parastrongyloides tricosuri bm513702 j mccarter personal communication spr 4 also strong similarity e3x10 43 c28g14 c elegans nm 0770981 twenty one first 34 amino acids identical spr 4 c28g14 region followed proteins highly acidic stretch suggesting region forms functional domain fig 5c central region c28g14 resemble protein c28g14 34 identical spr 4 n terminal section znf13 end protein contains zinc fingers region except znf15 suggesting spr 4 c28g14 may related function fig 5c however rna interference feeding kamath et al 2001 c28g14 obvious effects wild type strain n2 influence egl defect sel 12ar171 sel 12ar131 data shown dsrnai c28g14 also fails produce synthetic effect either spr 4by105 sel 12ar171 spr 4by105 background data shown results may suggest rnai effect induced bacterial feeding approach however rnai injection purified double stranded rna yk356a2 c28g14 cdna also induced phenotype maeda et al 2001 interestingly c28g14 homolog present draft c briggsae assembly suggesting c28g14 may recently diverged ancestral spr 4 like gene gene low selective pressure lost without phenotypic effects
0.49589044.12668626.html.plaintext.txt	73	spr 4 also similarity large number zinc finger proteins metazoans spr 4 similar members rest family transcriptional repressors fig 5d also weaker similarity known transcriptional repressors members ctcfccctc binding factor suggesting spr 4 like spr 3 may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	74	spr 4 also similarity large number zinc finger proteins metazoans spr 4 similar members rest family transcriptional repressors fig 5d also weaker similarity known transcriptional repressors members ctcfccctc binding factor suggesting spr 4 like spr 3 may also function transcriptional repressor
0.49589044.12668626.html.plaintext.txt	75	hop 1 transcription regulated spr 3 spr 4 spr 3 spr 4 encode c2h2 zinc finger proteins probably nuclearly localized might act transcription factors looked possible targets regulated spr 3 spr 4 therefore probed northern blots prepared mixed stage staged rna spr 3 spr 4 mutants several genes involved lin 12 glp 1 signaling significant differences transcript levels seen strains probed lin 12 glp 1 lag 1 apx 1 sup 17 data shown although probe exhaustively suggested spr 3 spr 4 might obvious effects transcription genes involved lin 12 glp 1 pathways
0.49589044.12668626.html.plaintext.txt	76	hop 1 transcription regulated spr 3 spr 4 spr 3 spr 4 encode c2h2 zinc finger proteins probably nuclearly localized might act transcription factors looked possible targets regulated spr 3 spr 4 therefore probed northern blots prepared mixed stage staged rna spr 3 spr 4 mutants several genes involved lin 12 glp 1 signaling significant differences transcript levels seen strains probed lin 12 glp 1 lag 1 apx 1 sup 17 data shown although probe exhaustively suggested spr 3 spr 4 might obvious effects transcription genes involved lin 12 glp 1 pathways
0.49589044.12668626.html.plaintext.txt	77	investigated whether spr 3 spr 4 might bypass need sel 12 regulating one presenilin genes spe 4 hop 1 results mixed stage blots suggested hop 1 spe 4 may differentially expressed data shown therefore probed staged northern blots transcript levels three c elegans presenilin genes various developmental stages reported previously find consistent known role spermatogenesis spe 4 expressed l4 larval stage hermaphrodites produce sperm fig 6ac sel 12 expressed strongly uniformly throughout development figs 6bc consistent strong ubiquitous expression sel 12egfp promoter fusion baumeister et al 1997 surprisingly hop 1 dynamic expression strongly expressed adult stage weakly embryo almost undetectable l1 stage figs 6ac hop 1 expression slowly increases remaining larval stages
0.49589044.12668626.html.plaintext.txt	78	investigated whether spr 3 spr 4 might bypass need sel 12 regulating one presenilin genes spe 4 hop 1 results mixed stage blots suggested hop 1 spe 4 may differentially expressed data shown therefore probed staged northern blots transcript levels three c elegans presenilin genes various developmental stages reported previously find consistent known role spermatogenesis spe 4 expressed l4 larval stage hermaphrodites produce sperm fig 6ac sel 12 expressed strongly uniformly throughout development figs 6bc consistent strong ubiquitous expression sel 12egfp promoter fusion baumeister et al 1997 surprisingly hop 1 dynamic expression strongly expressed adult stage weakly embryo almost undetectable l1 stage figs 6ac hop 1 expression slowly increases remaining larval stages
0.49589044.12668626.html.plaintext.txt	79	view larger version 54k fig 6 stage specific expression sel 12 spe 4 hop 1 transcripts stages fig 4a stage specific expression hop 1 spe 4 blot ama 1 equal loading control b stage specific expression sel 12 ama 1 loading control c relative expression various presenilin genes b correction equal loading
0.49589044.12668626.html.plaintext.txt	80	spr 3 spr 4 mutants found differences temporal pattern expression sel 12 spe 4 see increase hop 1 expression l1 l2 l3 larval stages stages hop 1 expression lowest data shown egg laying defect sel 12 animals due developmental defects occurring mid larval stages suppression sel 12 spr genes could explained stage specific alterations gene expression confirm result directly compare different strains prepared northern blot l1 rna n2 sel 12ar171 several spr strains probed hop 1 expression hop 1 lowest l1 stage reasoned increased expression stage might easiest detect increased amount total rna used 5 microglane 20 microglane expression hop 1 wild type worms near detection level tested l1 rna prepared n2 sel 12ar171 four spr 5 alleles one spr 4 allele three spr 3 alleles fig 7 spr strains tested hop 1 upregulated suggests spr genes may use mechanism bypass requirement sel 12 spr 4 upregulates hop 1 expression 11 fold whereas spr 3 alleles upregulate hop 1 four 12 fold fig 7 data confirmed separate experiments looked hop 1 expression l1 stage 1 seven spr 3 alleles isolated screens 2 one spr 5 allele two spr 3 alleles without sel 12 background spr alleles hop 1 strongly expressed controls see figs s1 s2 httpdevbiologistsorgsupplemental
0.49589044.12668626.html.plaintext.txt	81	spr 3 spr 4 mutants found differences temporal pattern expression sel 12 spe 4 see increase hop 1 expression l1 l2 l3 larval stages stages hop 1 expression lowest data shown egg laying defect sel 12 animals due developmental defects occurring mid larval stages suppression sel 12 spr genes could explained stage specific alterations gene expression confirm result directly compare different strains prepared northern blot l1 rna n2 sel 12ar171 several spr strains probed hop 1 expression hop 1 lowest l1 stage reasoned increased expression stage might easiest detect increased amount total rna used 5 microglane 20 microglane expression hop 1 wild type worms near detection level tested l1 rna prepared n2 sel 12ar171 four spr 5 alleles one spr 4 allele three spr 3 alleles fig 7 spr strains tested hop 1 upregulated suggests spr genes may use mechanism bypass requirement sel 12 spr 4 upregulates hop 1 expression 11 fold whereas spr 3 alleles upregulate hop 1 four 12 fold fig 7 data confirmed separate experiments looked hop 1 expression l1 stage 1 seven spr 3 alleles isolated screens 2 one spr 5 allele two spr 3 alleles without sel 12 background spr alleles hop 1 strongly expressed controls see figs s1 s2 httpdevbiologistsorgsupplemental
0.49589044.12668626.html.plaintext.txt	82	view larger version 35k fig 7 mutations spr 3 spr 4 de repress expression hop 1 message l1 stage expression hop 1 message ama 1 loading control l1 stage n2 wild type sel 12ar171 four spr 5 alleles by101 by119 by128 by139 one spr 4 allele by130 three spr 3 alleles by108 by135 by136 spr mutants sel 12ar171 background fold expression hop 1 compared n2 given correction equal loading first six lanes reproduced permission eimer et al eimer et al 2002b preliminary experiments 5 microglane rna gave qualitatively similar results see fig s1 httpdevbiologistsorgsupplemental additional spr 3 alleles
0.49589044.12668626.html.plaintext.txt	83	spr 3 spr 4 suppress synthetic lethality hop 1 sel 12 double mutants spr genes bypass need sel 12 upregulating expression hop 1 spr 3 spr 4 mutations suppress synthetic lethal phenotype induced reducing hop 1 sel 12 activity exactly find rnai feeding hop 1 gene sel 12ar171 spr 3by108 strain spr 4by105 sel 12ar171 strain induces range phenotypes seen one induces rnai hop 1 sel 12ar171 table 2 li greenwald 1997 animals display lethal phenotype emb lag ste consistent strong reduction lin 12 andor glp 1 signaling animals produce progeny egl indicates spr 3 spr 4 mutations bypass need presenilins per se sel 12 effect dependent activity hop 1 confirmed result constructing hop 1 sel 12 spr 3 triple mutant strains table 3 similar experiments spr 4 performed genetic proximity spr 4 hop 1 find spr 3 affect phenotype hop 1 sel 12 double mutants also shown spr 1 spr 2 spr 5 eimer et al 2002b jarriault greenwald 2002 wen et al 2000 furthermore 43 hop 1lg1501dpy 5e61 sel 12ar171 spr 3by108 animals one remaining copy hop 1 functional sel 12 gene display egl phenotype table 3 sel 12ar171 spr 3by108 animals never egl see fig 1 indicates sel 12 spr 3 background hop 1 haploinsufficient sel 12 spr 3 mutants presenilin activity near threshold necessary correct egg laying reducing hop 1 activity half brings worms threshold taken together results consistent spr 3 spr 4 suppressing sel 12 upregulating hop 1
0.49589044.12668626.html.plaintext.txt	84	view table table 2 hop 1 activity required spr 3 spr 4 mediated suppression sel 12 egg laying defect
0.49589044.12668626.html.plaintext.txt	85	view table table 3 hop 1 haploinsufficient sel 12 spr 3 background
0.49589044.12668626.html.plaintext.txt	86	discussion top summary introduction materials methods results discussion references difference expression patterns may explain phenotypes sel 12 hop 1 although sel 12 hop 1 similar biochemical functions interchangeable transgenic experiments mutations sel 12 hop 1 result different phenotypes suggests although genes may encode functionally equivalent proteins genes redundant different phenotypes may explained different expression patterns sel 12 strongly uniformly expressed hop 1 expression dynamic low throughout larval stages thus absence hop 1 expression still enough sel 12 presenilin activity times development consequently hop 1 mutants mild phenotype however absence sel 12 expression probably insufficient copies hop 1 transcript early larval stages compensate completely loss sel 12 expression therefore sel 12 mutants display postembryonic defects
0.49589044.12668626.html.plaintext.txt	87	discussion top summary introduction materials methods results discussion references difference expression patterns may explain phenotypes sel 12 hop 1 although sel 12 hop 1 similar biochemical functions interchangeable transgenic experiments mutations sel 12 hop 1 result different phenotypes suggests although genes may encode functionally equivalent proteins genes redundant different phenotypes may explained different expression patterns sel 12 strongly uniformly expressed hop 1 expression dynamic low throughout larval stages thus absence hop 1 expression still enough sel 12 presenilin activity times development consequently hop 1 mutants mild phenotype however absence sel 12 expression probably insufficient copies hop 1 transcript early larval stages compensate completely loss sel 12 expression therefore sel 12 mutants display postembryonic defects
0.49589044.12668626.html.plaintext.txt	88	spr genes may function mechanism provide evidence mechanism mutants spr 3 spr 4 suppress sel 12 loss function alleles involves de repression hop 1 transcription stages hop 1 expression alone suffice similarly shown recently spr 1 spr 5 proteins interact spr 5 upregulates hop 1 expression developmental stages mutations spr 3 spr 4 eimer et al 2002b suggests spr 1 spr 3 spr 4 spr 5 suppress sel 12 upregulating hop 1 replacing one presenilin another similarly mutations spr 2 genetically bypass need sel 12 bypass need sel 12 hop 1 wen et al 2000 although hop 1 activity required suppression mechanism wen et al find evidence hop 1 transcriptional de repression wen et al 2000 however stage specific de repression hop 1 transcription seen would detectable mixed stage northern blot thus propose spr 2 may also bypass need sel 12 mechanism spr 3 spr 4 spr 5
0.49589044.12668626.html.plaintext.txt	89	spr genes may function mechanism provide evidence mechanism mutants spr 3 spr 4 suppress sel 12 loss function alleles involves de repression hop 1 transcription stages hop 1 expression alone suffice similarly shown recently spr 1 spr 5 proteins interact spr 5 upregulates hop 1 expression developmental stages mutations spr 3 spr 4 eimer et al 2002b suggests spr 1 spr 3 spr 4 spr 5 suppress sel 12 upregulating hop 1 replacing one presenilin another similarly mutations spr 2 genetically bypass need sel 12 bypass need sel 12 hop 1 wen et al 2000 although hop 1 activity required suppression mechanism wen et al find evidence hop 1 transcriptional de repression wen et al 2000 however stage specific de repression hop 1 transcription seen would detectable mixed stage northern blot thus propose spr 2 may also bypass need sel 12 mechanism spr 3 spr 4 spr 5
0.49589044.12668626.html.plaintext.txt	90	upregulation hop 1 transcription early larval stages explain suppression sel 12 spr 3 spr 4 mutations spr 3 spr 4 clearly de repress transcription hop 1 early larval stages however even suppressor strains absolute hop 1 transcript levels early larval stages still much lower adult stage believe stage specific increase hop 1 expression sufficient explain spr 3 spr 4 suppress sel 12 even strong putative null sel 12 mutant sufficient hop 1 protein larval stages enable lin 12 dependent developmental decisions occur correctly sel 12 mutants ventral uterineanchor cell decision lateral inhibition vulval precursors sex myoblastcoelomocyte decision affected levitan greenwald 1995 indicating sufficient presenilin activity provided hop 1 present many cell types sel 12ar131 even cell fate executed correctly vast majority animals sel 12ar171 executed correctly animals sel 12 hop 1 double mutants 100 animals defective vulval uterine connection cinar et al 2001 eimer et al 2002a indicates sel 12 mutants expression hop 1 almost sufficient wild type cell induction therefore likely small increases hop 1 expression could sufficient compensate completely loss sel 12 developmental decisions
0.49589044.12668626.html.plaintext.txt	91	upregulation hop 1 transcription early larval stages explain suppression sel 12 spr 3 spr 4 mutations spr 3 spr 4 clearly de repress transcription hop 1 early larval stages however even suppressor strains absolute hop 1 transcript levels early larval stages still much lower adult stage believe stage specific increase hop 1 expression sufficient explain spr 3 spr 4 suppress sel 12 even strong putative null sel 12 mutant sufficient hop 1 protein larval stages enable lin 12 dependent developmental decisions occur correctly sel 12 mutants ventral uterineanchor cell decision lateral inhibition vulval precursors sex myoblastcoelomocyte decision affected levitan greenwald 1995 indicating sufficient presenilin activity provided hop 1 present many cell types sel 12ar131 even cell fate executed correctly vast majority animals sel 12ar171 executed correctly animals sel 12 hop 1 double mutants 100 animals defective vulval uterine connection cinar et al 2001 eimer et al 2002a indicates sel 12 mutants expression hop 1 almost sufficient wild type cell induction therefore likely small increases hop 1 expression could sufficient compensate completely loss sel 12 developmental decisions
0.49589044.12668626.html.plaintext.txt	92	also reasons believe small amounts presenilin message may sufficient provide adequate levels presenilin activity presenilins normally found part high molecular weight complex capell et al 1998 li et al 2000 thinakaran et al 1998 yu et al 1998 complex assembled er golgi proteins incorporated complex targeted cell membrane rapidly degraded ratovitski et al 1997 presenilins may required small amounts amount components complex limiting assembly edbauer et al 2002 consequently found cell culture presenilins cannot overproduced thinakaran et al 1996 furthermore presenilin complex thought enzymatic activity levels complex necessary biochemical function may normally vast excess required thus even amount complex present cell membrane spr sel 12 double mutants slightly lower wild type levels wild type phenotype double mutants indicates suffices ensure sufficient levels lin 12 signaling
0.49589044.12668626.html.plaintext.txt	93	also reasons believe small amounts presenilin message may sufficient provide adequate levels presenilin activity presenilins normally found part high molecular weight complex capell et al 1998 li et al 2000 thinakaran et al 1998 yu et al 1998 complex assembled er golgi proteins incorporated complex targeted cell membrane rapidly degraded ratovitski et al 1997 presenilins may required small amounts amount components complex limiting assembly edbauer et al 2002 consequently found cell culture presenilins cannot overproduced thinakaran et al 1996 furthermore presenilin complex thought enzymatic activity levels complex necessary biochemical function may normally vast excess required thus even amount complex present cell membrane spr sel 12 double mutants slightly lower wild type levels wild type phenotype double mutants indicates suffices ensure sufficient levels lin 12 signaling
0.49589044.12668626.html.plaintext.txt	94	increased expression hop 1 early larval stages seen spr 3 spr 4 mutants sufficient rescue later larval defects seen sel 12 mutants several reasons believe case first cell signaling events lead cell induction correct alignment sex muscles occur prior developmental changes cinar et al 2001 eimer et al 2002a presenilin activity presumably required time signaling second initial experiments suggested relative expression hop 1 increased l1 l2 l3 stages spr 3 spr 4 mutants chose pursue l1 stage thought upregulation hop 1 expression might obvious stage furthermore demonstrated cell culture assembled high molecular weight presenilin complex stable long time period edbauer et al 2002 ratovitski et al 1997 finally indications presenilin complex necessary small amounts persist 24 hours c elegans see rescue sex myoblastcoelomocyte cell fate decision hop 1sel 12 double mutants maternally provided hop 1 eimer et al 2002a thus presenilin protein produced embryo sufficiently stable produced sufficient amounts cell fate decision occurring l2 stage
0.49589044.12668626.html.plaintext.txt	95	increased expression hop 1 early larval stages seen spr 3 spr 4 mutants sufficient rescue later larval defects seen sel 12 mutants several reasons believe case first cell signaling events lead cell induction correct alignment sex muscles occur prior developmental changes cinar et al 2001 eimer et al 2002a presenilin activity presumably required time signaling second initial experiments suggested relative expression hop 1 increased l1 l2 l3 stages spr 3 spr 4 mutants chose pursue l1 stage thought upregulation hop 1 expression might obvious stage furthermore demonstrated cell culture assembled high molecular weight presenilin complex stable long time period edbauer et al 2002 ratovitski et al 1997 finally indications presenilin complex necessary small amounts persist 24 hours c elegans see rescue sex myoblastcoelomocyte cell fate decision hop 1sel 12 double mutants maternally provided hop 1 eimer et al 2002a thus presenilin protein produced embryo sufficiently stable produced sufficient amounts cell fate decision occurring l2 stage
0.49589044.12668626.html.plaintext.txt	96	spr 3 spr 4 perform conserved function although spr 3 spr 4 clear mammalian homologs may performing similar function known transcriptional repressors spr 3 spr 4 resemble known transcriptional repressors especially restnrsf re1 silencing transcription factorneural restrictive silencing factor different vertebrates c2h2 zinc finger factor rest mediates repression neuronal genes non neuronal cells recruiting co repressor complexes sin3 corest humphrey et al 2001 co repressor complexes contain multiple proteins including histone deacetylases presumably repress transcription part removing activating acetyl groups histones h3 h4 target locus possible spr 3 spr 4 may also function recruiting conserved co repressor complexes hop 1 locus three spr genes spr 1 spr 2 spr 5 encode proteins similar components known co repressors eimer et al 2002b jarriault greenwald 2002 wen et al 2000 spr 2 member nucleosome assembly protein nap family similar human oncogene set wen et al 2000 human set purified part inhat inhibitor acetyltransferases co repressor complex helps repress transcription binding histones masking acetyltransferase substrates p300cbp pcaf seo et al 2001 recently shown upregulation set also inhibits demethylation methylated dna may integrate epigenetic states dna associated histones cervoni et al 2002 another paper reported identification characterization spr 5 encodes polyamine oxidase like protein similar known component corest co repressor complex eimer et al 2002b core corest complex contains six proteins hakimi et al 2002 spr 1 encodes homolog myb domain containing protein corest eimer et al 2002b jarriault greenwald 2002 additional component corest co repressor complex shown spr 1 spr 5 interact biochemically vitro vivo eimer et al 2002b suggests similar complex present c elegans functions repress hop 1 transcription interestingly corest found associate least two large basic c2h2 zinc finger proteins znf217 rest et al 2001 may general co repressor complex recruited different loci different cell types binding different c2h2 zinc finger proteins recent work also suggests corest may interact components swi snf complex battaglioli et al 2002 may involved silencing chromosomal regions lunyak et al 2002
0.49589044.12668626.html.plaintext.txt	97	spr 3 spr 4 perform conserved function although spr 3 spr 4 clear mammalian homologs may performing similar function known transcriptional repressors spr 3 spr 4 resemble known transcriptional repressors especially restnrsf re1 silencing transcription factorneural restrictive silencing factor different vertebrates c2h2 zinc finger factor rest mediates repression neuronal genes non neuronal cells recruiting co repressor complexes sin3 corest humphrey et al 2001 co repressor complexes contain multiple proteins including histone deacetylases presumably repress transcription part removing activating acetyl groups histones h3 h4 target locus possible spr 3 spr 4 may also function recruiting conserved co repressor complexes hop 1 locus three spr genes spr 1 spr 2 spr 5 encode proteins similar components known co repressors eimer et al 2002b jarriault greenwald 2002 wen et al 2000 spr 2 member nucleosome assembly protein nap family similar human oncogene set wen et al 2000 human set purified part inhat inhibitor acetyltransferases co repressor complex helps repress transcription binding histones masking acetyltransferase substrates p300cbp pcaf seo et al 2001 recently shown upregulation set also inhibits demethylation methylated dna may integrate epigenetic states dna associated histones cervoni et al 2002 another paper reported identification characterization spr 5 encodes polyamine oxidase like protein similar known component corest co repressor complex eimer et al 2002b core corest complex contains six proteins hakimi et al 2002 spr 1 encodes homolog myb domain containing protein corest eimer et al 2002b jarriault greenwald 2002 additional component corest co repressor complex shown spr 1 spr 5 interact biochemically vitro vivo eimer et al 2002b suggests similar complex present c elegans functions repress hop 1 transcription interestingly corest found associate least two large basic c2h2 zinc finger proteins znf217 rest et al 2001 may general co repressor complex recruited different loci different cell types binding different c2h2 zinc finger proteins recent work also suggests corest may interact components swi snf complex battaglioli et al 2002 may involved silencing chromosomal regions lunyak et al 2002
0.49589044.12668626.html.plaintext.txt	98	proteins encoded spr genes may form one transcriptional repressor complexes thus spr 3 spr 4 may recruit one conserved co repressor complexes including one similar corest co repressor complex target loci propose following model spr genes functioning fact loss function mutations either spr 3 spr 4 suppress sel 12 de repress hop 1 transcription suggest spr 3 spr 4 normally recruited hop 1 locus associate co repressor proteins similar members inhat corest co repressor complexes unclear two zinc finger proteins co operatively bind co repressor proteins zinc finger protein associates different complex assembled complex complexes probably acts basal repressor hop 1 transcription overridden later developmental stages
0.49589044.12668626.html.plaintext.txt	99	proteins encoded spr genes may form one transcriptional repressor complexes thus spr 3 spr 4 may recruit one conserved co repressor complexes including one similar corest co repressor complex target loci propose following model spr genes functioning fact loss function mutations either spr 3 spr 4 suppress sel 12 de repress hop 1 transcription suggest spr 3 spr 4 normally recruited hop 1 locus associate co repressor proteins similar members inhat corest co repressor complexes unclear two zinc finger proteins co operatively bind co repressor proteins zinc finger protein associates different complex assembled complex complexes probably acts basal repressor hop 1 transcription overridden later developmental stages
0.49589044.12668626.html.plaintext.txt	100	mammalian inhat corest complexes purified studied biochemical approaches however yet little known biological function data available spr gene function suggest inhat corest complexes studied genetically biochemically c elegans suggest c elegans genetics may identify additional genes interact complexes may help elucidate biological function
0.49589044.12668626.html.plaintext.txt	101	mammalian inhat corest complexes purified studied biochemical approaches however yet little known biological function data available spr gene function suggest inhat corest complexes studied genetically biochemically c elegans suggest c elegans genetics may identify additional genes interact complexes may help elucidate biological function
0.49589044.12668626.html.plaintext.txt	102	acknowledgments thank gian garriga sophie jarriault iva greenwald jim mccarter sanger institute genome sequencing center washington university st louis communicating unpublished information jean claude labbe advice rna isolation northern analysis jonathan hodgkin iva greenwald strains yuji kohara cdna clones bob barstead cdna library alan coulson cosmid clones strains used work provided caenorhabditis genetics center funded national center research resources nih work supported embo fellowship bl grants dfg ec diadem bmbf ngfn rb
0.49589044.12668626.html.plaintext.txt	103	acknowledgments thank gian garriga sophie jarriault iva greenwald jim mccarter sanger institute genome sequencing center washington university st louis communicating unpublished information jean claude labbe advice rna isolation northern analysis jonathan hodgkin iva greenwald strains yuji kohara cdna clones bob barstead cdna library alan coulson cosmid clones strains used work provided caenorhabditis genetics center funded national center research resources nih work supported embo fellowship bl grants dfg ec diadem bmbf ngfn rb
0.49589044.12668626.html.plaintext.txt	104	footnotes supplemental data available online
0.49589044.12668626.html.plaintext.txt	105	references top summary introduction materials methods results discussion references
0.49589044.12668626.html.plaintext.txt	106	article summary figures full text pdf supplemental data alert article cited alert correction posted services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager google scholar articles lakowski b articles baumeister r articles citing article pubmed pubmed citation articles lakowski b articles baumeister r
0.49919817.11076969.html.plaintext.txt	0	identification ubiquilin novel presenilin interactor increases presenilin protein accumulation alex l maha george perryb mark smithb mervyn j monteiroa medical biotechnology center department neurology university maryland biotechnology institute baltimore maryland 21201 b institute pathology case western reserve university cleveland ohio 44106
0.49919817.11076969.html.plaintext.txt	1	correspondence mervyn j monteiro medical biotechnology center room n352 725 west lombard street baltimore md 21201 tel410 706 8132 fax410 706 1732
0.49919817.11076969.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	3	mutations highly homologous presenilin genes encoding presenilin 1 presenilin 2 ps1 ps2 linked early onset alzheimers disease ad however apart role early development neither normal function presenilins mechanisms mutant proteins cause ad well understood describe properties novel human interactor presenilins named ubiquilin yeast two hybrid y2h interaction glutathione transferase pull experiments colocalization proteins expressed vivo together coimmunoprecipitation cell fractionation studies provide compelling evidence ubiquilin interacts ps1 ps2 ubiquilin noteworthy since contains multiple ubiquitin related domains typically thought involved targeting proteins degradation however show ubiquilin promotes presenilin protein accumulation pulse labeling experiments indicate ubiquilin facilitates increased presenilin synthesis without substantially changing presenilin protein half life immunohistochemistry human brain tissue ubiquilin specific antibodies revealed prominent staining neurons moreover anti ubiquilin antibodies robustly stained neurofibrillary tangles lewy bodies ad parkinsons disease affected brains respectively results indicate ubiquilin may important modulator presenilin protein accumulation ubiquilin protein associated neuropathological neurofibrillary tangles lewy body inclusions diseased brain
0.49919817.11076969.html.plaintext.txt	4	mutations highly homologous presenilin genes encoding presenilin 1 presenilin 2 ps1 ps2 linked early onset alzheimers disease ad however apart role early development neither normal function presenilins mechanisms mutant proteins cause ad well understood describe properties novel human interactor presenilins named ubiquilin yeast two hybrid y2h interaction glutathione transferase pull experiments colocalization proteins expressed vivo together coimmunoprecipitation cell fractionation studies provide compelling evidence ubiquilin interacts ps1 ps2 ubiquilin noteworthy since contains multiple ubiquitin related domains typically thought involved targeting proteins degradation however show ubiquilin promotes presenilin protein accumulation pulse labeling experiments indicate ubiquilin facilitates increased presenilin synthesis without substantially changing presenilin protein half life immunohistochemistry human brain tissue ubiquilin specific antibodies revealed prominent staining neurons moreover anti ubiquilin antibodies robustly stained neurofibrillary tangles lewy bodies ad parkinsons disease affected brains respectively results indicate ubiquilin may important modulator presenilin protein accumulation ubiquilin protein associated neuropathological neurofibrillary tangles lewy body inclusions diseased brain
0.49919817.11076969.html.plaintext.txt	5	key words presenilins alzheimers disease ubiquilin ubiquitin proteasome
0.49919817.11076969.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	7	alzheimers disease ad1 progressive neurodegenerative disorder characterized impaired memory cognition well altered behavior majority ad cases late onset appearing people age 65 however small percent 5 cases termed early onset arise unusually young age early third decade life molecular genetic analysis linked early onset familial alzheimers disease fad autosomal dominant inheritance mutations three genes ss amyloid precursor protein app two homologous genes presenilin 1 2 ps1 ps2 hardy 1997 price et al 1998 mechanisms mutations three genes cause ad unresolved
0.49919817.11076969.html.plaintext.txt	8	alzheimers disease ad1 progressive neurodegenerative disorder characterized impaired memory cognition well altered behavior majority ad cases late onset appearing people age 65 however small percent 5 cases termed early onset arise unusually young age early third decade life molecular genetic analysis linked early onset familial alzheimers disease fad autosomal dominant inheritance mutations three genes ss amyloid precursor protein app two homologous genes presenilin 1 2 ps1 ps2 hardy 1997 price et al 1998 mechanisms mutations three genes cause ad unresolved
0.49919817.11076969.html.plaintext.txt	9	ps1 ps2 multitransmembrane proteins share 67 sequence identity topology presenilins debatable though widely drawn models show proteins weave membrane eight times nh2 cooh terminal domains large loop transmembrane domains six seven oriented towards cytoplasm see fig 1 haass de strooper 1999 although proteins share extensive sequence identity along entire lengths nh2 terminal domains second half loops highly divergent suggesting unique regions could modulate different functions two presenilins examination presenilin linked fad mutations mapped far reveals missense mutations identical residues spread throughout polypeptide presenilins suggesting conserved residues important function proteins
0.49919817.11076969.html.plaintext.txt	10	ps1 ps2 multitransmembrane proteins share 67 sequence identity topology presenilins debatable though widely drawn models show proteins weave membrane eight times nh2 cooh terminal domains large loop transmembrane domains six seven oriented towards cytoplasm see fig 1 haass de strooper 1999 although proteins share extensive sequence identity along entire lengths nh2 terminal domains second half loops highly divergent suggesting unique regions could modulate different functions two presenilins examination presenilin linked fad mutations mapped far reveals missense mutations identical residues spread throughout polypeptide presenilins suggesting conserved residues important function proteins
0.49919817.11076969.html.plaintext.txt	11	view larger version 120k figure 1 ubiquilin interacts two different regions presenilin proteins schematic diagram er bound human ps2 shows eight transmembrane domains nh2 terminus large hydrophilic loop cooh terminus protruding cytoplasm ps1 believed similar structure presenilin loop region loop white cooh terminus striped used y2h assays two ps2 mutants used study contained progressively longer cooh terminal deletions ps2c terminated arrowhead ps2lc terminated arrow b amino acid sequence ps1 ps2 cooh terminus loop regions used y2h baits c y2h ss galactosidase liquid culture interaction assay ubiquilin prey clone fig 2 iii construct b without gst ps2 cooh terminus ps2 c lexa alone nuclear lamin b cenp c baits ss galactosidase units normalized cenp c bait weakest interaction d ss galactosidase interaction assay data near full length ubiquilin prey clone fig 2 iii construct h without gst repeated baits described c along ps1 cooh ps1 c terminus ps2 loop ps2 l ps1 loop ps1 l baits ss galactosidase units normalized cenp c
0.49919817.11076969.html.plaintext.txt	12	view larger version 120k figure 1 ubiquilin interacts two different regions presenilin proteins schematic diagram er bound human ps2 shows eight transmembrane domains nh2 terminus large hydrophilic loop cooh terminus protruding cytoplasm ps1 believed similar structure presenilin loop region loop white cooh terminus striped used y2h assays two ps2 mutants used study contained progressively longer cooh terminal deletions ps2c terminated arrowhead ps2lc terminated arrow b amino acid sequence ps1 ps2 cooh terminus loop regions used y2h baits c y2h ss galactosidase liquid culture interaction assay ubiquilin prey clone fig 2 iii construct b without gst ps2 cooh terminus ps2 c lexa alone nuclear lamin b cenp c baits ss galactosidase units normalized cenp c bait weakest interaction d ss galactosidase interaction assay data near full length ubiquilin prey clone fig 2 iii construct h without gst repeated baits described c along ps1 cooh ps1 c terminus ps2 loop ps2 l ps1 loop ps1 l baits ss galactosidase units normalized cenp c
0.49919817.11076969.html.plaintext.txt	13	studies presenilin homologues various species indicated presenilin genes required proper development mutation caenorhabditis elegans presenilin gene sel 12 produces defects vulva development linked cell signaling defects involving notch based receptors levitan greenwald 1995 haass de strooper 1999 disruption drosophila melanogaster presenilin gene results embryonic lethality embryos displaying severe notch like phenotypes struhl greenwald 1999 ye et al 1999 mammalian presenilins also play important roles early development disruption mouse ps1 gene leads death shortly birth embryos displaying central nervous system defects together abnormal patterning axial skeleton spinal ganglia shen et al 1997 wong et al 1997 interestingly ps1 mice rescued human transgenes containing fad linked mutations indicating fad mutations affect presenilin functions related embryo development davis et al 1998 qian et al 1998 contrast disruption mouse ps2 gene produces obvious defects ps1ps2 double knock mice die earlier embryonic day 95 like ps1 mice display severe misexpression proteins involved notch signaling donoviel et al 1999 herreman et al 1999 results indicate functional redundancy ps1 ps2 ps1 compensate ps2 ps2 cannot compensate ps1 least early mouse development
0.49919817.11076969.html.plaintext.txt	14	studies presenilin homologues various species indicated presenilin genes required proper development mutation caenorhabditis elegans presenilin gene sel 12 produces defects vulva development linked cell signaling defects involving notch based receptors levitan greenwald 1995 haass de strooper 1999 disruption drosophila melanogaster presenilin gene results embryonic lethality embryos displaying severe notch like phenotypes struhl greenwald 1999 ye et al 1999 mammalian presenilins also play important roles early development disruption mouse ps1 gene leads death shortly birth embryos displaying central nervous system defects together abnormal patterning axial skeleton spinal ganglia shen et al 1997 wong et al 1997 interestingly ps1 mice rescued human transgenes containing fad linked mutations indicating fad mutations affect presenilin functions related embryo development davis et al 1998 qian et al 1998 contrast disruption mouse ps2 gene produces obvious defects ps1ps2 double knock mice die earlier embryonic day 95 like ps1 mice display severe misexpression proteins involved notch signaling donoviel et al 1999 herreman et al 1999 results indicate functional redundancy ps1 ps2 ps1 compensate ps2 ps2 cannot compensate ps1 least early mouse development
0.49919817.11076969.html.plaintext.txt	15	human presenilin genes ubiquitously expressed low levels brain proteins highly expressed neurons glia price et al 1998 knowledge presenilin proteins localize cells important understanding function however uncertainties exist regarding precise subcellular localization neurons endogenous ps1 ps2 localized er vesicular structures somatodentritic compartment axons price et al 1998 haass de strooper 1999 overexpressed proteins predominantly localize er golgi complex nuclear envelope kovacs et al 1996 janicki monteiro 1997 haass de strooper 1999 however nonneuronal cells endogenous presenilins localized er golgi complex centrosomes centromeres cell surface georgakopoulos et al 1999 haass de strooper 1999 raina et al 1999 known extent diverse locations reflect true sites presenilin function
0.49919817.11076969.html.plaintext.txt	16	human presenilin genes ubiquitously expressed low levels brain proteins highly expressed neurons glia price et al 1998 knowledge presenilin proteins localize cells important understanding function however uncertainties exist regarding precise subcellular localization neurons endogenous ps1 ps2 localized er vesicular structures somatodentritic compartment axons price et al 1998 haass de strooper 1999 overexpressed proteins predominantly localize er golgi complex nuclear envelope kovacs et al 1996 janicki monteiro 1997 haass de strooper 1999 however nonneuronal cells endogenous presenilins localized er golgi complex centrosomes centromeres cell surface georgakopoulos et al 1999 haass de strooper 1999 raina et al 1999 known extent diverse locations reflect true sites presenilin function
0.49919817.11076969.html.plaintext.txt	17	presenilin proteins linked several cellular functions interestingly cellular functions compromised altered expression ps genes containing fad mutations presenilin proteins shown play important roles apoptosis calcium homeostasis cell cycle regulation regulation misfolded proteins er cleavage app guo et al 1997 janicki monteiro 1997 janicki monteiro 1999 cotman 1998 mattson et al 1998 haass de strooper 1999 katayama et al 1999 leissring et al 1999 niwa et al 1999 clues regarding presenilin functions emerging growing list proteins presenilin interacts previously identified characterized calmyrin newly discovered calcium binding protein preferentially interacts ps2 loop modulates presenilin induced cell death stabler et al 1999 describe novel human presenilin interacting protein named ubiquilin describe evidence indicates ubiquilin modulates presenilin protein levels associated neuropathological lesions nfts lewy bodies ad pd affected brains
0.49919817.11076969.html.plaintext.txt	18	presenilin proteins linked several cellular functions interestingly cellular functions compromised altered expression ps genes containing fad mutations presenilin proteins shown play important roles apoptosis calcium homeostasis cell cycle regulation regulation misfolded proteins er cleavage app guo et al 1997 janicki monteiro 1997 janicki monteiro 1999 cotman 1998 mattson et al 1998 haass de strooper 1999 katayama et al 1999 leissring et al 1999 niwa et al 1999 clues regarding presenilin functions emerging growing list proteins presenilin interacts previously identified characterized calmyrin newly discovered calcium binding protein preferentially interacts ps2 loop modulates presenilin induced cell death stabler et al 1999 describe novel human presenilin interacting protein named ubiquilin describe evidence indicates ubiquilin modulates presenilin protein levels associated neuropathological lesions nfts lewy bodies ad pd affected brains
0.49919817.11076969.html.plaintext.txt	19	materials methods top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	20	ubiquilin cdna protein sequences genbankemblddbj ubiquilin cdna accession number af176069 ubiquilin protein accession number aad49751 see updated nm013438
0.49919817.11076969.html.plaintext.txt	21	yeast two hybrid experiments yeast two hybrid y2h procedure utilizes lexatransactivation system performed described previously stabler et al 1999 ps2 cooh terminal 39 amino acids residues k410 i448 see fig 1a fig b used bait screen human fetal brain cdna library 107 primary yeast transformants 50 clones selected analysis based growth absence leucine substantial blue color change grown 5 bromo 4 chloro 3 indolyl ss d galactopyranoside x gal plates false positives subsequently eliminated based interactions negative control baits lexa alone nuclear lamin b cenp c centromere protein plasmid dnas isolated clones fulfilled requirements dna sequences inserts determined compared genbankemblddbj databases using blast search program two interactors contained overlapping portions 3 end novel human transcript named ubiquilin interaction ubiquilin proteins various ps1 ps2 baits quantified liquid culture assays enzymatic conversion o nitrophenyl ss d galactopyranoside onpg o nitrophenol d galactose ss galactosidase enzyme encoded y2h reporter plasmid
0.49919817.11076969.html.plaintext.txt	22	rapid amplification cdna ends race 5 race using strategically designed ubiquilin specific primers performed obtain full length coding sequence ubiquilin pcr reactions carried according instructions provided manufacturer using ap1 adaptor ligated human adult brain cdna library template advantage cdna polymerase mix clontech laboratories inc procedure resulted isolation 1053 additional bps 5 sequence respect longest original y2h clone full length ubiquilin open reading frame orf subsequently obtained sequencing human expressed sequence tag est clone american type culture collection provided extra 108 bps 5 sequence including atg start codon kozak consensus sequence upstream frame stop codon addition comparison sequence tigr tentative human consensus database returned another independent est sequence thc296552 corroborated atg start codon
0.49919817.11076969.html.plaintext.txt	23	rapid amplification cdna ends race 5 race using strategically designed ubiquilin specific primers performed obtain full length coding sequence ubiquilin pcr reactions carried according instructions provided manufacturer using ap1 adaptor ligated human adult brain cdna library template advantage cdna polymerase mix clontech laboratories inc procedure resulted isolation 1053 additional bps 5 sequence respect longest original y2h clone full length ubiquilin open reading frame orf subsequently obtained sequencing human expressed sequence tag est clone american type culture collection provided extra 108 bps 5 sequence including atg start codon kozak consensus sequence upstream frame stop codon addition comparison sequence tigr tentative human consensus database returned another independent est sequence thc296552 corroborated atg start codon
0.49919817.11076969.html.plaintext.txt	24	radiation hybrid mapping genebridge 4 radiation hybrid panel research genetics performed two ubiquilin gene specific primers rh1 5 gcagcgacaacttttgtctaaccctg 3 rh2 5 caggcaccaaatttggcgcagtag 3 93 indexed human genomic dna template pools conditions pcr reactions similar 5 race procedure except longer initial denaturation step used positive negative reactions 1 0 respectively 2 represents ambiguous reaction compiled 0100010001 1002100110 0000011000 1011000000 1100000001 0010001001 0100010000 0111100000 1000000000 000 vector data submitted whitehead institutemit center genome research website httpcarbonwimitedu8000cgi bincontigrhmapperpl comparison radiation hybrid database
0.49919817.11076969.html.plaintext.txt	25	radiation hybrid mapping genebridge 4 radiation hybrid panel research genetics performed two ubiquilin gene specific primers rh1 5 gcagcgacaacttttgtctaaccctg 3 rh2 5 caggcaccaaatttggcgcagtag 3 93 indexed human genomic dna template pools conditions pcr reactions similar 5 race procedure except longer initial denaturation step used positive negative reactions 1 0 respectively 2 represents ambiguous reaction compiled 0100010001 1002100110 0000011000 1011000000 1100000001 0010001001 0100010000 0111100000 1000000000 000 vector data submitted whitehead institutemit center genome research website httpcarbonwimitedu8000cgi bincontigrhmapperpl comparison radiation hybrid database
0.49919817.11076969.html.plaintext.txt	26	northern blot analysis cdna hybridization probes 32p radiolabeled random primer labeling 100 ng two ubiquilin cdna restriction fragments x bases 1132 1860 y bases 284 967 shown fig 2 ii probe hybridized different human mrna northern blot human multiple tissue northern blot human brain mtn ii respectively clontech laboratories inc hybridization blots washed twice 20x ssc 005 sds 50 degrees c twice 01x ssc 01 sds 50 degrees c exposure autoradiography film blots subsequently stripped near boiling temperature 05 sds reprobed radiolabeled human ss actin cdna control probe clontech laboratories inc band intensities quantified using gelexpert 97 20 nucleotech corp divided ss actin control band intensity lane normalized lowest value
0.49919817.11076969.html.plaintext.txt	27	northern blot analysis cdna hybridization probes 32p radiolabeled random primer labeling 100 ng two ubiquilin cdna restriction fragments x bases 1132 1860 y bases 284 967 shown fig 2 ii probe hybridized different human mrna northern blot human multiple tissue northern blot human brain mtn ii respectively clontech laboratories inc hybridization blots washed twice 20x ssc 005 sds 50 degrees c twice 01x ssc 01 sds 50 degrees c exposure autoradiography film blots subsequently stripped near boiling temperature 05 sds reprobed radiolabeled human ss actin cdna control probe clontech laboratories inc band intensities quantified using gelexpert 97 20 nucleotech corp divided ss actin control band intensity lane normalized lowest value
0.49919817.11076969.html.plaintext.txt	28	view larger version 40k figure 2 schematic drawings ubiquilin expression constructs full length ubiquilin polypeptide consists 595 residues contains nh2 terminal ub domain speckled cooh terminal uba domain striped several regularly spaced asparagine proline asn pro repeats vertical bars ii probes used human northern blots iii gst fusion constructs n393 s595 aa b q378 s595 aa c q113 m377 aa d q541 s595 aa e d449 s595 aa f d449 l540 aa g n393 l540 aa h m37 s595 aa m37 l540 aa j q113 l540 aa k q113 s595 aa l gst alone ubiquilin portions constructs b isolated original y2h screen bacterially expressed gst fusion b c polypeptides used immunogens anti ubiquilin pab production iv mammalian expression constructs m full length untagged ubiquilin n nh2 terminal gfp tagged ubiquilin fused residue 20 ala o cooh terminal myc epitope tagged ubiquilin
0.49919817.11076969.html.plaintext.txt	29	view larger version 40k figure 2 schematic drawings ubiquilin expression constructs full length ubiquilin polypeptide consists 595 residues contains nh2 terminal ub domain speckled cooh terminal uba domain striped several regularly spaced asparagine proline asn pro repeats vertical bars ii probes used human northern blots iii gst fusion constructs n393 s595 aa b q378 s595 aa c q113 m377 aa d q541 s595 aa e d449 s595 aa f d449 l540 aa g n393 l540 aa h m37 s595 aa m37 l540 aa j q113 l540 aa k q113 s595 aa l gst alone ubiquilin portions constructs b isolated original y2h screen bacterially expressed gst fusion b c polypeptides used immunogens anti ubiquilin pab production iv mammalian expression constructs m full length untagged ubiquilin n nh2 terminal gfp tagged ubiquilin fused residue 20 ala o cooh terminal myc epitope tagged ubiquilin
0.49919817.11076969.html.plaintext.txt	30	bacterial expression ubiquilin proteins express full length nonfusion ubiquilin protein bacteria ncoixhoi cdna fragment containing entire ubiquilin orf subcloned pet 15b novagen transformed escherichia coli bl21de3 ubiquilin protein expression induced 10 mm iptg 37 degrees c 2 3 h bacteria lysed protein extracts separated sds page proteins transferred onto nitrocellulose filters immunoblotted anti ubiquilin pab addition various partial length gst ubiquilin fusion proteins constructed expressed purified using gst protein purification procedures described previously janicki monteiro 1997 specific subregions ubiquilin expressed depicted fig 2 iii
0.49919817.11076969.html.plaintext.txt	31	bacterial expression ubiquilin proteins express full length nonfusion ubiquilin protein bacteria ncoixhoi cdna fragment containing entire ubiquilin orf subcloned pet 15b novagen transformed escherichia coli bl21de3 ubiquilin protein expression induced 10 mm iptg 37 degrees c 2 3 h bacteria lysed protein extracts separated sds page proteins transferred onto nitrocellulose filters immunoblotted anti ubiquilin pab addition various partial length gst ubiquilin fusion proteins constructed expressed purified using gst protein purification procedures described previously janicki monteiro 1997 specific subregions ubiquilin expressed depicted fig 2 iii
0.49919817.11076969.html.plaintext.txt	32	rabbit pab production affinity purification rabbit anti ubiquilin polyclonal antisera generated purified gst ubiquilin fusion proteins b c fig 2 iii covance research products inc affinity purified anti ubiquilin c antibodies obtained passing anti c serum first column containing gst alone coupled ch sepharose 4b beads 4 degrees c overnight eliminate antibodies binding gst mixing flow fraction ubiquilin coupled ch sepharose 4b beads 4 degrees c overnight extensive washing antibodies bound ubiquilin coupled beads eluted dropwise 01 m sodium citrate 03 m sodium chloride solution ph 22 collected 240 microl fractions tubes containing 40 microl 1 m tris hcl ph 91 restore neutral ph
0.49919817.11076969.html.plaintext.txt	33	rabbit pab production affinity purification rabbit anti ubiquilin polyclonal antisera generated purified gst ubiquilin fusion proteins b c fig 2 iii covance research products inc affinity purified anti ubiquilin c antibodies obtained passing anti c serum first column containing gst alone coupled ch sepharose 4b beads 4 degrees c overnight eliminate antibodies binding gst mixing flow fraction ubiquilin coupled ch sepharose 4b beads 4 degrees c overnight extensive washing antibodies bound ubiquilin coupled beads eluted dropwise 01 m sodium citrate 03 m sodium chloride solution ph 22 collected 240 microl fractions tubes containing 40 microl 1 m tris hcl ph 91 restore neutral ph
0.49919817.11076969.html.plaintext.txt	34	vitro transcription translation 35smethionine radiolabeled ubiquilin luciferase proteins synthesized rabbit reticulocyte lysates vitro transcription translation system promega 30 degrees c 90 min 35smethionine radiolabeled ps2 ps1 synthesized using system addition canine pancreatic microsomal membranes promega transcription translation
0.49919817.11076969.html.plaintext.txt	35	vitro transcription translation 35smethionine radiolabeled ubiquilin luciferase proteins synthesized rabbit reticulocyte lysates vitro transcription translation system promega 30 degrees c 90 min 35smethionine radiolabeled ps2 ps1 synthesized using system addition canine pancreatic microsomal membranes promega transcription translation
0.49919817.11076969.html.plaintext.txt	36	gst pull binding assay various purified gst ubiquilin fusion proteins already bound glutathione agarose beads incubated 25 microl 35smethionine radiolabeled presenilin protein addition protease inhibitors 08 bsa 4 degrees c 1 h rocking beads washed several times pull buffer 05 np 40 10x pbs 200 mm kcl pull buffer several times pull buffer alone supernatants washes discarded whereas bound proteins beads mixed sample loading buffer janicki monteiro 1999 separated sds page gel stained coomassie blue ensure equal loading gst ubiquilin fusion proteins gels dried exposed autoradiography film
0.49919817.11076969.html.plaintext.txt	37	gst pull binding assay various purified gst ubiquilin fusion proteins already bound glutathione agarose beads incubated 25 microl 35smethionine radiolabeled presenilin protein addition protease inhibitors 08 bsa 4 degrees c 1 h rocking beads washed several times pull buffer 05 np 40 10x pbs 200 mm kcl pull buffer several times pull buffer alone supernatants washes discarded whereas bound proteins beads mixed sample loading buffer janicki monteiro 1999 separated sds page gel stained coomassie blue ensure equal loading gst ubiquilin fusion proteins gels dried exposed autoradiography film
0.49919817.11076969.html.plaintext.txt	38	mammalian expression fusion constructs full length ubiquilin expressed using pgem cmv mammalian expression vector janicki monteiro 1997 see fig 2 iv addition two ubiquilin fusion proteins constructed within expression vector one green fluorescent protein gfp fused nh2 terminus ubiquilin beginning residue 20 ala whereas myc epitope tag fused cooh terminus full length ubiquilin
0.49919817.11076969.html.plaintext.txt	39	mammalian expression fusion constructs full length ubiquilin expressed using pgem cmv mammalian expression vector janicki monteiro 1997 see fig 2 iv addition two ubiquilin fusion proteins constructed within expression vector one green fluorescent protein gfp fused nh2 terminus ubiquilin beginning residue 20 ala whereas myc epitope tag fused cooh terminus full length ubiquilin
0.49919817.11076969.html.plaintext.txt	40	hela cell culture dna transfection hela cells grown 37 degrees c dme supplemented 10 fbs transfected plasmid dnas using calcium phosphate coprecipitation method
0.49919817.11076969.html.plaintext.txt	41	western blot analysis cells lysed buffer containing protease inhibitors monteiro mical 1996 protein concentrations determined bicinchonic acid bca assay lysates containing known amounts protein mixed sample loading buffer janicki monteiro 1999 either heated 100 degrees c 5 min 37 degrees c 15 min separation sds page 37 degrees c incubation used detect presenilin proteins minimizing tendency aggregate resist entry gels gel electrophoresis proteins transferred onto nitrocellulose filters immunoblotted according procedures described previously janicki monteiro 1997 addition rabbit anti ubiquilin antibodies also used following primary antibodies goat anti ps1 anti ps2 anti bip nh2 terminus specific santa cruz biotechnology inc rabbit anti ps2 nh2 terminus loop specific raised corresponding gst ps2 fusion proteins janicki monteiro 1997 janicki monteiro 1999 anti ubiquitin dako anti lamin ac mical monteiro 1998 anti calnexin anti calreticulin stressgen mouse anti gfp zymed laboratories anti tubulin sigma aldrich anti lamin b matritect binding primary antibodies detected 125i protein incubation appropriate secondary horseradish peroxidase conjugated antibodies new england biolabs inc using autoradiography chemiluminescence respectively
0.49919817.11076969.html.plaintext.txt	42	western blot analysis cells lysed buffer containing protease inhibitors monteiro mical 1996 protein concentrations determined bicinchonic acid bca assay lysates containing known amounts protein mixed sample loading buffer janicki monteiro 1999 either heated 100 degrees c 5 min 37 degrees c 15 min separation sds page 37 degrees c incubation used detect presenilin proteins minimizing tendency aggregate resist entry gels gel electrophoresis proteins transferred onto nitrocellulose filters immunoblotted according procedures described previously janicki monteiro 1997 addition rabbit anti ubiquilin antibodies also used following primary antibodies goat anti ps1 anti ps2 anti bip nh2 terminus specific santa cruz biotechnology inc rabbit anti ps2 nh2 terminus loop specific raised corresponding gst ps2 fusion proteins janicki monteiro 1997 janicki monteiro 1999 anti ubiquitin dako anti lamin ac mical monteiro 1998 anti calnexin anti calreticulin stressgen mouse anti gfp zymed laboratories anti tubulin sigma aldrich anti lamin b matritect binding primary antibodies detected 125i protein incubation appropriate secondary horseradish peroxidase conjugated antibodies new england biolabs inc using autoradiography chemiluminescence respectively
0.49919817.11076969.html.plaintext.txt	43	immunoprecipitation cell fractionation studies hela cells 17 h transfection ps2 plasmid dna collected immunoprecipitation buffer 50 mm tris hcl ph 75 150 mm nacl 05 np 40 2 mm edta homogenized gentle strokes dounce homogenizer centrifugation pellet discarded proteins immunoprecipitated remaining supernatant adding rabbit antisera preimmune anti ps2 nh2 terminus anti ps2 loop protein sepharose cl 4b beads stabler et al 1999 beads recovered centrifugation washed 05 np 40 10x pbs boiled sample loading buffer bound proteins analyzed sds page immunoblotting blots probed primary anti ubiquilin b antibodies subsequently detected 125i protein soluble insoluble triton x 100 soluble triton x 100 insoluble protein fractions untransfected ps2 transfected hela cells prepared according procedure described previously stabler et al 1999 equal amounts fraction separated sds page electroblot transfer nitrocellulose filters immunoblotted either affinity purified anti ubiquilin c antibody anti ps2 nh2 terminus antibody anti lamin ac antibody mical monteiro 1998 partitioning endogenous lamin ac proteins monitored since cell fractionation behavior known mical monteiro 1998 stabler et al 1999
0.49919817.11076969.html.plaintext.txt	44	cell staining immunofluorescence microscopy procedure used immunofluorescence staining hela cells described previously janicki monteiro 1997 indirect immunofluorescent microscopy digital image capture subsequent manipulation merging images done leica dm irb microscope attached powermac computer running signal analytics iplab spectrum software stabler et al 1999 confocal images captured axiovert 100 microscope using lsm software zeiss primary antibodies used rabbit anti ubiquilin b affinity purified anti ubiquilin c goat anti ps1 anti ps2 nh2 terminus specific santa cruz biotechnology inc mouse anti myc mical monteiro 1998
0.49919817.11076969.html.plaintext.txt	45	cell staining immunofluorescence microscopy procedure used immunofluorescence staining hela cells described previously janicki monteiro 1997 indirect immunofluorescent microscopy digital image capture subsequent manipulation merging images done leica dm irb microscope attached powermac computer running signal analytics iplab spectrum software stabler et al 1999 confocal images captured axiovert 100 microscope using lsm software zeiss primary antibodies used rabbit anti ubiquilin b affinity purified anti ubiquilin c goat anti ps1 anti ps2 nh2 terminus specific santa cruz biotechnology inc mouse anti myc mical monteiro 1998
0.49919817.11076969.html.plaintext.txt	46	human brain immunohistochemistry hippocampus brain tissue six ad cases aged 77 95 five control cases aged 19 71 fixed methacarn 631 chloroformmethanolacetic acid overnight locus coreuleus substantia nigra brain tissue three pd cases aged 53 66 fixed formalin overnight whereas frontal cortex brain tissue two cases diffuse lewy body disease aged 49 85 fixed either formalin methacarn overnight samples dehydrated embedded paraffin sections cut 6 microm thick mounted onto glass slides deparaffinization xylene sections hydrated graded ethanol treatment endogenous peroxidase activity eliminated incubation 3 hydrogen peroxide 30 min nonspecific binding sites blocked 10 normal goat serum tris buffered saline 50 mm tris hcl 150 mm nacl ph 76 30 min application either preimmune sera affinity purified anti ubiquilin c antibody anti ubiquilin b antibody immunostaining performed using peroxidase anti peroxidase method dab cosubstrate sternberger 1986 color images stained slides captured using sony digital photo camera dkc 5000 nikon eclipse e600 microscope using adobe photoshop software
0.49919817.11076969.html.plaintext.txt	47	human brain immunohistochemistry hippocampus brain tissue six ad cases aged 77 95 five control cases aged 19 71 fixed methacarn 631 chloroformmethanolacetic acid overnight locus coreuleus substantia nigra brain tissue three pd cases aged 53 66 fixed formalin overnight whereas frontal cortex brain tissue two cases diffuse lewy body disease aged 49 85 fixed either formalin methacarn overnight samples dehydrated embedded paraffin sections cut 6 microm thick mounted onto glass slides deparaffinization xylene sections hydrated graded ethanol treatment endogenous peroxidase activity eliminated incubation 3 hydrogen peroxide 30 min nonspecific binding sites blocked 10 normal goat serum tris buffered saline 50 mm tris hcl 150 mm nacl ph 76 30 min application either preimmune sera affinity purified anti ubiquilin c antibody anti ubiquilin b antibody immunostaining performed using peroxidase anti peroxidase method dab cosubstrate sternberger 1986 color images stained slides captured using sony digital photo camera dkc 5000 nikon eclipse e600 microscope using adobe photoshop software
0.49919817.11076969.html.plaintext.txt	48	protein accumulation studies hela cells transfected expression constructs encoding ubiquilin protein 15 microg plasmid dna ps2 protein 7 microg plasmid dna 12 h transfection cells incubated additional 5 6 h dmefbs media absence presence proteasome inhibitors 20 microm synthetic lactacystin 40 microm mg 132 calbiochem novabiochemcalbiochem novabiochem afterwards cells lysed buffer containing protease inhibitors protein concentrations determined protein extracts totaling 100 microg loaded per lane separated sds page immunodetected various antibodies follow experiment hela cells cotransfected constant amount ps2 7 microg plasmid dna increasing amounts either ubiquilin 0 1 2 3 4 microg plasmid dna gfp 0 1 2 3 4 microg plasmid dna expression vectors
0.49919817.11076969.html.plaintext.txt	49	protein accumulation studies hela cells transfected expression constructs encoding ubiquilin protein 15 microg plasmid dna ps2 protein 7 microg plasmid dna 12 h transfection cells incubated additional 5 6 h dmefbs media absence presence proteasome inhibitors 20 microm synthetic lactacystin 40 microm mg 132 calbiochem novabiochemcalbiochem novabiochem afterwards cells lysed buffer containing protease inhibitors protein concentrations determined protein extracts totaling 100 microg loaded per lane separated sds page immunodetected various antibodies follow experiment hela cells cotransfected constant amount ps2 7 microg plasmid dna increasing amounts either ubiquilin 0 1 2 3 4 microg plasmid dna gfp 0 1 2 3 4 microg plasmid dna expression vectors
0.49919817.11076969.html.plaintext.txt	50	pulse chase experiments exponentially growing hela cells maintained flasks trypsinized resuspended density 268 x 106 cellsml opti mem medium gibco brl two 05 ml aliquots cell suspension electroporated mixture either 7 microg ps2 15 microg egfp c1 clontech laboratories inc expression plasmid dna 7 microg ps2 15 microg ubiquilin expression plasmid dna aliquots containing dna mixture combined resuspended 28 ml optimem medium containing 10 fbs 2 ml suspension plated 14 separate wells 95 cm2 cells incubated 7 h allow attachment dishes medium removed replaced dme containing 10 fbs incubation continued additional 14 h cells starved 45 min methionine deficient dme containing 10 dialyzed fbs medium removed cells well pulse labeled adding 1 ml methionine deficient medium containing 150 microci 35smethionine 1000 cimmol amersham pharmacia biotech 1 h labeling cells washed twice dme containing 1 mm nonradioactive l methionine 10 dialyzed fbs chased 2 ml medium 0 6 h appropriate time intervals cells washed three times ice cold 10x pbs lysed buffer containing protease inhibitors monteiro mical 1996 lysates diluted 10 fold immunoprecipitation buffer ps2 proteins immunoprecipitated done addition 5 microl rabbit anti loop ps2 antibody directed gst ps2 loop purified protein janicki monteiro 1997 100 microl slurry protein sepharose amersham pharmacia biotech immunoprecipitated proteins attached sepharose beads eluted incubation protein sample loading buffer lacking sds contained 8 m urea 10 mm dtt 10 ss mercaptoethanol janicki monteiro 1999 37 degrees c 15 min entire volume samples separated sds page 85 gels electrophoresis gel stained coomassie blue impregnated 25 diphenyloxazole dried stabler et al 1999 radioactivity immunoprecipitated ps2 band lane corresponding full length ps2 protein quantified using molecular dynamics storm 840 phosphoimager using imagequant software molecular dynamics
0.49919817.11076969.html.plaintext.txt	51	pulse chase experiments exponentially growing hela cells maintained flasks trypsinized resuspended density 268 x 106 cellsml opti mem medium gibco brl two 05 ml aliquots cell suspension electroporated mixture either 7 microg ps2 15 microg egfp c1 clontech laboratories inc expression plasmid dna 7 microg ps2 15 microg ubiquilin expression plasmid dna aliquots containing dna mixture combined resuspended 28 ml optimem medium containing 10 fbs 2 ml suspension plated 14 separate wells 95 cm2 cells incubated 7 h allow attachment dishes medium removed replaced dme containing 10 fbs incubation continued additional 14 h cells starved 45 min methionine deficient dme containing 10 dialyzed fbs medium removed cells well pulse labeled adding 1 ml methionine deficient medium containing 150 microci 35smethionine 1000 cimmol amersham pharmacia biotech 1 h labeling cells washed twice dme containing 1 mm nonradioactive l methionine 10 dialyzed fbs chased 2 ml medium 0 6 h appropriate time intervals cells washed three times ice cold 10x pbs lysed buffer containing protease inhibitors monteiro mical 1996 lysates diluted 10 fold immunoprecipitation buffer ps2 proteins immunoprecipitated done addition 5 microl rabbit anti loop ps2 antibody directed gst ps2 loop purified protein janicki monteiro 1997 100 microl slurry protein sepharose amersham pharmacia biotech immunoprecipitated proteins attached sepharose beads eluted incubation protein sample loading buffer lacking sds contained 8 m urea 10 mm dtt 10 ss mercaptoethanol janicki monteiro 1999 37 degrees c 15 min entire volume samples separated sds page 85 gels electrophoresis gel stained coomassie blue impregnated 25 diphenyloxazole dried stabler et al 1999 radioactivity immunoprecipitated ps2 band lane corresponding full length ps2 protein quantified using molecular dynamics storm 840 phosphoimager using imagequant software molecular dynamics
0.49919817.11076969.html.plaintext.txt	52	half life endogenous hela ubiquilin protein estimated pulse labeling mock electroporated hela cells 1 h 100 microci 35smethionine followed chase nonradioactive medium 0 21 h ubiquilin protein immunoprecipitated using 5 microl rabbit anti ubiquilin c antibody amount radioactivity incorporated ubiquilin bands determined sds page phosphoimage analysis
0.49919817.11076969.html.plaintext.txt	53	half life endogenous hela ubiquilin protein estimated pulse labeling mock electroporated hela cells 1 h 100 microci 35smethionine followed chase nonradioactive medium 0 21 h ubiquilin protein immunoprecipitated using 5 microl rabbit anti ubiquilin c antibody amount radioactivity incorporated ubiquilin bands determined sds page phosphoimage analysis
0.49919817.11076969.html.plaintext.txt	54	results top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	55	identification human ubiquilin novel interactor presenilin proteins novel human protein named ubiquilin protein ubiquitin related protein domains interacts presenilins identified yeast two hybrid screen y2h proteins interact ps2 cooh terminal sequence fig 1a fig b two overlapping clones encoding cooh terminal 203 218 residues ubiquilin isolated screen clone entire ubiquilin orf 5 race performed yielded 1053 bps additional upstream sequence including frame methionine codon located beginning ubiquitin like ub domain conceptual translation methionine predicted 559 amino acid protein however methionine unlikely authentic start codon since translation produced protein noticeably smaller seen sds page endogenous ubiquilin detected using pab raised cooh terminal 218 residues ubiquilin data shown subsequent est database searches sequencing putative overlapping clones yielded clone longer 5 end included upstream frame methionine codon corresponding 595 amino acid protein several lines evidence indicate methionine codon authentic start methionine ubiquilin start methionine contained kozak consensus sequence upstream frame stop codon b polypeptides translated start codon matched endogenous ubiquilin protein size 66 kd hela human cell types c mammalian overexpression complete ubiquilin orf see fig 3 d f vitro transcribed translated ubiquilin rabbit reticulocyte lysates see fig 3 g human ubiquilin protein synthesized bacteria see fig 3 h generated 66 kd proteins data indicated cloned complete ubiquilin orf protein probably extensively modified mammalian cells since bacterially eukaryotically expressed human ubiquilin proteins similar molecular masses separated sds page
0.49919817.11076969.html.plaintext.txt	56	identification human ubiquilin novel interactor presenilin proteins novel human protein named ubiquilin protein ubiquitin related protein domains interacts presenilins identified yeast two hybrid screen y2h proteins interact ps2 cooh terminal sequence fig 1a fig b two overlapping clones encoding cooh terminal 203 218 residues ubiquilin isolated screen clone entire ubiquilin orf 5 race performed yielded 1053 bps additional upstream sequence including frame methionine codon located beginning ubiquitin like ub domain conceptual translation methionine predicted 559 amino acid protein however methionine unlikely authentic start codon since translation produced protein noticeably smaller seen sds page endogenous ubiquilin detected using pab raised cooh terminal 218 residues ubiquilin data shown subsequent est database searches sequencing putative overlapping clones yielded clone longer 5 end included upstream frame methionine codon corresponding 595 amino acid protein several lines evidence indicate methionine codon authentic start methionine ubiquilin start methionine contained kozak consensus sequence upstream frame stop codon b polypeptides translated start codon matched endogenous ubiquilin protein size 66 kd hela human cell types c mammalian overexpression complete ubiquilin orf see fig 3 d f vitro transcribed translated ubiquilin rabbit reticulocyte lysates see fig 3 g human ubiquilin protein synthesized bacteria see fig 3 h generated 66 kd proteins data indicated cloned complete ubiquilin orf protein probably extensively modified mammalian cells since bacterially eukaryotically expressed human ubiquilin proteins similar molecular masses separated sds page
0.49919817.11076969.html.plaintext.txt	57	view larger version 64k figure 3 ubiquilin mrna protein expression human multiple tissue analyzed northern blot probed ubiquilin cdna fragment x fig 2 ii stripping blot reprobed ss actin control fragment shown b northern blot specific regions human brain probed ubiquilin cdna fragment y fig 2 ii reprobe ss actin shown c quantification ubiquilin mrna expression levels relative expression ubiquilin different tissues determined densitometric analysis autoradiographs relating ubiquilin band intensities levels ss actin hybridization lanes values presented normalization skeletal muscle spinal cord d f characterization anti ubiquilin antibodies rabbit antibodies raised gst ubiquilin fusion proteins b c generating anti ubiquilin b anti ubiquilin c antibodies respectively d anti ubiquilin b antibody used detect overexpressed endogenous ubiquilin ubiquilin transfected mock transfected untransfected endogenous hela cells anti ubiquilin b antibody detected 66 kd doublet band whereas preimmune sera e anti ubiquilin c antibody also recognized 66 kd band untransfected hela lysates varying extents 55 kd band hela cells transfected gfp ubiquilin fig 2 iv n contain additional 93 kd reactive band due fusion 27 kd moiety gfp ubiquilin f affinity purified anti ubiquilin c antibody specifically reacts 66 kd band transfected hela cell lysates g full length vitro transcribed translated 35smethionine radiolabeled human ubiquilin polypeptides migrated 66 kd whereas radiolabeled luciferase migrated 61 kd h uninduced iptg induced lysates bacteria transformed untagged full length human ubiquilin probed anti ubiquilin b antibodies full length immunoreactive ubiquilin 66 kd series smaller breakdown products seen induced lysate
0.49919817.11076969.html.plaintext.txt	58	view larger version 64k figure 3 ubiquilin mrna protein expression human multiple tissue analyzed northern blot probed ubiquilin cdna fragment x fig 2 ii stripping blot reprobed ss actin control fragment shown b northern blot specific regions human brain probed ubiquilin cdna fragment y fig 2 ii reprobe ss actin shown c quantification ubiquilin mrna expression levels relative expression ubiquilin different tissues determined densitometric analysis autoradiographs relating ubiquilin band intensities levels ss actin hybridization lanes values presented normalization skeletal muscle spinal cord d f characterization anti ubiquilin antibodies rabbit antibodies raised gst ubiquilin fusion proteins b c generating anti ubiquilin b anti ubiquilin c antibodies respectively d anti ubiquilin b antibody used detect overexpressed endogenous ubiquilin ubiquilin transfected mock transfected untransfected endogenous hela cells anti ubiquilin b antibody detected 66 kd doublet band whereas preimmune sera e anti ubiquilin c antibody also recognized 66 kd band untransfected hela lysates varying extents 55 kd band hela cells transfected gfp ubiquilin fig 2 iv n contain additional 93 kd reactive band due fusion 27 kd moiety gfp ubiquilin f affinity purified anti ubiquilin c antibody specifically reacts 66 kd band transfected hela cell lysates g full length vitro transcribed translated 35smethionine radiolabeled human ubiquilin polypeptides migrated 66 kd whereas radiolabeled luciferase migrated 61 kd h uninduced iptg induced lysates bacteria transformed untagged full length human ubiquilin probed anti ubiquilin b antibodies full length immunoreactive ubiquilin 66 kd series smaller breakdown products seen induced lysate
0.49919817.11076969.html.plaintext.txt	59	interaction ubiquilin presenilins quantified y2h ss galactosidase liquid culture assays partial ubiquilin clone encoding cooh terminal 218 residues isolated y2h screen near full length clone encoding residues 37 595 bound ps2 cooh terminal bait 55 fold compared negative control baits fig 1c fig d respectively however longer ubiquilin clone interacted less strongly ps1 cooh terminal bait interaction nevertheless still 12 fold compared negative control baits fig 1 d also tested whether ubiquilin would interact portions loop regions presenilins fig 1a fig b used another y2h study stabler et al 1999 interestingly near full length ubiquilin construct also interacted well ps2 ps1 loop sequences surprisingly interaction approximately twice strong ps2 cooh terminal bait fig 1 d suggested two separate regions within presenilin proteins could interact ubiquilin
0.49919817.11076969.html.plaintext.txt	60	interaction ubiquilin presenilins quantified y2h ss galactosidase liquid culture assays partial ubiquilin clone encoding cooh terminal 218 residues isolated y2h screen near full length clone encoding residues 37 595 bound ps2 cooh terminal bait 55 fold compared negative control baits fig 1c fig d respectively however longer ubiquilin clone interacted less strongly ps1 cooh terminal bait interaction nevertheless still 12 fold compared negative control baits fig 1 d also tested whether ubiquilin would interact portions loop regions presenilins fig 1a fig b used another y2h study stabler et al 1999 interestingly near full length ubiquilin construct also interacted well ps2 ps1 loop sequences surprisingly interaction approximately twice strong ps2 cooh terminal bait fig 1 d suggested two separate regions within presenilin proteins could interact ubiquilin
0.49919817.11076969.html.plaintext.txt	61	gene ubiquilin located chromosome 9q22 widely expressed northern blot analysis human tissues indicated ubiquilin mrna widely expressed major 44 kb transcript several smaller differentially expressed minor transcripts fig 2 ii x fig 3 comparison ubiquilin band intensities correction mrna loading ss actin control bands normalized skeletal muscle value suggested expression 44 kb transcript highest brain pancreas fig 3 c additional northern blot analysis mrna different subregions human brain revealed slight variation 10 15 fold ubiquilin expression 44 kb transcript predominant species fig 2 ii y fig 3b fig c
0.49919817.11076969.html.plaintext.txt	62	gene ubiquilin located chromosome 9q22 widely expressed northern blot analysis human tissues indicated ubiquilin mrna widely expressed major 44 kb transcript several smaller differentially expressed minor transcripts fig 2 ii x fig 3 comparison ubiquilin band intensities correction mrna loading ss actin control bands normalized skeletal muscle value suggested expression 44 kb transcript highest brain pancreas fig 3 c additional northern blot analysis mrna different subregions human brain revealed slight variation 10 15 fold ubiquilin expression 44 kb transcript predominant species fig 2 ii y fig 3b fig c
0.49919817.11076969.html.plaintext.txt	63	determined chromosomal location ubiquilin gene using pcr radiation hybrid mapping see materials methods data shown procedure resulted unambiguous assignment ubiquilin nearby two loci chlcgata22h04 chlcgata81c04 located chromosome 9q22 close 9q213 border interestingly chromosome region ubiquilin maps thought contain susceptibility genes involved late onset ad kehoe et al 1999
0.49919817.11076969.html.plaintext.txt	64	determined chromosomal location ubiquilin gene using pcr radiation hybrid mapping see materials methods data shown procedure resulted unambiguous assignment ubiquilin nearby two loci chlcgata22h04 chlcgata81c04 located chromosome 9q22 close 9q213 border interestingly chromosome region ubiquilin maps thought contain susceptibility genes involved late onset ad kehoe et al 1999
0.49919817.11076969.html.plaintext.txt	65	ubiquilin contains ubiquitin related protein domains member highly conserved gene family complete ubiquilin orf consists 595 residues sequence rich glutamines serines 109 111 respectively lacking cysteines fig 4 protein calculated isoelectric point pi 497 predicted soluble based high hydrophilic profile using macvector 65 software oxford molecular group data shown currently known protein structural motifs residing within ubiquilin include nh2 terminal ub domain cooh terminal ubiquitin associated uba domain implicated targeting degradation proteins ubiquitin proteasome pathway predicted ubiquilin protein also contains numerous regularly spaced asparagine proline asn pro repeats unknown function fig 4 first sequenced apparent mammalian homologue ubiquilin deposited genbankemblddbj databases however significant homology several full length genes unknown function c elegans f15c112 gene 36 identical two related genes arabidopsis thaliana 34 35 identical addition protein weak homology saccharomyces cerevisiae dsk2 gene 31 identical suppress kar1 defect biggins et al 1996 kar1 essential gene involved duplication yeast microtubule organizing center known spindle pole body interestingly ubiquilin homology dsk2 primarily confined ub uba domains however since ub uba domains present many proteins uncertain whether ubiquilin dsk2 true orthologs
0.49919817.11076969.html.plaintext.txt	66	view larger version 140k figure 4 ubiquilin shares significant homology several proteins inferred amino acid sequence human ubiquilin orf homology several related proteins homo sapiens chap1 protein involved binding hsp70 like stch protein mus musculus plic 1 plic 2 proteins involved linking integrins vimentin x laevis xdrp1 protein binds cyclin c elegans f15c112 two thaliana proteins proteins unknown functions cerevisiae dsk2 involved spindle pole body duplication identical residues darkly shaded whereas similar residues lightly shaded homology five sequences shown proteins contain ub domains square box uba domains rounded box extremely well conserved sequence addition central region ub uba domains contain several asparagine proline repeats either regularly spaced apart closed circles located elsewhere throughout protein open circles high overall homology proteins suggests belong multigene family
0.49919817.11076969.html.plaintext.txt	67	view larger version 140k figure 4 ubiquilin shares significant homology several proteins inferred amino acid sequence human ubiquilin orf homology several related proteins homo sapiens chap1 protein involved binding hsp70 like stch protein mus musculus plic 1 plic 2 proteins involved linking integrins vimentin x laevis xdrp1 protein binds cyclin c elegans f15c112 two thaliana proteins proteins unknown functions cerevisiae dsk2 involved spindle pole body duplication identical residues darkly shaded whereas similar residues lightly shaded homology five sequences shown proteins contain ub domains square box uba domains rounded box extremely well conserved sequence addition central region ub uba domains contain several asparagine proline repeats either regularly spaced apart closed circles located elsewhere throughout protein open circles high overall homology proteins suggests belong multigene family
0.49919817.11076969.html.plaintext.txt	68	time ubiquilin sequence deposited genbankemblddbj xenopus laevis protein involved inhibiting cyclin protein degradation called xdrp1 60 identity ubiquilin submitted funakoshi et al 1999 since two mus musculus proteins thought interlink integrin associated proteins vimentin cytoskeleton called plic 1 plic 2 84 69 identical respectively wu et al 1999 human chap1 protein renamed ubiquilin 2 79 identical binds hsp70 like stch complement dsk2 yeast mutant kaye et al 2000 described high degree homology among protein sequences seen aligned macvector 65 clustalw protein alignment program fig 4 comparison revealed human mouse xenopus sequences closely related one another c elegans thaliana cerevisiae sequences would expected higher eukaryotes former group proteins shared extensive homology across entire length ubiquilin polypeptide four regions highest homology include ub uba domains two stretches rich asn pro repeats residues g157 p326 p375 p482 located two ubiquitin related domains differences divergent regions instructive especially insert residues l485 t527 chap1 conserved plic 2 missing ubiquilin plic 1 xdrp1 based homology human mouse sequences appears ubiquilin closely related plic 1 whereas chap1 closely related plic 2 collectively proteins likely members related multigene family since least two independent genes known exist humans mice thaliana
0.49919817.11076969.html.plaintext.txt	69	evidence ubiquilin protein directly binds ps1 ps2 gst fusion proteins containing uba domain nine cooh terminal residues qhhssisvs ubiquilin necessary sufficient bind 35smethionine radiolabeled ps2 ps1 gst pull assay fig 5a fig b respectively interestingly slower migrating forms presenilins much tightly bound full length forms whether slower migrating forms ubiquitinated extensively modified merely hydrophobic aggregates known expected gst alone fig 5a fig b lane l bind either presenilin region ubiquilin tested able pull either presenilins indicating binding presenilin ubiquilin mediated sequences spanning uba domain cooh terminal tail vitro binding assay results consistent interaction data ubiquilin recovered y2h screen
0.49919817.11076969.html.plaintext.txt	70	evidence ubiquilin protein directly binds ps1 ps2 gst fusion proteins containing uba domain nine cooh terminal residues qhhssisvs ubiquilin necessary sufficient bind 35smethionine radiolabeled ps2 ps1 gst pull assay fig 5a fig b respectively interestingly slower migrating forms presenilins much tightly bound full length forms whether slower migrating forms ubiquitinated extensively modified merely hydrophobic aggregates known expected gst alone fig 5a fig b lane l bind either presenilin region ubiquilin tested able pull either presenilins indicating binding presenilin ubiquilin mediated sequences spanning uba domain cooh terminal tail vitro binding assay results consistent interaction data ubiquilin recovered y2h screen
0.49919817.11076969.html.plaintext.txt	71	view larger version 65k figure 5 ubiquilin binds presenilins vitro b gst pull experiments full length vitro synthesized 35s labeled ps2 ps1 first lanes migrated sds page gels broad bands 54 48 kd arrowheads respectively along smear slower migrating forms presumably due highly hydrophobic nature proteins 35sps complexes especially slower migrating forms retained gst ubiquilin constructs containing uba domain lane letters correspond constructs shown fig 2 iii lacking domain gst alone c immunoprecipitation experiments ps2 transfected hela cell lysates immunoprecipitated preimmune sera corresponding anti ps2 loop antibody anti ps2 nh2 terminus antibody separation sds page coprecipitating ubiquilin arrowhead detected immunoblotting anti ubiquilin b antibody d f cell fractionation experiments parallel immunoblots equal portions soluble supernatant insoluble pellet p hela cellular fractions prepared without use detergent presence 1 triton x 100 d f anti ubiquilin e anti ps2 antibodies hela cells used cell fractionation d untransfected whereas e f cells transfected full length wild type ps2 construct relative ratio ubiquilin protein p compared fractions determined densitometric analysis autoradiographs analysis indicated transfection presenilin caused 30 f ubiquilin protein partition pellet fraction absence detergent compared d untransfected cells partitioning lamin ac proteins cell fractionation untransfected ps2 transfected cells monitored anti lamin ac antibodies shown d f respectively
0.49919817.11076969.html.plaintext.txt	72	view larger version 65k figure 5 ubiquilin binds presenilins vitro b gst pull experiments full length vitro synthesized 35s labeled ps2 ps1 first lanes migrated sds page gels broad bands 54 48 kd arrowheads respectively along smear slower migrating forms presumably due highly hydrophobic nature proteins 35sps complexes especially slower migrating forms retained gst ubiquilin constructs containing uba domain lane letters correspond constructs shown fig 2 iii lacking domain gst alone c immunoprecipitation experiments ps2 transfected hela cell lysates immunoprecipitated preimmune sera corresponding anti ps2 loop antibody anti ps2 nh2 terminus antibody separation sds page coprecipitating ubiquilin arrowhead detected immunoblotting anti ubiquilin b antibody d f cell fractionation experiments parallel immunoblots equal portions soluble supernatant insoluble pellet p hela cellular fractions prepared without use detergent presence 1 triton x 100 d f anti ubiquilin e anti ps2 antibodies hela cells used cell fractionation d untransfected whereas e f cells transfected full length wild type ps2 construct relative ratio ubiquilin protein p compared fractions determined densitometric analysis autoradiographs analysis indicated transfection presenilin caused 30 f ubiquilin protein partition pellet fraction absence detergent compared d untransfected cells partitioning lamin ac proteins cell fractionation untransfected ps2 transfected cells monitored anti lamin ac antibodies shown d f respectively
0.49919817.11076969.html.plaintext.txt	73	support vitro binding data coimmunoprecipitation cell fractionation experiments ps2 endogenous ubiquilin also performed ps2 transfected hela cell extracts immunoprecipitated two different anti ps2 specific antibodies separated sds page immunoblotted anti ubiquilin b antibodies ubiquilin protein coimmunoprecipitated anti ps2 antibodies one raised loop nh2 terminal sequences coimmunoprecipitate preimmune sera used fig 5 c additional verification ubiquilin binding ps2 obtained cell fractionation studies untransfected ps2 transfected hela cells fractionated either absence presence triton x 100 detergent soluble insoluble fractions equivalent amounts fractions immunoblotted determine amount ubiquilin protein two fractions untransfected cells almost ubiquilin protein present soluble fraction independent detergent treatment fig 5 d lanes consistent predicted hydrophilic nature ubiquilin protein however ps2 transfected cells 30 ubiquilin protein separated pellet fraction absence detergent treatment fig 5 f lane p change solubility likely consequence ubiquilin binding overexpressed membrane bound ps2 also fractionated insoluble membrane containing pellet fraction fig 5 e lane p expected integral membrane proteins triton x 100 treatment caused release ps2 soluble fraction fig 5 e lane coincided ubiquilin separating completely soluble fraction fig 5 f lane
0.49919817.11076969.html.plaintext.txt	74	support vitro binding data coimmunoprecipitation cell fractionation experiments ps2 endogenous ubiquilin also performed ps2 transfected hela cell extracts immunoprecipitated two different anti ps2 specific antibodies separated sds page immunoblotted anti ubiquilin b antibodies ubiquilin protein coimmunoprecipitated anti ps2 antibodies one raised loop nh2 terminal sequences coimmunoprecipitate preimmune sera used fig 5 c additional verification ubiquilin binding ps2 obtained cell fractionation studies untransfected ps2 transfected hela cells fractionated either absence presence triton x 100 detergent soluble insoluble fractions equivalent amounts fractions immunoblotted determine amount ubiquilin protein two fractions untransfected cells almost ubiquilin protein present soluble fraction independent detergent treatment fig 5 d lanes consistent predicted hydrophilic nature ubiquilin protein however ps2 transfected cells 30 ubiquilin protein separated pellet fraction absence detergent treatment fig 5 f lane p change solubility likely consequence ubiquilin binding overexpressed membrane bound ps2 also fractionated insoluble membrane containing pellet fraction fig 5 e lane p expected integral membrane proteins triton x 100 treatment caused release ps2 soluble fraction fig 5 e lane coincided ubiquilin separating completely soluble fraction fig 5 f lane
0.49919817.11076969.html.plaintext.txt	75	ubiquilin localizes nucleus cytoplasm determine intracellular distribution ubiquilin used rabbit pab generated two different gst ubiquilin fusion proteins see materials methods antisera detected endogenous overexpressed 66 kd ubiquilin polypeptides detected preimmune sera fig 3 d although one antiserum reacted unknown protein 55 kd fig 3 e reactivity subsequently removed affinity purification antibody fig 3 f immunofluorescence staining ubiquilin within cells performed specific anti ubiquilin antibodies compared preimmune sera fig 6a fig d antibodies revealed similar staining patterns fig 6b fig e indirect immunofluorescence well laser confocal microscopy revealed endogenous intracellular localization ubiquilin hela cells nucleus cytoplasm fig 6b fig e fig g cells endogenous ubiquilin staining stronger nucleus fig 6 e arrowheads furthermore small subset cells ubiquilin within cytoplasm localized punctate structures fig 6b fig e arrows frequency structures dramatically increased upon overexpression full length untagged ubiquilin fig 6c fig f corroborate anti ubiquilin staining pattern performed additional localization studies myc gfp tagged ubiquilin proteins hela cells fig 2 iv o n respectively overexpressed myc tagged ubiquilin stained anti myc mab exhibited intracellular structures fig 6 overexpressed wild type ubiquilin fig 6c fig f finally fluorescent staining pattern reproduced upon overexpression gfp ubiquilin fig 6 h since gfp ubiquilin image fig 6 h captured live unfixed cells without antibodies established anti ubiquilin structures seen previously artifacts paraformaldehyde fixation immunofluorescence staining procedures
0.49919817.11076969.html.plaintext.txt	76	ubiquilin localizes nucleus cytoplasm determine intracellular distribution ubiquilin used rabbit pab generated two different gst ubiquilin fusion proteins see materials methods antisera detected endogenous overexpressed 66 kd ubiquilin polypeptides detected preimmune sera fig 3 d although one antiserum reacted unknown protein 55 kd fig 3 e reactivity subsequently removed affinity purification antibody fig 3 f immunofluorescence staining ubiquilin within cells performed specific anti ubiquilin antibodies compared preimmune sera fig 6a fig d antibodies revealed similar staining patterns fig 6b fig e indirect immunofluorescence well laser confocal microscopy revealed endogenous intracellular localization ubiquilin hela cells nucleus cytoplasm fig 6b fig e fig g cells endogenous ubiquilin staining stronger nucleus fig 6 e arrowheads furthermore small subset cells ubiquilin within cytoplasm localized punctate structures fig 6b fig e arrows frequency structures dramatically increased upon overexpression full length untagged ubiquilin fig 6c fig f corroborate anti ubiquilin staining pattern performed additional localization studies myc gfp tagged ubiquilin proteins hela cells fig 2 iv o n respectively overexpressed myc tagged ubiquilin stained anti myc mab exhibited intracellular structures fig 6 overexpressed wild type ubiquilin fig 6c fig f finally fluorescent staining pattern reproduced upon overexpression gfp ubiquilin fig 6 h since gfp ubiquilin image fig 6 h captured live unfixed cells without antibodies established anti ubiquilin structures seen previously artifacts paraformaldehyde fixation immunofluorescence staining procedures
0.49919817.11076969.html.plaintext.txt	77	view larger version 132k figure 6 ubiquilin localizes nucleus cytoplasm b d e indirect immunofluorescence microscopy endogenous ubiquilin staining untransfected hela cells c f confocal microscopy hela cells transfected ubiquilin myc tagged ubiquilin b preimmune corresponding anti ubiquilin b antibody staining respectively shown c overexpressed ubiquilin detected anti ubiquilin b antibody d e preimmune corresponding anti ubiquilin c antibody staining respectively shown f overexpressed ubiquilin shown detected affinity purified anti ubiquilin c antibody anti ubiquilin sera showed specific staining cytoplasm nucleus along cytoplasmic punctate structures subset untransfected cells arrows expression levels ubiquilin protein within nucleus varied cells containing substantially nuclear protein arrowheads transient overexpression wild type ubiquilin caused frequent accumulation ubiquilin intracellular punctate structures g endogenous ubiquilin shown detected affinity purified anti ubiquilin c antibody confocal microscopy h overexpressed gfp tagged ubiquilin live hela cells seen fluorescence microscopy revealed accumulation fusion protein cytoplasm similar punctate structures additional evidence intracellular localization ubiquilin using myc tagged construct stained anti myc mab confocal microscopy shown bar 25 microm
0.49919817.11076969.html.plaintext.txt	78	view larger version 132k figure 6 ubiquilin localizes nucleus cytoplasm b d e indirect immunofluorescence microscopy endogenous ubiquilin staining untransfected hela cells c f confocal microscopy hela cells transfected ubiquilin myc tagged ubiquilin b preimmune corresponding anti ubiquilin b antibody staining respectively shown c overexpressed ubiquilin detected anti ubiquilin b antibody d e preimmune corresponding anti ubiquilin c antibody staining respectively shown f overexpressed ubiquilin shown detected affinity purified anti ubiquilin c antibody anti ubiquilin sera showed specific staining cytoplasm nucleus along cytoplasmic punctate structures subset untransfected cells arrows expression levels ubiquilin protein within nucleus varied cells containing substantially nuclear protein arrowheads transient overexpression wild type ubiquilin caused frequent accumulation ubiquilin intracellular punctate structures g endogenous ubiquilin shown detected affinity purified anti ubiquilin c antibody confocal microscopy h overexpressed gfp tagged ubiquilin live hela cells seen fluorescence microscopy revealed accumulation fusion protein cytoplasm similar punctate structures additional evidence intracellular localization ubiquilin using myc tagged construct stained anti myc mab confocal microscopy shown bar 25 microm
0.49919817.11076969.html.plaintext.txt	79	intracellular colocalization presenilin ubiquilin proteins overexpressed presenilin proteins localized predominantly er ubiquilin protein hela cells found throughout nucleus cytoplasm determined ubiquilin colocalized presenilins latter overexpressed indeed dramatic change ubiquilin staining hela cells coexpressing either ps1 ps2 ubiquilin resulting almost complete colocalization presenilin ubiquilin intracellular staining patterns seen laser confocal immunofluorescence microscopy fig 7a fig b careful examination colocalized proteins revealed ubiquilin staining punctate whereas presenilin staining could traced er like pattern particularly striking colocalization ubiquilin irregularly shaped presenilin enriched structures within cytoplasm overexpressing cells contrast little colocalization nucleus ubiquilin presenilin staining could found
0.49919817.11076969.html.plaintext.txt	80	intracellular colocalization presenilin ubiquilin proteins overexpressed presenilin proteins localized predominantly er ubiquilin protein hela cells found throughout nucleus cytoplasm determined ubiquilin colocalized presenilins latter overexpressed indeed dramatic change ubiquilin staining hela cells coexpressing either ps1 ps2 ubiquilin resulting almost complete colocalization presenilin ubiquilin intracellular staining patterns seen laser confocal immunofluorescence microscopy fig 7a fig b careful examination colocalized proteins revealed ubiquilin staining punctate whereas presenilin staining could traced er like pattern particularly striking colocalization ubiquilin irregularly shaped presenilin enriched structures within cytoplasm overexpressing cells contrast little colocalization nucleus ubiquilin presenilin staining could found
0.49919817.11076969.html.plaintext.txt	81	view larger version 83k figure 7 intracellular colocalization ubiquilin presenilins d hela cells cotransfected ubiquilin either wild type ps1 b wild type ps2 c ps2c deletion mutant d ps2lc deletion mutant costained appropriate goat anti presenilin antibodies left images affinity purified rabbit anti ubiquilin c antibody center images green fluorescein red rhodamine confocal images row merged shown right yellow indicating colocalization ubiquilin presenilin proteins bar 10 microm
0.49919817.11076969.html.plaintext.txt	82	view larger version 83k figure 7 intracellular colocalization ubiquilin presenilins d hela cells cotransfected ubiquilin either wild type ps1 b wild type ps2 c ps2c deletion mutant d ps2lc deletion mutant costained appropriate goat anti presenilin antibodies left images affinity purified rabbit anti ubiquilin c antibody center images green fluorescein red rhodamine confocal images row merged shown right yellow indicating colocalization ubiquilin presenilin proteins bar 10 microm
0.49919817.11076969.html.plaintext.txt	83	since y2h data suggested ubiquilin interacts loop cooh terminal domains presenilins examined whether removal regions ps2 would abolish colocalization proteins vivo assess possibility two ps2 constructs containing progressively longer cooh terminal deletions made first ps2c 39 amino acid cooh terminal domain deleted fig 1 arrowhead whereas second ps2lc large hydrophilic loop sequences downstream deleted fig 1 arrow expressed hela cells ps2c still colocalized ubiquilin fig 7 c presumably since ps2 loop region remained could bind ubiquilin suggested strong interaction two y2h assays fig 1 d however hydrophilic loop region cooh terminus removed ps2lc longer colocalized ubiquilin fig 7 d suggesting nh2 terminus first six transmembrane domains ps2 contain additional ubiquilin binding sites notable feature overexpression ps2lc accumulation large spherical aggregates failed stain positively ubiquilin
0.49919817.11076969.html.plaintext.txt	84	since y2h data suggested ubiquilin interacts loop cooh terminal domains presenilins examined whether removal regions ps2 would abolish colocalization proteins vivo assess possibility two ps2 constructs containing progressively longer cooh terminal deletions made first ps2c 39 amino acid cooh terminal domain deleted fig 1 arrowhead whereas second ps2lc large hydrophilic loop sequences downstream deleted fig 1 arrow expressed hela cells ps2c still colocalized ubiquilin fig 7 c presumably since ps2 loop region remained could bind ubiquilin suggested strong interaction two y2h assays fig 1 d however hydrophilic loop region cooh terminus removed ps2lc longer colocalized ubiquilin fig 7 d suggesting nh2 terminus first six transmembrane domains ps2 contain additional ubiquilin binding sites notable feature overexpression ps2lc accumulation large spherical aggregates failed stain positively ubiquilin
0.49919817.11076969.html.plaintext.txt	85	ubiquilin expression promotes increased accumulation presenilin proteins since ubiquilin contains multiple ubiquitin related structural motifs investigated whether association presenilin would effect presenilin protein modification andor stability treatment mock transfected ps2 transfected hela cells proteasome inhibitors lactacystin 20 microm mg 132 40 microm expected increased overall amount ubiquitinated proteins cells fig 8 lanes 2 3 5 6 8 9 versus lanes 1 4 7 respectively however conditions markedly increase ps2 protein levels fig 8 b lanes 4 6 remarkably coexpression ubiquilin ps2 caused substantial 10 fold increase ps2 protein accumulation fig 8 b lanes 7 9 compared overexpression ps2 alone fig 8 b lanes 4 6 effect independent treatment lactacystin mg 132 also occurred robustly cells treated proteasome inhibitors particularly striking increased accumulation sds page gels full length uncleaved ps2 protein fig 8 b arrowhead higher molecular weight complexes ps2 forms increasing amount transfected ubiquilin plasmid dna whereas maintaining constant levels transfected ps2 plasmid dna revealed dose dependent effect ubiquilin ps2 accumulation within cells fig 8 e lanes 1 5 effect specific ubiquilin expression since cotransfection increasing amounts gfp plasmid dna ps2 increase ps2 protein accumulation fig 8 f lanes 1 5 blot fig 8 e exposed shorter time fig 8 f optimally illustrate subtle changes ps2 protein levels experiments routinely observed accumulation full length ps2 protein endoproteolytic cleaved forms protein haass de strooper 1999 fact recent reports indicated cleavage presenilins essential biological function presenilins namely ability rescue ps activity c elegans jacobsen et al 1999 steiner et al 1999 absence detectable endoproteolytic cleaved forms ps2 clearly illustrated fig 8 g shows antibody specific ps2 loop sequences downstream proposed endoproteolytic cleavage site recognized 54 kd higher ps2 species ps2 nh2 terminal specific antibody interestingly though ubiquilin caused dose dependent increase presenilin accumulation alter accumulation levels various endogenous hela proteins lamin b calreticulin calnexin bip tubulin fig 8 h similar experiments repeated ps1 indicated ubiquilin also promoted dose dependent increase ps1 protein accumulation hela cells data shown
0.49919817.11076969.html.plaintext.txt	86	ubiquilin expression promotes increased accumulation presenilin proteins since ubiquilin contains multiple ubiquitin related structural motifs investigated whether association presenilin would effect presenilin protein modification andor stability treatment mock transfected ps2 transfected hela cells proteasome inhibitors lactacystin 20 microm mg 132 40 microm expected increased overall amount ubiquitinated proteins cells fig 8 lanes 2 3 5 6 8 9 versus lanes 1 4 7 respectively however conditions markedly increase ps2 protein levels fig 8 b lanes 4 6 remarkably coexpression ubiquilin ps2 caused substantial 10 fold increase ps2 protein accumulation fig 8 b lanes 7 9 compared overexpression ps2 alone fig 8 b lanes 4 6 effect independent treatment lactacystin mg 132 also occurred robustly cells treated proteasome inhibitors particularly striking increased accumulation sds page gels full length uncleaved ps2 protein fig 8 b arrowhead higher molecular weight complexes ps2 forms increasing amount transfected ubiquilin plasmid dna whereas maintaining constant levels transfected ps2 plasmid dna revealed dose dependent effect ubiquilin ps2 accumulation within cells fig 8 e lanes 1 5 effect specific ubiquilin expression since cotransfection increasing amounts gfp plasmid dna ps2 increase ps2 protein accumulation fig 8 f lanes 1 5 blot fig 8 e exposed shorter time fig 8 f optimally illustrate subtle changes ps2 protein levels experiments routinely observed accumulation full length ps2 protein endoproteolytic cleaved forms protein haass de strooper 1999 fact recent reports indicated cleavage presenilins essential biological function presenilins namely ability rescue ps activity c elegans jacobsen et al 1999 steiner et al 1999 absence detectable endoproteolytic cleaved forms ps2 clearly illustrated fig 8 g shows antibody specific ps2 loop sequences downstream proposed endoproteolytic cleavage site recognized 54 kd higher ps2 species ps2 nh2 terminal specific antibody interestingly though ubiquilin caused dose dependent increase presenilin accumulation alter accumulation levels various endogenous hela proteins lamin b calreticulin calnexin bip tubulin fig 8 h similar experiments repeated ps1 indicated ubiquilin also promoted dose dependent increase ps1 protein accumulation hela cells data shown
0.49919817.11076969.html.plaintext.txt	87	view larger version 63k figure 8 ubiquilin promotes increased ps2 protein accumulation d hela cells 12 h transfection ubiquilin 15 microg expression plasmid lanes 1 3 ps2 7 microg expression plasmid lanes 4 6 lanes 7 9 either left untreated lanes 1 4 7 treated 5 6 h proteasome inhibitors 20 microm synthetic lactacystin lanes 2 5 8 40 microm mg 132 lanes 3 6 9 equivalent amounts protein 100 microg sample immunoblotted anti ubiquitin b anti ps2 nh2 terminus c affinity purified anti ubiquilin c d anti tubulin antibodies expected anti ubiquitin antibodies detected larger molecular weight proteins cells treated proteasome inhibitors lanes 2 3 5 6 8 9 compared untreated cells lanes 1 4 7 significantly ps2 protein slower migrating forms could seen cells cotransfected ubiquilin lanes 7 9 arrowhead compared transfected ps2 alone lanes 4 6 doublet weakly reactive bands detected lysates considered nonspecific proteins anti tubulin blot shows equal protein loading sample e hela cells transfected ps2 alone 9 microg expression plasmid lane 1 cotransfected along increasing amounts ubiquilin 1 2 3 4 microg expression plasmid lanes 2 5 respectively equivalent amounts transfected lysates separated 85 polyacrylamide gel immunoblotted anti ps2 nh2 terminus antibody f e except increasing amounts gfp expression plasmid lanes 2 5 instead ubiquilin g e proteins separated 10 polyacrylamide gel immunoblotted anti ps2 loop antibody note absence detectable ps2 cleavage products corresponding endoproteolytic ps2 cleavage loop h blot shown g parallel blots immunoblotted lamin b calreticulin calnexin bip tubulin relative levels endogenous proteins remained relatively unchanged compared ps2 levels
0.49919817.11076969.html.plaintext.txt	88	view larger version 63k figure 8 ubiquilin promotes increased ps2 protein accumulation d hela cells 12 h transfection ubiquilin 15 microg expression plasmid lanes 1 3 ps2 7 microg expression plasmid lanes 4 6 lanes 7 9 either left untreated lanes 1 4 7 treated 5 6 h proteasome inhibitors 20 microm synthetic lactacystin lanes 2 5 8 40 microm mg 132 lanes 3 6 9 equivalent amounts protein 100 microg sample immunoblotted anti ubiquitin b anti ps2 nh2 terminus c affinity purified anti ubiquilin c d anti tubulin antibodies expected anti ubiquitin antibodies detected larger molecular weight proteins cells treated proteasome inhibitors lanes 2 3 5 6 8 9 compared untreated cells lanes 1 4 7 significantly ps2 protein slower migrating forms could seen cells cotransfected ubiquilin lanes 7 9 arrowhead compared transfected ps2 alone lanes 4 6 doublet weakly reactive bands detected lysates considered nonspecific proteins anti tubulin blot shows equal protein loading sample e hela cells transfected ps2 alone 9 microg expression plasmid lane 1 cotransfected along increasing amounts ubiquilin 1 2 3 4 microg expression plasmid lanes 2 5 respectively equivalent amounts transfected lysates separated 85 polyacrylamide gel immunoblotted anti ps2 nh2 terminus antibody f e except increasing amounts gfp expression plasmid lanes 2 5 instead ubiquilin g e proteins separated 10 polyacrylamide gel immunoblotted anti ps2 loop antibody note absence detectable ps2 cleavage products corresponding endoproteolytic ps2 cleavage loop h blot shown g parallel blots immunoblotted lamin b calreticulin calnexin bip tubulin relative levels endogenous proteins remained relatively unchanged compared ps2 levels
0.49919817.11076969.html.plaintext.txt	89	ubiquilin facilitates increased ps2 expression dramatically alter ps2 protein turnover determine ubiquilin induced increase presenilin accumulation due change rate presenilin protein turnover carried pulse chase experiments hela cells ps2 protein coexpressed either ubiquilin gfp control ps2 protein pulse chase lysates immunoprecipitated using anti ps2 loop antibody resolved sds page fig 9 phosphoimage analysis immunoprecipitated full length ps2 band 54 kd indicated half life ps2 protein approximately similar 31 29 h coexpressed gfp ubiquilin respectively fig 9a fig b apart prominent ps2 band 54 kd smear bands varying intensity resolved sds page using ps2 loop antibody immunoprecipitation bands appear ps2 related especially higher molecular weight species corresponded similar ps2 immunoreactive species using ps2 antibodies fig 8e fig g janicki monteiro 1997 janicki monteiro 1999 phosphoimage analysis smear bands 97 kd marker indicated rate turnover larger ps2 complexes also similar gfp ubiquilin coexpressing cells data shown
0.49919817.11076969.html.plaintext.txt	90	ubiquilin facilitates increased ps2 expression dramatically alter ps2 protein turnover determine ubiquilin induced increase presenilin accumulation due change rate presenilin protein turnover carried pulse chase experiments hela cells ps2 protein coexpressed either ubiquilin gfp control ps2 protein pulse chase lysates immunoprecipitated using anti ps2 loop antibody resolved sds page fig 9 phosphoimage analysis immunoprecipitated full length ps2 band 54 kd indicated half life ps2 protein approximately similar 31 29 h coexpressed gfp ubiquilin respectively fig 9a fig b apart prominent ps2 band 54 kd smear bands varying intensity resolved sds page using ps2 loop antibody immunoprecipitation bands appear ps2 related especially higher molecular weight species corresponded similar ps2 immunoreactive species using ps2 antibodies fig 8e fig g janicki monteiro 1997 janicki monteiro 1999 phosphoimage analysis smear bands 97 kd marker indicated rate turnover larger ps2 complexes also similar gfp ubiquilin coexpressing cells data shown
0.49919817.11076969.html.plaintext.txt	91	view larger version 66k figure 9 ubiquilin facilitates increased presenilin protein expression substantially change presenilin protein turnover hela cells electroporated mixture either ps2 gfp expression plasmids 7 microg ps2 15 microg pegfp c1 ps2 ubiquilin expression plasmids 7 microg ps2 15 microg ubiquilin pulse labeled 35smethionine 1 h chased nonradioactive medium 0 6 h appropriate time intervals indicated lane cells lysed ps2 protein immunoprecipitated using rabbit anti ps2 loop antibody immunoprecipitated proteins separated sds page 85 gel radioactivity band corresponding full length ps2 arrowhead lane determined phosphoimage analysis light band probably nonps2 related protein whose radioactivity changed little chase period experiment therefore useful normalizing protein amounts loaded lane b graph showing exponential decline pulse labeled ps2 protein time calculated half life ps2 experiment 31 29 h coexpressed gfp ubiquilin respectively two experiments 14 16 fold ps2 protein synthesized normalization coexpressed ubiquilin gfp c mock electroporated hela cells pulse labeled 35smethionine 1 h chased nonradioactive medium 0 21 h ubiquilin protein immunoprecipitated lysates using rabbit anti ubiquilin c antibodies radioactivity immunoprecipitated ubiquilin band determined phosphoimage analysis analysis revealed small decline radioactivity 15 reduction 21 h indicating endogenous ubiquilin hela cells long lived estimated half life 90 h
0.49919817.11076969.html.plaintext.txt	92	view larger version 66k figure 9 ubiquilin facilitates increased presenilin protein expression substantially change presenilin protein turnover hela cells electroporated mixture either ps2 gfp expression plasmids 7 microg ps2 15 microg pegfp c1 ps2 ubiquilin expression plasmids 7 microg ps2 15 microg ubiquilin pulse labeled 35smethionine 1 h chased nonradioactive medium 0 6 h appropriate time intervals indicated lane cells lysed ps2 protein immunoprecipitated using rabbit anti ps2 loop antibody immunoprecipitated proteins separated sds page 85 gel radioactivity band corresponding full length ps2 arrowhead lane determined phosphoimage analysis light band probably nonps2 related protein whose radioactivity changed little chase period experiment therefore useful normalizing protein amounts loaded lane b graph showing exponential decline pulse labeled ps2 protein time calculated half life ps2 experiment 31 29 h coexpressed gfp ubiquilin respectively two experiments 14 16 fold ps2 protein synthesized normalization coexpressed ubiquilin gfp c mock electroporated hela cells pulse labeled 35smethionine 1 h chased nonradioactive medium 0 21 h ubiquilin protein immunoprecipitated lysates using rabbit anti ubiquilin c antibodies radioactivity immunoprecipitated ubiquilin band determined phosphoimage analysis analysis revealed small decline radioactivity 15 reduction 21 h indicating endogenous ubiquilin hela cells long lived estimated half life 90 h
0.49919817.11076969.html.plaintext.txt	93	notable difference pulse labeling experiments increased amount immunoprecipitated ps2 labeled proteins cells overexpressing ubiquilin compared gfp despite using similar amounts ps2 dna electroporation within parallel labeling experiments routinely obtained 16 20 fold increase ps2 labeled protein ps2 coexpressed ubiquilin compared gfp effect seen three separate experiments data shown overall results suggest ubiquilin induced elevation presenilin accumulation involve substantial change rate presenilin protein turnover instead may facilitate increased ps2 protein synthesis finally determine rate endogenous ubiquilin protein turnover performed another pulse chase experiment mock transfected hela cells immunoprecipitated endogenous ubiquilin protein using anti ubiquilin c antibody fig 9 c phosphoimage analysis indicated pulse labeled ubiquilin decays exceedingly slowly 15 21 h chase period estimate half life protein 90 h
0.49919817.11076969.html.plaintext.txt	94	notable difference pulse labeling experiments increased amount immunoprecipitated ps2 labeled proteins cells overexpressing ubiquilin compared gfp despite using similar amounts ps2 dna electroporation within parallel labeling experiments routinely obtained 16 20 fold increase ps2 labeled protein ps2 coexpressed ubiquilin compared gfp effect seen three separate experiments data shown overall results suggest ubiquilin induced elevation presenilin accumulation involve substantial change rate presenilin protein turnover instead may facilitate increased ps2 protein synthesis finally determine rate endogenous ubiquilin protein turnover performed another pulse chase experiment mock transfected hela cells immunoprecipitated endogenous ubiquilin protein using anti ubiquilin c antibody fig 9 c phosphoimage analysis indicated pulse labeled ubiquilin decays exceedingly slowly 15 21 h chase period estimate half life protein 90 h
0.49919817.11076969.html.plaintext.txt	95	immunohistochemistry human brain tissue sections reveals ubiquilin immunoreactivity neurons well within neuropathological lesions neurofibrillary tangles lewy bodies since neuropathological lesions ad pd found highly immunoreactive ubiquitin antibodies investigated whether structures may also contain ubiquilin immunoreactivity immunohistochemistry adult human brain sections performed anti ubiquilin b anti ubiquilin c antibodies former raised ubiquilin polypeptides devoid ub domain whereas latter raised ubiquilin polypeptides lacking uba domain well fig 2 iii b c respectively compared preimmune sera showed specific staining fig 10a fig c antibodies strongly stained neurons little staining glia fig 10b fig d fig e general anti ubiquilin c antibody stained neurons greater clarity intensity cultured cells anti ubiquilin staining neurons nucleus cytoplasm addition clear evidence ubiquilin staining within long axonal processes fig 10 d interestingly neurons containing neurofibrillary tangles nfts ad affected brains seemed stain intensely compared control neurons fig 10 e f moreover examination ubiquilin staining brains afflicted pd shown diffuse lb disease revealed robust staining lewy bodies fig 10 h
0.49919817.11076969.html.plaintext.txt	96	immunohistochemistry human brain tissue sections reveals ubiquilin immunoreactivity neurons well within neuropathological lesions neurofibrillary tangles lewy bodies since neuropathological lesions ad pd found highly immunoreactive ubiquitin antibodies investigated whether structures may also contain ubiquilin immunoreactivity immunohistochemistry adult human brain sections performed anti ubiquilin b anti ubiquilin c antibodies former raised ubiquilin polypeptides devoid ub domain whereas latter raised ubiquilin polypeptides lacking uba domain well fig 2 iii b c respectively compared preimmune sera showed specific staining fig 10a fig c antibodies strongly stained neurons little staining glia fig 10b fig d fig e general anti ubiquilin c antibody stained neurons greater clarity intensity cultured cells anti ubiquilin staining neurons nucleus cytoplasm addition clear evidence ubiquilin staining within long axonal processes fig 10 d interestingly neurons containing neurofibrillary tangles nfts ad affected brains seemed stain intensely compared control neurons fig 10 e f moreover examination ubiquilin staining brains afflicted pd shown diffuse lb disease revealed robust staining lewy bodies fig 10 h
0.49919817.11076969.html.plaintext.txt	97	view larger version 107k figure 10 anti ubiquilin staining human brain tissue reveals strong staining neurons human brain robust staining nfts lewy bodies ad pd respectively sections human brain stained either preimmune anti ubiquilin b anti ubiquilin c antibodies d consecutive sections hippocampus ad afflicted brain stained either c preimmune serum corresponding b anti ubiquilin b d anti ubiquilin c antibodies e f examples strong staining nfts arrows hippocampal sections ad afflicted brains anti ubiquilin c antibodies g anti ubiquilin c antibody staining control nonad human brain showing strong staining neurons h cortical human brain section dlbd afflicted brain showing strong anti ubiquilin c staining lewy bodies arrows bars d g h 40 microm e f 20 microm
0.49919817.11076969.html.plaintext.txt	98	view larger version 107k figure 10 anti ubiquilin staining human brain tissue reveals strong staining neurons human brain robust staining nfts lewy bodies ad pd respectively sections human brain stained either preimmune anti ubiquilin b anti ubiquilin c antibodies d consecutive sections hippocampus ad afflicted brain stained either c preimmune serum corresponding b anti ubiquilin b d anti ubiquilin c antibodies e f examples strong staining nfts arrows hippocampal sections ad afflicted brains anti ubiquilin c antibodies g anti ubiquilin c antibody staining control nonad human brain showing strong staining neurons h cortical human brain section dlbd afflicted brain showing strong anti ubiquilin c staining lewy bodies arrows bars d g h 40 microm e f 20 microm
0.49919817.11076969.html.plaintext.txt	99	discussion top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	100	describe novel human presenilin interacting protein named ubiquilin y2h interaction gst pull experiments coimmunoprecipitation studies changes cellular fractionation proteins colocalization proteins expressed vivo provide compelling evidence ubiquilin presenilins interact one another ubiquilin important protein contains multiple ubiquitin related domains typically thought involved targeting proteins degradation yet ubiquilin promotes increased presenilin protein accumulation moreover ubiquilin highly expressed neurons human brain associated nfts lewy bodies ad pd brains respectively
0.49919817.11076969.html.plaintext.txt	101	describe novel human presenilin interacting protein named ubiquilin y2h interaction gst pull experiments coimmunoprecipitation studies changes cellular fractionation proteins colocalization proteins expressed vivo provide compelling evidence ubiquilin presenilins interact one another ubiquilin important protein contains multiple ubiquitin related domains typically thought involved targeting proteins degradation yet ubiquilin promotes increased presenilin protein accumulation moreover ubiquilin highly expressed neurons human brain associated nfts lewy bodies ad pd brains respectively
0.49919817.11076969.html.plaintext.txt	102	promotion presenilin protein accumulation ubiquilin overexpression noteworthy new means presenilin levels may modulated conducting pulse chase experiments found ubiquilin induced increase presenilin protein maturation dramatically affect presenilin protein turnover net effect time increased presenilin protein synthesis undisturbed turnover rate would eventually lead elevation intracellular pool presenilin proteins modulation presenilin levels ubiquilin may important consequences cellular functions presenilins linked various biological processes including notch signaling calcium regulation apoptosis cell cycle regulation unfolded protein response well app associated gamma secretase activity see introduction
0.49919817.11076969.html.plaintext.txt	103	promotion presenilin protein accumulation ubiquilin overexpression noteworthy new means presenilin levels may modulated conducting pulse chase experiments found ubiquilin induced increase presenilin protein maturation dramatically affect presenilin protein turnover net effect time increased presenilin protein synthesis undisturbed turnover rate would eventually lead elevation intracellular pool presenilin proteins modulation presenilin levels ubiquilin may important consequences cellular functions presenilins linked various biological processes including notch signaling calcium regulation apoptosis cell cycle regulation unfolded protein response well app associated gamma secretase activity see introduction
0.49919817.11076969.html.plaintext.txt	104	interesting determine precise mechanism ubiquilin induces increased presenilin protein synthesis ubiquilin could increase presenilin synthesis simply increasing presenilin transcription increasing presenilin translation facilitating correct polypeptide folding maturation intracellular targeting polytopic transmembrane presenilin protein based various properties especially intrigued possibility ubiquilin may act molecular chaperone studies xenopus ubiquilin homologue xdrp1 suggested ubiquilin act posttranscriptionally like molecular chaperone prevent degradation vitro translated cyclin protein funakoshi et al 1999 b chap1 ubiquilin 2 shown bind stch hsp70 like protein kaye et al 2000 turn many heat shock proteins shown function molecular chaperones preventing protein aggregation protein degradation warrick et al 1999 krobitsch lindquist 2000 c recent evidence linked ubiquilin proteins proteasome kleijnen et al 2000 meanwhile 19s regulatory subunit 26s proteasome degradation complex ubiquitin tagged proteins shown possess protein unfolding activity braun et al 1999 d indirect evidence ubiquilin may aid presenilin protein folding targeting comes observation presenilin construct ps2lc deletions loop cooh terminal ubiquilin interaction sites demonstrated y2h assays lack colocalization ubiquilin within cells frequently accumulated large cytoplasmic aggregates contrast presenilin molecules contained ubiquilin interaction sites rarely formed large protein aggregates connection aggregate accumulation loss ubiquilin interaction may entirely coincidental however possibility two interconnected cannot discounted finally presenilins proteins linked molecular chaperones er involved unfolded protein response katayama et al 1999 niwa et al 1999
0.49919817.11076969.html.plaintext.txt	105	interesting determine precise mechanism ubiquilin induces increased presenilin protein synthesis ubiquilin could increase presenilin synthesis simply increasing presenilin transcription increasing presenilin translation facilitating correct polypeptide folding maturation intracellular targeting polytopic transmembrane presenilin protein based various properties especially intrigued possibility ubiquilin may act molecular chaperone studies xenopus ubiquilin homologue xdrp1 suggested ubiquilin act posttranscriptionally like molecular chaperone prevent degradation vitro translated cyclin protein funakoshi et al 1999 b chap1 ubiquilin 2 shown bind stch hsp70 like protein kaye et al 2000 turn many heat shock proteins shown function molecular chaperones preventing protein aggregation protein degradation warrick et al 1999 krobitsch lindquist 2000 c recent evidence linked ubiquilin proteins proteasome kleijnen et al 2000 meanwhile 19s regulatory subunit 26s proteasome degradation complex ubiquitin tagged proteins shown possess protein unfolding activity braun et al 1999 d indirect evidence ubiquilin may aid presenilin protein folding targeting comes observation presenilin construct ps2lc deletions loop cooh terminal ubiquilin interaction sites demonstrated y2h assays lack colocalization ubiquilin within cells frequently accumulated large cytoplasmic aggregates contrast presenilin molecules contained ubiquilin interaction sites rarely formed large protein aggregates connection aggregate accumulation loss ubiquilin interaction may entirely coincidental however possibility two interconnected cannot discounted finally presenilins proteins linked molecular chaperones er involved unfolded protein response katayama et al 1999 niwa et al 1999
0.49919817.11076969.html.plaintext.txt	106	another mechanism ubiquilin might increase presenilin accumulation alter presenilin degradation rates especially ubiquitinated forms presenilins fact recent report kleijnen et al 2000 found evidence overexpression human ubiquilin proteins hplic 1 ubiquilin 1 hplic 2 ubiquilin 2 interfered ubiquitin dependent degradation p53 ikb although find significant change turnover rate major 54 kd ps2 polypeptide species corresponding full length ps2 cannot exclude possibility certain ubiquitinated forms presenilins may altered turnover rates ubiquitinated forms presenilins migrated smear sds page gels made quantification turnover rates species difficult important future studies determine ubiquilin involved ubiquitin dependent degradation presenilins
0.49919817.11076969.html.plaintext.txt	107	another mechanism ubiquilin might increase presenilin accumulation alter presenilin degradation rates especially ubiquitinated forms presenilins fact recent report kleijnen et al 2000 found evidence overexpression human ubiquilin proteins hplic 1 ubiquilin 1 hplic 2 ubiquilin 2 interfered ubiquitin dependent degradation p53 ikb although find significant change turnover rate major 54 kd ps2 polypeptide species corresponding full length ps2 cannot exclude possibility certain ubiquitinated forms presenilins may altered turnover rates ubiquitinated forms presenilins migrated smear sds page gels made quantification turnover rates species difficult important future studies determine ubiquilin involved ubiquitin dependent degradation presenilins
0.49919817.11076969.html.plaintext.txt	108	region ubiquilin binds presenilins mapped cooh terminal region containing uba domain highly conserved ubiquilin family members human yeast fig 4 sequence necessary sufficient bind ps1 ps2 vitro uba domain recently recognized motif present one two copies variety proteins involved ubiquitinproteasome foldingdegradation pathway uv excision repair phosphorylation hofmann bucher 1996 uba domain consists 55 total residues 45 appear core residues 15 core residues extremely well conserved suggesting may important determining overall structure domain nuclear magnetic resonance structure cooh terminal uba domain human dna repair protein hhr23a rad23 homologue determined compact three helix bundle exposed hydrophobic surface predicted involved protein protein interactions dieckmann et al 1998 strong binding ubiquilin uba domain presenilins may facilitated similar protein protein interactions important determine sequence variation uba domain different proteins influences binding specificity different target proteins
0.49919817.11076969.html.plaintext.txt	109	region ubiquilin binds presenilins mapped cooh terminal region containing uba domain highly conserved ubiquilin family members human yeast fig 4 sequence necessary sufficient bind ps1 ps2 vitro uba domain recently recognized motif present one two copies variety proteins involved ubiquitinproteasome foldingdegradation pathway uv excision repair phosphorylation hofmann bucher 1996 uba domain consists 55 total residues 45 appear core residues 15 core residues extremely well conserved suggesting may important determining overall structure domain nuclear magnetic resonance structure cooh terminal uba domain human dna repair protein hhr23a rad23 homologue determined compact three helix bundle exposed hydrophobic surface predicted involved protein protein interactions dieckmann et al 1998 strong binding ubiquilin uba domain presenilins may facilitated similar protein protein interactions important determine sequence variation uba domain different proteins influences binding specificity different target proteins
0.49919817.11076969.html.plaintext.txt	110	vitro binding assays indicated ub domain nh2 terminal portion ubiquilin required binding presenilins although domain shares high homology conserved 76 amino acid ubiquitin polypeptide unlikely involved covalent linkage lysine residues target proteins since lacks obligate cooh terminal glycine residue required cleavage conjugation another possibility could ub domain modified conjugation either ubiquitin small ubiquitin like proteins eg sumo nedd8 etc lysine group groups forming ubiquitin conjugates pickart 1998 also unlikely occur ubiquilin immunoblots show expected ladder ubiquitin conjugated bands therefore ub domain may play role function example yeast rad23 human homologues hhr23a hhr23b ub domains involved binding subunits proteasome whereas xdrp1 ub domain necessary binding cyclin clearly insight ubiquilins function emerge understanding protein protein interactions roles different domains
0.49919817.11076969.html.plaintext.txt	111	vitro binding assays indicated ub domain nh2 terminal portion ubiquilin required binding presenilins although domain shares high homology conserved 76 amino acid ubiquitin polypeptide unlikely involved covalent linkage lysine residues target proteins since lacks obligate cooh terminal glycine residue required cleavage conjugation another possibility could ub domain modified conjugation either ubiquitin small ubiquitin like proteins eg sumo nedd8 etc lysine group groups forming ubiquitin conjugates pickart 1998 also unlikely occur ubiquilin immunoblots show expected ladder ubiquitin conjugated bands therefore ub domain may play role function example yeast rad23 human homologues hhr23a hhr23b ub domains involved binding subunits proteasome whereas xdrp1 ub domain necessary binding cyclin clearly insight ubiquilins function emerge understanding protein protein interactions roles different domains
0.49919817.11076969.html.plaintext.txt	112	using combination immunological gfp tagging approaches demonstrated ubiquilin localized nucleus cytoplasm hela cells intensity nuclear staining variable nuclei staining brightly variability may related cell cycle changes cyclin protein ubiquilins homologue xdrp1 shown interact levels within nucleus cytoplasmic distribution ubiquilin also variable untransfected cells endogenous ubiquilin fine punctate appearance hints association network like pattern possibly er cells ubiquilin accumulated larger spherical structures throughout cytoplasm whose number size variable upon ubiquilin overexpression cells formed even larger numerous ubiquilin containing structures confocal microscopy ubiquilin staining pattern colocalized almost perfectly presenilin staining pattern considering two presenilin interaction sites cooh terminus loop domains face cytoplasm according predicted topology presenilins membranes surprising ubiquilin colocalized er membrane bound presenilin still many proteins also shown interact two domains presenilins clearly understanding dynamics different protein protein interactions provide clues regarding presenilin functions study mouse plic 1 plic 2 suggested involvement linking integrins via integrin associated proteins vimentin cytoskeleton wu et al 1999 observed significant staining ubiquilin cell periphery know way related lack expression particular integrin associated proteins integrins hela cells nevertheless interesting vimentin presenilins linked one another aggresomes structures involved cellular response misfolded proteins johnston et al 1998 moreover recent evidence indicates aggresomes involved recruitment proteasome hsp70 chaperones garcia mata et al 1999 circumstantially suggests mechanism ubiquilin could associated proteins misfolded protein response
0.49919817.11076969.html.plaintext.txt	113	using combination immunological gfp tagging approaches demonstrated ubiquilin localized nucleus cytoplasm hela cells intensity nuclear staining variable nuclei staining brightly variability may related cell cycle changes cyclin protein ubiquilins homologue xdrp1 shown interact levels within nucleus cytoplasmic distribution ubiquilin also variable untransfected cells endogenous ubiquilin fine punctate appearance hints association network like pattern possibly er cells ubiquilin accumulated larger spherical structures throughout cytoplasm whose number size variable upon ubiquilin overexpression cells formed even larger numerous ubiquilin containing structures confocal microscopy ubiquilin staining pattern colocalized almost perfectly presenilin staining pattern considering two presenilin interaction sites cooh terminus loop domains face cytoplasm according predicted topology presenilins membranes surprising ubiquilin colocalized er membrane bound presenilin still many proteins also shown interact two domains presenilins clearly understanding dynamics different protein protein interactions provide clues regarding presenilin functions study mouse plic 1 plic 2 suggested involvement linking integrins via integrin associated proteins vimentin cytoskeleton wu et al 1999 observed significant staining ubiquilin cell periphery know way related lack expression particular integrin associated proteins integrins hela cells nevertheless interesting vimentin presenilins linked one another aggresomes structures involved cellular response misfolded proteins johnston et al 1998 moreover recent evidence indicates aggresomes involved recruitment proteasome hsp70 chaperones garcia mata et al 1999 circumstantially suggests mechanism ubiquilin could associated proteins misfolded protein response
0.49919817.11076969.html.plaintext.txt	114	several lines evidence link ubiquitin genes tissues involved ad first presenilin proteins thought ubiquitinated since treatment proteasome inhibitors cause accumulation large complexes migrate sds gels manner consistent modification ubiquitin kim et al 1997 fraser et al 1998 honda et al 1999 second well known ubiquitin immunoreactivity strongly associated nfts senile plaques ad hallmark lesions ad pathology mori et al 1987 perry et al 1987 strong ubiquilin immunoreactivity associated nfts lewy bodies intriguing considering lesions known contain misfolded proteins present results provide clues whether ubiquilin acting causative role end result association misfolded accumulated proteins plan pursue future
0.49919817.11076969.html.plaintext.txt	115	several lines evidence link ubiquitin genes tissues involved ad first presenilin proteins thought ubiquitinated since treatment proteasome inhibitors cause accumulation large complexes migrate sds gels manner consistent modification ubiquitin kim et al 1997 fraser et al 1998 honda et al 1999 second well known ubiquitin immunoreactivity strongly associated nfts senile plaques ad hallmark lesions ad pathology mori et al 1987 perry et al 1987 strong ubiquilin immunoreactivity associated nfts lewy bodies intriguing considering lesions known contain misfolded proteins present results provide clues whether ubiquilin acting causative role end result association misfolded accumulated proteins plan pursue future
0.49919817.11076969.html.plaintext.txt	116	summary ubiquilin first presenilin interacting protein knowledge found regulate presenilin levels cells presence multiple ubiquitin related domains suggests ubiquilin may involved regulation presenilin protein levels proteasome folding andor degradation pathway
0.49919817.11076969.html.plaintext.txt	117	summary ubiquilin first presenilin interacting protein knowledge found regulate presenilin levels cells presence multiple ubiquitin related domains suggests ubiquilin may involved regulation presenilin protein levels proteasome folding andor degradation pathway
0.49919817.11076969.html.plaintext.txt	118	1 abbreviations used paper aa amino acid ad alzheimers disease app ss amyloid precursor protein est expressed sequence tag fad familial alzheimers disease gfp green fluorescent protein nft neurofibrillary tangles orf open reading frame pd parkinsons disease ps presenilin race rapid amplification cdna ends ub ubiquitin uba ubiquitin associated y2h yeast two hybrid
0.49919817.11076969.html.plaintext.txt	119	acknowledgements top abstract introduction materials methods results discussion acknowledgements references
0.49919817.11076969.html.plaintext.txt	120	work funded part grants national institute aging ag11386 ag16839 mj monteiro
0.49919817.11076969.html.plaintext.txt	121	submitted 29 february 2000 revised 12 september 2000 accepted 26 september 2000
0.49919817.11076969.html.plaintext.txt	122	references top abstract introduction materials methods results discussion acknowledgements references
0.51095337.11136203.html.plaintext.txt	0	genetic risk alzheimers disease advising relatives m b liddell mrcpsych
0.51095337.11136203.html.plaintext.txt	1	department psychological medicine university wales college medicine cardiff
0.51095337.11136203.html.plaintext.txt	2	institute psychiatry london
0.51095337.11136203.html.plaintext.txt	3	department psychological medicine university wales college medicine cardiff
0.51095337.11136203.html.plaintext.txt	4	abstract top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references background clinicians increasingly asked relatives patients alzheimers disease advise genetic risk developing alzheimers disease later life many clinicians find difficult question answer
0.51095337.11136203.html.plaintext.txt	5	aims provide information old age psychiatrists wishing advise relatives risk developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	6	method selective review key literature genetic epidemiology alzheimers disease
0.51095337.11136203.html.plaintext.txt	7	results currently dna diagnosis attainable 70 families autosomal dominant alzheimers disease first degree relatives cases risk increased three four fold relative controls one third realised average life span apolipoprotein e genotyping cannot used predictive test confers minimal diagnostic benefit
0.51095337.11136203.html.plaintext.txt	8	results currently dna diagnosis attainable 70 families autosomal dominant alzheimers disease first degree relatives cases risk increased three four fold relative controls one third realised average life span apolipoprotein e genotyping cannot used predictive test confers minimal diagnostic benefit
0.51095337.11136203.html.plaintext.txt	9	conclusions pedigrees familial alzheimers disease referred regional centre medical genetics accurate risk prediction possible vast majority pedigrees alzheimers disease although possible psychiatrist give rough estimate risk reasonably couched reassuring terms
0.51095337.11136203.html.plaintext.txt	10	conclusions pedigrees familial alzheimers disease referred regional centre medical genetics accurate risk prediction possible vast majority pedigrees alzheimers disease although possible psychiatrist give rough estimate risk reasonably couched reassuring terms
0.51095337.11136203.html.plaintext.txt	11	introduction top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references eighty per cent typical old age psychiatrists time spent assessment management dementia due alzheimers disease combination alzheimers disease vascular dementia increased public awareness advances genetics efforts advocacy groups explaining latest research findings relatives people alzheimers disease increasingly asking question risk childrens risk developing alzheimers disease aim article summarise relevant research suggest ways answered
0.51095337.11136203.html.plaintext.txt	12	autosomal dominant familial alzheimers disease top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references highly publicised advances genetics alzheimers disease concerned rare families autosomal dominant forms disease called familial alzheimers disease fad kindred 50 generation regardless gender succumb alzheimers disease usually early mid life reviewed selkoe 1999 identification causative mutations within amyloid precursor protein app presenilin genes psen1 psen2 probably overinflated publics perception role genes causing far common forms alzheimers disease show autosomal dominant transmission yet important able recognise fad possible offer kindreds definitive genetic counselling provided causative mutation identified furthermore study campion et al 1999 suggests fad may occur frequency around 40 per 100 000 persons risk implies 600 affected individuals found england wales number suggests psychiatrist neurologist encounter individual fad pedigree time working life
0.51095337.11136203.html.plaintext.txt	13	suggested approach highly familial forms alzheimers disease top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references function psychiatrist straight forward first step confirm diagnosis actually one alzheimers disease one often familial dementias huntingtons disease frontal temporal dementias creutzfeldt jakob disease cjd cerebral autosomal dominant arteriopathy subcortical infarcts leukoencephalopathy cadasil next clinician take detailed family history possible order try determine whether sufferer comes pedigree autosomal dominant fad occurrence numerous individuals early onset disease 55 years several generations highly suggestive presence many affected individuals one generation may also raise suspicion forgotten early death causes might prevent manifestation disorder carriers disease gene practice recommend families containing three members history early onset alzheimers disease occurring age 60 years request advice referred clinical geneticist forms fad linked psen2 mutations occur age 65 years psychiatrist low threshold discussing pedigree clinical geneticist
0.51095337.11136203.html.plaintext.txt	14	predictive prenatal testing potentially feasible families fad depend upon availability dna least one affected individual order establish mutation causing disease family worth stating genetic counselling highly specialised area strongly recommended psychiatrists involve without appropriate training
0.51095337.11136203.html.plaintext.txt	15	predictive prenatal testing potentially feasible families fad depend upon availability dna least one affected individual order establish mutation causing disease family worth stating genetic counselling highly specialised area strongly recommended psychiatrists involve without appropriate training
0.51095337.11136203.html.plaintext.txt	16	study campion et al 1999 analysed dna 34 families fad obtained france causative mutations probably pathogenic mutations found psen1 gene 19 families mutations within app gene another 5 mutations psen1 psen2 app genes remaining 10 families thus individuals fad pedigrees need informed 30 chance current state knowledge causative mutation found mutation found pedigree strongly suggestive autosomal dominant disorder geneticist may choose go search mutations genes associated similar conditions prion protein prp cjd tau frontal temporal dementias example yet another factor consider one report apparent non penetrance psen1 mutation healthy 68 year old member fad pedigree rossor et al 1996 notwithstanding caveats absence preventive treatment take predictive testing likely low case huntingtons disease binedell et al 1998
0.51095337.11136203.html.plaintext.txt	17	study campion et al 1999 analysed dna 34 families fad obtained france causative mutations probably pathogenic mutations found psen1 gene 19 families mutations within app gene another 5 mutations psen1 psen2 app genes remaining 10 families thus individuals fad pedigrees need informed 30 chance current state knowledge causative mutation found mutation found pedigree strongly suggestive autosomal dominant disorder geneticist may choose go search mutations genes associated similar conditions prion protein prp cjd tau frontal temporal dementias example yet another factor consider one report apparent non penetrance psen1 mutation healthy 68 year old member fad pedigree rossor et al 1996 notwithstanding caveats absence preventive treatment take predictive testing likely low case huntingtons disease binedell et al 1998
0.51095337.11136203.html.plaintext.txt	18	suggested approach non mendelian alzheimers disease top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references great majority cases alzheimers disease result disease causing mutations single gene inheritance follow simple mendelian ratios appears reflect presence number different genetic risk factors together environmental factors
0.51095337.11136203.html.plaintext.txt	19	faced someone worried risk developing alzheimers disease often worth pointing risk developing alzheimers disease provided live long enough large rotterdam study suggests risk age 55 years developing dementia following 35 years 026 woman 015 man ott et al 1998 study 73 dementia wholly partially attributable alzheimers disease large continuing framingham study yields somewhat lower lifetime risks alzheimers disease age 65 years 63 men 12 women corresponding risk dementia 109 19 respectively seshadri et al 1997 many epidemiological studies suggest women increased risk alzheimers disease reasons clear increased longevity compared men increased survival disease increase intrinsic vulnerability probably play part
0.51095337.11136203.html.plaintext.txt	20	faced someone worried risk developing alzheimers disease often worth pointing risk developing alzheimers disease provided live long enough large rotterdam study suggests risk age 55 years developing dementia following 35 years 026 woman 015 man ott et al 1998 study 73 dementia wholly partially attributable alzheimers disease large continuing framingham study yields somewhat lower lifetime risks alzheimers disease age 65 years 63 men 12 women corresponding risk dementia 109 19 respectively seshadri et al 1997 many epidemiological studies suggest women increased risk alzheimers disease reasons clear increased longevity compared men increased survival disease increase intrinsic vulnerability probably play part
0.51095337.11136203.html.plaintext.txt	21	prevalence studies tell us dementia doubles every 5 years age 65 years age around 85 years time rate increase appears slow heeren et al 1991 skoog et al 1993 ritchie kildea 1995 breitner et al 1999 von strauss et al 1999 likely slowing due old people living long dementia younger sufferers although also possible survivors late old age relatively resistant developing dementia drachman 1994 prevalence data summarised table 1
0.51095337.11136203.html.plaintext.txt	22	prevalence studies tell us dementia doubles every 5 years age 65 years age around 85 years time rate increase appears slow heeren et al 1991 skoog et al 1993 ritchie kildea 1995 breitner et al 1999 von strauss et al 1999 likely slowing due old people living long dementia younger sufferers although also possible survivors late old age relatively resistant developing dementia drachman 1994 prevalence data summarised table 1
0.51095337.11136203.html.plaintext.txt	23	view table table 1 prevalence dementia age ritchie kildea 1995 permission
0.51095337.11136203.html.plaintext.txt	24	fact two nearly completely ascertained community based studies one japan one netherlands found prevalence dementia centenarians high 70 japanese 88 dutch sample asada et al 1996 blansjaar et al 2000 asada et al 1996 attributed 76 dementia alzheimers disease demonstrated 6 month mortality rate 27 centenarians dementia whereas none non demented centenarians died
0.51095337.11136203.html.plaintext.txt	25	fact two nearly completely ascertained community based studies one japan one netherlands found prevalence dementia centenarians high 70 japanese 88 dutch sample asada et al 1996 blansjaar et al 2000 asada et al 1996 attributed 76 dementia alzheimers disease demonstrated 6 month mortality rate 27 centenarians dementia whereas none non demented centenarians died
0.51095337.11136203.html.plaintext.txt	26	thus prevalence figures dementia tell us many us risk developing dementia provided live long enough obviously simplistic people expect live mid 90s much reasonable question chance developing alzheimers disease age 85 years family studies alzheimers disease go way towards allowing us answer question relatives affected individuals
0.51095337.11136203.html.plaintext.txt	27	thus prevalence figures dementia tell us many us risk developing dementia provided live long enough obviously simplistic people expect live mid 90s much reasonable question chance developing alzheimers disease age 85 years family studies alzheimers disease go way towards allowing us answer question relatives affected individuals
0.51095337.11136203.html.plaintext.txt	28	family studies risk dementia top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references 1980s early 1990s number family studies attempted identify inheritance pattern alzheimers disease quantify risk first degree relatives families history alzheimers disease comparison family members control individuals summarised mcguffin et al 1994 also studies based representative community samples
0.51095337.11136203.html.plaintext.txt	29	overall findings studies based memory clinics likely centres secondary referral suggest 30 48 probands alzheimers disease history affected first degree relatives compared 13 19 controls translates 6 14 relatives patients alzheimers disease history alzheimers disease compared 35 7 first degree relatives healthy controls kaplan meier life table analysis used studies infer cumulative risk dementia age 90 varies 30 50 compared 10 23 control relatives however pointed breitner owing competing causes death one third theoretical familial predisposition alzheimers disease realised usual life span translates actual predicted risk developing alzheimers disease first degree relatives probands alzheimers disease 15 19 compared 5 controls breitner et al 1988 breitner 1991
0.51095337.11136203.html.plaintext.txt	30	overall findings studies based memory clinics likely centres secondary referral suggest 30 48 probands alzheimers disease history affected first degree relatives compared 13 19 controls translates 6 14 relatives patients alzheimers disease history alzheimers disease compared 35 7 first degree relatives healthy controls kaplan meier life table analysis used studies infer cumulative risk dementia age 90 varies 30 50 compared 10 23 control relatives however pointed breitner owing competing causes death one third theoretical familial predisposition alzheimers disease realised usual life span translates actual predicted risk developing alzheimers disease first degree relatives probands alzheimers disease 15 19 compared 5 controls breitner et al 1988 breitner 1991
0.51095337.11136203.html.plaintext.txt	31	latest systematically ascertained twin studies heritability alzheimers disease also tend support estimates familial risk derived family studies probandwise concordance rates 40 84 respectively seen fraternal identical twins bergem et al 1997 fraternal twins genetically equivalent ordinary first degree relatives observed morbid risk developing alzheimers disease similar estimated first degree relatives family studies
0.51095337.11136203.html.plaintext.txt	32	latest systematically ascertained twin studies heritability alzheimers disease also tend support estimates familial risk derived family studies probandwise concordance rates 40 84 respectively seen fraternal identical twins bergem et al 1997 fraternal twins genetically equivalent ordinary first degree relatives observed morbid risk developing alzheimers disease similar estimated first degree relatives family studies
0.51095337.11136203.html.plaintext.txt	33	study silverman et al 1994 suggested large measure familial component risk relatives probands alzheimers disease expended end ninth decade time risk similar controls number family history studies suggested familial factors prominent onset earlier mcguffin et al 1994 thus much alzheimers disease late old age may considered familial merely expression one ways ageing process manifested survivors late old age
0.51095337.11136203.html.plaintext.txt	34	study silverman et al 1994 suggested large measure familial component risk relatives probands alzheimers disease expended end ninth decade time risk similar controls number family history studies suggested familial factors prominent onset earlier mcguffin et al 1994 thus much alzheimers disease late old age may considered familial merely expression one ways ageing process manifested survivors late old age
0.51095337.11136203.html.plaintext.txt	35	findings family studies used advise relatives broadest terms one little say balance risk first degree relatives patients alzheimers disease developed disorder time age 85 years increased threefold fourfold relative risk controls would seem translate risk developing alzheimers disease one five one six although improvement risk one two still rather frightening order put risk better perspective help allay clients anxiety may preferable present risk estimates graphical form done fig 1 breitner et al 1988 done clients see even 78 years age greatest risk actual predicted risk 3 cumulative risk half area curve fx sx age 65 78 probably less 10 experience many tell us reassuring partly worries getting alzheimers disease fifties familial alzheimers disease happens sixtiesseventies thus preventing enjoying retirement
0.51095337.11136203.html.plaintext.txt	36	findings family studies used advise relatives broadest terms one little say balance risk first degree relatives patients alzheimers disease developed disorder time age 85 years increased threefold fourfold relative risk controls would seem translate risk developing alzheimers disease one five one six although improvement risk one two still rather frightening order put risk better perspective help allay clients anxiety may preferable present risk estimates graphical form done fig 1 breitner et al 1988 done clients see even 78 years age greatest risk actual predicted risk 3 cumulative risk half area curve fx sx age 65 78 probably less 10 experience many tell us reassuring partly worries getting alzheimers disease fifties familial alzheimers disease happens sixtiesseventies thus preventing enjoying retirement
0.51095337.11136203.html.plaintext.txt	37	view larger version 15k fig 1 fx represents probability hypothetical relative patient alzheimers disease developing alzheimers disease age x absence competing form mortality sx represents actuarial probability surviving age x product fx sx represents probability relative surviving age x developing alzheimers disease adapted breitner et al 1988
0.51095337.11136203.html.plaintext.txt	38	view larger version 15k fig 1 fx represents probability hypothetical relative patient alzheimers disease developing alzheimers disease age x absence competing form mortality sx represents actuarial probability surviving age x product fx sx represents probability relative surviving age x developing alzheimers disease adapted breitner et al 1988
0.51095337.11136203.html.plaintext.txt	39	case patients alzheimers disease became demented late old age say 80s relatives probably run 30 50 risk developing dementia anyone else lives age 90 years beyond course possible genes confer longevity may also increase risk developing alzheimers disease like disorders reflect combined action several genes risk relatives drops rapidly degree genetic relatedness falls data limited risk second degree relatives grand children probably less twice population levels heston et al 1981
0.51095337.11136203.html.plaintext.txt	40	case patients alzheimers disease became demented late old age say 80s relatives probably run 30 50 risk developing dementia anyone else lives age 90 years beyond course possible genes confer longevity may also increase risk developing alzheimers disease like disorders reflect combined action several genes risk relatives drops rapidly degree genetic relatedness falls data limited risk second degree relatives grand children probably less twice population levels heston et al 1981
0.51095337.11136203.html.plaintext.txt	41	apolipoprotein e effect top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references apolipoprotein e apoe protein roles lipid metabolism tissue repair primary site biosynthesis liver second major site synthesis brain like app synthesis apoe regulated nervous system damaged three commonly occurring polymorphic forms apoe known apoe2 apoe3 apoe4 originate apoe 2 apoe 3 apoe 4 alleles gene key observation originally made strittmatter et al 1993 frequency apoe 4 patients alzheimers disease namely 03 05 greater apoe 4 frequency 01 015 age matched population controls studies suggest apoe 2 allele represented alzheimers disease may inference protective reviewed farrer et al 1997 consistent idea finding healthy centenarians higher apoe 2 frequency general population controls schachter et al 1994 kehoe et al 1999
0.51095337.11136203.html.plaintext.txt	42	apoe 4 association alzheimers disease replicated many laboratories around world meta analysis summarised data demonstrated association found people european african american american hispanic japanese origin farrer et al 1997 exactly apoe 4 apoe4 protein influence pathophysiology alzheimers disease still unknown bearers risk allele appear get alzheimers disease earlier develop heavier amyloid burden
0.51095337.11136203.html.plaintext.txt	43	apoe 4 association alzheimers disease replicated many laboratories around world meta analysis summarised data demonstrated association found people european african american american hispanic japanese origin farrer et al 1997 exactly apoe 4 apoe4 protein influence pathophysiology alzheimers disease still unknown bearers risk allele appear get alzheimers disease earlier develop heavier amyloid burden
0.51095337.11136203.html.plaintext.txt	44	clinical significance apolipoprotein e genotype top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references studies show patients alzheimers disease apoe 4 deteriorate rapidly without allele corder et al 1995 growdon et al 1996 holmes et al 1996 kurz et al 1996 stern et al 1997 possible apoe 4 marker poor response treatment acetylcholinesterese inhibitors particularly perhaps women poirer et al 1995 farlow et al 1998
0.51095337.11136203.html.plaintext.txt	45	consensus opinion appears apoe genotype determines rather whether one succumbs alzheimers disease example cache county study meyer et al 1998 breitner et al 1999 elderly population almost 5000 found 22 cases alzheimers disease among 141 apoe 4 homozygotes 118 among 1452 apoe 4 heterozygotes 80 among 3339 bearing apoe 4 allele appeared plateau groups survival curve beyond new cases alzheimers disease seen apoe 4 homozygotes new cases seen age 84 years nine individuals surviving without alzheimers disease combined total 37 years apoe 4 heterozygotes last onset alzheimers disease 99 years four long term survivors last onset dementia individuals without apoe 4 allele age 95 years 31 surviving free dementia combined total 100 years thereafter differential effect apoe genotype age maximum risk alzheimers disease also suggested apoe meta analysis farrer et al 1997 also study asada et al 1996
0.51095337.11136203.html.plaintext.txt	46	consensus opinion appears apoe genotype determines rather whether one succumbs alzheimers disease example cache county study meyer et al 1998 breitner et al 1999 elderly population almost 5000 found 22 cases alzheimers disease among 141 apoe 4 homozygotes 118 among 1452 apoe 4 heterozygotes 80 among 3339 bearing apoe 4 allele appeared plateau groups survival curve beyond new cases alzheimers disease seen apoe 4 homozygotes new cases seen age 84 years nine individuals surviving without alzheimers disease combined total 37 years apoe 4 heterozygotes last onset alzheimers disease 99 years four long term survivors last onset dementia individuals without apoe 4 allele age 95 years 31 surviving free dementia combined total 100 years thereafter differential effect apoe genotype age maximum risk alzheimers disease also suggested apoe meta analysis farrer et al 1997 also study asada et al 1996
0.51095337.11136203.html.plaintext.txt	47	bayesian analysis used seshadri et al 1995 relate apoe genotype lifetime risk developing alzheimers disease estimates dementia risk derived framingham study seshadri et al 1997 substituted analysis somewhat lower risk estimates stratified according gender obtained table 2
0.51095337.11136203.html.plaintext.txt	48	bayesian analysis used seshadri et al 1995 relate apoe genotype lifetime risk developing alzheimers disease estimates dementia risk derived framingham study seshadri et al 1997 substituted analysis somewhat lower risk estimates stratified according gender obtained table 2
0.51095337.11136203.html.plaintext.txt	49	view table table 2 remaining lifetime risk age 65 years developing alzheimers disease according gender apolipoprotein e apoe status
0.51095337.11136203.html.plaintext.txt	50	estimates suggest 50 apoe 4 homozygotes develop alzheimers disease within lifetime predictions agree well general population based study henderson et al 1995 suggested risk developing dementia age 90 years apoe 4 homozygotes 50
0.51095337.11136203.html.plaintext.txt	51	estimates suggest 50 apoe 4 homozygotes develop alzheimers disease within lifetime predictions agree well general population based study henderson et al 1995 suggested risk developing dementia age 90 years apoe 4 homozygotes 50
0.51095337.11136203.html.plaintext.txt	52	possible clinical uses apoe genotyping alzheimers disease top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references foregoing obvious knowledge persons apoe genotype little use predicting chances succumbing alzheimers disease knowledge family history dementia seems even individuals apoe 4apoe 4 genotype average greater 50 chance escaping disease therefore apoe genotyping currently role predicting risk developing alzheimers disease
0.51095337.11136203.html.plaintext.txt	53	claims made apoe genotyping may aid diagnosing alzheimers disease study mayeux et al 1998 suggested patients referred specialised assessment centres alzheimers disease apoe genotyping used combination clinical criteria might improve specificity diagnosis data show whereas demonstration one apoe 4 allele person suspected suffering dementia slightly increases accuracy clinical diagnosis alzheimers disease absence apoe 4 allele little value either endorsing refuting clinical diagnosis alzheimers disease thus even selected group patients presumably high priori chance alzheimers disease apoe genotyping seems confer negligible diagnostic benefit
0.51095337.11136203.html.plaintext.txt	54	claims made apoe genotyping may aid diagnosing alzheimers disease study mayeux et al 1998 suggested patients referred specialised assessment centres alzheimers disease apoe genotyping used combination clinical criteria might improve specificity diagnosis data show whereas demonstration one apoe 4 allele person suspected suffering dementia slightly increases accuracy clinical diagnosis alzheimers disease absence apoe 4 allele little value either endorsing refuting clinical diagnosis alzheimers disease thus even selected group patients presumably high priori chance alzheimers disease apoe genotyping seems confer negligible diagnostic benefit
0.51095337.11136203.html.plaintext.txt	55	genetic counselling alzheimers disease top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references number groups uk usa formulated consensus guidelines regarding genetic testing genetic counselling alzheimers disease including alzheimers disease international brodaty et al 1996 american college medical geneticsamerican society human genetics working group apoe alzheimers disease farrer et al 1995 alzheimers associationnational institute aging davies et al 1998 uk alzheimers disease genetics consortium meets regularly discuss issues surrounding clinical use genetics alzheimers disease issues include whether test counsel patients issues regarding confidentiality consent research ethics concerns regarding insurance tunstall lovestone 1999 various groups drawn following consensus guidelines generally one mind regard clinical response growing understanding genetics alzheimers disease
0.51095337.11136203.html.plaintext.txt	56	families evidence fad indeed familial early onset dementia referred specialist centre uk regional genetics department counselling families follow process established huntingtons disease late onset alzheimers disease groups agreed role apoe genotyping prediction risk assessment
0.51095337.11136203.html.plaintext.txt	57	families evidence fad indeed familial early onset dementia referred specialist centre uk regional genetics department counselling families follow process established huntingtons disease late onset alzheimers disease groups agreed role apoe genotyping prediction risk assessment
0.51095337.11136203.html.plaintext.txt	58	recommendations top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references apparent fad early onset familial dementia straight forward refer regional genetics department
0.51095337.11136203.html.plaintext.txt	59	late onset alzheimers disease late onset alzheimers disease wide agreement genetic test available genetic testing genetic counselling absence test mean relatives denied information opportunity discuss concerns asked likely get alzheimers disease relative patient late onset alzheimers disease one answer cases alzheimers disease possible advise relatives risk broadest terms extrapolating family history studies possible say risk children region one five one six one prepared illustrate means easy understand graphical form believe permissible broad estimate risk imparted consultant doctor specifically trained genetic counselling
0.51095337.11136203.html.plaintext.txt	60	late onset alzheimers disease late onset alzheimers disease wide agreement genetic test available genetic testing genetic counselling absence test mean relatives denied information opportunity discuss concerns asked likely get alzheimers disease relative patient late onset alzheimers disease one answer cases alzheimers disease possible advise relatives risk broadest terms extrapolating family history studies possible say risk children region one five one six one prepared illustrate means easy understand graphical form believe permissible broad estimate risk imparted consultant doctor specifically trained genetic counselling
0.51095337.11136203.html.plaintext.txt	61	occasionally psychiatrists encounter families several siblings affected late onset alzheimers disease history dementia previous generations families almost certainly exhibit high genetic loading reliable data whether extent risk increases number affected relatives although studies common disorders suggest likely case however borne mind number affected relatives may well depend factors affecting longevity well degree genetic loading alzheimers disease may advisable possible base discussion risk estimates increased several relatives affected late old age also preliminary evidence substantially increased risk offspring parents diagnosis alzheimers disease bird et al 1993 pedigrees relatives request information may worth taking detailed family history consulting clinical geneticist
0.51095337.11136203.html.plaintext.txt	62	occasionally psychiatrists encounter families several siblings affected late onset alzheimers disease history dementia previous generations families almost certainly exhibit high genetic loading reliable data whether extent risk increases number affected relatives although studies common disorders suggest likely case however borne mind number affected relatives may well depend factors affecting longevity well degree genetic loading alzheimers disease may advisable possible base discussion risk estimates increased several relatives affected late old age also preliminary evidence substantially increased risk offspring parents diagnosis alzheimers disease bird et al 1993 pedigrees relatives request information may worth taking detailed family history consulting clinical geneticist
0.51095337.11136203.html.plaintext.txt	63	clinical implications limitations top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references clinical implications taking family history look cases dementia first degree relatives part every routine dementia diagnostic process clinician able recognise possible familial alzheimers disease able refer family regional genetics centre members family request genetic counselling clinician able advise relatives less highly genetically loaded pedigrees alzheimers disease risk broad terms seek advice regional genetics centre clarification required
0.51095337.11136203.html.plaintext.txt	64	limitations interests space clarity citation literature selective estimates risk instances approximate may need modified light future work data relating vascular mixed forms dementia available
0.51095337.11136203.html.plaintext.txt	65	limitations interests space clarity citation literature selective estimates risk instances approximate may need modified light future work data relating vascular mixed forms dementia available
0.51095337.11136203.html.plaintext.txt	66	acknowledgments top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references work supported medical research council cooperative group grant
0.51095337.11136203.html.plaintext.txt	67	references top abstract introduction autosomal dominant familial suggested approach highly suggested approach non family studies risk apolipoprotein e effect clinical significance possible clinical uses genetic counselling recommendations clinical implications acknowledgments references asada yamagata z kilnoshita et al 1996 prevalence dementia distribution apoe alleles japanese centenarians almost complete survey yamanashi prefecture japan journal american geriatrics society 44 151 155medline
0.51095337.11136203.html.plaintext.txt	68	received publication february 14 2000 revision received june 26 2000 accepted publication june 28 2000
0.51095337.11136203.html.plaintext.txt	69	received publication february 14 2000 revision received june 26 2000 accepted publication june 28 2000
0.5120089.12944419.html.plaintext.txt	0	reporter amyloid precursor protein secretase activity drosophila ming guo1 elizabeth j hong2 jolene fernandes2 larry zipursky3 bruce hay2
0.5120089.12944419.html.plaintext.txt	1	1department neurology brain research institute david geffen school medicine university california los angeles 90095 usa 2division biology mc156 29 california institute technology pasadena ca 91125 usa 3department biological chemistry howard hughes medical institute university california los angeles ca 90095 usa
0.5120089.12944419.html.plaintext.txt	2	received june 18 2003 accepted august 16 2003
0.5120089.12944419.html.plaintext.txt	3	abstract top abstract introduction results discussion materials methods references key event pathogenesis alzheimers disease ad deposition senile plaques consisting largely peptide known ss amyloid ass derived amyloid precursor protein app proteolytic activity called secretase cleaves app transmembrane domain required ass generation aberrant secretase cleavage app underlies majority early onset familial ad secretase resides large multi protein complex presenilin nicastrin aph 1 pen 2 four essential components thus identifying components pathways secretase activity regulated crucial understanding mechanisms underlying ad pathogenesis may provide new diagnostic tools therapeutic targets describe generation drosophila act living reporters secretase activity fly eye reporter flies size eye correlates level endogenous secretase activity sensitive levels three genes required app secretase activity presenilin nicastrin aph 1 thus flies provide sensitized system identify components secretase complex regulators activity used flies carry screen mutations suppress secretase activity identified small chromosomal region contains gene genes whose products may promote secretase activity
0.5120089.12944419.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references key event pathogenesis alzheimers disease ad deposition senile plaques consisting largely peptide known ss amyloid ass derived amyloid precursor protein app proteolytic activity called secretase cleaves app transmembrane domain required ass generation aberrant secretase cleavage app underlies majority early onset familial ad secretase resides large multi protein complex presenilin nicastrin aph 1 pen 2 four essential components thus identifying components pathways secretase activity regulated crucial understanding mechanisms underlying ad pathogenesis may provide new diagnostic tools therapeutic targets describe generation drosophila act living reporters secretase activity fly eye reporter flies size eye correlates level endogenous secretase activity sensitive levels three genes required app secretase activity presenilin nicastrin aph 1 thus flies provide sensitized system identify components secretase complex regulators activity used flies carry screen mutations suppress secretase activity identified small chromosomal region contains gene genes whose products may promote secretase activity
0.5120089.12944419.html.plaintext.txt	5	introduction top abstract introduction results discussion materials methods references alzheimers disease ad neurodegenerative disease brain manifests decline memory cognitive functions critical pathogenic event leading ad progressive accumulation amyloid plaques consisting primarily amyloid ss peptide ass reviewed 12 ass derived amyloid precursor protein app type 1 transmembrane protein action two proteolytic activities known ss secretase secretase fig 1a sequential action ss secretase cleaves app extracellular domain secretase cleaves app within transmembrane domain generates ass peptides releases intracellular domain app aicd membrane association fig 1a reviewed 1 4 secretase generates two major ass peptides 40 42 43 residues length differing length c termini longer forms ass ass42 43 prone aggregate thought seed formation amyloid plaques reviewed 3 5 understanding secretase mediated app cleavage achieved crucial understand ad pathogenesis secretase also cleaves signaling proteins within transmembrane domains reviewed 6 one notable ones notch key transmembrane receptor plays important roles cell cell communication development adulthood reviewed 7 cleavage notch secretase essential notch function function secretase evolutionarily conserved 67
0.5120089.12944419.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references alzheimers disease ad neurodegenerative disease brain manifests decline memory cognitive functions critical pathogenic event leading ad progressive accumulation amyloid plaques consisting primarily amyloid ss peptide ass reviewed 12 ass derived amyloid precursor protein app type 1 transmembrane protein action two proteolytic activities known ss secretase secretase fig 1a sequential action ss secretase cleaves app extracellular domain secretase cleaves app within transmembrane domain generates ass peptides releases intracellular domain app aicd membrane association fig 1a reviewed 1 4 secretase generates two major ass peptides 40 42 43 residues length differing length c termini longer forms ass ass42 43 prone aggregate thought seed formation amyloid plaques reviewed 3 5 understanding secretase mediated app cleavage achieved crucial understand ad pathogenesis secretase also cleaves signaling proteins within transmembrane domains reviewed 6 one notable ones notch key transmembrane receptor plays important roles cell cell communication development adulthood reviewed 7 cleavage notch secretase essential notch function function secretase evolutionarily conserved 67
0.5120089.12944419.html.plaintext.txt	7	view larger version 83k figure 1 fly eye based reporter secretase activity schematic illustration app cleavage sites sequential action ss secretase cleaves app extracellular domain ecd secretase cleaves app within transmembrane domain tmd generates ass b schematic illustrating secretase reporter reporter contains two components chimeric protein app gal4 substrate uas grim construct output app gal4 specifically expressed eye absence secretase mediated app cleavage left panel cell death observed vivo presence secretase right panel unleashed app fragment gal4 translocated nucleus activate grim dependent cell death c f scanning electron micrographs adult fly eyes various genotypes genotypes follows c gmr app gal4 d uas grim e gmr app gal4 uas grim f gmr p35 gmr app gal4 uas grim expression gmr app gal4 c uas grim d isolation resulted flies wildtype appearing eyes contrast expression gmr app gal4 uas grim reporter results adult flies small eyes e indicative retinal cell death retinal cell death present reporter flies eliminated eye size restored normal coexpression caspase inhibitor baculovirus p35 f
0.5120089.12944419.html.plaintext.txt	8	view larger version 83k figure 1 fly eye based reporter secretase activity schematic illustration app cleavage sites sequential action ss secretase cleaves app extracellular domain ecd secretase cleaves app within transmembrane domain tmd generates ass b schematic illustrating secretase reporter reporter contains two components chimeric protein app gal4 substrate uas grim construct output app gal4 specifically expressed eye absence secretase mediated app cleavage left panel cell death observed vivo presence secretase right panel unleashed app fragment gal4 translocated nucleus activate grim dependent cell death c f scanning electron micrographs adult fly eyes various genotypes genotypes follows c gmr app gal4 d uas grim e gmr app gal4 uas grim f gmr p35 gmr app gal4 uas grim expression gmr app gal4 c uas grim d isolation resulted flies wildtype appearing eyes contrast expression gmr app gal4 uas grim reporter results adult flies small eyes e indicative retinal cell death retinal cell death present reporter flies eliminated eye size restored normal coexpression caspase inhibitor baculovirus p35 f
0.5120089.12944419.html.plaintext.txt	9	secretase activity resides large multi protein complex 8 exact molecular weight composition still elucidated reviewed 910 recent observations indicate activity four proteins presenilin nicastrin aph 1 pen 2 necessary secretase activity reviewed 10 human genome encodes two presenilins presenilin 1 ps1 presenilin 2 ps2 presenilins bind app probably provide active catalytic core secretase act intimate cofactors reviewed 2611 14 mutations ps1 ps2 associated majority familial ad cases 4 nicastrin transmembrane glycoprotein isolated via ability bind ps1 15 promote notch signaling c elegans 16 aph 1 polytopic membrane protein originally identified regulator notch signaling c elegans 1718 binds presenilins nicastrin 19 21 pen 2 small protein spans membrane twice also first identified regulator notch signaling c elegans 18 four proteins coexpressed cerevisiae lacks endogenous secretase activity sufficient create active secretase complex 22 reviewed 10 finding suggests four proteins minimal core components secretase although exclude possibility factors yeast may also contribute formation active secretase complex four proteins regulate stability maturation tissue culture 19 26 regulation occurs unknown also unknown signaling pathways regulate secretase activity modifying assembly activity proteins
0.5120089.12944419.html.plaintext.txt	10	secretase activity resides large multi protein complex 8 exact molecular weight composition still elucidated reviewed 910 recent observations indicate activity four proteins presenilin nicastrin aph 1 pen 2 necessary secretase activity reviewed 10 human genome encodes two presenilins presenilin 1 ps1 presenilin 2 ps2 presenilins bind app probably provide active catalytic core secretase act intimate cofactors reviewed 2611 14 mutations ps1 ps2 associated majority familial ad cases 4 nicastrin transmembrane glycoprotein isolated via ability bind ps1 15 promote notch signaling c elegans 16 aph 1 polytopic membrane protein originally identified regulator notch signaling c elegans 1718 binds presenilins nicastrin 19 21 pen 2 small protein spans membrane twice also first identified regulator notch signaling c elegans 18 four proteins coexpressed cerevisiae lacks endogenous secretase activity sufficient create active secretase complex 22 reviewed 10 finding suggests four proteins minimal core components secretase although exclude possibility factors yeast may also contribute formation active secretase complex four proteins regulate stability maturation tissue culture 19 26 regulation occurs unknown also unknown signaling pathways regulate secretase activity modifying assembly activity proteins
0.5120089.12944419.html.plaintext.txt	11	drosophila secretase four known components functionally conserved drosophila endogenous secretase activity app notch 27 mechanism action formation high molecular weight complex presenilin also conserved 28 drosophila single homolog presenilin psn 29 31 nicastrin nct 32 34 aph 1 pen 2 18 loss psn nct function drosophila results notch like phenotypes 32 37 removing aph 1 pen 2 drosophila schneider 2 s2 culture cells via rna interference rnai suppresses cleavage app notch 18 together observations indicate mechanisms app cleavage occurs flies well pathways activity regulated conserved mammals
0.5120089.12944419.html.plaintext.txt	12	drosophila secretase four known components functionally conserved drosophila endogenous secretase activity app notch 27 mechanism action formation high molecular weight complex presenilin also conserved 28 drosophila single homolog presenilin psn 29 31 nicastrin nct 32 34 aph 1 pen 2 18 loss psn nct function drosophila results notch like phenotypes 32 37 removing aph 1 pen 2 drosophila schneider 2 s2 culture cells via rna interference rnai suppresses cleavage app notch 18 together observations indicate mechanisms app cleavage occurs flies well pathways activity regulated conserved mammals
0.5120089.12944419.html.plaintext.txt	13	genes regulate cleavage app isolated successfully several approaches positional cloning familial ad genes resulted identification ps1 ps2 biochemical purification ps1 associated proteins led identification nicastrin reviewed 3 5 function based vivo genetic screens conducted model systems c elegans drosophila phenotypes suggestive alteration secretase activity provide important complementary strategy identifying new genes regulating secretase example screens c elegans mutants notch like presenilin like developmental defects identified secretase regulators aph 2 nicastrin 16 aph 1 pen 2 1718 advantage vivo genetic approach rely direct physical binding existing proteins presenilins thus limited low affinity abundance important interacting components addition potential identify components regulatory pathways secretase activity may bind presenilin describe reporter allows determination endogenous levels secretase activity easy visualize nonessential neuronal tissue adult fly eye reporter designed identify changes cleavage app contrast previous c elegans drosophila based screens used presenilin notch mutant phenotypes development surrogate markers 16 18 addition describe results screen utilizing flies identified small region second chromosome containing one genes whose products may promote app secretase activity
0.5120089.12944419.html.plaintext.txt	14	genes regulate cleavage app isolated successfully several approaches positional cloning familial ad genes resulted identification ps1 ps2 biochemical purification ps1 associated proteins led identification nicastrin reviewed 3 5 function based vivo genetic screens conducted model systems c elegans drosophila phenotypes suggestive alteration secretase activity provide important complementary strategy identifying new genes regulating secretase example screens c elegans mutants notch like presenilin like developmental defects identified secretase regulators aph 2 nicastrin 16 aph 1 pen 2 1718 advantage vivo genetic approach rely direct physical binding existing proteins presenilins thus limited low affinity abundance important interacting components addition potential identify components regulatory pathways secretase activity may bind presenilin describe reporter allows determination endogenous levels secretase activity easy visualize nonessential neuronal tissue adult fly eye reporter designed identify changes cleavage app contrast previous c elegans drosophila based screens used presenilin notch mutant phenotypes development surrogate markers 16 18 addition describe results screen utilizing flies identified small region second chromosome containing one genes whose products may promote app secretase activity
0.5120089.12944419.html.plaintext.txt	15	results top abstract introduction results discussion materials methods references reporter app secretase activity living flies outlined figure 1b generated transgenic flies expressing chimeric type 1 transmembrane protein serves secretase substrate n terminus protein cleavable signal sequence followed fragment human app c terminal ss secretase cleavage site yeast transcription factor gal4 appended app c terminus protein known app gal4 targeted secretory pathway n terminal signal sequence cotranslational cleavage signal sequence app inserted membrane generates protein c terminal ss secretase cleavage site specifically expressed app gal4 eye control eye specific gmr promoter 38 reporter flies also carry secretase reporter output construct consists gal4 responsive transcriptional cassette driving expression drosophila cell death activator grim 39 absence secretase gal4 remains tethered membrane therefore unable enter nucleus activate transcription presence secretase activity cleavage app releases membrane fragment consisting intracellular domain app aicd gal4 fragment migrates nucleus activates grim transcription thereby promoting cell death eye fig 1b cells organisms act reporters caspase family proteases well notch app secretase activity generated previously 40 43 reporters proteolytic cleavage event linked transcriptional activation reporter lacz luciferase strategy utilizes retinal cell death readout generate visible quantifiable eye phenotype living animals hence facilitates vivo genetic screens
0.5120089.12944419.html.plaintext.txt	16	results top abstract introduction results discussion materials methods references reporter app secretase activity living flies outlined figure 1b generated transgenic flies expressing chimeric type 1 transmembrane protein serves secretase substrate n terminus protein cleavable signal sequence followed fragment human app c terminal ss secretase cleavage site yeast transcription factor gal4 appended app c terminus protein known app gal4 targeted secretory pathway n terminal signal sequence cotranslational cleavage signal sequence app inserted membrane generates protein c terminal ss secretase cleavage site specifically expressed app gal4 eye control eye specific gmr promoter 38 reporter flies also carry secretase reporter output construct consists gal4 responsive transcriptional cassette driving expression drosophila cell death activator grim 39 absence secretase gal4 remains tethered membrane therefore unable enter nucleus activate transcription presence secretase activity cleavage app releases membrane fragment consisting intracellular domain app aicd gal4 fragment migrates nucleus activates grim transcription thereby promoting cell death eye fig 1b cells organisms act reporters caspase family proteases well notch app secretase activity generated previously 40 43 reporters proteolytic cleavage event linked transcriptional activation reporter lacz luciferase strategy utilizes retinal cell death readout generate visible quantifiable eye phenotype living animals hence facilitates vivo genetic screens
0.5120089.12944419.html.plaintext.txt	17	flies expressing gmr app gal4 alone wildtype appearing eyes fig 1c flies carrying uas grim fig 1d contrast flies expressing gmr app gal4 uas grim referred hereafter reporter flies small eyes fig 1e importantly reporter small eye phenotype completely suppressed reporter flies also expressed gmr control potent cell death caspase inhibitor baculovirus p35 38 fig 1f drosophila cell death caspase inhibitor diap1 44 data shown observations indicate reporter small eye phenotype strictly due grim induced caspase dependent cell death result developmental defects activation signal transduction pathways cleaved app gal4 reporter protein
0.5120089.12944419.html.plaintext.txt	18	flies expressing gmr app gal4 alone wildtype appearing eyes fig 1c flies carrying uas grim fig 1d contrast flies expressing gmr app gal4 uas grim referred hereafter reporter flies small eyes fig 1e importantly reporter small eye phenotype completely suppressed reporter flies also expressed gmr control potent cell death caspase inhibitor baculovirus p35 38 fig 1f drosophila cell death caspase inhibitor diap1 44 data shown observations indicate reporter small eye phenotype strictly due grim induced caspase dependent cell death result developmental defects activation signal transduction pathways cleaved app gal4 reporter protein
0.5120089.12944419.html.plaintext.txt	19	secretase reporter flies act useful genetic background carry screens secretase regulators see screen genetic chemical generates false positives ie mutations act modifiers interesting project hand case sources modifiers include mutations affect efficiency gmr gal4 dependent transcriptional activation efficacy grim dependent cell death signaling intended use gmr gal4 uas grim eliminate false positives however since gmr gal4 uas grim flies lethal chose utilize two strains flies act reporters false positives first strain gmr grim expresses grim directly gmr control small eyes fig 2d second strain gmr gal4 uas grim greaper 45 chimeric protein greaper n terminus grim c terminus second cell death activator reaper rpr 46 gmr gal4 uas grpr flies also small eye phenotype due induction caspase dependent cell death 45 fig 2g true modifiers secretase activity alter eye size reporter flies false positive reporter flies false positives hand modify eye size similarly presence reporter false positive reporters example latter reduction levels glass encodes transcription factor drives gmr dependent expression 47 results suppression small eye phenotype reporter flies well false positive reporters data shown
0.5120089.12944419.html.plaintext.txt	20	secretase reporter flies act useful genetic background carry screens secretase regulators see screen genetic chemical generates false positives ie mutations act modifiers interesting project hand case sources modifiers include mutations affect efficiency gmr gal4 dependent transcriptional activation efficacy grim dependent cell death signaling intended use gmr gal4 uas grim eliminate false positives however since gmr gal4 uas grim flies lethal chose utilize two strains flies act reporters false positives first strain gmr grim expresses grim directly gmr control small eyes fig 2d second strain gmr gal4 uas grim greaper 45 chimeric protein greaper n terminus grim c terminus second cell death activator reaper rpr 46 gmr gal4 uas grpr flies also small eye phenotype due induction caspase dependent cell death 45 fig 2g true modifiers secretase activity alter eye size reporter flies false positive reporter flies false positives hand modify eye size similarly presence reporter false positive reporters example latter reduction levels glass encodes transcription factor drives gmr dependent expression 47 results suppression small eye phenotype reporter flies well false positive reporters data shown
0.5120089.12944419.html.plaintext.txt	21	view larger version 176k figure 2 secretase reporter flies sensitive levels psn scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim psnc1 c gmr app gal4 uas grim gmr psndn d gmr grim e gmr grim psnc1 f gmr grim gmr psndn g gmr gal4 uas grpr h gmr gal4 uas grpr psnc1 gmr gal4 uas grpr gmr psndn identical figure 1e crosses figures 1 3 set parallel decreasing psn levels suppress gmr app gal4 uas grim dependent small eye phenotype b c cf small eye phenotypes associated gmr grim e f cf d gmr gal4 uas grpr h cf g
0.5120089.12944419.html.plaintext.txt	22	view larger version 176k figure 2 secretase reporter flies sensitive levels psn scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim psnc1 c gmr app gal4 uas grim gmr psndn d gmr grim e gmr grim psnc1 f gmr grim gmr psndn g gmr gal4 uas grpr h gmr gal4 uas grpr psnc1 gmr gal4 uas grpr gmr psndn identical figure 1e crosses figures 1 3 set parallel decreasing psn levels suppress gmr app gal4 uas grim dependent small eye phenotype b c cf small eye phenotypes associated gmr grim e f cf d gmr gal4 uas grpr h cf g
0.5120089.12944419.html.plaintext.txt	23	activity reporter depends presenilin nicastrin aph 1 presenilin nicastrin aph 1 required secretase dependent cleavage app mammals drosophila reviewed 1014 thus important prediction eye phenotype reporter flies false positive reporter flies gmr grim gmr gal4 uas grpr sensitive levels psn nct aph 1 used two approaches decrease psn levels first made reporter flies heterozygous psn null mutation psnc1 35 thereby decreasing psn genetic dose 50 second generated expressed dominant negative version drosophila psn gmr control gmr psndn flies see materials methods details heterozygous flies psnc1 gmr psndn alone wild type appearing eyes data shown contrast decreasing psn levels suppressed small eye phenotype reporter fig 2b c cf small eye phenotypes associated gmr grim fig 2e f cf d gmr gal4 uas grpr fig 2h cf g
0.5120089.12944419.html.plaintext.txt	24	activity reporter depends presenilin nicastrin aph 1 presenilin nicastrin aph 1 required secretase dependent cleavage app mammals drosophila reviewed 1014 thus important prediction eye phenotype reporter flies false positive reporter flies gmr grim gmr gal4 uas grpr sensitive levels psn nct aph 1 used two approaches decrease psn levels first made reporter flies heterozygous psn null mutation psnc1 35 thereby decreasing psn genetic dose 50 second generated expressed dominant negative version drosophila psn gmr control gmr psndn flies see materials methods details heterozygous flies psnc1 gmr psndn alone wild type appearing eyes data shown contrast decreasing psn levels suppressed small eye phenotype reporter fig 2b c cf small eye phenotypes associated gmr grim fig 2e f cf d gmr gal4 uas grpr fig 2h cf g
0.5120089.12944419.html.plaintext.txt	25	results similar series experiments showed reporter eye phenotype also sensitive levels second component secretase complex nct fig 3 used two approaches reduce levels nct first made reporter flies heterozygous nct null allele nct j2 33 thereby decreasing nct genetic dose 50 second generated flies expressed nct rna interference construct gmr control gmr rnai nct flies see materials methods details introduced reporter background heterozygous flies nctj2 gmr rnai nct isolation wild type appearing eyes data shown however led strong suppression reporter dependent small eye phenotype fig 3b c cf psn reduction nct dose effect eye size false positive reporter flies gmr grim fig 3e f cf d gmr gal4 uas grpr fig 3h cf g
0.5120089.12944419.html.plaintext.txt	26	view larger version 176k figure 3 secretase reporter flies sensitive levels nct scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim nctj2 c gmr app gal4 uas grim gmr rnai nct d gmr grim e gmr grim nctj2 f gmr grim gmr rnai nct g gmr gal4 uas grpr h gmr gal4 uas grpr nctj2 gmr gal4 uas grpr gmr rnai nct identical figures 1e 2a d identical figure 2d g identical figure 2g crosses figures 1 3 set parallel decreasing nct levels suppresses gmr app gal4 uas grim dependent small eye phenotype b c cf small eye phenotypes associated gmr grim e f cf d gmr gal4 uasgrpr h cf g
0.5120089.12944419.html.plaintext.txt	27	view larger version 176k figure 3 secretase reporter flies sensitive levels nct scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim nctj2 c gmr app gal4 uas grim gmr rnai nct d gmr grim e gmr grim nctj2 f gmr grim gmr rnai nct g gmr gal4 uas grpr h gmr gal4 uas grpr nctj2 gmr gal4 uas grpr gmr rnai nct identical figures 1e 2a d identical figure 2d g identical figure 2g crosses figures 1 3 set parallel decreasing nct levels suppresses gmr app gal4 uas grim dependent small eye phenotype b c cf small eye phenotypes associated gmr grim e f cf d gmr gal4 uasgrpr h cf g
0.5120089.12944419.html.plaintext.txt	28	aph 1 third conserved protein required secretase activity mutations drosophila aph 1 available therefore determine loss aph 1 function suppressed reporter small eye phenotype generated flies expressed aph 1 rnai construct gmr control gmr rnai aph 1 flies flies wild type appearance data shown acted strong suppressors small eye phenotype reporter fig 4b false positive reporters gmr grim fig 4d gmr gal4 uas grpr fig 4f thus secretase reporter fly eye phenotype sensitive small changes roughly 2 fold levels three known components regulators secretase complex psn nct aph 1 observations argue gmr app gal4uas grim flies function reporters endogenous secretase activity constitute sensitized background screen secretase regulators components
0.5120089.12944419.html.plaintext.txt	29	aph 1 third conserved protein required secretase activity mutations drosophila aph 1 available therefore determine loss aph 1 function suppressed reporter small eye phenotype generated flies expressed aph 1 rnai construct gmr control gmr rnai aph 1 flies flies wild type appearance data shown acted strong suppressors small eye phenotype reporter fig 4b false positive reporters gmr grim fig 4d gmr gal4 uas grpr fig 4f thus secretase reporter fly eye phenotype sensitive small changes roughly 2 fold levels three known components regulators secretase complex psn nct aph 1 observations argue gmr app gal4uas grim flies function reporters endogenous secretase activity constitute sensitized background screen secretase regulators components
0.5120089.12944419.html.plaintext.txt	30	view larger version 115k figure 4 secretase reporter flies sensitive levels aph 1 scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim gmr rnai aph 1 c gmr grim d gmr grim gmr rnai aph 1 e gmr gal4 uas grpr f gmr gal4 uas grpr gmr rnai aph 1 decreasing aph 1 levels suppress gmr app gal4 uas grim dependent small eye phenotype b cf small eye phenotypes associated gmr grim d cf c gmr gal4 uas grpr f cf e
0.5120089.12944419.html.plaintext.txt	31	view larger version 115k figure 4 secretase reporter flies sensitive levels aph 1 scanning electron micrographs various genotypes shown genotypes follows gmr app gal4 uas grim b gmr app gal4 uas grim gmr rnai aph 1 c gmr grim d gmr grim gmr rnai aph 1 e gmr gal4 uas grpr f gmr gal4 uas grpr gmr rnai aph 1 decreasing aph 1 levels suppress gmr app gal4 uas grim dependent small eye phenotype b cf small eye phenotypes associated gmr grim d cf c gmr gal4 uas grpr f cf e
0.5120089.12944419.html.plaintext.txt	32	23c1 3 region contains potential regulators secretase activity carried genetic screen suppressors app secretase activity drosophila screened second chromosome using publicly available deficiency kit contains 85 stocks total delete 80 chromosome makes two fifths drosophila genome heterozygous deletion bearing flies crossed reporter flies progeny bearing deletion reporter identified scored suppression compared flies carrying reporter alone several regions contained strong suppressor activity identified table 1 one 55a 55f defined df2r1547 contains pen 2 gene 55c1 5 encodes fourth component mammalian drosophila secretase complex second strong suppressor region identified 23a1 c5 defined deficiency df2l90 fig 5a c region contains aph 1 23a6 df2l3910 23a6 b1 also removes aph 1 deficiency acted reporter suppressor much weaker one df2l90 fig 5d suggested region deleted df2l90 contains additional secretase suppressor loci used smaller deficiencies region map suppressor activity df2l97 23c3 d2 df2l4954 23d2 23e3 df2l6875 23c5 23e2 suppress reporter phenotype however df2l1567 deletes 23c1 e2 overlap df2l3910 acted strong reporter suppressor fig 5e df2l1567 suppress small eye phenotypes two false positive reporter lines gmr grim gmr gal4 uas grpr fig 5g together observations place suppressor 23c1 3 region based current annotations berkeley drosophila genome project bdgp region spans roughly 150 kb contains 10 15 annotated genes
0.5120089.12944419.html.plaintext.txt	33	23c1 3 region contains potential regulators secretase activity carried genetic screen suppressors app secretase activity drosophila screened second chromosome using publicly available deficiency kit contains 85 stocks total delete 80 chromosome makes two fifths drosophila genome heterozygous deletion bearing flies crossed reporter flies progeny bearing deletion reporter identified scored suppression compared flies carrying reporter alone several regions contained strong suppressor activity identified table 1 one 55a 55f defined df2r1547 contains pen 2 gene 55c1 5 encodes fourth component mammalian drosophila secretase complex second strong suppressor region identified 23a1 c5 defined deficiency df2l90 fig 5a c region contains aph 1 23a6 df2l3910 23a6 b1 also removes aph 1 deficiency acted reporter suppressor much weaker one df2l90 fig 5d suggested region deleted df2l90 contains additional secretase suppressor loci used smaller deficiencies region map suppressor activity df2l97 23c3 d2 df2l4954 23d2 23e3 df2l6875 23c5 23e2 suppress reporter phenotype however df2l1567 deletes 23c1 e2 overlap df2l3910 acted strong reporter suppressor fig 5e df2l1567 suppress small eye phenotypes two false positive reporter lines gmr grim gmr gal4 uas grpr fig 5g together observations place suppressor 23c1 3 region based current annotations berkeley drosophila genome project bdgp region spans roughly 150 kb contains 10 15 annotated genes
0.5120089.12944419.html.plaintext.txt	34	view table figure 5 23c1 3 region contains potential regulator secretase activity schematic drawings chromosomal region 23a e left arm second chromosome 2l solid black bar deficiencies utilized crosses indicated left regions deleted indicted gaps bars location aph 1 indicated asterisk strength reporter suppression deficiency indicated right strongest see also c boundaries 23c1 3 region identified containing suppressor indicated dashed vertical lines b e representative scanning electron micrographs fly eyes different genotypes df2l90 results strong suppression gmr app gal4 uas grim small eye phenotype c cf b df2l3910 much smaller deficiency deletes aph 1 results weaker suppression d df2l1567 include aph 1 also results suppression gmr app gal4 uas grim small eye phenotype e df2l1567 suppress gmr grim g cf f gmr gal4 uas grpr cf h together observations consistent hypothesis 23c1 3 region contains genes promotes secretase activity
0.5120089.12944419.html.plaintext.txt	35	observations consistent hypothesis region contains genes promote secretase activity however cannot exclude possibility modifier functions instead regulate fate aicd gal4 appended see also discussion possibility uninteresting aicd shown interact number proteins evidence suggests participate multiple cell biological processes reviewed 948 responsible modifier gene identified cell culture based assays using rnai interference follow aicd processing fate absence gene 18 distinguish possibilities
0.5120089.12944419.html.plaintext.txt	36	observations consistent hypothesis region contains genes promote secretase activity however cannot exclude possibility modifier functions instead regulate fate aicd gal4 appended see also discussion possibility uninteresting aicd shown interact number proteins evidence suggests participate multiple cell biological processes reviewed 948 responsible modifier gene identified cell culture based assays using rnai interference follow aicd processing fate absence gene 18 distinguish possibilities
0.5120089.12944419.html.plaintext.txt	37	discussion top abstract introduction results discussion materials methods references mutations three genes presenilin 1 presenilin 2 app result early onset ad polymorphism apoe4 associated increased susceptibility late onset ad however genes thought account little 30 genetic variance ad susceptibility 5 indicating important regulators remain identified pathogenesis ad results increased deposition ass seems likely components regulators secretase activity among
0.5120089.12944419.html.plaintext.txt	38	discussion top abstract introduction results discussion materials methods references mutations three genes presenilin 1 presenilin 2 app result early onset ad polymorphism apoe4 associated increased susceptibility late onset ad however genes thought account little 30 genetic variance ad susceptibility 5 indicating important regulators remain identified pathogenesis ad results increased deposition ass seems likely components regulators secretase activity among
0.5120089.12944419.html.plaintext.txt	39	described generation flies function living reporters app secretase activity flies secretase dependent cleavage app tethered transcription factor protease substrate expressed specifically developing eye leads transcriptional activation cell death activator grim thus levels endogenous secretase activity read function grim dependent cell death manifests flies decreased eye size drosophila eye particularly useful screening system regulators secretase activity since cell population dominated neurons eye dispensable viability fertility importantly reporter small eye phenotype easily quantifiable regulated dose dependent manner modest changes roughly 2 fold levels psn nct aph 1 encode known components secretase containing complex thus flies constitute sensitized background carry genetic screens regulators secretase activity
0.5120089.12944419.html.plaintext.txt	40	described generation flies function living reporters app secretase activity flies secretase dependent cleavage app tethered transcription factor protease substrate expressed specifically developing eye leads transcriptional activation cell death activator grim thus levels endogenous secretase activity read function grim dependent cell death manifests flies decreased eye size drosophila eye particularly useful screening system regulators secretase activity since cell population dominated neurons eye dispensable viability fertility importantly reporter small eye phenotype easily quantifiable regulated dose dependent manner modest changes roughly 2 fold levels psn nct aph 1 encode known components secretase containing complex thus flies constitute sensitized background carry genetic screens regulators secretase activity
0.5120089.12944419.html.plaintext.txt	41	important point surprising modest changes levels secretase components 2 fold reductions associated heterozygosity alter reporter eye phenotype effect secretase dependent developmental processes eye notch signaling reporter specifically designed sensitive able report levels secretase activity within normal physiologic range thus reporter flies engineered display dominant eye phenotype response wild type levels secretase activity brought several different ways reporter protein contains n terminal signal sequence removed cotranslationally generating protein n terminus ss secretase cleaved app therefore contrast endogenous substrates reporter protein require ss secretase cleavage order become suitable substrate secretase extent prior cleavage events rate limiting reporter become preferred substrate addition reporter flies app gal4 expressed high levels probably much higher endogenous secretase substrates notch therefore likely reporter protein becomes molar basis dominant substrate finally output reporter cell death eye requires gal4 dependent transcriptional activation uas grim element five optimized gal4 binding sites present construct 49 thereby conferring significant level transcription dependent amplification sensitized background modest changes level secretase activity brought changes levels components would expected result modification eye phenotype contrast engineered situation heterozygosity almost genes fly genome including psn nct aph 1 result observable phenotypes normal development residual 50 gene activity sufficient mediate normal signaling within cells words endogenous cellular signaling pathways notch normally buffered phenotypic variability response modest changes activity genes required notch processing reviewed 50
0.5120089.12944419.html.plaintext.txt	42	important point surprising modest changes levels secretase components 2 fold reductions associated heterozygosity alter reporter eye phenotype effect secretase dependent developmental processes eye notch signaling reporter specifically designed sensitive able report levels secretase activity within normal physiologic range thus reporter flies engineered display dominant eye phenotype response wild type levels secretase activity brought several different ways reporter protein contains n terminal signal sequence removed cotranslationally generating protein n terminus ss secretase cleaved app therefore contrast endogenous substrates reporter protein require ss secretase cleavage order become suitable substrate secretase extent prior cleavage events rate limiting reporter become preferred substrate addition reporter flies app gal4 expressed high levels probably much higher endogenous secretase substrates notch therefore likely reporter protein becomes molar basis dominant substrate finally output reporter cell death eye requires gal4 dependent transcriptional activation uas grim element five optimized gal4 binding sites present construct 49 thereby conferring significant level transcription dependent amplification sensitized background modest changes level secretase activity brought changes levels components would expected result modification eye phenotype contrast engineered situation heterozygosity almost genes fly genome including psn nct aph 1 result observable phenotypes normal development residual 50 gene activity sufficient mediate normal signaling within cells words endogenous cellular signaling pathways notch normally buffered phenotypic variability response modest changes activity genes required notch processing reviewed 50
0.5120089.12944419.html.plaintext.txt	43	secretase reporter flies designed identify factors regulate secretase cleavage however important note several sorts interesting modifiers may identified include factors influence stability subcellular localization app gal4 aicd secretase components could also include factors regulate proteolysis reporter outside secretase target site particular regulators recently identified cleavage c terminal cleavage site also regulated psn 51 54 may also detected many factors would potential relevance understanding alzheimers disease mechanisms
0.5120089.12944419.html.plaintext.txt	44	secretase reporter flies designed identify factors regulate secretase cleavage however important note several sorts interesting modifiers may identified include factors influence stability subcellular localization app gal4 aicd secretase components could also include factors regulate proteolysis reporter outside secretase target site particular regulators recently identified cleavage c terminal cleavage site also regulated psn 51 54 may also detected many factors would potential relevance understanding alzheimers disease mechanisms
0.5120089.12944419.html.plaintext.txt	45	reporter several advantages conducting genome wide genetic screens first small eye phenotype reporter flies acts readout endogenous physiological levels secretase stands contrast situation many eye based dominant modifier screens sensitized background results hyperactivation signaling pathway 55 thus modification reporter small eye phenotype genetic manipulations chemical compounds directly reflects modifications endogenous physiologically relevant level secretase activity second reporter allows us conduct screens focused specifically identifying genes regulate cleavage app makes assumption role psn secretase function thus constitutes unbiased approach identifying factors regulating app processing stands contrast screens focused identifying genes use notch psn loss function phenotypes development surrogate marker third sensitivity reporter allows us conduct f1 dominant modifier screens since large number flies screened short period time f1 first generation sets stage genome wide search mutations affecting secretase moreover disruption one copy almost genes fly genome leads flies viable fertile thus function genes tested even though homozygous deletion gene might lethal earlier development finally reporter flies also useful exploring roles candidate genes secretase regulation particular fact levels specific genes eyes reporter flies selectively decreased using gmr rnai constructs illustrated nct aph 1 provides rapid method test candidate secretase regulators neural tissue vivo
0.5120089.12944419.html.plaintext.txt	46	reporter several advantages conducting genome wide genetic screens first small eye phenotype reporter flies acts readout endogenous physiological levels secretase stands contrast situation many eye based dominant modifier screens sensitized background results hyperactivation signaling pathway 55 thus modification reporter small eye phenotype genetic manipulations chemical compounds directly reflects modifications endogenous physiologically relevant level secretase activity second reporter allows us conduct screens focused specifically identifying genes regulate cleavage app makes assumption role psn secretase function thus constitutes unbiased approach identifying factors regulating app processing stands contrast screens focused identifying genes use notch psn loss function phenotypes development surrogate marker third sensitivity reporter allows us conduct f1 dominant modifier screens since large number flies screened short period time f1 first generation sets stage genome wide search mutations affecting secretase moreover disruption one copy almost genes fly genome leads flies viable fertile thus function genes tested even though homozygous deletion gene might lethal earlier development finally reporter flies also useful exploring roles candidate genes secretase regulation particular fact levels specific genes eyes reporter flies selectively decreased using gmr rnai constructs illustrated nct aph 1 provides rapid method test candidate secretase regulators neural tissue vivo
0.5120089.12944419.html.plaintext.txt	47	materials methods top abstract introduction results discussion materials methods references constructs transgenes app gal4 coding sequence contains cleavable signal sequence followed c terminal fragment human app 56 initiates immediately downstream ss cleavage site residue 671 also lacks stop codon gal4 57 appended c terminus app generating app gal4
0.5120089.12944419.html.plaintext.txt	48	materials methods top abstract introduction results discussion materials methods references constructs transgenes app gal4 coding sequence contains cleavable signal sequence followed c terminal fragment human app 56 initiates immediately downstream ss cleavage site residue 671 also lacks stop codon gal4 57 appended c terminus app generating app gal4
0.5120089.12944419.html.plaintext.txt	49	residue d278 drosophila psn corresponds one two evolutionarily conserved aspartate residues located putative transmembrane domains 6 7 29 mutation either conserved residues alanine mammalian ps1 creates protein dominant negative activity 58 generated dominant negative version drosophila psn psn d278a psn cdna ld25307 obtained research genetics using stratagene quikchange site directed mutagenesis kit psn d278a introduced gmr vector generating gmr psn d278a
0.5120089.12944419.html.plaintext.txt	50	residue d278 drosophila psn corresponds one two evolutionarily conserved aspartate residues located putative transmembrane domains 6 7 29 mutation either conserved residues alanine mammalian ps1 creates protein dominant negative activity 58 generated dominant negative version drosophila psn psn d278a psn cdna ld25307 obtained research genetics using stratagene quikchange site directed mutagenesis kit psn d278a introduced gmr vector generating gmr psn d278a
0.5120089.12944419.html.plaintext.txt	51	gmr driven nct aph 1 rnai constructs generated following strategy results transcription sense antisense strands transgene expressed gmr control 59 similar strategy developed drive double stranded rna production uas control 60 fragment drosophila nct coding region residues 291 696 aph 1 coding region amino acid residues 29 174 introduced two gmr promoter sequences oriented opposite directions vector pcasper generating gmr rnai nct gmr rnai aph 1 respectively ensure rnai effect specific transgene question transgenic flies containing gmr rnai nct suppresses small eye phenotype gmr app gal4 uas grim reporter crossed flies small eyes due expression gmr grim gmr reaper rpr gmr hid 4461 small eye phenotypes flies suppressed data shown
0.5120089.12944419.html.plaintext.txt	52	gmr driven nct aph 1 rnai constructs generated following strategy results transcription sense antisense strands transgene expressed gmr control 59 similar strategy developed drive double stranded rna production uas control 60 fragment drosophila nct coding region residues 291 696 aph 1 coding region amino acid residues 29 174 introduced two gmr promoter sequences oriented opposite directions vector pcasper generating gmr rnai nct gmr rnai aph 1 respectively ensure rnai effect specific transgene question transgenic flies containing gmr rnai nct suppresses small eye phenotype gmr app gal4 uas grim reporter crossed flies small eyes due expression gmr grim gmr reaper rpr gmr hid 4461 small eye phenotypes flies suppressed data shown
0.5120089.12944419.html.plaintext.txt	53	transformants generated using standard microinjection 62 procedures 0 1 h w1118 embryos multiple transgenic lines obtained microinjections experiment least four different insertion lines tested
0.5120089.12944419.html.plaintext.txt	54	transformants generated using standard microinjection 62 procedures 0 1 h w1118 embryos multiple transgenic lines obtained microinjections experiment least four different insertion lines tested
0.5120089.12944419.html.plaintext.txt	55	fly strains genetics drosophila strains raised standard cornmeal yeast agar medium 25 degrees c except gmr gal4 uas greaper stock raised room temperature 20 degrees c alleles used study follows psnc1 psnc2 struhl 35 nctj2 nctj1 ncta7 fortini 33 gmr greaper 45 nambu gmr p35 38 gmr diap1 44
0.5120089.12944419.html.plaintext.txt	56	fly strains genetics drosophila strains raised standard cornmeal yeast agar medium 25 degrees c except gmr gal4 uas greaper stock raised room temperature 20 degrees c alleles used study follows psnc1 psnc2 struhl 35 nctj2 nctj1 ncta7 fortini 33 gmr greaper 45 nambu gmr p35 38 gmr diap1 44
0.5120089.12944419.html.plaintext.txt	57	flies carrying one copy gmr app gal4 one copy uas grim chromosome generated meiotic recombination resulting gmr app gal4 uas grim chromosome balanced cyo gmr app gal4 uas grim flies crossed different genetic backgrounds appropriate progeny compared progeny gmr app gal4 uas grim outcrossed w1118 background stock gmr driven transgenes introduced similar crosses carried two false positive reporters gmr grim gmr gal4 uas grpr crosses carried 25 degrees c except involving gmr gal4 uas grpr carried room temperature 20 degrees c
0.5120089.12944419.html.plaintext.txt	58	flies carrying one copy gmr app gal4 one copy uas grim chromosome generated meiotic recombination resulting gmr app gal4 uas grim chromosome balanced cyo gmr app gal4 uas grim flies crossed different genetic backgrounds appropriate progeny compared progeny gmr app gal4 uas grim outcrossed w1118 background stock gmr driven transgenes introduced similar crosses carried two false positive reporters gmr grim gmr gal4 uas grpr crosses carried 25 degrees c except involving gmr gal4 uas grpr carried room temperature 20 degrees c
0.5120089.12944419.html.plaintext.txt	59	group stocks deficiency kit together delete one piece time large fraction second chromosome obtained bloomington stock center lines crossed reporter flies reporter progeny carrying one copy deficiency chromosome examined suppression reporter small eye phenotype deficiencies tested positive assay characterized similar crosses false positive reporter strains gmr grim gmr gal4 uas grpr
0.5120089.12944419.html.plaintext.txt	60	group stocks deficiency kit together delete one piece time large fraction second chromosome obtained bloomington stock center lines crossed reporter flies reporter progeny carrying one copy deficiency chromosome examined suppression reporter small eye phenotype deficiencies tested positive assay characterized similar crosses false positive reporter strains gmr grim gmr gal4 uas grpr
0.5120089.12944419.html.plaintext.txt	61	scanning electron microscopy samples flies dehydrated ethanol series incubated overnight hexamethyldisilazane sigma air dried prior analyzed using hitachi scanning electron microscopy others flies quickly frozen 80 degrees c mounted analyzed directly methods preparation gave identical results
0.5120089.12944419.html.plaintext.txt	62	scanning electron microscopy samples flies dehydrated ethanol series incubated overnight hexamethyldisilazane sigma air dried prior analyzed using hitachi scanning electron microscopy others flies quickly frozen 80 degrees c mounted analyzed directly methods preparation gave identical results
0.5120089.12944419.html.plaintext.txt	63	acknowledgements thank john nambu gary struhl mark fortini gift fly stocks bloomington drosophila stock center deficiency kit george jackson demonstrating sem technique hong yu technical assistance mg wishes thank members zipursky laboratory daniel geschwind helpful discussions robert collins encouragement support ruilan wang support assistance fly work work supported national institute health career development award ko8 ns 42580 john douglas french alzheimers foundation fellowship ucla alzheimer disease research center pilot grant giannini family foundation fellowship mg grants burroughs wellcome fund new investigator award pharmacological sciences ellison medical foundation bah
0.5120089.12944419.html.plaintext.txt	64	footnotes correspondence addressed tel 1 3102067597 fax 1 3102069406 email mingflyatuclaedu
0.5120089.12944419.html.plaintext.txt	65	footnotes correspondence addressed tel 1 3102067597 fax 1 3102069406 email mingflyatuclaedu
0.5120089.12944419.html.plaintext.txt	66	references top abstract introduction results discussion materials methods references walter j kaether c steiner h haass c 2001 cell biology alzheimers disease uncovering secrets secretases curr opin neurobiol 11 585 590crossrefisimedline
0.5120089.12944419.html.plaintext.txt	67	st george hyslop p 2000 molecular genetics alzheimers disease biol psych 47 183 199crossrefisimedline
0.5120089.12944419.html.plaintext.txt	68	de strooper b 2003 aph 1 pen 2 nicastrin presenilin generate active secretase complex neuron 38 9 12isimedline
0.5120089.12944419.html.plaintext.txt	69	checler f 2001 multiple paradoxes presenilins j neurochem 76 1621 1627crossrefisimedline
0.5120089.12944419.html.plaintext.txt	70	rutherford 2003 genotype phenotype protein chaperones evolvability nat rev genet 4 263 274crossrefisimedline
0.5120089.12944419.html.plaintext.txt	71	article abstract free full text pdf versions article 12202669 recent ddg292v1 alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager search citing articles isi web science 5 request permissions google scholar articles guo m articles hay b pubmed pubmed citation articles guo m articles hay b online issn 1460 2083 print issn 0964 6906 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.5472486.15123653.html.plaintext.txt	0	notch oncoproteins depend secretasepresenilin activity processing function indranil das colleen craig yasuhiro funahashi kwang mook jung tae wan kim richard byers andrew p weng jeffery l kutok jon c aster jan kitajewski
0.5472486.15123653.html.plaintext.txt	1	department pathology obstetricsgynecology columbia university college physicians surgeons new york new york 10032 dana farber cancer institute boston massachusetts 02115 department pathology brigham womens hospital harvard medical school boston massachusetts 02115
0.5472486.15123653.html.plaintext.txt	2	received publication august 20 2003 revised form may 3 2004
0.5472486.15123653.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references normal development notch receptor signaling important regulating numerous cell fate decisions mutations truncate extracellular domain notch receptors cause aberrant signaling promote unregulated cell growth examined two types truncated notch oncoproteins arise proviral insertion notch4 gene notch4int 3 chromosomal translocation involving notch1 gene tan 1 notch4int 3 tan 1 oncoproteins lack ectodomain normal notch signaling requires secretasepresenilin mediated proteolytic processing whether notch oncoproteins also dependent secretasepresenilin activity known demonstrate notch4int 3 induced activation downstream transcription factor csl abrogated cells deficient presenilins treated pharmacological inhibitor secretasepresenilins furthermore find notch4int 3 tan 1 accumulate cell surface presenilin dependent cleavage occurs secretasepresenilin activity inhibited secretasepresenilin inhibition effectively blocks cellular responses notch4int 3 tan 1 apparently tan 1 polypeptides lack transmembrane domains require secretasepresenilin activity nuclear access studies highlight potential uses limitations secretasepresenilin inhibitors targeted therapy notch related neoplasms
0.5472486.15123653.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references normal development notch receptor signaling important regulating numerous cell fate decisions mutations truncate extracellular domain notch receptors cause aberrant signaling promote unregulated cell growth examined two types truncated notch oncoproteins arise proviral insertion notch4 gene notch4int 3 chromosomal translocation involving notch1 gene tan 1 notch4int 3 tan 1 oncoproteins lack ectodomain normal notch signaling requires secretasepresenilin mediated proteolytic processing whether notch oncoproteins also dependent secretasepresenilin activity known demonstrate notch4int 3 induced activation downstream transcription factor csl abrogated cells deficient presenilins treated pharmacological inhibitor secretasepresenilins furthermore find notch4int 3 tan 1 accumulate cell surface presenilin dependent cleavage occurs secretasepresenilin activity inhibited secretasepresenilin inhibition effectively blocks cellular responses notch4int 3 tan 1 apparently tan 1 polypeptides lack transmembrane domains require secretasepresenilin activity nuclear access studies highlight potential uses limitations secretasepresenilin inhibitors targeted therapy notch related neoplasms
0.5472486.15123653.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references notch proteins family single pass transmembrane receptors regulate cell fate decisions development including differentiation arterial versus venous fates vascular system 1 cell versus b cell development immune system 2 3 appropriate levels notch signaling critical normal development loss notch signaling excessive notch signaling leads embryonic lethal phenotypes 4 5 additionally abnormal activation several notch proteins associated tumorigenesis including subset human cell acute lymphoblastic leukemias all1
0.5472486.15123653.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references notch proteins family single pass transmembrane receptors regulate cell fate decisions development including differentiation arterial versus venous fates vascular system 1 cell versus b cell development immune system 2 3 appropriate levels notch signaling critical normal development loss notch signaling excessive notch signaling leads embryonic lethal phenotypes 4 5 additionally abnormal activation several notch proteins associated tumorigenesis including subset human cell acute lymphoblastic leukemias all1
0.5472486.15123653.html.plaintext.txt	7	vertebrates full length notch proteins part family four receptors notch1 4 five ligands include members jagged delta families notch receptors extracellular ec domain consisting largely multiple epidermal growth factor like repeats within binding sites ligands notch receptors also cytoplasmic region containing ram domain seven ankyrin repeats c terminal pest domain newly synthesized notch receptors processed initially trans golgi furin like convertase generating ligand binding ectodomain transmembrane signaling domain remain associated transport plasma membrane 6 8 ligand binding ectodomain induces several successive proteolytic cleavage events transmembrane subunit result release intracellular domain cell membrane initial cleavage adam disintegrin metalloprotease type metalloproteases occurs external transmembrane tm domain 9 10 serves facilitate additional cleavages secretasespresenilins within tm domain 11 mammalian presenilins ps 1 ps 2 polytopic membrane proteins appear function aspartyl proteases within high molecular mass multiprotein complex also includes proteins nicastrin aph 1 pen 2 12 15 presenilins provide active site secretase proteolytic activity 16
0.5472486.15123653.html.plaintext.txt	8	vertebrates full length notch proteins part family four receptors notch1 4 five ligands include members jagged delta families notch receptors extracellular ec domain consisting largely multiple epidermal growth factor like repeats within binding sites ligands notch receptors also cytoplasmic region containing ram domain seven ankyrin repeats c terminal pest domain newly synthesized notch receptors processed initially trans golgi furin like convertase generating ligand binding ectodomain transmembrane signaling domain remain associated transport plasma membrane 6 8 ligand binding ectodomain induces several successive proteolytic cleavage events transmembrane subunit result release intracellular domain cell membrane initial cleavage adam disintegrin metalloprotease type metalloproteases occurs external transmembrane tm domain 9 10 serves facilitate additional cleavages secretasespresenilins within tm domain 11 mammalian presenilins ps 1 ps 2 polytopic membrane proteins appear function aspartyl proteases within high molecular mass multiprotein complex also includes proteins nicastrin aph 1 pen 2 12 15 presenilins provide active site secretase proteolytic activity 16
0.5472486.15123653.html.plaintext.txt	9	presenilin mediated cleavage involved activation four mammalian notch receptors 17 18 case notch1 occurs several sites within tm domain 19 notch1 cleavage prevented addition secretase inhibitors mutations within critical aspartate residues presenilin 20 21 delta 1 induced signaling notch1 also reduced cells deficient presenilins cells treated secretase inhibitors 21 23 presenilins recently recognized multiple substrates addition notch including amyloid precursor protein erbb4 n e cadherins cd44 24 28 presenilins necessary ectodomain shedding cleavage subsequent nuclear translocation intracellular domains polypeptides 11 25 27 29 case notch presenilin mediated cleavage allows notch intracellular domain ic gain access nucleus binds transcription factor cbf1csl binding event converts csl transcriptional repressor transcriptional activator leading expression target genes 30
0.5472486.15123653.html.plaintext.txt	10	presenilin mediated cleavage involved activation four mammalian notch receptors 17 18 case notch1 occurs several sites within tm domain 19 notch1 cleavage prevented addition secretase inhibitors mutations within critical aspartate residues presenilin 20 21 delta 1 induced signaling notch1 also reduced cells deficient presenilins cells treated secretase inhibitors 21 23 presenilins recently recognized multiple substrates addition notch including amyloid precursor protein erbb4 n e cadherins cd44 24 28 presenilins necessary ectodomain shedding cleavage subsequent nuclear translocation intracellular domains polypeptides 11 25 27 29 case notch presenilin mediated cleavage allows notch intracellular domain ic gain access nucleus binds transcription factor cbf1csl binding event converts csl transcriptional repressor transcriptional activator leading expression target genes 30
0.5472486.15123653.html.plaintext.txt	11	notch signaling normally activated interaction notch receptor ligand expressed adjacent cell truncated forms notch containing deletions spanning ec domain bypass need ligand binding signal constitutively two notch deletions involving mouse notch4 human notch1 initially named tan 1 translocation associated notch homolog 1 originally identified oncogenes int 3 oncogene refer notch4int 3 arises retroviral integration mouse mammary tumor virus notch4 locus causes murine mammary tumors 31 33 cases viral integration results production truncated transcript encodes tm ic domain notch4 see fig 8 similar fashion tan 1 oncogene associated generated truncation human notch1 caused recurrent 7 9 chromosomal translocation involving notch1 gene cell receptor gene 34 breakpoints identified date occur within intron prior exon encoding 34th epidermal growth factor repeat result fusion 3 end notch1 cell receptor promoterenhancer elements fusion gene drives expression multiple truncated mrnas encode series n terminally truncated tan 1 polypeptides ranging size slightly larger slightly smaller normal notch1 transmembrane subunit 35 precise structure origin polypeptides defined
0.5472486.15123653.html.plaintext.txt	12	notch signaling normally activated interaction notch receptor ligand expressed adjacent cell truncated forms notch containing deletions spanning ec domain bypass need ligand binding signal constitutively two notch deletions involving mouse notch4 human notch1 initially named tan 1 translocation associated notch homolog 1 originally identified oncogenes int 3 oncogene refer notch4int 3 arises retroviral integration mouse mammary tumor virus notch4 locus causes murine mammary tumors 31 33 cases viral integration results production truncated transcript encodes tm ic domain notch4 see fig 8 similar fashion tan 1 oncogene associated generated truncation human notch1 caused recurrent 7 9 chromosomal translocation involving notch1 gene cell receptor gene 34 breakpoints identified date occur within intron prior exon encoding 34th epidermal growth factor repeat result fusion 3 end notch1 cell receptor promoterenhancer elements fusion gene drives expression multiple truncated mrnas encode series n terminally truncated tan 1 polypeptides ranging size slightly larger slightly smaller normal notch1 transmembrane subunit 35 precise structure origin polypeptides defined
0.5472486.15123653.html.plaintext.txt	13	view larger version 72k fig 8 model notch processing signaling ligand binding full length notch may induce structural changes allow tumor necrosis factor alpha converting enzyme tace presenilin cleavage release notchic membrane notch4int 3 lacks ectodomain inserted membranes traffics cell surface cleaved readily presenilins blockade presenilin mediated activity inhibit signal induction notch4int 3 fl notch tan 1 polypeptides demonstrate partial dependence presenilins like notch4int 3 tan 1 polypeptides inserted membranes depend proteolytic cleavage presenilins mtan 1 tan 1 polypeptides however may localized cell surface targeted nucleus presenilin independent manner ctan 1
0.5472486.15123653.html.plaintext.txt	14	understand mechanism action activities notch engineered notch proteins constitutively active studied engineered notch proteins include forms either consisting ic ic linked tm domain small portion ec domain leader peptide notche forms active variety assays oncogenic 36 38 notche depends presenilin activity 18 39 instance pharmacologic inhibition presenilin suppresses growth notch1e induced alls alls induced notch1 ic domain n1ic 40
0.5472486.15123653.html.plaintext.txt	15	understand mechanism action activities notch engineered notch proteins constitutively active studied engineered notch proteins include forms either consisting ic ic linked tm domain small portion ec domain leader peptide notche forms active variety assays oncogenic 36 38 notche depends presenilin activity 18 39 instance pharmacologic inhibition presenilin suppresses growth notch1e induced alls alls induced notch1 ic domain n1ic 40
0.5472486.15123653.html.plaintext.txt	16	study asked whether notch4int 3 tan 1 oncogenic forms notch proteins require presenilins proper processing signaling function activity based known sites truncation within notch1 notch4 genes oncogenic conversion tan 1 notch4int 3 predicted encode proteins including tm domains lacking signal peptides thus unclear whether oncoproteins would insert membranes require presenilin activity activation
0.5472486.15123653.html.plaintext.txt	17	study asked whether notch4int 3 tan 1 oncogenic forms notch proteins require presenilins proper processing signaling function activity based known sites truncation within notch1 notch4 genes oncogenic conversion tan 1 notch4int 3 predicted encode proteins including tm domains lacking signal peptides thus unclear whether oncoproteins would insert membranes require presenilin activity activation
0.5472486.15123653.html.plaintext.txt	18	results show notch4int 3 tan 1 targeted membrane subject presenilin mediated proteolytic processing notch4int 3 requires presenilin activity csl mediated signaling biological activity endothelial cells tan 1 however demonstrates partial dependence presenilin activity although blockade presenilin function alters tan 1 processing affect growth cells apparently tan 1 polypeptides bypass requirement presenilin processing nuclear access finding oncogenic forms notch depend presenilin activity function suggests potential avenues therapeutic intervention
0.5472486.15123653.html.plaintext.txt	19	results show notch4int 3 tan 1 targeted membrane subject presenilin mediated proteolytic processing notch4int 3 requires presenilin activity csl mediated signaling biological activity endothelial cells tan 1 however demonstrates partial dependence presenilin activity although blockade presenilin function alters tan 1 processing affect growth cells apparently tan 1 polypeptides bypass requirement presenilin processing nuclear access finding oncogenic forms notch depend presenilin activity function suggests potential avenues therapeutic intervention
0.5472486.15123653.html.plaintext.txt	20	experimental procedures top abstract introduction experimental procedures results discussion references reagents compound e cpde gift golde antibodies ps 1 loop ps 2 loop provided g thinakaran immortalized fibroblasts lacking ps 1 ps 2 provided b de strooper
0.5472486.15123653.html.plaintext.txt	21	luciferase reporter assays transient transfections performed calcium phosphate precipitation assessment activated notch signaling hela cells cells plated 24 h prior transfection 6 well plates 10 x 105 cellswell cells transfected triplicate 250 ng pqncn1ic ha 250 ng plncnotch4int 3 ha combination 500 ng csl luciferase reporter pga981 6 250 ng plnclacz control transfection efficiency activated notch signaling mefs wild type ps 12 assessed plating cells 24 h prior transfection 6 well plates 3 x 105 cellswell mefs transfected triplicate 1 microg pqncn1ic ha 1 microg plncnotch4int 3 ha combination 670 ng pga981 6 333 ng plnclacz
0.5472486.15123653.html.plaintext.txt	22	luciferase reporter assays transient transfections performed calcium phosphate precipitation assessment activated notch signaling hela cells cells plated 24 h prior transfection 6 well plates 10 x 105 cellswell cells transfected triplicate 250 ng pqncn1ic ha 250 ng plncnotch4int 3 ha combination 500 ng csl luciferase reporter pga981 6 250 ng plnclacz control transfection efficiency activated notch signaling mefs wild type ps 12 assessed plating cells 24 h prior transfection 6 well plates 3 x 105 cellswell mefs transfected triplicate 1 microg pqncn1ic ha 1 microg plncnotch4int 3 ha combination 670 ng pga981 6 333 ng plnclacz
0.5472486.15123653.html.plaintext.txt	23	determine ligand induced notch signaling coculture assays performed using hela 293 derived bosc cells hela cells plated 1 day earlier 10 cm plates 15 x 106 transfected 75 microg pbos notch1 pbos notch2 4 microg pga981 6 1 microg plnc lacz bosc cells plated 1 day prior 10 cm plates 4 x 106 transfected either 25 microg phytc jagged1 phytc delta 1 phytc delta 4 phytc x empty vector one day transfection cells cocultured triplicate helabosc 12 12 well plates 24 h
0.5472486.15123653.html.plaintext.txt	24	determine ligand induced notch signaling coculture assays performed using hela 293 derived bosc cells hela cells plated 1 day earlier 10 cm plates 15 x 106 transfected 75 microg pbos notch1 pbos notch2 4 microg pga981 6 1 microg plnc lacz bosc cells plated 1 day prior 10 cm plates 4 x 106 transfected either 25 microg phytc jagged1 phytc delta 1 phytc delta 4 phytc x empty vector one day transfection cells cocultured triplicate helabosc 12 12 well plates 24 h
0.5472486.15123653.html.plaintext.txt	25	cases cultures treated plus minus cpde 16 h prior harvest cells cells harvested luciferase activity determined 2 days post transfection using enhanced luciferase assay kit pharmingen galactosidase activity determined using galacto light plus kit pe biosystems assays performed berthold dual injection luminometer reporter activation normalized transfection efficiency fold reduction cpde calculated ratio normalized reporter activity untreated cells cpde treated cells
0.5472486.15123653.html.plaintext.txt	26	cases cultures treated plus minus cpde 16 h prior harvest cells cells harvested luciferase activity determined 2 days post transfection using enhanced luciferase assay kit pharmingen galactosidase activity determined using galacto light plus kit pe biosystems assays performed berthold dual injection luminometer reporter activation normalized transfection efficiency fold reduction cpde calculated ratio normalized reporter activity untreated cells cpde treated cells
0.5472486.15123653.html.plaintext.txt	27	biotinylation assays membrane expression tan 1 notch4int 3 n1ic ha determined performing surface biotinylation experiments notch4int 3 n1ic transiently transfected hela cells lipofectamine 2000 according manufacturers instructions invitrogen supt1 cells expressing tan 1 transfected hela cells treated plus minus cpde 16 h prior harvest supt1 cells transfected hela cells washed phosphate buffered saline labeled ez link sulfo nhs biotin pierce 30 min 4 degrees c biotin quenched phosphate buffered saline glycine cells washed phosphate buffered saline cells cultured 6 cm plates lysed tent buffer clearing lysates small aliquot saved load 50 ng whole cell lysate remainder lysate used purify surface proteins incubating immunopure immobilized streptavidin beads pierce overnight 4 degrees c streptavidin precipitated proteins whole cell lysates treated phosphatase new england biolabs separated sds page transferred polyvinylidene difluoride membranes probed antibodies tc detect tan 1 41 corb2 2 detect notch4int 3 42 12ca5 detect ha tagged n1ic anti glycogen synthetase kinase 3 transduction laboratories anti tubulin sigma anti 1 integrin 43 provided eugene marcantonio columbia university ps 1 loop ps 2 loop antibodies detect presenilins 1 2 respectively 44 proteins visualized ecl amersham biosciences
0.5472486.15123653.html.plaintext.txt	28	biotinylation assays membrane expression tan 1 notch4int 3 n1ic ha determined performing surface biotinylation experiments notch4int 3 n1ic transiently transfected hela cells lipofectamine 2000 according manufacturers instructions invitrogen supt1 cells expressing tan 1 transfected hela cells treated plus minus cpde 16 h prior harvest supt1 cells transfected hela cells washed phosphate buffered saline labeled ez link sulfo nhs biotin pierce 30 min 4 degrees c biotin quenched phosphate buffered saline glycine cells washed phosphate buffered saline cells cultured 6 cm plates lysed tent buffer clearing lysates small aliquot saved load 50 ng whole cell lysate remainder lysate used purify surface proteins incubating immunopure immobilized streptavidin beads pierce overnight 4 degrees c streptavidin precipitated proteins whole cell lysates treated phosphatase new england biolabs separated sds page transferred polyvinylidene difluoride membranes probed antibodies tc detect tan 1 41 corb2 2 detect notch4int 3 42 12ca5 detect ha tagged n1ic anti glycogen synthetase kinase 3 transduction laboratories anti tubulin sigma anti 1 integrin 43 provided eugene marcantonio columbia university ps 1 loop ps 2 loop antibodies detect presenilins 1 2 respectively 44 proteins visualized ecl amersham biosciences
0.5472486.15123653.html.plaintext.txt	29	analysis notch4int 3 expression 293 cells 293 cells maintained dulbeccos modified eagles medium supplemented 10 fetal bovine serum penicillinstreptomycin stable cell lines dwt dasp maintained dulbeccos modified eagles medium supplemented 10 fetal bovine serum penicillinstreptomycin presence 250 microgml zeocin invitrogen transient transfection cells transfected 100 mm dishes 10 microg plncint 3 ha notch1e plasmids using superfect transfection reagent according manufacturers instructions qiagen cultures treated cpde l 685458 calbiochem aebsf roche applied science pepstatin roche applied science me2so 16 h prior harvest cells 48 h post transfection cells lysed using buffer ip 10 mm tris hcl ph 74 150 mm nacl 1 triton x 100 025 nonidet p 40 2 mm edta supplemented protease inhibitor mixture tablet roche applied science protein quantification sds page western blot analyses carried described previously 27 primary anti ha antibody ha 11 covance used dilution 11000 anti cleaved notch1 val1744 antibody cell signaling used dilution 11000 anti tubulin sigma used 15000
0.5472486.15123653.html.plaintext.txt	30	analysis notch4int 3 expression 293 cells 293 cells maintained dulbeccos modified eagles medium supplemented 10 fetal bovine serum penicillinstreptomycin stable cell lines dwt dasp maintained dulbeccos modified eagles medium supplemented 10 fetal bovine serum penicillinstreptomycin presence 250 microgml zeocin invitrogen transient transfection cells transfected 100 mm dishes 10 microg plncint 3 ha notch1e plasmids using superfect transfection reagent according manufacturers instructions qiagen cultures treated cpde l 685458 calbiochem aebsf roche applied science pepstatin roche applied science me2so 16 h prior harvest cells 48 h post transfection cells lysed using buffer ip 10 mm tris hcl ph 74 150 mm nacl 1 triton x 100 025 nonidet p 40 2 mm edta supplemented protease inhibitor mixture tablet roche applied science protein quantification sds page western blot analyses carried described previously 27 primary anti ha antibody ha 11 covance used dilution 11000 anti cleaved notch1 val1744 antibody cell signaling used dilution 11000 anti tubulin sigma used 15000
0.5472486.15123653.html.plaintext.txt	31	culture human umbilical vein endothelial cells huvec huvec isolated human umbilical vein method described previously 45 huvec grown egm2 kit bio whittaker san diego containing vascular endothelial growth factor basic fibroblast growth factor epidermal growth factor insulin 2 fetal bovine serum type collagen coated 10 cm dishes harvested 80 confluence trypsin
0.5472486.15123653.html.plaintext.txt	32	culture human umbilical vein endothelial cells huvec huvec isolated human umbilical vein method described previously 45 huvec grown egm2 kit bio whittaker san diego containing vascular endothelial growth factor basic fibroblast growth factor epidermal growth factor insulin 2 fetal bovine serum type collagen coated 10 cm dishes harvested 80 confluence trypsin
0.5472486.15123653.html.plaintext.txt	33	adenoviral gene transfer 75 x 105 cells huvec passage 3 seeded type collagen coated 6 well plates day adenoviral infection adenoviral infection ad lacz ad notch4int 3 virus 42 performed multiplicity infection 60 incubated 37 degrees c 1 h occasional swirling plates infected cells harvested day infection experiments
0.5472486.15123653.html.plaintext.txt	34	sprouting assay making collagen gels ice cold solution porcine type collagen nitta gelatin tokyo japan mixed 10 x rpmi 1640 medium neutralization buffer ratio 811 aliquots collagen gel 400 microl added 24 well plates allowed gel least 1 h 37 degrees c adenoviral infection huvec harvested plated 13 x 105 cellswell onto top collagen gel 24 well plates 08 ml egm2 medium huvec became nearly confluent 48 h plating seeding medium changed every 2 days next 3 weeks treatment cpde started day 2 continued 3 weeks sprouting observed photographs taken 3 weeks olympus digital camera mounted microscope quantification number sprouts five fieldseach well selected randomly sprouting counted microscopy blind manner two investigators
0.5472486.15123653.html.plaintext.txt	35	sprouting assay making collagen gels ice cold solution porcine type collagen nitta gelatin tokyo japan mixed 10 x rpmi 1640 medium neutralization buffer ratio 811 aliquots collagen gel 400 microl added 24 well plates allowed gel least 1 h 37 degrees c adenoviral infection huvec harvested plated 13 x 105 cellswell onto top collagen gel 24 well plates 08 ml egm2 medium huvec became nearly confluent 48 h plating seeding medium changed every 2 days next 3 weeks treatment cpde started day 2 continued 3 weeks sprouting observed photographs taken 3 weeks olympus digital camera mounted microscope quantification number sprouts five fieldseach well selected randomly sprouting counted microscopy blind manner two investigators
0.5472486.15123653.html.plaintext.txt	36	cell cycle analysis supt1 cells seeded 1 x 106ml dulbeccos modified eagles medium containing 10 fetal calf serum indicated concentrations cpde carrier alone me2so cells split every 2 days fresh medium drug maintain cell density 05 15 x 106ml day 4 cells harvested fixed 70 etoh stained propidium iodide analyzed flow cytometry dna content cell cycle fractions determined using multicycle software
0.5472486.15123653.html.plaintext.txt	37	cell cycle analysis supt1 cells seeded 1 x 106ml dulbeccos modified eagles medium containing 10 fetal calf serum indicated concentrations cpde carrier alone me2so cells split every 2 days fresh medium drug maintain cell density 05 15 x 106ml day 4 cells harvested fixed 70 etoh stained propidium iodide analyzed flow cytometry dna content cell cycle fractions determined using multicycle software
0.5472486.15123653.html.plaintext.txt	38	immunostaining supt1 cells jurkat cells grown dulbeccos modified eagles medium 10 fetal calf serum plus minus 1 microm cpde 24 h washed twice phosphate buffered saline fixed 15 min 10 buffered formalin centrifuged 1000 x g 5 min cell pellets dehydrated embedded paraffin sectioned 5 microm dewaxing graded ethanols sections subjected antigen retrieval heating 10 mm edta ph 80 zymed laboratories inc south san francisco ca steam pressure cooker decloaking chamber biocare medical walnut creek ca according manufacturers instructions washes distilled water slides pretreated peroxidase block dako usa carpinteria ca 5 min followed goat serum 15 50 mm tris cl ph 74 20 min sections incubated rabbit anti notch1ic tc 15000 41 50 mm tris cl ph 74 containing 3 goat serum followed goat anti rabbit horseradish peroxidase conjugated antibody envision detection kit dako washing immunoperoxidase staining developed using diaminobenzidine chromogen dako followed enhancing solution zymed laboratories inc south san francisco ca
0.5472486.15123653.html.plaintext.txt	39	immunostaining supt1 cells jurkat cells grown dulbeccos modified eagles medium 10 fetal calf serum plus minus 1 microm cpde 24 h washed twice phosphate buffered saline fixed 15 min 10 buffered formalin centrifuged 1000 x g 5 min cell pellets dehydrated embedded paraffin sectioned 5 microm dewaxing graded ethanols sections subjected antigen retrieval heating 10 mm edta ph 80 zymed laboratories inc south san francisco ca steam pressure cooker decloaking chamber biocare medical walnut creek ca according manufacturers instructions washes distilled water slides pretreated peroxidase block dako usa carpinteria ca 5 min followed goat serum 15 50 mm tris cl ph 74 20 min sections incubated rabbit anti notch1ic tc 15000 41 50 mm tris cl ph 74 containing 3 goat serum followed goat anti rabbit horseradish peroxidase conjugated antibody envision detection kit dako washing immunoperoxidase staining developed using diaminobenzidine chromogen dako followed enhancing solution zymed laboratories inc south san francisco ca
0.5472486.15123653.html.plaintext.txt	40	spectral imaging sections stained anti notch1ic tc antibody subjected analysis using cri nuance spectral imaging system cri cambridge ma briefly conventional bright field images x400 magnification captured sequentially 10 nm wavelength intervals 420 nm blue 680 nm red resultant image cube concatenated stack images wavelength interval per pixel analyzed using cri nuance software diaminobenzidine spectral profile applied across image cubes determine intensity diaminobenzidine staining per pixel staining intensities converted composite false color images
0.5472486.15123653.html.plaintext.txt	41	spectral imaging sections stained anti notch1ic tc antibody subjected analysis using cri nuance spectral imaging system cri cambridge ma briefly conventional bright field images x400 magnification captured sequentially 10 nm wavelength intervals 420 nm blue 680 nm red resultant image cube concatenated stack images wavelength interval per pixel analyzed using cri nuance software diaminobenzidine spectral profile applied across image cubes determine intensity diaminobenzidine staining per pixel staining intensities converted composite false color images
0.5472486.15123653.html.plaintext.txt	42	results top abstract introduction experimental procedures results discussion references presenilin activity required ligand induced activation notch1 notch2 established genetic analysis presenilins function ligand dependent cleavage cell surface notch proteins processing notche proteins mediated presenilin dependent secretase activity use specific secretase inhibitors dominant negative forms presenilin established requirement secretasepresenilin processing notche proteins also processing notch1 receptor upon delta 1 activation
0.5472486.15123653.html.plaintext.txt	43	results top abstract introduction experimental procedures results discussion references presenilin activity required ligand induced activation notch1 notch2 established genetic analysis presenilins function ligand dependent cleavage cell surface notch proteins processing notche proteins mediated presenilin dependent secretase activity use specific secretase inhibitors dominant negative forms presenilin established requirement secretasepresenilin processing notche proteins also processing notch1 receptor upon delta 1 activation
0.5472486.15123653.html.plaintext.txt	44	wanted establish secretasepresenilin activity general requirement ligand induced notch signaling wanted determine whether notch family proteins addition notch1 depend secretasepresenilin address issue used pharmacological inhibitor secretase cpde 46 conjunction vitro cocultivation assay ligand receptor expressed independently two different cell types cocultured cpde shown bind ps 1 ps 2 cell membrane 46 additionally cpde blocks cleavage event releases notch1e cell surface 27 also blocks growth cells transformed membrane tethered notch1e 40 ligand mediated signaling notch1 notch2 assessed via reporter construct encoding six csl binding sites transfected notch expressing cells assess notch activation csl mediated signaling observed notch1 notch2 jagged1 fig 1a also delta 1 delta 4 data shown jagged1 stimulated notch1 activity 8 fold control stimulated notch2 activity 10 fold control cpde added vitro coculture assays 16 h prior harvest cells csl reporter activity reduced notch1 notch2 via different ligands tested fig 1b cpde caused 3 fold inhibition jagged1 induced signaling 5 fold inhibition delta 4 induced signaling notch1 notch2 additionally delta 1 induced signaling reduced 5 fold 4 fold notch1 notch2 respectively thus attenuation signaling secretasepresenilin inhibitor demonstrates requirement secretasepresenilin activity notch1 notch2 signaling whether via ligand jagged1 delta 1 delta 4
0.5472486.15123653.html.plaintext.txt	45	wanted establish secretasepresenilin activity general requirement ligand induced notch signaling wanted determine whether notch family proteins addition notch1 depend secretasepresenilin address issue used pharmacological inhibitor secretase cpde 46 conjunction vitro cocultivation assay ligand receptor expressed independently two different cell types cocultured cpde shown bind ps 1 ps 2 cell membrane 46 additionally cpde blocks cleavage event releases notch1e cell surface 27 also blocks growth cells transformed membrane tethered notch1e 40 ligand mediated signaling notch1 notch2 assessed via reporter construct encoding six csl binding sites transfected notch expressing cells assess notch activation csl mediated signaling observed notch1 notch2 jagged1 fig 1a also delta 1 delta 4 data shown jagged1 stimulated notch1 activity 8 fold control stimulated notch2 activity 10 fold control cpde added vitro coculture assays 16 h prior harvest cells csl reporter activity reduced notch1 notch2 via different ligands tested fig 1b cpde caused 3 fold inhibition jagged1 induced signaling 5 fold inhibition delta 4 induced signaling notch1 notch2 additionally delta 1 induced signaling reduced 5 fold 4 fold notch1 notch2 respectively thus attenuation signaling secretasepresenilin inhibitor demonstrates requirement secretasepresenilin activity notch1 notch2 signaling whether via ligand jagged1 delta 1 delta 4
0.5472486.15123653.html.plaintext.txt	46	view larger version 34k fig 1 ligand induced signaling notch1 notch2 receptors requires presenilin activity jagged1 expressing cells cocultured cells expressing csl luciferase reporter either notch1 notch2 cells treated presence absence 100 nm cpde 16 h prior lysis graphs show normalized values luciferase reporter activation relative control cocultures ligand values represent mean fold induction obtained least three experiments b experiments similar performed examine effects cpde notch signaling indicated ligands data represented fold reduction notch1 notch2 signaling cpde indicates p 005
0.5472486.15123653.html.plaintext.txt	47	presenilin activity necessary notch4int 3 signaling test dependence notch4int 3 presenilin activity relied expression construct drives expression polypeptides observed mouse mammary tumors caused proviral insertion notch4int 3 translation initiated construct internal notch4 start codon resulting synthesis polypeptide includes 30 amino acids ec domain tm domain ic domain notch4 signal peptide absent polypeptide second construct encoding ic domain notch n1ic signals presenilin independent fashion used negative control
0.5472486.15123653.html.plaintext.txt	48	presenilin activity necessary notch4int 3 signaling test dependence notch4int 3 presenilin activity relied expression construct drives expression polypeptides observed mouse mammary tumors caused proviral insertion notch4int 3 translation initiated construct internal notch4 start codon resulting synthesis polypeptide includes 30 amino acids ec domain tm domain ic domain notch4 signal peptide absent polypeptide second construct encoding ic domain notch n1ic signals presenilin independent fashion used negative control
0.5472486.15123653.html.plaintext.txt	49	transient expression either notch4int 3 n1ic led robust induction csl mediated reporter activity hela cells ref 47 data shown determined whether blocking secretasepresenilin activity would affect reporter activity induced constitutively active notch proteins notch4int 3 n1ic expressed independently hela cells mefs presence absence cpde cell lines cpde attenuated activity notch4int 3 17 fold hela cells 38 fold mefs fig 2 b contrast cpde inhibit n1ic induced activity fig 2 b furthermore notch4int 3 activity mef line deficient ps 1 ps 2 almost completely abrogated compared activity wild type mefs fig 2c level n1ic signaling similar wild type ps 12 mefs results indicate presenilins necessary notch4int 3 induced csl signaling consistent intramembrane cleavage presenilin tm domain notch4int 3 n1ic encode tm domain therefore dependent presenilin cleavage subsequent nuclear translocation
0.5472486.15123653.html.plaintext.txt	50	view larger version 33k fig 2 csl mediated signaling notch4int 3 dependent presenilin activity notch4int 3 ha n1ic ha transfected hela cells mefs b together csl reporter cells treated presence absence 100 nm cpde 16 h prior harvest graphs depict fold reduction notch4int 3 n1ic signaling cpde treatment c notch4int 3 ha n1ic ha transfected native mefs mefs deficient ps 1 ps 2 ps12 cells treated cpde assayed normalized values reporter activity relative cells transfected control plasmid wt wild type indicates p 0005
0.5472486.15123653.html.plaintext.txt	51	blockade presenilin activity alters protein expression pattern notch4int 3 tan 1 noted previously membrane tethered forms truncated notch1 notche accumulate presence presenilin inhibitors 40 raising possibility presenilin blockade would also stabilize notch4int 3 tan 1 polypeptides transient expression notch4int 3 transfected 293 cells led appearance multiple closely spaced notch4 isoforms phosphorylated differentially 47 treatment two different presenilin inhibitors cpde l 685458 shifted protein band pattern toward higher molecular mass fig 3 b drug treatment decrease levels lowest molecular mass band increase levels two higher molecular mass bands became pronounced increasing drug concentrations regulation higher molecular mass notch4int 3 proteins likely attributed accumulation unprocessed larger forms notch4int 3 would arise protein cleaved tm domain presenilin consistent result similar shift notch4int 3 proteins observed 293 cells stably coexpressing dominant negative forms presenilin d385a ps1 d366a ps2 48 relative 293 cells stably coexpressing wild type forms presenilins fig 3c demonstrate inhibitory effects cpde l 685458 specific secretase activity experiments performed two unrelated protease inhibitors aebsf pepstatin affect secretasepresenilin cleavage indicated concentration use nonspecific inhibitors relatively high concentrations 1 microm alter processing notch4int 3 fig 3e notch1e fig 3f observed cpde fig 3 e f
0.5472486.15123653.html.plaintext.txt	52	blockade presenilin activity alters protein expression pattern notch4int 3 tan 1 noted previously membrane tethered forms truncated notch1 notche accumulate presence presenilin inhibitors 40 raising possibility presenilin blockade would also stabilize notch4int 3 tan 1 polypeptides transient expression notch4int 3 transfected 293 cells led appearance multiple closely spaced notch4 isoforms phosphorylated differentially 47 treatment two different presenilin inhibitors cpde l 685458 shifted protein band pattern toward higher molecular mass fig 3 b drug treatment decrease levels lowest molecular mass band increase levels two higher molecular mass bands became pronounced increasing drug concentrations regulation higher molecular mass notch4int 3 proteins likely attributed accumulation unprocessed larger forms notch4int 3 would arise protein cleaved tm domain presenilin consistent result similar shift notch4int 3 proteins observed 293 cells stably coexpressing dominant negative forms presenilin d385a ps1 d366a ps2 48 relative 293 cells stably coexpressing wild type forms presenilins fig 3c demonstrate inhibitory effects cpde l 685458 specific secretase activity experiments performed two unrelated protease inhibitors aebsf pepstatin affect secretasepresenilin cleavage indicated concentration use nonspecific inhibitors relatively high concentrations 1 microm alter processing notch4int 3 fig 3e notch1e fig 3f observed cpde fig 3 e f
0.5472486.15123653.html.plaintext.txt	53	view larger version 42k fig 3 notch4int 3 tan 1 polypeptides processed secretasepresenilin b notch4int3 ha transfected 293 cells incubated presence indicated concentrations cpde l685458 b 16 h detergent lysates analyzed western blot ha 11 c stable 293 cells coexpressing either wild type ps 1 ps 2 wt loss function variants ps 1 ps 2 d385a ps 1 d366a ps 2 respectively dasp transfected notch4int3 ha lysed analyzed western blot ha 11 c arrows denote lower molecular mass species notch4int 3 decreases secretase inhibited brackets denote higher molecular mass proteins regulated d supt1 cells incubated without 100 nm cpde 16 h detergent lysates analyzed western blot anti notch1ic antibody tc protein species increase bracket decrease arrow cpde treatment denoted e notch4int3ha transfected f notch1e transfected 293 cells incubated presence cpde aebsf pepstatin pep 1 microm vehicle me2so dmso alone lysates analyzed western blot ha 11 e anticleaved notch1 val1744 f lower panels blots probed tubulin control sample loading
0.5472486.15123653.html.plaintext.txt	54	effects secretasepresenilin inhibitors processing tan 1 polypeptides examined human lymphoblastic cell line supt1 carries two copies 79 normal notch1 genes 49 multiple truncated notch1 mrna species observed supt1 cells initiate cryptic promoters lying near chromosomal breakpoint 34 transcripts give rise series polypeptides ranging size 100 125 kda fig 3d polypeptides detected two different anti notch1ic antibodies 35 polypeptides likely arise part cryptic translational start sites 35 treatment cpde altered expression pattern tan 1 polypeptides increasing level prominent broad band 110 kda decreasing level band slightly lower molecular mass fig 3d suggesting precursorproduct relationship normally cleavage might occur spontaneously presence secretasepresenilin inhibitor conversion prevented thus tan 1 notch4int 3 polypeptides accumulate secretasepresenilin cleavage inhibited
0.5472486.15123653.html.plaintext.txt	55	effects secretasepresenilin inhibitors processing tan 1 polypeptides examined human lymphoblastic cell line supt1 carries two copies 79 normal notch1 genes 49 multiple truncated notch1 mrna species observed supt1 cells initiate cryptic promoters lying near chromosomal breakpoint 34 transcripts give rise series polypeptides ranging size 100 125 kda fig 3d polypeptides detected two different anti notch1ic antibodies 35 polypeptides likely arise part cryptic translational start sites 35 treatment cpde altered expression pattern tan 1 polypeptides increasing level prominent broad band 110 kda decreasing level band slightly lower molecular mass fig 3d suggesting precursorproduct relationship normally cleavage might occur spontaneously presence secretasepresenilin inhibitor conversion prevented thus tan 1 notch4int 3 polypeptides accumulate secretasepresenilin cleavage inhibited
0.5472486.15123653.html.plaintext.txt	56	notch4int 3 tan 1 targeted membrane presenilin mediated cleavage within tm domain notch thought occur predominantly cell surface within plasma membrane 18 19 50 notch4int 3 tan 1 derived polypeptides substrates presenilin blockage presenilin activity would thus expected increase levels notch4int 3 tan 1 polypeptides cell surface
0.5472486.15123653.html.plaintext.txt	57	notch4int 3 tan 1 targeted membrane presenilin mediated cleavage within tm domain notch thought occur predominantly cell surface within plasma membrane 18 19 50 notch4int 3 tan 1 derived polypeptides substrates presenilin blockage presenilin activity would thus expected increase levels notch4int 3 tan 1 polypeptides cell surface
0.5472486.15123653.html.plaintext.txt	58	determine localization notch4int 3 tan 1 presenilins used cell surface biotinylation followed streptavidin affinity purification immunoblotting transiently expressing hela cells notch4int 3 proteins expressed cell surface whole cell lysate fig 4a whereas n1ic localizes nucleus biotinylated examine tan 1 polypeptides supt1 cells biotinylated western analysis performed using antibody specifically recognizes intracellular domain notch1 revealed minor tan 1 polypeptide precipitated streptavidin agarose fig 4b control nonspecific labeling intracellular proteins samples probed antibody intracellular protein glycogen synthetase kinase 3 expected glycogen synthetase kinase 3 detected biotin streptavidin precipitated samples indicating cytoplasmic proteins biotinylated fig 4 b
0.5472486.15123653.html.plaintext.txt	59	determine localization notch4int 3 tan 1 presenilins used cell surface biotinylation followed streptavidin affinity purification immunoblotting transiently expressing hela cells notch4int 3 proteins expressed cell surface whole cell lysate fig 4a whereas n1ic localizes nucleus biotinylated examine tan 1 polypeptides supt1 cells biotinylated western analysis performed using antibody specifically recognizes intracellular domain notch1 revealed minor tan 1 polypeptide precipitated streptavidin agarose fig 4b control nonspecific labeling intracellular proteins samples probed antibody intracellular protein glycogen synthetase kinase 3 expected glycogen synthetase kinase 3 detected biotin streptavidin precipitated samples indicating cytoplasmic proteins biotinylated fig 4 b
0.5472486.15123653.html.plaintext.txt	60	view larger version 44k fig 4 notch4int 3 tan 1 expressed cell membrane accumulate secretase inhibition hela cells transfected either notch4int 3 ha n1ic ha transfected hela cells supt1 cells b incubated without cpde 16 h treated membrane impermeable biotin label cell surface proteins detergent lysates made biotinylated proteins captured streptavidin agarose beads proteins bound beads mem whole cell lysates cl analyzed western blot indicated proteins antibody 1 integrin used control demonstrating cpde nonspecifically affect membrane protein levels antibody glycogen synthetase kinase 3 gsk 3 used cytosolic protein control
0.5472486.15123653.html.plaintext.txt	61	normal notch polypeptides associate presenilin early secretory pathway within golgiendoplasmic reticulum move cell surface 51 found hela cells express ps 1 ps 2 whereas supt1 cells express ps 1 fig 4 b data shown cell lines presenilins present cell surface based susceptibility biotinylation fig 4 b
0.5472486.15123653.html.plaintext.txt	62	normal notch polypeptides associate presenilin early secretory pathway within golgiendoplasmic reticulum move cell surface 51 found hela cells express ps 1 ps 2 whereas supt1 cells express ps 1 fig 4 b data shown cell lines presenilins present cell surface based susceptibility biotinylation fig 4 b
0.5472486.15123653.html.plaintext.txt	63	cleavage notch oncoproteins presenilins occurs cell surface one may expect inhibition secretasepresenilin activity would alter membrane bound forms proteins preventing cleavage analysis performed treating cells cpde examine effects membrane expression truncated notch proteins cell surface expression level notch4int 3 proteins transfected hela cells increased noticeably cpde treatment fig 4a similarly cpde treatment supt1 cells led dramatic increase levels specific tan 1 polypeptide cell surface fig 4b cpde nonspecifically alter expression cell surface proteins 1 integrin levels membrane similar cpde treatment thus presenilin inhibition causes cell surface accumulation notch4int 3 tan 1 polypeptides presumably represent presenilin substrates
0.5472486.15123653.html.plaintext.txt	64	cleavage notch oncoproteins presenilins occurs cell surface one may expect inhibition secretasepresenilin activity would alter membrane bound forms proteins preventing cleavage analysis performed treating cells cpde examine effects membrane expression truncated notch proteins cell surface expression level notch4int 3 proteins transfected hela cells increased noticeably cpde treatment fig 4a similarly cpde treatment supt1 cells led dramatic increase levels specific tan 1 polypeptide cell surface fig 4b cpde nonspecifically alter expression cell surface proteins 1 integrin levels membrane similar cpde treatment thus presenilin inhibition causes cell surface accumulation notch4int 3 tan 1 polypeptides presumably represent presenilin substrates
0.5472486.15123653.html.plaintext.txt	65	differential biological effects notch oncoproteins observed secretase inhibition next asked whether inhibition secretasepresenilin activity would abrogate biological activity notch4int 3 proteins vitro angiogenesis assay tan 1 proteins growth inhibition assay supt1 cells recent studies indicate notch signaling involved endothelial cell development angiogenesis 42 52 54 several vitro assays developed demonstrate role notch signaling angiogenesis2 three dimensional collagen gel bioassay expression notch4int 3 huvec induces endothelial cell sprouts fig 5a results help define potential roles notch4 signaling angiogenesis treatment presenilin inhibitor cpde caused dramatic decrease huvec sprouting fig 5b indicating notch4int 3 activity dependent presenilin mediated cleavage specificity cpde activity membrane bound notch apparent also used endothelial tube formation culture assay notch4int 3 n1ic inhibited endothelial tube formation cpde relieved block tube formation caused notch4int 3 n1ic data shown
0.5472486.15123653.html.plaintext.txt	66	differential biological effects notch oncoproteins observed secretase inhibition next asked whether inhibition secretasepresenilin activity would abrogate biological activity notch4int 3 proteins vitro angiogenesis assay tan 1 proteins growth inhibition assay supt1 cells recent studies indicate notch signaling involved endothelial cell development angiogenesis 42 52 54 several vitro assays developed demonstrate role notch signaling angiogenesis2 three dimensional collagen gel bioassay expression notch4int 3 huvec induces endothelial cell sprouts fig 5a results help define potential roles notch4 signaling angiogenesis treatment presenilin inhibitor cpde caused dramatic decrease huvec sprouting fig 5b indicating notch4int 3 activity dependent presenilin mediated cleavage specificity cpde activity membrane bound notch apparent also used endothelial tube formation culture assay notch4int 3 n1ic inhibited endothelial tube formation cpde relieved block tube formation caused notch4int 3 n1ic data shown
0.5472486.15123653.html.plaintext.txt	67	view larger version 99k fig 5 secretase inhibition prevents ad notch4int3 induced sprouting huvec cultured collagen gel b morphology adenovirus infected huvec ad lacz infected huvec b ad notch4int3 infected huvec ad lacz infected huvec made confluent monolayer whereas ad notch4int3 infected huvec made sprouts beneath monolayer arrows show branched sprouting ad notch4int3 infected huvec photographs taken x130 c effect cpde treatment number ad notch4int3 induced sprouts huvec number sprouts determined described experimental procedures experiments performed triplicate
0.5472486.15123653.html.plaintext.txt	68	constitutive notch1 signaling induces appearance cell lymphoblastic neoplasms 37 55 require sustained notch1 signaling growth survival 40 murine cell lines transformed notch1e require presenilin cleavage nuclear access treatment cpde led growth arrest apoptosis cells 40 similarly dominant negative inhibitors csln1ic nuclear complex cause g1 cell cycle arrest apoptosis supt1 cells 40 indicating nuclear notch1 also needed growth survival human cells despite requirement treatment supt1 cells 7 days 5 microm cpde effect growth assessed cell number shown cell cycle analysis fig 6
0.5472486.15123653.html.plaintext.txt	69	constitutive notch1 signaling induces appearance cell lymphoblastic neoplasms 37 55 require sustained notch1 signaling growth survival 40 murine cell lines transformed notch1e require presenilin cleavage nuclear access treatment cpde led growth arrest apoptosis cells 40 similarly dominant negative inhibitors csln1ic nuclear complex cause g1 cell cycle arrest apoptosis supt1 cells 40 indicating nuclear notch1 also needed growth survival human cells despite requirement treatment supt1 cells 7 days 5 microm cpde effect growth assessed cell number shown cell cycle analysis fig 6
0.5472486.15123653.html.plaintext.txt	70	view larger version 25k fig 6 growth sup t1 cells unaffected secretase inhibition supt1 cells cultured 4 days indicated doses cpde drug carrier me2so stained propidium iodide analyzed cell cycle fractions described experimental procedures
0.5472486.15123653.html.plaintext.txt	71	observations together western blot data shown fig 3c suggest partial requirement secretasepresenilin activity tan 1 polypeptides enter nucleus study extent nuclear access tan 1 polypeptides secretasepresenilin dependent supt1 cells treated cpde carrier immunostained antibody specific c terminal portion intracellular domain notch1 anti tc fig 7 nuclear cytoplasmic staining observed absence drug fig 7a nuclear staining decreased preferentially treatment cpde fig 7b documented analysis anti notch1ic tc staining control treated supt1 cells spectral imager confirmed substantial redistribution tan 1 polypeptides nucleus cytoplasm cells treated cpde fig 7 c d contrast distribution intensity anti notch1ic tc staining unchanged cpde treated jurkat cells control cell leukemia cell line expresses normal notch1 polypeptides modest levels fig 7 e f data consistent existence two pools tan 1 polypeptides major pool dependent secretasepresenilin nuclear access minor pool access nucleus secretasepresenilin independent fashion see fig 8 support existence latter type tan 1 polypeptide seen western blots fig 3c one tan 1 polypeptide slightly smaller size membrane associated presenilin sensitive polypeptides unaffected drug treatment polypeptide also fails appear cell surface fig 4b presumably lacks tm domain thus would expected require secretasepresenilin activity processing nuclear access tan 1 polypeptide may generate sufficient constitutive notch activity maintain growth supt1 cells presence secretasepresenilin blockade
0.5472486.15123653.html.plaintext.txt	72	observations together western blot data shown fig 3c suggest partial requirement secretasepresenilin activity tan 1 polypeptides enter nucleus study extent nuclear access tan 1 polypeptides secretasepresenilin dependent supt1 cells treated cpde carrier immunostained antibody specific c terminal portion intracellular domain notch1 anti tc fig 7 nuclear cytoplasmic staining observed absence drug fig 7a nuclear staining decreased preferentially treatment cpde fig 7b documented analysis anti notch1ic tc staining control treated supt1 cells spectral imager confirmed substantial redistribution tan 1 polypeptides nucleus cytoplasm cells treated cpde fig 7 c d contrast distribution intensity anti notch1ic tc staining unchanged cpde treated jurkat cells control cell leukemia cell line expresses normal notch1 polypeptides modest levels fig 7 e f data consistent existence two pools tan 1 polypeptides major pool dependent secretasepresenilin nuclear access minor pool access nucleus secretasepresenilin independent fashion see fig 8 support existence latter type tan 1 polypeptide seen western blots fig 3c one tan 1 polypeptide slightly smaller size membrane associated presenilin sensitive polypeptides unaffected drug treatment polypeptide also fails appear cell surface fig 4b presumably lacks tm domain thus would expected require secretasepresenilin activity processing nuclear access tan 1 polypeptide may generate sufficient constitutive notch activity maintain growth supt1 cells presence secretasepresenilin blockade
0.5472486.15123653.html.plaintext.txt	73	view larger version 117k fig 7 effect secretase inhibition nuclear localization tan 1 polypeptides supt1 cells 5 microm sections paraffin embedded supt1 cells treated 24 h me2so c 1 microm cpde b d stained antibody specific intracellular domain notch1 anti tc b show representative conventional light microscopic images cells stained using immunoperoxidase method produces brown stain c d show composite false color spectral images arrows b denote redistribution notch staining cytoplasm e f jurkat cells sectioned immunostained notch1 culturing absence e presence 1 microm cpde f
0.5472486.15123653.html.plaintext.txt	74	discussion top abstract introduction experimental procedures results discussion references proteolytic cleavage secretasepresenilin critical event ligand induced proteolytic processing notch1 demonstrate secretasepresenilin cleavage general requirement activation notch signaling pathway via notch1 notch2 conclusion based finding secretasepresenilin inhibition greatly reduced ability notch1 notch2 receptors activate csl upon exposure ligand jagged1 delta 1 delta 4 studies consistent observation notch1 4e polypeptides require secretasepresenilin activate csl 17 18 notch4int 3 tan 1 oncoproteins also truncated lack ec domain however unlike engineered notche proteins notch4int 3 tan 1 possess signal peptides thus unclear whether polypeptides would inserted membranes require secretasepresenilin downstream signaling studies demonstrate notch4int 3 tan 1 polypeptides inserted membranes treatment secretasepresenilin inhibitor results accumulation notch4int 3 tan 1 proteins cell surface
0.5472486.15123653.html.plaintext.txt	75	discussion top abstract introduction experimental procedures results discussion references proteolytic cleavage secretasepresenilin critical event ligand induced proteolytic processing notch1 demonstrate secretasepresenilin cleavage general requirement activation notch signaling pathway via notch1 notch2 conclusion based finding secretasepresenilin inhibition greatly reduced ability notch1 notch2 receptors activate csl upon exposure ligand jagged1 delta 1 delta 4 studies consistent observation notch1 4e polypeptides require secretasepresenilin activate csl 17 18 notch4int 3 tan 1 oncoproteins also truncated lack ec domain however unlike engineered notche proteins notch4int 3 tan 1 possess signal peptides thus unclear whether polypeptides would inserted membranes require secretasepresenilin downstream signaling studies demonstrate notch4int 3 tan 1 polypeptides inserted membranes treatment secretasepresenilin inhibitor results accumulation notch4int 3 tan 1 proteins cell surface
0.5472486.15123653.html.plaintext.txt	76	membrane targeting notch4int 3 tan 1 presenilins notch interact early secretory pathway within golgiendoplasmic reticulum 51 even notch constructs devoid ec domain 50 51 perhaps association promotes membrane insertion truncated notch polypeptides lacking signal peptides retaining tm domains insertion truncated notch would competent transport cell surface part complex containing presenilin consistent coimmunoprecipitation experiments showing notch proteins targeted membrane associated presenilin 50 presenilins expressed membrane biologically active complex nicastrin 15 56 membrane tethered notch also observed complex nicastrin 14 thus possible affinity notch presenilin andor nicastrin mediates localization notch oncoproteins cell surface
0.5472486.15123653.html.plaintext.txt	77	membrane targeting notch4int 3 tan 1 presenilins notch interact early secretory pathway within golgiendoplasmic reticulum 51 even notch constructs devoid ec domain 50 51 perhaps association promotes membrane insertion truncated notch polypeptides lacking signal peptides retaining tm domains insertion truncated notch would competent transport cell surface part complex containing presenilin consistent coimmunoprecipitation experiments showing notch proteins targeted membrane associated presenilin 50 presenilins expressed membrane biologically active complex nicastrin 15 56 membrane tethered notch also observed complex nicastrin 14 thus possible affinity notch presenilin andor nicastrin mediates localization notch oncoproteins cell surface
0.5472486.15123653.html.plaintext.txt	78	idea presenilins assist cell surface targeting notch supported studies role presenilins trafficking amyloid precursor protein app 56 57 aberrant processing amyloid precursor protein presenilin associated alzheimers disease addition role presenilins also necessary trafficking amyloid precursor protein trans golgi endoplasmic reticulum 57 cell surface endosomes 56 additionally presenilins required proper maturation trafficking nicastrin cell membrane 58 60 presenilins may serve similar function trafficking notch function would independent proteolytic activity mutations critical aspartate residues abrogate proteolytic activity presenilin without affecting trafficking notch cell surface 21
0.5472486.15123653.html.plaintext.txt	79	idea presenilins assist cell surface targeting notch supported studies role presenilins trafficking amyloid precursor protein app 56 57 aberrant processing amyloid precursor protein presenilin associated alzheimers disease addition role presenilins also necessary trafficking amyloid precursor protein trans golgi endoplasmic reticulum 57 cell surface endosomes 56 additionally presenilins required proper maturation trafficking nicastrin cell membrane 58 60 presenilins may serve similar function trafficking notch function would independent proteolytic activity mutations critical aspartate residues abrogate proteolytic activity presenilin without affecting trafficking notch cell surface 21
0.5472486.15123653.html.plaintext.txt	80	differential effects presenilin inhibitor biological activity mediated tan 1 notch4int 3 although notch4int 3 tan 1 polypeptides exhibit altered proteolytic processing accumulate cell surface presenilin activity blocked secretasepresenilin inhibition yields different effects biological activity oncoproteins biological activity notch4int 3 examined bioassay established detect endothelial sprouting huvec notch4int 3 induced strong sprouting response assay demonstrating role notch4 signaling initial processes angiogenesis effect almost completely inhibited secretasepresenilin inhibitor studies suggest blockade presenilin activity may means inhibiting notch mediated angiogenesis could useful tool regulating tumor associated angiogenesis
0.5472486.15123653.html.plaintext.txt	81	differential effects presenilin inhibitor biological activity mediated tan 1 notch4int 3 although notch4int 3 tan 1 polypeptides exhibit altered proteolytic processing accumulate cell surface presenilin activity blocked secretasepresenilin inhibition yields different effects biological activity oncoproteins biological activity notch4int 3 examined bioassay established detect endothelial sprouting huvec notch4int 3 induced strong sprouting response assay demonstrating role notch4 signaling initial processes angiogenesis effect almost completely inhibited secretasepresenilin inhibitor studies suggest blockade presenilin activity may means inhibiting notch mediated angiogenesis could useful tool regulating tumor associated angiogenesis
0.5472486.15123653.html.plaintext.txt	82	biological activity tan 1 studied growth assay supt1 cells two truncated normal notch1 genes supt1 cells contain increased levels nuclear notch1 required persistent notch1 signaling growth based effect dominant negative inhibitors n1iccsl function 40 however supt1 cell growth unaffected cpde despite evidence altered tan 1 processing accumulation tan 1 polypeptides cell surface unresponsiveness supt1 cells may result expression tan 1 polypeptides dependent presenilin mediated proteolysis nuclear access specifically smallest tan 1 polypeptide detected supt1 whole cell lysates unaltered cpde fig 3d polypeptide may arise cryptic translational start site downstream region encoding extracellular domain aberrant initiation codons demonstrated within tm domains murine notch1 61 feline notch2 62 whether sites purely pathophysiologic utilized normal circumstances unknown hypothesize tan 1 polypeptide accesses nucleus presenilin independent fashion accounting refractoriness supt1 cells presenilin blockade
0.5472486.15123653.html.plaintext.txt	83	biological activity tan 1 studied growth assay supt1 cells two truncated normal notch1 genes supt1 cells contain increased levels nuclear notch1 required persistent notch1 signaling growth based effect dominant negative inhibitors n1iccsl function 40 however supt1 cell growth unaffected cpde despite evidence altered tan 1 processing accumulation tan 1 polypeptides cell surface unresponsiveness supt1 cells may result expression tan 1 polypeptides dependent presenilin mediated proteolysis nuclear access specifically smallest tan 1 polypeptide detected supt1 whole cell lysates unaltered cpde fig 3d polypeptide may arise cryptic translational start site downstream region encoding extracellular domain aberrant initiation codons demonstrated within tm domains murine notch1 61 feline notch2 62 whether sites purely pathophysiologic utilized normal circumstances unknown hypothesize tan 1 polypeptide accesses nucleus presenilin independent fashion accounting refractoriness supt1 cells presenilin blockade
0.5472486.15123653.html.plaintext.txt	84	model notch4int 3 tan 1 cleavage presenilins studies consistent current models notch processing activation 9 63 illustrated fig 8 models propose notch receptor normally inhibited proteolytic processing conformational constraints imposed ec domain ligand binding may induce structural changes allow proteolytic cleavage tace tumor necrosis alpha converting enzyme metalloproteases consequent shedding ec domain enables subsequent proteolysis mediated presenilins gain function mutations notch could either act independently presenilin function presenilin mediated cleavage studies indicate presenilin dependent independent forms tan 1 oncoproteins
0.5472486.15123653.html.plaintext.txt	85	still controversial whether presenilins recognize specific consensus sequence within notch required cleavage four notch receptors cleaved presenilin conserved valine within tm domain mutation valine residue within notch1 notch4 greatly reduces efficiency cleavage 18 however notch cleavage also observed another site within tm domain n terminal conserved valine 19 additionally studies drosophila show size notch ec domain critical whether presenilin cleave shorter ec domain efficient cleavage 63 lack cleavage site specificity also observed substrates suggests presenilins may serve general role facilitating cleavage particular single pass tm proteins short ec domains
0.5472486.15123653.html.plaintext.txt	86	still controversial whether presenilins recognize specific consensus sequence within notch required cleavage four notch receptors cleaved presenilin conserved valine within tm domain mutation valine residue within notch1 notch4 greatly reduces efficiency cleavage 18 however notch cleavage also observed another site within tm domain n terminal conserved valine 19 additionally studies drosophila show size notch ec domain critical whether presenilin cleave shorter ec domain efficient cleavage 63 lack cleavage site specificity also observed substrates suggests presenilins may serve general role facilitating cleavage particular single pass tm proteins short ec domains
0.5472486.15123653.html.plaintext.txt	87	notch oncoproteins cancer n terminal truncations within notch proteins lead oncogenic gain function phenotypes truncations observed human alls chromosomal translocations notch1 alls mice cats proviral insertions notch1 64 notch2 65 respectively murine mammary tumors proviral insertions notch4 33 66 interestingly various human tumor cell lines exhibit regulation rna species encoding truncated form notch4 also transforming potential 67 studies one might predict regulation presenilin mediated proteolysis subsequent activation notch oncoproteins dependent upon whether protein encodes tm domain
0.5472486.15123653.html.plaintext.txt	88	notch oncoproteins cancer n terminal truncations within notch proteins lead oncogenic gain function phenotypes truncations observed human alls chromosomal translocations notch1 alls mice cats proviral insertions notch1 64 notch2 65 respectively murine mammary tumors proviral insertions notch4 33 66 interestingly various human tumor cell lines exhibit regulation rna species encoding truncated form notch4 also transforming potential 67 studies one might predict regulation presenilin mediated proteolysis subsequent activation notch oncoproteins dependent upon whether protein encodes tm domain
0.5472486.15123653.html.plaintext.txt	89	tumors driven notch oncoproteins containing tm domain secretasepresenilin inhibitors may effective therapy notch4int 3 oncoprotein potent mammary oncogene dependent presenilin signal activation function addition ligand dependent signaling full length notch receptors may also important neoplasms example ligand dependent activation full length notch receptors contributes growth hodgkin anaplastic large cell lymphoma cell lines 68 many neoplasms express one notch receptors reliable means measuring notch activation mediated low levels nuclear notch readily available presenilin inhibitors may generally useful tools evaluating role notch signaling various neoplasms
0.5472486.15123653.html.plaintext.txt	90	tumors driven notch oncoproteins containing tm domain secretasepresenilin inhibitors may effective therapy notch4int 3 oncoprotein potent mammary oncogene dependent presenilin signal activation function addition ligand dependent signaling full length notch receptors may also important neoplasms example ligand dependent activation full length notch receptors contributes growth hodgkin anaplastic large cell lymphoma cell lines 68 many neoplasms express one notch receptors reliable means measuring notch activation mediated low levels nuclear notch readily available presenilin inhibitors may generally useful tools evaluating role notch signaling various neoplasms
0.5472486.15123653.html.plaintext.txt	91	footnotes work supported public health service grant hl 62454 nhlbi national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5472486.15123653.html.plaintext.txt	92	footnotes work supported public health service grant hl 62454 nhlbi national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5472486.15123653.html.plaintext.txt	93	correspondence addressed columbia university college physicians surgeons 16 419 630 w 168th st new york ny 10032 e mail jkk9atcolumbiaedu u d
0.5472486.15123653.html.plaintext.txt	94	1 abbreviations used cell acute lymphoblastic leukemia cpde compound e ec domain extracellular domain ha hemagglutinin huvec human umbilical vein endothelial cells ic domain intracellular domain mef mouse embryo fibroblast me2so dimethyl sulfoxide n1ic notch1 ic domain ps presenilin tm domain transmembrane domain
0.5472486.15123653.html.plaintext.txt	95	2 y funahashi manuscript preparation
0.5472486.15123653.html.plaintext.txt	96	acknowledgments thank gina finan kimara glaser kirschenbaum technical assistance
0.5472486.15123653.html.plaintext.txt	97	references top abstract introduction experimental procedures results discussion references lawson n d scheer n pham v n kim c h chitnis b campos ortega j weinstein b m 2001 development 128 3675 3683abstractfree full text pui j c allman d xu l derocco karnell f g bakkour lee j y kadesch hardy r r aster j c pear w 1999 immunity 11 299 308medline order article via infotrieve radtke f wilson stark g bauer m van meerwijk j macdonald h r aguet m 1999 immunity 10 547 558medline order article via infotrieve krebs l xue y norton c r shutter j r maguire m sundberg j p gallahan d closson v kitajewski j callahan r smith g h stark k l gridley 2000 genes dev 14 1343 1352abstractfree full text uyttendaele h ho j rossant j kitajewski j 2001 proc natl acad sci u 98 5643 5648abstractfree full text blaumueller c m qi h zagouras p artavanis tsakonas 1997 cell 90 281 291medline order article via infotrieve logeat f bessia c brou c lebail o jarriault seidah n g israel 1998 proc natl acad sci u 95 8108 8112abstractfree full text rand m d grimm l m artavanis tsakonas patriub v blacklow c sklar j aster j c 2000 mol cell biol 20 1825 1835abstractfree full text mumm j schroeter e h saxena m griesemer tian x pan d j ray w j kopan r 2000 mol cell 5 197 206medline order article via infotrieve brou c logeat f gupta n bessia c lebail o doedens j r cumano roux p black r israel 2000 mol cell 5 207 216medline order article via infotrieve de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 398 518 522crossrefmedline order article via infotrieve de strooper b 2003 neuron 38 9 12medline order article via infotrieve haass c de strooper b 1999 science 286 916 919abstractfree full text chen f yu g arawaka nishimura m kawarai yu h tandon supala song y q rogaeva e milman p sato c yu c janus c lee j song l zhang l fraser p e st george hyslop p h 2001 nat cell biol 3 751 754crossrefmedline order article via infotrieve yu g nishimura m arawaka levitan d zhang l tandon song y q rogaeva e chen f kawarai supala levesque l yu h yang d holmes e milman p liang y zhang d m xu d h sato c rogaev e smith m janus c zhang y aebersold r farrer l sorbi bruni fraser p st george hyslop p 2000 nature 407 48 54crossrefmedline order article via infotrieve haass c steiner h 2002 trends cell biol 12 556 562crossrefmedline order article via infotrieve mizutani taniguchi y aoki hashimoto n honjo 2001 proc natl acad sci u 98 9026 9031abstractfree full text saxena m schroeter e h mumm j kopan r 2001 j biol chem 276 40268 40273abstractfree full text okochi m steiner h fukumori tanii h tomita tanaka iwatsubo kudo takeda m haass c 2002 embo j 21 5408 5416abstractfree full text song w nadeau p yuan m yang x shen j yankner b 1999 proc natl acad sci u 96 6959 6963abstractfree full text berezovska o jack c mclean p aster j c hicks c xia w wolfe m kimberly w weinmaster g selkoe d j hyman b 2000 j neurochem 75 583 593crossrefmedline order article via infotrieve berechid b e kitzmann m foltz d r roach h seiffert d thompson l olson r e bernstein donoviel d b nye j 2002 j biol chem 277 8154 8165abstractfree full text berechid b e thinakaran g wong p c sisodia nye j 1999 curr biol 9 1493 1496crossrefmedline order article via infotrieve naruse thinakaran g luo j j kusiak j w tomita iwatsubo qian x ginty d d price d l borchelt d r wong p c sisodia 1998 neuron 21 1213 1221medline order article via infotrieve ni c y murphy m p golde e carpenter g 2001 science 294 2179 2181abstractfree full text marambaud p shioi j serban g georgakopoulos sarner nagy v baki l wen p efthimiopoulos shao z wisniewski robakis n k 2002 embo j 21 1948 1956abstractfree full text lee h j jung k m huang y z bennett l b lee j mei l kim w 2002 j biol chem 277 6318 6323abstractfree full text lammich okochi m takeda m kaether c capell zimmer k edbauer d walter j steiner h haass c 2002 j biol chem 277 44754 44759abstractfree full text schroeter e h kisslinger j kopan r 1998 nature 393 382 386crossrefmedline order article via infotrieve jarriault brou c logeat f schroeter e h kopan r israel 1995 nature 377 355 358crossrefmedline order article via infotrieve uyttendaele h marazzi g wu g yan q sassoon d kitajewski j 1996 development 122 2251 2259abstractfree full text shirayoshi y yuasa y suzuki sugaya k kawase e ikemura nakatsuji n 1997 genes cells 2 213 224abstractfree full text gallahan d callahan r 1997 oncogene 14 1883 1890crossrefmedline order article via infotrieve ellisen l w bird j west d c soreng l reynolds c smith d sklar j 1991 cell 66 649 661medline order article via infotrieve aster j c pear w hasserjian r erba h davi f luo b scott m baltimore d sklar j 1995 cold spring harbor symp quant biol 49 125 136 jhappan c gallahan d stahle c chu e smith g h merlino g callahan r 1992 genes dev 6 345 355abstract pear w aster j c scott m l hasserjian r p soffer b sklar j baltimore d 1996 j exp med 183 2283 2291abstract capobianco j zagouras p blaumueller c m artavanis tsakonas bishop j m 1997 mol cell biol 17 6265 6273abstract struhl g greenwald 1999 nature 398 522 525crossrefmedline order article via infotrieve weng p nam y wolfe m pear w griffin j d blacklow c aster j c 2003 mol cell biol 23 655 664abstractfree full text hasserjian r p aster j c davi f weinberg d sklar j 1996 blood 88 970 976abstractfree full text uyttendaele h closson v wu g roux f weinmaster g kitajewski j 2000 microvasc res 60 91 103crossrefmedline order article via infotrieve marcantonio e e hynes r o 1988 j cell biol 106 1765 1772abstract thinakaran g borchelt d r lee m k slunt h h spitzer l kim g ratovitsky davenport f nordstedt c seeger m hardy j levey gandy e jenkins n copeland n g price d l sisodia 1996 neuron 17 181 190medline order article via infotrieve jaffe e nachman r l becker c g minick c r 1973 j clin invest 52 2745 2756medline order article via infotrieve seiffert d bradley j d rominger c m rominger d h yang f meredith j e jr wang q roach h thompson l spitz m higaki j n prakash r combs p copeland r arneric p hartig p r robertson d w cordell b stern m olson r e zaczek r 2000 j biol chem 275 34086 34091abstractfree full text wu g lyapina das li j gurney m pauley chui deshaies r j kitajewski j 2001 mol cell biol 21 7403 7415abstractfree full text steiner h haass c 2000 nat rev mol cell biol 1 217 224crossrefmedline order article via infotrieve smith d mcfall p morgan r link m hecht f cleary m sklar j 1989 blood 73 2182 2187abstract ray w j yao m mumm j schroeter e h saftig p wolfe m selkoe d j kopan r goate m 1999 j biol chem 274 36801 36807abstractfree full text ray w j yao m nowotny p mumm j zhang w wu j y kopan r goate m 1999 proc natl acad sci u 96 3263 3268abstractfree full text taylor k l henderson m hughes c c 2002 microvasc res 64 372 383crossrefmedline order article via infotrieve leong k g hu x li l noseda m larrivee b hull c hood l wong f karsan 2002 mol cell biol 22 2830 2841abstractfree full text liu z j shirakawa li y soma oka m dotto g p fairman r m velazquez o c herlyn m 2003 mol cell biol 23 14 25abstractfree full text aster j c xu l karnell f g patriub v pui j c pear w 2000 mol cell biol 20 7505 7515abstractfree full text kaether c lammich edbauer d ertl m rietdorf j capell steiner h haass c 2002 j cell biol 158 551 561abstractfree full text cai d leem j y greenfield j p wang p kim b wang r lopes k o kim h zheng h greengard p sisodia thinakaran g xu h 2003 j biol chem 278 3446 3454abstractfree full text chen f tandon sanjo n gu y j hasegawa h arawaka lee f j ruan x mastrangelo p erdebil wang l westaway d mount h yankner b fraser p e st george hyslop p 2003 j biol chem 278 19974 19979abstractfree full text edbauer d winkler e haass c steiner h 2002 proc natl acad sci u 99 8666 8671abstractfree full text herreman van gassen g bentahir m nyabi o craessaerts k mueller u annaert w de strooper b 2003 j cell sci 116 1127 1136abstractfree full text kopan r schroeter e h weintraub h nye j 1996 proc natl acad sci u 93 1683 1688abstractfree full text lauring overbaugh j 2000 mol cell 6 939 945medline order article via infotrieve struhl g adachi 2000 mol cell 6 625 636medline order article via infotrieve girard l hanna z beaulieu n hoemann c d simard c kozak c jolicoeur p 1996 genes dev 10 1930 1944abstract rohn j l moser m gwynn r baldwin d n overbaugh j 1998 j virol 72 2686 2696abstractfree full text robbins j blondel b j gallahan d callahan r 1992 j virol 66 2594 2599abstract imatani callahan r 2000 oncogene 19 223 231crossrefmedline order article via infotrieve jundt f anagnostopoulos forster r mathas stein h dorken b 2002 blood 99 3398 3403abstractfree full text
0.5697466.15003956.html.plaintext.txt	0	meta analysis association cathepsin d ala224val gene polymorphism risk alzheimer disease huge gene disease association review christos ntais1 anastasia polycarpou1 john p ioannidis123
0.5697466.15003956.html.plaintext.txt	1	1 clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece 2 biomedical research institute foundation research technology hellas ioannina greece 3 institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.5697466.15003956.html.plaintext.txt	2	1 clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece 2 biomedical research institute foundation research technology hellas ioannina greece 3 institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.5697466.15003956.html.plaintext.txt	3	received publication august 5 2003 accepted publication october 10 2003
0.5697466.15003956.html.plaintext.txt	4	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon 2 cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis 14 studies 16 comparisons ctsd genotyping 3174 alzheimer disease cases 3298 controls overall random effects odds ratio versus c allele 117 95 confidence interval ci 095 144 study heterogeneity p 001 significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio 111 95 ci 091 135 p 029 summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e 4 allele apoe4 increased susceptibility alzheimer disease conferred apoe4 carriage tended prominent presence allele random effects 607 95 ci 419 879 409 95 ci 315 531 carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoe4 effect cannot excluded
0.5697466.15003956.html.plaintext.txt	5	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon 2 cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis 14 studies 16 comparisons ctsd genotyping 3174 alzheimer disease cases 3298 controls overall random effects odds ratio versus c allele 117 95 confidence interval ci 095 144 study heterogeneity p 001 significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio 111 95 ci 091 135 p 029 summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e 4 allele apoe4 increased susceptibility alzheimer disease conferred apoe4 carriage tended prominent presence allele random effects 607 95 ci 419 879 409 95 ci 315 531 carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoe4 effect cannot excluded
0.5697466.15003956.html.plaintext.txt	6	alzheimer disease cathepsin d ctsd epidemiology genetics meta analysis polymorphism genetics
0.5697466.15003956.html.plaintext.txt	7	abbreviations abbreviations ci confidence interval odds ratio
0.5697466.15003956.html.plaintext.txt	8	introduction top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references editor note paper also available website human genome epidemiology network httpwwwcdcgovgenomicshugenetdefaulthtm
0.5697466.15003956.html.plaintext.txt	9	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein 1 2 cathepsin d gene ctsd located short arm chromosome 11 11p155 consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.5697466.15003956.html.plaintext.txt	10	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein 1 2 cathepsin d gene ctsd located short arm chromosome 11 11p155 consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.5697466.15003956.html.plaintext.txt	11	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position 224 exon 2 polymorphism results ala38 val substitution cathepsin d profragment 3 polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study 3 moreover allele associated 50 percent decrease beta amyloid peptide 1 42 levels cerebrospinal fluid patients alzheimer disease 4 finally polymorphism recently reported significantly associated general intelligence healthy elderly people 5
0.5697466.15003956.html.plaintext.txt	12	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position 224 exon 2 polymorphism results ala38 val substitution cathepsin d profragment 3 polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study 3 moreover allele associated 50 percent decrease beta amyloid peptide 1 42 levels cerebrospinal fluid patients alzheimer disease 4 finally polymorphism recently reported significantly associated general intelligence healthy elderly people 5
0.5697466.15003956.html.plaintext.txt	13	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease 6 19 also controversy whether polymorphism may interact apolipoprotein e 4 allele apoe4 best known genetic determinant sporadic alzhei mer disease 20 single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.5697466.15003956.html.plaintext.txt	14	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease 6 19 also controversy whether polymorphism may interact apolipoprotein e 4 allele apoe4 best known genetic determinant sporadic alzhei mer disease 20 single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.5697466.15003956.html.plaintext.txt	15	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately 1 percent 65 69 years increasing 40 percent elderly 85 years age 21 22 mutations amyloid precursor protein presenilin 1 presenilin 2 genes account 5 percent cases result autosomally dominant pattern expressed complete penetrance early manifestations 23 alzheimer disease probably slightly common females 24 proven postulated risk factors include head injury particular among males 25 well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome 26 27 conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women 27 physical activity diets high levels vitamins b6 b12 folate red wine moderate quantities may protective 27 prevalence alzheimer disease varies considerably among different population groups 28 least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available 23 29 among conclusive evidence several studies meta analysis thereof apoe4 strong risk factor developing alzheimer disease male female subjects early onset 65 years late onset disease 20 approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoe4 attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature 30 35 suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism 30 intronic promoter region polymorphisms presenilin 1 late onset disease 31 insertion deletion polymorphism missense mutation alpha 2 macroglobulin gene 32 several polymorphisms protein tau gene 33 associations modest effect size odds ratios ors 130 135 claimed meta analyses low density lipoprotein receptor related protein gene exon 3 polymorphism 34 insertion deletion polymorphism angiotensin converting enzyme gene 35
0.5697466.15003956.html.plaintext.txt	16	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately 1 percent 65 69 years increasing 40 percent elderly 85 years age 21 22 mutations amyloid precursor protein presenilin 1 presenilin 2 genes account 5 percent cases result autosomally dominant pattern expressed complete penetrance early manifestations 23 alzheimer disease probably slightly common females 24 proven postulated risk factors include head injury particular among males 25 well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome 26 27 conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women 27 physical activity diets high levels vitamins b6 b12 folate red wine moderate quantities may protective 27 prevalence alzheimer disease varies considerably among different population groups 28 least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available 23 29 among conclusive evidence several studies meta analysis thereof apoe4 strong risk factor developing alzheimer disease male female subjects early onset 65 years late onset disease 20 approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoe4 attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature 30 35 suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism 30 intronic promoter region polymorphisms presenilin 1 late onset disease 31 insertion deletion polymorphism missense mutation alpha 2 macroglobulin gene 32 several polymorphisms protein tau gene 33 associations modest effect size odds ratios ors 130 135 claimed meta analyses low density lipoprotein receptor related protein gene exon 3 polymorphism 34 insertion deletion polymorphism angiotensin converting enzyme gene 35
0.5697466.15003956.html.plaintext.txt	17	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january 1994 september 2003 search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.5697466.15003956.html.plaintext.txt	18	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january 1994 september 2003 search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.5697466.15003956.html.plaintext.txt	19	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.5697466.15003956.html.plaintext.txt	20	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.5697466.15003956.html.plaintext.txt	21	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.5697466.15003956.html.plaintext.txt	22	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.5697466.15003956.html.plaintext.txt	23	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.5697466.15003956.html.plaintext.txt	24	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.5697466.15003956.html.plaintext.txt	25	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic 36 heterogeneity considered significant p 010 data combined using fixed effects mantel haenszel random effects dersimonian laird models 37 random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present 37
0.5697466.15003956.html.plaintext.txt	26	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic 36 heterogeneity considered significant p 010 data combined using fixed effects mantel haenszel random effects dersimonian laird models 37 random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present 37
0.5697466.15003956.html.plaintext.txt	27	also performed cumulative meta analysis 38 recursive cumulative meta analysis 39 40 evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations 41 inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient 42 evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones 43 finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.5697466.15003956.html.plaintext.txt	28	also performed cumulative meta analysis 38 recursive cumulative meta analysis 39 40 evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations 41 inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient 42 evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones 43 finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.5697466.15003956.html.plaintext.txt	29	previous investigations alluded possibility allele may interact apoe4 allele conferring susceptibility alzheimer disease 7 9 thus also evaluated effect allele carriage risk alzheimer disease separately apoe4 positive apoe4 negative subjects moreover evaluated genetic effect conferred presence apoe4 separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.5697466.15003956.html.plaintext.txt	30	previous investigations alluded possibility allele may interact apoe4 allele conferring susceptibility alzheimer disease 7 9 thus also evaluated effect allele carriage risk alzheimer disease separately apoe4 positive apoe4 negative subjects moreover evaluated genetic effect conferred presence apoe4 separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.5697466.15003956.html.plaintext.txt	31	analyses performed spss 110 spss inc chicago illinois meta analyst joseph lau boston massachusetts software whenever 0 values 2 x 2 table added 05 four cells odds ratio could calculated p values two tailed
0.5697466.15003956.html.plaintext.txt	32	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified 6 19 profiled table 1 two eligible studies 6 15 contained subjects two different ethnic groups total 16 separate comparisons considered considerable diversity ethnic groups eleven studies 6 15 19 selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies 16 18 selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study 17 clarify exact criteria used diagnosis alzheimer disease five studies 13 17 also included autopsy confirmed alzheimer disease cases two studies 7 16 mentioned included cases family history alzheimer disease eight studies 9 14 18 19 specifically excluded patients remaining clarify background family history one study 6 mentioned 61 percent alzheimer disease cases late onset disease age onset 65 years five studies 8 12 14 19 specifically included late onset alzheimer disease cases one study 18 specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.5697466.15003956.html.plaintext.txt	33	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified 6 19 profiled table 1 two eligible studies 6 15 contained subjects two different ethnic groups total 16 separate comparisons considered considerable diversity ethnic groups eleven studies 6 15 19 selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies 16 18 selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study 17 clarify exact criteria used diagnosis alzheimer disease five studies 13 17 also included autopsy confirmed alzheimer disease cases two studies 7 16 mentioned included cases family history alzheimer disease eight studies 9 14 18 19 specifically excluded patients remaining clarify background family history one study 6 mentioned 61 percent alzheimer disease cases late onset disease age onset 65 years five studies 8 12 14 19 specifically included late onset alzheimer disease cases one study 18 specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.5697466.15003956.html.plaintext.txt	34	view table table 1 characteristics studies included meta analysis specific matching age described five studies 10 12 15 one study also matched sex 10 one study 7 specifically mentioned blinding personnel performed genotyping appropriate molecular methods genotyping used studies used polymerase chain reaction two studies 14 18 also used dynamic allele specific hybridization
0.5697466.15003956.html.plaintext.txt	35	meta analysis database eligible studies summarized table 2 included total 3175 cases alzheimer disease 3334 controls 3174 3298 respectively genotype data allele highly represented among controls american descent overall prevalence 86 percent 95 percent confidence interval ci 71 101 controls european 78 percent 95 percent ci 70 86 asian 09 percent 95 percent ci 03 15 descent significant heterogeneity prevalence rates allele even across control subjects european descent rate 143 percent among hispanic americans 104 percent italy 101 percent spain lower rates northern european countries 76 percent united kingdom 63 percent sweden 61 percent germany lowest prevalence rate 45 percent polish population overall prevalence tt homozygosity 03 percent 08 percent 02 percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity 166 percent 140 percent 15 percent respective rates cc homozygosity 831 percent 852 percent 983 percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.5697466.15003956.html.plaintext.txt	36	meta analysis database eligible studies summarized table 2 included total 3175 cases alzheimer disease 3334 controls 3174 3298 respectively genotype data allele highly represented among controls american descent overall prevalence 86 percent 95 percent confidence interval ci 71 101 controls european 78 percent 95 percent ci 70 86 asian 09 percent 95 percent ci 03 15 descent significant heterogeneity prevalence rates allele even across control subjects european descent rate 143 percent among hispanic americans 104 percent italy 101 percent spain lower rates northern european countries 76 percent united kingdom 63 percent sweden 61 percent germany lowest prevalence rate 45 percent polish population overall prevalence tt homozygosity 03 percent 08 percent 02 percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity 166 percent 140 percent 15 percent respective rates cc homozygosity 831 percent 852 percent 983 percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.5697466.15003956.html.plaintext.txt	37	view table table 2 distribution ctsd alleles among alzheimer disease cases controls included studies overall effects trend suggesting allele may confer increased susceptibility alzheimer disease figure 1 shown table 3 summary odds ratio 117 random effects p 014 significant heterogeneity among 16 study comparisons p 001 heterogeneity found evidence association tt genotype risk alzheimer disease relative cc genotype significant study heterogeneity evidence association alzhei mer disease discerned also recessive model examined effect trend association seen dominant model random effects 119 95 percent ci 097 147 p 010 study heterogeneity recessive model contrast significant heterogeneity p 005 still seen dominant model contrast subgroup analysis studies cases controls european descent yielded similar results 15 comparisons 11436 alleles 118 95 percent ci 096 146 p 012 p 001 heterogeneity
0.5697466.15003956.html.plaintext.txt	38	view larger version 26k figure 1 meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown represents summary random effects estimate comparison along respective 95 confidence interval values 1 denote increased risk alzheimer disease allele
0.5697466.15003956.html.plaintext.txt	39	view larger version 26k figure 1 meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown represents summary random effects estimate comparison along respective 95 confidence interval values 1 denote increased risk alzheimer disease allele
0.5697466.15003956.html.plaintext.txt	40	view table table 3 summary odds ratios various contrasts bias diagnostics cumulative meta analysis recursive cumulative meta analysis magnitude summary odds ratio stable time changed considerably per year apparent dissipation postulated effect random effects summary vs c 205 end 1999 141 end 2000 116 end 2001 114 end 2002 117 2003 excluding first hypothesis generating study 9 found summary odds ratio became 111 95 percent ci 091 135 p 029 significant study heterogeneity p 005 evidence association even comparison homozygotes tt vs cc 096 95 percent ci 048 190 p 091 study heterogeneity relation effect size variance study suggesting larger studies agreed results smaller studies analyses limited studies intensive efforts exclude alzheimer disease controls yielded similar results 11 comparisons 10382 alleles 122 95 percent ci 096 154 p 010 p 002 heterogeneity
0.5697466.15003956.html.plaintext.txt	41	interaction apoe genotype nine studies 7 9 11 14 16 18 obtained data ctsd apoe genotypes one study 8 separating male female subjects 10 comparisons became available
0.5697466.15003956.html.plaintext.txt	42	interaction apoe genotype nine studies 7 9 11 14 16 18 obtained data ctsd apoe genotypes one study 8 separating male female subjects 10 comparisons became available
0.5697466.15003956.html.plaintext.txt	43	nine comparative studies tended gave slightly inflated effect allele compared full meta analysis 14 comparisons summary random effects 123 vs 117 complete meta analysis thus inferences cautious among carriers high risk apoe4 allele allele carriers random effects odds ratio 138 95 percent ci 089 215 alzheimer disease compared subjects carrying allele among subjects carrying apoe4 allele respective odds ratio 113 95 percent ci 090 142 significant study heterogeneity apoe4 positive group p 007 two effect sizes overlapped widely
0.5697466.15003956.html.plaintext.txt	44	among carriers allele presence apoe4 increased risk alzheimer disease 607 fold 95 percent ci 419 879 study heterogeneity among subjects without allele presence apoe4 increased risk alzheimer disease 409 fold 95 percent ci 315 531 significant study heterogeneity p 001 two estimates overlapped widely individual studies overall typically odds ratios larger group allele carriers figure 2
0.5697466.15003956.html.plaintext.txt	45	view larger version 22k figure 2 meta analysis effect apoe4 allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective 95 confidence interval papassotiropoulos 2 1 pertain following respective references 7 9
0.5697466.15003956.html.plaintext.txt	46	view larger version 22k figure 2 meta analysis effect apoe4 allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective 95 confidence interval papassotiropoulos 2 1 pertain following respective references 7 9
0.5697466.15003956.html.plaintext.txt	47	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data 14 case control studies 6000 genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence cannot exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also cannot exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoe4 however even true would pertain relatively small group subjects carry apoe4 ctsd alleles impact allele population level would small present
0.5697466.15003956.html.plaintext.txt	48	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data 14 case control studies 6000 genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence cannot exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also cannot exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoe4 however even true would pertain relatively small group subjects carry apoe4 ctsd alleles impact allele population level would small present
0.5697466.15003956.html.plaintext.txt	49	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro 1 2 cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains 44 might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d 3 noted clear whether ctsd polymorphism functional consequences mature form enzyme although cannot exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome 11 region ctsd gene located 45 47
0.5697466.15003956.html.plaintext.txt	50	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro 1 2 cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains 44 might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d 3 noted clear whether ctsd polymorphism functional consequences mature form enzyme although cannot exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome 11 region ctsd gene located 45 47
0.5697466.15003956.html.plaintext.txt	51	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.5697466.15003956.html.plaintext.txt	52	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.5697466.15003956.html.plaintext.txt	53	subgroup effects effect modification eg differential effects genetic polymorphism early vs late onset alzheimer disease cases familial vs sporadic disease complex interactions genes may also need considered 48 analyses addressed interactions apoe4 major known genetic determinant alzhei mer disease interactions genetic environmental factors studied trend stronger effect apoe4 presence allele carriage interesting light data suggesting carriage may affect general intelligence 5 however subgroup interaction analyses interpreted cautiously since differences subgroups may occur chance 49 validation would require studies even larger sample sizes several thousand included meta analysis finally population stratification may theoretically affected results constituent studies meta analysis 50 since documented frequency allele varied considerably among different ethnic groups even among different ethnic groups european descent however studies strictly ethnically defined population stratification effect unlikely considerable magnitude
0.5697466.15003956.html.plaintext.txt	54	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding 23 29 reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings 41 51 52 even genetic associations replicated usually major public health impact would lead screening recommendations 53 nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.5697466.15003956.html.plaintext.txt	55	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding 23 29 reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings 41 51 52 even genetic associations replicated usually major public health impact would lead screening recommendations 53 nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.5697466.15003956.html.plaintext.txt	56	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction 9 dynamic allele specific hybridization 14 error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.5697466.15003956.html.plaintext.txt	57	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction 9 dynamic allele specific hybridization 14 error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.5697466.15003956.html.plaintext.txt	58	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.5697466.15003956.html.plaintext.txt	59	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.5697466.15003956.html.plaintext.txt	60	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.5697466.15003956.html.plaintext.txt	61	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.5697466.15003956.html.plaintext.txt	62	notes correspondence dr john p ioannidis department hygiene epidemiology university ioannina school medicine ioannina 45110 greece e mail jioannidatccuoigr u d
0.5697466.15003956.html.plaintext.txt	63	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport 199672163 6isimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res 199775011 19crossrefisimedline touitou capony f brouillet jp et al missense polymorphism ct224 human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer 199430a390 4isimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloid42 patients alzheimer disease related exon 2 polymorphism cathepsin d gene neuroreport 2002131291 4crossrefisimedline payton holland f diggle p et al cathepsin d exon 2 polymorphism associated general intelligence healthy older population mol psychiatry 2003814 18crossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett 200028961 5crossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol 200047399 40330co2 5 105179 82crossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett 1999262171 4crossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon 2 polymorphism sporadic alzheimer disease neurosci lett 1999273140 1crossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet 200211431 3crossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord 200316151 5crossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin 6 genes risk alzheimer disease neurosci lett 200028821 4crossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet 20019437 44crossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol 200149544 5 bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett 2002328273 6crossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon 2 polymorphism alzheimer disease ann neurol 200149114 1630co2 m disease highlight problems complex disease analysis trends genet 200117407 13crossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett 200334499 102crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama 19972781349 56abstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama 19952731354 9abstract cummings jl cole g alzheimer disease jama 20022872335 8free full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry 200047183 99crossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry 199855809 15abstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence 10 years partial replication j neurol neurosurg psychiatry 200374857 62abstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology 19995278 84abstractfree full text mcdowell alzheimer disease insights epidemiology aging milano 200113143 62isimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease 2 communities jama 2001285739 47abstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord 20021441 54crossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett 200232633 6crossrefisimedline dermaut b roks g theuns j et al variable expression presenilin 1 major determinant risk late onset alzheimer disease j neurol 2001248935 9crossrefisimedline koster mn dermaut b cruts m et al 2 macroglobulin gene ad population based study meta analysis neurology 200055678 84abstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett 200131492 6crossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon 3 polymorphism alzheimer disease neurosci lett 200131617 20crossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet 200312859 67abstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med 1997127820 6abstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press 1994 lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med 1992327248 54abstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol 199952281 91crossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u 200198831 6abstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet 200129306 9crossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics 1994501088 101isimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet 2003361567 71crossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem 1997692026 38isimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet 19998237 45abstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet 200096823 3033co2 9 12415 22abstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med 199211678 84isimedline cardon lr palmer lj population stratification spurious allelic association lancet 2003361598 604crossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet 200333177 82crossrefisimedline ioannidis jpa genetic associations false true trends mol med 20039135 8crossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol 2003157667 73free full text
0.5697466.15003956.html.plaintext.txt	64	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport 199672163 6isimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res 199775011 19crossrefisimedline touitou capony f brouillet jp et al missense polymorphism ct224 human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer 199430a390 4isimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloid42 patients alzheimer disease related exon 2 polymorphism cathepsin d gene neuroreport 2002131291 4crossrefisimedline payton holland f diggle p et al cathepsin d exon 2 polymorphism associated general intelligence healthy older population mol psychiatry 2003814 18crossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett 200028961 5crossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol 200047399 40330co2 5 105179 82crossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett 1999262171 4crossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon 2 polymorphism sporadic alzheimer disease neurosci lett 1999273140 1crossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet 200211431 3crossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord 200316151 5crossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin 6 genes risk alzheimer disease neurosci lett 200028821 4crossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet 20019437 44crossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol 200149544 5 bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett 2002328273 6crossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon 2 polymorphism alzheimer disease ann neurol 200149114 1630co2 m disease highlight problems complex disease analysis trends genet 200117407 13crossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett 200334499 102crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama 19972781349 56abstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama 19952731354 9abstract cummings jl cole g alzheimer disease jama 20022872335 8free full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry 200047183 99crossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry 199855809 15abstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence 10 years partial replication j neurol neurosurg psychiatry 200374857 62abstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology 19995278 84abstractfree full text mcdowell alzheimer disease insights epidemiology aging milano 200113143 62isimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease 2 communities jama 2001285739 47abstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord 20021441 54crossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett 200232633 6crossrefisimedline dermaut b roks g theuns j et al variable expression presenilin 1 major determinant risk late onset alzheimer disease j neurol 2001248935 9crossrefisimedline koster mn dermaut b cruts m et al 2 macroglobulin gene ad population based study meta analysis neurology 200055678 84abstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett 200131492 6crossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon 3 polymorphism alzheimer disease neurosci lett 200131617 20crossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet 200312859 67abstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med 1997127820 6abstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press 1994 lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med 1992327248 54abstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol 199952281 91crossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u 200198831 6abstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet 200129306 9crossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics 1994501088 101isimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet 2003361567 71crossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem 1997692026 38isimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet 19998237 45abstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet 200096823 3033co2 9 12415 22abstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med 199211678 84isimedline cardon lr palmer lj population stratification spurious allelic association lancet 2003361598 604crossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet 200333177 82crossrefisimedline ioannidis jpa genetic associations false true trends mol med 20039135 8crossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol 2003157667 73free full text
0.6103489.15220354.html.plaintext.txt	0	functional implications presenilin dimerization reconstitution secretase activity assembly catalytic site dimer interface two catalytically inactive presenilins sara cervantes carlos saura esther pomares roser gonzalez duarte gemma marfany
0.6103489.15220354.html.plaintext.txt	1	functional implications presenilin dimerization reconstitution secretase activity assembly catalytic site dimer interface two catalytically inactive presenilins sara cervantes carlos saura esther pomares roser gonzalez duarte gemma marfany
0.6103489.15220354.html.plaintext.txt	2	departament de genetica facultat de biologia universitat de barcelona avda diagonal 645 e 08028 barcelona spain center neurologic diseases brigham womens hospital harvard medical school boston massachusetts 02115
0.6103489.15220354.html.plaintext.txt	3	departament de genetica facultat de biologia universitat de barcelona avda diagonal 645 e 08028 barcelona spain center neurologic diseases brigham womens hospital harvard medical school boston massachusetts 02115
0.6103489.15220354.html.plaintext.txt	4	received publication april 30 2004 revised form june 22 2004
0.6103489.15220354.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references presenilins catalytic components secretase intramembrane cleaving protease whose substrates include amyloid precursor protein app notch receptors type transmembrane proteins undergo two distinct presenilin dependent cleavages within transmembrane region result production app intracellular domain app notch intracellular domain signaling peptide cases familial alzheimers disease caused presenilin mutations scattered throughout coding sequence although underlying molecular mechanism yet known familial alzheimers disease mutations produce shift ratio long short forms peptide generated secretase others previously shown presenilin homodimerizes suggested presenilin dimer catalytic core secretase demonstrate presenilin transmembrane domains contribute formation dimer frame substitution hydrophilic loop 1 located transmembranes ii modulates interactions within n terminal fragmentn terminal fragment dimer abolishes presenilinase secretase activities addition reconstituting secretase activity two catalytically inactive presenilin aspartic mutants provide evidence active diaspartyl group assembled interface two presenilin monomers conditions catalytic group mediates generation app intracellular domain notch intracellular domain therefore suggesting specific diaspartyl groups within presenilin catalytic core secretase mediate cleavage different substrates
0.6103489.15220354.html.plaintext.txt	6	abstract top abstract introduction experimental procedures results discussion references presenilins catalytic components secretase intramembrane cleaving protease whose substrates include amyloid precursor protein app notch receptors type transmembrane proteins undergo two distinct presenilin dependent cleavages within transmembrane region result production app intracellular domain app notch intracellular domain signaling peptide cases familial alzheimers disease caused presenilin mutations scattered throughout coding sequence although underlying molecular mechanism yet known familial alzheimers disease mutations produce shift ratio long short forms peptide generated secretase others previously shown presenilin homodimerizes suggested presenilin dimer catalytic core secretase demonstrate presenilin transmembrane domains contribute formation dimer frame substitution hydrophilic loop 1 located transmembranes ii modulates interactions within n terminal fragmentn terminal fragment dimer abolishes presenilinase secretase activities addition reconstituting secretase activity two catalytically inactive presenilin aspartic mutants provide evidence active diaspartyl group assembled interface two presenilin monomers conditions catalytic group mediates generation app intracellular domain notch intracellular domain therefore suggesting specific diaspartyl groups within presenilin catalytic core secretase mediate cleavage different substrates
0.6103489.15220354.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references presenilins ps1 components high molecular weight multimeric enzymatic complex secretase 1 2 enzymatic activity whose identity elusive years responsible production a4042 peptides deposition insoluble aggregates a4042 mainly a42 results generation amyloid plaques one hallmarks alzheimers disease peptides produced series proteolytic cleavages precursor app type transmembrane tm protein cleavage app secretases generates c terminal fragments ctf ctf respectively substrates secretase intramembrane proteolytic cleavage secretase ctf generates soluble p3 peptide whereas cleavage ctf generates peptides abundant peptide forms a40 a4243 produced 91 ratio reviewed ref 3 mutations presenilin 1 2 ps1 ps2 genes cause familiar autosomal dominant ad fad date 145 missense mutations reported available world wide web molgen wwwuiaacbeadmutations mutations scattered throughout coding sequence trigger shift ratio a4042 production favor longer peptide form a4243 4 5 less soluble serves core amyloid plaque formation 6 addition secretase also releases app intracellular domain aicd cleavage site 7 8 aicd translocates nucleus together recruited proteins initiates transcriptional events 9 10 another type tm substrate notch receptor cleaved s3 site secretase proteolytic cleavage also within tm region key step notch signal transduction since releases notch intracellular domain nicd 11 analogous notch s3 app sites located within tm region near cytoplasmic domain 7 8 addition notch also undergoes additional secretase mediated proteolysis middle transmembrane region s4 site analogous producing secretase cleavage 12
0.6103489.15220354.html.plaintext.txt	8	introduction top abstract introduction experimental procedures results discussion references presenilins ps1 components high molecular weight multimeric enzymatic complex secretase 1 2 enzymatic activity whose identity elusive years responsible production a4042 peptides deposition insoluble aggregates a4042 mainly a42 results generation amyloid plaques one hallmarks alzheimers disease peptides produced series proteolytic cleavages precursor app type transmembrane tm protein cleavage app secretases generates c terminal fragments ctf ctf respectively substrates secretase intramembrane proteolytic cleavage secretase ctf generates soluble p3 peptide whereas cleavage ctf generates peptides abundant peptide forms a40 a4243 produced 91 ratio reviewed ref 3 mutations presenilin 1 2 ps1 ps2 genes cause familiar autosomal dominant ad fad date 145 missense mutations reported available world wide web molgen wwwuiaacbeadmutations mutations scattered throughout coding sequence trigger shift ratio a4042 production favor longer peptide form a4243 4 5 less soluble serves core amyloid plaque formation 6 addition secretase also releases app intracellular domain aicd cleavage site 7 8 aicd translocates nucleus together recruited proteins initiates transcriptional events 9 10 another type tm substrate notch receptor cleaved s3 site secretase proteolytic cleavage also within tm region key step notch signal transduction since releases notch intracellular domain nicd 11 analogous notch s3 app sites located within tm region near cytoplasmic domain 7 8 addition notch also undergoes additional secretase mediated proteolysis middle transmembrane region s4 site analogous producing secretase cleavage 12
0.6103489.15220354.html.plaintext.txt	9	widely accepted ps1 ps2 catalytic components secretase complex appears aspartyl protease whose activity resides interface two presenilin fragments n terminal ntf c terminal ctf fragments 13 14 ntf ctf presenilin moieties probably produced autocatalytic presenilinase activity stable ps holoprotein 15 16 ntf ctf heterodimerize 11 stoichiometry within secretase complex 17 18 complex also contains nicastrin aph 1 pen 2 yet undetermined stoichiometry 2 19 20
0.6103489.15220354.html.plaintext.txt	10	widely accepted ps1 ps2 catalytic components secretase complex appears aspartyl protease whose activity resides interface two presenilin fragments n terminal ntf c terminal ctf fragments 13 14 ntf ctf presenilin moieties probably produced autocatalytic presenilinase activity stable ps holoprotein 15 16 ntf ctf heterodimerize 11 stoichiometry within secretase complex 17 18 complex also contains nicastrin aph 1 pen 2 yet undetermined stoichiometry 2 19 20
0.6103489.15220354.html.plaintext.txt	11	many biochemical properties secretase activity poorly understood perplexing ability cleave two different sites within transmembrane region substrates cleavages app s3 s4 sites notch heterogeneity cleavage site yields peptides ranging 32 43 amino acids 21 although presenilin catalytic center composed diaspartyl group different inhibitory profiles secretase inhibitors obtained a40 a42 notch cleavage suggest presence distinct catalytic activities 22 24 addition presenilin fad non fad mutations behave gain function mutations respect production loss function mutations respect aicd nicd release 25 26 supporting hypothesis activities separated 25 27 30 nonetheless despite wealth information gathered still lack knowledge mechanisms fad presenilin mutations mainly located far catalytic site translated subtle modifications secretase cleavage preferences studies different inhibitors shed light presenilin catalytic mechanism 31 35 however many issues related substrate specificity cleavage site specificity substrate binding site sites remain clarified several scenarios postulated explain intriguing findings reports argue secretase catalytic properties incompatible single catalytic activity propose notch app cleaved different proteases protease different catalytic sites 36 39 contrast authors propose secretase activity performed unique albeit particularly complex enzyme latter model recently expanded since several newly described isoforms components secretase might allow formation four different variants secretase complex 40
0.6103489.15220354.html.plaintext.txt	12	many biochemical properties secretase activity poorly understood perplexing ability cleave two different sites within transmembrane region substrates cleavages app s3 s4 sites notch heterogeneity cleavage site yields peptides ranging 32 43 amino acids 21 although presenilin catalytic center composed diaspartyl group different inhibitory profiles secretase inhibitors obtained a40 a42 notch cleavage suggest presence distinct catalytic activities 22 24 addition presenilin fad non fad mutations behave gain function mutations respect production loss function mutations respect aicd nicd release 25 26 supporting hypothesis activities separated 25 27 30 nonetheless despite wealth information gathered still lack knowledge mechanisms fad presenilin mutations mainly located far catalytic site translated subtle modifications secretase cleavage preferences studies different inhibitors shed light presenilin catalytic mechanism 31 35 however many issues related substrate specificity cleavage site specificity substrate binding site sites remain clarified several scenarios postulated explain intriguing findings reports argue secretase catalytic properties incompatible single catalytic activity propose notch app cleaved different proteases protease different catalytic sites 36 39 contrast authors propose secretase activity performed unique albeit particularly complex enzyme latter model recently expanded since several newly described isoforms components secretase might allow formation four different variants secretase complex 40
0.6103489.15220354.html.plaintext.txt	13	new view secretase complex put forward group others providing evidence functional secretase core contains two presenilin molecules 26 41 43 presenilin fad mutants may produce subtle alterations presenilin dimerization hence alter secretase tertiary quaternary structure 41 report demonstrate hydrophobic transmembrane regions presenilin contribute interactions within dimer alterations dimer related catalytic site affecting hl1 domain impair secretase function addition reconstituting secretase activity two catalytically inactive presenilin aspartic mutants demonstrate functional diaspartyl catalytic group formed interface ntf ctf moieties two different presenilin molecules
0.6103489.15220354.html.plaintext.txt	14	new view secretase complex put forward group others providing evidence functional secretase core contains two presenilin molecules 26 41 43 presenilin fad mutants may produce subtle alterations presenilin dimerization hence alter secretase tertiary quaternary structure 41 report demonstrate hydrophobic transmembrane regions presenilin contribute interactions within dimer alterations dimer related catalytic site affecting hl1 domain impair secretase function addition reconstituting secretase activity two catalytically inactive presenilin aspartic mutants demonstrate functional diaspartyl catalytic group formed interface ntf ctf moieties two different presenilin molecules
0.6103489.15220354.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references dna constructs initial split ubiquitin constructs containing wild type drosophila psn ntf amino acids 1 322 ctf amino acids 321 541 generated nub cub derived constructs 44 described elsewhere 41 brief yeast centromeric plasmid used constitutively express psn ntf psn ctf derived constructs fused frame cub prota lexa vp16 fusion constructs containing nubg fused psn ntf psn ctf cloned multicopy yeast plasmid control inducible cup1 promoter presenilin variants analyzed generated combining corresponding pcr fragments frame integrity coding sequence confirmed sequencing final construct
0.6103489.15220354.html.plaintext.txt	16	experimental procedures top abstract introduction experimental procedures results discussion references dna constructs initial split ubiquitin constructs containing wild type drosophila psn ntf amino acids 1 322 ctf amino acids 321 541 generated nub cub derived constructs 44 described elsewhere 41 brief yeast centromeric plasmid used constitutively express psn ntf psn ctf derived constructs fused frame cub prota lexa vp16 fusion constructs containing nubg fused psn ntf psn ctf cloned multicopy yeast plasmid control inducible cup1 promoter presenilin variants analyzed generated combining corresponding pcr fragments frame integrity coding sequence confirmed sequencing final construct
0.6103489.15220354.html.plaintext.txt	17	generate constructs expressed sl2 cells frame fusion containing ha n terminal tagged drosophila presenilin h psn pact 2 pact psn subcloned expression vector pactppa kindly provided dr vaquero drive expression ha psn drosophila actin 5c expression cassette expression constructs bearing n terminal c myc tagged psn forward strand oligonucleotide 5 catggaggaacaaaagctgatttctgaagaagacttgg 3 complementary reverse strand oligonucleotide 5 aattccaagtcttcttcagaaatcagcttttgttcctc 3 coding c myc epitope annealed cloned ncoi ecori sites pas2 1 psn entire c myc psn fusion subcloned pactppa expression vector aspartic mutant psns obtained site directed mutagenesis using psn template described elsewhere 45 frame substitution hl1 amino acids 123 154 hl5 amino acids 261 267 two step cloning strategy used resulting psn cdna containing n terminal ha tag hl5 region tmi cloned pactppa expression plasmid generate pactppa ha psnhl1 5 pactppa expression plasmids containing two psn expression cassettes obtained subcloning sali fragment containing actin 5c expression cassette driving expression c myc tagged psn unique bstz17i site plasmid pactppa ha psn
0.6103489.15220354.html.plaintext.txt	18	cleavage reporter assay drosophila necn necn gv3 construct pbluescript sk obtained substituting 400 bp aatii fragment ogg513 11 kb aatii fragment containing gal4vp16 n932 plasmids ogg513 n932 kindly provided dr g struhl tested vivo drosophila 46 necn gv3 fusion subcloned kpniecorv sites pactppa c99 gal4vp16 construct pcdna31 kindly provided dr j lundkvist 47 pcmv luciferase plasmid stratagene hsp70mp 5xg4 gal construct gift dr vaquero used reporters
0.6103489.15220354.html.plaintext.txt	19	cleavage reporter assay drosophila necn necn gv3 construct pbluescript sk obtained substituting 400 bp aatii fragment ogg513 11 kb aatii fragment containing gal4vp16 n932 plasmids ogg513 n932 kindly provided dr g struhl tested vivo drosophila 46 necn gv3 fusion subcloned kpniecorv sites pactppa c99 gal4vp16 construct pcdna31 kindly provided dr j lundkvist 47 pcmv luciferase plasmid stratagene hsp70mp 5xg4 gal construct gift dr vaquero used reporters
0.6103489.15220354.html.plaintext.txt	20	assessment production sc100 construct encoding human c99 secretase substrate signal peptide rat preproenkephalin cdna cloned pac51v5 kindly provided dr tomita 48
0.6103489.15220354.html.plaintext.txt	21	assessment production sc100 construct encoding human c99 secretase substrate signal peptide rat preproenkephalin cdna cloned pac51v5 kindly provided dr tomita 48
0.6103489.15220354.html.plaintext.txt	22	integrity conserved reading frame dna constructs confirmed sequencing perkinelmer life sciences big dye 21 using 3700 3730 dna analyzer
0.6103489.15220354.html.plaintext.txt	23	integrity conserved reading frame dna constructs confirmed sequencing perkinelmer life sciences big dye 21 using 3700 3730 dna analyzer
0.6103489.15220354.html.plaintext.txt	24	split ubiquitin assay yeast strain l40 cotransformed corresponding nub cub derived constructs 44 using standard lithium acetate procedure transformants selected growth sd trp leu supplemented 25 mm 3 aminotriazole 02 mm cu2 necessary proteinprotein interactions quantified assessment galactosidase activity reporter gene liquid culture using o nitrophenyl p d galactopyranoside substrate following standard procedures
0.6103489.15220354.html.plaintext.txt	25	split ubiquitin assay yeast strain l40 cotransformed corresponding nub cub derived constructs 44 using standard lithium acetate procedure transformants selected growth sd trp leu supplemented 25 mm 3 aminotriazole 02 mm cu2 necessary proteinprotein interactions quantified assessment galactosidase activity reporter gene liquid culture using o nitrophenyl p d galactopyranoside substrate following standard procedures
0.6103489.15220354.html.plaintext.txt	26	cell culture transfection drosophila schneiders 2 cell line sl2 cells maintained drosophila schneiders insect medium sigma supplemented 10 fetal bovine serum penicillinstreptomycin invitrogen 27 degrees c transient transfections performed 4 microg dna cellfectin invitrogen 35 mm plates 6 well plates following manufacturers instructions cells harvested 72 h post transfection stable transfections corresponding pactppa expression plasmid cotransfected pcohygro kindly provided dr d huertas two days post transfection cells selected 125 microg microl hygromycin invitrogen 3 weeks stable cell lines expanded cycloheximide treatment performed follows 1 x 107 cells cell line seeded 60 mm plates allowed attach plate surface subsequently medium removed replaced fresh medium supplemented 30 microgml cycloheximide cells 60 mm plate harvested specified time points washed cold phosphate buffered saline frozen 80 degrees c analysis
0.6103489.15220354.html.plaintext.txt	27	cell culture transfection drosophila schneiders 2 cell line sl2 cells maintained drosophila schneiders insect medium sigma supplemented 10 fetal bovine serum penicillinstreptomycin invitrogen 27 degrees c transient transfections performed 4 microg dna cellfectin invitrogen 35 mm plates 6 well plates following manufacturers instructions cells harvested 72 h post transfection stable transfections corresponding pactppa expression plasmid cotransfected pcohygro kindly provided dr d huertas two days post transfection cells selected 125 microg microl hygromycin invitrogen 3 weeks stable cell lines expanded cycloheximide treatment performed follows 1 x 107 cells cell line seeded 60 mm plates allowed attach plate surface subsequently medium removed replaced fresh medium supplemented 30 microgml cycloheximide cells 60 mm plate harvested specified time points washed cold phosphate buffered saline frozen 80 degrees c analysis
0.6103489.15220354.html.plaintext.txt	28	rna interference experiments dsrna corresponding 5 3 utrs drosophila presenilin gene obtained vitro transcription pbluescript sk 5 144 bp 3 106 bp psn utr sequence previously cloned dsrna specifically targeted disrupt endogenous presenilin expression without affecting exogenous presenilin since 5 3 utrs latter provided expression vector briefly transcription t7 t3 promoter yielded forward reverse single stranded rnas respectively two complementary rna strands annealed heating 10 min 70 degrees c subsequent incubation 10 min 37 degrees c obtain 250 bp 5 utr 3 utr dsrna either 1 2 microg dsrna co transfected specified dna constructs 4 microg dnadsrna mixture cellfectin described cells harvested 72 h post transfection allow protein turnover rna interference residual endogenous presenilin
0.6103489.15220354.html.plaintext.txt	29	rna interference experiments dsrna corresponding 5 3 utrs drosophila presenilin gene obtained vitro transcription pbluescript sk 5 144 bp 3 106 bp psn utr sequence previously cloned dsrna specifically targeted disrupt endogenous presenilin expression without affecting exogenous presenilin since 5 3 utrs latter provided expression vector briefly transcription t7 t3 promoter yielded forward reverse single stranded rnas respectively two complementary rna strands annealed heating 10 min 70 degrees c subsequent incubation 10 min 37 degrees c obtain 250 bp 5 utr 3 utr dsrna either 1 2 microg dsrna co transfected specified dna constructs 4 microg dnadsrna mixture cellfectin described cells harvested 72 h post transfection allow protein turnover rna interference residual endogenous presenilin
0.6103489.15220354.html.plaintext.txt	30	protein extractions immunoblotting stable transiently transfected cells harvested washed cold phosphate buffered saline centrifugation 500 x g 5 min ha psn detection total proteins extracted 250 microl 35 mm plate transiently transfected cells 500 microl 25 cm2 flask 60 mm plate stably transfected cells lysis buffer 50 mm tris hcl ph 74 150 mm nacl 2 mm edta 1 nonidet p 40 05 triton x 100 1 mm phenylmethylsulfonyl fluoride protease inhibitor mixture sonicated 20 ice using branson sonicator 250 insoluble proteins cell debris removed centrifugation 13000 rpm 15 min 4 degrees c proteins quantified using bio rad dc protein assay immunoblotting 10 microg protein extracts loaded onto 6 m urea sds page transferred polyvinylidene difluoride membrane immunodetected monoclonal antibody ha11 babco
0.6103489.15220354.html.plaintext.txt	31	protein extractions immunoblotting stable transiently transfected cells harvested washed cold phosphate buffered saline centrifugation 500 x g 5 min ha psn detection total proteins extracted 250 microl 35 mm plate transiently transfected cells 500 microl 25 cm2 flask 60 mm plate stably transfected cells lysis buffer 50 mm tris hcl ph 74 150 mm nacl 2 mm edta 1 nonidet p 40 05 triton x 100 1 mm phenylmethylsulfonyl fluoride protease inhibitor mixture sonicated 20 ice using branson sonicator 250 insoluble proteins cell debris removed centrifugation 13000 rpm 15 min 4 degrees c proteins quantified using bio rad dc protein assay immunoblotting 10 microg protein extracts loaded onto 6 m urea sds page transferred polyvinylidene difluoride membrane immunodetected monoclonal antibody ha11 babco
0.6103489.15220354.html.plaintext.txt	32	c myc psn analysis cell membranes extracted 05 dodecyl maltoside buffer follows cells resuspended volumes homogenization buffer 10 mm hepes ph 74 1 mm edta 250 mm sucrose 2 brij 35 1 mm phenylmethylsulfonyl fluoride protease inhibitors indicated subjected mechanical lysis polytron homogenizer presenilin enriched membrane fraction obtained subsequent centrifugation 14000 x g 30 min 4 degrees c psn solubilized membrane pellet 50 100 microl buffer ii 50 mm sodium citrate ph 64 1 mm edta 5 glycerol 1 mm phenylmethylsulfonyl fluoride protease inhibitors 20 60 min ice subsequently total protein concentration quantified using bio rad dc protein assay clarifying spin 20 microg protein subjected electrophoresis c myc psn immunodetected monoclonal anti myc antibody 9e10 santa cruz biotechnology inc santa cruz ca
0.6103489.15220354.html.plaintext.txt	33	c myc psn analysis cell membranes extracted 05 dodecyl maltoside buffer follows cells resuspended volumes homogenization buffer 10 mm hepes ph 74 1 mm edta 250 mm sucrose 2 brij 35 1 mm phenylmethylsulfonyl fluoride protease inhibitors indicated subjected mechanical lysis polytron homogenizer presenilin enriched membrane fraction obtained subsequent centrifugation 14000 x g 30 min 4 degrees c psn solubilized membrane pellet 50 100 microl buffer ii 50 mm sodium citrate ph 64 1 mm edta 5 glycerol 1 mm phenylmethylsulfonyl fluoride protease inhibitors 20 60 min ice subsequently total protein concentration quantified using bio rad dc protein assay clarifying spin 20 microg protein subjected electrophoresis c myc psn immunodetected monoclonal anti myc antibody 9e10 santa cruz biotechnology inc santa cruz ca
0.6103489.15220354.html.plaintext.txt	34	detection app ctfs protein extracts prepared drosophila schneider sl2 cells lysis ice radioimmune precipitation buffer 50 mm tris hcl ph 74 150 mm nacl 1 mm edta 1 triton x 100 1 sodium deoxycholate 01 sds supplemented protease inhibitors sigma lysates sonicated protein concentration determined using bca protein assay kit pierce protein extracts 10 microg mixed 2x sds sample buffer resolved 4 20 trisglycine gels invitrogen immunoblot analysis proteins transferred polyvinylidene difluoride membranes incubated 30 min blocking buffer 10 nonfat milk 01 bovine serum albumin phosphate buffered saline ph 74 followed incubation primary polyclonal antiserum specific c terminal residues 665 695 app saeko 110000 49 app ctfs detected ecl plus chemiluminescence kit perkinelmer life sciences density band quantified using nih image software normalized tubulin sigma data represent average plus minus se three independent experiments
0.6103489.15220354.html.plaintext.txt	35	detection app ctfs protein extracts prepared drosophila schneider sl2 cells lysis ice radioimmune precipitation buffer 50 mm tris hcl ph 74 150 mm nacl 1 mm edta 1 triton x 100 1 sodium deoxycholate 01 sds supplemented protease inhibitors sigma lysates sonicated protein concentration determined using bca protein assay kit pierce protein extracts 10 microg mixed 2x sds sample buffer resolved 4 20 trisglycine gels invitrogen immunoblot analysis proteins transferred polyvinylidene difluoride membranes incubated 30 min blocking buffer 10 nonfat milk 01 bovine serum albumin phosphate buffered saline ph 74 followed incubation primary polyclonal antiserum specific c terminal residues 665 695 app saeko 110000 49 app ctfs detected ecl plus chemiluminescence kit perkinelmer life sciences density band quantified using nih image software normalized tubulin sigma data represent average plus minus se three independent experiments
0.6103489.15220354.html.plaintext.txt	36	cleavage c99 s3 cleavage necn substrates co expression c99 gal4vp16 necn gal4vp16 fusion proteins substrates secretase together hsp70mp 5xg4 gal reporter construct hereafter referred hsp70 uas gal allowed quantification presenilin mediated cleavage stably transfected cells expressing presenilin constructs transiently transfected 23 microg c99 gal4vp16 500 ng hsp70 uas gal 200 ng cytomegalovirusluciferase control plasmid 1 microg dsrna analysis nicd production cells transfected 50 ng necn gal4vp16 185 microg hsp70 uas gal 100 ng pcmv luciferase control plasmid 2 microg dsrna transfections performed 6 well plates amount transfected dnarna kept 4 microg seventy two hours post transfection cells harvested washed cold phosphate buffered saline lysed quantify galactosidase luciferase activities galactosidase reporter gene assay chemiluminescent roche applied science luciferase assay system invitrogen respectively following manufacturers instructions
0.6103489.15220354.html.plaintext.txt	37	cleavage c99 s3 cleavage necn substrates co expression c99 gal4vp16 necn gal4vp16 fusion proteins substrates secretase together hsp70mp 5xg4 gal reporter construct hereafter referred hsp70 uas gal allowed quantification presenilin mediated cleavage stably transfected cells expressing presenilin constructs transiently transfected 23 microg c99 gal4vp16 500 ng hsp70 uas gal 200 ng cytomegalovirusluciferase control plasmid 1 microg dsrna analysis nicd production cells transfected 50 ng necn gal4vp16 185 microg hsp70 uas gal 100 ng pcmv luciferase control plasmid 2 microg dsrna transfections performed 6 well plates amount transfected dnarna kept 4 microg seventy two hours post transfection cells harvested washed cold phosphate buffered saline lysed quantify galactosidase luciferase activities galactosidase reporter gene assay chemiluminescent roche applied science luciferase assay system invitrogen respectively following manufacturers instructions
0.6103489.15220354.html.plaintext.txt	38	elisas sl2 cells stably expressing wild type mutant ps variants transiently transfected cdna encoding c terminal 99 amino acids app sc100 andor dsrna using cellfectin invitrogen following manufacturers instructions cells incubated 48 h allow inactivation endogenous psn expression old medium replaced fresh medium additional 48 h culture medium collected ice centrifuged 1000 x g 10 min supernatants collected coded used elisa analysis a40 a42 levels determined 2g3266b 21f12266b sandwich elisa previously described 50 51 values normalized cellular protein represent average three independent transfections analyzed duplicate
0.6103489.15220354.html.plaintext.txt	39	elisas sl2 cells stably expressing wild type mutant ps variants transiently transfected cdna encoding c terminal 99 amino acids app sc100 andor dsrna using cellfectin invitrogen following manufacturers instructions cells incubated 48 h allow inactivation endogenous psn expression old medium replaced fresh medium additional 48 h culture medium collected ice centrifuged 1000 x g 10 min supernatants collected coded used elisa analysis a40 a42 levels determined 2g3266b 21f12266b sandwich elisa previously described 50 51 values normalized cellular protein represent average three independent transfections analyzed duplicate
0.6103489.15220354.html.plaintext.txt	40	results top abstract introduction experimental procedures results discussion references contribution presenilin transmembrane domains ntfntf ctfctf ntfctf interactions previously shown drosophila presenilin psn forms tetramer two ntfs two ctfs 41 properly named dimer since ntf ctf processed products single molecule psn holoprotein exhaustive analysis presenilin domain interactions yeast two hybrid assay results highlighted contribution hydrophilic loop connecting transmembranes ii hl1 ntfntf homodimerization although similar domains could defined ctfctf ntfctf interactions 41 presenilins show complex topology eight transmembrane domains may also interact among contribute dimer formation dissect possible contribution transmembrane domains ntfntf also ctfctf ntfctf dimerization relied alternative strategy specifically designed test proteinprotein interactions proteins anchored membrane split ubiquitin system 44 system proteins assayed interaction independently fused either n terminal nub domain c terminal cub domain ubiquitin turn attached transcription factor lexa vp16 two assayed proteins interact would bring together two ubiquitin moieties reconstituting ubiquitin entity would recognized cleaved cellular deubiquitinating enzymes thus triggering transcription several sensitive reporter selective genes his3 lacz genes 44 strategy already successfully applied detect dissect membrane protein interactions several proteins including presenilin 41 52 several requirements met order analyze series transmembrane deletions frame one requisites approach nub cub moieties ubiquitin localized cytosol cub lexa vp16 fusion end terminus protein fusion 44 addition presenilin molecule maintain topology membrane requisites limited number combination presenilin transmembrane domains could tested deleted frame even numbers
0.6103489.15220354.html.plaintext.txt	41	results top abstract introduction experimental procedures results discussion references contribution presenilin transmembrane domains ntfntf ctfctf ntfctf interactions previously shown drosophila presenilin psn forms tetramer two ntfs two ctfs 41 properly named dimer since ntf ctf processed products single molecule psn holoprotein exhaustive analysis presenilin domain interactions yeast two hybrid assay results highlighted contribution hydrophilic loop connecting transmembranes ii hl1 ntfntf homodimerization although similar domains could defined ctfctf ntfctf interactions 41 presenilins show complex topology eight transmembrane domains may also interact among contribute dimer formation dissect possible contribution transmembrane domains ntfntf also ctfctf ntfctf dimerization relied alternative strategy specifically designed test proteinprotein interactions proteins anchored membrane split ubiquitin system 44 system proteins assayed interaction independently fused either n terminal nub domain c terminal cub domain ubiquitin turn attached transcription factor lexa vp16 two assayed proteins interact would bring together two ubiquitin moieties reconstituting ubiquitin entity would recognized cleaved cellular deubiquitinating enzymes thus triggering transcription several sensitive reporter selective genes his3 lacz genes 44 strategy already successfully applied detect dissect membrane protein interactions several proteins including presenilin 41 52 several requirements met order analyze series transmembrane deletions frame one requisites approach nub cub moieties ubiquitin localized cytosol cub lexa vp16 fusion end terminus protein fusion 44 addition presenilin molecule maintain topology membrane requisites limited number combination presenilin transmembrane domains could tested deleted frame even numbers
0.6103489.15220354.html.plaintext.txt	42	combinations tested result interaction assay depicted fig 1 c specificity interaction confirmed absence growth yeast co transformed either psn ntf cub prota lexa vp16 psn ctf cub prota lexa vp16 another yeast er transmembrane protein alg5 nubg shown ref 41 main conclusion interaction assays transmembrane domains indeed play important role ntfntf ctfctf ntfctf dimerization particularly transmembranes 3 6 ntf 7 8 ctf
0.6103489.15220354.html.plaintext.txt	43	view larger version 37k fig 1 contribution presenilin transmembrane domains ntfctf ntfntf ctfctf dimerization assayed yeast split ubiquitin system presenilin domains tested different combinations frame fusion constructs either nub cub lexa vp16 indicated interactions detected selective growth medium lacking histidine dissection transmembrane domain contribution ntfctf interaction b dissection transmembrane domain contribution ntfntf interaction c dissection transmembrane domain contribution ctfctf interaction d effect substitution hl1 hl5 ntfntf dimerization assessed quantification activation lacz reporter gene using o nitrophenyl p d galactopyranoside substrate asterisk indicates statistical significance u mann whitney test p 005 p 001 n 4 replicates
0.6103489.15220354.html.plaintext.txt	44	previous work proposed hl1 played important role dimer formation probably conformation presenilin secretase complex due homomeric proteinprotein interactions mediated domain support 14 145 mutations ps1 ps2 cluster 32 amino acid loop fad mutations analyzed altered hl1hl1 dimerization 41 nonetheless results depicted fig 1 b suggested region comprising n terminus tmi hl1 tmii domains required ntfntf ntfctf interactions given deletion affect strength ntfntf ntfctf interactions compared wild type fragments assessed semiquantitatively growth selective medium address role hl1 ntfntf homodimerization undertook new series experiments analyze whether ntfntf interaction dimerization would altered hl1 loop sequence substituted another connecting loop topology relative position transmembrane domains still maintained end generated ntf variant named ntf1 5 hl1 amino acids 123 154 psn replaced hl5 shorter er facing connecting loop peptide psn amino acids 261 267 psn frame substitution alter number transmembranes connecting loops general ntf topology preserved directly test ntfntf interaction membrane resorted split ubiquitin system previously shown allowed presenilin properly anchored membrane interaction different combinations wild type ntf ntf1 5 assessed quantification lacz reporter activity fig 1d according results replacement hl1 increases strength ntfntf interaction thus confirming contribution domains formation stability dimer indicating hl1 may modulatory role ntfntf interaction thus presenilin dimerization contrast none hydrophilic domains ctf domain seemed determinant structural interactions since could deleted without affecting ctfctf ntfctf interactions fig 1 c
0.6103489.15220354.html.plaintext.txt	45	previous work proposed hl1 played important role dimer formation probably conformation presenilin secretase complex due homomeric proteinprotein interactions mediated domain support 14 145 mutations ps1 ps2 cluster 32 amino acid loop fad mutations analyzed altered hl1hl1 dimerization 41 nonetheless results depicted fig 1 b suggested region comprising n terminus tmi hl1 tmii domains required ntfntf ntfctf interactions given deletion affect strength ntfntf ntfctf interactions compared wild type fragments assessed semiquantitatively growth selective medium address role hl1 ntfntf homodimerization undertook new series experiments analyze whether ntfntf interaction dimerization would altered hl1 loop sequence substituted another connecting loop topology relative position transmembrane domains still maintained end generated ntf variant named ntf1 5 hl1 amino acids 123 154 psn replaced hl5 shorter er facing connecting loop peptide psn amino acids 261 267 psn frame substitution alter number transmembranes connecting loops general ntf topology preserved directly test ntfntf interaction membrane resorted split ubiquitin system previously shown allowed presenilin properly anchored membrane interaction different combinations wild type ntf ntf1 5 assessed quantification lacz reporter activity fig 1d according results replacement hl1 increases strength ntfntf interaction thus confirming contribution domains formation stability dimer indicating hl1 may modulatory role ntfntf interaction thus presenilin dimerization contrast none hydrophilic domains ctf domain seemed determinant structural interactions since could deleted without affecting ctfctf ntfctf interactions fig 1 c
0.6103489.15220354.html.plaintext.txt	46	expression metabolism hl1 presenilin mutant observations pointing modulatory role hl1 formation presenilin dimer prompted us investigate contribution er facing loop presenilinase secretase activities vivo ntf1 5 variant engineered new psn mutant hl1 substituted hl5 recombinant psn named psnhl1 5 already mentioned frame substitution hl1 alter number tms connecting loops resulting psn fig 2a using drosophila sl2 cells homologous expression system stably transfected overexpressed several constructs bearing either wild type mutant n terminal ha tagged psns wtpsn psnhl1 5 assessed expression processing western blot analyses protein lysates fig 2b addition ha tag n terminus psn alter presenilinase processing wtpsn endoproteolytically cleaved transient stable transfectants contrast psnhl1 5 generate corresponding ntf fragment behaved like null presenilin mutants catalytic aspartic acid residues fig 2b thus demonstrating hl1 essential psn endoproteolysis
0.6103489.15220354.html.plaintext.txt	47	expression metabolism hl1 presenilin mutant observations pointing modulatory role hl1 formation presenilin dimer prompted us investigate contribution er facing loop presenilinase secretase activities vivo ntf1 5 variant engineered new psn mutant hl1 substituted hl5 recombinant psn named psnhl1 5 already mentioned frame substitution hl1 alter number tms connecting loops resulting psn fig 2a using drosophila sl2 cells homologous expression system stably transfected overexpressed several constructs bearing either wild type mutant n terminal ha tagged psns wtpsn psnhl1 5 assessed expression processing western blot analyses protein lysates fig 2b addition ha tag n terminus psn alter presenilinase processing wtpsn endoproteolytically cleaved transient stable transfectants contrast psnhl1 5 generate corresponding ntf fragment behaved like null presenilin mutants catalytic aspartic acid residues fig 2b thus demonstrating hl1 essential psn endoproteolysis
0.6103489.15220354.html.plaintext.txt	48	view larger version 34k fig 2 expression metabolism psnhl1 5 variant scheme showing predicted dimer structure psnhl1 5 psn mutant hl1 substituted hl5 note presenilinase cleavage depicted since autoproteolytic processing variant completely abolished b western blots total protein extracts 10 microg transiently left stably right transfected sl2 cells immunodetected anti ha monoclonal antibody c western blots total protein extracts 10 microg stably transfected cells expressed either wtpsn psnd461a psnhl1 5 variants treated cycloheximide block total protein synthesis indicated period time immunodetected anti ha
0.6103489.15220354.html.plaintext.txt	49	tested subcellular localization protein stability psnhl1 5 mutant immunofluorescent analysis transfected sl2 cells revealed similar subcellular distribution mainly er compartments wtpsn psnhl1 5 psnd461a mutant data shown assess presenilin stability total protein synthesis inhibited cycloheximide treatment cells harvested different times immunodetection lysates stably transfected cells using anti ha antibody showed psnhl1 5 holoprotein stable time wtpsn holoprotein fig 2c since substantial amounts psnhl1 5 still detected 10 h treatment observation indicates contrast wtpsn proportion psnhl1 5 holoprotein pool stabilized similarly reported mutant presenilin holoproteins 30 53
0.6103489.15220354.html.plaintext.txt	50	tested subcellular localization protein stability psnhl1 5 mutant immunofluorescent analysis transfected sl2 cells revealed similar subcellular distribution mainly er compartments wtpsn psnhl1 5 psnd461a mutant data shown assess presenilin stability total protein synthesis inhibited cycloheximide treatment cells harvested different times immunodetection lysates stably transfected cells using anti ha antibody showed psnhl1 5 holoprotein stable time wtpsn holoprotein fig 2c since substantial amounts psnhl1 5 still detected 10 h treatment observation indicates contrast wtpsn proportion psnhl1 5 holoprotein pool stabilized similarly reported mutant presenilin holoproteins 30 53
0.6103489.15220354.html.plaintext.txt	51	hl1 domain psn required secretase activity determine effects secretase activity due alteration psn hl1 domain next examined ability psnhl1 5 mutant mediate cleavages human app derived substrate c99 fused gal4vp16 c99 gvp generate aicd respectively previous control experiments sl2 cells stably transfected either wtpsn positive control psn single psnd461a psnd279a double psnd461ad279a aspartic mutants negative controls confirmed expression exogenous tagged psn variants analyzed production aicd performing quantitative assay based galactosidase reporter system activated substrate cleavage 47 chose assay secretase activity using reporter based assays since widely used monitor signaling pathways mediated cleavage drosophila highly sensitive easily quantified besides substrate similar assay successfully used recently characterize secretase activity ps1 variants 54 55
0.6103489.15220354.html.plaintext.txt	52	hl1 domain psn required secretase activity determine effects secretase activity due alteration psn hl1 domain next examined ability psnhl1 5 mutant mediate cleavages human app derived substrate c99 fused gal4vp16 c99 gvp generate aicd respectively previous control experiments sl2 cells stably transfected either wtpsn positive control psn single psnd461a psnd279a double psnd461ad279a aspartic mutants negative controls confirmed expression exogenous tagged psn variants analyzed production aicd performing quantitative assay based galactosidase reporter system activated substrate cleavage 47 chose assay secretase activity using reporter based assays since widely used monitor signaling pathways mediated cleavage drosophila highly sensitive easily quantified besides substrate similar assay successfully used recently characterize secretase activity ps1 variants 54 55
0.6103489.15220354.html.plaintext.txt	53	control assays using empty vector stably transfected cells showed detectable levels galactosidase activity thus indicating endogenous presenilin secretase activity avoid background endogenous presenilin designed performed rnai experiments dsrna 250 bp corresponding fused 5 3 utr sequences drosophila psn gene dsrna co transfected along assay constructs order specifically knock endogenous psn without altering levels tagged exogenous psn expression confirmed western blot analysis data shown treatment dsrna targeting endogenous presenilin produced significant decrease galactosidase activity stably vector transfected cells whereas galactosidase activity stably wtpsn transfected cells remained unaltered data shown assess whether 5 utr 3 utr dsrna reduced cleavage site c99 substrate endogenous presenilin therefore decreased production sl2 cells transiently transfected sc100 construct encoding c99 substrate 48 along dsrna forty eight hours post transfection medium replaced quantify de novo produced peptides rnai treatment production a40 a42 peptides clearly reduced dsrna treatment fig 3a left indicating efficient disruption endogenous presenilin activity interestingly dsrna treatment alter production a42 peptide relative total thus a4042 ratio remained unaffected dsrna treated cells fig 3a right decrease endogenous presenilin activity measured production correlated accumulation ctf stubs generated secretase cleavage fig 3b results confirmed efficiency dsrna interference thus experiments performed dsrna treated cells
0.6103489.15220354.html.plaintext.txt	54	control assays using empty vector stably transfected cells showed detectable levels galactosidase activity thus indicating endogenous presenilin secretase activity avoid background endogenous presenilin designed performed rnai experiments dsrna 250 bp corresponding fused 5 3 utr sequences drosophila psn gene dsrna co transfected along assay constructs order specifically knock endogenous psn without altering levels tagged exogenous psn expression confirmed western blot analysis data shown treatment dsrna targeting endogenous presenilin produced significant decrease galactosidase activity stably vector transfected cells whereas galactosidase activity stably wtpsn transfected cells remained unaltered data shown assess whether 5 utr 3 utr dsrna reduced cleavage site c99 substrate endogenous presenilin therefore decreased production sl2 cells transiently transfected sc100 construct encoding c99 substrate 48 along dsrna forty eight hours post transfection medium replaced quantify de novo produced peptides rnai treatment production a40 a42 peptides clearly reduced dsrna treatment fig 3a left indicating efficient disruption endogenous presenilin activity interestingly dsrna treatment alter production a42 peptide relative total thus a4042 ratio remained unaffected dsrna treated cells fig 3a right decrease endogenous presenilin activity measured production correlated accumulation ctf stubs generated secretase cleavage fig 3b results confirmed efficiency dsrna interference thus experiments performed dsrna treated cells
0.6103489.15220354.html.plaintext.txt	55	view larger version 37k fig 3 substitution hl1 impairs aicd nicd production control assays sl2 cells dsrna targeting 5 3 utrs psn showed reduction endogenous psn activity measured following a4042 production analyzed sandwich elisa sl2 cells transiently transfected sc100 construct left ratio production a42 total altered dsrna treatment right b secretase cleavage excess sc100 substrate cleaved secretase produced ctf stub c sl2 cells stably expressing indicated psn variants transiently transfected c99 gal4vp16 construct along dsrna n 8 three independent experiments d a4042 production quantified sandwich elisa sl2 cells stably transfected indicated psn variants transiently transfected sc100 construct along dsrna n 3 independent transfections e western blots protein lysates cells analyzed d immunodetected antibody specific c terminus app amino acids 665 695 f sl2 cells stably expressing indicated psn variants transiently transfected necn gal4vp16 construct along dsrna n 4 two independent experiments statistical significance according u mann whitney test follows p 005 p 0005
0.6103489.15220354.html.plaintext.txt	56	assess activity psnhl1 5 mutant analyzed production aicd cleavage nicd s3 cleavage cleavage ha psnhl1 5 stably transfected cells using aforementioned quantitative reporter based strategy several timing controls cells harvested 72 h post transfection allow efficient rna interference endogenous presenilin protein turnover galactosidase activity measured aicd production cleavage obtained mutant stably transfected cells compared wtpsn considered 100 remarkably secretase activity psnhl1 5 stable cell lines assessed c99 gvp substrate completely abolished yielding values similar tmvii aspartic mutant presenilin psnd461a fig 3c result showed hl1 appears essential cleavage app consequently aicd production next tested whether psnhl1 5 mutant cleaved app derived substrate produce a40 a42 peptides cleavage stable cell lines expressing different presenilin variants transiently transfected sc100 construct production cell medium subsequently analyzed shown fig 3d expression psnhl1 5 mutant resulted significant 10 fold decrease production impairment secretase activity correlated accumulation ctf stubs fig 3e results demonstrate hl1 psn required cleavages app
0.6103489.15220354.html.plaintext.txt	57	assess activity psnhl1 5 mutant analyzed production aicd cleavage nicd s3 cleavage cleavage ha psnhl1 5 stably transfected cells using aforementioned quantitative reporter based strategy several timing controls cells harvested 72 h post transfection allow efficient rna interference endogenous presenilin protein turnover galactosidase activity measured aicd production cleavage obtained mutant stably transfected cells compared wtpsn considered 100 remarkably secretase activity psnhl1 5 stable cell lines assessed c99 gvp substrate completely abolished yielding values similar tmvii aspartic mutant presenilin psnd461a fig 3c result showed hl1 appears essential cleavage app consequently aicd production next tested whether psnhl1 5 mutant cleaved app derived substrate produce a40 a42 peptides cleavage stable cell lines expressing different presenilin variants transiently transfected sc100 construct production cell medium subsequently analyzed shown fig 3d expression psnhl1 5 mutant resulted significant 10 fold decrease production impairment secretase activity correlated accumulation ctf stubs fig 3e results demonstrate hl1 psn required cleavages app
0.6103489.15220354.html.plaintext.txt	58	examined ability psnhl1 5 cleave notch substrate s3 site using reporter based strategy drosophila notch derived substrate lacking extracellular domain necn fused transcription factor gal4vp16 necn gvp co transfected aforementioned reporter constructs sl2 cells galactosidase activity significantly decreased psnhl1 5 mutant psnd461a mutant compared wtpsn fig 3f altogether results confirmed indeed hl1 domain plays modulating role presenilin dimerization showed substitution hl1 another connecting domain resulted complete loss secretase function concerning presenilinase activity cleavages app well s3 cleavage notch without affecting psn stability
0.6103489.15220354.html.plaintext.txt	59	examined ability psnhl1 5 cleave notch substrate s3 site using reporter based strategy drosophila notch derived substrate lacking extracellular domain necn fused transcription factor gal4vp16 necn gvp co transfected aforementioned reporter constructs sl2 cells galactosidase activity significantly decreased psnhl1 5 mutant psnd461a mutant compared wtpsn fig 3f altogether results confirmed indeed hl1 domain plays modulating role presenilin dimerization showed substitution hl1 another connecting domain resulted complete loss secretase function concerning presenilinase activity cleavages app well s3 cleavage notch without affecting psn stability
0.6103489.15220354.html.plaintext.txt	60	aspartic residues asp279 asp461 different presenilin holoproteins constitute active catalytic center results indicate correct presenilin dimerization required secretase function probably means ensure correct positioning transmembrane domains hence aspartic residues catalytic core presenilin dimerization would bring together four aspartic residues two monomer thus allowing different combinations functional aspartyl groups catalytic core secretase several points raised model least whether presenilin dimer requirement secretase activity whether four aspartic residues required secretase activity two aspartic residues sufficient cleavage latter case new questions posed whether diaspartyl combinations equally functional whether specific diaspartyl groups mediate substrate recognition andor cleavage site preferences proposed presenilin quaternary conformation 26 41 42 enables formation six catalytic diaspartyl groups within secretase complex fig 4a reciprocal diaspartyl combinations shown simplicity assembly functional diaspartyl groups involving either two tmvi aspartic residues asp257 human ps1 corresponding asp279 drosophila psn two aspartic residues tm vii asp385 human ps1 corresponding asp461 drosophila psn discarded fig 4a schemes left since ps aspartic mutants d257a d385a clearly shown impair presenilinase secretase activities reviewed ref 56 expression either ntf ctf peptides ps deficient cells able cleave app derived substrate 55 therefore besides expected diaspartyl groups formed ntf ctf within monomer fig 4a second scheme right reciprocal diaspartyl group shown two secretase catalytic centers may assembled trans interface two presenilin monomers contributing one different aspartic asp257 asp385 human ps1 catalytic core fig 4a last scheme right reciprocal diaspartyl group shown
0.6103489.15220354.html.plaintext.txt	61	aspartic residues asp279 asp461 different presenilin holoproteins constitute active catalytic center results indicate correct presenilin dimerization required secretase function probably means ensure correct positioning transmembrane domains hence aspartic residues catalytic core presenilin dimerization would bring together four aspartic residues two monomer thus allowing different combinations functional aspartyl groups catalytic core secretase several points raised model least whether presenilin dimer requirement secretase activity whether four aspartic residues required secretase activity two aspartic residues sufficient cleavage latter case new questions posed whether diaspartyl combinations equally functional whether specific diaspartyl groups mediate substrate recognition andor cleavage site preferences proposed presenilin quaternary conformation 26 41 42 enables formation six catalytic diaspartyl groups within secretase complex fig 4a reciprocal diaspartyl combinations shown simplicity assembly functional diaspartyl groups involving either two tmvi aspartic residues asp257 human ps1 corresponding asp279 drosophila psn two aspartic residues tm vii asp385 human ps1 corresponding asp461 drosophila psn discarded fig 4a schemes left since ps aspartic mutants d257a d385a clearly shown impair presenilinase secretase activities reviewed ref 56 expression either ntf ctf peptides ps deficient cells able cleave app derived substrate 55 therefore besides expected diaspartyl groups formed ntf ctf within monomer fig 4a second scheme right reciprocal diaspartyl group shown two secretase catalytic centers may assembled trans interface two presenilin monomers contributing one different aspartic asp257 asp385 human ps1 catalytic core fig 4a last scheme right reciprocal diaspartyl group shown
0.6103489.15220354.html.plaintext.txt	62	view larger version 31k fig 4 asp279 asp461 different psn holoproteins constitute active catalytic center scheme psn dimer model depicting tms vi vii potential functional diaspartyl groups black boxes acting arrows potential substrate diaspartyl groups formed two tmvi 257 aspartic residues left two tmvii 385 aspartic residues second scheme left aspartic residuesof ntf ctf psn monomer second scheme right aspartic residues ntf ctf different psn monomers right numbering according human ps1 b protein lysates sl2 cells stably expressing indicated psn variants immunodetected anti ha left anti c myc right c sl2 cells stably expressing indicated psn variants transiently transfected c99 gal4vp16 construct galactosidase luciferase reporter plasmids dsrna n 10 four independent experiments d production quantified sandwich elisa sl2 cells stably transfected psn variants indicated transiently transfected sc100 construct along dsrna n 3 independent transfections normalized protein concentration last lane indicates endogenous activity end cells untreated dsrna e a42 total differ wtpsn reconstituted secretase activity ha psnd279amyc psnd461a endogenous psn f western blots protein lysates cells analyzed d immunodetected antibody specific c terminus app amino acids 665 695 relative quantification g sl2 cells stably expressing indicated psn variants transiently transfected necn gal4vp16 construct two reporter plasmids along dsrna n 4 replicates two independent experiments statistical significance according u mann whitney test follows p 005 p 0005
0.6103489.15220354.html.plaintext.txt	63	designed experimental approach based genetic complementation two different aspartic mutants assess whether tmvi aspartic residue asp279 drosophila psnasp257 human ps1 one monomer formed functional diaspartyl group tmvii aspartic residue asp461 drosophila psnasp385 human ps1 case able reconstitute secretase activity two catalytically inactive aspartic mutants thus providing evidence presenilins functions dimer vivo least two aspartic residues required knowledge possibility formally tested constructed double cassette expression plasmid stably co express two presenilin mutants ha psnd279a c myc psnd461a sl2 cells assess secretase activity analyzed production aicd nicd using corresponding substrates cells stably expressing psn mutants predicted formation three different complexes inactive homodimers containing mutation thus containing either two 461 two 279 aspartic residues ha psnd279aha psnd279a myc psnd461amyc psnd461a respectively heterodimeric complex one aspartic 461 one aspartic 279 ha psnd279amyc psnd461a 112 ratio functional catalytic site formed two mutant monomers would expect presenilin heterodimer psnd279apsnd461a would produce one presenilin dependent cleavage products aicd nicd a4042
0.6103489.15220354.html.plaintext.txt	64	designed experimental approach based genetic complementation two different aspartic mutants assess whether tmvi aspartic residue asp279 drosophila psnasp257 human ps1 one monomer formed functional diaspartyl group tmvii aspartic residue asp461 drosophila psnasp385 human ps1 case able reconstitute secretase activity two catalytically inactive aspartic mutants thus providing evidence presenilins functions dimer vivo least two aspartic residues required knowledge possibility formally tested constructed double cassette expression plasmid stably co express two presenilin mutants ha psnd279a c myc psnd461a sl2 cells assess secretase activity analyzed production aicd nicd using corresponding substrates cells stably expressing psn mutants predicted formation three different complexes inactive homodimers containing mutation thus containing either two 461 two 279 aspartic residues ha psnd279aha psnd279a myc psnd461amyc psnd461a respectively heterodimeric complex one aspartic 461 one aspartic 279 ha psnd279amyc psnd461a 112 ratio functional catalytic site formed two mutant monomers would expect presenilin heterodimer psnd279apsnd461a would produce one presenilin dependent cleavage products aicd nicd a4042
0.6103489.15220354.html.plaintext.txt	65	first analyzed expression levels different presenilin mutants stably transfected sl2 cells western blot analyses cell lysates showed high levels expression ha tagged fig 4b left myc tagged presenilins fig 4b right even co expressed contrast cells co expressing ha wtpsn c myc wtpsn presenilinase activity detected ha psnd279a c myc psnd461a mutants co expressed fig 4b right thus presenilinase activity reconstituted mutant presenilin holoproteins could assemble dimer core secretase complex cells
0.6103489.15220354.html.plaintext.txt	66	first analyzed expression levels different presenilin mutants stably transfected sl2 cells western blot analyses cell lysates showed high levels expression ha tagged fig 4b left myc tagged presenilins fig 4b right even co expressed contrast cells co expressing ha wtpsn c myc wtpsn presenilinase activity detected ha psnd279a c myc psnd461a mutants co expressed fig 4b right thus presenilinase activity reconstituted mutant presenilin holoproteins could assemble dimer core secretase complex cells
0.6103489.15220354.html.plaintext.txt	67	evaluate production aicd generated cleavage activity stable cell lines co transfected c99 gvp substrate corresponding reporter constructs interestingly observed contrast galactosidase activities single double aspartic d279a d461a mutants co expression single mutant presenilins resulted significantly higher secretase activity fig 4c amounting 50 wild type presenilin value result shows co expression two mutants psnd279a psnd461a restores aicd production providing strong evidence active catalytic site formed ntf ctf aspartics different presenilins within complex similarly production a4042 c99 substrate determined contrast abolition a40 a42 production cells expressing one single either psnd279a psnd461a double psnd279ad461a aspartic mutants coexpression two psn mutants restored production a40 a42 level endogenous psn cells untreated dsrna fig 4d around 25 30 achieved overexpression wtpsn furthermore a4042 ratio cells expressing combination aspartic mutants similar wtpsn fig 4e rescue secretase activity due co expression two aspartic mutants confirmed significant reduction ctfs levels cells compared cells expressing mutant psnd279a psnd461a alone fig 4f note statistical significance decrease ctf levels co expressing two mutants lane 5 compared single double mutants expressed lanes 2 4 statistically different among
0.6103489.15220354.html.plaintext.txt	68	evaluate production aicd generated cleavage activity stable cell lines co transfected c99 gvp substrate corresponding reporter constructs interestingly observed contrast galactosidase activities single double aspartic d279a d461a mutants co expression single mutant presenilins resulted significantly higher secretase activity fig 4c amounting 50 wild type presenilin value result shows co expression two mutants psnd279a psnd461a restores aicd production providing strong evidence active catalytic site formed ntf ctf aspartics different presenilins within complex similarly production a4042 c99 substrate determined contrast abolition a40 a42 production cells expressing one single either psnd279a psnd461a double psnd279ad461a aspartic mutants coexpression two psn mutants restored production a40 a42 level endogenous psn cells untreated dsrna fig 4d around 25 30 achieved overexpression wtpsn furthermore a4042 ratio cells expressing combination aspartic mutants similar wtpsn fig 4e rescue secretase activity due co expression two aspartic mutants confirmed significant reduction ctfs levels cells compared cells expressing mutant psnd279a psnd461a alone fig 4f note statistical significance decrease ctf levels co expressing two mutants lane 5 compared single double mutants expressed lanes 2 4 statistically different among
0.6103489.15220354.html.plaintext.txt	69	assess s3 cleavage performed similar series experiments necn gvp substrate remarkably contrast app derived c99 substrate co expression psnd279a psnd461a mutants restore nicd production fig 4g fact null values obtained comparable single psnd461a mutant taken together results indicate functional diaspartyl group formed ntf ctf two different presenilins restore secretase activity least mediate cleavages c99 also diaspartyl group may display substrate specificity since able discriminate two substrates c99 necn
0.6103489.15220354.html.plaintext.txt	70	assess s3 cleavage performed similar series experiments necn gvp substrate remarkably contrast app derived c99 substrate co expression psnd279a psnd461a mutants restore nicd production fig 4g fact null values obtained comparable single psnd461a mutant taken together results indicate functional diaspartyl group formed ntf ctf two different presenilins restore secretase activity least mediate cleavages c99 also diaspartyl group may display substrate specificity since able discriminate two substrates c99 necn
0.6103489.15220354.html.plaintext.txt	71	discussion top abstract introduction experimental procedures results discussion references aim study provide evidence support presenilin dimer catalytic core functional secretase complex end focused two different aspects presenilin protein structure function one hand assessed contribution transmembrane domains ntfntf ctfctf ntfctf interactions analyzed functional consequences substituting short region putatively involved modulating ntfntf homodimerization explored contribution potential diaspartyl catalytic groups predicted dimeric presenilin secretase function
0.6103489.15220354.html.plaintext.txt	72	discussion top abstract introduction experimental procedures results discussion references aim study provide evidence support presenilin dimer catalytic core functional secretase complex end focused two different aspects presenilin protein structure function one hand assessed contribution transmembrane domains ntfntf ctfctf ntfctf interactions analyzed functional consequences substituting short region putatively involved modulating ntfntf homodimerization explored contribution potential diaspartyl catalytic groups predicted dimeric presenilin secretase function
0.6103489.15220354.html.plaintext.txt	73	evidence presenilin dimerization first gathered yeast two hybrid assays mostly assessed ability hydrophilic domains large presenilin fragments selfassociate 41 42 nonetheless exhaustive analysis situ interactions performed membrane anchored presenilin domains study contribution hydrophobic transmembranes dimerization missing split ubiquitin system 44 allowed us design test assaying different combinations tm regions grouped even numbers order preserve general presenilin topology cytosoliclumen direction domains results show presenilin transmembrane domains relevant interactions within ntfntf ctfctf ntfctf dimers either assembly stabilization therefore maintenance tertiary quaternary presenilin structure context fact hydrophobic domains evolutionarily conserved presenilin regions fad mutations mainly concentrated transmembrane domains indicate even conservative changes may cause subtle disturbances dimerization final quaternary structure reflected shifts substrate cleavage sites
0.6103489.15220354.html.plaintext.txt	74	evidence presenilin dimerization first gathered yeast two hybrid assays mostly assessed ability hydrophilic domains large presenilin fragments selfassociate 41 42 nonetheless exhaustive analysis situ interactions performed membrane anchored presenilin domains study contribution hydrophobic transmembranes dimerization missing split ubiquitin system 44 allowed us design test assaying different combinations tm regions grouped even numbers order preserve general presenilin topology cytosoliclumen direction domains results show presenilin transmembrane domains relevant interactions within ntfntf ctfctf ntfctf dimers either assembly stabilization therefore maintenance tertiary quaternary presenilin structure context fact hydrophobic domains evolutionarily conserved presenilin regions fad mutations mainly concentrated transmembrane domains indicate even conservative changes may cause subtle disturbances dimerization final quaternary structure reflected shifts substrate cleavage sites
0.6103489.15220354.html.plaintext.txt	75	previous results group showed hl1 domain hydrophilic loop connecting tmi tmii two ntfs interacted involved ntfntf homodimerization 41 addition largest er facing loop highly evolutionarily conserved hl1 domain presenilin hydrophilic region clusters highest number fad mutations remarkably fad mutations analyzed altered formation hl1 hl1 complex 41 substitution domain increased ntfntf interaction thus indicating requirement interaction may rather play modulatory role dimerization means achieve correct presenilin tertiary quaternary structure therefore focused domain assess contribution presenilin structure function interestingly substitution hl1 another er hydrophilic connecting loop hl5 presumably generates topologically equivalent presenilin protein totally inhibited presenilinase activity addition production aicd nicd completely absent cells expressing psn variant abrogation presenilinase secretase activities due increased presenilin instability since psnhl1 5 mutant holoprotein still detected 10 h cycloheximide treatment thus proving much stable wtpsn holoprotein although cannot rule possibility inhibition secretase activity psn mutant secondary effect lack presenilin endoproteolysis favor explanation since presenilinase secretase activities necessarily correlate 30 57 another presenilin variant lacking hl1 analyzed tm1 2 ps1 mutant deletion comprising tmi hl1 tmii regions able generate peptides 30 although maturation trafficking secretase complex components highly altered similar effect psnhl1 5 mutant could assumed however deem unlikely since presenilin transmembrane regions integrally maintained psnhl1 5 tm1 2 mutant mediate interactions within secretase complex 58 60 recently suggested presenilin endoproteolysis regulatory event causes cleavage induced conformational change presenilin becomes activated enzyme 61 according report presenilinase cleavage would retrieve loop encoded exon 9 would otherwise occupy presenilin substrate binding site case surmise tm1 2 mutant adopted conformation relieved exon 9 peptide binding pocket whereas conformation psnhl1 5 variant allowed neither endoproteolysis processing retrieval exon 9 peptide hence secretase activity might severely compromised
0.6103489.15220354.html.plaintext.txt	76	previous results group showed hl1 domain hydrophilic loop connecting tmi tmii two ntfs interacted involved ntfntf homodimerization 41 addition largest er facing loop highly evolutionarily conserved hl1 domain presenilin hydrophilic region clusters highest number fad mutations remarkably fad mutations analyzed altered formation hl1 hl1 complex 41 substitution domain increased ntfntf interaction thus indicating requirement interaction may rather play modulatory role dimerization means achieve correct presenilin tertiary quaternary structure therefore focused domain assess contribution presenilin structure function interestingly substitution hl1 another er hydrophilic connecting loop hl5 presumably generates topologically equivalent presenilin protein totally inhibited presenilinase activity addition production aicd nicd completely absent cells expressing psn variant abrogation presenilinase secretase activities due increased presenilin instability since psnhl1 5 mutant holoprotein still detected 10 h cycloheximide treatment thus proving much stable wtpsn holoprotein although cannot rule possibility inhibition secretase activity psn mutant secondary effect lack presenilin endoproteolysis favor explanation since presenilinase secretase activities necessarily correlate 30 57 another presenilin variant lacking hl1 analyzed tm1 2 ps1 mutant deletion comprising tmi hl1 tmii regions able generate peptides 30 although maturation trafficking secretase complex components highly altered similar effect psnhl1 5 mutant could assumed however deem unlikely since presenilin transmembrane regions integrally maintained psnhl1 5 tm1 2 mutant mediate interactions within secretase complex 58 60 recently suggested presenilin endoproteolysis regulatory event causes cleavage induced conformational change presenilin becomes activated enzyme 61 according report presenilinase cleavage would retrieve loop encoded exon 9 would otherwise occupy presenilin substrate binding site case surmise tm1 2 mutant adopted conformation relieved exon 9 peptide binding pocket whereas conformation psnhl1 5 variant allowed neither endoproteolysis processing retrieval exon 9 peptide hence secretase activity might severely compromised
0.6103489.15220354.html.plaintext.txt	77	case complete loss presenilinase secretase activities previously achieved mutating catalytic aspartic residues altering c terminal region appears relevant presenilin stability altering regions proximal presenilinase catalytic site 16 53 55 62 show alteration region located far catalytic site involved presenilin stability causes inhibition presenilinase secretase functions hence substitution hl1 plays important role psn structure assembly devastating functional effects suggests proper presenilin dimerization assembly within secretase complex essential proteolytic function context fad mutations located hl1 may subtly alter presenilin dimerization positioning transmembranes thus generate shift substrate cleavage site preferences
0.6103489.15220354.html.plaintext.txt	78	case complete loss presenilinase secretase activities previously achieved mutating catalytic aspartic residues altering c terminal region appears relevant presenilin stability altering regions proximal presenilinase catalytic site 16 53 55 62 show alteration region located far catalytic site involved presenilin stability causes inhibition presenilinase secretase functions hence substitution hl1 plays important role psn structure assembly devastating functional effects suggests proper presenilin dimerization assembly within secretase complex essential proteolytic function context fad mutations located hl1 may subtly alter presenilin dimerization positioning transmembranes thus generate shift substrate cleavage site preferences
0.6103489.15220354.html.plaintext.txt	79	one prediction presenilin dimer secretase core formation one catalytic diaspartyl group addressed whether diaspartyl combinations functional results showed reconstitution active secretase two different presenilin aspartic mutants co expressed functional diaspartyl group formed tmvi asp279 aspartic residue asp257 human ps1 one psn monomer tmvii d461 aspartic residue asp385 human ps1 fig 4 c d diaspartyl group cleave c99 app derived substrate sites also produced a40 a42 peptides ratio wtpsn thus suggesting similar diaspartyl combination responsible app cleavages vivo remarkably fact experimental conditions catalytic group generate nicd s3 cleavage supports idea different requirements met app notch cleavages agreement previous reports 25 27 29 63 addition results suggest presenilinase activity requires formation diaspartyl group ntf ctf monomer according results endoproteolytic processing longer requirement presenilin activation co expressing two presenilin aspartic mutants presenilin aspartic mutants might adopt slightly different conformation would need retrieve exon 9 binding substrate site 61
0.6103489.15220354.html.plaintext.txt	80	one prediction presenilin dimer secretase core formation one catalytic diaspartyl group addressed whether diaspartyl combinations functional results showed reconstitution active secretase two different presenilin aspartic mutants co expressed functional diaspartyl group formed tmvi asp279 aspartic residue asp257 human ps1 one psn monomer tmvii d461 aspartic residue asp385 human ps1 fig 4 c d diaspartyl group cleave c99 app derived substrate sites also produced a40 a42 peptides ratio wtpsn thus suggesting similar diaspartyl combination responsible app cleavages vivo remarkably fact experimental conditions catalytic group generate nicd s3 cleavage supports idea different requirements met app notch cleavages agreement previous reports 25 27 29 63 addition results suggest presenilinase activity requires formation diaspartyl group ntf ctf monomer according results endoproteolytic processing longer requirement presenilin activation co expressing two presenilin aspartic mutants presenilin aspartic mutants might adopt slightly different conformation would need retrieve exon 9 binding substrate site 61
0.6103489.15220354.html.plaintext.txt	81	ruled possible concerns reconstitution secretase activity experimental conditions following grounds discarded domain swapping two mutant presenilin molecules first event already ruled presenilins several authors previous reports 26 64 65 moreover case presenilin domain swapping completely prevented since expressed mutants endoproteolytically cleaved ntf ctf fragments ii even considering residual endogenous presenilin dependent independent secretase activity rnai treatment fact presenilin mutants might equally effective replacing residual activity fact individual mutant abrogated secretase activity measured loss aicd nicd production fig 4 c d g whereas experimental conditions co expression two mutants restored 30 50 wild type activity accordance heterodimer psnd279apsnd461a representing one half dimer population indicated genetic complementation two mutants occurred functional diaspartyl group assembled trans finally iii reconstituted secretase activity cleaved app derived substrates whereas activity notch derived ones completely impaired presenilin independent activities account app processing notch cleavage activities detected mutant controls obviously case
0.6103489.15220354.html.plaintext.txt	82	ruled possible concerns reconstitution secretase activity experimental conditions following grounds discarded domain swapping two mutant presenilin molecules first event already ruled presenilins several authors previous reports 26 64 65 moreover case presenilin domain swapping completely prevented since expressed mutants endoproteolytically cleaved ntf ctf fragments ii even considering residual endogenous presenilin dependent independent secretase activity rnai treatment fact presenilin mutants might equally effective replacing residual activity fact individual mutant abrogated secretase activity measured loss aicd nicd production fig 4 c d g whereas experimental conditions co expression two mutants restored 30 50 wild type activity accordance heterodimer psnd279apsnd461a representing one half dimer population indicated genetic complementation two mutants occurred functional diaspartyl group assembled trans finally iii reconstituted secretase activity cleaved app derived substrates whereas activity notch derived ones completely impaired presenilin independent activities account app processing notch cleavage activities detected mutant controls obviously case
0.6103489.15220354.html.plaintext.txt	83	hence fact secretase activity restored co expression two aspartic mutant presenilins within cell activity discriminates two substrates contrast wild type endogenous presenilin makes complementation two presenilin mutants highest likely explanation restoration secretase activity concluded reconstituted presenilin catalytic function due bona fide formation diaspartyl group trans interface two mutant presenilins providing one different aspartic residue results also completely consistent provide feasible explanation recent report rescue presenilinase secretase activity c99 substrate co expression inactive c terminally truncated presenilin mutant wild type ctf mutant aspartic ctf ps deficient cells 54
0.6103489.15220354.html.plaintext.txt	84	hence fact secretase activity restored co expression two aspartic mutant presenilins within cell activity discriminates two substrates contrast wild type endogenous presenilin makes complementation two presenilin mutants highest likely explanation restoration secretase activity concluded reconstituted presenilin catalytic function due bona fide formation diaspartyl group trans interface two mutant presenilins providing one different aspartic residue results also completely consistent provide feasible explanation recent report rescue presenilinase secretase activity c99 substrate co expression inactive c terminally truncated presenilin mutant wild type ctf mutant aspartic ctf ps deficient cells 54
0.6103489.15220354.html.plaintext.txt	85	based results propose model catalytic diaspartyl groups responsible cleaving substrates partially overlap within presenilin secretase complex thus asp257asp385 group formed trans interface two presenilin monomers would cleave c99 substrate whereas asp257asp385 group cis ntf ctf moieties molecule would process necn substrate fig 5 experimental approach two aspartic mutants allow test second possibility hypothesis consistent divergent transmembrane sequences substrates according model would cleaved different diaspartyl combinations noted observations presented fully compatible recently proposed models secretase may contain separated docking catalytic sites 26 35 66 68 scenarios also compatible observations one conformation ha psnd279amyc psnd461a heterodimer hinders access catalytic site necn substrate c99 context conformations mutants slightly different wild type protein mutations catalytic site could alter turn accessibility binding site allowing access c99 still hampering necn substrate second alternative might mutant presenilins addressed cellular compartment different wild type allowing access app derived substrate precluding notch substrate another alternative recognition andor cleavage necn substrate requires least three aspartic residues presenilin dimer similar suggested 26 finally authors proposed different isoforms ps 1 ps 2 aph 1al aph 1as aph 1b assemble different secretase complexes provide substrate specificity 40 apply model components secretase complex encoded single copy genes drosophila 2 notwithstanding irrespective number composition secretase complexes substrate reached catalytic center may cleaved specific diaspartyl group could differ different substrates
0.6103489.15220354.html.plaintext.txt	86	based results propose model catalytic diaspartyl groups responsible cleaving substrates partially overlap within presenilin secretase complex thus asp257asp385 group formed trans interface two presenilin monomers would cleave c99 substrate whereas asp257asp385 group cis ntf ctf moieties molecule would process necn substrate fig 5 experimental approach two aspartic mutants allow test second possibility hypothesis consistent divergent transmembrane sequences substrates according model would cleaved different diaspartyl combinations noted observations presented fully compatible recently proposed models secretase may contain separated docking catalytic sites 26 35 66 68 scenarios also compatible observations one conformation ha psnd279amyc psnd461a heterodimer hinders access catalytic site necn substrate c99 context conformations mutants slightly different wild type protein mutations catalytic site could alter turn accessibility binding site allowing access c99 still hampering necn substrate second alternative might mutant presenilins addressed cellular compartment different wild type allowing access app derived substrate precluding notch substrate another alternative recognition andor cleavage necn substrate requires least three aspartic residues presenilin dimer similar suggested 26 finally authors proposed different isoforms ps 1 ps 2 aph 1al aph 1as aph 1b assemble different secretase complexes provide substrate specificity 40 apply model components secretase complex encoded single copy genes drosophila 2 notwithstanding irrespective number composition secretase complexes substrate reached catalytic center may cleaved specific diaspartyl group could differ different substrates
0.6103489.15220354.html.plaintext.txt	87	view larger version 22k fig 5 hypothetical model c99 necn presenilin secretase cleavage diaspartyl group formed one aspartic acid 257 one aspartic acid 385 black two presenilin molecules cleaves c99 substrate sites whereas necn substrate b cleaved diaspartyl group black formed ntf ctf monomer numbering according human ps1
0.6103489.15220354.html.plaintext.txt	88	fad mutations analyzed date alter presenilin mediated secretase cleavages site site s3 site manner suggesting molecular mechanisms involved regulating secretase activities complex 25 27 fad mutations alter a4240 ratio whereas effects nicd aicd production variable according model presenilin fad mutation would specific effect diaspartyl combination thus entailing shift cleavage site preferences even substrate affinity
0.6103489.15220354.html.plaintext.txt	89	fad mutations analyzed date alter presenilin mediated secretase cleavages site site s3 site manner suggesting molecular mechanisms involved regulating secretase activities complex 25 27 fad mutations alter a4240 ratio whereas effects nicd aicd production variable according model presenilin fad mutation would specific effect diaspartyl combination thus entailing shift cleavage site preferences even substrate affinity
0.6103489.15220354.html.plaintext.txt	90	presenilins belong emerging family unusual diaspartyl proteases clips 56 69 whose characteristics include complex structural topology ability carry regulated intramembraneous proteolysis substrates 70 remarkably another members signal peptide peptidase recently reported form homodimer labeled inhibitors directed active site secretase 71 finding two aspartyl clips signal peptide peptidase presenilins function dimers recognized active site inhibitor suggests dimerization may general requirement function regulation family proteases provides new insights regulated intramembraneous proteolysis may take place
0.6103489.15220354.html.plaintext.txt	91	presenilins belong emerging family unusual diaspartyl proteases clips 56 69 whose characteristics include complex structural topology ability carry regulated intramembraneous proteolysis substrates 70 remarkably another members signal peptide peptidase recently reported form homodimer labeled inhibitors directed active site secretase 71 finding two aspartyl clips signal peptide peptidase presenilins function dimers recognized active site inhibitor suggests dimerization may general requirement function regulation family proteases provides new insights regulated intramembraneous proteolysis may take place
0.6103489.15220354.html.plaintext.txt	92	sum main conclusion reconstituted secretase activity co expression two distinct catalytically inactive aspartic presenilin mutants provided evidence presenilin functions dimer within secretase complex functional diaspartyl group formed interface dimer disturbance presenilin dimerization compromise even abrogates presenilinase secretase activities
0.6103489.15220354.html.plaintext.txt	93	sum main conclusion reconstituted secretase activity co expression two distinct catalytically inactive aspartic presenilin mutants provided evidence presenilin functions dimer within secretase complex functional diaspartyl group formed interface dimer disturbance presenilin dimerization compromise even abrogates presenilinase secretase activities
0.6103489.15220354.html.plaintext.txt	94	footnotes study funded ministerio de ciencia y tecnologia grant pm99 0168 r g d new investigator research grant alzheimers association c costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.6103489.15220354.html.plaintext.txt	95	present address ucsf diabetes center parnassus campus san francisco ca 94143
0.6103489.15220354.html.plaintext.txt	96	present address institut de neurociencies universitat autogravenoma de barcelona bellaterra barcelona 08193 spain
0.6103489.15220354.html.plaintext.txt	97	correspondence addressed tel 34 934021502 fax 34 934110969 e mail gmarfanyatubedu u d
0.6103489.15220354.html.plaintext.txt	98	1 abbreviations used ps presenilins psn drosophila presenilins wtpsn wild type psn fad familiar autosomal dominant alzheimers disease tm transmembrane ctf c terminal fragment ntf n terminal fragment aicd app intracellular domain nicd notch intracellular domain ha hemagglutinin dsrna double stranded rna utr untranslated region er endoplasmic reticulum elisa enzyme linked immunosorbent assay app amyloid precursor protein
0.6103489.15220354.html.plaintext.txt	99	acknowledgments grateful neus abella technical support jennifer strahle weiming xia elisa assays peptides grateful dr dori huertas consejo superior de investigaciones cientificas csic barcelona spain gift plasmid pcohygro dr alejandro vaquero csic gift plasmids constructs pactppa pactppa gal4bd hsp70mp 5xg4 gal dr gary struhl columbia university new york gift ogg513 n932 constructs dr johan lundkvist karolinska institute stockholm sweden gift c99 gal4vp16 construct dr taisuke tomita university tokyo gift sc100 construct dr mikio shoji saeko antibody thank serveis cientifico tecnics de la universitat de barcelona use 3700 3730 dna analyzer robin rycroft revising english
0.6103489.15220354.html.plaintext.txt	100	references top abstract introduction experimental procedures results discussion references li y m lai m xu m huang q dimuzio m j sardana m k shi x p yin k c shafer j gardell j 2000 proc natl acad sci u 97 6138 6143abstractfree full text francis r mcgrath g zhang j ruddy d sym m apfeld j nicoll m maxwell m hai b ellis m c parks l xu w li j gurney m myers r l himes c hiebsch r ruble c nye j curtis d 2002 dev cell 3 85 97medline order article via infotrieve de strooper b annaert w 2000 j cell sci 113 1857 1870abstractfree full text borchelt d r thinakaran g eckman c b lee m k davenport f ratovitsky prada c m kim g seekins yager d slunt h h wang r seeger m levey gandy e copeland n g jenkins n price d l younkin g sisodia 1996 neuron 17 1005 1013medline order article via infotrieve scheuner d eckman c jensen m song x citron m suzuki n bird d hardy j hutton m kukull w larson e levy lahad e viitanen m peskind e poorkaj p schellenberg g tanzi r wasco w lannfelt l selkoe d younkin 1996 nat med 2 864 870medline order article via infotrieve jarrett j berger e p lansbury p j 1993 biochemistry 32 4693 4697medline order article via infotrieve gu y misonou h sato dohmae n takio k ihara y 2001 j biol chem 276 35235 35238abstractfree full text sastre m steiner h fuchs k capell multhaup g condron m m teplow d b haass c 2001 embo rep 2 835 841abstractfree full text cao x sudhof c 2001 science 293 115 120abstractfree full text kimberly w zheng j b guenette y selkoe d j 2001 j biol chem 276 40288 40292abstractfree full text de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r 1999 nature 398 518 522crossrefmedline order article via infotrieve okochi m steiner h fukumori tanii h tomita tanaka iwatsubo kudo takeda m haass c 2002 embo j 21 5408 5416abstractfree full text esler w p kimberly w ostaszewski b l diehl moore c l tsai j y rahmati xia w m selkoe d j wolfe m 2000 nat cell biol 2 428 434crossrefmedline order article via infotrieve li y m xu m lai m huang q castro j l dimuzio m j harrison lellis c nadin j l neduvelil j g register r b sardana m k shearman m smith l shi x p yin k c shafer j gardell j 2000 nature 405 689 694crossrefmedline order article via infotrieve ratovitski slunt h h thinakaran g price d l sisodia borchelt d r 1997 j biol chem 272 24536 24541abstractfree full text wolfe m xia w ostaszewski b l diehl kimberly w selkoe d j 1999 nature 398 513 517crossrefmedline order article via infotrieve thinakaran g borchelt d r lee m k slunt h h spitzer l kim g ratovitsky davenport f nordstedt c seeger m hardy j levey gandy e jenkins n copeland n g price d l sisodia 1996 neuron 17 181 190medline order article via infotrieve seeger m nordstedt c petanceska kovacs d m gouras g k hahne fraser p levesque l czernik j george h p sisodia thinakaran g tanzi r e greengard p gandy 1997 proc natl acad sci u 94 5090 5094abstractfree full text yu g nishimura m arawaka levita d zhang l tandon song y q rogaeva e chen f kawarai supala levesque l yu h yang d holmes e milman p liang y zhang d m xu d h sato c rogaev e smith m janues c zhang y aebersold r farrer l sorbi bruni fraser p st george hyslop p 2000 nature 407 48 54crossrefmedline order article via infotrieve edbauer d winkler e haass c steiner h 2002 proc natl acad sci u 99 8666 8671abstractfree full text wang r sweeney d gandy e sisodia 1996 j biol chem 271 31894 31902abstractfree full text citron m diehl gordon g biere l seubert p selkoe d j 1996 proc natl acad sci u 93 13170 13175abstractfree full text murphy m p uljon n fraser p e fauq lookingbill h findlay k smith e lewis p mclendon d c wang r golde e 2000 j biol chem 275 26277 26284abstractfree full text petit bihel f alves da costa c pourquie o checler f kraus j l 2001 nat cell biol 3 507 511crossrefmedline order article via infotrieve moehlmann winkler e xia x edbauer d murrell j capell kaether c zheng h ghetti b haass c steiner h 2002 proc natl acad sci u 99 8025 8030abstractfree full text schroeter e h ilagan m x brunkan l hecimovic li y m xu m lewis h d saxena m de strooper b coonrod tomita iwatsubo moore c l goate wolfe m shearman m kopan r 2003 proc natl acad sci u 100 13075 13080abstractfree full text song w nadeau p yuan m yang x shen j yankner b 1999 proc natl acad sci u 96 6959 6963abstractfree full text kulic l walter j multhaup g teplow d b baumeister r romig h capell steiner h haass c 2000 proc natl acad sci u 97 5913 5918abstractfree full text chen f gu y hasegawa h ruan x arawaka fraser p westaway d mount h st george hyslop p 2002 j biol chem 277 36521 36526abstractfree full text leem j y saura c pietrzik c christianson j wanamaker c king l veselits m l tomita gasparini l iwatsubo xu h green w n koo e h thinakaran g 2002 neurobiol dis 11 64 82crossrefmedline order article via infotrieve murphy m p hickman l j eckman c b uljon n wang r golde e 1999 j biol chem 274 11914 11923abstractfree full text lichtenthaler f beher d grimm h wang r shearman m masters c l beyreuther k 2002 proc natl acad sci u 99 1365 1370abstractfree full text kimberly w esler w p ye w ostaszewski b l gao j diehl selkoe d j wolfe m 2003 biochemistry 42 137 144crossrefmedline order article via infotrieve lewis h d perez revuelta b nadin neduvelil j g harrison pollack j shearman m 2003 biochemistry 42 7580 7586crossrefmedline order article via infotrieve tian g ghanekar v aharony d shenvi b jacobs r liu x greenberg b d 2003 j biol chem 278 28968 28975abstractfree full text chen f yu g arawaka nishimura m kawarai yu h tandon supala song y q rogaeva e milman p sato c yu c janus c lee j song l zhang l fraser p e st george hyslop p h 2001 nat cell biol 3 751 754crossrefmedline order article via infotrieve kim h leem j y lah j j slunt h h levey thinakaran g sisodia 2001 j biol chem 276 43343 43350abstractfree full text yu c kim h ikeuchi xu h gasparini l wang r sisodia 2001 j biol chem 276 43756 43760abstractfree full text taniguchi y karlstrom h lundkvist j mizutani otaka vestling m bernstein donoviel d lendahl u honjo 2002 proc natl acad sci u 99 4014 4019abstractfree full text de strooper b 2003 neuron 38 9 12medline order article via infotrieve cervantes gonzalez duarte r marfany g 2001 febs lett 505 81 86crossrefmedline order article via infotrieve hebert godin c levesque g 2003 febs lett 550 30 34crossrefmedline order article via infotrieve hebert godin c tomiyama mori h levesque g 2003 biochem biophys res commun 301 119 126crossrefmedline order article via infotrieve stagljar korostensky c johnsson n teheesen 1998 proc natl acad sci u 95 5187 5192abstractfree full text cols n marfany g atrian gonzalez duarte r 1993 febs lett 319 90 94crossrefmedline order article via infotrieve struhl g adachi 1998 cell 93 649 660medline order article via infotrieve karlstrom h bergman lendahl u naslund j lundkvist j 2002 j biol chem 277 6763 6766abstractfree full text takasugi n takahashi y morohashi y tomita iwatsubo 2002 j biol chem 277 50198 50205abstractfree full text kawarabayashi shoji m sato m sasaki ho l eckman c b prada c m younkin g kobayashi tada n matsubara e iizuka harigaya y kasai k hirai 1996 neurobiol aging 17 215 222crossrefmedline order article via infotrieve johnson wood k lee m motter r hu k gordon g barbour r khan k gordon m tan h games d lieberburg schenk d seubert p mcconlogue l 1997 proc natl acad sci u 94 1550 1555abstractfree full text yu h saura c choi y sun l d yang x handler m kawarabayashi younkin l fedeles b wilson m younkin kandel e r kirkwood shen j 2001 neuron 31 713 726medline order article via infotrieve goo j h park w j 2004 dna cell biol 23 59 65crossrefmedline order article via infotrieve wang j brunkan l hecimovic walker e goate 2004 neurobiol dis 15 654 666crossrefmedline order article via infotrieve laudon h mathews p m karlstrom h bergman farmery m r nixon r winblad b gandy e lendahl u lundkvist j naslund j 2004 j neurochem 89 44 53crossrefmedline order article via infotrieve laudon h karlstrom h mathews p m farmery m r gandy e lundkvist j lendahl u naslund j 2004 j biol chem 279 23925 23932abstractfree full text haass c steiner h 2002 trends cell biol 12 556 562crossrefmedline order article via infotrieve steiner h romig h pesold b philipp u baader m citron m loetscher h jacobsen h haass c 1999 biochemistry 38 14600 14605crossrefmedline order article via infotrieve capell kaether c edbauer d shirotani k merkl steiner h haass c 2003 j biol chem 278 52519 52523abstractfree full text lee f shah yu c wigley c li h lim m pedersen k han w thomas p lundkvist j hao y h yu g 2003 j biol chem 279 4144 4152crossrefmedline order article via infotrieve morais v crystal pijak d carlin d costa j lee v m doms r w 2003 j biol chem 278 43284 43291abstractfree full text knappenberger k tian g ye x sobotka briner c ghanekar v greenberg b d scott cw 2004 biochemistry 43 6208 6218crossrefmedline order article via infotrieve tomita watabiki takikawa r morohashi y takasugi n kopan r de strooper b iwatsubo 2001 j biol chem 276 33273 33281abstractfree full text capell steiner h romig h keck baader m grim m g baumeister r haass c 2000 nat cell biol 2 205 211crossrefmedline order article via infotrieve saura c tomita davenport f harris c l iwatsubo thinakaran g 1999 j biol chem 274 13818 13823abstractfree full text levitan d lee j song l manning r wong g parker e zhang l 2001 proc natl acad sci u 98 12186 12190abstractfree full text annaert w g esselens c baert v boeve c snellings g cupers p craessaerts k de strooper b 2001 neuron 32 579 589medline order article via infotrieve kornilova y das c wolfe m 2003 j biol chem 278 16470 16473abstractfree full text ramdya p skoch j bacskai b j hyman b berezovska o 2003 j neurochem 87 843 850crossrefmedline order article via infotrieve wolfe m selkoe d j 2002 science 296 2156 2157free full text brown m ye j rawson r b goldstein j l 2000 cell 100 391 398medline order article via infotrieve nyborg c kornilova y jansen k ladd b wolfe m golde e 2004 j biol chem 279 15153 15160abstractfree full text
0.62542415.8817335.html.plaintext.txt	0	alzheimers disease associated mutations presenilin 2 rare variably penetrant alzheimers disease associated mutations presenilin 2 rare variably penetrant r sherrington1 froelich2 sorbi3 d campion4 h chi1 e rogaeva1 g levesque1 e rogaev1 c lin1 y liang1 m ikeda1 l mar5 brice6 y agid6 m e percy7 f clerget darpoux8 piacentini3 g marcon9 b nacmias3 l amaducci3 frebourg4 l lannfelt2 j m rommens5 p h st george hyslop1
0.62542415.8817335.html.plaintext.txt	1	1centre research neurodegenerative diseases department medicine university toronto department medicine division neurology toronto hospital toronto ontario m5s 1a8 canada 2karolinska institute department clinical neurosciences geriatric medicine novum kfc 141 86 huddinge sweden 3department neurology psychiatry university florence viale morgagni 65 florence italy 4laboratoire de genetique moleculaire chu rouen 76031 rouen france 5department medical molecular genetics university toronto research institute hospital sick children 555 university avenue toronto ontario canada 6department neurology hopital de la salpetriere inserm u289 75013 paris france 7surrey place centre department obstetrics gynaecology dept physiology university toronto toronto ontario m5s 1a8 canada 8inserm u155 chateau de longchamp 75016 paris france 9department neurology university udine udine italy
0.62542415.8817335.html.plaintext.txt	2	1centre research neurodegenerative diseases department medicine university toronto department medicine division neurology toronto hospital toronto ontario m5s 1a8 canada 2karolinska institute department clinical neurosciences geriatric medicine novum kfc 141 86 huddinge sweden 3department neurology psychiatry university florence viale morgagni 65 florence italy 4laboratoire de genetique moleculaire chu rouen 76031 rouen france 5department medical molecular genetics university toronto research institute hospital sick children 555 university avenue toronto ontario canada 6department neurology hopital de la salpetriere inserm u289 75013 paris france 7surrey place centre department obstetrics gynaecology dept physiology university toronto toronto ontario m5s 1a8 canada 8inserm u155 chateau de longchamp 75016 paris france 9department neurology university udine udine italy
0.62542415.8817335.html.plaintext.txt	3	received february 20 1996 revised accepted april 17 1996
0.62542415.8817335.html.plaintext.txt	4	missense mutations presenilin 2 ps 2 gene chromosome 1 sought direct nucleotide sequence analysis open reading frame 60 pedigrees familial alzheimers disease fad majority pedigrees ps 1 beta amyloid precursor protein betaapp gene mutations excluded additional ps 2 pathogenic mutations detected four silent nucleotide substitutions alternative splicing nucleotides 1338 1340 glu325 observed analysis additional members pedigree known segregate met239val mutation ps 2 revealed age onset symptoms highly variable range 45 88 years variability attributable differences apoe genotypes results suggest contrast mutations ps 1 mutations ps 2 relatively rare cause fad ii genetic environmental factors modify ad phenotype associated ps 2 mutations iii still fad susceptibility genes remain identified introduction
0.62542415.8817335.html.plaintext.txt	5	missense mutations presenilin 2 ps 2 gene chromosome 1 sought direct nucleotide sequence analysis open reading frame 60 pedigrees familial alzheimers disease fad majority pedigrees ps 1 beta amyloid precursor protein betaapp gene mutations excluded additional ps 2 pathogenic mutations detected four silent nucleotide substitutions alternative splicing nucleotides 1338 1340 glu325 observed analysis additional members pedigree known segregate met239val mutation ps 2 revealed age onset symptoms highly variable range 45 88 years variability attributable differences apoe genotypes results suggest contrast mutations ps 1 mutations ps 2 relatively rare cause fad ii genetic environmental factors modify ad phenotype associated ps 2 mutations iii still fad susceptibility genes remain identified introduction
0.62542415.8817335.html.plaintext.txt	6	missense mutations associated early onsetalzheimers disease ad discovered two related genes termed presenilin chromosome 14 1 presenilin ii chromosome 1 2 3 analysis number large data sets revealed missense mutations presenilin ps 1 gene frequent cause early onset familial alzheimers disease fad accounting perhaps much 50 cases early onset fad 1 2 4 6 order determine frequency mutations presenilin ii ps 2 gene undertook survey mutations open reading frame orf ps 2 gene 60 pedigrees fad disease families characterized occurrence ad consistent ninds adrda criteria least three closely related subjects often one generation pedigrees age onset range 35 82 years 36 mean age onset 64 years 14 mean age onset 65 years 10 insufficient reliable data age onset overlapped observed pedigrees known ps 2 mutations onset 45 72 years determine penetrance ps 2 mutations also examined several additional members flo10 pedigree previously described met239val missense mutation ps 2 gene 2 data suggest missense mutations ps 2 gene rare cause ad missense mutations may subject modifying action genes environmental influences results
0.62542415.8817335.html.plaintext.txt	7	missense mutations associated early onsetalzheimers disease ad discovered two related genes termed presenilin chromosome 14 1 presenilin ii chromosome 1 2 3 analysis number large data sets revealed missense mutations presenilin ps 1 gene frequent cause early onset familial alzheimers disease fad accounting perhaps much 50 cases early onset fad 1 2 4 6 order determine frequency mutations presenilin ii ps 2 gene undertook survey mutations open reading frame orf ps 2 gene 60 pedigrees fad disease families characterized occurrence ad consistent ninds adrda criteria least three closely related subjects often one generation pedigrees age onset range 35 82 years 36 mean age onset 64 years 14 mean age onset 65 years 10 insufficient reliable data age onset overlapped observed pedigrees known ps 2 mutations onset 45 72 years determine penetrance ps 2 mutations also examined several additional members flo10 pedigree previously described met239val missense mutation ps 2 gene 2 data suggest missense mutations ps 2 gene rare cause ad missense mutations may subject modifying action genes environmental influences results
0.62542415.8817335.html.plaintext.txt	8	fibroblasts transformed lymphoblasts peripheral blood samples obtained least one affected member 60 kindreds multiple 3 family members affected fad ascertained familial alzheimers disease registry university toronto clinics university florence massachusetts alzheimers disease research centre karolinska institute stockholm sweden french university hospitals national inserm network france indiana university alzheimers disease dna bank nia sponsored repository coriell institute diagnosis ad affected members used ninds adrda criteria similar cerad criteria mutations ps 1 beta amyloid precursor protein betaapp genes previously excluded majority pedigrees sequencing reverse transcriptase polymerase chain reaction rt pcr products corresponding ps 1 gene genomic pcr products corresponding exons 16 17 betaapp
0.62542415.8817335.html.plaintext.txt	9	fibroblasts transformed lymphoblasts peripheral blood samples obtained least one affected member 60 kindreds multiple 3 family members affected fad ascertained familial alzheimers disease registry university toronto clinics university florence massachusetts alzheimers disease research centre karolinska institute stockholm sweden french university hospitals national inserm network france indiana university alzheimers disease dna bank nia sponsored repository coriell institute diagnosis ad affected members used ninds adrda criteria similar cerad criteria mutations ps 1 beta amyloid precursor protein betaapp genes previously excluded majority pedigrees sequencing reverse transcriptase polymerase chain reaction rt pcr products corresponding ps 1 gene genomic pcr products corresponding exons 16 17 betaapp
0.62542415.8817335.html.plaintext.txt	10	analysis nucleotide sequence rt pcr products corresponding orf ps 2 60 fad pedigrees failed uncover additional mutations beyond two initial mutations asn141ile mutation three related kindreds volga german origin met239val mutation flo10 pedigree italian origin previously reported data set 2 specific screening asn141ile met239val mutations supplemental set genomic dna samples affected probands 81 swedish fad pedigrees also failed identify instances either mutation however although pathogenic nucleotide sequence differences observed four silent nucleotide substitutions detected c 626 bpcodon 23 c 806 bpcodon 147 c 1571 bpcodon 402 g 1670 bpcodon 435 sequence numbering accession l44577 substitutions occurred third nucleotide position codon would therefore predicted cause change amino acid sequence fifth sequence variant variable presence nucleotides 1338 1340 encoding glu325 residuewas found transcripts tissues transcripts without nucleotides 1338 1340 reflects use alternate splice donor sequence approximately equal abundance brain fibroblasts leukocytes
0.62542415.8817335.html.plaintext.txt	11	analysis nucleotide sequence rt pcr products corresponding orf ps 2 60 fad pedigrees failed uncover additional mutations beyond two initial mutations asn141ile mutation three related kindreds volga german origin met239val mutation flo10 pedigree italian origin previously reported data set 2 specific screening asn141ile met239val mutations supplemental set genomic dna samples affected probands 81 swedish fad pedigrees also failed identify instances either mutation however although pathogenic nucleotide sequence differences observed four silent nucleotide substitutions detected c 626 bpcodon 23 c 806 bpcodon 147 c 1571 bpcodon 402 g 1670 bpcodon 435 sequence numbering accession l44577 substitutions occurred third nucleotide position codon would therefore predicted cause change amino acid sequence fifth sequence variant variable presence nucleotides 1338 1340 encoding glu325 residuewas found transcripts tissues transcripts without nucleotides 1338 1340 reflects use alternate splice donor sequence approximately equal abundance brain fibroblasts leukocytes
0.62542415.8817335.html.plaintext.txt	12	investigation ps 2 gene several newly ascertained members flo10 pedigree segregating met239val mutation ps 2 identified additional carrier mutation subject iii 20 table 1 surprisingly subject aged 87 years evidence cognitive memory impairment serial follow several years age 84 years noted become mildly demented profoundly demented mini mental status examination score 430 clinical features sustain diagnosis probable ad ninds adrda criteria review clinical data additional members extended pedigree also uncovered two subjects direct lineage family either historical evidence late onset ad subject 2 affected grandfather iii 20 died 75 years dementia currently clinical features consistent probable ad using ninds adrda criteria subject iii 39 onset 88 years others previously reported genotype apolipoprotein e gene modulate age onset alzheimers disease subjects val717ile mutation betaapp 7 8 however flo10 family met239val mutation ps 2 apoe genotypes correlate age onset table 1 thus elderly symptomatic subject iii 20 onset 84 years apoe genotype epsilon3epsilon3 three affected carriers met239val mutation developed symptoms younger age onset 45 72 years moreover affected carrier iv 21 apoe genotype epsilon3epsilon4 developed symptoms age 48 years similar affected sibling iv 18 apoe genotype epsilon3epsilon3 onset 45 years table 1 fig 1 sample size small draw reliable conclusions presence absence interactions apoe genotype asn141ile mutation table 1
0.62542415.8817335.html.plaintext.txt	13	investigation ps 2 gene several newly ascertained members flo10 pedigree segregating met239val mutation ps 2 identified additional carrier mutation subject iii 20 table 1 surprisingly subject aged 87 years evidence cognitive memory impairment serial follow several years age 84 years noted become mildly demented profoundly demented mini mental status examination score 430 clinical features sustain diagnosis probable ad ninds adrda criteria review clinical data additional members extended pedigree also uncovered two subjects direct lineage family either historical evidence late onset ad subject 2 affected grandfather iii 20 died 75 years dementia currently clinical features consistent probable ad using ninds adrda criteria subject iii 39 onset 88 years others previously reported genotype apolipoprotein e gene modulate age onset alzheimers disease subjects val717ile mutation betaapp 7 8 however flo10 family met239val mutation ps 2 apoe genotypes correlate age onset table 1 thus elderly symptomatic subject iii 20 onset 84 years apoe genotype epsilon3epsilon3 three affected carriers met239val mutation developed symptoms younger age onset 45 72 years moreover affected carrier iv 21 apoe genotype epsilon3epsilon4 developed symptoms age 48 years similar affected sibling iv 18 apoe genotype epsilon3epsilon3 onset 45 years table 1 fig 1 sample size small draw reliable conclusions presence absence interactions apoe genotype asn141ile mutation table 1
0.62542415.8817335.html.plaintext.txt	14	figure 1abbreviated pedigree diagram flo10 small type face roman numerals pedigree locations subject solid symbols ad affected subjects hatched symbols risk subjects open symbols risk known age onset age death denoted arabic numerals apoe genotypes depicted exception subject iii 39 whose genotypes ps 2 apoe unknown biological samples available affected subjects carried ps 2 met239val mutation discussion
0.62542415.8817335.html.plaintext.txt	15	although large cadre fad pedigrees reported represent unbiased survey paucity missense mutations ps 2 gene amongst fad pedigrees data set suggests contrast mutations orf ps 1 mutations orf gene rare cause fad least caucasian populations confidently exclude mutations intronic sequences associated rna splice sites indeed one mutation affects splicing exon 10 ps 1 found fad affected subjects miki et al preparation however 5 utr 3 utr sequences searched pathogenic mutations cannot exclude formal possibility mutations might exist sequences pedigrees nevertheless two corollaries conclusion ps 2 orf mutations rare first unless phenotype uniquely associated least enriched subjects ps 2 mutants found screening programs mutations orf ps 2 likely low yield second importantly yet unidentified fad susceptibility loci must exist
0.62542415.8817335.html.plaintext.txt	16	although large cadre fad pedigrees reported represent unbiased survey paucity missense mutations ps 2 gene amongst fad pedigrees data set suggests contrast mutations orf ps 1 mutations orf gene rare cause fad least caucasian populations confidently exclude mutations intronic sequences associated rna splice sites indeed one mutation affects splicing exon 10 ps 1 found fad affected subjects miki et al preparation however 5 utr 3 utr sequences searched pathogenic mutations cannot exclude formal possibility mutations might exist sequences pedigrees nevertheless two corollaries conclusion ps 2 orf mutations rare first unless phenotype uniquely associated least enriched subjects ps 2 mutants found screening programs mutations orf ps 2 likely low yield second importantly yet unidentified fad susceptibility loci must exist
0.62542415.8817335.html.plaintext.txt	17	table 1 age onset relative genotypes apoe ps 2 genes subject
0.62542415.8817335.html.plaintext.txt	18	age symptom onset current age ps 2 mutation carriers displayed along subjects apoe genotype
0.62542415.8817335.html.plaintext.txt	19	conclusion drawn data age symptom onset subjects ps 2 mutations generally older 45 88 years observed ps 1 mutations 25 65 years highly variable even amongst affected members pedigree contrasts sharply experience ps 1 mutations age onset generally quite similar amongst affected members family often amongst members different families mutation 1 2 4 6 date subjects ad flo10 pedigree inherited met239val mutation unlikely late onset cases represent phenocopies andor represents polymorphism linkage disequilibrium nearby pathogenic mutation consequently parsimonious explanation single cause disease met239val mutation phenotype modified genetic environmental factors limited number subjects asn141ile mutation data set prevents rigorous conclusions interactions apoe genotype mutation however analysis larger data set bird g schellenberg also reveals obvious interaction genotypes apoe ps 2 asn141ile manuscript preparation absence close correlation apoe genotype age symptom onset subjects ps 2 mutation two implications first view parallel observations showing apparent interaction apoe genotype mutations ps 1 7 9 10 together structural amino acid sequence similarities ps 1 ps 2 proteins 1 3 likely functional effect ps 1 ps 2 mutations similar either remote functional effect apoe epsilon4 allele affect biochemical pathway leading ad different influenced apoe epsilon4 second variation age onset ps 2 mutation carriers argues modifying environmental genetic factors eg polymorphisms within presenilin genes differences genes must exist nature factors remains determined however modifying factors identified might exploitable therapeutic tool materials methods
0.62542415.8817335.html.plaintext.txt	20	conclusion drawn data age symptom onset subjects ps 2 mutations generally older 45 88 years observed ps 1 mutations 25 65 years highly variable even amongst affected members pedigree contrasts sharply experience ps 1 mutations age onset generally quite similar amongst affected members family often amongst members different families mutation 1 2 4 6 date subjects ad flo10 pedigree inherited met239val mutation unlikely late onset cases represent phenocopies andor represents polymorphism linkage disequilibrium nearby pathogenic mutation consequently parsimonious explanation single cause disease met239val mutation phenotype modified genetic environmental factors limited number subjects asn141ile mutation data set prevents rigorous conclusions interactions apoe genotype mutation however analysis larger data set bird g schellenberg also reveals obvious interaction genotypes apoe ps 2 asn141ile manuscript preparation absence close correlation apoe genotype age symptom onset subjects ps 2 mutation two implications first view parallel observations showing apparent interaction apoe genotype mutations ps 1 7 9 10 together structural amino acid sequence similarities ps 1 ps 2 proteins 1 3 likely functional effect ps 1 ps 2 mutations similar either remote functional effect apoe epsilon4 allele affect biochemical pathway leading ad different influenced apoe epsilon4 second variation age onset ps 2 mutation carriers argues modifying environmental genetic factors eg polymorphisms within presenilin genes differences genes must exist nature factors remains determined however modifying factors identified might exploitable therapeutic tool materials methods
0.62542415.8817335.html.plaintext.txt	21	subjects familially clustered alzheimers disease defined occurrence least three first second degree relatives ad recruited patients referred investigation dementia university toronto university florence massachusetts alzheimers disease research centre huddinge hospital karolinska institute french university hospitals subjects provided informed consent using institutionally approved protocols diagnosis ad made affected pedigree members direct clinical examination standard laboratory procedures met exceeded stringency nincds adrda criteria 11 12 evidence ad deceased family members ascertained investigation medical family records previously described 13 additional fad pedigree samples obtained cornell institute camden nj n 4 indiana university alzheimers disease dna bank indianapolis n 6
0.62542415.8817335.html.plaintext.txt	22	subjects familially clustered alzheimers disease defined occurrence least three first second degree relatives ad recruited patients referred investigation dementia university toronto university florence massachusetts alzheimers disease research centre huddinge hospital karolinska institute french university hospitals subjects provided informed consent using institutionally approved protocols diagnosis ad made affected pedigree members direct clinical examination standard laboratory procedures met exceeded stringency nincds adrda criteria 11 12 evidence ad deceased family members ascertained investigation medical family records previously described 13 additional fad pedigree samples obtained cornell institute camden nj n 4 indiana university alzheimers disease dna bank indianapolis n 6
0.62542415.8817335.html.plaintext.txt	23	mutations sought orf ps 1 gene 4760 pedigrees exon 16 17 betaapp gene 5160 pedigrees using methods previously described 1 14 15 ps 2 gene orf investigated north american italian pedigrees isolating complimentary dna fragments amplification using rt pcr oligonucleotide primer sequences reaction conditions previously described 2 french families rt pcr performed using primers f1 5 caggaaacagctatgaccgagctgaccctcaaatacgg f2 5 tgtaaaacgacggccagtgagatcatacacagagatgg recover codons 85 257 primers f3 5 caggaaacagctatgacctcaagtacctcccagagtgg f4 5 tgtaaaacgacggccagtagcctgtggcacaccatgtc recover codons 251 448 nucleotide sequence rt pcr products affected pedigree member determined using fluorescent dye terminator dye primer cycle sequencing mutations detected analysis resultant chromatograms heterozygous nucleotidesubstitutions using direct inspection factura ver 120 sequence navigator ver 101b15 software packages abi foster city ca
0.62542415.8817335.html.plaintext.txt	24	mutations sought orf ps 1 gene 4760 pedigrees exon 16 17 betaapp gene 5160 pedigrees using methods previously described 1 14 15 ps 2 gene orf investigated north american italian pedigrees isolating complimentary dna fragments amplification using rt pcr oligonucleotide primer sequences reaction conditions previously described 2 french families rt pcr performed using primers f1 5 caggaaacagctatgaccgagctgaccctcaaatacgg f2 5 tgtaaaacgacggccagtgagatcatacacagagatgg recover codons 85 257 primers f3 5 caggaaacagctatgacctcaagtacctcccagagtgg f4 5 tgtaaaacgacggccagtagcctgtggcacaccatgtc recover codons 251 448 nucleotide sequence rt pcr products affected pedigree member determined using fluorescent dye terminator dye primer cycle sequencing mutations detected analysis resultant chromatograms heterozygous nucleotidesubstitutions using direct inspection factura ver 120 sequence navigator ver 101b15 software packages abi foster city ca
0.62542415.8817335.html.plaintext.txt	25	presence c substitution base pair 1624 ps 2 cdna sequence gives rise met239val mutation assessed genomic dna previously described 2
0.62542415.8817335.html.plaintext.txt	26	genotypes apoe determined pcr amplification hhai digestion previously described 16 17 acknowledgements
0.62542415.8817335.html.plaintext.txt	27	work supported alzheimer association ontario canadian genetic diseases network medical research council canada american health assistance foundation national institute health scottish rite charitable foundation eva gordon memorial trust lifebeat swedish medical research council project 10819ll inserm network 492002 consiglio nazionale delle richerche pf aging 952631 ss telethon italy e304 bn glaxo canada rs helen b hunter foundation gl hc peterborough burgess fellowship ear ontario mental health foundation mep pstgh jmr scholars medical research council canada cell lines obtained indiana university alzheimers disease dna bank p30 ag10133 references 1 sherrington r rogaev e liang y et al 1995 cloning gene bearing missense mutations early onset familial alzheimers disease nature 375 754 760 medline abstract
0.62542415.8817335.html.plaintext.txt	28	work supported alzheimer association ontario canadian genetic diseases network medical research council canada american health assistance foundation national institute health scottish rite charitable foundation eva gordon memorial trust lifebeat swedish medical research council project 10819ll inserm network 492002 consiglio nazionale delle richerche pf aging 952631 ss telethon italy e304 bn glaxo canada rs helen b hunter foundation gl hc peterborough burgess fellowship ear ontario mental health foundation mep pstgh jmr scholars medical research council canada cell lines obtained indiana university alzheimers disease dna bank p30 ag10133 references 1 sherrington r rogaev e liang y et al 1995 cloning gene bearing missense mutations early onset familial alzheimers disease nature 375 754 760 medline abstract
0.62542415.8817335.html.plaintext.txt	29	6 alzheimers disease collaborative group 1995 structure presenilin gene identification six mutations early onset ad pedigrees nature genet 11 219 222
0.62542415.8817335.html.plaintext.txt	30	10 french alzheimers disease collaborative study group 1996 apolipoprotein e genotype affect age onset patients chromosome 14 encoded alzheimers disease j med genet press
0.62542415.8817335.html.plaintext.txt	31	correspondence addressed page maintained oup admin last updated thu oct 31 152515 gmt 1996 part oup journals world wide web servicecopyright oxford university press 1996
0.62542415.8817335.html.plaintext.txt	32	correspondence addressed page maintained oup admin last updated thu oct 31 152515 gmt 1996 part oup journals world wide web servicecopyright oxford university press 1996
